data_4hir_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 4hir _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.0 t . . . . . 0 N--CA 1.488 1.437 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 67.8 m-85 -126.05 -166.91 1.63 Allowed 'General case' 0 N--CA 1.499 1.981 0 C-N-CA 119.608 -0.837 . . . . 0.0 110.993 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.414 ' H ' ' HG1' ' A' ' 4' ' ' THR . 7.7 p -105.71 179.92 4.13 Favored 'General case' 0 C--O 1.199 -1.568 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.256 -179.211 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.471 ' OD1' ' N ' ' A' ' 5' ' ' ASP . 0.3 OUTLIER -83.54 156.84 22.6 Favored 'General case' 0 C--N 1.295 -1.802 0 C-N-CA 118.365 -1.334 . . . . 0.0 110.597 179.846 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.438 ' N ' ' HB2' ' A' ' 14' ' ' CYS . 0.1 OUTLIER -75.6 -178.64 4.24 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.666 178.127 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.463 ' H ' ' NE2' ' A' ' 11' ' ' GLN . 1.3 p -123.72 -20.82 5.36 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 114.953 -1.022 . . . . 0.0 109.791 176.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -162.52 162.44 27.38 Favored 'General case' 0 C--N 1.276 -2.587 0 CA-C-N 114.236 -1.347 . . . . 0.0 111.712 -178.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.87 143.07 57.97 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 115.014 -0.994 . . . . 0.0 108.753 179.439 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 108.24 -26.76 15.83 Favored Glycine 0 N--CA 1.487 2.094 1 N-CA-C 126.837 5.495 . . . . 0.0 126.837 -171.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.463 ' NE2' ' H ' ' A' ' 7' ' ' THR . 11.0 mt-30 -71.26 -171.38 0.59 Allowed 'General case' 0 N--CA 1.497 1.9 0 CA-C-N 114.642 -0.779 . . . . 0.0 109.889 178.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.453 ' O ' ' O ' ' A' ' 22' ' ' CYS . 4.3 m-20 -135.53 -69.98 0.49 Allowed 'General case' 0 N--CA 1.509 2.477 0 N-CA-C 114.558 1.318 . . . . 0.0 114.558 -175.284 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 50.9 mt -77.45 50.32 0.79 Allowed 'General case' 0 C--N 1.277 -2.565 0 C-N-CA 118.403 -1.319 . . . . 0.0 111.006 -175.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.438 ' HB2' ' N ' ' A' ' 6' ' ' CYS . 29.8 p -123.81 -161.02 0.95 Allowed 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 119.577 -0.849 . . . . 0.0 109.98 175.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.436 ' O ' ' SG ' ' A' ' 6' ' ' CYS . 39.9 mt -113.28 121.65 45.07 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.495 176.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -128.56 -31.42 2.25 Favored 'General case' 0 N--CA 1.51 2.565 0 C-N-CA 118.899 -1.121 . . . . 0.0 110.48 -179.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.418 ' O ' ' N ' ' A' ' 19' ' ' SER . 0.6 OUTLIER -87.16 82.13 7.77 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 119.09 -1.044 . . . . 0.0 108.796 177.708 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 64.94 -81.4 0.07 OUTLIER Glycine 0 N--CA 1.488 2.131 0 C-N-CA 119.23 -1.462 . . . . 0.0 109.593 -178.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.418 ' N ' ' O ' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -141.34 0.22 1.48 Allowed 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 122.018 0.914 . . . . 0.0 110.643 178.656 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -83.56 149.11 26.79 Favored 'General case' 0 C--N 1.26 -3.303 0 CA-C-N 113.84 -1.527 . . . . 0.0 110.333 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.5 t -68.56 148.19 11.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 C-N-CA 119.102 -1.039 . . . . 0.0 110.983 -178.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.56 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 0.0 OUTLIER -149.64 107.88 3.76 Favored 'General case' 0 C--N 1.287 -2.125 0 CA-C-N 114.832 -1.076 . . . . 0.0 109.852 -179.789 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.451 ' O ' ' O ' ' A' ' 26' ' ' ASN . . . 159.47 -45.04 0.44 Allowed Glycine 0 N--CA 1.489 2.183 1 N-CA-C 131.612 7.405 . . . . 0.0 131.612 -177.244 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.424 ' C ' ' H ' ' A' ' 26' ' ' ASN . 3.2 tt0 -53.88 118.81 4.27 Favored 'General case' 0 C--N 1.306 -1.296 0 C-N-CA 118.652 -1.219 . . . . 0.0 110.547 -179.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.72 -19.62 6.01 Favored Glycine 0 N--CA 1.48 1.582 0 C-N-CA 119.399 -1.381 . . . . 0.0 110.084 -179.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.451 ' O ' ' O ' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -121.15 -169.7 1.89 Allowed 'General case' 0 C--O 1.213 -0.86 0 C-N-CA 119.953 -0.699 . . . . 0.0 110.074 -179.712 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.496 ' O ' ' O ' ' A' ' 40' ' ' VAL . 21.0 ttpt -152.47 119.98 6.01 Favored 'General case' 0 N--CA 1.495 1.786 0 C-N-CA 118.573 -1.251 . . . . 0.0 110.978 177.193 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.56 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -83.75 165.63 18.7 Favored 'General case' 0 CA--C 1.476 -1.873 0 C-N-CA 117.6 -1.64 . . . . 0.0 111.805 179.228 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 7.5 mm -131.47 90.3 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.261 -3.252 0 CA-C-N 112.006 -2.361 . . . . 0.0 108.854 175.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.1 pp . . . . . 0 C--N 1.305 -1.358 0 C-N-CA 118.694 -1.202 . . . . 0.0 111.52 -177.664 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 120.615 0.245 . . . . 0.0 110.383 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 23.3 tt0 -161.82 156.0 22.12 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 119.302 -0.959 . . . . 0.0 110.394 176.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.51 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 0.1 OUTLIER -103.54 120.9 41.78 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 113.472 0.915 . . . . 0.0 113.472 179.934 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.512 ' CG2' ' N ' ' A' ' 41' ' ' THR . 2.4 p -131.44 158.75 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 CA-C-N 114.751 -1.113 . . . . 0.0 110.477 173.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.512 ' N ' ' CG2' ' A' ' 40' ' ' VAL . 0.0 OUTLIER -83.02 144.04 30.21 Favored 'General case' 0 C--N 1.278 -2.531 0 CA-C-N 114.76 -1.109 . . . . 0.0 111.755 179.995 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 177.94 -124.99 0.97 Allowed Glycine 0 N--CA 1.492 2.369 1 N-CA-C 131.092 7.197 . . . . 0.0 131.092 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -130.96 109.02 10.23 Favored 'General case' 0 N--CA 1.497 1.875 0 C-N-CA 119.998 -0.681 . . . . 0.0 110.058 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -158.12 -162.56 11.88 Favored Glycine 0 N--CA 1.494 2.535 0 C-N-CA 119.044 -1.55 . . . . 0.0 110.962 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -144.04 155.25 58.76 Favored Pre-proline 0 N--CA 1.489 1.508 0 C-N-CA 119.476 -0.89 . . . . 0.0 110.378 -179.135 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -54.46 148.8 41.31 Favored 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 121.836 1.691 . . . . 0.0 111.325 175.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.558 1.282 0 C-N-CA 119.462 -0.895 . . . . 0.0 112.57 178.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 10.5 t . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 44.5 m-85 -97.87 -168.95 1.75 Allowed 'General case' 0 C--N 1.298 -1.636 0 C-N-CA 119.095 -1.042 . . . . 0.0 110.31 -179.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.581 ' OG1' ' N ' ' A' ' 5' ' ' ASP . 0.1 OUTLIER -105.31 -178.36 3.63 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 179.543 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.581 ' N ' ' OG1' ' A' ' 4' ' ' THR . 0.3 OUTLIER -88.46 157.43 18.66 Favored 'General case' 0 C--N 1.287 -2.14 0 C-N-CA 118.559 -1.257 . . . . 0.0 110.297 179.543 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.408 ' SG ' ' CB ' ' A' ' 11' ' ' GLN . 1.5 m -73.17 176.7 5.63 Favored 'General case' 0 C--N 1.289 -2.056 0 CA-C-N 115.102 -0.953 . . . . 0.0 111.1 177.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.726 ' H ' HE22 ' A' ' 11' ' ' GLN . 1.2 p -123.56 -19.38 5.85 Favored 'General case' 0 C--N 1.289 -2.054 0 CA-C-N 113.792 -1.549 . . . . 0.0 109.793 176.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.42 ' H ' ' NE2' ' A' ' 11' ' ' GLN . 3.5 pt-20 -163.12 163.24 25.81 Favored 'General case' 0 C--N 1.269 -2.917 0 CA-C-N 113.824 -1.535 . . . . 0.0 110.46 178.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.423 ' HA ' ' H ' ' A' ' 30' ' ' LEU . 0.7 OUTLIER -66.58 159.93 26.39 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.982 -177.828 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.44 -23.42 32.15 Favored Glycine 0 N--CA 1.507 3.426 0 C-N-CA 119.282 -1.437 . . . . 0.0 112.03 -179.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.726 HE22 ' H ' ' A' ' 7' ' ' THR . 2.5 mt-30 -62.22 -166.08 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.266 0 C-N-CA 119.765 -0.774 . . . . 0.0 111.163 -178.605 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.528 ' N ' ' O ' ' A' ' 45' ' ' THR . 22.5 t-20 -144.2 -78.94 0.2 Allowed 'General case' 0 N--CA 1.502 2.158 0 N-CA-C 114.629 1.344 . . . . 0.0 114.629 -176.187 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.464 ' O ' ' OE2' ' A' ' 47' ' ' GLU . 87.1 mt -75.25 48.66 0.43 Allowed 'General case' 0 C--N 1.275 -2.672 0 C-N-CA 118.597 -1.241 . . . . 0.0 111.072 -173.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.654 ' SG ' ' N ' ' A' ' 15' ' ' LEU . 7.8 p -120.91 -151.87 0.49 Allowed 'General case' 0 N--CA 1.497 1.92 0 C-N-CA 119.183 -1.007 . . . . 0.0 110.729 177.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.654 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 7.7 mt -123.6 133.21 53.98 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 114.179 -1.373 . . . . 0.0 110.395 179.266 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.7 m -120.59 -68.1 0.93 Allowed 'General case' 0 N--CA 1.503 2.181 0 C-N-CA 119.306 -0.957 . . . . 0.0 110.401 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -84.55 88.0 7.29 Favored 'General case' 0 C--N 1.298 -1.65 0 C-N-CA 119.178 -1.009 . . . . 0.0 110.143 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 70.25 -123.69 12.57 Favored Glycine 0 N--CA 1.487 2.064 0 C-N-CA 119.562 -1.304 . . . . 0.0 111.21 178.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.406 ' O ' ' OG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -98.87 1.93 46.19 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 121.871 0.843 . . . . 0.0 110.974 -177.713 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -79.61 128.18 33.07 Favored 'General case' 0 C--N 1.253 -3.611 0 CA-C-N 114.003 -1.453 . . . . 0.0 110.726 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -78.59 148.75 5.98 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.026 0 C-N-CA 119.088 -1.045 . . . . 0.0 109.495 179.112 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.462 ' O ' ' O ' ' A' ' 12' ' ' ASN . 3.2 m -148.13 122.84 9.89 Favored 'General case' 0 C--N 1.285 -2.218 0 C-N-CA 118.418 -1.313 . . . . 0.0 110.547 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.488 ' O ' ' N ' ' A' ' 26' ' ' ASN . . . 170.66 -87.6 0.09 OUTLIER Glycine 0 C--O 1.197 -2.173 0 C-N-CA 118.425 -1.845 . . . . 0.0 111.76 -177.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.447 ' N ' ' OD1' ' A' ' 12' ' ' ASN . 43.2 tt0 -40.08 128.47 2.22 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 120.08 -0.648 . . . . 0.0 111.283 -177.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.478 ' C ' ' ND2' ' A' ' 26' ' ' ASN . . . 90.07 -24.08 17.7 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 109.012 -1.635 . . . . 0.0 109.012 -177.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.488 ' N ' ' O ' ' A' ' 23' ' ' GLY . 2.3 m-80 -143.79 -162.33 1.44 Allowed 'General case' 0 N--CA 1.493 1.713 0 CA-C-N 114.773 -0.713 . . . . 0.0 109.737 179.311 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.469 ' O ' ' O ' ' A' ' 40' ' ' VAL . 0.5 OUTLIER -139.06 143.48 38.39 Favored 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 119.646 -0.822 . . . . 0.0 109.035 175.786 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -89.66 160.99 16.34 Favored 'General case' 0 C--N 1.298 -1.657 0 C-N-CA 117.719 -1.593 . . . . 0.0 111.101 179.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 20.1 mm -147.54 94.28 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.255 -3.521 0 CA-C-N 112.523 -2.126 . . . . 0.0 108.496 176.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.423 ' H ' ' HA ' ' A' ' 9' ' ' SER . 1.8 pp . . . . . 0 N--CA 1.484 1.236 0 C-N-CA 118.815 -1.154 . . . . 0.0 112.501 -176.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 . . . . . 0 N--CA 1.481 1.098 0 CA-C-O 120.656 0.265 . . . . 0.0 111.114 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.414 ' CG ' ' N ' ' A' ' 39' ' ' CYS . 10.8 tt0 -161.71 157.49 24.48 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 119.179 -1.008 . . . . 0.0 111.11 179.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.414 ' N ' ' CG ' ' A' ' 38' ' ' GLN . 7.1 m -109.39 94.89 5.27 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.799 178.39 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.469 ' O ' ' O ' ' A' ' 27' ' ' LYS . 0.5 OUTLIER -102.54 145.59 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.568 0 C-N-CA 118.712 -1.195 . . . . 0.0 112.736 -177.892 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.5 t -66.18 143.85 57.01 Favored 'General case' 0 C--N 1.285 -2.235 0 CA-C-N 114.061 -1.427 . . . . 0.0 111.52 177.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 152.23 -159.27 28.28 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -179.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.401 ' O ' ' CG ' ' A' ' 43' ' ' GLU . 5.8 pt-20 -104.93 113.41 26.99 Favored 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 119.546 -0.861 . . . . 0.0 110.273 179.561 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -114.39 -168.54 16.17 Favored Glycine 0 N--CA 1.5 2.913 0 C-N-CA 120.053 -1.07 . . . . 0.0 110.555 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.528 ' O ' ' N ' ' A' ' 12' ' ' ASN . 0.5 OUTLIER -141.72 148.6 50.32 Favored Pre-proline 0 N--CA 1.493 1.676 0 C-N-CA 119.55 -0.86 . . . . 0.0 110.421 -179.767 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -57.17 167.72 3.16 Favored 'Trans proline' 0 C--O 1.214 -0.683 0 C-N-CA 121.724 1.616 . . . . 0.0 111.949 179.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.55 ' CD ' ' H ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.524 0 C-N-CA 119.544 -0.863 . . . . 0.0 109.971 179.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.424 HG11 ' H ' ' A' ' 3' ' ' TYR . 1.5 t . . . . . 0 N--CA 1.486 1.326 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.424 ' H ' HG11 ' A' ' 2' ' ' VAL . 76.9 m-85 -131.08 -161.91 1.17 Allowed 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 119.865 -0.734 . . . . 0.0 111.301 -178.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.495 ' H ' ' HG1' ' A' ' 4' ' ' THR . 0.2 OUTLIER -98.07 -176.82 3.54 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.024 179.937 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.509 ' N ' ' OD1' ' A' ' 5' ' ' ASP . 0.1 OUTLIER -97.48 156.54 16.44 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.139 -1.025 . . . . 0.0 110.493 178.127 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.503 ' SG ' ' O ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -74.91 151.7 38.89 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.518 177.857 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.444 ' O ' ' CG2' ' A' ' 7' ' ' THR . 1.4 m -116.65 -3.94 11.73 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 119.68 -0.808 . . . . 0.0 111.114 178.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -160.34 178.2 9.84 Favored 'General case' 0 C--N 1.275 -2.647 0 CA-C-N 114.785 -1.098 . . . . 0.0 110.906 -179.289 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.401 ' HB3' ' H ' ' A' ' 30' ' ' LEU . 0.3 OUTLIER -79.27 140.64 37.54 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.912 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.44 ' O ' ' O ' ' A' ' 11' ' ' GLN . . . 98.65 -16.97 59.03 Favored Glycine 0 N--CA 1.507 3.369 1 N-CA-C 128.641 6.216 . . . . 0.0 128.641 -174.525 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.44 ' O ' ' O ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -51.89 -169.04 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 114.471 -0.864 . . . . 0.0 110.984 179.742 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.509 ' C ' ' H ' ' A' ' 14' ' ' CYS . 15.8 t-20 -140.68 -83.22 0.23 Allowed 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 118.486 -1.286 . . . . 0.0 113.044 -179.07 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.451 ' O ' ' OE2' ' A' ' 47' ' ' GLU . 60.6 mt -75.42 45.28 0.29 Allowed 'General case' 0 C--N 1.276 -2.627 0 C-N-CA 117.71 -1.596 . . . . 0.0 109.916 -175.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.509 ' H ' ' C ' ' A' ' 12' ' ' ASN . 31.1 p -109.23 -158.16 0.64 Allowed 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 119.318 -0.953 . . . . 0.0 109.362 178.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.503 ' O ' ' SG ' ' A' ' 6' ' ' CYS . 6.0 mt -124.09 129.49 50.96 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.336 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 89.8 m -120.91 -65.95 1.1 Allowed 'General case' 0 N--CA 1.502 2.127 0 C-N-CA 119.408 -0.917 . . . . 0.0 111.498 -177.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -79.56 85.48 5.3 Favored 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 118.87 -1.132 . . . . 0.0 110.816 -178.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 72.54 -92.55 0.6 Allowed Glycine 0 N--CA 1.491 2.326 0 C-N-CA 119.526 -1.321 . . . . 0.0 110.827 179.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.448 ' O ' ' OG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -133.58 4.55 3.65 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-O 122.264 1.031 . . . . 0.0 110.463 -178.931 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 28.0 m-80 -80.54 130.46 35.15 Favored 'General case' 0 C--N 1.254 -3.577 0 CA-C-N 113.485 -1.689 . . . . 0.0 109.787 178.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.4 t -69.8 149.24 10.79 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 C-N-CA 119.195 -1.002 . . . . 0.0 110.547 -179.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.452 ' O ' ' O ' ' A' ' 12' ' ' ASN . 12.7 m -145.82 116.17 7.53 Favored 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 118.453 -1.299 . . . . 0.0 110.419 177.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 26' ' ' ASN . . . 170.39 -68.08 0.15 Allowed Glycine 0 C--O 1.203 -1.793 0 C-N-CA 118.261 -1.923 . . . . 0.0 112.598 -177.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -56.91 111.61 1.08 Allowed 'General case' 0 C--N 1.298 -1.65 0 C-N-CA 118.917 -1.113 . . . . 0.0 110.827 -177.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.418 ' C ' ' ND2' ' A' ' 26' ' ' ASN . . . 99.27 -14.77 60.88 Favored Glycine 0 N--CA 1.484 1.844 0 N-CA-C 109.959 -1.256 . . . . 0.0 109.959 -179.022 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.463 ' O ' ' O ' ' A' ' 23' ' ' GLY . 8.6 m-80 -149.3 -167.72 2.91 Favored 'General case' 0 N--CA 1.494 1.762 0 C-N-CA 119.255 -0.978 . . . . 0.0 111.409 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.513 ' CG ' ' N ' ' A' ' 28' ' ' CYS . 12.6 tttp -134.61 165.17 25.84 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.155 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.513 ' N ' ' CG ' ' A' ' 27' ' ' LYS . 0.1 OUTLIER -127.4 160.3 31.83 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 118.889 -1.124 . . . . 0.0 110.686 177.968 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 7.7 mm -138.85 126.75 27.6 Favored 'Isoleucine or valine' 0 C--N 1.255 -3.506 0 CA-C-N 113.088 -1.869 . . . . 0.0 109.639 177.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.401 ' H ' ' HB3' ' A' ' 9' ' ' SER . 19.5 mt . . . . . 0 N--CA 1.495 1.792 0 C-N-CA 118.28 -1.368 . . . . 0.0 110.307 178.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.5 ' OD1' ' N ' ' A' ' 37' ' ' ASN . 0.1 OUTLIER . . . . . 0 N--CA 1.485 1.307 0 CA-C-O 121.258 0.551 . . . . 0.0 111.678 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -159.2 152.92 22.98 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.286 175.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 9.6 m -112.14 112.48 24.12 Favored 'General case' 0 C--N 1.298 -1.66 0 C-N-CA 119.729 -0.788 . . . . 0.0 111.737 -177.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.465 ' O ' ' O ' ' A' ' 27' ' ' LYS . 1.3 p -123.43 140.82 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.323 0 C-N-CA 118.745 -1.182 . . . . 0.0 112.668 177.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.5 t -41.28 157.44 0.02 OUTLIER 'General case' 0 C--N 1.283 -2.304 0 CA-C-N 113.371 -1.74 . . . . 0.0 111.255 178.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.433 ' O ' ' OE1' ' A' ' 43' ' ' GLU . . . 150.04 -120.43 1.14 Allowed Glycine 0 N--CA 1.49 2.275 1 N-CA-C 130.274 6.87 . . . . 0.0 130.274 179.557 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.433 ' OE1' ' O ' ' A' ' 42' ' ' GLY . 1.3 tp10 -154.34 104.53 2.6 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 119.37 -0.932 . . . . 0.0 109.974 179.161 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -128.57 179.94 16.29 Favored Glycine 0 N--CA 1.495 2.579 0 C-N-CA 119.867 -1.158 . . . . 0.0 110.695 -179.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -130.54 153.65 81.48 Favored Pre-proline 0 N--CA 1.495 1.817 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -53.16 163.97 2.02 Favored 'Trans proline' 0 C--O 1.214 -0.688 0 C-N-CA 121.153 1.236 . . . . 0.0 110.477 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.557 ' CD ' ' H ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.534 0 C-N-CA 118.911 -1.116 . . . . 0.0 109.755 -179.383 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.8 t . . . . . 0 N--CA 1.484 1.229 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -112.29 -166.09 1.05 Allowed 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 119.986 -0.686 . . . . 0.0 109.666 179.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.474 ' H ' ' HG1' ' A' ' 4' ' ' THR . 2.9 p -97.51 177.75 5.41 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 178.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.405 ' O ' ' OE2' ' A' ' 47' ' ' GLU . 0.2 OUTLIER -88.46 155.51 19.63 Favored 'General case' 0 C--N 1.293 -1.864 0 C-N-CA 118.458 -1.297 . . . . 0.0 110.066 178.583 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.42 ' SG ' ' O ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -75.4 166.66 23.26 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.693 178.108 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 14.0 p -133.95 2.33 3.37 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 119.431 -0.908 . . . . 0.0 110.39 177.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -162.52 -178.7 6.41 Favored 'General case' 0 C--N 1.28 -2.435 0 CA-C-N 114.631 -1.168 . . . . 0.0 111.253 178.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.414 ' H ' ' HG ' ' A' ' 9' ' ' SER . 0.4 OUTLIER -82.27 158.71 23.38 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.535 -178.215 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.498 ' N ' ' O ' ' A' ' 28' ' ' CYS . . . 82.87 -18.0 18.44 Favored Glycine 0 N--CA 1.497 2.706 0 C-N-CA 119.853 -1.165 . . . . 0.0 112.573 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.645 ' H ' HE21 ' A' ' 11' ' ' GLN . 0.9 OUTLIER -53.05 170.35 0.08 Allowed 'General case' 0 N--CA 1.501 2.12 0 C-N-CA 119.03 -1.068 . . . . 0.0 110.226 -179.948 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.535 ' C ' ' H ' ' A' ' 14' ' ' CYS . 22.0 m-20 -144.56 -63.42 0.36 Allowed 'General case' 0 N--CA 1.499 2.011 0 C-N-CA 118.317 -1.353 . . . . 0.0 113.433 -179.088 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 49.7 mt -76.5 41.85 0.26 Allowed 'General case' 0 C--N 1.287 -2.136 0 C-N-CA 119.011 -1.076 . . . . 0.0 109.811 -177.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.535 ' H ' ' C ' ' A' ' 12' ' ' ASN . 31.6 p -121.94 -157.67 0.74 Allowed 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 114.906 -1.043 . . . . 0.0 108.801 177.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.42 ' O ' ' SG ' ' A' ' 6' ' ' CYS . 40.6 mt -108.7 107.12 17.45 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 115.21 -0.904 . . . . 0.0 108.679 175.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 68.4 m -96.32 -74.29 0.57 Allowed 'General case' 0 C--N 1.278 -2.532 0 CA-C-N 114.167 -1.379 . . . . 0.0 111.235 -174.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -84.73 115.62 22.79 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 118.601 -1.239 . . . . 0.0 110.102 179.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 66.42 -107.69 2.09 Favored Glycine 0 N--CA 1.489 2.193 0 C-N-CA 119.324 -1.417 . . . . 0.0 110.448 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.416 ' O ' ' OG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -134.6 4.68 3.38 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-O 122.197 0.999 . . . . 0.0 110.185 -179.804 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -79.13 152.87 30.51 Favored 'General case' 0 C--N 1.261 -3.281 0 CA-C-N 113.431 -1.713 . . . . 0.0 110.607 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.2 t -85.9 142.39 13.2 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 C-N-CA 119.195 -1.002 . . . . 0.0 112.117 -177.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.454 ' O ' ' O ' ' A' ' 12' ' ' ASN . 0.1 OUTLIER -99.96 150.32 22.53 Favored 'General case' 0 N--CA 1.508 2.457 0 CA-C-N 114.964 -1.016 . . . . 0.0 108.94 169.295 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.448 ' O ' ' C ' ' A' ' 24' ' ' GLN . . . -113.81 110.81 2.51 Favored Glycine 0 CA--C 1.482 -2.031 0 C-N-CA 119.652 -1.261 . . . . 0.0 110.487 -169.118 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.448 ' C ' ' O ' ' A' ' 23' ' ' GLY . 4.2 tt0 -32.93 117.29 0.25 Allowed 'General case' 0 C--N 1.252 -3.64 0 CA-C-N 111.974 -2.113 . . . . 0.0 109.941 175.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 146.28 -25.69 1.71 Allowed Glycine 0 C--N 1.283 -2.401 0 N-CA-C 105.005 -3.238 . . . . 0.0 105.005 -174.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.539 ' N ' ' OD1' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -110.72 -172.39 2.02 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 113.208 -1.496 . . . . 0.0 107.292 175.056 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.462 ' O ' ' O ' ' A' ' 40' ' ' VAL . 21.9 tttm -144.18 108.86 4.9 Favored 'General case' 0 N--CA 1.502 2.133 0 C-N-CA 118.512 -1.275 . . . . 0.0 110.933 178.217 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.562 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 3.6 m -84.17 152.2 24.41 Favored 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 117.722 -1.591 . . . . 0.0 110.136 178.075 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.438 ' CD1' ' NZ ' ' A' ' 27' ' ' LYS . 2.1 mm -127.68 131.0 70.38 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.288 0 CA-C-N 114.382 -1.281 . . . . 0.0 109.39 177.212 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 17.5 mt . . . . . 0 N--CA 1.497 1.909 0 C-N-CA 118.471 -1.292 . . . . 0.0 110.162 178.474 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.0 p30 . . . . . 0 C--O 1.214 -0.778 0 CA-C-O 121.558 0.694 . . . . 0.0 111.815 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -155.37 149.72 26.01 Favored 'General case' 0 C--N 1.295 -1.782 0 CA-C-N 114.828 -1.078 . . . . 0.0 108.982 176.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.562 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 1.3 m -107.92 93.32 4.47 Favored 'General case' 0 C--N 1.296 -1.741 0 C-N-CA 119.608 -0.837 . . . . 0.0 111.2 -177.507 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.462 ' O ' ' O ' ' A' ' 27' ' ' LYS . 0.9 OUTLIER -107.7 143.41 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.31 0 C-N-CA 118.816 -1.154 . . . . 0.0 110.759 179.027 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.1 t -50.94 157.89 0.77 Allowed 'General case' 0 C--N 1.274 -2.697 0 CA-C-N 114.31 -1.314 . . . . 0.0 111.036 -178.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 153.52 -154.97 25.86 Favored Glycine 0 N--CA 1.492 2.424 0 C-N-CA 119.528 -1.32 . . . . 0.0 110.748 179.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -122.83 67.52 0.97 Allowed 'General case' 0 N--CA 1.498 1.947 0 C-N-CA 120.039 -0.664 . . . . 0.0 110.215 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -74.01 173.34 50.56 Favored Glycine 0 N--CA 1.491 2.346 0 C-N-CA 119.425 -1.369 . . . . 0.0 110.523 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -106.22 145.56 31.21 Favored Pre-proline 0 N--CA 1.491 1.616 0 C-N-CA 119.679 -0.808 . . . . 0.0 109.527 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -62.63 130.85 31.15 Favored 'Trans proline' 0 C--O 1.216 -0.615 0 C-N-CA 120.901 1.067 . . . . 0.0 110.872 176.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.431 ' OE1' ' OG1' ' A' ' 4' ' ' THR . 1.0 OUTLIER . . . . . 0 C--N 1.3 -1.566 0 C-N-CA 119.547 -0.861 . . . . 0.0 110.362 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.7 t . . . . . 0 N--CA 1.496 1.872 0 CA-C-O 120.696 0.284 . . . . 0.0 111.143 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -123.94 -173.69 2.81 Favored 'General case' 0 N--CA 1.5 2.026 0 C-N-CA 119.931 -0.707 . . . . 0.0 110.652 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -101.52 173.0 6.63 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 115.171 -0.922 . . . . 0.0 108.557 178.241 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.531 ' N ' ' OD1' ' A' ' 5' ' ' ASP . 0.0 OUTLIER -91.06 152.23 20.72 Favored 'General case' 0 C--N 1.294 -1.826 0 C-N-CA 118.489 -1.285 . . . . 0.0 108.877 176.684 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.3 m -75.41 179.88 4.95 Favored 'General case' 0 C--N 1.29 -2.018 0 C-N-CA 119.221 -0.992 . . . . 0.0 111.019 179.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.1 t -150.56 16.84 0.8 Allowed 'General case' 0 C--N 1.281 -2.412 0 CA-C-N 113.601 -1.636 . . . . 0.0 109.393 177.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -159.42 175.08 13.75 Favored 'General case' 0 C--N 1.29 -1.991 0 CA-C-N 114.443 -1.253 . . . . 0.0 110.643 -178.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -76.88 -170.27 1.56 Allowed 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.265 179.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.559 ' N ' ' O ' ' A' ' 28' ' ' CYS . . . 26.1 18.23 0.0 OUTLIER Glycine 0 N--CA 1.503 3.126 1 N-CA-C 130.913 7.125 . . . . 0.0 130.913 178.974 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -87.76 -166.88 1.71 Allowed 'General case' 0 N--CA 1.503 2.216 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 176.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.52 ' C ' ' H ' ' A' ' 14' ' ' CYS . 10.6 m120 -151.48 -55.5 0.14 Allowed 'General case' 0 N--CA 1.503 2.183 0 N-CA-C 116.612 2.078 . . . . 0.0 116.612 -178.366 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 24.3 mt -75.79 41.7 0.22 Allowed 'General case' 0 C--N 1.29 -1.981 0 C-N-CA 118.134 -1.426 . . . . 0.0 110.716 -174.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.52 ' H ' ' C ' ' A' ' 12' ' ' ASN . 30.5 p -124.21 -148.23 0.39 Allowed 'General case' 0 C--N 1.288 -2.073 0 CA-C-N 114.817 -1.083 . . . . 0.0 108.298 176.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 6.2 mt -119.21 110.72 17.35 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 176.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 55.9 m -104.56 -61.51 1.45 Allowed 'General case' 0 C--N 1.281 -2.396 0 CA-C-N 114.009 -1.45 . . . . 0.0 112.085 -172.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -96.27 94.52 7.52 Favored 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 118.76 -1.176 . . . . 0.0 110.392 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 73.15 -108.93 2.64 Favored Glycine 0 N--CA 1.492 2.378 0 C-N-CA 119.467 -1.349 . . . . 0.0 110.788 179.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.402 ' O ' ' OG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -119.29 1.82 11.31 Favored 'General case' 0 CA--C 1.492 -1.286 0 CA-C-O 122.34 1.067 . . . . 0.0 109.896 -179.358 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -78.52 127.74 32.58 Favored 'General case' 0 C--N 1.257 -3.454 0 CA-C-N 113.204 -1.816 . . . . 0.0 109.758 179.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -78.33 137.97 21.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 C-N-CA 118.961 -1.096 . . . . 0.0 110.103 179.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.549 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 0.1 OUTLIER -86.66 146.22 26.39 Favored 'General case' 0 C--N 1.283 -2.289 0 C-N-CA 118.29 -1.364 . . . . 0.0 109.589 173.186 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.488 ' O ' ' ND2' ' A' ' 26' ' ' ASN . . . -116.07 104.42 1.27 Allowed Glycine 0 C--N 1.296 -1.656 0 N-CA-C 108.809 -1.716 . . . . 0.0 108.809 -174.193 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.444 ' C ' ' O ' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -31.86 124.52 0.27 Allowed 'General case' 0 C--N 1.26 -3.29 0 CA-C-N 112.632 -1.784 . . . . 0.0 110.941 179.186 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 140.79 -23.25 2.64 Favored Glycine 0 C--N 1.29 -1.972 0 N-CA-C 105.139 -3.184 . . . . 0.0 105.139 -173.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.509 ' OD1' ' N ' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -111.41 -162.29 0.79 Allowed 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 112.907 -1.647 . . . . 0.0 107.282 175.601 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.538 ' O ' ' N ' ' A' ' 40' ' ' VAL . 14.9 tttp -144.6 147.54 33.27 Favored 'General case' 0 C--N 1.297 -1.703 0 C-N-CA 118.661 -1.216 . . . . 0.0 109.949 175.317 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.559 ' O ' ' N ' ' A' ' 10' ' ' GLY . 56.6 m -111.99 157.53 20.61 Favored 'General case' 0 CA--C 1.483 -1.603 0 C-N-CA 118.711 -1.195 . . . . 0.0 109.775 177.29 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 11.3 mm -140.05 126.96 23.24 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.7 0 CA-C-N 114.629 -1.169 . . . . 0.0 109.954 175.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 15.3 mt . . . . . 0 N--CA 1.496 1.856 0 C-N-CA 118.671 -1.212 . . . . 0.0 110.094 178.925 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.645 ' ND2' ' N ' ' A' ' 38' ' ' GLN . 0.3 OUTLIER . . . . . 0 C--O 1.216 -0.672 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.645 ' N ' ' ND2' ' A' ' 37' ' ' ASN . 23.5 tt0 -140.59 155.75 46.48 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 119.447 -0.901 . . . . 0.0 110.773 -179.636 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.419 ' N ' ' CG ' ' A' ' 38' ' ' GLN . 1.5 m -101.47 89.03 3.6 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 119.662 -0.815 . . . . 0.0 110.843 -179.191 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.538 ' N ' ' O ' ' A' ' 27' ' ' LYS . 0.3 OUTLIER -94.87 141.71 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.675 0 C-N-CA 118.299 -1.36 . . . . 0.0 112.029 179.835 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.5 t -54.13 145.4 17.22 Favored 'General case' 0 C--N 1.276 -2.59 0 CA-C-N 114.661 -1.154 . . . . 0.0 110.633 -179.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 157.81 -173.43 35.12 Favored Glycine 0 N--CA 1.494 2.536 0 C-N-CA 119.164 -1.493 . . . . 0.0 110.778 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -111.23 122.16 47.16 Favored 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 120.081 -0.648 . . . . 0.0 110.362 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -138.41 -145.28 4.8 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 179.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -139.81 153.2 69.66 Favored Pre-proline 0 N--CA 1.491 1.607 0 C-N-CA 119.59 -0.844 . . . . 0.0 109.997 179.43 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -60.48 -169.25 0.05 OUTLIER 'Trans proline' 0 C--O 1.216 -0.622 0 C-N-CA 121.417 1.412 . . . . 0.0 111.515 178.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.437 ' OE2' ' O ' ' A' ' 5' ' ' ASP . 3.8 tt0 . . . . . 0 C--N 1.312 -1.036 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.043 179.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.6 t . . . . . 0 N--CA 1.489 1.498 0 CA-C-O 121.06 0.457 . . . . 0.0 110.081 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -150.56 -169.91 3.51 Favored 'General case' 0 C--N 1.297 -1.7 0 C-N-CA 119.774 -0.77 . . . . 0.0 109.808 179.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.552 ' OG1' ' N ' ' A' ' 5' ' ' ASP . 0.0 OUTLIER -109.76 174.97 5.62 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 177.891 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.552 ' N ' ' OG1' ' A' ' 4' ' ' THR . 0.2 OUTLIER -84.2 151.24 24.96 Favored 'General case' 0 C--N 1.28 -2.456 0 C-N-CA 118.106 -1.438 . . . . 0.0 110.322 -178.199 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.42 ' SG ' ' CB ' ' A' ' 11' ' ' GLN . 0.1 OUTLIER -76.65 -176.79 3.94 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-O 122.147 0.975 . . . . 0.0 111.756 178.62 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.3 p -157.02 15.87 0.28 Allowed 'General case' 0 C--N 1.283 -2.292 0 CA-C-N 113.391 -1.731 . . . . 0.0 109.709 177.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.421 ' N ' HE22 ' A' ' 11' ' ' GLN . 2.0 mt-10 -163.24 174.3 12.27 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-N 114.935 -1.03 . . . . 0.0 111.513 179.247 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.437 ' C ' ' H ' ' A' ' 11' ' ' GLN . 0.4 OUTLIER -88.38 170.06 11.27 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.175 -178.21 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.456 ' O ' ' O ' ' A' ' 11' ' ' GLN . . . 73.44 -33.54 0.82 Allowed Glycine 0 N--CA 1.504 3.197 0 C-N-CA 119.668 -1.253 . . . . 0.0 112.378 177.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.456 ' O ' ' O ' ' A' ' 10' ' ' GLY . 12.4 mt-30 -51.8 -173.6 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.241 0 C-N-CA 119.507 -0.877 . . . . 0.0 110.153 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.523 ' C ' ' H ' ' A' ' 14' ' ' CYS . 1.6 m120 -158.85 -51.88 0.06 Allowed 'General case' 0 N--CA 1.503 2.176 0 C-N-CA 117.043 -1.863 . . . . 0.0 115.29 -179.199 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 67.1 mt -76.49 40.1 0.22 Allowed 'General case' 0 C--N 1.288 -2.091 0 C-N-CA 118.642 -1.223 . . . . 0.0 110.639 -175.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.523 ' H ' ' C ' ' A' ' 12' ' ' ASN . 10.0 p -124.76 -158.36 0.82 Allowed 'General case' 0 C--N 1.29 -1.995 0 CA-C-N 114.502 -1.226 . . . . 0.0 108.831 178.21 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 6.6 mt -109.91 116.17 31.15 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 119.65 -0.82 . . . . 0.0 110.662 178.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -111.93 -68.96 0.89 Allowed 'General case' 0 C--N 1.295 -1.786 0 CA-C-N 114.403 -1.271 . . . . 0.0 110.838 -177.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -79.38 99.01 6.97 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 119.585 -0.846 . . . . 0.0 110.376 -179.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.0 -113.56 5.48 Favored Glycine 0 N--CA 1.486 1.975 0 C-N-CA 119.408 -1.377 . . . . 0.0 110.451 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.422 ' O ' ' OG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -111.71 3.78 18.05 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-O 122.43 1.11 . . . . 0.0 109.694 -179.544 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -78.5 129.27 34.67 Favored 'General case' 0 C--N 1.256 -3.491 0 CA-C-N 113.229 -1.805 . . . . 0.0 110.248 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -78.36 144.06 11.77 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 C-N-CA 118.993 -1.083 . . . . 0.0 110.349 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.6 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 0.1 OUTLIER -90.97 143.97 26.15 Favored 'General case' 0 C--N 1.286 -2.166 0 C-N-CA 118.813 -1.155 . . . . 0.0 110.621 173.325 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.658 ' O ' ' N ' ' A' ' 25' ' ' GLY . . . -113.63 110.47 2.46 Favored Glycine 0 CA--C 1.486 -1.779 0 N-CA-C 107.844 -2.102 . . . . 0.0 107.844 -174.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -37.36 -5.2 0.0 OUTLIER 'General case' 0 C--N 1.254 -3.565 0 CA-C-N 112.521 -1.84 . . . . 0.0 114.491 178.576 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.658 ' N ' ' O ' ' A' ' 23' ' ' GLY . . . -69.27 -9.57 61.02 Favored Glycine 0 C--N 1.263 -3.498 0 N-CA-C 106.695 -2.562 . . . . 0.0 106.695 173.332 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 47.2 m-20 -135.41 -167.3 1.99 Allowed 'General case' 0 N--CA 1.485 1.309 0 CA-C-N 113.594 -1.303 . . . . 0.0 108.069 178.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.555 ' N ' ' O ' ' A' ' 40' ' ' VAL . 0.2 OUTLIER -123.12 166.84 14.51 Favored 'General case' 0 N--CA 1.503 2.217 0 C-N-CA 119.578 -0.849 . . . . 0.0 110.923 179.756 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.6 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 0.6 OUTLIER -136.34 154.89 50.71 Favored 'General case' 0 CA--C 1.472 -2.023 0 CA-C-O 122.203 1.002 . . . . 0.0 110.016 175.492 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 26.4 mm -145.56 127.78 9.19 Favored 'Isoleucine or valine' 1 C--N 1.24 -4.182 0 CA-C-N 113.083 -1.872 . . . . 0.0 109.528 177.098 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.407 ' H ' ' HB3' ' A' ' 9' ' ' SER . 17.6 mt . . . . . 0 N--CA 1.49 1.559 0 C-N-CA 118.467 -1.293 . . . . 0.0 110.429 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.548 ' OD1' ' N ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.474 0.756 0 CA-C-O 120.817 0.342 . . . . 0.0 110.176 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -156.74 152.41 26.97 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 119.143 -1.023 . . . . 0.0 110.511 176.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.575 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 0.9 OUTLIER -125.42 87.65 2.74 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.562 -179.793 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.555 ' O ' ' N ' ' A' ' 27' ' ' LYS . 2.4 p -111.35 146.77 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.621 0 C-N-CA 118.447 -1.301 . . . . 0.0 112.773 -179.289 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.407 ' N ' ' CG2' ' A' ' 40' ' ' VAL . 6.1 t -43.76 161.48 0.02 OUTLIER 'General case' 0 C--N 1.285 -2.226 0 CA-C-N 113.328 -1.76 . . . . 0.0 112.035 178.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 120.93 143.55 6.76 Favored Glycine 0 N--CA 1.497 2.76 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -84.57 131.86 34.58 Favored 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 119.188 -1.005 . . . . 0.0 111.1 -178.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -131.79 -156.2 8.3 Favored Glycine 0 N--CA 1.496 2.668 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 179.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.428 ' O ' ' CG2' ' A' ' 45' ' ' THR . 14.4 t -102.48 127.87 29.45 Favored Pre-proline 0 N--CA 1.493 1.681 0 C-N-CA 119.476 -0.89 . . . . 0.0 110.351 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.431 ' O ' ' C ' ' A' ' 47' ' ' GLU . 1.4 Cg_endo -64.69 115.02 2.99 Favored 'Trans proline' 0 C--O 1.214 -0.687 0 C-N-CA 120.591 0.861 . . . . 0.0 110.822 178.56 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.431 ' C ' ' O ' ' A' ' 46' ' ' PRO . 1.2 tt0 . . . . . 0 N--CA 1.503 2.212 0 C-N-CA 120.229 -0.588 . . . . 0.0 110.702 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.4 t . . . . . 0 N--CA 1.489 1.491 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -107.72 -167.38 1.25 Allowed 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 119.879 -0.729 . . . . 0.0 110.505 -179.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -96.9 176.91 5.8 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 178.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.537 ' N ' ' OD1' ' A' ' 5' ' ' ASP . 0.4 OUTLIER -89.96 157.09 18.0 Favored 'General case' 0 C--N 1.293 -1.856 0 C-N-CA 118.099 -1.441 . . . . 0.0 109.19 176.984 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.496 ' SG ' ' O ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -75.58 165.89 24.39 Favored 'General case' 0 C--N 1.285 -2.223 0 C-N-CA 119.745 -0.782 . . . . 0.0 110.708 178.571 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.701 ' H ' HE22 ' A' ' 11' ' ' GLN . 2.0 t -130.94 3.5 4.42 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.231 177.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.478 ' H ' HE22 ' A' ' 11' ' ' GLN . 2.7 mm-40 -162.34 161.55 27.53 Favored 'General case' 0 C--N 1.28 -2.456 0 CA-C-N 113.671 -1.604 . . . . 0.0 110.414 -179.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.421 ' HA ' ' H ' ' A' ' 30' ' ' LEU . 0.6 OUTLIER -77.24 154.84 32.61 Favored 'General case' 0 C--N 1.291 -1.962 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.323 -179.43 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.436 ' O ' ' O ' ' A' ' 11' ' ' GLN . . . 96.21 -33.47 5.59 Favored Glycine 0 N--CA 1.501 2.984 0 C-N-CA 119.27 -1.443 . . . . 0.0 112.296 -179.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.701 HE22 ' H ' ' A' ' 7' ' ' THR . 8.8 mt-30 -51.72 -176.63 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.181 0 C-N-CA 119.128 -1.029 . . . . 0.0 110.698 -178.475 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.517 ' O ' ' O ' ' A' ' 22' ' ' CYS . 1.5 m-20 -144.64 -64.4 0.35 Allowed 'General case' 0 N--CA 1.5 2.059 0 C-N-CA 118.45 -1.3 . . . . 0.0 113.97 -176.202 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 85.2 mt -76.87 50.05 0.69 Allowed 'General case' 0 C--N 1.271 -2.809 0 C-N-CA 117.596 -1.642 . . . . 0.0 110.101 -176.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.564 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 29.7 p -125.56 -152.01 0.5 Allowed 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.011 -0.995 . . . . 0.0 108.684 177.59 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.496 ' O ' ' SG ' ' A' ' 6' ' ' CYS . 76.0 mt -117.37 117.23 28.94 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 115.179 -0.919 . . . . 0.0 108.918 176.365 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.564 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 1.5 m -126.36 17.35 7.67 Favored 'General case' 0 N--CA 1.498 1.958 0 C-N-CA 118.81 -1.156 . . . . 0.0 111.036 -176.294 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -152.3 83.3 1.25 Allowed 'General case' 0 C--N 1.295 -1.795 0 C-N-CA 119.662 -0.815 . . . . 0.0 108.9 178.239 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 67.32 -85.11 0.13 Allowed Glycine 0 N--CA 1.486 1.989 0 C-N-CA 119.193 -1.479 . . . . 0.0 109.727 -178.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -140.42 -2.18 1.44 Allowed 'General case' 0 N--CA 1.486 1.361 0 CA-C-O 121.891 0.853 . . . . 0.0 111.14 179.363 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -82.88 144.99 29.69 Favored 'General case' 0 C--N 1.258 -3.402 0 CA-C-N 114.189 -1.369 . . . . 0.0 111.057 -179.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.2 t -71.96 144.8 12.83 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.523 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.545 ' O ' ' SG ' ' A' ' 28' ' ' CYS . 0.7 OUTLIER -146.4 127.47 14.64 Favored 'General case' 0 C--N 1.279 -2.487 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 177.353 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.528 ' C ' ' H ' ' A' ' 25' ' ' GLY . . . 166.82 -83.81 0.1 OUTLIER Glycine 0 N--CA 1.482 1.703 0 C-N-CA 116.465 -2.778 . . . . 0.0 113.764 -175.489 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -72.66 17.39 0.11 Allowed 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 118.712 -1.195 . . . . 0.0 112.691 -173.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.528 ' H ' ' C ' ' A' ' 23' ' ' GLY . . . -126.86 -11.35 3.59 Favored Glycine 0 C--N 1.264 -3.422 0 N-CA-C 107.937 -2.065 . . . . 0.0 107.937 173.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.44 ' O ' ' O ' ' A' ' 23' ' ' GLY . 1.5 m-80 -158.22 -146.65 0.16 Allowed 'General case' 0 C--O 1.213 -0.834 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 -177.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.579 ' N ' ' O ' ' A' ' 40' ' ' VAL . 0.0 OUTLIER -141.34 138.44 33.08 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 175.45 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.545 ' SG ' ' O ' ' A' ' 22' ' ' CYS . 36.3 m -101.82 148.6 25.11 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 118.108 -1.437 . . . . 0.0 111.808 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 35.1 mm -140.32 90.1 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.263 -3.156 0 CA-C-N 112.918 -1.947 . . . . 0.0 106.878 175.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.461 ' CD1' ' C ' ' A' ' 30' ' ' LEU . 0.4 OUTLIER . . . . . 0 C--N 1.305 -1.34 0 C-N-CA 118.955 -1.098 . . . . 0.0 110.296 -176.245 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.471 ' OD1' ' N ' ' A' ' 37' ' ' ASN . 1.6 m-20 . . . . . 0 N--CA 1.482 1.134 0 CA-C-O 121.098 0.475 . . . . 0.0 110.938 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.461 ' CG ' ' N ' ' A' ' 39' ' ' CYS . 13.7 tt0 -157.38 157.61 34.37 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 119.26 -0.976 . . . . 0.0 110.973 179.468 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.461 ' N ' ' CG ' ' A' ' 38' ' ' GLN . 82.0 m -115.82 74.33 0.89 Allowed 'General case' 0 N--CA 1.492 1.669 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.453 178.403 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.579 ' O ' ' N ' ' A' ' 27' ' ' LYS . 0.2 OUTLIER -81.01 143.21 12.69 Favored 'Isoleucine or valine' 0 C--O 1.193 -1.873 0 C-N-CA 118.684 -1.206 . . . . 0.0 111.548 -177.75 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.5 t -64.1 140.18 58.84 Favored 'General case' 0 C--N 1.272 -2.777 0 CA-C-N 114.596 -1.184 . . . . 0.0 111.551 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 163.8 -140.92 6.76 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 178.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -145.86 113.43 6.34 Favored 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 119.272 -0.971 . . . . 0.0 110.32 179.593 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -114.37 -163.37 14.58 Favored Glycine 0 N--CA 1.498 2.812 0 C-N-CA 119.966 -1.111 . . . . 0.0 110.89 -179.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -131.1 153.02 81.63 Favored Pre-proline 0 N--CA 1.498 1.97 0 C-N-CA 120.04 -0.664 . . . . 0.0 109.627 -179.612 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -54.12 160.18 6.65 Favored 'Trans proline' 0 C--O 1.216 -0.621 0 C-N-CA 121.604 1.536 . . . . 0.0 112.177 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.545 ' CD ' ' H ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.25 0 C-N-CA 119.519 -0.872 . . . . 0.0 108.796 178.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 6.0 t . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -130.04 -167.62 1.84 Allowed 'General case' 0 N--CA 1.497 1.89 0 C-N-CA 119.779 -0.768 . . . . 0.0 109.948 -179.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.0 p -98.42 176.95 5.51 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 119.541 -0.864 . . . . 0.0 108.866 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -88.06 153.07 21.56 Favored 'General case' 0 C--N 1.29 -1.979 0 C-N-CA 118.468 -1.293 . . . . 0.0 110.79 179.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.528 ' SG ' ' CB ' ' A' ' 11' ' ' GLN . 1.2 m -74.39 179.13 4.76 Favored 'General case' 0 C--N 1.287 -2.127 0 CA-C-N 114.754 -1.112 . . . . 0.0 111.564 176.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -152.81 13.41 0.53 Allowed 'General case' 0 C--N 1.29 -2.018 0 CA-C-N 113.657 -1.61 . . . . 0.0 110.015 176.404 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.596 ' CG ' ' NE2' ' A' ' 11' ' ' GLN . 0.9 OUTLIER -163.5 -171.81 2.7 Favored 'General case' 0 C--N 1.286 -2.157 0 CA-C-N 114.511 -1.222 . . . . 0.0 109.947 179.271 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.481 ' HB3' ' H ' ' A' ' 30' ' ' LEU . 0.8 OUTLIER -99.91 172.99 6.89 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 119.911 -0.716 . . . . 0.0 110.707 -178.007 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 63.57 22.21 65.64 Favored Glycine 0 N--CA 1.502 3.063 0 C-N-CA 119.978 -1.106 . . . . 0.0 112.661 176.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.596 ' NE2' ' CG ' ' A' ' 8' ' ' GLU . 0.0 OUTLIER -89.2 -166.53 1.62 Allowed 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 118.95 -1.1 . . . . 0.0 111.213 178.804 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.489 ' OD1' ' CA ' ' A' ' 23' ' ' GLY . 2.0 m-20 -153.76 -70.37 0.14 Allowed 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 118.81 -1.156 . . . . 0.0 113.265 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 94.4 mt -77.97 45.6 0.53 Allowed 'General case' 0 C--N 1.282 -2.343 0 C-N-CA 118.64 -1.224 . . . . 0.0 111.291 -176.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.476 ' SG ' ' N ' ' A' ' 15' ' ' LEU . 15.3 p -123.82 -154.88 0.63 Allowed 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 174.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.476 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 63.3 mt -116.62 109.8 17.69 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-N 114.654 -1.157 . . . . 0.0 108.406 176.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.7 m -104.89 -58.97 1.81 Allowed 'General case' 0 C--N 1.288 -2.099 0 C-N-CA 118.939 -1.104 . . . . 0.0 111.027 -175.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -83.79 85.45 7.29 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 118.363 -1.335 . . . . 0.0 109.233 177.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.53 -116.8 5.28 Favored Glycine 0 N--CA 1.489 2.191 0 C-N-CA 119.384 -1.388 . . . . 0.0 110.317 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.411 ' O ' ' OG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -109.74 1.41 19.41 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-O 122.261 1.029 . . . . 0.0 109.91 -179.581 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 32.2 m120 -79.32 139.03 37.93 Favored 'General case' 0 C--N 1.26 -3.324 0 CA-C-N 113.244 -1.798 . . . . 0.0 111.081 -178.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.6 t -74.09 142.45 14.79 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 C-N-CA 118.987 -1.085 . . . . 0.0 110.206 179.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.515 ' O ' ' SG ' ' A' ' 28' ' ' CYS . 4.0 m -145.55 99.25 3.26 Favored 'General case' 0 C--N 1.284 -2.264 0 C-N-CA 118.873 -1.131 . . . . 0.0 109.408 177.538 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.489 ' CA ' ' OD1' ' A' ' 12' ' ' ASN . . . -161.91 -78.33 0.03 OUTLIER Glycine 0 C--N 1.297 -1.631 1 N-CA-C 131.482 7.353 . . . . 0.0 131.482 -177.489 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.527 ' O ' ' ND2' ' A' ' 26' ' ' ASN . 3.9 tt0 -45.9 124.56 5.43 Favored 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 119.506 -0.877 . . . . 0.0 111.188 -178.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.66 -26.15 2.77 Favored Glycine 0 N--CA 1.478 1.454 0 C-N-CA 119.61 -1.281 . . . . 0.0 110.255 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.548 ' N ' ' ND2' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -110.21 -167.58 1.21 Allowed 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 119.54 -0.864 . . . . 0.0 110.726 -178.92 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.537 ' O ' ' O ' ' A' ' 40' ' ' VAL . 16.6 tttt -148.08 166.08 28.87 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 119.466 -0.894 . . . . 0.0 110.056 179.2 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.515 ' SG ' ' O ' ' A' ' 22' ' ' CYS . 59.0 m -136.06 158.89 43.31 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.261 -0.975 . . . . 0.0 110.147 176.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 22.3 mm -142.68 136.73 27.53 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.505 0 CA-C-N 114.793 -1.094 . . . . 0.0 110.536 177.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.481 ' H ' ' HB3' ' A' ' 9' ' ' SER . 18.1 mt . . . . . 0 N--CA 1.485 1.288 0 C-N-CA 119.943 -0.703 . . . . 0.0 110.967 177.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.637 ' ND2' ' N ' ' A' ' 38' ' ' GLN . 0.2 OUTLIER . . . . . 0 N--CA 1.439 -0.991 0 CA-C-O 121.165 0.507 . . . . 0.0 110.737 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.637 ' N ' ' ND2' ' A' ' 37' ' ' ASN . 13.1 tt0 -127.04 143.16 51.36 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 114.93 -1.032 . . . . 0.0 108.994 176.061 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 66.6 m -96.28 108.19 20.64 Favored 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 119.212 -0.995 . . . . 0.0 111.136 -178.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.537 ' O ' ' O ' ' A' ' 27' ' ' LYS . 0.2 OUTLIER -110.26 142.26 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.407 0 C-N-CA 118.908 -1.117 . . . . 0.0 111.285 177.007 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 15.1 t -70.25 151.48 45.28 Favored 'General case' 0 C--N 1.273 -2.76 0 CA-C-N 114.692 -1.14 . . . . 0.0 110.314 178.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 144.37 -116.54 0.96 Allowed Glycine 0 N--CA 1.493 2.472 1 N-CA-C 130.847 7.099 . . . . 0.0 130.847 -178.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 -116.26 72.61 0.82 Allowed 'General case' 0 N--CA 1.5 2.065 0 C-N-CA 119.957 -0.697 . . . . 0.0 110.556 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.47 ' CA ' HD22 ' A' ' 12' ' ' ASN . . . -107.67 151.16 16.95 Favored Glycine 0 N--CA 1.497 2.704 0 C-N-CA 119.795 -1.193 . . . . 0.0 110.53 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -117.61 152.53 49.79 Favored Pre-proline 0 N--CA 1.496 1.839 0 C-N-CA 120.097 -0.641 . . . . 0.0 109.532 179.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -53.36 161.47 3.88 Favored 'Trans proline' 0 C--O 1.215 -0.629 0 C-N-CA 121.287 1.324 . . . . 0.0 111.137 177.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 . . . . . 0 C--N 1.307 -1.246 0 C-N-CA 118.987 -1.085 . . . . 0.0 111.048 178.022 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.48 1.075 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -82.53 -170.82 3.15 Favored 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 118.961 -1.096 . . . . 0.0 110.791 -179.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.51 ' OG1' ' N ' ' A' ' 5' ' ' ASP . 0.0 OUTLIER -118.76 -169.07 1.65 Allowed 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.35 179.608 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.51 ' N ' ' OG1' ' A' ' 4' ' ' THR . 0.0 OUTLIER -90.46 151.81 21.23 Favored 'General case' 0 C--N 1.288 -2.073 0 C-N-CA 118.774 -1.17 . . . . 0.0 111.903 -176.649 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.423 ' SG ' ' NE2' ' A' ' 11' ' ' GLN . 0.7 OUTLIER -75.57 179.48 5.3 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-N 114.215 -1.357 . . . . 0.0 112.28 177.348 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.737 ' H ' HE22 ' A' ' 11' ' ' GLN . 5.3 p -159.09 16.26 0.17 Allowed 'General case' 0 C--N 1.285 -2.204 0 CA-C-N 112.979 -1.919 . . . . 0.0 109.342 177.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.402 ' CG ' ' O ' ' A' ' 7' ' ' THR . 33.1 mt-10 -160.96 168.07 25.29 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 114.949 -1.023 . . . . 0.0 110.704 -178.179 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.464 ' HB3' ' H ' ' A' ' 30' ' ' LEU . 0.7 OUTLIER -88.33 159.42 18.08 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.06 -179.892 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.449 ' N ' ' O ' ' A' ' 28' ' ' CYS . . . 82.99 -28.47 3.64 Favored Glycine 0 N--CA 1.501 2.971 0 C-N-CA 119.446 -1.359 . . . . 0.0 112.531 177.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.737 HE22 ' H ' ' A' ' 7' ' ' THR . 5.6 mt-30 -49.55 -178.59 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.13 0 C-N-CA 119.496 -0.882 . . . . 0.0 110.817 -179.059 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.474 ' ND2' ' O ' ' A' ' 23' ' ' GLY . 13.2 m-20 -143.68 -67.83 0.34 Allowed 'General case' 0 N--CA 1.501 2.108 0 C-N-CA 118.493 -1.283 . . . . 0.0 114.289 -176.031 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 94.2 mt -77.78 48.28 0.68 Allowed 'General case' 0 C--N 1.275 -2.638 0 C-N-CA 118.803 -1.159 . . . . 0.0 111.399 -175.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.402 ' H ' ' C ' ' A' ' 12' ' ' ASN . 29.4 p -122.93 -159.35 0.83 Allowed 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 119.677 -0.809 . . . . 0.0 110.566 176.214 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 64.7 mt -117.17 121.93 42.62 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.958 177.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 63.5 m -110.18 -73.47 0.68 Allowed 'General case' 0 N--CA 1.5 2.07 0 C-N-CA 119.028 -1.069 . . . . 0.0 110.883 -179.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -79.69 93.23 5.5 Favored 'General case' 0 C--N 1.295 -1.767 0 C-N-CA 118.828 -1.149 . . . . 0.0 110.185 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 72.83 -118.9 6.66 Favored Glycine 0 N--CA 1.488 2.143 0 C-N-CA 119.494 -1.336 . . . . 0.0 110.73 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.42 ' O ' ' OG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -110.65 4.59 20.3 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-O 122.286 1.041 . . . . 0.0 109.947 -178.918 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 61.5 m-80 -78.37 135.24 37.42 Favored 'General case' 0 C--N 1.259 -3.366 0 CA-C-N 113.2 -1.818 . . . . 0.0 110.742 -179.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.1 t -75.67 144.67 11.7 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 C-N-CA 119.451 -0.9 . . . . 0.0 110.754 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.463 ' O ' ' O ' ' A' ' 12' ' ' ASN . 53.8 m -141.68 99.78 3.62 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 118.768 -1.173 . . . . 0.0 110.137 176.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.474 ' O ' ' ND2' ' A' ' 12' ' ' ASN . . . -176.14 -42.05 0.06 OUTLIER Glycine 0 N--CA 1.487 2.043 1 N-CA-C 129.921 6.728 . . . . 0.0 129.921 -178.012 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 12.1 tt0 -86.33 118.19 25.61 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 118.879 -1.128 . . . . 0.0 109.117 177.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.42 -22.6 29.24 Favored Glycine 0 C--N 1.294 -1.802 0 N-CA-C 108.719 -1.753 . . . . 0.0 108.719 -176.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.455 ' O ' ' O ' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -131.72 164.79 25.17 Favored 'General case' 0 C--O 1.209 -1.077 0 C-N-CA 120.021 -0.672 . . . . 0.0 110.035 179.156 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.539 ' O ' ' O ' ' A' ' 40' ' ' VAL . 10.0 ttpt -122.12 147.87 45.6 Favored 'General case' 0 N--CA 1.506 2.37 0 C-N-CA 119.752 -0.779 . . . . 0.0 110.189 178.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.449 ' O ' ' N ' ' A' ' 10' ' ' GLY . 0.7 OUTLIER -109.37 163.1 13.71 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 118.289 -1.364 . . . . 0.0 111.282 176.917 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 18.8 mm -145.49 130.07 12.3 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.355 0 CA-C-N 112.286 -2.234 . . . . 0.0 109.462 177.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.464 ' H ' ' HB3' ' A' ' 9' ' ' SER . 24.3 mt . . . . . 0 C--N 1.302 -1.457 0 C-N-CA 118.518 -1.273 . . . . 0.0 109.39 178.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.458 ' OD1' ' N ' ' A' ' 37' ' ' ASN . 1.3 m120 . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 121.349 0.595 . . . . 0.0 111.994 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.436 ' O ' ' SG ' ' A' ' 28' ' ' CYS . 7.3 tt0 -154.76 161.16 41.61 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.771 177.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.413 ' H ' ' HG3' ' A' ' 38' ' ' GLN . 62.6 m -128.3 84.08 2.21 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 120.037 -0.665 . . . . 0.0 110.445 -179.159 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.539 ' O ' ' O ' ' A' ' 27' ' ' LYS . 0.2 OUTLIER -91.69 139.17 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.606 0 C-N-CA 118.124 -1.43 . . . . 0.0 112.317 -178.722 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.9 t -47.61 163.17 0.05 Allowed 'General case' 0 C--N 1.277 -2.583 0 CA-C-N 114.137 -1.392 . . . . 0.0 111.599 -178.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 130.36 -150.5 19.21 Favored Glycine 0 N--CA 1.492 2.43 1 N-CA-C 130.289 6.875 . . . . 0.0 130.289 -179.335 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -123.72 141.86 51.62 Favored 'General case' 0 N--CA 1.498 1.934 0 C-N-CA 119.88 -0.728 . . . . 0.0 109.958 178.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.438 ' N ' HD22 ' A' ' 12' ' ' ASN . . . -161.4 -177.56 34.59 Favored Glycine 0 N--CA 1.487 2.085 0 C-N-CA 119.224 -1.465 . . . . 0.0 110.614 -179.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.424 ' O ' ' O ' ' A' ' 46' ' ' PRO . 0.4 OUTLIER -101.86 154.8 37.08 Favored Pre-proline 0 N--CA 1.49 1.559 0 C-N-CA 119.849 -0.741 . . . . 0.0 109.388 -179.701 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.424 ' O ' ' O ' ' A' ' 45' ' ' THR . 4.6 Cg_exo -54.96 -159.81 0.01 OUTLIER 'Trans proline' 0 C--O 1.213 -0.757 0 C-N-CA 121.273 1.315 . . . . 0.0 110.708 176.416 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 . . . . . 0 C--N 1.306 -1.325 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.062 179.63 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.1 t . . . . . 0 N--CA 1.479 1.005 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -103.75 -167.19 1.34 Allowed 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 119.443 -0.903 . . . . 0.0 111.02 -178.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.96 174.13 7.09 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.278 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -94.52 150.83 19.86 Favored 'General case' 0 C--N 1.296 -1.73 0 C-N-CA 118.737 -1.185 . . . . 0.0 109.833 179.182 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.518 ' SG ' ' O ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -75.86 165.94 24.26 Favored 'General case' 0 C--N 1.292 -1.93 0 C-N-CA 119.655 -0.818 . . . . 0.0 111.028 178.919 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 34.2 p -135.96 12.02 3.36 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-N 114.61 -1.177 . . . . 0.0 108.871 175.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.469 ' O ' ' NE2' ' A' ' 11' ' ' GLN . 2.1 tt0 -162.54 175.43 11.46 Favored 'General case' 0 C--N 1.284 -2.248 0 CA-C-N 114.321 -1.309 . . . . 0.0 111.729 -179.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -85.33 154.46 21.88 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 114.816 -1.084 . . . . 0.0 110.296 -179.266 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.449 ' O ' ' O ' ' A' ' 11' ' ' GLN . . . 89.42 -21.21 30.02 Favored Glycine 0 N--CA 1.502 3.077 0 C-N-CA 119.261 -1.447 . . . . 0.0 112.855 178.124 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.469 ' NE2' ' O ' ' A' ' 8' ' ' GLU . 1.5 mp0 -49.66 179.35 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.338 0 C-N-CA 118.588 -1.245 . . . . 0.0 110.187 -179.012 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.513 ' O ' ' O ' ' A' ' 22' ' ' CYS . 15.6 t-20 -138.12 -76.49 0.38 Allowed 'General case' 0 N--CA 1.497 1.879 0 C-N-CA 118.963 -1.095 . . . . 0.0 112.438 -178.105 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 83.1 mt -78.36 47.34 0.68 Allowed 'General case' 0 C--N 1.264 -3.149 0 C-N-CA 117.968 -1.493 . . . . 0.0 110.594 -177.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.409 ' H ' ' C ' ' A' ' 12' ' ' ASN . 31.9 p -117.03 -157.13 0.65 Allowed 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 119.482 -0.887 . . . . 0.0 110.13 177.492 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.518 ' O ' ' SG ' ' A' ' 6' ' ' CYS . 4.6 mt -122.8 127.98 49.83 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.371 177.266 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 82.8 m -116.35 -64.61 1.29 Allowed 'General case' 0 N--CA 1.511 2.604 0 C-N-CA 119.287 -0.965 . . . . 0.0 110.951 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 85.3 mt-10 -79.23 76.35 5.77 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 119.08 -1.048 . . . . 0.0 110.287 -178.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 73.77 -108.57 2.54 Favored Glycine 0 N--CA 1.488 2.144 0 C-N-CA 119.481 -1.342 . . . . 0.0 111.123 179.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -108.2 0.26 21.36 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 122.119 0.962 . . . . 0.0 110.773 -177.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 72.9 m-20 -79.66 127.01 31.65 Favored 'General case' 0 C--N 1.256 -3.481 0 CA-C-N 113.838 -1.528 . . . . 0.0 110.435 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.2 t -66.68 148.69 11.98 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 C-N-CA 118.835 -1.146 . . . . 0.0 109.168 178.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.513 ' O ' ' O ' ' A' ' 12' ' ' ASN . 0.0 OUTLIER -143.55 113.59 7.24 Favored 'General case' 0 C--N 1.289 -2.053 0 C-N-CA 118.802 -1.159 . . . . 0.0 110.754 -178.574 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.43 ' O ' ' O ' ' A' ' 26' ' ' ASN . . . 162.08 -57.59 0.3 Allowed Glycine 0 N--CA 1.483 1.824 1 N-CA-C 130.29 6.876 . . . . 0.0 130.29 -178.01 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.509 ' N ' ' OD1' ' A' ' 12' ' ' ASN . 15.8 tt0 -61.47 126.69 28.27 Favored 'General case' 0 C--N 1.31 -1.137 0 C-N-CA 119.037 -1.065 . . . . 0.0 110.51 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.41 -25.56 8.0 Favored Glycine 0 N--CA 1.482 1.708 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -178.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.484 ' OD1' ' N ' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -123.11 -167.18 1.56 Allowed 'General case' 0 C--N 1.316 -0.867 0 C-N-CA 120.322 -0.551 . . . . 0.0 110.021 179.992 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.475 ' O ' ' O ' ' A' ' 40' ' ' VAL . 15.4 tttp -145.65 115.93 7.51 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 178.136 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.51 ' SG ' ' O ' ' A' ' 38' ' ' GLN . 0.1 OUTLIER -80.11 163.72 23.91 Favored 'General case' 0 CA--C 1.477 -1.828 0 C-N-CA 117.528 -1.669 . . . . 0.0 112.415 178.503 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 18.1 mm -149.39 124.7 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.265 -3.076 0 CA-C-N 111.982 -2.372 . . . . 0.0 108.218 178.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 26.9 mt . . . . . 0 N--CA 1.49 1.544 0 C-N-CA 118.337 -1.345 . . . . 0.0 110.421 -178.505 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.209 0 CA-C-O 120.498 0.189 . . . . 0.0 110.647 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.51 ' O ' ' SG ' ' A' ' 28' ' ' CYS . 42.1 tt0 -157.33 152.83 26.44 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 118.791 -1.164 . . . . 0.0 111.223 178.379 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -113.1 107.24 15.67 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 115.226 -0.897 . . . . 0.0 112.058 178.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.483 ' CG2' ' N ' ' A' ' 41' ' ' THR . 1.6 p -110.45 155.99 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 C-N-CA 119.01 -1.076 . . . . 0.0 109.494 174.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.483 ' N ' ' CG2' ' A' ' 40' ' ' VAL . 6.0 t -78.87 152.28 31.32 Favored 'General case' 0 C--N 1.279 -2.479 0 CA-C-N 114.814 -1.084 . . . . 0.0 112.202 -177.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 153.28 -113.87 0.6 Allowed Glycine 0 N--CA 1.491 2.331 1 N-CA-C 128.945 6.338 . . . . 0.0 128.945 -179.529 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -154.62 101.34 2.32 Favored 'General case' 0 N--CA 1.494 1.753 0 C-N-CA 119.299 -0.961 . . . . 0.0 110.268 177.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -114.73 -165.69 15.1 Favored Glycine 0 N--CA 1.496 2.656 0 C-N-CA 120.013 -1.089 . . . . 0.0 110.579 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -134.32 148.25 66.94 Favored Pre-proline 0 N--CA 1.489 1.513 0 C-N-CA 119.965 -0.694 . . . . 0.0 110.152 -179.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -59.74 143.64 99.59 Favored 'Trans proline' 0 C--O 1.211 -0.83 0 C-N-CA 121.314 1.343 . . . . 0.0 110.997 176.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 . . . . . 0 CA--C 1.565 1.523 0 C-N-CA 119.628 -0.829 . . . . 0.0 110.588 -179.721 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.1 t . . . . . 0 N--CA 1.481 1.088 0 CA-C-O 121.065 0.459 . . . . 0.0 110.498 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -100.48 -165.07 1.17 Allowed 'General case' 0 N--CA 1.492 1.648 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.283 179.223 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -94.18 -179.58 4.99 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.125 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 5' ' ' ASP . 0.2 OUTLIER -93.05 154.65 17.99 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 118.462 -1.295 . . . . 0.0 110.781 179.478 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.9 m -75.41 179.17 5.38 Favored 'General case' 0 C--N 1.294 -1.841 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.056 178.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.3 p -134.24 -2.54 2.81 Favored 'General case' 0 C--N 1.29 -2.019 0 CA-C-N 113.904 -1.498 . . . . 0.0 109.924 176.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -162.84 157.04 20.83 Favored 'General case' 0 C--N 1.279 -2.493 0 CA-C-N 114.237 -1.347 . . . . 0.0 110.053 179.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.585 ' OG ' ' N ' ' A' ' 30' ' ' LEU . 1.4 m -62.59 -175.79 0.09 Allowed 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 119.73 -0.788 . . . . 0.0 110.496 179.237 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.453 ' N ' ' O ' ' A' ' 28' ' ' CYS . . . 73.64 -42.58 1.07 Allowed Glycine 0 N--CA 1.5 2.919 0 C-N-CA 120.111 -1.042 . . . . 0.0 112.9 178.173 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.442 ' O ' ' O ' ' A' ' 10' ' ' GLY . 2.5 mp0 -53.79 -173.02 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.607 0 C-N-CA 119.022 -1.071 . . . . 0.0 110.222 -177.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.506 ' ND2' ' O ' ' A' ' 26' ' ' ASN . 11.4 m-20 -151.59 -57.63 0.15 Allowed 'General case' 0 N--CA 1.503 2.212 0 C-N-CA 117.691 -1.604 . . . . 0.0 114.707 -177.044 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 15.0 mt -75.7 49.75 0.53 Allowed 'General case' 0 C--N 1.287 -2.133 0 C-N-CA 118.989 -1.085 . . . . 0.0 110.107 -176.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.593 ' SG ' ' N ' ' A' ' 15' ' ' LEU . 19.5 p -130.37 -142.31 0.24 Allowed 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 114.662 -1.154 . . . . 0.0 108.821 176.207 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.593 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 88.1 mt -122.9 108.8 13.39 Favored 'General case' 0 C--N 1.288 -2.083 0 CA-C-N 114.592 -1.185 . . . . 0.0 109.365 176.523 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.426 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 8.6 m -111.22 -46.74 3.27 Favored 'General case' 0 C--N 1.288 -2.068 0 CA-C-N 113.941 -1.481 . . . . 0.0 110.598 -175.382 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -87.82 73.88 9.16 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 119.17 -1.012 . . . . 0.0 109.307 178.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 73.39 -107.61 2.28 Favored Glycine 0 N--CA 1.489 2.195 0 C-N-CA 119.304 -1.427 . . . . 0.0 109.938 -178.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -111.31 -0.13 16.49 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-O 122.337 1.065 . . . . 0.0 109.89 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -82.75 145.62 29.46 Favored 'General case' 0 C--N 1.261 -3.256 0 CA-C-N 113.201 -1.818 . . . . 0.0 111.467 -179.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.4 t -84.17 142.2 13.7 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.258 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.503 ' O ' ' O ' ' A' ' 12' ' ' ASN . 0.0 OUTLIER -109.85 146.44 35.07 Favored 'General case' 0 N--CA 1.504 2.229 0 N-CA-C 106.012 -1.848 . . . . 0.0 106.012 168.637 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -105.13 -154.58 22.29 Favored Glycine 0 CA--C 1.49 -1.491 0 C-N-CA 118.256 -1.926 . . . . 0.0 111.13 -173.271 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.5 ' C ' ' H ' ' A' ' 26' ' ' ASN . 4.0 tt0 -92.82 170.89 9.34 Favored 'General case' 0 C--N 1.246 -3.926 0 CA-C-N 112.075 -2.063 . . . . 0.0 109.55 -177.25 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.41 ' H ' ' HG2' ' A' ' 24' ' ' GLN . . . 81.06 -35.32 2.36 Favored Glycine 0 N--CA 1.48 1.616 0 N-CA-C 108.595 -1.802 . . . . 0.0 108.595 -177.464 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.506 ' O ' ' ND2' ' A' ' 12' ' ' ASN . 0.0 OUTLIER -100.49 173.77 6.41 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 177.542 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.485 ' O ' ' O ' ' A' ' 40' ' ' VAL . 0.1 OUTLIER -128.76 131.53 47.85 Favored 'General case' 0 N--CA 1.502 2.155 0 C-N-CA 119.461 -0.896 . . . . 0.0 111.057 -179.388 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.453 ' O ' ' N ' ' A' ' 10' ' ' GLY . 81.3 m -93.01 153.71 18.56 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 118.359 -1.336 . . . . 0.0 110.067 176.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 30.3 mm -140.77 81.04 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.265 -3.091 0 CA-C-N 114.142 -1.39 . . . . 0.0 108.869 176.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.585 ' N ' ' OG ' ' A' ' 9' ' ' SER . 1.1 pp . . . . . 0 C--N 1.304 -1.403 0 C-N-CA 119.257 -0.977 . . . . 0.0 110.998 -178.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.413 ' OD1' ' N ' ' A' ' 37' ' ' ASN . 4.3 m-20 . . . . . 0 N--CA 1.482 1.135 0 CA-C-O 121.141 0.495 . . . . 0.0 111.903 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.471 ' CG ' ' N ' ' A' ' 39' ' ' CYS . 7.0 tt0 -161.45 157.91 25.82 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.099 177.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.471 ' N ' ' CG ' ' A' ' 38' ' ' GLN . 0.9 OUTLIER -117.52 92.04 3.74 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 120.124 -0.63 . . . . 0.0 109.649 178.892 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.485 ' O ' ' O ' ' A' ' 27' ' ' LYS . 0.6 OUTLIER -101.23 134.33 41.76 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.267 0 C-N-CA 118.482 -1.287 . . . . 0.0 112.476 -178.417 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 6.0 t -57.15 157.17 6.35 Favored 'General case' 0 C--N 1.273 -2.743 0 CA-C-N 113.044 -1.889 . . . . 0.0 111.019 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 148.69 -104.59 0.28 Allowed Glycine 0 N--CA 1.492 2.427 1 N-CA-C 130.866 7.106 . . . . 0.0 130.866 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -160.13 106.55 1.58 Allowed 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 119.441 -0.904 . . . . 0.0 110.368 -179.557 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -146.28 -174.63 18.59 Favored Glycine 0 N--CA 1.493 2.496 0 C-N-CA 119.548 -1.311 . . . . 0.0 110.437 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.7 t -107.47 144.77 29.89 Favored Pre-proline 0 N--CA 1.492 1.632 0 C-N-CA 119.781 -0.768 . . . . 0.0 110.37 -179.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -63.76 132.48 35.2 Favored 'Trans proline' 0 C--O 1.214 -0.699 0 C-N-CA 120.904 1.07 . . . . 0.0 110.53 174.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.488 1.451 0 C-N-CA 119.515 -0.874 . . . . 0.0 110.703 -179.143 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 1.6 t . . . . . 0 N--CA 1.484 1.238 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -92.52 -164.86 1.24 Allowed 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 119.55 -0.86 . . . . 0.0 110.93 -179.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.457 ' H ' ' HG1' ' A' ' 4' ' ' THR . 1.1 p -93.05 180.0 5.27 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.501 ' N ' ' OD1' ' A' ' 5' ' ' ASP . 0.0 OUTLIER -92.4 151.46 20.24 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 118.997 -1.081 . . . . 0.0 110.152 178.435 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.517 ' SG ' ' O ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -75.04 165.77 24.72 Favored 'General case' 0 C--N 1.296 -1.75 0 C-N-CA 120.017 -0.673 . . . . 0.0 111.189 178.445 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.0 p -141.67 12.47 2.09 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 119.446 -0.901 . . . . 0.0 110.062 177.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -162.78 179.51 7.6 Favored 'General case' 0 C--N 1.287 -2.126 0 CA-C-N 114.687 -1.142 . . . . 0.0 110.826 178.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.455 ' HB3' ' H ' ' A' ' 30' ' ' LEU . 0.8 OUTLIER -89.81 163.91 14.85 Favored 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 119.252 -0.979 . . . . 0.0 109.741 179.849 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 71.54 14.52 74.92 Favored Glycine 0 N--CA 1.495 2.585 0 C-N-CA 119.028 -1.558 . . . . 0.0 111.777 179.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.7 mm-40 -74.77 -167.43 0.57 Allowed 'General case' 0 N--CA 1.498 1.958 0 C-N-CA 118.977 -1.089 . . . . 0.0 109.991 179.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.477 ' O ' ' O ' ' A' ' 22' ' ' CYS . 0.9 OUTLIER -155.09 -80.31 0.09 Allowed 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 117.693 -1.603 . . . . 0.0 113.554 -179.45 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 92.6 mt -77.03 51.75 0.83 Allowed 'General case' 0 C--N 1.273 -2.755 0 C-N-CA 117.815 -1.554 . . . . 0.0 109.602 -176.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.471 ' H ' ' C ' ' A' ' 12' ' ' ASN . 23.1 p -122.36 -156.07 0.67 Allowed 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.754 176.486 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.517 ' O ' ' SG ' ' A' ' 6' ' ' CYS . 8.6 mt -124.68 124.52 42.36 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 114.784 -1.098 . . . . 0.0 109.917 179.025 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.2 m -108.19 -68.24 0.92 Allowed 'General case' 0 N--CA 1.504 2.227 0 C-N-CA 119.058 -1.057 . . . . 0.0 111.519 -177.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -87.27 91.17 8.63 Favored 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 118.701 -1.2 . . . . 0.0 110.915 -177.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.06 -98.53 1.1 Allowed Glycine 0 N--CA 1.49 2.289 0 C-N-CA 119.632 -1.27 . . . . 0.0 111.598 177.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.406 ' O ' ' OG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -129.83 5.81 5.05 Favored 'General case' 0 N--CA 1.483 1.187 0 CA-C-O 122.293 1.044 . . . . 0.0 110.224 -177.763 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.607 ' N ' ' ND2' ' A' ' 20' ' ' ASN . 1.0 OUTLIER -81.35 130.81 35.19 Favored 'General case' 0 C--N 1.253 -3.605 0 CA-C-N 113.438 -1.71 . . . . 0.0 110.296 178.97 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.6 t -75.38 146.46 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 C-N-CA 119.377 -0.929 . . . . 0.0 110.459 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.477 ' O ' ' O ' ' A' ' 12' ' ' ASN . 21.2 m -143.36 109.95 5.48 Favored 'General case' 0 N--CA 1.505 2.283 0 C-N-CA 118.587 -1.245 . . . . 0.0 110.483 177.31 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.447 ' O ' ' O ' ' A' ' 26' ' ' ASN . . . -175.91 -91.39 0.08 OUTLIER Glycine 0 C--O 1.203 -1.784 0 C-N-CA 118.331 -1.89 . . . . 0.0 112.177 -178.038 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -50.77 120.75 5.05 Favored 'General case' 0 C--N 1.297 -1.677 0 C-N-CA 119.086 -1.046 . . . . 0.0 110.548 -178.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.68 -26.78 21.78 Favored Glycine 0 N--CA 1.481 1.667 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -178.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.447 ' O ' ' O ' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -137.17 -163.81 1.49 Allowed 'General case' 0 C--N 1.313 -0.994 0 C-N-CA 120.148 -0.621 . . . . 0.0 111.122 -179.508 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.534 ' N ' ' O ' ' A' ' 40' ' ' VAL . 16.0 ttpt -142.38 165.46 27.35 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 177.417 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -130.79 163.37 27.48 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 118.893 -1.123 . . . . 0.0 110.494 175.374 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 15.4 mm -151.42 129.47 2.58 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.104 0 CA-C-N 113.176 -1.829 . . . . 0.0 109.186 179.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.455 ' H ' ' HB3' ' A' ' 9' ' ' SER . 29.2 mt . . . . . 0 C--N 1.303 -1.454 0 C-N-CA 118.602 -1.239 . . . . 0.0 109.529 178.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.415 ' OD1' ' N ' ' A' ' 37' ' ' ASN . 1.6 m-20 . . . . . 0 N--CA 1.502 2.133 0 CA-C-O 121.062 0.458 . . . . 0.0 112.187 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -156.46 155.44 32.06 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 119.626 -0.829 . . . . 0.0 110.407 177.406 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 96.9 m -112.99 98.53 7.22 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 119.897 -0.721 . . . . 0.0 110.642 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.534 ' O ' ' N ' ' A' ' 27' ' ' LYS . 0.2 OUTLIER -98.48 142.78 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.237 0 C-N-CA 118.777 -1.169 . . . . 0.0 111.619 179.844 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.9 t -63.42 150.04 44.54 Favored 'General case' 0 C--N 1.275 -2.636 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.949 179.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 141.6 -147.54 19.12 Favored Glycine 0 N--CA 1.495 2.58 0 C-N-CA 119.697 -1.24 . . . . 0.0 110.428 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -135.62 117.1 14.77 Favored 'General case' 0 N--CA 1.498 1.939 0 C-N-CA 119.798 -0.761 . . . . 0.0 110.349 179.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -113.33 177.17 17.92 Favored Glycine 0 N--CA 1.499 2.888 0 C-N-CA 119.965 -1.112 . . . . 0.0 110.409 -179.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 8.8 t -90.03 127.79 52.3 Favored Pre-proline 0 CA--C 1.566 1.594 0 C-N-CA 119.224 -0.99 . . . . 0.0 110.444 -179.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -59.78 147.84 90.65 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 121.266 1.311 . . . . 0.0 112.019 179.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.435 ' OE1' ' O ' ' A' ' 5' ' ' ASP . 28.0 tt0 . . . . . 0 CA--C 1.554 1.115 0 C-N-CA 119.674 -0.81 . . . . 0.0 111.896 177.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.405 HG11 ' H ' ' A' ' 3' ' ' TYR . 1.3 t . . . . . 0 N--CA 1.481 1.083 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.405 ' H ' HG11 ' A' ' 2' ' ' VAL . 38.4 m-85 -132.18 -174.13 3.35 Favored 'General case' 0 N--CA 1.495 1.789 0 C-N-CA 119.525 -0.87 . . . . 0.0 110.411 179.189 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.71 ' HG1' ' H ' ' A' ' 5' ' ' ASP . 0.1 OUTLIER -101.68 -178.18 3.64 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 178.857 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.71 ' H ' ' HG1' ' A' ' 4' ' ' THR . 0.0 OUTLIER -93.05 154.03 18.36 Favored 'General case' 0 C--N 1.288 -2.078 0 C-N-CA 119.162 -1.015 . . . . 0.0 109.605 178.074 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 3.7 m -73.99 174.89 7.95 Favored 'General case' 0 C--N 1.295 -1.784 0 C-N-CA 118.944 -1.102 . . . . 0.0 110.778 177.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.9 t -155.13 11.88 0.35 Allowed 'General case' 0 C--N 1.276 -2.588 0 CA-C-N 113.554 -1.657 . . . . 0.0 109.806 177.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.419 ' CB ' HE22 ' A' ' 11' ' ' GLN . 4.7 mm-40 -154.82 173.86 15.87 Favored 'General case' 0 C--N 1.29 -1.997 0 CA-C-N 114.313 -1.312 . . . . 0.0 109.498 -177.344 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.465 ' HB3' ' H ' ' A' ' 30' ' ' LEU . 0.9 OUTLIER -89.18 157.26 18.34 Favored 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 119.325 -0.95 . . . . 0.0 109.807 179.205 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 28' ' ' CYS . . . 94.12 -51.49 2.19 Favored Glycine 0 N--CA 1.502 3.054 0 C-N-CA 119.075 -1.536 . . . . 0.0 112.396 178.156 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.449 ' O ' ' OD1' ' A' ' 12' ' ' ASN . 3.9 mp0 -40.24 164.03 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.452 0 C-N-CA 120.29 -0.564 . . . . 0.0 111.91 -176.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.529 ' ND2' ' O ' ' A' ' 26' ' ' ASN . 85.1 m-20 -140.69 -50.45 0.45 Allowed 'General case' 0 N--CA 1.507 2.409 0 C-N-CA 119.149 -1.02 . . . . 0.0 113.413 -177.407 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 14.7 mt -77.35 43.47 0.38 Allowed 'General case' 0 C--N 1.295 -1.787 0 C-N-CA 119.09 -1.044 . . . . 0.0 110.359 -177.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.654 ' SG ' ' N ' ' A' ' 15' ' ' LEU . 14.1 p -123.05 -148.44 0.4 Allowed 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 114.725 -1.125 . . . . 0.0 108.491 176.73 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.654 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 83.3 mt -116.23 98.73 6.76 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 114.497 -1.229 . . . . 0.0 107.866 173.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.469 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 57.6 m -95.9 -51.24 4.55 Favored 'General case' 0 C--N 1.276 -2.595 0 CA-C-N 113.429 -1.714 . . . . 0.0 110.947 -173.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -94.49 94.0 7.97 Favored 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 119.433 -0.907 . . . . 0.0 109.89 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 62.81 -92.7 0.09 OUTLIER Glycine 0 N--CA 1.49 2.242 0 C-N-CA 119.335 -1.412 . . . . 0.0 110.315 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -131.15 3.05 4.31 Favored 'General case' 0 N--CA 1.483 1.219 0 CA-C-O 122.138 0.971 . . . . 0.0 110.114 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 68.6 m-80 -79.34 140.87 37.39 Favored 'General case' 0 C--N 1.258 -3.374 0 CA-C-N 113.409 -1.723 . . . . 0.0 110.544 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.1 t -82.55 135.57 24.61 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 C-N-CA 118.875 -1.13 . . . . 0.0 111.404 -179.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.495 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 0.1 OUTLIER -91.19 151.52 20.91 Favored 'General case' 0 N--CA 1.513 2.708 0 C-N-CA 118.559 -1.256 . . . . 0.0 108.057 169.682 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.459 ' O ' ' OD1' ' A' ' 26' ' ' ASN . . . -118.74 124.93 6.2 Favored Glycine 0 C--O 1.213 -1.211 0 C-N-CA 119.922 -1.132 . . . . 0.0 110.42 -170.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.434 ' C ' ' O ' ' A' ' 23' ' ' GLY . 2.8 tt0 -36.06 132.43 0.52 Allowed 'General case' 0 C--N 1.255 -3.52 0 CA-C-N 112.652 -1.774 . . . . 0.0 110.127 178.073 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 126.6 -30.14 4.3 Favored Glycine 0 N--CA 1.482 1.715 0 N-CA-C 107.716 -2.154 . . . . 0.0 107.716 -175.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.637 ' N ' ' ND2' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -102.13 -159.77 0.75 Allowed 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 177.47 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.51 ' O ' ' O ' ' A' ' 40' ' ' VAL . 4.8 ttpp -152.81 104.5 2.87 Favored 'General case' 0 N--CA 1.498 1.945 0 C-N-CA 119.194 -1.003 . . . . 0.0 111.594 179.593 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.515 ' O ' ' N ' ' A' ' 10' ' ' GLY . 32.5 m -79.43 157.2 27.6 Favored 'General case' 0 C--O 1.201 -1.492 0 C-N-CA 117.617 -1.633 . . . . 0.0 110.071 178.183 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 28.0 mm -140.73 138.1 35.32 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.487 0 CA-C-N 114.825 -1.08 . . . . 0.0 110.173 177.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.465 ' H ' ' HB3' ' A' ' 9' ' ' SER . 21.1 mt . . . . . 0 N--CA 1.493 1.709 0 C-N-CA 119.054 -1.058 . . . . 0.0 109.345 177.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.522 ' OD1' ' N ' ' A' ' 37' ' ' ASN . 0.6 OUTLIER . . . . . 0 N--CA 1.495 1.787 0 CA-C-O 121.374 0.607 . . . . 0.0 111.901 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -154.93 147.03 23.69 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 115.003 -0.998 . . . . 0.0 109.29 176.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.441 ' SG ' ' CB ' ' A' ' 16' ' ' CYS . 1.0 OUTLIER -104.15 91.34 3.9 Favored 'General case' 0 C--N 1.299 -1.604 0 C-N-CA 119.521 -0.872 . . . . 0.0 110.208 -179.984 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.516 ' CG2' ' N ' ' A' ' 41' ' ' THR . 3.4 p -106.76 160.15 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 C-N-CA 118.617 -1.233 . . . . 0.0 110.567 179.299 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.516 ' N ' ' CG2' ' A' ' 40' ' ' VAL . 8.8 t -80.14 154.81 27.79 Favored 'General case' 0 C--N 1.276 -2.606 0 CA-C-N 114.87 -1.059 . . . . 0.0 112.128 -178.613 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 166.94 -120.75 0.93 Allowed Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.906 -1.277 . . . . 0.0 109.906 178.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -142.98 123.74 14.19 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 119.374 -0.93 . . . . 0.0 110.109 179.145 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -142.11 -171.19 12.93 Favored Glycine 0 N--CA 1.489 2.186 1 N-CA-C 131.0 7.16 . . . . 0.0 131.0 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -136.16 154.0 77.06 Favored Pre-proline 0 N--CA 1.492 1.669 0 C-N-CA 119.904 -0.718 . . . . 0.0 109.48 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -56.82 -175.88 0.05 OUTLIER 'Trans proline' 0 C--N 1.324 -0.719 0 C-N-CA 120.994 1.129 . . . . 0.0 110.396 175.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.567 ' CD ' ' H ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.304 -1.397 0 C-N-CA 118.814 -1.154 . . . . 0.0 109.202 178.518 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.404 HG11 ' H ' ' A' ' 3' ' ' TYR . 1.6 t . . . . . 0 N--CA 1.485 1.318 0 CA-C-O 120.914 0.388 . . . . 0.0 110.807 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.404 ' H ' HG11 ' A' ' 2' ' ' VAL . 97.0 m-85 -107.77 -163.96 0.93 Allowed 'General case' 0 N--CA 1.495 1.814 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.707 -179.617 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.659 ' HG1' ' H ' ' A' ' 5' ' ' ASP . 0.5 OUTLIER -127.61 -172.91 2.78 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 177.052 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.659 ' H ' ' HG1' ' A' ' 4' ' ' THR . 0.3 OUTLIER -81.3 157.53 25.08 Favored 'General case' 0 C--N 1.288 -2.067 0 C-N-CA 118.358 -1.337 . . . . 0.0 111.332 -178.693 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -75.83 -179.69 4.96 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.242 177.459 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.1 t -138.34 -0.85 1.96 Allowed 'General case' 0 N--CA 1.497 1.892 0 C-N-CA 119.001 -1.08 . . . . 0.0 111.408 178.128 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -163.33 169.17 19.46 Favored 'General case' 0 C--N 1.273 -2.741 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.985 177.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.18 149.37 44.72 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.587 -178.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.59 -12.15 62.98 Favored Glycine 0 N--CA 1.504 3.229 0 C-N-CA 119.473 -1.346 . . . . 0.0 112.458 179.066 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.414 ' CA ' ' OE1' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -66.56 178.18 1.35 Allowed 'General case' 0 N--CA 1.503 2.203 0 C-N-CA 119.181 -1.008 . . . . 0.0 110.961 -179.043 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.568 ' O ' ' O ' ' A' ' 22' ' ' CYS . 44.5 m-20 -143.85 -72.18 0.29 Allowed 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 118.648 -1.221 . . . . 0.0 113.031 -178.472 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 12.9 mt -75.51 48.31 0.44 Allowed 'General case' 0 C--N 1.289 -2.042 0 C-N-CA 119.542 -0.863 . . . . 0.0 110.032 -176.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.479 ' H ' ' C ' ' A' ' 12' ' ' ASN . 31.5 p -122.39 -151.5 0.48 Allowed 'General case' 0 C--N 1.302 -1.5 0 CA-C-N 114.261 -1.336 . . . . 0.0 108.409 176.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 67.6 mt -114.63 110.93 20.52 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-N 115.097 -0.956 . . . . 0.0 108.852 175.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 69.7 m -107.4 -70.41 0.8 Allowed 'General case' 0 C--N 1.285 -2.21 0 CA-C-N 114.437 -1.256 . . . . 0.0 110.243 -175.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -79.03 89.9 4.79 Favored 'General case' 0 C--N 1.297 -1.682 0 C-N-CA 118.829 -1.149 . . . . 0.0 109.472 178.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 70.9 -127.5 15.47 Favored Glycine 0 N--CA 1.483 1.827 0 C-N-CA 119.416 -1.374 . . . . 0.0 110.032 -178.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.404 ' O ' ' OG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -101.63 2.42 38.79 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 122.279 1.038 . . . . 0.0 109.629 179.677 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -78.82 140.73 38.14 Favored 'General case' 0 C--N 1.26 -3.289 0 CA-C-N 113.227 -1.806 . . . . 0.0 110.466 -179.541 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.3 t -80.88 142.47 13.8 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.977 -178.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.568 ' O ' ' O ' ' A' ' 12' ' ' ASN . 0.0 OUTLIER -114.65 161.59 17.9 Favored 'General case' 0 N--CA 1.505 2.319 0 N-CA-C 104.908 -2.256 . . . . 0.0 104.908 168.849 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -137.79 -139.31 3.85 Favored Glycine 0 CA--C 1.483 -1.963 0 C-N-CA 116.809 -2.615 . . . . 0.0 112.134 -175.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -91.57 150.15 21.33 Favored 'General case' 0 C--N 1.253 -3.615 0 CA-C-N 112.343 -1.929 . . . . 0.0 110.543 -174.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.6 -31.96 8.04 Favored Glycine 0 C--N 1.297 -1.634 0 N-CA-C 108.948 -1.661 . . . . 0.0 108.948 -177.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -109.61 -174.74 2.57 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 119.767 -0.773 . . . . 0.0 109.415 179.41 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.403 ' O ' ' O ' ' A' ' 40' ' ' VAL . 51.1 tttp -142.53 114.69 8.29 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 118.994 -1.083 . . . . 0.0 110.01 176.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.472 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 28.9 m -84.38 151.12 24.9 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 117.519 -1.672 . . . . 0.0 110.241 178.008 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 6.3 mm -130.23 125.01 59.05 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.748 0 CA-C-N 113.926 -1.488 . . . . 0.0 109.185 177.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 18.5 mt . . . . . 0 N--CA 1.498 1.966 0 C-N-CA 118.475 -1.29 . . . . 0.0 110.126 -179.959 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 . . . . . 0 N--CA 1.484 1.238 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -103.26 148.61 25.61 Favored 'General case' 0 C--N 1.308 -1.217 0 C-N-CA 119.375 -0.93 . . . . 0.0 110.483 -177.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.472 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 1.6 m -103.38 88.5 3.12 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 119.445 -0.902 . . . . 0.0 110.844 -179.335 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.403 ' O ' ' O ' ' A' ' 27' ' ' LYS . 0.2 OUTLIER -97.47 139.68 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 C-N-CA 118.41 -1.316 . . . . 0.0 110.332 179.047 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 15.2 t -53.19 152.92 4.02 Favored 'General case' 0 C--N 1.272 -2.773 0 CA-C-N 113.887 -1.506 . . . . 0.0 111.021 -178.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 152.19 -167.17 31.22 Favored Glycine 0 N--CA 1.49 2.296 0 C-N-CA 119.08 -1.534 . . . . 0.0 110.797 179.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 18.5 mp0 -83.44 -176.77 6.47 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 119.396 -0.922 . . . . 0.0 110.367 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.483 ' CA ' HD22 ' A' ' 12' ' ' ASN . . . 177.76 172.23 42.02 Favored Glycine 0 N--CA 1.486 2.031 1 N-CA-C 129.575 6.59 . . . . 0.0 129.575 179.831 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -128.45 140.87 39.63 Favored Pre-proline 0 N--CA 1.486 1.363 0 C-N-CA 119.291 -0.964 . . . . 0.0 109.925 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -58.54 -163.16 0.02 OUTLIER 'Trans proline' 0 C--O 1.214 -0.692 0 C-N-CA 121.067 1.178 . . . . 0.0 111.059 178.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 . . . . . 0 C--N 1.305 -1.353 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.409 178.614 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.1 t . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 110.319 -0.252 . . . . 0.0 110.319 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -100.32 -169.44 1.73 Allowed 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 119.487 -0.885 . . . . 0.0 110.676 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.612 ' OG1' ' N ' ' A' ' 5' ' ' ASP . 0.1 OUTLIER -108.89 -175.42 2.76 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -179.953 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.612 ' N ' ' OG1' ' A' ' 4' ' ' THR . 0.0 OUTLIER -86.13 156.86 20.18 Favored 'General case' 0 C--N 1.293 -1.878 0 C-N-CA 118.982 -1.087 . . . . 0.0 110.619 -179.615 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.6 m -73.43 178.71 4.42 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 119.541 -0.864 . . . . 0.0 110.711 176.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 13.3 t -146.01 4.17 0.95 Allowed 'General case' 0 C--N 1.286 -2.182 0 CA-C-N 114.391 -1.277 . . . . 0.0 110.75 177.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -163.96 170.49 16.6 Favored 'General case' 0 C--N 1.282 -2.358 0 CA-C-N 114.575 -1.193 . . . . 0.0 110.284 178.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.44 ' HB3' ' H ' ' A' ' 30' ' ' LEU . 0.4 OUTLIER -83.31 151.37 25.61 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 119.603 -0.839 . . . . 0.0 109.117 178.479 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.13 -1.99 71.04 Favored Glycine 0 N--CA 1.493 2.447 0 C-N-CA 119.061 -1.542 . . . . 0.0 112.839 179.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.24 -165.24 0.46 Allowed 'General case' 0 N--CA 1.501 2.095 0 C-N-CA 118.752 -1.179 . . . . 0.0 109.723 179.248 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.543 ' OD1' ' N ' ' A' ' 24' ' ' GLN . 12.7 t-20 -150.63 -77.33 0.14 Allowed 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 117.987 -1.485 . . . . 0.0 114.5 -177.324 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.446 ' H ' ' HA ' ' A' ' 46' ' ' PRO . 12.4 mt -76.22 53.91 0.85 Allowed 'General case' 0 C--N 1.273 -2.755 0 C-N-CA 118.557 -1.257 . . . . 0.0 110.857 -175.268 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.638 ' SG ' ' N ' ' A' ' 15' ' ' LEU . 8.8 p -123.53 -152.47 0.51 Allowed 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 114.85 -1.068 . . . . 0.0 108.802 176.012 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.638 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 51.7 mt -112.97 119.6 38.48 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 115.044 -0.98 . . . . 0.0 108.646 176.558 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.406 ' SG ' ' O ' ' A' ' 22' ' ' CYS . 1.6 m -122.47 7.91 9.57 Favored 'General case' 0 N--CA 1.502 2.138 0 C-N-CA 118.634 -1.227 . . . . 0.0 111.15 -176.715 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -157.51 82.2 0.9 Allowed 'General case' 0 C--N 1.298 -1.647 0 C-N-CA 119.412 -0.915 . . . . 0.0 109.35 177.114 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.83 -112.76 3.69 Favored Glycine 0 N--CA 1.485 1.939 0 C-N-CA 119.424 -1.369 . . . . 0.0 109.981 -178.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.48 0.39 14.7 Favored 'General case' 0 CA--C 1.493 -1.249 0 CA-C-O 122.336 1.065 . . . . 0.0 109.551 179.534 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 71.8 m-20 -79.52 128.78 33.79 Favored 'General case' 0 C--N 1.257 -3.435 0 CA-C-N 113.099 -1.864 . . . . 0.0 111.278 -178.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.5 t -69.13 143.99 14.51 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 C-N-CA 118.594 -1.242 . . . . 0.0 108.563 177.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.517 ' O ' ' SG ' ' A' ' 28' ' ' CYS . 0.9 OUTLIER -146.71 128.17 14.99 Favored 'General case' 0 C--N 1.272 -2.768 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 179.642 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.536 ' C ' HD22 ' A' ' 12' ' ' ASN . . . 164.49 -79.85 0.13 Allowed Glycine 0 C--O 1.201 -1.908 0 C-N-CA 117.22 -2.419 . . . . 0.0 112.151 -176.373 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.543 ' N ' ' OD1' ' A' ' 12' ' ' ASN . 0.1 OUTLIER -44.78 125.13 4.76 Favored 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 119.647 -0.821 . . . . 0.0 111.66 -176.753 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.69 -26.2 8.6 Favored Glycine 0 N--CA 1.483 1.808 0 N-CA-C 109.899 -1.28 . . . . 0.0 109.899 -179.287 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.617 ' N ' ' ND2' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -129.53 -175.95 3.75 Favored 'General case' 0 C--N 1.311 -1.074 0 C-N-CA 120.22 -0.592 . . . . 0.0 111.066 -178.871 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.45 ' O ' ' N ' ' A' ' 40' ' ' VAL . 0.0 OUTLIER -120.56 153.83 36.2 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.038 175.187 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.517 ' SG ' ' O ' ' A' ' 22' ' ' CYS . 86.1 m -120.26 146.44 46.08 Favored 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 119.169 -1.013 . . . . 0.0 109.613 174.636 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.416 ' CD1' ' HZ2' ' A' ' 27' ' ' LYS . 2.3 mm -131.99 132.29 61.39 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.953 0 CA-C-N 114.314 -1.312 . . . . 0.0 109.93 179.489 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.44 ' H ' ' HB3' ' A' ' 9' ' ' SER . 14.8 mt . . . . . 0 N--CA 1.494 1.725 0 C-N-CA 118.327 -1.349 . . . . 0.0 108.891 176.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.522 ' OD1' ' N ' ' A' ' 37' ' ' ASN . 0.3 OUTLIER . . . . . 0 C--O 1.215 -0.717 0 CA-C-O 120.966 0.412 . . . . 0.0 110.829 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -120.78 149.56 42.36 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.144 -0.934 . . . . 0.0 109.727 178.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 3.0 m -100.33 105.73 17.28 Favored 'General case' 0 C--N 1.298 -1.658 0 C-N-CA 119.441 -0.904 . . . . 0.0 110.316 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.656 ' CG2' ' H ' ' A' ' 41' ' ' THR . 7.4 p -99.77 -176.81 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 C-N-CA 118.518 -1.273 . . . . 0.0 110.241 177.479 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.656 ' H ' ' CG2' ' A' ' 40' ' ' VAL . 12.5 t -91.67 160.05 15.56 Favored 'General case' 0 C--N 1.288 -2.068 0 CA-C-N 114.629 -1.169 . . . . 0.0 110.926 179.657 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 138.28 -147.47 19.25 Favored Glycine 0 N--CA 1.496 2.695 1 N-CA-C 131.793 7.477 . . . . 0.0 131.793 179.178 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -108.88 111.46 23.18 Favored 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 119.933 -0.707 . . . . 0.0 110.412 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -130.52 156.56 21.68 Favored Glycine 0 N--CA 1.491 2.363 1 N-CA-C 129.783 6.673 . . . . 0.0 129.783 178.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 5.8 t -111.31 145.2 32.04 Favored Pre-proline 0 N--CA 1.495 1.823 0 C-N-CA 119.59 -0.844 . . . . 0.0 110.197 -178.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.446 ' HA ' ' H ' ' A' ' 13' ' ' LEU . 7.2 Cg_exo -52.44 -176.97 0.02 OUTLIER 'Trans proline' 0 C--O 1.211 -0.854 0 C-N-CA 120.9 1.066 . . . . 0.0 110.351 175.727 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.555 ' CD ' ' H ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.306 -1.322 0 C-N-CA 118.866 -1.134 . . . . 0.0 108.519 178.594 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.509 ' CG1' ' H ' ' A' ' 3' ' ' TYR . 38.6 t . . . . . 0 N--CA 1.489 1.497 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.509 ' H ' ' CG1' ' A' ' 2' ' ' VAL . 35.8 m-85 -139.5 -166.24 2.02 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 119.722 -0.791 . . . . 0.0 110.125 -179.381 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -93.09 -174.95 3.71 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 119.679 -0.809 . . . . 0.0 108.858 179.064 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -100.58 154.09 18.85 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 119.03 -1.068 . . . . 0.0 110.441 179.069 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 4.3 m -74.67 174.91 8.43 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-O 122.144 0.973 . . . . 0.0 111.188 178.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -140.26 7.49 2.19 Favored 'General case' 0 C--N 1.285 -2.232 0 CA-C-N 113.549 -1.659 . . . . 0.0 109.471 177.592 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -163.13 162.64 25.72 Favored 'General case' 0 C--N 1.279 -2.481 0 CA-C-N 113.784 -1.553 . . . . 0.0 109.0 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.604 ' OG ' ' N ' ' A' ' 30' ' ' LEU . 0.9 OUTLIER -65.1 -168.11 0.03 OUTLIER 'General case' 0 C--N 1.293 -1.876 0 C-N-CA 118.992 -1.083 . . . . 0.0 110.057 -179.087 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 37.1 6.05 0.0 OUTLIER Glycine 0 N--CA 1.505 3.281 1 N-CA-C 130.124 6.81 . . . . 0.0 130.124 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -74.79 -167.0 0.52 Allowed 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 175.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.474 ' ND2' ' C ' ' A' ' 23' ' ' GLY . 1.4 m-20 -143.01 -70.24 0.33 Allowed 'General case' 0 N--CA 1.5 2.072 0 C-N-CA 117.55 -1.66 . . . . 0.0 114.987 -178.41 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 15.0 mt -77.67 50.45 0.83 Allowed 'General case' 0 C--N 1.27 -2.879 0 C-N-CA 117.244 -1.782 . . . . 0.0 111.111 -174.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.575 ' SG ' ' N ' ' A' ' 15' ' ' LEU . 15.6 p -119.76 -146.48 0.38 Allowed 'General case' 0 C--O 1.207 -1.146 0 CA-C-N 114.948 -1.023 . . . . 0.0 108.397 175.178 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.575 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 7.7 mt -128.85 130.77 47.34 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.822 177.657 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.421 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 7.9 m -139.0 21.47 2.63 Favored 'General case' 0 N--CA 1.498 1.971 0 C-N-CA 119.127 -1.029 . . . . 0.0 110.536 -179.417 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -146.41 55.16 1.14 Allowed 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 177.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.7 -66.92 2.01 Favored Glycine 0 N--CA 1.487 2.063 0 C-N-CA 119.479 -1.344 . . . . 0.0 110.19 -179.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.411 ' O ' ' OG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -144.4 1.72 1.08 Allowed 'General case' 0 C--N 1.309 -1.191 0 C-N-CA 119.445 -0.902 . . . . 0.0 111.57 -179.833 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -90.1 134.91 33.98 Favored 'General case' 0 C--N 1.253 -3.615 0 CA-C-N 114.37 -1.286 . . . . 0.0 110.464 179.033 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.3 t -74.2 144.12 12.79 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 C-N-CA 119.459 -0.897 . . . . 0.0 109.718 179.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.466 ' O ' ' O ' ' A' ' 12' ' ' ASN . 1.2 m -141.82 121.28 13.24 Favored 'General case' 0 C--N 1.29 -1.979 0 C-N-CA 118.857 -1.137 . . . . 0.0 109.384 178.398 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.474 ' C ' ' ND2' ' A' ' 12' ' ' ASN . . . 173.91 -87.69 0.08 OUTLIER Glycine 0 C--O 1.205 -1.664 0 C-N-CA 117.851 -2.119 . . . . 0.0 111.803 -176.223 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -49.8 126.49 14.08 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 119.291 -0.964 . . . . 0.0 110.491 -178.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.52 -26.27 14.68 Favored Glycine 0 N--CA 1.482 1.716 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -178.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.449 ' O ' ' O ' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -138.88 -160.9 1.11 Allowed 'General case' 0 C--N 1.311 -1.087 0 C-N-CA 119.954 -0.699 . . . . 0.0 111.139 -179.855 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.534 ' O ' ' O ' ' A' ' 40' ' ' VAL . 21.1 ttpt -148.5 148.0 29.74 Favored 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 119.66 -0.816 . . . . 0.0 109.88 177.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 87.3 m -99.59 160.45 14.29 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 118.31 -1.356 . . . . 0.0 111.053 178.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 18.5 mm -151.77 90.46 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.274 -2.705 0 CA-C-N 113.574 -1.648 . . . . 0.0 106.711 175.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.604 ' N ' ' OG ' ' A' ' 9' ' ' SER . 3.1 pp . . . . . 0 C--N 1.288 -2.069 0 C-N-CA 118.051 -1.46 . . . . 0.0 113.359 -173.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.464 ' HA ' ' HA ' ' A' ' 30' ' ' LEU . 58.4 m-80 . . . . . 0 C--O 1.216 -0.665 0 CA-C-O 120.246 0.07 . . . . 0.0 110.937 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -110.41 145.32 37.79 Favored 'General case' 0 C--N 1.309 -1.183 0 C-N-CA 119.595 -0.842 . . . . 0.0 110.172 178.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 86.5 m -110.84 85.17 2.06 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.715 179.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.534 ' O ' ' O ' ' A' ' 27' ' ' LYS . 1.2 p -97.27 141.74 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 C-N-CA 118.617 -1.233 . . . . 0.0 112.704 -177.52 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.6 t -62.68 140.13 58.69 Favored 'General case' 0 C--N 1.27 -2.876 0 CA-C-N 113.807 -1.542 . . . . 0.0 110.656 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 168.87 -136.06 3.89 Favored Glycine 0 N--CA 1.493 2.456 0 C-N-CA 119.396 -1.383 . . . . 0.0 110.692 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -140.96 113.73 8.3 Favored 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 119.752 -0.779 . . . . 0.0 109.864 -179.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -127.54 171.13 19.01 Favored Glycine 0 N--CA 1.501 3.032 0 C-N-CA 119.725 -1.226 . . . . 0.0 111.247 -178.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -104.83 150.22 38.41 Favored Pre-proline 0 C--N 1.307 -1.254 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 179.6 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -53.51 -164.79 0.01 OUTLIER 'Trans proline' 0 C--O 1.215 -0.641 0 C-N-CA 121.392 1.395 . . . . 0.0 111.765 177.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 . . . . . 0 C--N 1.308 -1.234 0 CA-C-N 115.086 -0.961 . . . . 0.0 108.648 177.553 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.2 t . . . . . 0 N--CA 1.489 1.494 0 CA-C-O 122.043 0.925 . . . . 0.0 110.272 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 -89.61 -178.29 5.51 Favored 'General case' 0 C--N 1.262 -3.235 0 CA-C-N 114.082 -1.417 . . . . 0.0 111.517 -178.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.4 ' H ' ' HG1' ' A' ' 4' ' ' THR . 23.2 p -116.38 -178.5 3.43 Favored 'General case' 0 N--CA 1.486 1.331 0 CA-C-N 114.821 -1.081 . . . . 0.0 108.857 179.19 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.1 154.23 22.18 Favored 'General case' 0 C--N 1.29 -1.998 0 C-N-CA 118.373 -1.331 . . . . 0.0 110.767 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.46 ' SG ' ' O ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -75.37 145.53 41.57 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.116 177.727 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.451 ' O ' ' OG1' ' A' ' 7' ' ' THR . 0.0 OUTLIER -114.69 8.14 16.13 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.703 -0.799 . . . . 0.0 109.506 178.525 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -162.3 171.01 17.94 Favored 'General case' 0 C--N 1.283 -2.287 0 CA-C-N 114.349 -1.296 . . . . 0.0 111.489 179.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -84.47 155.28 22.27 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 114.922 -1.035 . . . . 0.0 110.451 -178.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 87.66 -2.55 86.13 Favored Glycine 0 N--CA 1.498 2.783 0 C-N-CA 119.295 -1.431 . . . . 0.0 111.978 179.064 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -71.53 -174.91 1.18 Allowed 'General case' 0 N--CA 1.505 2.3 0 C-N-CA 119.232 -0.987 . . . . 0.0 110.219 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.537 ' ND2' ' O ' ' A' ' 26' ' ' ASN . 7.1 m120 -146.62 -71.67 0.23 Allowed 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 118.244 -1.382 . . . . 0.0 113.313 -179.106 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 24.6 mt -77.65 50.94 0.87 Allowed 'General case' 0 C--N 1.273 -2.718 0 C-N-CA 118.22 -1.392 . . . . 0.0 110.201 -177.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.423 ' H ' ' C ' ' A' ' 12' ' ' ASN . 30.6 p -119.06 -156.44 0.65 Allowed 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.895 176.738 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.46 ' O ' ' SG ' ' A' ' 6' ' ' CYS . 6.0 mt -123.16 128.67 50.38 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 114.877 -1.056 . . . . 0.0 108.551 175.74 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 93.6 m -115.1 -44.0 3.05 Favored 'General case' 0 N--CA 1.518 2.969 0 C-N-CA 118.221 -1.391 . . . . 0.0 110.61 -179.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -102.19 116.25 32.26 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.058 -1.057 . . . . 0.0 110.057 178.326 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 47.87 -96.95 0.01 OUTLIER Glycine 0 N--CA 1.493 2.443 0 C-N-CA 119.546 -1.311 . . . . 0.0 111.299 179.213 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.432 ' O ' ' OG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -131.44 6.72 4.47 Favored 'General case' 0 N--CA 1.485 1.32 0 CA-C-O 122.556 1.169 . . . . 0.0 110.211 -178.01 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 19.2 m-80 -80.11 132.18 35.89 Favored 'General case' 0 C--N 1.251 -3.674 0 CA-C-N 113.373 -1.739 . . . . 0.0 110.39 178.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.6 t -66.64 151.08 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 119.232 -0.987 . . . . 0.0 110.184 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.496 ' O ' ' O ' ' A' ' 12' ' ' ASN . 0.0 OUTLIER -150.74 112.82 4.57 Favored 'General case' 0 C--N 1.284 -2.28 0 C-N-CA 118.936 -1.106 . . . . 0.0 110.861 -179.882 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 154.77 -45.56 0.55 Allowed Glycine 0 N--CA 1.483 1.771 1 N-CA-C 130.522 6.969 . . . . 0.0 130.522 -177.169 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.539 ' C ' ' H ' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -56.92 133.45 54.68 Favored 'General case' 0 C--N 1.31 -1.134 0 C-N-CA 119.347 -0.941 . . . . 0.0 110.228 179.871 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 73.89 -23.8 1.07 Allowed Glycine 0 C--N 1.298 -1.578 0 C-N-CA 119.264 -1.446 . . . . 0.0 110.149 -179.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.539 ' H ' ' C ' ' A' ' 24' ' ' GLN . 0.0 OUTLIER -111.14 -155.14 0.56 Allowed 'General case' 0 C--O 1.213 -0.849 0 C-N-CA 119.743 -0.783 . . . . 0.0 110.571 -179.311 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.519 ' O ' ' O ' ' A' ' 40' ' ' VAL . 0.3 OUTLIER -157.83 105.91 2.02 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.623 179.389 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.501 ' SG ' ' O ' ' A' ' 38' ' ' GLN . 0.0 OUTLIER -77.21 162.95 26.98 Favored 'General case' 0 CA--C 1.481 -1.68 0 C-N-CA 117.457 -1.697 . . . . 0.0 111.342 -179.055 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 23.7 mm -144.24 119.21 3.82 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.347 0 CA-C-N 112.276 -2.238 . . . . 0.0 108.273 -179.263 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 16.3 mt . . . . . 0 N--CA 1.488 1.444 0 C-N-CA 118.199 -1.4 . . . . 0.0 112.104 -176.707 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 65.1 m-20 . . . . . 0 N--CA 1.493 1.682 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.501 ' O ' ' SG ' ' A' ' 28' ' ' CYS . 10.2 tt0 -150.77 153.06 34.76 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 117.82 -1.552 . . . . 0.0 112.66 -178.151 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -108.03 114.42 28.31 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 114.602 -1.181 . . . . 0.0 112.004 179.334 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.522 ' CG2' ' N ' ' A' ' 41' ' ' THR . 5.8 p -128.24 158.74 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 C-N-CA 118.579 -1.248 . . . . 0.0 110.172 173.647 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.522 ' N ' ' CG2' ' A' ' 40' ' ' VAL . 0.5 OUTLIER -88.07 138.31 31.56 Favored 'General case' 0 C--N 1.27 -2.862 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.707 -179.876 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 178.48 -153.15 12.28 Favored Glycine 0 N--CA 1.489 2.184 0 C-N-CA 119.43 -1.367 . . . . 0.0 110.411 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -98.97 108.78 21.55 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 119.531 -0.867 . . . . 0.0 110.786 -179.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -129.49 170.28 20.46 Favored Glycine 0 N--CA 1.493 2.445 1 N-CA-C 129.34 6.496 . . . . 0.0 129.34 178.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.2 t -113.61 141.14 25.5 Favored Pre-proline 0 N--CA 1.496 1.843 0 C-N-CA 119.103 -1.039 . . . . 0.0 110.128 -179.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.441 ' O ' ' C ' ' A' ' 47' ' ' GLU . 9.5 Cg_endo -71.72 107.77 2.27 Favored 'Trans proline' 0 C--O 1.213 -0.755 0 C-N-CA 120.989 1.126 . . . . 0.0 110.123 174.675 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.441 ' C ' ' O ' ' A' ' 46' ' ' PRO . 3.6 tm-20 . . . . . 0 N--CA 1.503 2.187 0 C-N-CA 120.056 -0.658 . . . . 0.0 110.673 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.411 HG11 ' H ' ' A' ' 3' ' ' TYR . 0.5 OUTLIER . . . . . 0 N--CA 1.478 0.95 0 CA-C-O 120.936 0.398 . . . . 0.0 110.573 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.411 ' H ' HG11 ' A' ' 2' ' ' VAL . 22.4 m-85 -137.7 -164.71 1.65 Allowed 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.993 -0.683 . . . . 0.0 109.943 -179.323 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -93.98 167.49 11.57 Favored 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 119.266 -0.974 . . . . 0.0 109.281 -179.778 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.485 ' OD1' ' N ' ' A' ' 5' ' ' ASP . 0.0 OUTLIER -84.92 144.49 28.32 Favored 'General case' 0 C--N 1.291 -1.937 0 C-N-CA 118.464 -1.294 . . . . 0.0 109.979 179.599 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -72.11 -178.49 2.44 Favored 'General case' 0 C--N 1.287 -2.136 0 CA-C-O 122.147 0.975 . . . . 0.0 110.542 177.523 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.2 t -159.47 18.31 0.17 Allowed 'General case' 0 C--N 1.272 -2.784 0 CA-C-N 113.538 -1.665 . . . . 0.0 109.263 177.064 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -162.7 -178.46 6.2 Favored 'General case' 0 C--N 1.293 -1.866 0 CA-C-N 114.218 -1.355 . . . . 0.0 110.055 -178.122 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.476 ' HB3' ' H ' ' A' ' 30' ' ' LEU . 0.8 OUTLIER -98.24 166.26 11.48 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.303 -179.787 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.459 ' O ' ' O ' ' A' ' 11' ' ' GLN . . . 84.12 -43.65 3.22 Favored Glycine 0 N--CA 1.509 3.519 0 C-N-CA 119.584 -1.293 . . . . 0.0 113.235 176.819 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.459 ' O ' ' O ' ' A' ' 10' ' ' GLY . 10.9 mt-30 -47.65 178.68 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.563 0 C-N-CA 119.727 -0.789 . . . . 0.0 111.099 -177.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.551 ' O ' ' O ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -144.38 -59.21 0.38 Allowed 'General case' 0 N--CA 1.507 2.418 0 C-N-CA 118.16 -1.416 . . . . 0.0 114.372 -176.31 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.501 ' N ' ' CG ' ' A' ' 12' ' ' ASN . 12.7 mt -76.79 48.07 0.55 Allowed 'General case' 0 C--N 1.27 -2.866 0 C-N-CA 117.156 -1.818 . . . . 0.0 110.995 -176.269 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.586 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 25.0 p -123.38 -160.24 0.89 Allowed 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 176.325 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 70.6 mt -109.03 110.29 21.53 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 176.232 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.586 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 1.9 m -117.62 9.34 13.09 Favored 'General case' 0 N--CA 1.505 2.287 0 C-N-CA 119.19 -1.004 . . . . 0.0 110.345 -176.202 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.419 ' OE2' ' SG ' ' A' ' 22' ' ' CYS . 34.5 mt-10 -141.73 60.78 1.48 Allowed 'General case' 0 C--N 1.288 -2.07 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 177.189 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 79.66 -105.82 2.35 Favored Glycine 0 N--CA 1.484 1.862 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 -177.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.37 -3.22 17.26 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-O 122.232 1.015 . . . . 0.0 109.708 179.165 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 -81.16 133.53 35.47 Favored 'General case' 0 C--N 1.262 -3.2 0 CA-C-N 113.327 -1.76 . . . . 0.0 111.443 -178.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.3 t -70.0 142.3 16.04 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 C-N-CA 119.015 -1.074 . . . . 0.0 109.708 178.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.58 ' O ' ' SG ' ' A' ' 28' ' ' CYS . 0.1 OUTLIER -143.49 119.79 10.88 Favored 'General case' 0 C--N 1.281 -2.39 0 C-N-CA 119.025 -1.07 . . . . 0.0 109.467 177.387 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.445 ' O ' ' O ' ' A' ' 26' ' ' ASN . . . 151.78 -39.55 0.78 Allowed Glycine 0 C--N 1.294 -1.759 1 N-CA-C 130.544 6.978 . . . . 0.0 130.544 -178.806 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -58.28 115.03 2.69 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 118.882 -1.127 . . . . 0.0 110.266 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.49 -23.33 8.73 Favored Glycine 0 C--N 1.3 -1.447 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -178.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.644 ' N ' ' ND2' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -115.31 -168.99 1.48 Allowed 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.638 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.509 ' O ' ' O ' ' A' ' 40' ' ' VAL . 7.4 tttt -148.59 135.94 20.34 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 118.523 -1.271 . . . . 0.0 110.078 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.58 ' SG ' ' O ' ' A' ' 22' ' ' CYS . 2.9 m -95.65 153.72 17.58 Favored 'General case' 0 C--N 1.307 -1.282 0 C-N-CA 118.289 -1.365 . . . . 0.0 111.458 179.513 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 14.9 mm -136.18 130.53 48.15 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.47 0 CA-C-N 114.05 -1.432 . . . . 0.0 109.811 174.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.476 ' H ' ' HB3' ' A' ' 9' ' ' SER . 23.3 mt . . . . . 0 N--CA 1.496 1.868 0 C-N-CA 119.271 -0.972 . . . . 0.0 108.473 177.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.558 ' OD1' ' N ' ' A' ' 37' ' ' ASN . 0.2 OUTLIER . . . . . 0 C--O 1.215 -0.719 0 CA-C-O 121.294 0.568 . . . . 0.0 111.0 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.77 145.93 27.81 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-N 115.267 -0.878 . . . . 0.0 109.64 178.602 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -83.75 116.62 22.78 Favored 'General case' 0 C--N 1.288 -2.106 0 CA-C-N 115.32 -0.854 . . . . 0.0 112.615 -177.624 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.509 ' O ' ' O ' ' A' ' 27' ' ' LYS . 0.9 OUTLIER -119.22 129.69 74.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 CA-C-O 122.606 1.193 . . . . 0.0 110.596 173.707 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 10.1 t -46.98 148.78 1.01 Allowed 'General case' 0 C--N 1.258 -3.378 0 CA-C-N 113.42 -1.718 . . . . 0.0 111.134 -178.032 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.401 ' O ' ' C ' ' A' ' 26' ' ' ASN . . . 149.37 149.66 5.04 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.954 -1.259 . . . . 0.0 109.954 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -80.01 63.4 4.52 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 119.035 -1.066 . . . . 0.0 110.873 -179.323 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -63.36 162.91 32.14 Favored Glycine 0 N--CA 1.49 2.296 0 C-N-CA 119.181 -1.485 . . . . 0.0 109.437 178.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.4 t -79.87 141.04 54.68 Favored Pre-proline 0 N--CA 1.488 1.474 0 C-N-CA 118.514 -1.275 . . . . 0.0 109.835 -179.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.414 ' O ' ' C ' ' A' ' 47' ' ' GLU . 8.4 Cg_endo -67.14 116.46 4.19 Favored 'Trans proline' 0 C--O 1.213 -0.768 0 C-N-CA 121.117 1.211 . . . . 0.0 111.36 178.263 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.414 ' C ' ' O ' ' A' ' 46' ' ' PRO . 0.4 OUTLIER . . . . . 0 N--CA 1.504 2.24 0 C-N-CA 120.284 -0.567 . . . . 0.0 110.929 179.741 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.8 t . . . . . 0 N--CA 1.489 1.48 0 CA-C-O 120.866 0.365 . . . . 0.0 110.303 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 -130.0 -164.59 1.43 Allowed 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 120.038 -0.665 . . . . 0.0 109.782 179.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -92.83 176.76 6.31 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 119.366 -0.934 . . . . 0.0 108.58 179.069 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.527 ' N ' ' OD1' ' A' ' 5' ' ' ASP . 0.2 OUTLIER -97.02 151.88 19.28 Favored 'General case' 0 C--N 1.294 -1.815 0 C-N-CA 118.889 -1.124 . . . . 0.0 109.554 178.013 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.407 ' N ' ' HB2' ' A' ' 14' ' ' CYS . 1.5 m -70.29 176.76 3.71 Favored 'General case' 0 C--N 1.285 -2.212 0 C-N-CA 119.216 -0.993 . . . . 0.0 110.165 177.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.476 ' H ' HE22 ' A' ' 11' ' ' GLN . 0.1 OUTLIER -153.9 7.72 0.35 Allowed 'General case' 0 C--N 1.274 -2.707 0 CA-C-N 114.112 -1.404 . . . . 0.0 110.474 177.795 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -166.46 173.02 10.28 Favored 'General case' 0 C--N 1.284 -2.248 0 CA-C-N 114.505 -1.225 . . . . 0.0 109.761 -179.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.5 136.19 33.53 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 119.375 -0.93 . . . . 0.0 109.124 -178.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.601 ' CA ' ' HZ3' ' A' ' 27' ' ' LYS . . . 112.13 -30.22 7.83 Favored Glycine 0 N--CA 1.493 2.486 1 N-CA-C 129.642 6.617 . . . . 0.0 129.642 -175.873 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.476 HE22 ' H ' ' A' ' 7' ' ' THR . 0.1 OUTLIER -56.21 -167.19 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.909 0 C-N-CA 119.34 -0.944 . . . . 0.0 109.672 178.7 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.582 ' ND2' ' O ' ' A' ' 23' ' ' GLY . 22.2 t-20 -142.18 -69.2 0.36 Allowed 'General case' 0 N--CA 1.496 1.837 0 C-N-CA 118.472 -1.291 . . . . 0.0 113.766 -176.343 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 14.1 mt -78.38 50.39 0.93 Allowed 'General case' 0 C--N 1.261 -3.258 0 C-N-CA 118.227 -1.389 . . . . 0.0 110.9 -176.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.56 ' SG ' ' N ' ' A' ' 15' ' ' LEU . 13.1 p -114.22 -153.14 0.52 Allowed 'General case' 0 N--CA 1.506 2.371 0 C-N-CA 118.788 -1.165 . . . . 0.0 110.719 177.345 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.56 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 7.7 mt -127.5 137.09 52.56 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 114.068 -1.424 . . . . 0.0 109.751 178.737 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.423 ' SG ' ' CB ' ' A' ' 22' ' ' CYS . 97.5 m -125.11 -77.85 0.59 Allowed 'General case' 0 N--CA 1.513 2.706 0 C-N-CA 118.998 -1.081 . . . . 0.0 111.531 179.504 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -80.07 112.33 17.28 Favored 'General case' 0 C--N 1.299 -1.604 0 C-N-CA 118.345 -1.342 . . . . 0.0 110.282 -178.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 66.06 -107.22 1.86 Allowed Glycine 0 N--CA 1.491 2.308 0 C-N-CA 119.497 -1.335 . . . . 0.0 110.36 -179.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.485 ' O ' ' OG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -134.87 11.43 3.65 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 122.981 1.372 . . . . 0.0 108.896 179.95 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.621 ' N ' HD21 ' A' ' 20' ' ' ASN . 0.8 OUTLIER -76.71 127.95 33.73 Favored 'General case' 0 C--N 1.255 -3.503 0 CA-C-N 112.712 -2.04 . . . . 0.0 109.479 178.366 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.3 t -63.57 146.54 12.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 C-N-CA 118.827 -1.149 . . . . 0.0 110.017 -179.01 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.507 ' O ' ' O ' ' A' ' 12' ' ' ASN . 0.0 OUTLIER -135.51 114.88 12.51 Favored 'General case' 0 C--N 1.299 -1.611 0 C-N-CA 119.164 -1.014 . . . . 0.0 109.773 179.566 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.582 ' O ' ' ND2' ' A' ' 12' ' ' ASN . . . 149.76 -55.14 0.48 Allowed Glycine 0 C--O 1.205 -1.712 1 N-CA-C 129.639 6.615 . . . . 0.0 129.639 -176.916 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.456 ' N ' ' OD1' ' A' ' 12' ' ' ASN . 1.1 tm0? -51.59 121.9 7.19 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 118.325 -1.35 . . . . 0.0 109.923 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.82 -26.34 6.05 Favored Glycine 0 C--N 1.297 -1.592 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 -177.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.489 ' N ' ' O ' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -126.0 -162.21 1.11 Allowed 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 119.974 -0.691 . . . . 0.0 111.263 -179.628 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.601 ' HZ3' ' CA ' ' A' ' 10' ' ' GLY . 0.5 OUTLIER -153.69 124.59 7.29 Favored 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 119.196 -1.002 . . . . 0.0 110.674 177.727 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -81.75 155.93 25.23 Favored 'General case' 0 CA--C 1.483 -1.628 0 C-N-CA 118.31 -1.356 . . . . 0.0 111.876 179.437 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 4.2 mm -133.09 117.54 29.37 Favored 'Isoleucine or valine' 0 C--N 1.256 -3.467 0 CA-C-N 112.201 -2.272 . . . . 0.0 109.2 177.106 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 21.1 mt . . . . . 0 N--CA 1.505 2.281 0 C-N-CA 118.631 -1.228 . . . . 0.0 111.171 -178.867 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.558 ' OD1' ' N ' ' A' ' 37' ' ' ASN . 0.1 OUTLIER . . . . . 0 N--CA 1.475 0.797 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -121.98 151.25 40.99 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 119.67 -0.812 . . . . 0.0 110.916 -178.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -105.13 109.34 21.29 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.777 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.513 ' CG2' ' N ' ' A' ' 41' ' ' THR . 2.3 p -125.59 159.74 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.153 0 C-N-CA 118.869 -1.132 . . . . 0.0 110.06 175.14 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.513 ' N ' ' CG2' ' A' ' 40' ' ' VAL . 3.0 t -69.58 146.96 51.35 Favored 'General case' 0 C--N 1.275 -2.645 0 CA-C-N 115.124 -0.944 . . . . 0.0 111.183 -179.366 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 175.79 160.99 24.31 Favored Glycine 0 N--CA 1.489 2.217 0 C-N-CA 119.28 -1.438 . . . . 0.0 110.494 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -81.28 104.85 12.03 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 119.452 -0.899 . . . . 0.0 110.286 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -123.4 165.28 16.16 Favored Glycine 0 N--CA 1.492 2.395 1 N-CA-C 130.306 6.882 . . . . 0.0 130.306 179.474 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 14.3 t -100.38 142.86 25.43 Favored Pre-proline 0 N--CA 1.49 1.563 0 C-N-CA 119.266 -0.973 . . . . 0.0 110.564 -178.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -53.5 171.88 0.27 Allowed 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 121.246 1.297 . . . . 0.0 111.187 175.178 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.449 ' OE1' ' NE2' ' A' ' 11' ' ' GLN . 12.2 tp10 . . . . . 0 CA--C 1.561 1.383 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.72 178.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.6 t . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -126.29 -166.6 1.59 Allowed 'General case' 0 N--CA 1.496 1.827 0 C-N-CA 119.946 -0.702 . . . . 0.0 110.917 -178.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.0 p -102.43 179.17 4.38 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.099 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -84.92 152.38 23.56 Favored 'General case' 0 C--N 1.294 -1.836 0 C-N-CA 118.502 -1.279 . . . . 0.0 110.906 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.423 ' N ' ' HB2' ' A' ' 14' ' ' CYS . 0.8 OUTLIER -74.82 -177.49 3.29 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.883 176.582 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.8 t -151.84 11.11 0.56 Allowed 'General case' 0 C--N 1.281 -2.413 0 CA-C-N 114.673 -1.149 . . . . 0.0 110.749 177.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -160.49 158.0 28.53 Favored 'General case' 0 C--N 1.29 -2.008 0 CA-C-N 114.557 -1.201 . . . . 0.0 109.514 -178.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.404 ' HA ' ' H ' ' A' ' 30' ' ' LEU . 0.3 OUTLIER -79.32 138.49 37.74 Favored 'General case' 0 C--N 1.293 -1.856 0 C-N-CA 119.605 -0.838 . . . . 0.0 108.995 -179.116 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.66 ' CA ' ' HZ3' ' A' ' 27' ' ' LYS . . . 107.27 -35.14 5.21 Favored Glycine 0 N--CA 1.5 2.912 1 N-CA-C 129.64 6.616 . . . . 0.0 129.64 -173.72 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 -56.86 -166.21 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.167 0 C-N-CA 119.729 -0.788 . . . . 0.0 110.22 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.475 ' ND2' ' C ' ' A' ' 23' ' ' GLY . 1.4 m-20 -141.37 -66.78 0.41 Allowed 'General case' 0 N--CA 1.508 2.46 0 N-CA-C 115.41 1.633 . . . . 0.0 115.41 -175.633 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 35.7 mt -76.51 51.81 0.75 Allowed 'General case' 0 C--N 1.277 -2.562 0 C-N-CA 118.048 -1.461 . . . . 0.0 111.022 -173.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.423 ' HB2' ' N ' ' A' ' 6' ' ' CYS . 27.3 p -123.62 -154.22 0.6 Allowed 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 114.908 -1.042 . . . . 0.0 108.943 176.285 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 70.8 mt -117.77 116.72 27.57 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 176.155 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.421 ' O ' ' OE1' ' A' ' 17' ' ' GLU . 2.8 m -116.7 -7.06 11.57 Favored 'General case' 0 N--CA 1.5 2.027 0 C-N-CA 118.617 -1.233 . . . . 0.0 111.746 -176.747 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.5 ' OE1' ' SG ' ' A' ' 39' ' ' CYS . 0.3 OUTLIER -127.09 75.49 1.58 Allowed 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 119.245 -0.982 . . . . 0.0 109.255 177.194 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 71.59 -81.26 0.51 Allowed Glycine 0 N--CA 1.489 2.221 0 C-N-CA 119.475 -1.345 . . . . 0.0 110.605 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -135.38 0.88 2.84 Favored 'General case' 0 N--CA 1.486 1.348 0 CA-C-O 121.907 0.86 . . . . 0.0 110.89 -179.24 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.489 ' N ' ' OD1' ' A' ' 20' ' ' ASN . 0.9 OUTLIER -85.13 139.99 31.28 Favored 'General case' 0 C--N 1.257 -3.455 0 CA-C-N 113.824 -1.535 . . . . 0.0 111.234 -179.011 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.2 t -73.79 144.55 12.46 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 C-N-CA 118.704 -1.198 . . . . 0.0 109.867 178.03 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.484 ' O ' ' SG ' ' A' ' 28' ' ' CYS . 3.8 m -149.98 119.95 7.16 Favored 'General case' 0 C--N 1.278 -2.502 0 C-N-CA 118.775 -1.17 . . . . 0.0 108.593 178.07 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.475 ' C ' ' ND2' ' A' ' 12' ' ' ASN . . . 173.09 -84.8 0.08 OUTLIER Glycine 0 C--N 1.3 -1.466 0 C-N-CA 117.688 -2.196 . . . . 0.0 112.055 -176.241 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.504 ' C ' ' H ' ' A' ' 26' ' ' ASN . 25.9 tt0 -42.43 133.68 3.22 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.868 -0.733 . . . . 0.0 111.321 -178.003 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.476 ' C ' HD21 ' A' ' 26' ' ' ASN . . . 76.69 -27.51 1.59 Allowed Glycine 0 N--CA 1.479 1.547 0 C-N-CA 119.679 -1.248 . . . . 0.0 110.083 -179.533 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.518 ' ND2' ' N ' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -128.84 -159.94 0.99 Allowed 'General case' 0 C--N 1.316 -0.871 0 C-N-CA 119.696 -0.802 . . . . 0.0 111.6 -179.039 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.66 ' HZ3' ' CA ' ' A' ' 10' ' ' GLY . 3.4 ttpp -142.98 175.39 9.88 Favored 'General case' 0 N--CA 1.498 1.955 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.815 179.184 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.484 ' SG ' ' O ' ' A' ' 22' ' ' CYS . 57.3 m -138.55 160.66 39.01 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 118.965 -1.094 . . . . 0.0 111.173 176.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 7.8 mm -140.69 97.75 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.13 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 174.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.52 ' CD1' ' C ' ' A' ' 30' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--N 1.291 -1.944 0 C-N-CA 118.129 -1.428 . . . . 0.0 110.743 -176.216 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.652 ' ND2' ' N ' ' A' ' 38' ' ' GLN . 0.2 OUTLIER . . . . . 0 C--O 1.217 -0.656 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.652 ' N ' ' ND2' ' A' ' 37' ' ' ASN . 10.3 tt0 -131.89 143.29 50.04 Favored 'General case' 0 C--N 1.311 -1.086 0 C-N-CA 119.823 -0.751 . . . . 0.0 110.321 177.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.5 ' SG ' ' OE1' ' A' ' 17' ' ' GLU . 66.2 m -97.93 99.7 11.01 Favored 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 119.539 -0.864 . . . . 0.0 110.01 179.121 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.525 ' O ' ' N ' ' A' ' 27' ' ' LYS . 11.2 p -112.89 155.13 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.334 0 C-N-CA 118.436 -1.306 . . . . 0.0 111.532 179.513 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.4 t -75.0 148.12 40.18 Favored 'General case' 0 C--N 1.265 -3.077 0 CA-C-N 113.836 -1.529 . . . . 0.0 111.292 -179.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 158.72 -179.82 34.1 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 110.119 -1.192 . . . . 0.0 110.119 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -90.8 110.66 21.86 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 119.332 -0.947 . . . . 0.0 110.423 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -128.71 165.76 21.45 Favored Glycine 0 N--CA 1.497 2.701 0 N-CA-C 110.235 -1.146 . . . . 0.0 110.235 179.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -104.5 145.14 30.12 Favored Pre-proline 0 N--CA 1.494 1.774 0 C-N-CA 119.649 -0.82 . . . . 0.0 109.953 -179.649 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -56.47 142.94 89.06 Favored 'Trans proline' 0 C--O 1.216 -0.617 0 C-N-CA 121.232 1.288 . . . . 0.0 111.297 177.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 . . . . . 0 CA--C 1.558 1.261 0 C-N-CA 119.5 -0.88 . . . . 0.0 112.418 -179.795 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.0 t . . . . . 0 N--CA 1.488 1.439 0 CA-C-O 121.043 0.449 . . . . 0.0 110.676 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -94.13 -163.69 1.08 Allowed 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 119.714 -0.795 . . . . 0.0 110.07 179.463 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.641 ' HG1' ' N ' ' A' ' 5' ' ' ASP . 0.1 OUTLIER -96.39 179.48 5.01 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.705 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.641 ' N ' ' HG1' ' A' ' 4' ' ' THR . 0.0 OUTLIER -93.77 153.45 18.3 Favored 'General case' 0 C--N 1.289 -2.048 0 C-N-CA 118.92 -1.112 . . . . 0.0 109.858 179.856 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.499 ' SG ' ' OE1' ' A' ' 11' ' ' GLN . 1.2 m -74.13 177.07 5.99 Favored 'General case' 0 C--N 1.291 -1.945 0 C-N-CA 119.406 -0.918 . . . . 0.0 110.515 177.087 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.7 t -152.69 10.84 0.49 Allowed 'General case' 0 C--N 1.279 -2.48 0 CA-C-N 113.924 -1.489 . . . . 0.0 110.151 177.334 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -163.02 167.54 22.27 Favored 'General case' 0 C--N 1.283 -2.318 0 CA-C-N 114.453 -1.248 . . . . 0.0 109.939 178.758 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -84.41 145.16 28.33 Favored 'General case' 0 C--N 1.296 -1.726 0 C-N-CA 119.136 -1.026 . . . . 0.0 108.83 -178.798 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 102.41 -29.46 12.46 Favored Glycine 0 N--CA 1.512 3.706 1 N-CA-C 130.151 6.82 . . . . 0.0 130.151 -175.286 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.499 ' OE1' ' SG ' ' A' ' 6' ' ' CYS . 72.9 mt-30 -58.42 -158.92 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.065 0 C-N-CA 119.83 -0.748 . . . . 0.0 110.756 -179.777 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.527 ' ND2' ' O ' ' A' ' 23' ' ' GLY . 3.0 m-20 -147.41 -67.13 0.26 Allowed 'General case' 0 N--CA 1.503 2.202 0 C-N-CA 118.21 -1.396 . . . . 0.0 114.561 -177.37 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 32.9 mt -77.96 49.33 0.78 Allowed 'General case' 0 C--N 1.274 -2.708 0 C-N-CA 118.434 -1.306 . . . . 0.0 111.218 -174.946 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.401 ' SG ' ' N ' ' A' ' 15' ' ' LEU . 17.5 p -119.41 -154.46 0.57 Allowed 'General case' 0 N--CA 1.497 1.912 0 C-N-CA 119.155 -1.018 . . . . 0.0 110.374 176.484 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.401 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 7.2 mt -125.51 135.2 52.03 Favored 'General case' 0 N--CA 1.485 1.31 0 CA-C-N 114.569 -1.196 . . . . 0.0 110.526 179.764 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.3 m -120.35 -58.76 1.83 Allowed 'General case' 0 N--CA 1.508 2.44 0 C-N-CA 119.274 -0.97 . . . . 0.0 111.228 179.6 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.61 97.18 8.83 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 119.441 -0.903 . . . . 0.0 110.725 -178.499 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 68.77 -113.59 5.35 Favored Glycine 0 N--CA 1.488 2.125 0 C-N-CA 119.444 -1.36 . . . . 0.0 110.815 179.16 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.411 ' O ' ' OG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -113.88 3.71 15.55 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-O 122.133 0.968 . . . . 0.0 110.24 -178.544 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -78.35 129.59 35.17 Favored 'General case' 0 C--N 1.256 -3.469 0 CA-C-N 113.589 -1.641 . . . . 0.0 110.39 -179.979 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -79.32 149.16 5.52 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 C-N-CA 119.473 -0.891 . . . . 0.0 110.227 -179.656 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.477 ' O ' ' O ' ' A' ' 12' ' ' ASN . 15.6 m -143.8 112.58 6.6 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 118.717 -1.193 . . . . 0.0 110.205 179.111 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.527 ' O ' ' ND2' ' A' ' 12' ' ' ASN . . . 178.51 -63.0 0.08 OUTLIER Glycine 0 N--CA 1.484 1.858 1 N-CA-C 130.007 6.763 . . . . 0.0 130.007 -177.274 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -63.54 120.62 12.08 Favored 'General case' 0 C--N 1.311 -1.093 0 C-N-CA 118.466 -1.294 . . . . 0.0 109.842 179.269 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.416 ' C ' ' ND2' ' A' ' 26' ' ' ASN . . . 95.48 -17.2 59.75 Favored Glycine 0 N--CA 1.485 1.918 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 -178.349 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.465 ' O ' ' O ' ' A' ' 23' ' ' GLY . 2.1 m-80 -139.26 -172.87 3.44 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.389 -0.924 . . . . 0.0 110.694 179.07 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.503 ' O ' ' O ' ' A' ' 40' ' ' VAL . 0.0 OUTLIER -138.74 125.68 21.13 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 119.502 -0.879 . . . . 0.0 109.148 177.623 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.49 ' SG ' ' O ' ' A' ' 38' ' ' GLN . 0.1 OUTLIER -82.14 164.9 20.98 Favored 'General case' 0 C--N 1.289 -2.051 0 C-N-CA 116.959 -1.896 . . . . 0.0 109.927 178.206 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 26.8 mm -144.08 125.96 10.54 Favored 'Isoleucine or valine' 0 C--N 1.245 -3.938 0 CA-C-N 113.856 -1.52 . . . . 0.0 108.869 178.74 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 17.7 mt . . . . . 0 N--CA 1.495 1.783 0 C-N-CA 118.51 -1.276 . . . . 0.0 110.135 -179.066 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.215 -0.743 0 CA-C-O 121.89 0.852 . . . . 0.0 113.191 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.49 ' O ' ' SG ' ' A' ' 28' ' ' CYS . 15.8 tt0 -151.63 164.34 37.11 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 113.976 -1.466 . . . . 0.0 108.24 176.039 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.454 ' N ' ' CG ' ' A' ' 38' ' ' GLN . 29.0 m -127.12 97.43 4.93 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 119.407 -0.917 . . . . 0.0 110.86 -178.308 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.503 ' O ' ' O ' ' A' ' 27' ' ' LYS . 0.4 OUTLIER -111.84 140.79 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.485 0 C-N-CA 118.73 -1.188 . . . . 0.0 112.569 -179.719 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.5 t -56.9 149.35 18.8 Favored 'General case' 0 C--N 1.279 -2.462 0 CA-C-N 113.563 -1.653 . . . . 0.0 111.672 177.943 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 145.16 -130.03 3.71 Favored Glycine 0 N--CA 1.489 2.228 1 N-CA-C 131.116 7.206 . . . . 0.0 131.116 179.622 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 31.9 mm-40 -112.75 106.07 14.34 Favored 'General case' 0 N--CA 1.499 2.007 0 C-N-CA 119.884 -0.726 . . . . 0.0 111.053 -179.044 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -140.02 178.86 19.49 Favored Glycine 0 N--CA 1.493 2.499 0 C-N-CA 119.659 -1.258 . . . . 0.0 110.152 179.377 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -128.61 146.38 59.87 Favored Pre-proline 0 N--CA 1.495 1.815 0 C-N-CA 119.903 -0.719 . . . . 0.0 109.511 179.681 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -57.65 164.06 8.06 Favored 'Trans proline' 0 C--O 1.216 -0.589 0 C-N-CA 121.179 1.253 . . . . 0.0 111.587 -178.809 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 52.3 tp10 . . . . . 0 C--N 1.314 -0.968 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.203 179.54 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.588 ' CG1' ' H ' ' A' ' 3' ' ' TYR . 22.0 t . . . . . 0 N--CA 1.493 1.719 0 CA-C-O 120.657 0.265 . . . . 0.0 110.652 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.588 ' H ' ' CG1' ' A' ' 2' ' ' VAL . 85.1 m-85 -114.89 -166.49 1.12 Allowed 'General case' 0 N--CA 1.5 2.063 0 C-N-CA 120.106 -0.638 . . . . 0.0 110.425 -179.939 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.611 ' HG1' ' N ' ' A' ' 5' ' ' ASP . 0.1 OUTLIER -113.01 -177.82 3.23 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 178.816 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.611 ' N ' ' HG1' ' A' ' 4' ' ' THR . 0.2 OUTLIER -90.33 154.2 19.87 Favored 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 118.681 -1.208 . . . . 0.0 110.746 -179.597 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -75.73 -178.85 4.41 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-N 115.001 -1.0 . . . . 0.0 112.005 178.567 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.4 t -157.15 15.18 0.27 Allowed 'General case' 0 C--N 1.291 -1.978 0 CA-C-N 113.435 -1.712 . . . . 0.0 110.02 177.848 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -161.42 172.01 17.23 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 114.505 -1.225 . . . . 0.0 109.533 -179.261 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.507 ' HB3' ' H ' ' A' ' 30' ' ' LEU . 0.9 OUTLIER -91.64 164.31 13.79 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 119.612 -0.835 . . . . 0.0 110.786 -179.303 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.436 ' O ' ' O ' ' A' ' 11' ' ' GLN . . . 79.69 -25.14 2.99 Favored Glycine 0 N--CA 1.499 2.895 0 C-N-CA 119.541 -1.314 . . . . 0.0 112.906 177.216 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.436 ' O ' ' O ' ' A' ' 10' ' ' GLY . 0.5 OUTLIER -54.93 -171.36 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.065 0 C-N-CA 118.495 -1.282 . . . . 0.0 110.577 -178.499 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.484 ' O ' ' O ' ' A' ' 22' ' ' CYS . 2.1 m-20 -148.4 -66.33 0.24 Allowed 'General case' 0 N--CA 1.501 2.076 0 N-CA-C 115.227 1.565 . . . . 0.0 115.227 -176.978 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 95.5 mt -77.17 49.8 0.71 Allowed 'General case' 0 C--N 1.268 -2.963 0 C-N-CA 117.978 -1.489 . . . . 0.0 111.284 -174.179 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.426 ' H ' ' C ' ' A' ' 12' ' ' ASN . 28.3 p -125.84 -156.42 0.73 Allowed 'General case' 0 C--O 1.207 -1.181 0 CA-C-N 114.988 -1.005 . . . . 0.0 109.082 176.499 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 58.1 mt -115.57 120.22 38.74 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 115.115 -0.948 . . . . 0.0 108.957 176.654 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.0 m -117.56 -61.29 1.72 Allowed 'General case' 0 C--N 1.293 -1.861 0 C-N-CA 119.147 -1.021 . . . . 0.0 110.955 -177.237 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.493 ' CG ' ' SG ' ' A' ' 39' ' ' CYS . 3.1 mm-40 -78.74 90.55 4.63 Favored 'General case' 0 C--N 1.295 -1.783 0 C-N-CA 117.81 -1.556 . . . . 0.0 109.708 179.512 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 71.52 -101.78 1.03 Allowed Glycine 0 N--CA 1.488 2.101 0 C-N-CA 119.481 -1.342 . . . . 0.0 109.904 -179.068 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.42 ' O ' ' OG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -128.66 2.96 5.5 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-O 122.35 1.071 . . . . 0.0 109.873 179.837 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -78.72 136.52 37.43 Favored 'General case' 0 C--N 1.258 -3.376 0 CA-C-N 113.313 -1.767 . . . . 0.0 110.228 -179.887 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.1 t -67.21 145.19 13.96 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 C-N-CA 118.438 -1.305 . . . . 0.0 109.493 178.999 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.529 ' O ' ' SG ' ' A' ' 28' ' ' CYS . 20.0 m -148.72 118.95 7.26 Favored 'General case' 0 C--N 1.277 -2.582 0 C-N-CA 118.426 -1.31 . . . . 0.0 109.333 176.82 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.471 ' O ' ' O ' ' A' ' 26' ' ' ASN . . . 171.64 -82.87 0.08 OUTLIER Glycine 0 C--N 1.291 -1.941 0 C-N-CA 118.557 -1.782 . . . . 0.0 110.395 -176.636 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -55.83 117.46 3.69 Favored 'General case' 0 C--N 1.292 -1.902 0 C-N-CA 119.132 -1.027 . . . . 0.0 109.64 179.058 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 102.26 -26.16 25.2 Favored Glycine 0 N--CA 1.484 1.871 0 N-CA-C 109.077 -1.609 . . . . 0.0 109.077 -177.683 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.471 ' O ' ' O ' ' A' ' 23' ' ' GLY . 0.1 OUTLIER -142.67 -154.83 0.54 Allowed 'General case' 0 C--N 1.309 -1.178 0 C-N-CA 119.943 -0.703 . . . . 0.0 110.147 179.767 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.5 ' N ' ' O ' ' A' ' 40' ' ' VAL . 10.0 tttp -148.21 160.01 43.38 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 176.85 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.529 ' SG ' ' O ' ' A' ' 22' ' ' CYS . 72.1 m -121.47 157.56 30.33 Favored 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 118.923 -1.111 . . . . 0.0 111.828 178.495 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 19.9 mm -146.5 133.76 14.64 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.501 0 CA-C-N 113.375 -1.739 . . . . 0.0 109.945 177.104 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.507 ' H ' ' HB3' ' A' ' 9' ' ' SER . 19.9 mt . . . . . 0 N--CA 1.505 2.277 0 C-N-CA 119.862 -0.735 . . . . 0.0 109.871 179.135 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.507 ' OD1' ' N ' ' A' ' 37' ' ' ASN . 0.4 OUTLIER . . . . . 0 C--O 1.217 -0.638 0 CA-C-O 120.806 0.336 . . . . 0.0 110.736 . . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -109.39 147.19 33.19 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.87 179.691 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.493 ' SG ' ' CG ' ' A' ' 17' ' ' GLU . 15.6 m -96.33 90.45 5.44 Favored 'General case' 0 C--N 1.293 -1.865 0 C-N-CA 119.423 -0.911 . . . . 0.0 110.63 -179.423 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.5 ' O ' ' N ' ' A' ' 27' ' ' LYS . 0.6 OUTLIER -90.08 142.81 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 C-N-CA 118.024 -1.471 . . . . 0.0 111.283 179.932 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -65.33 140.35 58.67 Favored 'General case' 0 C--N 1.274 -2.677 0 CA-C-N 114.225 -1.352 . . . . 0.0 110.831 178.844 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 152.89 -156.15 26.54 Favored Glycine 0 N--CA 1.488 2.11 0 C-N-CA 119.545 -1.312 . . . . 0.0 110.252 -179.903 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -114.29 133.37 55.7 Favored 'General case' 0 N--CA 1.497 1.923 0 C-N-CA 120.033 -0.667 . . . . 0.0 110.399 -179.74 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -137.39 158.69 24.53 Favored Glycine 0 N--CA 1.496 2.638 0 C-N-CA 119.704 -1.236 . . . . 0.0 110.455 -179.943 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 5.8 t -87.21 143.9 35.31 Favored Pre-proline 0 N--CA 1.488 1.456 0 C-N-CA 119.631 -0.827 . . . . 0.0 109.929 -179.858 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -58.16 143.69 96.41 Favored 'Trans proline' 0 C--O 1.218 -0.523 0 C-N-CA 121.006 1.137 . . . . 0.0 111.153 178.195 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 . . . . . 0 C--N 1.302 -1.458 0 C-N-CA 119.706 -0.798 . . . . 0.0 110.343 -179.819 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.476 0.844 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -143.15 -178.77 6.01 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 118.845 -1.142 . . . . 0.0 111.591 179.653 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.45 ' H ' ' HG1' ' A' ' 4' ' ' THR . 7.7 p -109.97 -179.58 3.84 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 114.772 -1.104 . . . . 0.0 108.862 -179.328 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.456 ' OD1' ' N ' ' A' ' 5' ' ' ASP . 0.1 OUTLIER -88.15 151.79 22.45 Favored 'General case' 0 C--N 1.291 -1.977 0 C-N-CA 118.344 -1.342 . . . . 0.0 109.351 177.424 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.436 ' N ' ' HB2' ' A' ' 14' ' ' CYS . 0.8 OUTLIER -71.79 -178.12 2.18 Favored 'General case' 0 C--N 1.285 -2.214 0 C-N-CA 119.401 -0.919 . . . . 0.0 110.2 178.894 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.0 t -157.46 17.65 0.27 Allowed 'General case' 0 C--N 1.279 -2.47 0 CA-C-N 114.323 -1.308 . . . . 0.0 110.16 178.662 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.531 ' N ' ' OE1' ' A' ' 8' ' ' GLU . 1.2 pm0 -165.45 169.43 15.61 Favored 'General case' 0 C--N 1.285 -2.236 0 CA-C-N 114.773 -1.103 . . . . 0.0 110.076 179.229 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.456 ' HB3' ' H ' ' A' ' 30' ' ' LEU . 0.3 OUTLIER -84.14 138.56 32.95 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 119.244 -0.983 . . . . 0.0 108.859 -179.525 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.428 ' O ' ' O ' ' A' ' 11' ' ' GLN . . . 104.53 -35.14 5.25 Favored Glycine 0 N--CA 1.501 2.982 1 N-CA-C 130.249 6.859 . . . . 0.0 130.249 -174.976 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.428 ' O ' ' O ' ' A' ' 10' ' ' GLY . 1.2 mt-30 -54.78 -170.03 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.128 0 C-N-CA 119.292 -0.963 . . . . 0.0 109.895 -179.82 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.466 ' O ' ' O ' ' A' ' 22' ' ' CYS . 4.8 m-20 -141.82 -66.92 0.4 Allowed 'General case' 0 N--CA 1.498 1.937 0 C-N-CA 118.055 -1.458 . . . . 0.0 114.631 -176.209 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 13.0 mt -75.67 53.95 0.75 Allowed 'General case' 0 C--N 1.268 -2.943 0 C-N-CA 117.613 -1.635 . . . . 0.0 110.274 -175.777 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.436 ' HB2' ' N ' ' A' ' 6' ' ' CYS . 25.9 p -124.89 -160.64 0.96 Allowed 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.023 175.696 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 52.6 mt -118.1 126.72 52.81 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.147 178.446 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.3 m -110.92 -64.5 1.27 Allowed 'General case' 0 N--CA 1.502 2.131 0 C-N-CA 118.98 -1.088 . . . . 0.0 111.197 179.813 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -89.98 92.32 8.94 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 119.05 -1.06 . . . . 0.0 110.67 -178.875 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.43 -105.39 1.84 Allowed Glycine 0 N--CA 1.489 2.222 0 C-N-CA 119.723 -1.227 . . . . 0.0 111.153 178.601 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.404 ' O ' ' OG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -122.43 3.4 9.69 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 122.417 1.103 . . . . 0.0 109.997 -178.354 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 38.1 m-20 -77.22 138.08 39.22 Favored 'General case' 0 C--N 1.259 -3.35 0 CA-C-N 113.278 -1.783 . . . . 0.0 110.598 -179.841 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.0 t -81.68 146.82 6.74 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 C-N-CA 119.441 -0.904 . . . . 0.0 110.357 179.812 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.466 ' O ' ' O ' ' A' ' 12' ' ' ASN . 20.9 m -144.35 114.21 7.28 Favored 'General case' 0 N--CA 1.5 2.043 0 C-N-CA 118.939 -1.104 . . . . 0.0 109.263 177.362 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.484 ' O ' ' N ' ' A' ' 26' ' ' ASN . . . -179.77 -87.78 0.07 OUTLIER Glycine 0 N--CA 1.479 1.538 0 C-N-CA 117.156 -2.449 . . . . 0.0 113.449 -176.726 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.451 ' C ' ' H ' ' A' ' 26' ' ' ASN . 1.5 tt0 -42.15 129.75 3.68 Favored 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 119.931 -0.708 . . . . 0.0 111.681 -175.947 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 81.19 -30.04 2.74 Favored Glycine 0 N--CA 1.477 1.428 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 -179.09 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.484 ' N ' ' O ' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -122.4 -166.86 1.47 Allowed 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 119.935 -0.706 . . . . 0.0 111.412 -178.839 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.496 ' O ' ' O ' ' A' ' 40' ' ' VAL . 0.6 OUTLIER -153.15 127.11 8.97 Favored 'General case' 0 N--CA 1.505 2.287 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.237 -179.996 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -86.17 168.31 14.11 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 122.728 1.252 . . . . 0.0 112.337 -178.695 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 11.0 mm -146.31 131.89 12.67 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.754 0 CA-C-N 112.52 -2.127 . . . . 0.0 108.09 175.349 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.456 ' H ' ' HB3' ' A' ' 9' ' ' SER . 23.6 mt . . . . . 0 C--N 1.298 -1.643 0 C-N-CA 117.554 -1.659 . . . . 0.0 108.995 177.629 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.465 ' OD1' ' N ' ' A' ' 37' ' ' ASN . 1.1 m-20 . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 120.692 0.282 . . . . 0.0 111.228 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.495 ' CG ' ' N ' ' A' ' 39' ' ' CYS . 34.2 tt0 -151.94 159.96 43.64 Favored 'General case' 0 C--N 1.312 -1.034 0 C-N-CA 119.051 -1.06 . . . . 0.0 110.329 178.113 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.495 ' N ' ' CG ' ' A' ' 38' ' ' GLN . 91.5 m -131.73 94.28 3.48 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 119.886 -0.726 . . . . 0.0 110.472 -179.902 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.574 ' CG2' ' N ' ' A' ' 41' ' ' THR . 4.4 p -110.02 173.57 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.336 0 C-N-CA 119.105 -1.038 . . . . 0.0 110.217 179.577 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.574 ' N ' ' CG2' ' A' ' 40' ' ' VAL . 8.8 t -84.12 156.49 22.11 Favored 'General case' 0 C--N 1.283 -2.326 0 CA-C-N 115.353 -0.839 . . . . 0.0 111.142 178.727 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 159.39 -140.72 7.02 Favored Glycine 0 N--CA 1.492 2.404 0 C-N-CA 119.681 -1.247 . . . . 0.0 110.497 -179.973 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -146.08 89.56 1.89 Allowed 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 119.529 -0.868 . . . . 0.0 110.459 -179.826 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -97.98 -156.15 29.86 Favored Glycine 0 N--CA 1.492 2.395 0 C-N-CA 119.52 -1.324 . . . . 0.0 110.742 -179.538 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -139.91 153.01 69.23 Favored Pre-proline 0 N--CA 1.492 1.666 0 C-N-CA 119.571 -0.852 . . . . 0.0 110.418 -179.98 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -53.47 153.97 16.53 Favored 'Trans proline' 0 CA--C 1.543 0.965 0 C-N-CA 122.112 1.875 . . . . 0.0 113.035 177.952 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.2 tm-20 . . . . . 0 N--CA 1.483 1.188 0 CA-C-N 115.937 -0.574 . . . . 0.0 112.292 177.671 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.499 ' CG1' ' H ' ' A' ' 3' ' ' TYR . 45.6 t . . . . . 0 N--CA 1.497 1.917 0 CA-C-O 120.995 0.426 . . . . 0.0 110.055 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.499 ' H ' ' CG1' ' A' ' 2' ' ' VAL . 10.8 m-85 -144.09 -167.53 2.63 Favored 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 119.896 -0.722 . . . . 0.0 109.89 179.905 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.589 ' OG1' ' N ' ' A' ' 5' ' ' ASP . 0.1 OUTLIER -104.74 -177.64 3.42 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 177.507 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.589 ' N ' ' OG1' ' A' ' 4' ' ' THR . 0.3 OUTLIER -92.1 154.37 18.77 Favored 'General case' 0 C--N 1.291 -1.955 0 C-N-CA 118.626 -1.229 . . . . 0.0 111.169 -179.429 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.482 ' SG ' ' O ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -73.11 170.16 15.51 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.526 177.388 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.419 ' O ' ' OG1' ' A' ' 7' ' ' THR . 0.2 OUTLIER -140.39 7.37 2.16 Favored 'General case' 0 C--N 1.296 -1.761 0 C-N-CA 119.108 -1.037 . . . . 0.0 110.187 176.489 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -163.97 -178.24 5.52 Favored 'General case' 0 C--N 1.288 -2.085 0 CA-C-N 114.449 -1.25 . . . . 0.0 110.198 179.395 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -86.01 164.37 17.41 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.369 -179.24 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.437 ' O ' ' O ' ' A' ' 11' ' ' GLN . . . 83.25 -30.77 3.27 Favored Glycine 0 N--CA 1.49 2.234 0 C-N-CA 119.189 -1.481 . . . . 0.0 111.32 179.531 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.514 ' OE1' ' N ' ' A' ' 11' ' ' GLN . 3.1 mp0 -44.09 168.39 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.068 0 C-N-CA 119.194 -1.002 . . . . 0.0 109.879 179.806 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.484 ' C ' ' H ' ' A' ' 14' ' ' CYS . 2.1 m-20 -141.9 -69.7 0.36 Allowed 'General case' 0 N--CA 1.5 2.051 0 C-N-CA 118.536 -1.266 . . . . 0.0 113.374 -177.647 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 81.7 mt -75.63 46.71 0.37 Allowed 'General case' 0 C--N 1.272 -2.765 0 C-N-CA 118.327 -1.349 . . . . 0.0 110.151 -177.0 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.484 ' H ' ' C ' ' A' ' 12' ' ' ASN . 29.9 p -123.58 -156.93 0.73 Allowed 'General case' 0 C--O 1.205 -1.269 0 CA-C-N 115.265 -0.88 . . . . 0.0 109.597 179.046 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.482 ' O ' ' SG ' ' A' ' 6' ' ' CYS . 71.2 mt -116.09 109.12 17.06 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 114.934 -1.03 . . . . 0.0 108.237 175.687 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.575 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 0.5 OUTLIER -110.31 -51.44 2.87 Favored 'General case' 0 C--N 1.289 -2.054 0 C-N-CA 118.933 -1.107 . . . . 0.0 110.71 -174.673 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.508 ' N ' ' SG ' ' A' ' 16' ' ' CYS . 18.4 tp10 -88.63 75.55 8.26 Favored 'General case' 0 C--N 1.294 -1.816 0 C-N-CA 118.649 -1.221 . . . . 0.0 109.048 177.862 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.38 -121.89 6.61 Favored Glycine 0 N--CA 1.486 2.0 0 C-N-CA 119.143 -1.503 . . . . 0.0 110.013 -178.57 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.81 -1.17 38.27 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 122.026 0.917 . . . . 0.0 110.22 -179.803 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -79.64 133.41 36.4 Favored 'General case' 0 C--N 1.26 -3.309 0 CA-C-N 113.719 -1.582 . . . . 0.0 110.861 -179.137 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.0 t -70.95 141.54 16.73 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.955 0 C-N-CA 118.879 -1.128 . . . . 0.0 109.081 177.71 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.461 ' O ' ' O ' ' A' ' 12' ' ' ASN . 0.1 OUTLIER -148.47 121.39 8.77 Favored 'General case' 0 C--N 1.277 -2.556 0 C-N-CA 118.346 -1.342 . . . . 0.0 109.458 177.304 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.482 ' O ' ' O ' ' A' ' 26' ' ' ASN . . . 175.0 -94.99 0.1 OUTLIER Glycine 0 C--O 1.201 -1.949 0 C-N-CA 118.304 -1.903 . . . . 0.0 111.505 -174.527 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -39.33 129.81 1.74 Allowed 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 120.494 -0.483 . . . . 0.0 111.553 -176.467 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.437 ' O ' ' OD1' ' A' ' 26' ' ' ASN . . . 90.65 -19.36 45.12 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -178.414 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.482 ' O ' ' O ' ' A' ' 23' ' ' GLY . 85.5 m-20 -155.96 -163.13 1.42 Allowed 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -179.862 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.468 ' O ' ' O ' ' A' ' 40' ' ' VAL . 0.0 OUTLIER -156.86 133.13 9.8 Favored 'General case' 0 N--CA 1.496 1.855 0 C-N-CA 117.871 -1.531 . . . . 0.0 111.345 176.143 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.502 ' SG ' ' OD1' ' A' ' 37' ' ' ASN . 0.1 OUTLIER -87.2 161.11 18.22 Favored 'General case' 0 CA--C 1.482 -1.663 0 CA-C-O 123.342 1.544 . . . . 0.0 113.028 179.897 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 31.5 mm -134.47 124.13 44.23 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.265 0 CA-C-N 111.057 -2.792 . . . . 0.0 109.677 -179.764 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 33.2 mt . . . . . 0 N--CA 1.501 2.121 0 C-N-CA 118.804 -1.159 . . . . 0.0 110.684 -179.42 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.553 ' ND2' ' SG ' ' A' ' 16' ' ' CYS . 1.4 t30 . . . . . 0 C--O 1.214 -0.776 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.48 ' O ' ' SG ' ' A' ' 28' ' ' CYS . 22.8 tt0 -145.88 142.76 29.08 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 118.984 -1.087 . . . . 0.0 110.604 178.833 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.575 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 36.0 m -91.1 94.23 9.51 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.063 -178.486 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.468 ' O ' ' O ' ' A' ' 27' ' ' LYS . 1.2 p -105.94 139.22 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 C-N-CA 118.491 -1.284 . . . . 0.0 111.998 179.297 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.436 ' OG1' ' OD1' ' A' ' 26' ' ' ASN . 4.9 t -58.65 143.2 47.33 Favored 'General case' 0 C--N 1.273 -2.76 0 CA-C-N 113.524 -1.671 . . . . 0.0 111.166 178.172 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 158.34 -141.25 7.54 Favored Glycine 0 N--CA 1.487 2.056 0 C-N-CA 119.6 -1.286 . . . . 0.0 110.007 179.671 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -130.5 131.76 45.28 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.837 -0.745 . . . . 0.0 109.816 179.25 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -137.11 -151.1 5.88 Favored Glycine 0 N--CA 1.489 2.198 0 C-N-CA 119.648 -1.263 . . . . 0.0 110.399 -179.515 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -145.48 152.32 49.34 Favored Pre-proline 0 C--N 1.302 -1.491 0 C-N-CA 119.54 -0.864 . . . . 0.0 109.703 179.989 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -56.16 -170.61 0.03 OUTLIER 'Trans proline' 0 C--O 1.214 -0.702 0 C-N-CA 121.124 1.216 . . . . 0.0 110.504 176.565 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 . . . . . 0 CA--C 1.56 1.352 0 C-N-CA 120.3 -0.56 . . . . 0.0 110.243 178.6 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 1.5 t . . . . . 0 N--CA 1.481 1.12 0 CA-C-O 120.818 0.342 . . . . 0.0 110.215 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.462 ' CG ' ' O ' ' A' ' 13' ' ' LEU . 7.3 m-85 -90.44 -164.98 1.25 Allowed 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 119.212 -0.995 . . . . 0.0 109.242 178.699 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.565 ' OG1' ' N ' ' A' ' 5' ' ' ASP . 0.2 OUTLIER -116.65 -176.7 3.02 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 178.9 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.565 ' N ' ' OG1' ' A' ' 4' ' ' THR . 0.2 OUTLIER -79.35 156.17 28.11 Favored 'General case' 0 C--N 1.289 -2.053 0 C-N-CA 118.528 -1.269 . . . . 0.0 110.406 -179.366 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -70.72 152.01 44.27 Favored 'General case' 0 C--N 1.291 -1.967 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.719 176.654 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.415 ' O ' ' CG ' ' A' ' 8' ' ' GLU . 43.0 p -119.36 4.43 11.23 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-O 121.813 0.816 . . . . 0.0 108.96 178.812 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.415 ' CG ' ' O ' ' A' ' 7' ' ' THR . 29.4 mt-10 -161.93 167.47 24.56 Favored 'General case' 0 C--N 1.283 -2.284 0 CA-C-N 113.914 -1.494 . . . . 0.0 111.18 -178.971 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.416 ' HB3' ' H ' ' A' ' 30' ' ' LEU . 0.9 OUTLIER -79.5 156.47 27.79 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 115.038 -0.983 . . . . 0.0 108.868 177.517 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.481 ' N ' ' O ' ' A' ' 28' ' ' CYS . . . 90.51 -13.92 64.15 Favored Glycine 0 N--CA 1.503 3.163 0 C-N-CA 118.739 -1.695 . . . . 0.0 112.45 179.264 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 47.5 mm-40 -61.17 -164.51 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.239 0 C-N-CA 119.139 -1.024 . . . . 0.0 111.073 -178.47 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.529 ' C ' ' H ' ' A' ' 14' ' ' CYS . 7.4 m-20 -160.51 -66.96 0.07 Allowed 'General case' 0 N--CA 1.5 2.057 0 C-N-CA 118.377 -1.329 . . . . 0.0 113.367 179.791 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.462 ' O ' ' CG ' ' A' ' 3' ' ' TYR . 86.1 mt -75.85 41.1 0.2 Allowed 'General case' 0 C--N 1.287 -2.123 0 C-N-CA 119.364 -0.934 . . . . 0.0 110.155 -178.396 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.529 ' H ' ' C ' ' A' ' 12' ' ' ASN . 29.1 p -120.3 -165.83 1.24 Allowed 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.232 178.607 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 47.1 mt -97.19 102.79 14.64 Favored 'General case' 0 C--N 1.294 -1.841 0 C-N-CA 119.248 -0.981 . . . . 0.0 109.441 178.188 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.413 ' CB ' ' SG ' ' A' ' 22' ' ' CYS . 0.5 OUTLIER -95.41 -35.31 11.78 Favored 'General case' 0 C--N 1.281 -2.397 0 CA-C-N 114.262 -1.336 . . . . 0.0 111.139 -176.021 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -114.19 89.65 3.14 Favored 'General case' 0 C--N 1.301 -1.513 0 C-N-CA 119.68 -0.808 . . . . 0.0 110.326 -179.143 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 73.96 -91.26 0.7 Allowed Glycine 0 N--CA 1.488 2.126 0 C-N-CA 119.511 -1.328 . . . . 0.0 110.486 179.418 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.404 ' O ' ' OG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -138.27 4.34 2.44 Favored 'General case' 0 N--CA 1.484 1.232 0 CA-C-O 122.026 0.917 . . . . 0.0 110.89 -178.841 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -85.03 138.89 32.16 Favored 'General case' 0 C--N 1.261 -3.257 0 CA-C-N 113.835 -1.529 . . . . 0.0 111.111 -179.556 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.4 t -77.28 139.5 18.61 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.124 0 C-N-CA 118.95 -1.1 . . . . 0.0 110.032 179.039 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.413 ' SG ' ' CB ' ' A' ' 16' ' ' CYS . 0.8 OUTLIER -80.7 -135.44 0.03 OUTLIER 'General case' 0 C--N 1.278 -2.502 0 C-N-CA 118.722 -1.191 . . . . 0.0 109.333 176.049 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.532 ' O ' ' ND2' ' A' ' 26' ' ' ASN . . . -172.68 107.14 0.24 Allowed Glycine 0 C--N 1.272 -3.028 0 C-N-CA 117.835 -2.126 . . . . 0.0 111.089 179.309 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.461 ' C ' ' O ' ' A' ' 23' ' ' GLY . 2.9 tt0 -34.32 131.92 0.3 Allowed 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 121.632 0.73 . . . . 0.0 110.422 178.665 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 131.23 -31.12 3.21 Favored Glycine 0 C--N 1.291 -1.96 0 N-CA-C 106.512 -2.635 . . . . 0.0 106.512 -174.714 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.589 ' N ' ' ND2' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -96.1 -161.2 0.85 Allowed 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 175.412 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.51 ' N ' ' O ' ' A' ' 40' ' ' VAL . 10.7 ttpp -144.56 113.45 6.8 Favored 'General case' 0 C--N 1.287 -2.116 0 C-N-CA 119.436 -0.906 . . . . 0.0 109.616 177.329 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.566 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 5.3 m -84.31 156.82 21.74 Favored 'General case' 0 CA--C 1.482 -1.662 0 C-N-CA 117.392 -1.723 . . . . 0.0 111.603 -179.665 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.443 ' CD1' ' HZ3' ' A' ' 27' ' ' LYS . 33.2 mm -144.77 125.38 7.89 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.167 0 CA-C-N 113.235 -1.802 . . . . 0.0 109.92 177.943 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.416 ' H ' ' HB3' ' A' ' 9' ' ' SER . 23.4 mt . . . . . 0 N--CA 1.498 1.964 0 C-N-CA 118.826 -1.15 . . . . 0.0 109.951 178.498 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 . . . . . 0 N--CA 1.488 1.455 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 43.1 tt0 -161.22 151.61 17.74 Favored 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 119.042 -1.063 . . . . 0.0 110.174 177.098 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.566 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 0.0 OUTLIER -101.84 104.47 15.22 Favored 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 119.55 -0.86 . . . . 0.0 111.607 179.789 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.51 ' O ' ' N ' ' A' ' 27' ' ' LYS . 1.1 p -99.01 137.5 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 C-N-CA 118.307 -1.357 . . . . 0.0 109.994 175.356 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 6.3 t -63.93 145.5 55.73 Favored 'General case' 0 C--N 1.266 -3.039 0 CA-C-N 114.008 -1.451 . . . . 0.0 110.811 -178.752 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 152.29 -146.81 15.81 Favored Glycine 0 N--CA 1.49 2.26 0 C-N-CA 119.459 -1.353 . . . . 0.0 110.64 179.094 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -116.36 129.44 56.25 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 120.083 -0.647 . . . . 0.0 109.797 -179.951 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -145.9 -165.03 11.19 Favored Glycine 0 N--CA 1.494 2.534 0 C-N-CA 119.284 -1.436 . . . . 0.0 110.616 -179.62 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.3 t -120.41 144.92 39.35 Favored Pre-proline 0 N--CA 1.491 1.618 0 C-N-CA 119.933 -0.707 . . . . 0.0 110.147 -179.671 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -64.69 176.27 3.0 Favored 'Trans proline' 0 C--O 1.213 -0.772 0 C-N-CA 120.948 1.099 . . . . 0.0 111.11 175.415 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 . . . . . 0 C--N 1.313 -0.985 0 C-N-CA 120.307 -0.557 . . . . 0.0 110.967 -179.822 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 1.6 t . . . . . 0 N--CA 1.477 0.898 0 N-CA-C 109.549 -0.538 . . . . 0.0 109.549 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -118.35 -171.42 2.07 Favored 'General case' 0 N--CA 1.498 1.942 0 C-N-CA 119.735 -0.786 . . . . 0.0 110.789 -178.337 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.2 p -106.22 -179.87 4.07 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-N 115.304 -0.862 . . . . 0.0 108.838 179.248 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -91.02 149.5 21.81 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 118.572 -1.251 . . . . 0.0 111.134 -179.546 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.513 ' SG ' ' O ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -74.06 178.46 4.99 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.972 178.397 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.2 p -148.68 21.02 1.03 Allowed 'General case' 0 C--N 1.285 -2.2 0 CA-C-N 114.149 -1.387 . . . . 0.0 109.032 175.406 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -160.81 171.89 17.99 Favored 'General case' 0 C--N 1.292 -1.92 0 CA-C-N 114.274 -1.33 . . . . 0.0 110.516 -179.272 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.486 ' O ' ' N ' ' A' ' 11' ' ' GLN . 0.5 OUTLIER -71.32 -176.68 1.55 Allowed 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 119.703 -0.799 . . . . 0.0 109.558 179.785 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.508 ' N ' ' O ' ' A' ' 28' ' ' CYS . . . 28.31 9.39 0.0 OUTLIER Glycine 0 N--CA 1.498 2.819 1 N-CA-C 130.224 6.85 . . . . 0.0 130.224 179.862 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.486 ' N ' ' O ' ' A' ' 9' ' ' SER . 0.0 OUTLIER -60.75 -165.1 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 176.45 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.522 HD21 ' C ' ' A' ' 23' ' ' GLY . 1.4 m-20 -148.76 -70.26 0.21 Allowed 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 117.266 -1.773 . . . . 0.0 114.225 -179.795 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.6 mt -75.74 47.46 0.42 Allowed 'General case' 0 C--N 1.263 -3.174 0 C-N-CA 117.936 -1.505 . . . . 0.0 110.663 -175.543 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.467 ' H ' ' C ' ' A' ' 12' ' ' ASN . 28.0 p -124.74 -156.58 0.73 Allowed 'General case' 0 C--O 1.211 -0.934 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.2 177.182 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.513 ' O ' ' SG ' ' A' ' 6' ' ' CYS . 5.8 mt -115.56 127.29 55.15 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.029 176.199 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.575 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -141.38 21.88 2.21 Favored 'General case' 0 C--N 1.297 -1.703 0 C-N-CA 118.409 -1.316 . . . . 0.0 111.439 -174.516 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -157.03 77.43 0.88 Allowed 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 119.6 -0.84 . . . . 0.0 109.145 176.047 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 77.2 -88.52 0.99 Allowed Glycine 0 N--CA 1.486 1.976 0 C-N-CA 119.386 -1.388 . . . . 0.0 109.881 -178.388 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.48 ' O ' ' OG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -145.56 11.67 1.29 Allowed 'General case' 0 C--N 1.303 -1.432 0 CA-C-O 122.511 1.148 . . . . 0.0 109.988 179.606 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -95.57 138.46 33.21 Favored 'General case' 0 C--N 1.258 -3.392 0 CA-C-N 113.238 -1.801 . . . . 0.0 110.288 178.105 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.4 t -72.64 145.21 12.19 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.059 -178.593 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.473 ' O ' ' O ' ' A' ' 12' ' ' ASN . 6.0 m -144.41 126.13 15.16 Favored 'General case' 0 N--CA 1.499 2.021 0 C-N-CA 118.732 -1.187 . . . . 0.0 109.436 177.212 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.522 ' C ' HD21 ' A' ' 12' ' ' ASN . . . 175.5 -91.05 0.08 OUTLIER Glycine 0 C--O 1.206 -1.604 0 C-N-CA 117.349 -2.358 . . . . 0.0 112.737 -178.043 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -48.9 126.22 11.81 Favored 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 119.453 -0.899 . . . . 0.0 111.007 -176.7 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.18 -29.09 9.22 Favored Glycine 0 N--CA 1.48 1.591 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -178.447 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.436 ' O ' ' O ' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -132.11 -168.95 2.12 Favored 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 120.163 -0.615 . . . . 0.0 110.929 -179.49 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.51 ' O ' ' O ' ' A' ' 40' ' ' VAL . 0.1 OUTLIER -142.71 159.53 42.05 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 177.955 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.508 ' O ' ' N ' ' A' ' 10' ' ' GLY . 74.0 m -127.03 163.27 24.1 Favored 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 118.657 -1.217 . . . . 0.0 111.917 178.666 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 10.8 mm -139.59 130.6 32.67 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.839 0 CA-C-N 113.081 -1.872 . . . . 0.0 109.545 176.494 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 16.7 mt . . . . . 0 N--CA 1.491 1.598 0 C-N-CA 118.091 -1.444 . . . . 0.0 108.31 176.894 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.505 ' OD1' ' N ' ' A' ' 37' ' ' ASN . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 120.935 0.398 . . . . 0.0 110.542 . . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.47 ' CG ' ' N ' ' A' ' 39' ' ' CYS . 36.6 tt0 -143.59 166.9 23.56 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 120.008 -0.677 . . . . 0.0 109.531 179.503 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.575 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 3.8 m -116.93 91.18 3.51 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 119.567 -0.853 . . . . 0.0 110.814 -179.611 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.51 ' O ' ' O ' ' A' ' 27' ' ' LYS . 0.2 OUTLIER -91.17 139.0 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.17 0 C-N-CA 118.235 -1.386 . . . . 0.0 111.432 179.261 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.525 ' HG1' ' N ' ' A' ' 42' ' ' GLY . 11.4 t -49.62 151.69 1.61 Allowed 'General case' 0 C--N 1.271 -2.829 0 CA-C-N 114.124 -1.398 . . . . 0.0 110.806 -178.767 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.525 ' N ' ' HG1' ' A' ' 41' ' ' THR . . . 146.78 -155.27 26.46 Favored Glycine 0 N--CA 1.489 2.209 0 C-N-CA 119.682 -1.247 . . . . 0.0 110.146 -179.378 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 81.4 mt-10 -144.39 143.15 30.79 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 119.497 -0.881 . . . . 0.0 110.282 179.844 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -146.95 -148.12 4.69 Favored Glycine 0 N--CA 1.494 2.53 0 C-N-CA 119.269 -1.443 . . . . 0.0 110.961 -179.525 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -132.56 155.92 80.68 Favored Pre-proline 0 N--CA 1.495 1.814 0 C-N-CA 120.183 -0.607 . . . . 0.0 109.64 -179.206 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -53.04 -168.92 0.01 OUTLIER 'Trans proline' 0 C--O 1.215 -0.657 0 C-N-CA 121.46 1.44 . . . . 0.0 111.44 176.933 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 . . . . . 0 C--N 1.312 -1.024 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.891 -179.706 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.3 t . . . . . 0 N--CA 1.493 1.679 0 CA-C-O 120.777 0.323 . . . . 0.0 110.516 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -122.82 -167.74 1.63 Allowed 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 177.601 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.505 ' H ' ' HG1' ' A' ' 4' ' ' THR . 10.4 p -106.07 173.49 6.29 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 119.441 -0.904 . . . . 0.0 109.304 -179.837 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -85.4 147.72 26.35 Favored 'General case' 0 C--N 1.286 -2.176 0 C-N-CA 118.653 -1.219 . . . . 0.0 109.74 179.485 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -75.29 -176.37 3.07 Favored 'General case' 0 C--N 1.285 -2.223 0 C-N-CA 119.547 -0.861 . . . . 0.0 110.336 177.545 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.404 ' O ' ' OG1' ' A' ' 7' ' ' THR . 1.6 t -155.04 12.95 0.38 Allowed 'General case' 0 C--N 1.277 -2.566 0 CA-C-N 114.1 -1.409 . . . . 0.0 110.501 178.696 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -163.82 178.55 7.74 Favored 'General case' 0 C--N 1.282 -2.343 0 CA-C-N 114.647 -1.161 . . . . 0.0 110.088 179.388 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.452 ' O ' ' N ' ' A' ' 11' ' ' GLN . 0.5 OUTLIER -74.66 -160.11 0.1 Allowed 'General case' 0 C--N 1.297 -1.702 0 C-N-CA 119.808 -0.757 . . . . 0.0 109.809 179.864 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 27.79 10.75 0.0 OUTLIER Glycine 0 N--CA 1.5 2.945 1 N-CA-C 130.68 7.032 . . . . 0.0 130.68 178.557 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.456 ' O ' ' OD1' ' A' ' 12' ' ' ASN . 1.3 mt-30 -86.59 -174.68 5.11 Favored 'General case' 0 N--CA 1.499 1.995 0 C-N-CA 119.01 -1.076 . . . . 0.0 108.537 176.726 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.551 ' ND2' ' O ' ' A' ' 26' ' ' ASN . 16.8 m-20 -138.92 -65.63 0.49 Allowed 'General case' 0 N--CA 1.502 2.141 0 C-N-CA 118.247 -1.381 . . . . 0.0 114.675 -174.641 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 21.2 mt -77.94 47.33 0.63 Allowed 'General case' 0 C--N 1.272 -2.796 0 C-N-CA 117.939 -1.504 . . . . 0.0 111.573 -174.946 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 11.0 p -125.35 -167.4 1.68 Allowed 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 119.804 -0.758 . . . . 0.0 109.327 176.732 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 57.2 mt -102.09 116.05 31.86 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 177.06 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 6.5 m -111.4 -42.44 3.89 Favored 'General case' 0 N--CA 1.505 2.285 0 C-N-CA 118.854 -1.138 . . . . 0.0 111.919 -175.642 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.34 92.26 4.86 Favored 'General case' 0 N--CA 1.498 1.952 0 C-N-CA 118.968 -1.093 . . . . 0.0 109.776 178.381 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 76.03 -98.21 1.19 Allowed Glycine 0 N--CA 1.491 2.306 0 C-N-CA 119.319 -1.419 . . . . 0.0 110.308 -179.756 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.416 ' O ' ' OG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -134.89 3.02 3.18 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-O 122.231 1.015 . . . . 0.0 110.451 179.77 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -83.95 139.27 32.69 Favored 'General case' 0 C--N 1.26 -3.303 0 CA-C-N 113.51 -1.677 . . . . 0.0 110.728 -179.358 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.3 t -64.42 142.59 16.68 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.035 0 C-N-CA 118.95 -1.1 . . . . 0.0 110.153 179.511 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.517 ' O ' ' SG ' ' A' ' 28' ' ' CYS . 0.0 OUTLIER -149.72 122.72 8.81 Favored 'General case' 0 C--N 1.28 -2.432 0 C-N-CA 118.659 -1.217 . . . . 0.0 109.403 177.395 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.424 ' O ' ' O ' ' A' ' 26' ' ' ASN . . . 148.91 -33.94 1.14 Allowed Glycine 0 C--N 1.296 -1.678 1 N-CA-C 130.077 6.791 . . . . 0.0 130.077 -177.234 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.466 ' C ' ' H ' ' A' ' 26' ' ' ASN . 0.6 OUTLIER -54.64 116.52 2.74 Favored 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 119.301 -0.959 . . . . 0.0 110.261 179.911 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 78.85 -20.7 4.33 Favored Glycine 0 N--CA 1.479 1.504 0 C-N-CA 119.317 -1.42 . . . . 0.0 109.749 -178.681 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.551 ' O ' ' ND2' ' A' ' 12' ' ' ASN . 0.0 OUTLIER -114.22 -170.53 1.74 Allowed 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 119.933 -0.707 . . . . 0.0 109.876 -179.8 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.525 ' O ' ' O ' ' A' ' 40' ' ' VAL . 0.2 OUTLIER -154.2 118.71 4.87 Favored 'General case' 0 N--CA 1.5 2.045 0 C-N-CA 119.084 -1.046 . . . . 0.0 111.205 -179.969 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.517 ' SG ' ' O ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -81.77 160.98 23.46 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 118.979 -1.088 . . . . 0.0 110.956 -179.174 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 36.5 mm -133.33 126.81 53.11 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 C-N-CA 119.385 -0.926 . . . . 0.0 110.455 179.685 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 13.3 mt . . . . . 0 N--CA 1.497 1.91 0 C-N-CA 118.612 -1.235 . . . . 0.0 109.935 178.065 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.553 ' C ' ' ND2' ' A' ' 37' ' ' ASN . 0.2 OUTLIER . . . . . 0 N--CA 1.432 -1.364 0 CA-C-O 121.12 0.486 . . . . 0.0 110.156 . . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 tt0 -113.19 140.35 48.01 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.647 179.177 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 77.1 m -91.49 107.65 19.35 Favored 'General case' 0 C--N 1.294 -1.847 0 C-N-CA 119.124 -1.03 . . . . 0.0 111.073 -179.887 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.547 ' CG2' ' N ' ' A' ' 41' ' ' THR . 2.5 p -123.58 162.6 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.5 0 C-N-CA 118.833 -1.147 . . . . 0.0 110.862 177.807 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.547 ' N ' ' CG2' ' A' ' 40' ' ' VAL . 1.3 t -90.0 144.99 25.43 Favored 'General case' 0 C--N 1.284 -2.257 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.805 179.585 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 178.49 -93.4 0.09 OUTLIER Glycine 0 N--CA 1.491 2.344 1 N-CA-C 130.25 6.86 . . . . 0.0 130.25 179.899 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -157.8 93.03 1.24 Allowed 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 119.561 -0.856 . . . . 0.0 110.027 179.399 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -131.62 -178.76 15.67 Favored Glycine 0 N--CA 1.493 2.467 1 N-CA-C 131.711 7.444 . . . . 0.0 131.711 -178.963 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -106.84 118.63 53.73 Favored Pre-proline 0 CA--C 1.561 1.386 0 C-N-CA 120.462 -0.495 . . . . 0.0 111.422 -179.341 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.41 ' O ' ' C ' ' A' ' 47' ' ' GLU . 4.3 Cg_exo -64.46 102.95 0.42 Allowed 'Trans proline' 0 C--O 1.215 -0.652 0 C-N-CA 120.935 1.09 . . . . 0.0 110.784 174.894 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.442 ' OE1' ' OG1' ' A' ' 4' ' ' THR . 6.5 tm-20 . . . . . 0 CA--C 1.56 1.343 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.162 179.603 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.473 ' CG1' ' H ' ' A' ' 3' ' ' TYR . 23.1 t . . . . . 0 N--CA 1.488 1.455 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 . . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.473 ' H ' ' CG1' ' A' ' 2' ' ' VAL . 23.4 m-85 -96.61 -166.25 1.39 Allowed 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 119.39 -0.924 . . . . 0.0 111.057 -178.013 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 13.8 p -96.9 176.19 6.06 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 119.792 -0.763 . . . . 0.0 109.225 -179.321 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -89.71 144.67 25.79 Favored 'General case' 0 C--N 1.289 -2.052 0 C-N-CA 118.722 -1.191 . . . . 0.0 109.335 178.321 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -73.81 -177.93 3.0 Favored 'General case' 0 C--N 1.286 -2.175 0 CA-C-O 122.144 0.973 . . . . 0.0 111.535 -179.864 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.7 p -154.37 18.56 0.48 Allowed 'General case' 0 C--N 1.283 -2.286 0 CA-C-N 113.476 -1.693 . . . . 0.0 109.076 178.486 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -163.2 177.93 8.64 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-N 114.4 -1.273 . . . . 0.0 110.568 -178.98 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.496 ' O ' ' N ' ' A' ' 11' ' ' GLN . 0.6 OUTLIER -83.91 -158.52 0.32 Allowed 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.985 -179.763 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 22.85 21.41 0.0 OUTLIER Glycine 0 N--CA 1.498 2.779 1 N-CA-C 129.973 6.749 . . . . 0.0 129.973 178.762 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.496 ' N ' ' O ' ' A' ' 9' ' ' SER . 7.7 mt-30 -94.49 -164.18 1.14 Allowed 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 114.492 -0.854 . . . . 0.0 109.575 178.233 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.607 HD22 ' H ' ' A' ' 44' ' ' GLY . 24.7 m-20 -147.57 -62.59 0.27 Allowed 'General case' 0 N--CA 1.501 2.082 0 C-N-CA 118.086 -1.446 . . . . 0.0 114.54 -177.311 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 16.2 mt -76.86 47.43 0.52 Allowed 'General case' 0 C--N 1.269 -2.909 0 C-N-CA 118.127 -1.429 . . . . 0.0 111.795 -174.586 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 7.0 p -129.85 -168.07 1.9 Allowed 'General case' 0 C--N 1.308 -1.203 0 C-N-CA 119.657 -0.817 . . . . 0.0 110.186 175.441 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 35.9 mt -104.41 120.12 40.51 Favored 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 119.586 -0.846 . . . . 0.0 108.935 178.232 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.1 m -119.67 -18.9 8.24 Favored 'General case' 0 N--CA 1.501 2.114 0 C-N-CA 119.163 -1.015 . . . . 0.0 111.816 -176.575 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.11 93.78 4.02 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 119.591 -0.844 . . . . 0.0 109.243 177.677 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 68.84 -101.75 0.83 Allowed Glycine 0 N--CA 1.486 2.001 0 C-N-CA 119.245 -1.455 . . . . 0.0 109.8 -178.268 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.442 ' O ' ' OG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -127.17 4.12 6.41 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 122.541 1.162 . . . . 0.0 109.269 178.931 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -78.09 140.1 39.06 Favored 'General case' 0 C--N 1.262 -3.211 0 CA-C-N 112.811 -1.995 . . . . 0.0 111.203 -179.077 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.1 t -77.27 145.75 9.61 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.19 0 C-N-CA 119.337 -0.945 . . . . 0.0 110.021 178.754 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.494 ' O ' ' SG ' ' A' ' 28' ' ' CYS . 15.0 m -146.57 109.89 4.78 Favored 'General case' 0 C--N 1.288 -2.099 0 C-N-CA 118.99 -1.084 . . . . 0.0 109.185 176.761 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -170.72 -78.75 0.04 OUTLIER Glycine 0 N--CA 1.479 1.523 1 N-CA-C 129.681 6.632 . . . . 0.0 129.681 -175.961 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.34 110.98 2.43 Favored 'General case' 0 C--N 1.311 -1.071 0 C-N-CA 118.308 -1.357 . . . . 0.0 109.309 179.441 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 105.44 -18.93 40.7 Favored Glycine 0 C--N 1.302 -1.359 0 N-CA-C 122.735 3.854 . . . . 0.0 122.735 -171.443 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -132.36 -167.94 1.97 Allowed 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 112.788 -1.706 . . . . 0.0 108.711 179.105 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.475 ' O ' ' O ' ' A' ' 40' ' ' VAL . 12.7 tttt -148.11 122.15 9.46 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 118.52 -1.272 . . . . 0.0 110.502 177.472 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.494 ' SG ' ' O ' ' A' ' 22' ' ' CYS . 19.2 m -86.55 153.58 21.72 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 117.825 -1.55 . . . . 0.0 110.819 178.624 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 13.6 mm -137.2 129.39 42.87 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.647 0 CA-C-N 114.492 -1.231 . . . . 0.0 109.303 175.839 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 17.2 mt . . . . . 0 N--CA 1.49 1.575 0 C-N-CA 118.191 -1.404 . . . . 0.0 108.914 178.001 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.431 ' OD1' ' N ' ' A' ' 37' ' ' ASN . 2.0 m-20 . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 . . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 40.2 tt0 -150.51 141.79 23.25 Favored 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 118.998 -1.081 . . . . 0.0 110.111 177.969 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 14.2 m -91.21 91.36 8.18 Favored 'General case' 0 C--N 1.293 -1.861 0 C-N-CA 119.49 -0.884 . . . . 0.0 111.173 -178.362 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.475 ' O ' ' O ' ' A' ' 27' ' ' LYS . 0.6 OUTLIER -95.53 139.69 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 C-N-CA 118.334 -1.347 . . . . 0.0 110.941 178.659 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.8 t -56.8 147.27 23.66 Favored 'General case' 0 C--N 1.271 -2.831 0 CA-C-N 114.085 -1.416 . . . . 0.0 110.918 -179.567 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 159.43 -141.25 7.39 Favored Glycine 0 N--CA 1.487 2.073 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 -179.263 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -146.57 106.44 3.98 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 119.34 -0.944 . . . . 0.0 110.229 179.785 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.607 ' H ' HD22 ' A' ' 12' ' ' ASN . . . -108.46 -156.54 18.46 Favored Glycine 0 N--CA 1.498 2.822 0 C-N-CA 119.834 -1.174 . . . . 0.0 111.1 -178.807 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -132.56 156.12 80.45 Favored Pre-proline 0 N--CA 1.497 1.876 0 C-N-CA 120.104 -0.638 . . . . 0.0 109.853 -178.941 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -53.84 165.33 1.92 Allowed 'Trans proline' 0 C--O 1.216 -0.623 0 C-N-CA 121.373 1.382 . . . . 0.0 111.092 175.828 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 . . . . . 0 CA--C 1.558 1.259 0 C-N-CA 119.293 -0.963 . . . . 0.0 110.952 177.958 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 4.2 t . . . . . 0 N--CA 1.485 1.314 0 CA-C-O 121.586 0.708 . . . . 0.0 110.768 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -138.32 -172.18 3.22 Favored 'General case' 0 C--N 1.273 -2.75 0 CA-C-N 114.509 -1.223 . . . . 0.0 111.182 179.808 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.6 p -123.22 -167.44 1.6 Allowed 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 114.797 -1.092 . . . . 0.0 108.563 178.314 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -93.54 156.14 16.91 Favored 'General case' 0 C--N 1.288 -2.106 0 C-N-CA 119.05 -1.06 . . . . 0.0 111.434 -177.939 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.447 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 1.7 m -72.23 162.17 29.84 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 114.931 -1.031 . . . . 0.0 110.44 177.286 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.732 ' H ' HE22 ' A' ' 11' ' ' GLN . 0.2 OUTLIER -138.44 8.73 2.66 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 119.46 -0.896 . . . . 0.0 110.034 178.328 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.634 ' H ' ' NE2' ' A' ' 11' ' ' GLN . 11.4 pt-20 -164.75 161.09 20.37 Favored 'General case' 0 C--N 1.281 -2.376 0 CA-C-N 114.29 -1.323 . . . . 0.0 110.379 178.886 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.474 ' HB3' ' H ' ' A' ' 30' ' ' LEU . 0.7 OUTLIER -70.36 150.37 46.37 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.644 -0.823 . . . . 0.0 109.905 -179.783 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 28' ' ' CYS . . . 101.66 -37.01 3.84 Favored Glycine 0 N--CA 1.502 3.085 0 C-N-CA 119.511 -1.328 . . . . 0.0 112.759 178.114 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.732 HE22 ' H ' ' A' ' 7' ' ' THR . 4.5 mt-30 -47.31 176.39 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.521 0 C-N-CA 119.539 -0.865 . . . . 0.0 111.583 -177.63 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.543 ' C ' ' H ' ' A' ' 14' ' ' CYS . 54.7 m-20 -147.93 -60.56 0.26 Allowed 'General case' 0 N--CA 1.502 2.164 0 C-N-CA 118.698 -1.201 . . . . 0.0 113.339 -178.161 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 19.0 mt -76.1 39.71 0.19 Allowed 'General case' 0 C--N 1.29 -2.016 0 C-N-CA 118.752 -1.179 . . . . 0.0 110.273 -177.88 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.587 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 17.2 p -122.27 -164.58 1.18 Allowed 'General case' 0 C--N 1.292 -1.908 0 CA-C-N 115.05 -0.977 . . . . 0.0 108.387 176.555 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 25.4 mt -100.29 99.39 10.05 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-O 122.286 1.041 . . . . 0.0 108.7 177.764 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.587 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 93.2 m -100.91 -61.62 1.35 Allowed 'General case' 0 C--N 1.276 -2.594 0 CA-C-N 113.273 -1.785 . . . . 0.0 110.708 -174.07 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -80.57 90.11 5.7 Favored 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 118.902 -1.119 . . . . 0.0 108.838 178.207 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 69.29 -127.59 21.07 Favored Glycine 0 N--CA 1.484 1.847 0 C-N-CA 118.953 -1.594 . . . . 0.0 109.465 -177.838 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -100.89 0.01 37.65 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 122.179 0.99 . . . . 0.0 109.966 179.688 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 67.7 m-80 -80.02 150.92 30.23 Favored 'General case' 0 C--N 1.261 -3.246 0 CA-C-N 113.483 -1.689 . . . . 0.0 111.256 -179.007 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.4 t -82.92 141.36 15.03 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 C-N-CA 119.566 -0.853 . . . . 0.0 111.477 -179.176 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.602 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 0.1 OUTLIER -77.76 -130.85 0.01 OUTLIER 'General case' 0 N--CA 1.514 2.764 0 C-N-CA 118.765 -1.174 . . . . 0.0 108.867 172.468 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.452 ' O ' ' C ' ' A' ' 24' ' ' GLN . . . -179.71 111.2 0.31 Allowed Glycine 0 C--N 1.275 -2.845 0 C-N-CA 117.96 -2.067 . . . . 0.0 111.617 177.527 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.452 ' C ' ' O ' ' A' ' 23' ' ' GLY . 36.4 tt0 -36.61 129.69 0.77 Allowed 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 119.979 -0.688 . . . . 0.0 109.244 176.13 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 121.31 -25.91 6.85 Favored Glycine 0 N--CA 1.483 1.813 0 N-CA-C 107.532 -2.227 . . . . 0.0 107.532 -175.142 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.625 ' N ' ' ND2' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -107.5 -161.25 0.77 Allowed 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 176.894 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.543 ' O ' ' O ' ' A' ' 40' ' ' VAL . 29.4 tttp -153.7 105.7 2.82 Favored 'General case' 0 N--CA 1.5 2.041 0 C-N-CA 118.799 -1.16 . . . . 0.0 111.918 179.866 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.602 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 3.3 m -78.55 154.81 30.09 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 118.39 -1.324 . . . . 0.0 110.146 178.71 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 8.2 mm -134.3 133.72 55.25 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.152 0 CA-C-N 114.968 -1.014 . . . . 0.0 110.283 175.655 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.474 ' H ' ' HB3' ' A' ' 9' ' ' SER . 17.7 mt . . . . . 0 N--CA 1.497 1.885 0 C-N-CA 119.123 -1.031 . . . . 0.0 110.038 177.354 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.499 ' OD1' ' N ' ' A' ' 37' ' ' ASN . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 121.187 0.518 . . . . 0.0 111.498 . . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 -160.78 135.86 7.71 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.859 177.581 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.423 ' SG ' ' HB2' ' A' ' 16' ' ' CYS . 1.0 OUTLIER -91.53 108.77 20.13 Favored 'General case' 0 C--N 1.295 -1.787 0 C-N-CA 119.705 -0.798 . . . . 0.0 110.741 -179.557 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.543 ' O ' ' O ' ' A' ' 27' ' ' LYS . 3.7 p -130.95 157.69 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.25 0 C-N-CA 118.219 -1.393 . . . . 0.0 111.359 176.459 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.52 ' N ' ' CG2' ' A' ' 40' ' ' VAL . 14.0 t -73.24 151.03 41.57 Favored 'General case' 0 C--N 1.275 -2.633 0 CA-C-N 114.399 -1.273 . . . . 0.0 111.662 -179.13 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 164.31 -143.13 8.29 Favored Glycine 0 N--CA 1.489 2.2 0 C-N-CA 119.479 -1.343 . . . . 0.0 110.43 179.587 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -120.78 100.26 7.0 Favored 'General case' 0 N--CA 1.495 1.814 0 C-N-CA 120.092 -0.643 . . . . 0.0 109.904 179.588 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -127.28 -155.06 8.7 Favored Glycine 0 N--CA 1.495 2.621 0 N-CA-C 110.255 -1.138 . . . . 0.0 110.255 -179.73 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -144.41 151.05 49.97 Favored Pre-proline 0 N--CA 1.488 1.428 0 C-N-CA 119.431 -0.908 . . . . 0.0 109.954 179.713 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -68.8 141.61 49.83 Favored 'Trans proline' 0 C--O 1.216 -0.612 0 C-N-CA 121.342 1.361 . . . . 0.0 111.336 177.177 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 . . . . . 0 CA--C 1.56 1.358 0 C-N-CA 119.488 -0.885 . . . . 0.0 109.512 178.506 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.514 ' CG1' ' H ' ' A' ' 3' ' ' TYR . 61.7 t . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 120.938 0.399 . . . . 0.0 109.983 . . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.514 ' H ' ' CG1' ' A' ' 2' ' ' VAL . 37.8 m-85 -114.39 -165.41 1.01 Allowed 'General case' 0 N--CA 1.493 1.685 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.67 -179.733 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.9 p -99.48 172.27 7.42 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 178.215 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -89.64 154.2 20.15 Favored 'General case' 0 C--N 1.285 -2.207 0 C-N-CA 118.2 -1.4 . . . . 0.0 110.366 -179.632 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.514 ' SG ' ' O ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -73.81 154.73 39.39 Favored 'General case' 0 C--N 1.291 -1.952 0 C-N-CA 119.729 -0.788 . . . . 0.0 110.223 177.35 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.4 t -129.94 14.35 5.79 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-O 122.055 0.931 . . . . 0.0 108.85 177.739 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -162.58 176.94 9.87 Favored 'General case' 0 C--N 1.281 -2.404 0 CA-C-N 113.695 -1.593 . . . . 0.0 109.58 179.488 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.461 ' O ' ' N ' ' A' ' 11' ' ' GLN . 0.5 OUTLIER -72.64 -163.75 0.14 Allowed 'General case' 0 C--N 1.297 -1.693 0 C-N-CA 119.264 -0.974 . . . . 0.0 109.5 -179.506 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.426 ' H ' HD12 ' A' ' 29' ' ' ILE . . . 24.66 19.73 0.0 OUTLIER Glycine 0 N--CA 1.494 2.541 1 N-CA-C 130.218 6.847 . . . . 0.0 130.218 179.264 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.461 ' N ' ' O ' ' A' ' 9' ' ' SER . 7.9 mm-40 -71.09 -163.38 0.08 Allowed 'General case' 0 C--N 1.295 -1.799 0 C-N-CA 119.432 -0.907 . . . . 0.0 109.35 177.241 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.518 ' N ' ' O ' ' A' ' 45' ' ' THR . 26.2 t-20 -148.52 -77.55 0.16 Allowed 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 118.188 -1.405 . . . . 0.0 112.975 -177.876 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 14.1 mt -78.08 42.13 0.39 Allowed 'General case' 0 C--N 1.271 -2.833 0 C-N-CA 118.02 -1.472 . . . . 0.0 110.495 -177.8 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.479 ' H ' ' C ' ' A' ' 12' ' ' ASN . 29.4 p -113.33 -159.88 0.7 Allowed 'General case' 0 N--CA 1.496 1.833 0 C-N-CA 119.483 -0.887 . . . . 0.0 110.129 178.012 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.514 ' O ' ' SG ' ' A' ' 6' ' ' CYS . 3.5 mt -124.82 133.0 53.28 Favored 'General case' 0 N--CA 1.499 2.006 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.518 177.584 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 3.4 m -111.92 -74.42 0.64 Allowed 'General case' 0 N--CA 1.513 2.713 0 C-N-CA 119.064 -1.054 . . . . 0.0 110.308 179.094 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -78.23 125.69 29.72 Favored 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 118.319 -1.352 . . . . 0.0 107.845 177.228 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 28.55 -72.64 0.0 OUTLIER Glycine 0 N--CA 1.502 3.06 1 N-CA-C 128.931 6.332 . . . . 0.0 128.931 -176.7 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -137.53 0.27 2.25 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-O 122.149 0.976 . . . . 0.0 110.324 177.456 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 35.8 m120 -80.27 128.16 33.21 Favored 'General case' 0 C--N 1.261 -3.264 0 CA-C-N 113.557 -1.656 . . . . 0.0 110.448 -179.84 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.1 t -70.34 148.98 10.61 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 C-N-CA 119.282 -0.967 . . . . 0.0 109.954 179.621 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.546 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 0.4 OUTLIER -134.54 101.14 4.86 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 119.0 -1.08 . . . . 0.0 110.699 178.781 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.517 ' O ' ' ND2' ' A' ' 12' ' ' ASN . . . 164.98 -55.4 0.27 Allowed Glycine 0 C--N 1.297 -1.61 1 N-CA-C 131.485 7.354 . . . . 0.0 131.485 179.465 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.503 ' N ' ' OD1' ' A' ' 12' ' ' ASN . 28.7 tt0 -51.47 117.85 2.92 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 118.875 -1.13 . . . . 0.0 110.732 -178.045 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 80.26 -22.37 4.52 Favored Glycine 0 N--CA 1.482 1.711 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -178.506 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.527 ' N ' ' OD1' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -119.8 -159.17 0.77 Allowed 'General case' 0 C--N 1.312 -1.037 0 C-N-CA 120.432 -0.507 . . . . 0.0 109.99 -179.689 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.593 ' N ' ' O ' ' A' ' 40' ' ' VAL . 40.3 tttt -157.98 162.35 38.19 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.654 -179.95 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.546 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -122.97 168.81 11.85 Favored 'General case' 0 CA--C 1.481 -1.706 0 CA-C-O 123.125 1.441 . . . . 0.0 111.638 174.249 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.426 HD12 ' H ' ' A' ' 10' ' ' GLY . 21.6 mm -143.72 130.43 16.95 Favored 'Isoleucine or valine' 0 C--N 1.249 -3.782 0 CA-C-N 111.755 -2.475 . . . . 0.0 108.816 174.324 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 15.2 mt . . . . . 0 N--CA 1.49 1.54 0 C-N-CA 118.275 -1.37 . . . . 0.0 110.016 -179.73 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 14.6 m-20 . . . . . 0 N--CA 1.485 1.306 0 N-CA-C 109.751 -0.462 . . . . 0.0 109.751 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.519 ' O ' ' SG ' ' A' ' 28' ' ' CYS . 38.3 tt0 -160.54 147.25 15.53 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 119.383 -0.927 . . . . 0.0 110.488 178.333 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -103.44 107.38 18.19 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 119.885 -0.726 . . . . 0.0 112.378 -179.55 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.593 ' O ' ' N ' ' A' ' 27' ' ' LYS . 0.1 OUTLIER -100.25 141.46 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.571 0 C-N-CA 118.709 -1.196 . . . . 0.0 110.615 174.778 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.9 t -78.79 47.41 0.74 Allowed 'General case' 0 C--N 1.279 -2.471 0 CA-C-N 113.942 -1.481 . . . . 0.0 113.232 -177.882 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -118.47 -124.51 3.37 Favored Glycine 0 N--CA 1.505 3.294 1 N-CA-C 131.198 7.239 . . . . 0.0 131.198 178.172 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -98.1 73.39 2.21 Favored 'General case' 0 N--CA 1.499 1.992 0 C-N-CA 119.412 -0.915 . . . . 0.0 111.215 -178.489 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -92.15 165.22 28.95 Favored Glycine 0 N--CA 1.494 2.559 0 C-N-CA 119.405 -1.378 . . . . 0.0 110.854 -179.597 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.518 ' O ' ' N ' ' A' ' 12' ' ' ASN . 0.5 OUTLIER -129.95 148.3 69.04 Favored Pre-proline 0 N--CA 1.498 1.925 0 C-N-CA 120.128 -0.629 . . . . 0.0 109.721 179.971 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.436 ' O ' ' O ' ' A' ' 45' ' ' THR . 2.7 Cg_exo -52.77 -164.03 0.0 OUTLIER 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 121.414 1.41 . . . . 0.0 111.131 177.717 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 . . . . . 0 C--N 1.305 -1.353 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.077 178.111 . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.0 t . . . . . 0 N--CA 1.486 1.37 0 CA-C-O 121.057 0.456 . . . . 0.0 110.494 . . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -87.65 -164.53 1.11 Allowed 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 119.909 -0.716 . . . . 0.0 110.417 -179.897 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.2 p -97.59 178.38 5.19 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 119.793 -0.763 . . . . 0.0 108.956 179.742 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -91.17 154.44 19.32 Favored 'General case' 0 C--N 1.297 -1.69 0 C-N-CA 118.796 -1.162 . . . . 0.0 110.322 178.929 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.486 ' SG ' ' O ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -75.13 165.75 24.73 Favored 'General case' 0 C--N 1.299 -1.592 0 C-N-CA 119.886 -0.726 . . . . 0.0 110.899 177.827 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 43.2 p -143.72 17.5 1.81 Allowed 'General case' 0 C--N 1.294 -1.835 0 CA-C-N 114.881 -1.054 . . . . 0.0 108.596 177.123 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -161.15 167.55 25.98 Favored 'General case' 0 C--N 1.288 -2.086 0 CA-C-N 113.64 -1.618 . . . . 0.0 109.853 -179.03 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.515 ' O ' ' N ' ' A' ' 11' ' ' GLN . 0.8 OUTLIER -68.97 -168.37 0.13 Allowed 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 119.043 -1.063 . . . . 0.0 108.765 178.599 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.445 ' H ' HD12 ' A' ' 29' ' ' ILE . . . 24.35 16.89 0.0 OUTLIER Glycine 0 N--CA 1.492 2.421 1 N-CA-C 130.158 6.823 . . . . 0.0 130.158 179.865 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.537 ' NE2' ' OE1' ' A' ' 47' ' ' GLU . 10.8 mt-30 -69.67 -164.97 0.07 Allowed 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 176.218 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.468 ' C ' ' H ' ' A' ' 14' ' ' CYS . 1.7 m-20 -150.43 -70.17 0.18 Allowed 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 117.551 -1.66 . . . . 0.0 113.952 -179.302 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 18.6 mt -77.28 48.96 0.66 Allowed 'General case' 0 C--N 1.272 -2.794 0 C-N-CA 117.705 -1.598 . . . . 0.0 110.189 -176.146 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.468 ' H ' ' C ' ' A' ' 12' ' ' ASN . 26.7 p -125.39 -161.47 1.03 Allowed 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.01 -0.995 . . . . 0.0 109.184 176.517 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.486 ' O ' ' SG ' ' A' ' 6' ' ' CYS . 38.3 mt -112.6 120.84 42.95 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 123.973 0.795 . . . . 0.0 109.131 176.665 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 8.6 m -116.06 -38.54 3.6 Favored 'General case' 0 N--CA 1.503 2.207 0 C-N-CA 119.038 -1.065 . . . . 0.0 111.176 -177.074 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -100.04 76.63 1.94 Allowed 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 119.236 -0.986 . . . . 0.0 110.088 179.236 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 76.1 -94.49 1.01 Allowed Glycine 0 N--CA 1.49 2.282 0 C-N-CA 119.359 -1.401 . . . . 0.0 110.637 179.743 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -125.53 -2.84 7.36 Favored 'General case' 0 N--CA 1.485 1.302 0 CA-C-O 122.058 0.932 . . . . 0.0 110.518 -179.211 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 60.4 m-80 -81.32 136.78 35.78 Favored 'General case' 0 C--N 1.257 -3.452 0 CA-C-N 113.629 -1.623 . . . . 0.0 110.862 -179.248 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.1 t -71.67 147.17 10.95 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 C-N-CA 119.366 -0.934 . . . . 0.0 110.071 179.09 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.441 ' O ' ' O ' ' A' ' 12' ' ' ASN . 6.2 m -149.14 118.56 6.9 Favored 'General case' 0 C--N 1.288 -2.081 0 C-N-CA 118.819 -1.152 . . . . 0.0 108.876 176.486 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.46 ' O ' ' O ' ' A' ' 26' ' ' ASN . . . 179.36 -92.23 0.08 OUTLIER Glycine 0 C--O 1.203 -1.831 0 C-N-CA 117.622 -2.227 . . . . 0.0 112.218 -177.37 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 15.3 tt0 -45.37 131.22 8.31 Favored 'General case' 0 C--N 1.299 -1.612 0 C-N-CA 119.352 -0.939 . . . . 0.0 110.861 -177.472 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.56 -32.15 4.01 Favored Glycine 0 N--CA 1.479 1.515 0 N-CA-C 109.261 -1.536 . . . . 0.0 109.261 -177.819 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.46 ' O ' ' O ' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -129.67 -160.47 1.04 Allowed 'General case' 0 C--N 1.313 -1.0 0 C-N-CA 120.205 -0.598 . . . . 0.0 110.833 -179.801 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.554 ' CG ' ' N ' ' A' ' 28' ' ' CYS . 26.6 tttt -151.51 167.49 27.87 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 177.748 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.554 ' N ' ' CG ' ' A' ' 27' ' ' LYS . 59.6 m -127.62 164.66 21.55 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 119.132 -1.027 . . . . 0.0 111.261 177.001 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.445 HD12 ' H ' ' A' ' 10' ' ' GLY . 20.1 mm -146.2 133.61 15.04 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.278 0 CA-C-N 114.184 -1.371 . . . . 0.0 109.94 176.194 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 18.5 mt . . . . . 0 N--CA 1.496 1.834 0 C-N-CA 118.952 -1.099 . . . . 0.0 109.381 177.993 . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.463 ' OD1' ' N ' ' A' ' 37' ' ' ASN . 1.8 m-20 . . . . . 0 N--CA 1.496 1.835 0 CA-C-O 121.007 0.432 . . . . 0.0 111.139 . . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -160.58 139.7 10.57 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.94 -0.704 . . . . 0.0 109.64 176.758 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 20.9 m -87.94 103.02 15.29 Favored 'General case' 0 C--N 1.297 -1.677 0 C-N-CA 119.175 -1.01 . . . . 0.0 110.993 -178.772 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.514 ' O ' ' N ' ' A' ' 27' ' ' LYS . 0.4 OUTLIER -100.14 142.07 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.232 0 C-N-CA 118.677 -1.209 . . . . 0.0 111.586 178.837 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.3 t -69.66 141.35 53.63 Favored 'General case' 0 C--N 1.277 -2.584 0 CA-C-N 114.207 -1.36 . . . . 0.0 110.955 179.311 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 157.97 -114.12 0.6 Allowed Glycine 0 N--CA 1.492 2.4 1 N-CA-C 130.492 6.957 . . . . 0.0 130.492 179.686 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -139.43 100.26 3.94 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 119.631 -0.828 . . . . 0.0 109.978 179.286 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -126.46 -175.04 14.0 Favored Glycine 0 N--CA 1.496 2.634 0 N-CA-C 110.33 -1.108 . . . . 0.0 110.33 -179.415 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -137.77 148.47 61.05 Favored Pre-proline 0 N--CA 1.491 1.589 0 C-N-CA 119.84 -0.744 . . . . 0.0 109.78 -179.984 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_exo -48.35 177.2 0.02 OUTLIER 'Trans proline' 0 C--O 1.214 -0.682 0 C-N-CA 121.475 1.45 . . . . 0.0 111.511 179.766 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.537 ' OE1' ' NE2' ' A' ' 11' ' ' GLN . 5.1 tp10 . . . . . 0 CA--C 1.558 1.258 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.747 178.857 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.438 ' CG1' ' H ' ' A' ' 3' ' ' TYR . 6.8 t . . . . . 0 N--CA 1.489 1.513 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 . . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.438 ' H ' ' CG1' ' A' ' 2' ' ' VAL . 61.1 m-85 -143.07 -172.47 3.68 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.135 -1.026 . . . . 0.0 111.23 -179.794 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.5 ' OG1' ' N ' ' A' ' 5' ' ' ASP . 0.1 OUTLIER -114.45 -165.66 1.03 Allowed 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 115.105 -0.952 . . . . 0.0 108.556 179.232 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.5 ' N ' ' OG1' ' A' ' 4' ' ' THR . 0.7 OUTLIER -92.2 155.05 18.26 Favored 'General case' 0 C--N 1.287 -2.119 0 C-N-CA 118.371 -1.332 . . . . 0.0 110.904 -179.363 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.418 ' N ' ' HB2' ' A' ' 14' ' ' CYS . 0.0 OUTLIER -73.82 171.23 13.74 Favored 'General case' 0 C--N 1.287 -2.148 0 CA-C-N 114.575 -1.193 . . . . 0.0 110.272 178.289 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.5 p -140.94 13.31 2.26 Favored 'General case' 0 C--N 1.294 -1.816 0 C-N-CA 119.367 -0.933 . . . . 0.0 109.687 177.284 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -162.13 174.22 13.25 Favored 'General case' 0 C--N 1.288 -2.108 0 CA-C-N 114.065 -1.425 . . . . 0.0 110.228 179.659 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.43 ' HB3' ' H ' ' A' ' 30' ' ' LEU . 0.7 OUTLIER -85.58 167.2 15.59 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 119.804 -0.758 . . . . 0.0 109.724 -179.945 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' A' ' 28' ' ' CYS . . . 71.34 14.63 74.47 Favored Glycine 0 N--CA 1.503 3.156 0 C-N-CA 119.182 -1.485 . . . . 0.0 112.225 178.693 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -84.52 -174.95 5.56 Favored 'General case' 0 N--CA 1.505 2.298 0 C-N-CA 119.034 -1.066 . . . . 0.0 110.616 179.159 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.519 ' C ' ' H ' ' A' ' 14' ' ' CYS . 10.3 m-20 -153.51 -69.51 0.14 Allowed 'General case' 0 N--CA 1.505 2.299 0 C-N-CA 118.403 -1.319 . . . . 0.0 113.514 -178.048 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 70.2 mt -75.22 45.96 0.3 Allowed 'General case' 0 C--N 1.288 -2.106 0 C-N-CA 118.595 -1.242 . . . . 0.0 109.74 -178.588 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.519 ' H ' ' C ' ' A' ' 12' ' ' ASN . 31.8 p -122.37 -149.5 0.43 Allowed 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 115.233 -0.894 . . . . 0.0 108.884 177.606 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 71.5 mt -120.0 100.18 7.06 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-O 122.25 1.024 . . . . 0.0 109.091 176.347 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.574 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 0.5 OUTLIER -74.21 -69.1 0.47 Allowed 'General case' 0 C--N 1.276 -2.616 0 CA-C-N 113.358 -1.746 . . . . 0.0 110.51 -176.088 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -100.37 95.4 6.74 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 119.029 -1.068 . . . . 0.0 111.302 -179.128 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.17 -95.21 0.84 Allowed Glycine 0 N--CA 1.492 2.398 0 C-N-CA 119.739 -1.219 . . . . 0.0 111.735 177.285 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -127.2 2.49 6.42 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-O 122.061 0.934 . . . . 0.0 110.743 -177.054 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -78.54 129.34 34.71 Favored 'General case' 0 C--N 1.255 -3.501 0 CA-C-N 113.702 -1.59 . . . . 0.0 110.864 -179.868 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.0 t -81.13 138.4 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 118.917 -1.113 . . . . 0.0 110.314 179.113 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.623 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 0.1 OUTLIER -77.94 -135.34 0.02 OUTLIER 'General case' 0 C--N 1.286 -2.184 0 C-N-CA 118.774 -1.171 . . . . 0.0 109.474 172.697 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.539 ' O ' ' ND2' ' A' ' 26' ' ' ASN . . . 179.49 115.83 0.48 Allowed Glycine 0 C--N 1.268 -3.196 0 C-N-CA 117.91 -2.091 . . . . 0.0 111.064 178.973 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.462 ' C ' ' O ' ' A' ' 23' ' ' GLY . 2.3 tt0 -36.22 135.19 0.37 Allowed 'General case' 0 C--N 1.284 -2.24 0 CA-C-N 114.872 -0.664 . . . . 0.0 109.773 176.721 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 116.79 -36.36 3.79 Favored Glycine 0 N--CA 1.486 1.979 0 N-CA-C 107.987 -2.045 . . . . 0.0 107.987 -175.632 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.539 ' ND2' ' O ' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -92.46 -162.46 0.93 Allowed 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 176.557 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.627 ' CB ' ' HZ1' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -151.75 105.25 3.11 Favored 'General case' 0 C--N 1.284 -2.278 0 C-N-CA 118.66 -1.216 . . . . 0.0 110.41 179.284 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.623 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 9.9 m -77.62 159.47 29.19 Favored 'General case' 0 C--O 1.196 -1.725 0 C-N-CA 117.908 -1.517 . . . . 0.0 110.692 -179.595 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.454 HD12 ' HZ2' ' A' ' 27' ' ' LYS . 27.9 mm -141.69 132.41 26.04 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.06 0 CA-C-N 114.005 -1.452 . . . . 0.0 110.207 177.817 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.431 ' CD2' HD22 ' A' ' 37' ' ' ASN . 20.3 mt . . . . . 0 N--CA 1.492 1.671 0 C-N-CA 119.338 -0.945 . . . . 0.0 110.156 177.799 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.58 ' OD1' ' N ' ' A' ' 37' ' ' ASN . 0.1 OUTLIER . . . . . 0 N--CA 1.484 1.257 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 . . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -154.75 137.18 15.01 Favored 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 119.492 -0.883 . . . . 0.0 109.368 176.694 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.574 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 2.0 m -78.97 105.99 10.69 Favored 'General case' 0 C--N 1.29 -1.994 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.844 -176.666 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.495 ' O ' ' O ' ' A' ' 27' ' ' LYS . 2.4 p -111.97 143.37 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.354 0 C-N-CA 118.395 -1.322 . . . . 0.0 110.996 175.85 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.2 t -66.24 150.2 49.16 Favored 'General case' 0 C--N 1.269 -2.899 0 CA-C-N 113.626 -1.625 . . . . 0.0 112.251 -178.348 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 165.31 -120.28 0.92 Allowed Glycine 0 N--CA 1.486 2.012 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 178.373 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -160.87 81.78 0.65 Allowed 'General case' 0 C--N 1.299 -1.587 0 C-N-CA 119.408 -0.917 . . . . 0.0 109.447 178.58 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -100.25 -158.88 28.15 Favored Glycine 0 N--CA 1.492 2.43 0 C-N-CA 119.853 -1.165 . . . . 0.0 110.949 -178.035 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -130.35 152.18 79.8 Favored Pre-proline 0 N--CA 1.493 1.681 0 C-N-CA 119.942 -0.703 . . . . 0.0 109.842 -179.759 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -55.85 -175.43 0.04 OUTLIER 'Trans proline' 0 C--O 1.214 -0.712 0 C-N-CA 121.475 1.45 . . . . 0.0 111.2 177.304 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 . . . . . 0 CA--C 1.558 1.255 0 C-N-CA 119.458 -0.897 . . . . 0.0 109.753 178.587 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 5.2 t . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.0 t -106.52 164.8 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.51 178.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 67.8 m-85 -126.05 -166.91 1.63 Allowed 'General case' 0 N--CA 1.499 1.981 0 C-N-CA 119.608 -0.837 . . . . 0.0 110.993 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.414 ' H ' ' HG1' ' A' ' 4' ' ' THR . 7.7 p -105.71 179.92 4.13 Favored 'General case' 0 C--O 1.199 -1.568 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.256 -179.211 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.471 ' OD1' ' N ' ' A' ' 5' ' ' ASP . 0.3 OUTLIER -83.54 156.84 22.6 Favored 'General case' 0 C--N 1.295 -1.802 0 C-N-CA 118.365 -1.334 . . . . 0.0 110.597 179.846 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.438 ' N ' ' HB2' ' A' ' 14' ' ' CYS . 0.1 OUTLIER -75.6 -178.64 4.24 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.666 178.127 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.463 ' H ' ' NE2' ' A' ' 11' ' ' GLN . 1.3 p -123.72 -20.82 5.36 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 114.953 -1.022 . . . . 0.0 109.791 176.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -162.52 162.44 27.38 Favored 'General case' 0 C--N 1.276 -2.587 0 CA-C-N 114.236 -1.347 . . . . 0.0 111.712 -178.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.87 143.07 57.97 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 115.014 -0.994 . . . . 0.0 108.753 179.439 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 108.24 -26.76 15.83 Favored Glycine 0 N--CA 1.487 2.094 1 N-CA-C 126.837 5.495 . . . . 0.0 126.837 -171.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.463 ' NE2' ' H ' ' A' ' 7' ' ' THR . 11.0 mt-30 -71.26 -171.38 0.59 Allowed 'General case' 0 N--CA 1.497 1.9 0 CA-C-N 114.642 -0.779 . . . . 0.0 109.889 178.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.453 ' O ' ' O ' ' A' ' 22' ' ' CYS . 4.3 m-20 -135.53 -69.98 0.49 Allowed 'General case' 0 N--CA 1.509 2.477 0 N-CA-C 114.558 1.318 . . . . 0.0 114.558 -175.284 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 50.9 mt -77.45 50.32 0.79 Allowed 'General case' 0 C--N 1.277 -2.565 0 C-N-CA 118.403 -1.319 . . . . 0.0 111.006 -175.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.438 ' HB2' ' N ' ' A' ' 6' ' ' CYS . 29.8 p -123.81 -161.02 0.95 Allowed 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 119.577 -0.849 . . . . 0.0 109.98 175.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.436 ' O ' ' SG ' ' A' ' 6' ' ' CYS . 39.9 mt -113.28 121.65 45.07 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.495 176.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -128.56 -31.42 2.25 Favored 'General case' 0 N--CA 1.51 2.565 0 C-N-CA 118.899 -1.121 . . . . 0.0 110.48 -179.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.418 ' O ' ' N ' ' A' ' 19' ' ' SER . 0.6 OUTLIER -87.16 82.13 7.77 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 119.09 -1.044 . . . . 0.0 108.796 177.708 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 64.94 -81.4 0.07 OUTLIER Glycine 0 N--CA 1.488 2.131 0 C-N-CA 119.23 -1.462 . . . . 0.0 109.593 -178.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.418 ' N ' ' O ' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -141.34 0.22 1.48 Allowed 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 122.018 0.914 . . . . 0.0 110.643 178.656 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -83.56 149.11 26.79 Favored 'General case' 0 C--N 1.26 -3.303 0 CA-C-N 113.84 -1.527 . . . . 0.0 110.333 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.5 t -68.56 148.19 11.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 C-N-CA 119.102 -1.039 . . . . 0.0 110.983 -178.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.56 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 0.0 OUTLIER -149.64 107.88 3.76 Favored 'General case' 0 C--N 1.287 -2.125 0 CA-C-N 114.832 -1.076 . . . . 0.0 109.852 -179.789 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.451 ' O ' ' O ' ' A' ' 26' ' ' ASN . . . 159.47 -45.04 0.44 Allowed Glycine 0 N--CA 1.489 2.183 1 N-CA-C 131.612 7.405 . . . . 0.0 131.612 -177.244 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.424 ' C ' ' H ' ' A' ' 26' ' ' ASN . 3.2 tt0 -53.88 118.81 4.27 Favored 'General case' 0 C--N 1.306 -1.296 0 C-N-CA 118.652 -1.219 . . . . 0.0 110.547 -179.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.72 -19.62 6.01 Favored Glycine 0 N--CA 1.48 1.582 0 C-N-CA 119.399 -1.381 . . . . 0.0 110.084 -179.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.451 ' O ' ' O ' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -121.15 -169.7 1.89 Allowed 'General case' 0 C--O 1.213 -0.86 0 C-N-CA 119.953 -0.699 . . . . 0.0 110.074 -179.712 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.496 ' O ' ' O ' ' A' ' 40' ' ' VAL . 21.0 ttpt -152.47 119.98 6.01 Favored 'General case' 0 N--CA 1.495 1.786 0 C-N-CA 118.573 -1.251 . . . . 0.0 110.978 177.193 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.56 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -83.75 165.63 18.7 Favored 'General case' 0 CA--C 1.476 -1.873 0 C-N-CA 117.6 -1.64 . . . . 0.0 111.805 179.228 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 7.5 mm -131.47 90.3 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.261 -3.252 0 CA-C-N 112.006 -2.361 . . . . 0.0 108.854 175.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.1 pp -79.91 123.29 27.64 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 118.694 -1.202 . . . . 0.0 111.52 -177.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.544 ' N ' ' OD1' ' A' ' 37' ' ' ASN . . . 59.38 90.49 0.02 OUTLIER Glycine 0 N--CA 1.477 1.433 0 C-N-CA 118.992 -1.575 . . . . 0.0 109.509 179.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.532 ' O ' ' N ' ' A' ' 34' ' ' GLY . 67.6 m -68.45 -124.2 0.0 OUTLIER 'General case' 0 C--O 1.199 -1.557 0 C-N-CA 118.468 -1.293 . . . . 0.0 108.469 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -73.94 67.99 1.3 Allowed 'General case' 0 C--N 1.249 -3.802 0 CA-C-N 114.379 -1.282 . . . . 0.0 108.583 -174.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 32' ' ' SER . . . 67.51 27.34 73.55 Favored Glycine 0 C--N 1.29 -2.019 0 N-CA-C 108.0 -2.04 . . . . 0.0 108.0 -177.206 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -116.47 -134.54 0.34 Allowed 'General case' 0 C--O 1.214 -0.773 0 CA-C-O 122.365 1.079 . . . . 0.0 112.599 -176.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 8.1 mtmp? -93.61 176.21 6.45 Favored 'General case' 0 C--N 1.271 -2.83 0 CA-C-N 112.96 -1.927 . . . . 0.0 113.603 -174.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.544 ' OD1' ' N ' ' A' ' 31' ' ' GLY . 3.5 m-20 -103.36 152.69 21.29 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 114.556 -1.202 . . . . 0.0 110.383 177.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 23.3 tt0 -161.82 156.0 22.12 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 119.302 -0.959 . . . . 0.0 110.394 176.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.51 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 0.1 OUTLIER -103.54 120.9 41.78 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 113.472 0.915 . . . . 0.0 113.472 179.934 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.512 ' CG2' ' N ' ' A' ' 41' ' ' THR . 2.4 p -131.44 158.75 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 CA-C-N 114.751 -1.113 . . . . 0.0 110.477 173.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.512 ' N ' ' CG2' ' A' ' 40' ' ' VAL . 0.0 OUTLIER -83.02 144.04 30.21 Favored 'General case' 0 C--N 1.278 -2.531 0 CA-C-N 114.76 -1.109 . . . . 0.0 111.755 179.995 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 177.94 -124.99 0.97 Allowed Glycine 0 N--CA 1.492 2.369 1 N-CA-C 131.092 7.197 . . . . 0.0 131.092 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -130.96 109.02 10.23 Favored 'General case' 0 N--CA 1.497 1.875 0 C-N-CA 119.998 -0.681 . . . . 0.0 110.058 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -158.12 -162.56 11.88 Favored Glycine 0 N--CA 1.494 2.535 0 C-N-CA 119.044 -1.55 . . . . 0.0 110.962 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -144.04 155.25 58.76 Favored Pre-proline 0 N--CA 1.489 1.508 0 C-N-CA 119.476 -0.89 . . . . 0.0 110.378 -179.135 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -54.46 148.8 41.31 Favored 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 121.836 1.691 . . . . 0.0 111.325 175.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.58 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 0.6 OUTLIER -82.7 -37.27 0.75 Allowed Pre-proline 0 CA--C 1.558 1.282 0 C-N-CA 119.462 -0.895 . . . . 0.0 112.57 178.793 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.58 ' CD ' ' N ' ' A' ' 47' ' ' GLU . 5.7 Cg_exo -61.37 141.04 91.19 Favored 'Trans proline' 0 C--O 1.214 -0.685 0 C-N-CA 120.458 0.772 . . . . 0.0 110.969 -177.528 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.5 pp0? . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 116.367 -1.778 . . . . 0.0 110.489 -179.732 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 1.9 p . . . . . 0 N--CA 1.489 1.513 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 10.5 t -116.6 168.03 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 177.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 44.5 m-85 -97.87 -168.95 1.75 Allowed 'General case' 0 C--N 1.298 -1.636 0 C-N-CA 119.095 -1.042 . . . . 0.0 110.31 -179.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.581 ' OG1' ' N ' ' A' ' 5' ' ' ASP . 0.1 OUTLIER -105.31 -178.36 3.63 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 179.543 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.581 ' N ' ' OG1' ' A' ' 4' ' ' THR . 0.3 OUTLIER -88.46 157.43 18.66 Favored 'General case' 0 C--N 1.287 -2.14 0 C-N-CA 118.559 -1.257 . . . . 0.0 110.297 179.543 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.408 ' SG ' ' CB ' ' A' ' 11' ' ' GLN . 1.5 m -73.17 176.7 5.63 Favored 'General case' 0 C--N 1.289 -2.056 0 CA-C-N 115.102 -0.953 . . . . 0.0 111.1 177.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.726 ' H ' HE22 ' A' ' 11' ' ' GLN . 1.2 p -123.56 -19.38 5.85 Favored 'General case' 0 C--N 1.289 -2.054 0 CA-C-N 113.792 -1.549 . . . . 0.0 109.793 176.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.42 ' H ' ' NE2' ' A' ' 11' ' ' GLN . 3.5 pt-20 -163.12 163.24 25.81 Favored 'General case' 0 C--N 1.269 -2.917 0 CA-C-N 113.824 -1.535 . . . . 0.0 110.46 178.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.423 ' HA ' ' H ' ' A' ' 30' ' ' LEU . 0.7 OUTLIER -66.58 159.93 26.39 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.982 -177.828 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.44 -23.42 32.15 Favored Glycine 0 N--CA 1.507 3.426 0 C-N-CA 119.282 -1.437 . . . . 0.0 112.03 -179.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.726 HE22 ' H ' ' A' ' 7' ' ' THR . 2.5 mt-30 -62.22 -166.08 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.266 0 C-N-CA 119.765 -0.774 . . . . 0.0 111.163 -178.605 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.528 ' N ' ' O ' ' A' ' 45' ' ' THR . 22.5 t-20 -144.2 -78.94 0.2 Allowed 'General case' 0 N--CA 1.502 2.158 0 N-CA-C 114.629 1.344 . . . . 0.0 114.629 -176.187 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.464 ' O ' ' OE2' ' A' ' 47' ' ' GLU . 87.1 mt -75.25 48.66 0.43 Allowed 'General case' 0 C--N 1.275 -2.672 0 C-N-CA 118.597 -1.241 . . . . 0.0 111.072 -173.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.654 ' SG ' ' N ' ' A' ' 15' ' ' LEU . 7.8 p -120.91 -151.87 0.49 Allowed 'General case' 0 N--CA 1.497 1.92 0 C-N-CA 119.183 -1.007 . . . . 0.0 110.729 177.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.654 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 7.7 mt -123.6 133.21 53.98 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 114.179 -1.373 . . . . 0.0 110.395 179.266 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.7 m -120.59 -68.1 0.93 Allowed 'General case' 0 N--CA 1.503 2.181 0 C-N-CA 119.306 -0.957 . . . . 0.0 110.401 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -84.55 88.0 7.29 Favored 'General case' 0 C--N 1.298 -1.65 0 C-N-CA 119.178 -1.009 . . . . 0.0 110.143 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 70.25 -123.69 12.57 Favored Glycine 0 N--CA 1.487 2.064 0 C-N-CA 119.562 -1.304 . . . . 0.0 111.21 178.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.406 ' O ' ' OG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -98.87 1.93 46.19 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 121.871 0.843 . . . . 0.0 110.974 -177.713 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -79.61 128.18 33.07 Favored 'General case' 0 C--N 1.253 -3.611 0 CA-C-N 114.003 -1.453 . . . . 0.0 110.726 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -78.59 148.75 5.98 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.026 0 C-N-CA 119.088 -1.045 . . . . 0.0 109.495 179.112 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.462 ' O ' ' O ' ' A' ' 12' ' ' ASN . 3.2 m -148.13 122.84 9.89 Favored 'General case' 0 C--N 1.285 -2.218 0 C-N-CA 118.418 -1.313 . . . . 0.0 110.547 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.488 ' O ' ' N ' ' A' ' 26' ' ' ASN . . . 170.66 -87.6 0.09 OUTLIER Glycine 0 C--O 1.197 -2.173 0 C-N-CA 118.425 -1.845 . . . . 0.0 111.76 -177.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.447 ' N ' ' OD1' ' A' ' 12' ' ' ASN . 43.2 tt0 -40.08 128.47 2.22 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 120.08 -0.648 . . . . 0.0 111.283 -177.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.478 ' C ' ' ND2' ' A' ' 26' ' ' ASN . . . 90.07 -24.08 17.7 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 109.012 -1.635 . . . . 0.0 109.012 -177.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.488 ' N ' ' O ' ' A' ' 23' ' ' GLY . 2.3 m-80 -143.79 -162.33 1.44 Allowed 'General case' 0 N--CA 1.493 1.713 0 CA-C-N 114.773 -0.713 . . . . 0.0 109.737 179.311 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.469 ' O ' ' O ' ' A' ' 40' ' ' VAL . 0.5 OUTLIER -139.06 143.48 38.39 Favored 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 119.646 -0.822 . . . . 0.0 109.035 175.786 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -89.66 160.99 16.34 Favored 'General case' 0 C--N 1.298 -1.657 0 C-N-CA 117.719 -1.593 . . . . 0.0 111.101 179.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 20.1 mm -147.54 94.28 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.255 -3.521 0 CA-C-N 112.523 -2.126 . . . . 0.0 108.496 176.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.423 ' H ' ' HA ' ' A' ' 9' ' ' SER . 1.8 pp -94.38 134.18 37.16 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 118.815 -1.154 . . . . 0.0 112.501 -176.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.529 ' N ' ' OD1' ' A' ' 37' ' ' ASN . . . 55.64 92.66 0.01 OUTLIER Glycine 0 N--CA 1.48 1.622 0 C-N-CA 119.322 -1.418 . . . . 0.0 110.279 177.607 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.54 ' O ' ' N ' ' A' ' 34' ' ' GLY . 15.2 m -75.51 -128.54 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 118.688 -1.205 . . . . 0.0 108.604 179.2 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.435 ' OD1' ' OE2' ' A' ' 35' ' ' GLU . 10.4 p-10 -75.05 68.29 1.83 Allowed 'General case' 0 C--N 1.252 -3.657 0 CA-C-N 114.415 -1.266 . . . . 0.0 108.765 -173.261 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.54 ' N ' ' O ' ' A' ' 32' ' ' SER . . . 70.52 28.66 70.77 Favored Glycine 0 C--N 1.289 -2.05 0 N-CA-C 108.383 -1.887 . . . . 0.0 108.383 -177.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.435 ' OE2' ' OD1' ' A' ' 33' ' ' ASP . 13.3 mt-10 -120.42 -136.58 0.33 Allowed 'General case' 0 C--O 1.214 -0.769 0 C-N-CA 118.97 -1.092 . . . . 0.0 112.378 -177.193 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 6.1 mmtp -94.56 -179.14 4.79 Favored 'General case' 0 C--N 1.266 -3.025 0 CA-C-N 113.025 -1.898 . . . . 0.0 113.616 -173.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.529 ' OD1' ' N ' ' A' ' 31' ' ' GLY . 6.7 m-20 -104.56 160.46 14.92 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-N 114.43 -1.259 . . . . 0.0 111.114 179.224 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.414 ' CG ' ' N ' ' A' ' 39' ' ' CYS . 10.8 tt0 -161.71 157.49 24.48 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 119.179 -1.008 . . . . 0.0 111.11 179.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.414 ' N ' ' CG ' ' A' ' 38' ' ' GLN . 7.1 m -109.39 94.89 5.27 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.799 178.39 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.469 ' O ' ' O ' ' A' ' 27' ' ' LYS . 0.5 OUTLIER -102.54 145.59 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.568 0 C-N-CA 118.712 -1.195 . . . . 0.0 112.736 -177.892 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.5 t -66.18 143.85 57.01 Favored 'General case' 0 C--N 1.285 -2.235 0 CA-C-N 114.061 -1.427 . . . . 0.0 111.52 177.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 152.23 -159.27 28.28 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -179.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.401 ' O ' ' CG ' ' A' ' 43' ' ' GLU . 5.8 pt-20 -104.93 113.41 26.99 Favored 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 119.546 -0.861 . . . . 0.0 110.273 179.561 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -114.39 -168.54 16.17 Favored Glycine 0 N--CA 1.5 2.913 0 C-N-CA 120.053 -1.07 . . . . 0.0 110.555 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.528 ' O ' ' N ' ' A' ' 12' ' ' ASN . 0.5 OUTLIER -141.72 148.6 50.32 Favored Pre-proline 0 N--CA 1.493 1.676 0 C-N-CA 119.55 -0.86 . . . . 0.0 110.421 -179.767 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -57.17 167.72 3.16 Favored 'Trans proline' 0 C--O 1.214 -0.683 0 C-N-CA 121.724 1.616 . . . . 0.0 111.949 179.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.55 ' CD ' ' H ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -79.64 159.06 72.57 Favored Pre-proline 0 N--CA 1.489 1.524 0 C-N-CA 119.544 -0.863 . . . . 0.0 109.971 179.684 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -62.79 173.22 3.89 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 121.424 1.416 . . . . 0.0 111.868 -178.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 . . . . . 0 N--CA 1.495 1.812 0 CA-C-O 116.364 -1.779 . . . . 0.0 110.024 178.977 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 24.9 m . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.424 HG11 ' H ' ' A' ' 3' ' ' TYR . 1.5 t -79.81 169.03 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 C-N-CA 119.436 -0.906 . . . . 0.0 110.044 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.424 ' H ' HG11 ' A' ' 2' ' ' VAL . 76.9 m-85 -131.08 -161.91 1.17 Allowed 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 119.865 -0.734 . . . . 0.0 111.301 -178.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.495 ' H ' ' HG1' ' A' ' 4' ' ' THR . 0.2 OUTLIER -98.07 -176.82 3.54 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.024 179.937 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.509 ' N ' ' OD1' ' A' ' 5' ' ' ASP . 0.1 OUTLIER -97.48 156.54 16.44 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.139 -1.025 . . . . 0.0 110.493 178.127 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.503 ' SG ' ' O ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -74.91 151.7 38.89 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.518 177.857 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.444 ' O ' ' CG2' ' A' ' 7' ' ' THR . 1.4 m -116.65 -3.94 11.73 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 119.68 -0.808 . . . . 0.0 111.114 178.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -160.34 178.2 9.84 Favored 'General case' 0 C--N 1.275 -2.647 0 CA-C-N 114.785 -1.098 . . . . 0.0 110.906 -179.289 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.401 ' HB3' ' H ' ' A' ' 30' ' ' LEU . 0.3 OUTLIER -79.27 140.64 37.54 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.912 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.44 ' O ' ' O ' ' A' ' 11' ' ' GLN . . . 98.65 -16.97 59.03 Favored Glycine 0 N--CA 1.507 3.369 1 N-CA-C 128.641 6.216 . . . . 0.0 128.641 -174.525 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.44 ' O ' ' O ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -51.89 -169.04 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 114.471 -0.864 . . . . 0.0 110.984 179.742 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.509 ' C ' ' H ' ' A' ' 14' ' ' CYS . 15.8 t-20 -140.68 -83.22 0.23 Allowed 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 118.486 -1.286 . . . . 0.0 113.044 -179.07 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.451 ' O ' ' OE2' ' A' ' 47' ' ' GLU . 60.6 mt -75.42 45.28 0.29 Allowed 'General case' 0 C--N 1.276 -2.627 0 C-N-CA 117.71 -1.596 . . . . 0.0 109.916 -175.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.509 ' H ' ' C ' ' A' ' 12' ' ' ASN . 31.1 p -109.23 -158.16 0.64 Allowed 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 119.318 -0.953 . . . . 0.0 109.362 178.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.503 ' O ' ' SG ' ' A' ' 6' ' ' CYS . 6.0 mt -124.09 129.49 50.96 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.336 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 89.8 m -120.91 -65.95 1.1 Allowed 'General case' 0 N--CA 1.502 2.127 0 C-N-CA 119.408 -0.917 . . . . 0.0 111.498 -177.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -79.56 85.48 5.3 Favored 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 118.87 -1.132 . . . . 0.0 110.816 -178.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 72.54 -92.55 0.6 Allowed Glycine 0 N--CA 1.491 2.326 0 C-N-CA 119.526 -1.321 . . . . 0.0 110.827 179.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.448 ' O ' ' OG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -133.58 4.55 3.65 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-O 122.264 1.031 . . . . 0.0 110.463 -178.931 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 28.0 m-80 -80.54 130.46 35.15 Favored 'General case' 0 C--N 1.254 -3.577 0 CA-C-N 113.485 -1.689 . . . . 0.0 109.787 178.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.4 t -69.8 149.24 10.79 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 C-N-CA 119.195 -1.002 . . . . 0.0 110.547 -179.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.452 ' O ' ' O ' ' A' ' 12' ' ' ASN . 12.7 m -145.82 116.17 7.53 Favored 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 118.453 -1.299 . . . . 0.0 110.419 177.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 26' ' ' ASN . . . 170.39 -68.08 0.15 Allowed Glycine 0 C--O 1.203 -1.793 0 C-N-CA 118.261 -1.923 . . . . 0.0 112.598 -177.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -56.91 111.61 1.08 Allowed 'General case' 0 C--N 1.298 -1.65 0 C-N-CA 118.917 -1.113 . . . . 0.0 110.827 -177.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.418 ' C ' ' ND2' ' A' ' 26' ' ' ASN . . . 99.27 -14.77 60.88 Favored Glycine 0 N--CA 1.484 1.844 0 N-CA-C 109.959 -1.256 . . . . 0.0 109.959 -179.022 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.463 ' O ' ' O ' ' A' ' 23' ' ' GLY . 8.6 m-80 -149.3 -167.72 2.91 Favored 'General case' 0 N--CA 1.494 1.762 0 C-N-CA 119.255 -0.978 . . . . 0.0 111.409 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.513 ' CG ' ' N ' ' A' ' 28' ' ' CYS . 12.6 tttp -134.61 165.17 25.84 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.155 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.513 ' N ' ' CG ' ' A' ' 27' ' ' LYS . 0.1 OUTLIER -127.4 160.3 31.83 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 118.889 -1.124 . . . . 0.0 110.686 177.968 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 7.7 mm -138.85 126.75 27.6 Favored 'Isoleucine or valine' 0 C--N 1.255 -3.506 0 CA-C-N 113.088 -1.869 . . . . 0.0 109.639 177.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.401 ' H ' ' HB3' ' A' ' 9' ' ' SER . 19.5 mt -78.2 124.43 28.06 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 118.28 -1.368 . . . . 0.0 110.307 178.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 79.65 100.56 0.27 Allowed Glycine 0 C--N 1.302 -1.341 0 C-N-CA 118.996 -1.573 . . . . 0.0 110.229 178.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.519 ' O ' ' N ' ' A' ' 34' ' ' GLY . 89.8 p -80.87 -123.41 0.02 OUTLIER 'General case' 0 C--O 1.202 -1.413 0 C-N-CA 118.455 -1.298 . . . . 0.0 108.858 179.288 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.447 ' N ' ' OG ' ' A' ' 32' ' ' SER . 1.1 m-20 -73.76 64.04 0.91 Allowed 'General case' 0 C--N 1.256 -3.488 0 CA-C-N 114.577 -1.192 . . . . 0.0 109.444 -172.581 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 32' ' ' SER . . . 74.06 29.42 62.7 Favored Glycine 0 C--N 1.288 -2.103 0 N-CA-C 108.48 -1.848 . . . . 0.0 108.48 -177.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 59.7 mm-40 -127.53 -134.25 0.24 Allowed 'General case' 0 C--O 1.213 -0.826 0 C-N-CA 118.773 -1.171 . . . . 0.0 112.495 -177.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 10.5 mtmm -98.17 -167.3 1.49 Allowed 'General case' 0 C--N 1.276 -2.623 0 CA-C-N 112.671 -2.059 . . . . 0.0 113.199 -175.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.5 ' OD1' ' N ' ' A' ' 37' ' ' ASN . 0.1 OUTLIER -59.75 157.23 12.43 Favored 'General case' 0 N--CA 1.485 1.307 0 CA-C-N 114.492 -1.231 . . . . 0.0 111.678 178.116 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -159.2 152.92 22.98 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.286 175.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 9.6 m -112.14 112.48 24.12 Favored 'General case' 0 C--N 1.298 -1.66 0 C-N-CA 119.729 -0.788 . . . . 0.0 111.737 -177.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.465 ' O ' ' O ' ' A' ' 27' ' ' LYS . 1.3 p -123.43 140.82 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.323 0 C-N-CA 118.745 -1.182 . . . . 0.0 112.668 177.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.5 t -41.28 157.44 0.02 OUTLIER 'General case' 0 C--N 1.283 -2.304 0 CA-C-N 113.371 -1.74 . . . . 0.0 111.255 178.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.433 ' O ' ' OE1' ' A' ' 43' ' ' GLU . . . 150.04 -120.43 1.14 Allowed Glycine 0 N--CA 1.49 2.275 1 N-CA-C 130.274 6.87 . . . . 0.0 130.274 179.557 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.433 ' OE1' ' O ' ' A' ' 42' ' ' GLY . 1.3 tp10 -154.34 104.53 2.6 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 119.37 -0.932 . . . . 0.0 109.974 179.161 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -128.57 179.94 16.29 Favored Glycine 0 N--CA 1.495 2.579 0 C-N-CA 119.867 -1.158 . . . . 0.0 110.695 -179.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -130.54 153.65 81.48 Favored Pre-proline 0 N--CA 1.495 1.817 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -53.16 163.97 2.02 Favored 'Trans proline' 0 C--O 1.214 -0.688 0 C-N-CA 121.153 1.236 . . . . 0.0 110.477 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.557 ' CD ' ' H ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -76.13 155.98 84.15 Favored Pre-proline 0 N--CA 1.49 1.534 0 C-N-CA 118.911 -1.116 . . . . 0.0 109.755 -179.383 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -52.69 127.67 25.38 Favored 'Trans proline' 0 C--O 1.214 -0.691 0 C-N-CA 121.497 1.465 . . . . 0.0 111.877 -177.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 . . . . . 0 N--CA 1.488 1.472 0 CA-C-O 116.297 -1.811 . . . . 0.0 110.227 179.343 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.441 ' O ' ' CG1' ' A' ' 1' ' ' VAL . 8.7 p . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.8 t -136.03 169.27 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 C-N-CA 119.696 -0.802 . . . . 0.0 110.019 179.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -112.29 -166.09 1.05 Allowed 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 119.986 -0.686 . . . . 0.0 109.666 179.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.474 ' H ' ' HG1' ' A' ' 4' ' ' THR . 2.9 p -97.51 177.75 5.41 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 178.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.405 ' O ' ' OE2' ' A' ' 47' ' ' GLU . 0.2 OUTLIER -88.46 155.51 19.63 Favored 'General case' 0 C--N 1.293 -1.864 0 C-N-CA 118.458 -1.297 . . . . 0.0 110.066 178.583 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.42 ' SG ' ' O ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -75.4 166.66 23.26 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.693 178.108 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 14.0 p -133.95 2.33 3.37 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 119.431 -0.908 . . . . 0.0 110.39 177.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -162.52 -178.7 6.41 Favored 'General case' 0 C--N 1.28 -2.435 0 CA-C-N 114.631 -1.168 . . . . 0.0 111.253 178.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.414 ' H ' ' HG ' ' A' ' 9' ' ' SER . 0.4 OUTLIER -82.27 158.71 23.38 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.535 -178.215 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.498 ' N ' ' O ' ' A' ' 28' ' ' CYS . . . 82.87 -18.0 18.44 Favored Glycine 0 N--CA 1.497 2.706 0 C-N-CA 119.853 -1.165 . . . . 0.0 112.573 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.645 ' H ' HE21 ' A' ' 11' ' ' GLN . 0.9 OUTLIER -53.05 170.35 0.08 Allowed 'General case' 0 N--CA 1.501 2.12 0 C-N-CA 119.03 -1.068 . . . . 0.0 110.226 -179.948 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.535 ' C ' ' H ' ' A' ' 14' ' ' CYS . 22.0 m-20 -144.56 -63.42 0.36 Allowed 'General case' 0 N--CA 1.499 2.011 0 C-N-CA 118.317 -1.353 . . . . 0.0 113.433 -179.088 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 49.7 mt -76.5 41.85 0.26 Allowed 'General case' 0 C--N 1.287 -2.136 0 C-N-CA 119.011 -1.076 . . . . 0.0 109.811 -177.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.535 ' H ' ' C ' ' A' ' 12' ' ' ASN . 31.6 p -121.94 -157.67 0.74 Allowed 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 114.906 -1.043 . . . . 0.0 108.801 177.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.42 ' O ' ' SG ' ' A' ' 6' ' ' CYS . 40.6 mt -108.7 107.12 17.45 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 115.21 -0.904 . . . . 0.0 108.679 175.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 68.4 m -96.32 -74.29 0.57 Allowed 'General case' 0 C--N 1.278 -2.532 0 CA-C-N 114.167 -1.379 . . . . 0.0 111.235 -174.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -84.73 115.62 22.79 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 118.601 -1.239 . . . . 0.0 110.102 179.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 66.42 -107.69 2.09 Favored Glycine 0 N--CA 1.489 2.193 0 C-N-CA 119.324 -1.417 . . . . 0.0 110.448 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.416 ' O ' ' OG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -134.6 4.68 3.38 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-O 122.197 0.999 . . . . 0.0 110.185 -179.804 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -79.13 152.87 30.51 Favored 'General case' 0 C--N 1.261 -3.281 0 CA-C-N 113.431 -1.713 . . . . 0.0 110.607 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.2 t -85.9 142.39 13.2 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 C-N-CA 119.195 -1.002 . . . . 0.0 112.117 -177.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.454 ' O ' ' O ' ' A' ' 12' ' ' ASN . 0.1 OUTLIER -99.96 150.32 22.53 Favored 'General case' 0 N--CA 1.508 2.457 0 CA-C-N 114.964 -1.016 . . . . 0.0 108.94 169.295 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.448 ' O ' ' C ' ' A' ' 24' ' ' GLN . . . -113.81 110.81 2.51 Favored Glycine 0 CA--C 1.482 -2.031 0 C-N-CA 119.652 -1.261 . . . . 0.0 110.487 -169.118 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.448 ' C ' ' O ' ' A' ' 23' ' ' GLY . 4.2 tt0 -32.93 117.29 0.25 Allowed 'General case' 0 C--N 1.252 -3.64 0 CA-C-N 111.974 -2.113 . . . . 0.0 109.941 175.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 146.28 -25.69 1.71 Allowed Glycine 0 C--N 1.283 -2.401 0 N-CA-C 105.005 -3.238 . . . . 0.0 105.005 -174.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.539 ' N ' ' OD1' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -110.72 -172.39 2.02 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 113.208 -1.496 . . . . 0.0 107.292 175.056 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.462 ' O ' ' O ' ' A' ' 40' ' ' VAL . 21.9 tttm -144.18 108.86 4.9 Favored 'General case' 0 N--CA 1.502 2.133 0 C-N-CA 118.512 -1.275 . . . . 0.0 110.933 178.217 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.562 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 3.6 m -84.17 152.2 24.41 Favored 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 117.722 -1.591 . . . . 0.0 110.136 178.075 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.438 ' CD1' ' NZ ' ' A' ' 27' ' ' LYS . 2.1 mm -127.68 131.0 70.38 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.288 0 CA-C-N 114.382 -1.281 . . . . 0.0 109.39 177.212 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 17.5 mt -79.03 136.3 37.15 Favored 'General case' 0 N--CA 1.497 1.909 0 C-N-CA 118.471 -1.292 . . . . 0.0 110.162 178.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.413 ' O ' ' CB ' ' A' ' 32' ' ' SER . . . -43.89 -78.08 0.08 OUTLIER Glycine 0 N--CA 1.487 2.06 0 C-N-CA 118.868 -1.634 . . . . 0.0 109.553 177.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.825 ' H ' ' CA ' ' A' ' 35' ' ' GLU . 1.0 OUTLIER 80.65 -54.35 0.33 Allowed 'General case' 0 CA--C 1.474 -1.975 0 CA-C-O 121.6 0.714 . . . . 0.0 109.137 177.968 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.702 ' H ' ' HG ' ' A' ' 32' ' ' SER . 1.1 t70 -78.34 4.75 12.12 Favored 'General case' 0 C--N 1.249 -3.785 0 N-CA-C 104.882 -2.266 . . . . 0.0 104.882 171.262 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.752 ' O ' ' N ' ' A' ' 36' ' ' LYS . . . -171.04 24.58 0.09 OUTLIER Glycine 0 C--N 1.29 -2.012 0 CA-C-N 111.005 -2.816 . . . . 0.0 107.949 177.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.825 ' CA ' ' H ' ' A' ' 32' ' ' SER . 1.8 tm-20 10.79 33.13 0.0 OUTLIER 'General case' 1 N--CA 1.56 5.061 0 CA-C-O 123.301 1.524 . . . . 0.0 115.004 -176.366 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.752 ' N ' ' O ' ' A' ' 34' ' ' GLY . 18.2 mtpt -84.96 -153.63 0.17 Allowed 'General case' 1 C--N 1.216 -5.201 0 CA-C-N 112.136 -2.302 . . . . 0.0 107.733 174.322 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -163.89 154.66 15.7 Favored 'General case' 0 C--N 1.277 -2.548 0 C-N-CA 119.244 -0.982 . . . . 0.0 111.815 178.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -155.37 149.72 26.01 Favored 'General case' 0 C--N 1.295 -1.782 0 CA-C-N 114.828 -1.078 . . . . 0.0 108.982 176.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.562 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 1.3 m -107.92 93.32 4.47 Favored 'General case' 0 C--N 1.296 -1.741 0 C-N-CA 119.608 -0.837 . . . . 0.0 111.2 -177.507 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.462 ' O ' ' O ' ' A' ' 27' ' ' LYS . 0.9 OUTLIER -107.7 143.41 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.31 0 C-N-CA 118.816 -1.154 . . . . 0.0 110.759 179.027 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.1 t -50.94 157.89 0.77 Allowed 'General case' 0 C--N 1.274 -2.697 0 CA-C-N 114.31 -1.314 . . . . 0.0 111.036 -178.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 153.52 -154.97 25.86 Favored Glycine 0 N--CA 1.492 2.424 0 C-N-CA 119.528 -1.32 . . . . 0.0 110.748 179.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -122.83 67.52 0.97 Allowed 'General case' 0 N--CA 1.498 1.947 0 C-N-CA 120.039 -0.664 . . . . 0.0 110.215 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -74.01 173.34 50.56 Favored Glycine 0 N--CA 1.491 2.346 0 C-N-CA 119.425 -1.369 . . . . 0.0 110.523 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -106.22 145.56 31.21 Favored Pre-proline 0 N--CA 1.491 1.616 0 C-N-CA 119.679 -0.808 . . . . 0.0 109.527 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -62.63 130.85 31.15 Favored 'Trans proline' 0 C--O 1.216 -0.615 0 C-N-CA 120.901 1.067 . . . . 0.0 110.872 176.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.431 ' OE1' ' OG1' ' A' ' 4' ' ' THR . 1.0 OUTLIER -51.66 116.07 7.37 Favored Pre-proline 0 C--N 1.3 -1.566 0 C-N-CA 119.547 -0.861 . . . . 0.0 110.362 -179.992 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -60.44 105.46 0.3 Allowed 'Trans proline' 0 C--O 1.216 -0.606 0 C-N-CA 120.419 0.746 . . . . 0.0 111.013 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 . . . . . 0 N--CA 1.489 1.506 0 CA-C-O 116.46 -1.733 . . . . 0.0 110.436 -179.839 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.7 t -103.05 171.13 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 C-N-CA 119.835 -0.746 . . . . 0.0 111.143 -178.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -123.94 -173.69 2.81 Favored 'General case' 0 N--CA 1.5 2.026 0 C-N-CA 119.931 -0.707 . . . . 0.0 110.652 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -101.52 173.0 6.63 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 115.171 -0.922 . . . . 0.0 108.557 178.241 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.531 ' N ' ' OD1' ' A' ' 5' ' ' ASP . 0.0 OUTLIER -91.06 152.23 20.72 Favored 'General case' 0 C--N 1.294 -1.826 0 C-N-CA 118.489 -1.285 . . . . 0.0 108.877 176.684 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.3 m -75.41 179.88 4.95 Favored 'General case' 0 C--N 1.29 -2.018 0 C-N-CA 119.221 -0.992 . . . . 0.0 111.019 179.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.1 t -150.56 16.84 0.8 Allowed 'General case' 0 C--N 1.281 -2.412 0 CA-C-N 113.601 -1.636 . . . . 0.0 109.393 177.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -159.42 175.08 13.75 Favored 'General case' 0 C--N 1.29 -1.991 0 CA-C-N 114.443 -1.253 . . . . 0.0 110.643 -178.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -76.88 -170.27 1.56 Allowed 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.265 179.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.559 ' N ' ' O ' ' A' ' 28' ' ' CYS . . . 26.1 18.23 0.0 OUTLIER Glycine 0 N--CA 1.503 3.126 1 N-CA-C 130.913 7.125 . . . . 0.0 130.913 178.974 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -87.76 -166.88 1.71 Allowed 'General case' 0 N--CA 1.503 2.216 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 176.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.52 ' C ' ' H ' ' A' ' 14' ' ' CYS . 10.6 m120 -151.48 -55.5 0.14 Allowed 'General case' 0 N--CA 1.503 2.183 0 N-CA-C 116.612 2.078 . . . . 0.0 116.612 -178.366 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 24.3 mt -75.79 41.7 0.22 Allowed 'General case' 0 C--N 1.29 -1.981 0 C-N-CA 118.134 -1.426 . . . . 0.0 110.716 -174.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.52 ' H ' ' C ' ' A' ' 12' ' ' ASN . 30.5 p -124.21 -148.23 0.39 Allowed 'General case' 0 C--N 1.288 -2.073 0 CA-C-N 114.817 -1.083 . . . . 0.0 108.298 176.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 6.2 mt -119.21 110.72 17.35 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 176.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 55.9 m -104.56 -61.51 1.45 Allowed 'General case' 0 C--N 1.281 -2.396 0 CA-C-N 114.009 -1.45 . . . . 0.0 112.085 -172.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -96.27 94.52 7.52 Favored 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 118.76 -1.176 . . . . 0.0 110.392 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 73.15 -108.93 2.64 Favored Glycine 0 N--CA 1.492 2.378 0 C-N-CA 119.467 -1.349 . . . . 0.0 110.788 179.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.402 ' O ' ' OG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -119.29 1.82 11.31 Favored 'General case' 0 CA--C 1.492 -1.286 0 CA-C-O 122.34 1.067 . . . . 0.0 109.896 -179.358 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -78.52 127.74 32.58 Favored 'General case' 0 C--N 1.257 -3.454 0 CA-C-N 113.204 -1.816 . . . . 0.0 109.758 179.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -78.33 137.97 21.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 C-N-CA 118.961 -1.096 . . . . 0.0 110.103 179.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.549 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 0.1 OUTLIER -86.66 146.22 26.39 Favored 'General case' 0 C--N 1.283 -2.289 0 C-N-CA 118.29 -1.364 . . . . 0.0 109.589 173.186 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.488 ' O ' ' ND2' ' A' ' 26' ' ' ASN . . . -116.07 104.42 1.27 Allowed Glycine 0 C--N 1.296 -1.656 0 N-CA-C 108.809 -1.716 . . . . 0.0 108.809 -174.193 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.444 ' C ' ' O ' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -31.86 124.52 0.27 Allowed 'General case' 0 C--N 1.26 -3.29 0 CA-C-N 112.632 -1.784 . . . . 0.0 110.941 179.186 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 140.79 -23.25 2.64 Favored Glycine 0 C--N 1.29 -1.972 0 N-CA-C 105.139 -3.184 . . . . 0.0 105.139 -173.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.509 ' OD1' ' N ' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -111.41 -162.29 0.79 Allowed 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 112.907 -1.647 . . . . 0.0 107.282 175.601 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.538 ' O ' ' N ' ' A' ' 40' ' ' VAL . 14.9 tttp -144.6 147.54 33.27 Favored 'General case' 0 C--N 1.297 -1.703 0 C-N-CA 118.661 -1.216 . . . . 0.0 109.949 175.317 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.559 ' O ' ' N ' ' A' ' 10' ' ' GLY . 56.6 m -111.99 157.53 20.61 Favored 'General case' 0 CA--C 1.483 -1.603 0 C-N-CA 118.711 -1.195 . . . . 0.0 109.775 177.29 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 11.3 mm -140.05 126.96 23.24 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.7 0 CA-C-N 114.629 -1.169 . . . . 0.0 109.954 175.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 15.3 mt -76.76 115.0 16.13 Favored 'General case' 0 N--CA 1.496 1.856 0 C-N-CA 118.671 -1.212 . . . . 0.0 110.094 178.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.482 ' N ' ' O ' ' A' ' 36' ' ' LYS . . . -33.83 -68.76 0.19 Allowed Glycine 0 N--CA 1.493 2.494 1 N-CA-C 128.899 6.32 . . . . 0.0 128.899 -179.402 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.493 ' O ' ' N ' ' A' ' 34' ' ' GLY . 0.8 OUTLIER -139.28 -137.99 0.13 Allowed 'General case' 0 C--O 1.203 -1.342 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 178.119 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.62 68.46 1.65 Allowed 'General case' 0 C--N 1.253 -3.612 0 CA-C-O 122.568 1.175 . . . . 0.0 109.398 -173.445 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.493 ' N ' ' O ' ' A' ' 32' ' ' SER . . . 74.28 27.43 65.98 Favored Glycine 0 C--N 1.285 -2.259 0 N-CA-C 108.073 -2.011 . . . . 0.0 108.073 -178.453 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.439 ' O ' ' O ' ' A' ' 36' ' ' LYS . 21.8 mt-10 -106.0 -117.28 0.24 Allowed 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 119.336 -0.946 . . . . 0.0 111.684 -177.227 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.482 ' O ' ' N ' ' A' ' 31' ' ' GLY . 0.9 OUTLIER -45.39 175.47 0.0 OUTLIER 'General case' 0 C--N 1.264 -3.119 0 CA-C-N 113.79 -1.55 . . . . 0.0 112.054 -177.556 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.645 ' ND2' ' N ' ' A' ' 38' ' ' GLN . 0.3 OUTLIER -174.67 133.28 0.36 Allowed 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 -178.361 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.645 ' N ' ' ND2' ' A' ' 37' ' ' ASN . 23.5 tt0 -140.59 155.75 46.48 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 119.447 -0.901 . . . . 0.0 110.773 -179.636 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.419 ' N ' ' CG ' ' A' ' 38' ' ' GLN . 1.5 m -101.47 89.03 3.6 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 119.662 -0.815 . . . . 0.0 110.843 -179.191 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.538 ' N ' ' O ' ' A' ' 27' ' ' LYS . 0.3 OUTLIER -94.87 141.71 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.675 0 C-N-CA 118.299 -1.36 . . . . 0.0 112.029 179.835 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.5 t -54.13 145.4 17.22 Favored 'General case' 0 C--N 1.276 -2.59 0 CA-C-N 114.661 -1.154 . . . . 0.0 110.633 -179.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 157.81 -173.43 35.12 Favored Glycine 0 N--CA 1.494 2.536 0 C-N-CA 119.164 -1.493 . . . . 0.0 110.778 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -111.23 122.16 47.16 Favored 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 120.081 -0.648 . . . . 0.0 110.362 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -138.41 -145.28 4.8 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 179.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -139.81 153.2 69.66 Favored Pre-proline 0 N--CA 1.491 1.607 0 C-N-CA 119.59 -0.844 . . . . 0.0 109.997 179.43 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -60.48 -169.25 0.05 OUTLIER 'Trans proline' 0 C--O 1.216 -0.622 0 C-N-CA 121.417 1.412 . . . . 0.0 111.515 178.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.437 ' OE2' ' O ' ' A' ' 5' ' ' ASP . 3.8 tt0 -126.97 77.06 75.52 Favored Pre-proline 0 C--N 1.312 -1.036 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.043 179.09 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -59.91 123.98 14.36 Favored 'Trans proline' 0 C--O 1.214 -0.713 0 C-N-CA 121.303 1.336 . . . . 0.0 111.412 -176.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 116.43 -1.748 . . . . 0.0 110.22 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 39.6 t . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.6 t -81.92 164.48 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 C-N-CA 119.087 -1.045 . . . . 0.0 110.081 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -150.56 -169.91 3.51 Favored 'General case' 0 C--N 1.297 -1.7 0 C-N-CA 119.774 -0.77 . . . . 0.0 109.808 179.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.552 ' OG1' ' N ' ' A' ' 5' ' ' ASP . 0.0 OUTLIER -109.76 174.97 5.62 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 177.891 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.552 ' N ' ' OG1' ' A' ' 4' ' ' THR . 0.2 OUTLIER -84.2 151.24 24.96 Favored 'General case' 0 C--N 1.28 -2.456 0 C-N-CA 118.106 -1.438 . . . . 0.0 110.322 -178.199 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.42 ' SG ' ' CB ' ' A' ' 11' ' ' GLN . 0.1 OUTLIER -76.65 -176.79 3.94 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-O 122.147 0.975 . . . . 0.0 111.756 178.62 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.3 p -157.02 15.87 0.28 Allowed 'General case' 0 C--N 1.283 -2.292 0 CA-C-N 113.391 -1.731 . . . . 0.0 109.709 177.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.421 ' N ' HE22 ' A' ' 11' ' ' GLN . 2.0 mt-10 -163.24 174.3 12.27 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-N 114.935 -1.03 . . . . 0.0 111.513 179.247 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.437 ' C ' ' H ' ' A' ' 11' ' ' GLN . 0.4 OUTLIER -88.38 170.06 11.27 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.175 -178.21 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.456 ' O ' ' O ' ' A' ' 11' ' ' GLN . . . 73.44 -33.54 0.82 Allowed Glycine 0 N--CA 1.504 3.197 0 C-N-CA 119.668 -1.253 . . . . 0.0 112.378 177.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.456 ' O ' ' O ' ' A' ' 10' ' ' GLY . 12.4 mt-30 -51.8 -173.6 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.241 0 C-N-CA 119.507 -0.877 . . . . 0.0 110.153 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.523 ' C ' ' H ' ' A' ' 14' ' ' CYS . 1.6 m120 -158.85 -51.88 0.06 Allowed 'General case' 0 N--CA 1.503 2.176 0 C-N-CA 117.043 -1.863 . . . . 0.0 115.29 -179.199 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 67.1 mt -76.49 40.1 0.22 Allowed 'General case' 0 C--N 1.288 -2.091 0 C-N-CA 118.642 -1.223 . . . . 0.0 110.639 -175.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.523 ' H ' ' C ' ' A' ' 12' ' ' ASN . 10.0 p -124.76 -158.36 0.82 Allowed 'General case' 0 C--N 1.29 -1.995 0 CA-C-N 114.502 -1.226 . . . . 0.0 108.831 178.21 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 6.6 mt -109.91 116.17 31.15 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 119.65 -0.82 . . . . 0.0 110.662 178.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -111.93 -68.96 0.89 Allowed 'General case' 0 C--N 1.295 -1.786 0 CA-C-N 114.403 -1.271 . . . . 0.0 110.838 -177.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -79.38 99.01 6.97 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 119.585 -0.846 . . . . 0.0 110.376 -179.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.0 -113.56 5.48 Favored Glycine 0 N--CA 1.486 1.975 0 C-N-CA 119.408 -1.377 . . . . 0.0 110.451 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.422 ' O ' ' OG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -111.71 3.78 18.05 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-O 122.43 1.11 . . . . 0.0 109.694 -179.544 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -78.5 129.27 34.67 Favored 'General case' 0 C--N 1.256 -3.491 0 CA-C-N 113.229 -1.805 . . . . 0.0 110.248 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -78.36 144.06 11.77 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 C-N-CA 118.993 -1.083 . . . . 0.0 110.349 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.6 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 0.1 OUTLIER -90.97 143.97 26.15 Favored 'General case' 0 C--N 1.286 -2.166 0 C-N-CA 118.813 -1.155 . . . . 0.0 110.621 173.325 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.658 ' O ' ' N ' ' A' ' 25' ' ' GLY . . . -113.63 110.47 2.46 Favored Glycine 0 CA--C 1.486 -1.779 0 N-CA-C 107.844 -2.102 . . . . 0.0 107.844 -174.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -37.36 -5.2 0.0 OUTLIER 'General case' 0 C--N 1.254 -3.565 0 CA-C-N 112.521 -1.84 . . . . 0.0 114.491 178.576 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.658 ' N ' ' O ' ' A' ' 23' ' ' GLY . . . -69.27 -9.57 61.02 Favored Glycine 0 C--N 1.263 -3.498 0 N-CA-C 106.695 -2.562 . . . . 0.0 106.695 173.332 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 47.2 m-20 -135.41 -167.3 1.99 Allowed 'General case' 0 N--CA 1.485 1.309 0 CA-C-N 113.594 -1.303 . . . . 0.0 108.069 178.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.555 ' N ' ' O ' ' A' ' 40' ' ' VAL . 0.2 OUTLIER -123.12 166.84 14.51 Favored 'General case' 0 N--CA 1.503 2.217 0 C-N-CA 119.578 -0.849 . . . . 0.0 110.923 179.756 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.6 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 0.6 OUTLIER -136.34 154.89 50.71 Favored 'General case' 0 CA--C 1.472 -2.023 0 CA-C-O 122.203 1.002 . . . . 0.0 110.016 175.492 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 26.4 mm -145.56 127.78 9.19 Favored 'Isoleucine or valine' 1 C--N 1.24 -4.182 0 CA-C-N 113.083 -1.872 . . . . 0.0 109.528 177.098 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.407 ' H ' ' HB3' ' A' ' 9' ' ' SER . 17.6 mt -78.36 132.96 37.61 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 118.467 -1.293 . . . . 0.0 110.429 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.507 ' N ' ' O ' ' A' ' 36' ' ' LYS . . . -45.1 -75.52 0.17 Allowed Glycine 0 N--CA 1.486 1.973 0 C-N-CA 119.106 -1.521 . . . . 0.0 109.94 178.471 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.7 t -139.0 -137.68 0.13 Allowed 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 119.621 -0.832 . . . . 0.0 110.041 179.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -75.63 70.14 2.42 Favored 'General case' 0 C--N 1.252 -3.651 0 CA-C-N 113.783 -1.553 . . . . 0.0 110.415 -170.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 75.24 21.7 77.43 Favored Glycine 0 C--N 1.281 -2.486 0 N-CA-C 108.242 -1.943 . . . . 0.0 108.242 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 70.5 mt-10 -98.01 -115.07 0.14 Allowed 'General case' 0 C--N 1.307 -1.259 0 C-N-CA 119.171 -1.011 . . . . 0.0 110.593 -178.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.507 ' O ' ' N ' ' A' ' 31' ' ' GLY . 1.3 mtpp -62.79 167.23 4.76 Favored 'General case' 0 C--N 1.26 -3.313 0 CA-C-N 114.304 -1.317 . . . . 0.0 110.369 -178.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.548 ' OD1' ' N ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -143.94 165.57 27.36 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.176 179.575 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -156.74 152.41 26.97 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 119.143 -1.023 . . . . 0.0 110.511 176.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.575 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 0.9 OUTLIER -125.42 87.65 2.74 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.562 -179.793 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.555 ' O ' ' N ' ' A' ' 27' ' ' LYS . 2.4 p -111.35 146.77 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.621 0 C-N-CA 118.447 -1.301 . . . . 0.0 112.773 -179.289 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.407 ' N ' ' CG2' ' A' ' 40' ' ' VAL . 6.1 t -43.76 161.48 0.02 OUTLIER 'General case' 0 C--N 1.285 -2.226 0 CA-C-N 113.328 -1.76 . . . . 0.0 112.035 178.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 120.93 143.55 6.76 Favored Glycine 0 N--CA 1.497 2.76 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -84.57 131.86 34.58 Favored 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 119.188 -1.005 . . . . 0.0 111.1 -178.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -131.79 -156.2 8.3 Favored Glycine 0 N--CA 1.496 2.668 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 179.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.428 ' O ' ' CG2' ' A' ' 45' ' ' THR . 14.4 t -102.48 127.87 29.45 Favored Pre-proline 0 N--CA 1.493 1.681 0 C-N-CA 119.476 -0.89 . . . . 0.0 110.351 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.431 ' O ' ' C ' ' A' ' 47' ' ' GLU . 1.4 Cg_endo -64.69 115.02 2.99 Favored 'Trans proline' 0 C--O 1.214 -0.687 0 C-N-CA 120.591 0.861 . . . . 0.0 110.822 178.56 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.431 ' C ' ' O ' ' A' ' 46' ' ' PRO . 1.2 tt0 -36.01 98.52 0.15 Allowed Pre-proline 0 N--CA 1.503 2.212 0 C-N-CA 120.229 -0.588 . . . . 0.0 110.702 -179.658 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -58.42 104.3 0.18 Allowed 'Trans proline' 0 C--O 1.215 -0.635 0 C-N-CA 120.778 0.985 . . . . 0.0 110.967 -177.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 . . . . . 0 C--N 1.302 -1.458 0 CA-C-O 116.251 -1.833 . . . . 0.0 110.41 -179.06 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 2.2 t . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.4 t -84.28 169.12 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 C-N-CA 119.336 -0.945 . . . . 0.0 109.961 179.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -107.72 -167.38 1.25 Allowed 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 119.879 -0.729 . . . . 0.0 110.505 -179.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -96.9 176.91 5.8 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 178.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.537 ' N ' ' OD1' ' A' ' 5' ' ' ASP . 0.4 OUTLIER -89.96 157.09 18.0 Favored 'General case' 0 C--N 1.293 -1.856 0 C-N-CA 118.099 -1.441 . . . . 0.0 109.19 176.984 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.496 ' SG ' ' O ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -75.58 165.89 24.39 Favored 'General case' 0 C--N 1.285 -2.223 0 C-N-CA 119.745 -0.782 . . . . 0.0 110.708 178.571 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.701 ' H ' HE22 ' A' ' 11' ' ' GLN . 2.0 t -130.94 3.5 4.42 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.231 177.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.478 ' H ' HE22 ' A' ' 11' ' ' GLN . 2.7 mm-40 -162.34 161.55 27.53 Favored 'General case' 0 C--N 1.28 -2.456 0 CA-C-N 113.671 -1.604 . . . . 0.0 110.414 -179.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.421 ' HA ' ' H ' ' A' ' 30' ' ' LEU . 0.6 OUTLIER -77.24 154.84 32.61 Favored 'General case' 0 C--N 1.291 -1.962 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.323 -179.43 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.436 ' O ' ' O ' ' A' ' 11' ' ' GLN . . . 96.21 -33.47 5.59 Favored Glycine 0 N--CA 1.501 2.984 0 C-N-CA 119.27 -1.443 . . . . 0.0 112.296 -179.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.701 HE22 ' H ' ' A' ' 7' ' ' THR . 8.8 mt-30 -51.72 -176.63 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.181 0 C-N-CA 119.128 -1.029 . . . . 0.0 110.698 -178.475 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.517 ' O ' ' O ' ' A' ' 22' ' ' CYS . 1.5 m-20 -144.64 -64.4 0.35 Allowed 'General case' 0 N--CA 1.5 2.059 0 C-N-CA 118.45 -1.3 . . . . 0.0 113.97 -176.202 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 85.2 mt -76.87 50.05 0.69 Allowed 'General case' 0 C--N 1.271 -2.809 0 C-N-CA 117.596 -1.642 . . . . 0.0 110.101 -176.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.564 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 29.7 p -125.56 -152.01 0.5 Allowed 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.011 -0.995 . . . . 0.0 108.684 177.59 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.496 ' O ' ' SG ' ' A' ' 6' ' ' CYS . 76.0 mt -117.37 117.23 28.94 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 115.179 -0.919 . . . . 0.0 108.918 176.365 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.564 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 1.5 m -126.36 17.35 7.67 Favored 'General case' 0 N--CA 1.498 1.958 0 C-N-CA 118.81 -1.156 . . . . 0.0 111.036 -176.294 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -152.3 83.3 1.25 Allowed 'General case' 0 C--N 1.295 -1.795 0 C-N-CA 119.662 -0.815 . . . . 0.0 108.9 178.239 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 67.32 -85.11 0.13 Allowed Glycine 0 N--CA 1.486 1.989 0 C-N-CA 119.193 -1.479 . . . . 0.0 109.727 -178.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -140.42 -2.18 1.44 Allowed 'General case' 0 N--CA 1.486 1.361 0 CA-C-O 121.891 0.853 . . . . 0.0 111.14 179.363 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -82.88 144.99 29.69 Favored 'General case' 0 C--N 1.258 -3.402 0 CA-C-N 114.189 -1.369 . . . . 0.0 111.057 -179.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.2 t -71.96 144.8 12.83 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.523 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.545 ' O ' ' SG ' ' A' ' 28' ' ' CYS . 0.7 OUTLIER -146.4 127.47 14.64 Favored 'General case' 0 C--N 1.279 -2.487 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 177.353 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.528 ' C ' ' H ' ' A' ' 25' ' ' GLY . . . 166.82 -83.81 0.1 OUTLIER Glycine 0 N--CA 1.482 1.703 0 C-N-CA 116.465 -2.778 . . . . 0.0 113.764 -175.489 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -72.66 17.39 0.11 Allowed 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 118.712 -1.195 . . . . 0.0 112.691 -173.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.528 ' H ' ' C ' ' A' ' 23' ' ' GLY . . . -126.86 -11.35 3.59 Favored Glycine 0 C--N 1.264 -3.422 0 N-CA-C 107.937 -2.065 . . . . 0.0 107.937 173.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.44 ' O ' ' O ' ' A' ' 23' ' ' GLY . 1.5 m-80 -158.22 -146.65 0.16 Allowed 'General case' 0 C--O 1.213 -0.834 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 -177.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.579 ' N ' ' O ' ' A' ' 40' ' ' VAL . 0.0 OUTLIER -141.34 138.44 33.08 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 175.45 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.545 ' SG ' ' O ' ' A' ' 22' ' ' CYS . 36.3 m -101.82 148.6 25.11 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 118.108 -1.437 . . . . 0.0 111.808 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 35.1 mm -140.32 90.1 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.263 -3.156 0 CA-C-N 112.918 -1.947 . . . . 0.0 106.878 175.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.461 ' CD1' ' C ' ' A' ' 30' ' ' LEU . 0.4 OUTLIER -78.41 130.79 36.51 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 118.955 -1.098 . . . . 0.0 110.296 -176.245 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.509 ' H ' ' HA ' ' A' ' 37' ' ' ASN . . . 60.02 86.75 0.03 OUTLIER Glycine 0 N--CA 1.483 1.796 0 C-N-CA 119.044 -1.55 . . . . 0.0 109.466 -178.062 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.566 ' O ' ' N ' ' A' ' 34' ' ' GLY . 67.8 m -68.32 -122.94 0.0 OUTLIER 'General case' 0 C--O 1.196 -1.715 0 C-N-CA 118.594 -1.242 . . . . 0.0 108.564 -179.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -73.54 66.88 1.04 Allowed 'General case' 0 C--N 1.252 -3.646 0 CA-C-N 114.523 -1.217 . . . . 0.0 108.518 -174.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.566 ' N ' ' O ' ' A' ' 32' ' ' SER . . . 66.08 26.95 72.54 Favored Glycine 0 C--N 1.286 -2.2 0 N-CA-C 107.741 -2.143 . . . . 0.0 107.741 -176.57 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -113.62 -136.67 0.37 Allowed 'General case' 0 C--O 1.216 -0.702 0 CA-C-O 122.418 1.104 . . . . 0.0 112.042 -176.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 6.2 mmmt -93.46 -176.12 4.01 Favored 'General case' 0 C--N 1.267 -2.997 0 CA-C-N 112.938 -1.937 . . . . 0.0 112.181 -176.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.509 ' HA ' ' H ' ' A' ' 31' ' ' GLY . 1.6 m-20 -90.95 162.79 14.6 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.938 178.427 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.461 ' CG ' ' N ' ' A' ' 39' ' ' CYS . 13.7 tt0 -157.38 157.61 34.37 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 119.26 -0.976 . . . . 0.0 110.973 179.468 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.461 ' N ' ' CG ' ' A' ' 38' ' ' GLN . 82.0 m -115.82 74.33 0.89 Allowed 'General case' 0 N--CA 1.492 1.669 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.453 178.403 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.579 ' O ' ' N ' ' A' ' 27' ' ' LYS . 0.2 OUTLIER -81.01 143.21 12.69 Favored 'Isoleucine or valine' 0 C--O 1.193 -1.873 0 C-N-CA 118.684 -1.206 . . . . 0.0 111.548 -177.75 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.5 t -64.1 140.18 58.84 Favored 'General case' 0 C--N 1.272 -2.777 0 CA-C-N 114.596 -1.184 . . . . 0.0 111.551 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 163.8 -140.92 6.76 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 178.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -145.86 113.43 6.34 Favored 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 119.272 -0.971 . . . . 0.0 110.32 179.593 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -114.37 -163.37 14.58 Favored Glycine 0 N--CA 1.498 2.812 0 C-N-CA 119.966 -1.111 . . . . 0.0 110.89 -179.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -131.1 153.02 81.63 Favored Pre-proline 0 N--CA 1.498 1.97 0 C-N-CA 120.04 -0.664 . . . . 0.0 109.627 -179.612 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -54.12 160.18 6.65 Favored 'Trans proline' 0 C--O 1.216 -0.621 0 C-N-CA 121.604 1.536 . . . . 0.0 112.177 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.545 ' CD ' ' H ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -74.19 148.01 86.04 Favored Pre-proline 0 N--CA 1.484 1.25 0 C-N-CA 119.519 -0.872 . . . . 0.0 108.796 178.44 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_endo -61.41 123.04 12.01 Favored 'Trans proline' 0 C--O 1.214 -0.677 0 C-N-CA 120.991 1.127 . . . . 0.0 111.783 -175.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 116.308 -1.806 . . . . 0.0 110.115 178.96 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 3.9 t . . . . . 0 N--CA 1.488 1.474 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 6.0 t -119.22 169.0 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 C-N-CA 120.016 -0.674 . . . . 0.0 109.51 178.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -130.04 -167.62 1.84 Allowed 'General case' 0 N--CA 1.497 1.89 0 C-N-CA 119.779 -0.768 . . . . 0.0 109.948 -179.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.0 p -98.42 176.95 5.51 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 119.541 -0.864 . . . . 0.0 108.866 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -88.06 153.07 21.56 Favored 'General case' 0 C--N 1.29 -1.979 0 C-N-CA 118.468 -1.293 . . . . 0.0 110.79 179.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.528 ' SG ' ' CB ' ' A' ' 11' ' ' GLN . 1.2 m -74.39 179.13 4.76 Favored 'General case' 0 C--N 1.287 -2.127 0 CA-C-N 114.754 -1.112 . . . . 0.0 111.564 176.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -152.81 13.41 0.53 Allowed 'General case' 0 C--N 1.29 -2.018 0 CA-C-N 113.657 -1.61 . . . . 0.0 110.015 176.404 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.596 ' CG ' ' NE2' ' A' ' 11' ' ' GLN . 0.9 OUTLIER -163.5 -171.81 2.7 Favored 'General case' 0 C--N 1.286 -2.157 0 CA-C-N 114.511 -1.222 . . . . 0.0 109.947 179.271 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.481 ' HB3' ' H ' ' A' ' 30' ' ' LEU . 0.8 OUTLIER -99.91 172.99 6.89 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 119.911 -0.716 . . . . 0.0 110.707 -178.007 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 63.57 22.21 65.64 Favored Glycine 0 N--CA 1.502 3.063 0 C-N-CA 119.978 -1.106 . . . . 0.0 112.661 176.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.596 ' NE2' ' CG ' ' A' ' 8' ' ' GLU . 0.0 OUTLIER -89.2 -166.53 1.62 Allowed 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 118.95 -1.1 . . . . 0.0 111.213 178.804 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.489 ' OD1' ' CA ' ' A' ' 23' ' ' GLY . 2.0 m-20 -153.76 -70.37 0.14 Allowed 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 118.81 -1.156 . . . . 0.0 113.265 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 94.4 mt -77.97 45.6 0.53 Allowed 'General case' 0 C--N 1.282 -2.343 0 C-N-CA 118.64 -1.224 . . . . 0.0 111.291 -176.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.476 ' SG ' ' N ' ' A' ' 15' ' ' LEU . 15.3 p -123.82 -154.88 0.63 Allowed 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 174.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.476 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 63.3 mt -116.62 109.8 17.69 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-N 114.654 -1.157 . . . . 0.0 108.406 176.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.7 m -104.89 -58.97 1.81 Allowed 'General case' 0 C--N 1.288 -2.099 0 C-N-CA 118.939 -1.104 . . . . 0.0 111.027 -175.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -83.79 85.45 7.29 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 118.363 -1.335 . . . . 0.0 109.233 177.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.53 -116.8 5.28 Favored Glycine 0 N--CA 1.489 2.191 0 C-N-CA 119.384 -1.388 . . . . 0.0 110.317 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.411 ' O ' ' OG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -109.74 1.41 19.41 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-O 122.261 1.029 . . . . 0.0 109.91 -179.581 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 32.2 m120 -79.32 139.03 37.93 Favored 'General case' 0 C--N 1.26 -3.324 0 CA-C-N 113.244 -1.798 . . . . 0.0 111.081 -178.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.6 t -74.09 142.45 14.79 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 C-N-CA 118.987 -1.085 . . . . 0.0 110.206 179.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.515 ' O ' ' SG ' ' A' ' 28' ' ' CYS . 4.0 m -145.55 99.25 3.26 Favored 'General case' 0 C--N 1.284 -2.264 0 C-N-CA 118.873 -1.131 . . . . 0.0 109.408 177.538 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.489 ' CA ' ' OD1' ' A' ' 12' ' ' ASN . . . -161.91 -78.33 0.03 OUTLIER Glycine 0 C--N 1.297 -1.631 1 N-CA-C 131.482 7.353 . . . . 0.0 131.482 -177.489 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.527 ' O ' ' ND2' ' A' ' 26' ' ' ASN . 3.9 tt0 -45.9 124.56 5.43 Favored 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 119.506 -0.877 . . . . 0.0 111.188 -178.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.66 -26.15 2.77 Favored Glycine 0 N--CA 1.478 1.454 0 C-N-CA 119.61 -1.281 . . . . 0.0 110.255 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.548 ' N ' ' ND2' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -110.21 -167.58 1.21 Allowed 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 119.54 -0.864 . . . . 0.0 110.726 -178.92 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.537 ' O ' ' O ' ' A' ' 40' ' ' VAL . 16.6 tttt -148.08 166.08 28.87 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 119.466 -0.894 . . . . 0.0 110.056 179.2 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.515 ' SG ' ' O ' ' A' ' 22' ' ' CYS . 59.0 m -136.06 158.89 43.31 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.261 -0.975 . . . . 0.0 110.147 176.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 22.3 mm -142.68 136.73 27.53 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.505 0 CA-C-N 114.793 -1.094 . . . . 0.0 110.536 177.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.481 ' H ' ' HB3' ' A' ' 9' ' ' SER . 18.1 mt -77.48 147.35 35.92 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 119.943 -0.703 . . . . 0.0 110.967 177.34 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -125.44 -112.13 1.87 Allowed Glycine 0 N--CA 1.475 1.246 0 CA-C-N 114.538 -1.21 . . . . 0.0 110.163 175.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.482 ' O ' ' CA ' ' A' ' 36' ' ' LYS . 7.5 m -152.91 -136.56 0.06 Allowed 'General case' 0 C--N 1.311 -1.108 0 CA-C-O 122.567 1.175 . . . . 0.0 111.967 -178.195 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -84.77 69.03 10.65 Favored 'General case' 0 C--N 1.265 -3.077 0 CA-C-N 113.001 -1.909 . . . . 0.0 110.635 -173.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 139.87 -12.28 3.13 Favored Glycine 0 C--N 1.277 -2.725 0 N-CA-C 108.227 -1.949 . . . . 0.0 108.227 179.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.662 ' O ' ' N ' ' A' ' 37' ' ' ASN . 6.3 mt-10 -138.36 14.63 2.79 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-O 122.663 1.22 . . . . 0.0 108.321 179.486 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.482 ' CA ' ' O ' ' A' ' 32' ' ' SER . 0.0 OUTLIER -35.21 -20.07 0.0 OUTLIER 'General case' 0 C--N 1.249 -3.765 0 CA-C-N 111.402 -2.636 . . . . 0.0 113.209 -175.504 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.662 ' N ' ' O ' ' A' ' 35' ' ' GLU . 0.2 OUTLIER -174.37 131.37 0.37 Allowed 'General case' 0 C--N 1.253 -3.61 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.737 178.992 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.637 ' N ' ' ND2' ' A' ' 37' ' ' ASN . 13.1 tt0 -127.04 143.16 51.36 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 114.93 -1.032 . . . . 0.0 108.994 176.061 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 66.6 m -96.28 108.19 20.64 Favored 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 119.212 -0.995 . . . . 0.0 111.136 -178.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.537 ' O ' ' O ' ' A' ' 27' ' ' LYS . 0.2 OUTLIER -110.26 142.26 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.407 0 C-N-CA 118.908 -1.117 . . . . 0.0 111.285 177.007 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 15.1 t -70.25 151.48 45.28 Favored 'General case' 0 C--N 1.273 -2.76 0 CA-C-N 114.692 -1.14 . . . . 0.0 110.314 178.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 144.37 -116.54 0.96 Allowed Glycine 0 N--CA 1.493 2.472 1 N-CA-C 130.847 7.099 . . . . 0.0 130.847 -178.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 -116.26 72.61 0.82 Allowed 'General case' 0 N--CA 1.5 2.065 0 C-N-CA 119.957 -0.697 . . . . 0.0 110.556 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.47 ' CA ' HD22 ' A' ' 12' ' ' ASN . . . -107.67 151.16 16.95 Favored Glycine 0 N--CA 1.497 2.704 0 C-N-CA 119.795 -1.193 . . . . 0.0 110.53 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -117.61 152.53 49.79 Favored Pre-proline 0 N--CA 1.496 1.839 0 C-N-CA 120.097 -0.641 . . . . 0.0 109.532 179.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -53.36 161.47 3.88 Favored 'Trans proline' 0 C--O 1.215 -0.629 0 C-N-CA 121.287 1.324 . . . . 0.0 111.137 177.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.447 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 2.6 tt0 -73.8 -45.8 6.97 Favored Pre-proline 0 C--N 1.307 -1.246 0 C-N-CA 118.987 -1.085 . . . . 0.0 111.048 178.022 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.447 ' HD2' ' N ' ' A' ' 47' ' ' GLU . 1.9 Cg_endo -64.98 139.92 63.76 Favored 'Trans proline' 0 C--O 1.214 -0.7 0 C-N-CA 120.429 0.753 . . . . 0.0 110.585 175.636 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 116.384 -1.77 . . . . 0.0 110.435 -179.882 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.406 ' O ' ' CG1' ' A' ' 1' ' ' VAL . 7.9 p . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -102.88 159.76 4.46 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 C-N-CA 119.937 -0.705 . . . . 0.0 109.767 179.421 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -82.53 -170.82 3.15 Favored 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 118.961 -1.096 . . . . 0.0 110.791 -179.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.51 ' OG1' ' N ' ' A' ' 5' ' ' ASP . 0.0 OUTLIER -118.76 -169.07 1.65 Allowed 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.35 179.608 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.51 ' N ' ' OG1' ' A' ' 4' ' ' THR . 0.0 OUTLIER -90.46 151.81 21.23 Favored 'General case' 0 C--N 1.288 -2.073 0 C-N-CA 118.774 -1.17 . . . . 0.0 111.903 -176.649 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.423 ' SG ' ' NE2' ' A' ' 11' ' ' GLN . 0.7 OUTLIER -75.57 179.48 5.3 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-N 114.215 -1.357 . . . . 0.0 112.28 177.348 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.737 ' H ' HE22 ' A' ' 11' ' ' GLN . 5.3 p -159.09 16.26 0.17 Allowed 'General case' 0 C--N 1.285 -2.204 0 CA-C-N 112.979 -1.919 . . . . 0.0 109.342 177.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.402 ' CG ' ' O ' ' A' ' 7' ' ' THR . 33.1 mt-10 -160.96 168.07 25.29 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 114.949 -1.023 . . . . 0.0 110.704 -178.179 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.464 ' HB3' ' H ' ' A' ' 30' ' ' LEU . 0.7 OUTLIER -88.33 159.42 18.08 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.06 -179.892 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.449 ' N ' ' O ' ' A' ' 28' ' ' CYS . . . 82.99 -28.47 3.64 Favored Glycine 0 N--CA 1.501 2.971 0 C-N-CA 119.446 -1.359 . . . . 0.0 112.531 177.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.737 HE22 ' H ' ' A' ' 7' ' ' THR . 5.6 mt-30 -49.55 -178.59 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.13 0 C-N-CA 119.496 -0.882 . . . . 0.0 110.817 -179.059 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.474 ' ND2' ' O ' ' A' ' 23' ' ' GLY . 13.2 m-20 -143.68 -67.83 0.34 Allowed 'General case' 0 N--CA 1.501 2.108 0 C-N-CA 118.493 -1.283 . . . . 0.0 114.289 -176.031 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 94.2 mt -77.78 48.28 0.68 Allowed 'General case' 0 C--N 1.275 -2.638 0 C-N-CA 118.803 -1.159 . . . . 0.0 111.399 -175.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.402 ' H ' ' C ' ' A' ' 12' ' ' ASN . 29.4 p -122.93 -159.35 0.83 Allowed 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 119.677 -0.809 . . . . 0.0 110.566 176.214 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 64.7 mt -117.17 121.93 42.62 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.958 177.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 63.5 m -110.18 -73.47 0.68 Allowed 'General case' 0 N--CA 1.5 2.07 0 C-N-CA 119.028 -1.069 . . . . 0.0 110.883 -179.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -79.69 93.23 5.5 Favored 'General case' 0 C--N 1.295 -1.767 0 C-N-CA 118.828 -1.149 . . . . 0.0 110.185 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 72.83 -118.9 6.66 Favored Glycine 0 N--CA 1.488 2.143 0 C-N-CA 119.494 -1.336 . . . . 0.0 110.73 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.42 ' O ' ' OG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -110.65 4.59 20.3 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-O 122.286 1.041 . . . . 0.0 109.947 -178.918 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 61.5 m-80 -78.37 135.24 37.42 Favored 'General case' 0 C--N 1.259 -3.366 0 CA-C-N 113.2 -1.818 . . . . 0.0 110.742 -179.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.1 t -75.67 144.67 11.7 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 C-N-CA 119.451 -0.9 . . . . 0.0 110.754 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.463 ' O ' ' O ' ' A' ' 12' ' ' ASN . 53.8 m -141.68 99.78 3.62 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 118.768 -1.173 . . . . 0.0 110.137 176.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.474 ' O ' ' ND2' ' A' ' 12' ' ' ASN . . . -176.14 -42.05 0.06 OUTLIER Glycine 0 N--CA 1.487 2.043 1 N-CA-C 129.921 6.728 . . . . 0.0 129.921 -178.012 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 12.1 tt0 -86.33 118.19 25.61 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 118.879 -1.128 . . . . 0.0 109.117 177.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.42 -22.6 29.24 Favored Glycine 0 C--N 1.294 -1.802 0 N-CA-C 108.719 -1.753 . . . . 0.0 108.719 -176.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.455 ' O ' ' O ' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -131.72 164.79 25.17 Favored 'General case' 0 C--O 1.209 -1.077 0 C-N-CA 120.021 -0.672 . . . . 0.0 110.035 179.156 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.539 ' O ' ' O ' ' A' ' 40' ' ' VAL . 10.0 ttpt -122.12 147.87 45.6 Favored 'General case' 0 N--CA 1.506 2.37 0 C-N-CA 119.752 -0.779 . . . . 0.0 110.189 178.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.449 ' O ' ' N ' ' A' ' 10' ' ' GLY . 0.7 OUTLIER -109.37 163.1 13.71 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 118.289 -1.364 . . . . 0.0 111.282 176.917 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 18.8 mm -145.49 130.07 12.3 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.355 0 CA-C-N 112.286 -2.234 . . . . 0.0 109.462 177.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.464 ' H ' ' HB3' ' A' ' 9' ' ' SER . 24.3 mt -77.41 115.9 17.56 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 118.518 -1.273 . . . . 0.0 109.39 178.55 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.93 107.03 2.42 Favored Glycine 0 N--CA 1.479 1.518 0 C-N-CA 119.116 -1.516 . . . . 0.0 110.308 -179.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.561 ' N ' ' O ' ' A' ' 36' ' ' LYS . 8.9 t -76.14 -129.61 0.01 OUTLIER 'General case' 0 C--O 1.199 -1.581 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 178.25 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.408 ' O ' ' OD2' ' A' ' 33' ' ' ASP . 6.7 p-10 -74.23 65.12 1.15 Allowed 'General case' 0 C--N 1.252 -3.673 0 CA-C-N 114.902 -1.045 . . . . 0.0 108.636 -175.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 32' ' ' SER . . . 76.1 28.95 59.46 Favored Glycine 0 C--N 1.289 -2.056 0 N-CA-C 108.602 -1.799 . . . . 0.0 108.602 -177.518 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -127.0 -128.94 0.23 Allowed 'General case' 0 C--O 1.214 -0.783 0 C-N-CA 118.992 -1.083 . . . . 0.0 112.499 -177.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.561 ' O ' ' N ' ' A' ' 32' ' ' SER . 21.3 mtmt -95.36 -171.66 2.45 Favored 'General case' 0 C--N 1.277 -2.554 0 CA-C-N 113.241 -1.8 . . . . 0.0 113.145 -176.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.458 ' OD1' ' N ' ' A' ' 37' ' ' ASN . 1.3 m120 -49.28 161.02 0.19 Allowed 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 114.851 -1.068 . . . . 0.0 111.994 179.349 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.436 ' O ' ' SG ' ' A' ' 28' ' ' CYS . 7.3 tt0 -154.76 161.16 41.61 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.771 177.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.413 ' H ' ' HG3' ' A' ' 38' ' ' GLN . 62.6 m -128.3 84.08 2.21 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 120.037 -0.665 . . . . 0.0 110.445 -179.159 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.539 ' O ' ' O ' ' A' ' 27' ' ' LYS . 0.2 OUTLIER -91.69 139.17 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.606 0 C-N-CA 118.124 -1.43 . . . . 0.0 112.317 -178.722 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.9 t -47.61 163.17 0.05 Allowed 'General case' 0 C--N 1.277 -2.583 0 CA-C-N 114.137 -1.392 . . . . 0.0 111.599 -178.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 130.36 -150.5 19.21 Favored Glycine 0 N--CA 1.492 2.43 1 N-CA-C 130.289 6.875 . . . . 0.0 130.289 -179.335 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -123.72 141.86 51.62 Favored 'General case' 0 N--CA 1.498 1.934 0 C-N-CA 119.88 -0.728 . . . . 0.0 109.958 178.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.438 ' N ' HD22 ' A' ' 12' ' ' ASN . . . -161.4 -177.56 34.59 Favored Glycine 0 N--CA 1.487 2.085 0 C-N-CA 119.224 -1.465 . . . . 0.0 110.614 -179.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.424 ' O ' ' O ' ' A' ' 46' ' ' PRO . 0.4 OUTLIER -101.86 154.8 37.08 Favored Pre-proline 0 N--CA 1.49 1.559 0 C-N-CA 119.849 -0.741 . . . . 0.0 109.388 -179.701 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.424 ' O ' ' O ' ' A' ' 45' ' ' THR . 4.6 Cg_exo -54.96 -159.81 0.01 OUTLIER 'Trans proline' 0 C--O 1.213 -0.757 0 C-N-CA 121.273 1.315 . . . . 0.0 110.708 176.416 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -112.22 88.71 10.92 Favored Pre-proline 0 C--N 1.306 -1.325 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.062 179.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -66.27 117.94 5.11 Favored 'Trans proline' 0 C--O 1.216 -0.604 0 C-N-CA 120.913 1.075 . . . . 0.0 110.779 177.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 . . . . . 0 C--N 1.302 -1.477 0 CA-C-O 116.337 -1.792 . . . . 0.0 110.493 -179.724 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 5.7 m . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.1 t -79.3 161.97 4.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 C-N-CA 118.994 -1.082 . . . . 0.0 109.262 179.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -103.75 -167.19 1.34 Allowed 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 119.443 -0.903 . . . . 0.0 111.02 -178.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.96 174.13 7.09 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.278 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -94.52 150.83 19.86 Favored 'General case' 0 C--N 1.296 -1.73 0 C-N-CA 118.737 -1.185 . . . . 0.0 109.833 179.182 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.518 ' SG ' ' O ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -75.86 165.94 24.26 Favored 'General case' 0 C--N 1.292 -1.93 0 C-N-CA 119.655 -0.818 . . . . 0.0 111.028 178.919 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 34.2 p -135.96 12.02 3.36 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-N 114.61 -1.177 . . . . 0.0 108.871 175.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.469 ' O ' ' NE2' ' A' ' 11' ' ' GLN . 2.1 tt0 -162.54 175.43 11.46 Favored 'General case' 0 C--N 1.284 -2.248 0 CA-C-N 114.321 -1.309 . . . . 0.0 111.729 -179.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -85.33 154.46 21.88 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 114.816 -1.084 . . . . 0.0 110.296 -179.266 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.449 ' O ' ' O ' ' A' ' 11' ' ' GLN . . . 89.42 -21.21 30.02 Favored Glycine 0 N--CA 1.502 3.077 0 C-N-CA 119.261 -1.447 . . . . 0.0 112.855 178.124 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.469 ' NE2' ' O ' ' A' ' 8' ' ' GLU . 1.5 mp0 -49.66 179.35 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.338 0 C-N-CA 118.588 -1.245 . . . . 0.0 110.187 -179.012 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.513 ' O ' ' O ' ' A' ' 22' ' ' CYS . 15.6 t-20 -138.12 -76.49 0.38 Allowed 'General case' 0 N--CA 1.497 1.879 0 C-N-CA 118.963 -1.095 . . . . 0.0 112.438 -178.105 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 83.1 mt -78.36 47.34 0.68 Allowed 'General case' 0 C--N 1.264 -3.149 0 C-N-CA 117.968 -1.493 . . . . 0.0 110.594 -177.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.409 ' H ' ' C ' ' A' ' 12' ' ' ASN . 31.9 p -117.03 -157.13 0.65 Allowed 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 119.482 -0.887 . . . . 0.0 110.13 177.492 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.518 ' O ' ' SG ' ' A' ' 6' ' ' CYS . 4.6 mt -122.8 127.98 49.83 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.371 177.266 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 82.8 m -116.35 -64.61 1.29 Allowed 'General case' 0 N--CA 1.511 2.604 0 C-N-CA 119.287 -0.965 . . . . 0.0 110.951 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 85.3 mt-10 -79.23 76.35 5.77 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 119.08 -1.048 . . . . 0.0 110.287 -178.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 73.77 -108.57 2.54 Favored Glycine 0 N--CA 1.488 2.144 0 C-N-CA 119.481 -1.342 . . . . 0.0 111.123 179.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -108.2 0.26 21.36 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 122.119 0.962 . . . . 0.0 110.773 -177.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 72.9 m-20 -79.66 127.01 31.65 Favored 'General case' 0 C--N 1.256 -3.481 0 CA-C-N 113.838 -1.528 . . . . 0.0 110.435 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.2 t -66.68 148.69 11.98 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 C-N-CA 118.835 -1.146 . . . . 0.0 109.168 178.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.513 ' O ' ' O ' ' A' ' 12' ' ' ASN . 0.0 OUTLIER -143.55 113.59 7.24 Favored 'General case' 0 C--N 1.289 -2.053 0 C-N-CA 118.802 -1.159 . . . . 0.0 110.754 -178.574 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.43 ' O ' ' O ' ' A' ' 26' ' ' ASN . . . 162.08 -57.59 0.3 Allowed Glycine 0 N--CA 1.483 1.824 1 N-CA-C 130.29 6.876 . . . . 0.0 130.29 -178.01 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.509 ' N ' ' OD1' ' A' ' 12' ' ' ASN . 15.8 tt0 -61.47 126.69 28.27 Favored 'General case' 0 C--N 1.31 -1.137 0 C-N-CA 119.037 -1.065 . . . . 0.0 110.51 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.41 -25.56 8.0 Favored Glycine 0 N--CA 1.482 1.708 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -178.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.484 ' OD1' ' N ' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -123.11 -167.18 1.56 Allowed 'General case' 0 C--N 1.316 -0.867 0 C-N-CA 120.322 -0.551 . . . . 0.0 110.021 179.992 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.475 ' O ' ' O ' ' A' ' 40' ' ' VAL . 15.4 tttp -145.65 115.93 7.51 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 178.136 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.51 ' SG ' ' O ' ' A' ' 38' ' ' GLN . 0.1 OUTLIER -80.11 163.72 23.91 Favored 'General case' 0 CA--C 1.477 -1.828 0 C-N-CA 117.528 -1.669 . . . . 0.0 112.415 178.503 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 18.1 mm -149.39 124.7 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.265 -3.076 0 CA-C-N 111.982 -2.372 . . . . 0.0 108.218 178.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 26.9 mt -77.33 137.44 38.76 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 118.337 -1.345 . . . . 0.0 110.421 -178.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.516 ' C ' ' H ' ' A' ' 33' ' ' ASP . . . -85.81 -86.93 0.99 Allowed Glycine 0 N--CA 1.492 2.419 0 C-N-CA 117.982 -2.056 . . . . 0.0 108.338 177.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.521 ' O ' ' N ' ' A' ' 34' ' ' GLY . 0.6 OUTLIER 73.87 -18.91 0.37 Allowed 'General case' 0 C--O 1.195 -1.788 0 C-N-CA 119.516 -0.873 . . . . 0.0 111.76 175.408 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.516 ' H ' ' C ' ' A' ' 31' ' ' GLY . 24.8 t0 -77.57 63.87 2.78 Favored 'General case' 0 C--N 1.256 -3.488 0 N-CA-C 106.544 -1.65 . . . . 0.0 106.544 -176.179 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 32' ' ' SER . . . 66.48 26.13 72.75 Favored Glycine 0 C--N 1.286 -2.199 0 N-CA-C 104.416 -3.474 . . . . 0.0 104.416 -171.213 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -140.86 170.78 15.1 Favored 'General case' 0 N--CA 1.419 -1.991 0 CA-C-O 123.345 1.545 . . . . 0.0 110.993 -174.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.75 170.09 9.02 Favored 'General case' 1 C--N 1.227 -4.752 0 CA-C-N 111.592 -2.549 . . . . 0.0 111.566 178.791 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.422 ' HA ' ' H ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -54.93 169.46 0.23 Allowed 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.647 174.676 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.51 ' O ' ' SG ' ' A' ' 28' ' ' CYS . 42.1 tt0 -157.33 152.83 26.44 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 118.791 -1.164 . . . . 0.0 111.223 178.379 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -113.1 107.24 15.67 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 115.226 -0.897 . . . . 0.0 112.058 178.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.483 ' CG2' ' N ' ' A' ' 41' ' ' THR . 1.6 p -110.45 155.99 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 C-N-CA 119.01 -1.076 . . . . 0.0 109.494 174.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.483 ' N ' ' CG2' ' A' ' 40' ' ' VAL . 6.0 t -78.87 152.28 31.32 Favored 'General case' 0 C--N 1.279 -2.479 0 CA-C-N 114.814 -1.084 . . . . 0.0 112.202 -177.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 153.28 -113.87 0.6 Allowed Glycine 0 N--CA 1.491 2.331 1 N-CA-C 128.945 6.338 . . . . 0.0 128.945 -179.529 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -154.62 101.34 2.32 Favored 'General case' 0 N--CA 1.494 1.753 0 C-N-CA 119.299 -0.961 . . . . 0.0 110.268 177.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -114.73 -165.69 15.1 Favored Glycine 0 N--CA 1.496 2.656 0 C-N-CA 120.013 -1.089 . . . . 0.0 110.579 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -134.32 148.25 66.94 Favored Pre-proline 0 N--CA 1.489 1.513 0 C-N-CA 119.965 -0.694 . . . . 0.0 110.152 -179.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -59.74 143.64 99.59 Favored 'Trans proline' 0 C--O 1.211 -0.83 0 C-N-CA 121.314 1.343 . . . . 0.0 110.997 176.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -72.31 117.65 60.51 Favored Pre-proline 0 CA--C 1.565 1.523 0 C-N-CA 119.628 -0.829 . . . . 0.0 110.588 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_endo -68.3 117.76 5.17 Favored 'Trans proline' 0 C--O 1.216 -0.596 0 C-N-CA 120.822 1.015 . . . . 0.0 111.17 178.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.494 1.768 0 CA-C-O 116.372 -1.775 . . . . 0.0 110.365 179.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 2.2 t . . . . . 0 N--CA 1.488 1.464 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.1 t -92.93 160.96 2.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 C-N-CA 119.205 -0.998 . . . . 0.0 110.498 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -100.48 -165.07 1.17 Allowed 'General case' 0 N--CA 1.492 1.648 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.283 179.223 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -94.18 -179.58 4.99 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.125 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 5' ' ' ASP . 0.2 OUTLIER -93.05 154.65 17.99 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 118.462 -1.295 . . . . 0.0 110.781 179.478 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.9 m -75.41 179.17 5.38 Favored 'General case' 0 C--N 1.294 -1.841 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.056 178.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.3 p -134.24 -2.54 2.81 Favored 'General case' 0 C--N 1.29 -2.019 0 CA-C-N 113.904 -1.498 . . . . 0.0 109.924 176.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -162.84 157.04 20.83 Favored 'General case' 0 C--N 1.279 -2.493 0 CA-C-N 114.237 -1.347 . . . . 0.0 110.053 179.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.585 ' OG ' ' N ' ' A' ' 30' ' ' LEU . 1.4 m -62.59 -175.79 0.09 Allowed 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 119.73 -0.788 . . . . 0.0 110.496 179.237 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.453 ' N ' ' O ' ' A' ' 28' ' ' CYS . . . 73.64 -42.58 1.07 Allowed Glycine 0 N--CA 1.5 2.919 0 C-N-CA 120.111 -1.042 . . . . 0.0 112.9 178.173 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.442 ' O ' ' O ' ' A' ' 10' ' ' GLY . 2.5 mp0 -53.79 -173.02 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.607 0 C-N-CA 119.022 -1.071 . . . . 0.0 110.222 -177.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.506 ' ND2' ' O ' ' A' ' 26' ' ' ASN . 11.4 m-20 -151.59 -57.63 0.15 Allowed 'General case' 0 N--CA 1.503 2.212 0 C-N-CA 117.691 -1.604 . . . . 0.0 114.707 -177.044 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 15.0 mt -75.7 49.75 0.53 Allowed 'General case' 0 C--N 1.287 -2.133 0 C-N-CA 118.989 -1.085 . . . . 0.0 110.107 -176.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.593 ' SG ' ' N ' ' A' ' 15' ' ' LEU . 19.5 p -130.37 -142.31 0.24 Allowed 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 114.662 -1.154 . . . . 0.0 108.821 176.207 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.593 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 88.1 mt -122.9 108.8 13.39 Favored 'General case' 0 C--N 1.288 -2.083 0 CA-C-N 114.592 -1.185 . . . . 0.0 109.365 176.523 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.426 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 8.6 m -111.22 -46.74 3.27 Favored 'General case' 0 C--N 1.288 -2.068 0 CA-C-N 113.941 -1.481 . . . . 0.0 110.598 -175.382 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -87.82 73.88 9.16 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 119.17 -1.012 . . . . 0.0 109.307 178.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 73.39 -107.61 2.28 Favored Glycine 0 N--CA 1.489 2.195 0 C-N-CA 119.304 -1.427 . . . . 0.0 109.938 -178.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -111.31 -0.13 16.49 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-O 122.337 1.065 . . . . 0.0 109.89 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -82.75 145.62 29.46 Favored 'General case' 0 C--N 1.261 -3.256 0 CA-C-N 113.201 -1.818 . . . . 0.0 111.467 -179.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.4 t -84.17 142.2 13.7 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.258 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.503 ' O ' ' O ' ' A' ' 12' ' ' ASN . 0.0 OUTLIER -109.85 146.44 35.07 Favored 'General case' 0 N--CA 1.504 2.229 0 N-CA-C 106.012 -1.848 . . . . 0.0 106.012 168.637 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -105.13 -154.58 22.29 Favored Glycine 0 CA--C 1.49 -1.491 0 C-N-CA 118.256 -1.926 . . . . 0.0 111.13 -173.271 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.5 ' C ' ' H ' ' A' ' 26' ' ' ASN . 4.0 tt0 -92.82 170.89 9.34 Favored 'General case' 0 C--N 1.246 -3.926 0 CA-C-N 112.075 -2.063 . . . . 0.0 109.55 -177.25 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.41 ' H ' ' HG2' ' A' ' 24' ' ' GLN . . . 81.06 -35.32 2.36 Favored Glycine 0 N--CA 1.48 1.616 0 N-CA-C 108.595 -1.802 . . . . 0.0 108.595 -177.464 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.506 ' O ' ' ND2' ' A' ' 12' ' ' ASN . 0.0 OUTLIER -100.49 173.77 6.41 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 177.542 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.485 ' O ' ' O ' ' A' ' 40' ' ' VAL . 0.1 OUTLIER -128.76 131.53 47.85 Favored 'General case' 0 N--CA 1.502 2.155 0 C-N-CA 119.461 -0.896 . . . . 0.0 111.057 -179.388 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.453 ' O ' ' N ' ' A' ' 10' ' ' GLY . 81.3 m -93.01 153.71 18.56 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 118.359 -1.336 . . . . 0.0 110.067 176.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 30.3 mm -140.77 81.04 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.265 -3.091 0 CA-C-N 114.142 -1.39 . . . . 0.0 108.869 176.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.585 ' N ' ' OG ' ' A' ' 9' ' ' SER . 1.1 pp -78.51 133.76 37.37 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 119.257 -0.977 . . . . 0.0 110.998 -178.138 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.428 ' H ' ' HA ' ' A' ' 37' ' ' ASN . . . 57.15 89.58 0.01 OUTLIER Glycine 0 N--CA 1.477 1.428 0 C-N-CA 118.483 -1.818 . . . . 0.0 108.585 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.493 ' O ' ' N ' ' A' ' 34' ' ' GLY . 1.7 t -67.13 -134.0 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.468 0 C-N-CA 118.825 -1.15 . . . . 0.0 108.463 -178.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -75.14 65.38 1.52 Allowed 'General case' 1 C--N 1.243 -4.038 0 CA-C-N 114.727 -1.124 . . . . 0.0 108.783 -174.347 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.493 ' N ' ' O ' ' A' ' 32' ' ' SER . . . 78.21 25.69 61.16 Favored Glycine 0 C--N 1.286 -2.232 0 N-CA-C 108.348 -1.901 . . . . 0.0 108.348 -177.583 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -121.44 -135.19 0.31 Allowed 'General case' 0 C--O 1.215 -0.762 0 CA-C-O 122.306 1.05 . . . . 0.0 112.147 -177.086 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.431 ' O ' ' N ' ' A' ' 32' ' ' SER . 13.7 mmtm -94.39 -173.34 3.03 Favored 'General case' 0 C--N 1.272 -2.783 0 CA-C-N 113.037 -1.892 . . . . 0.0 112.787 -175.31 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.428 ' HA ' ' H ' ' A' ' 31' ' ' GLY . 4.3 m-20 -101.32 164.7 11.65 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.903 179.59 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.471 ' CG ' ' N ' ' A' ' 39' ' ' CYS . 7.0 tt0 -161.45 157.91 25.82 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.099 177.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.471 ' N ' ' CG ' ' A' ' 38' ' ' GLN . 0.9 OUTLIER -117.52 92.04 3.74 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 120.124 -0.63 . . . . 0.0 109.649 178.892 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.485 ' O ' ' O ' ' A' ' 27' ' ' LYS . 0.6 OUTLIER -101.23 134.33 41.76 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.267 0 C-N-CA 118.482 -1.287 . . . . 0.0 112.476 -178.417 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 6.0 t -57.15 157.17 6.35 Favored 'General case' 0 C--N 1.273 -2.743 0 CA-C-N 113.044 -1.889 . . . . 0.0 111.019 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 148.69 -104.59 0.28 Allowed Glycine 0 N--CA 1.492 2.427 1 N-CA-C 130.866 7.106 . . . . 0.0 130.866 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -160.13 106.55 1.58 Allowed 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 119.441 -0.904 . . . . 0.0 110.368 -179.557 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -146.28 -174.63 18.59 Favored Glycine 0 N--CA 1.493 2.496 0 C-N-CA 119.548 -1.311 . . . . 0.0 110.437 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.7 t -107.47 144.77 29.89 Favored Pre-proline 0 N--CA 1.492 1.632 0 C-N-CA 119.781 -0.768 . . . . 0.0 110.37 -179.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -63.76 132.48 35.2 Favored 'Trans proline' 0 C--O 1.214 -0.699 0 C-N-CA 120.904 1.07 . . . . 0.0 110.53 174.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -53.15 114.79 6.45 Favored Pre-proline 0 N--CA 1.488 1.451 0 C-N-CA 119.515 -0.874 . . . . 0.0 110.703 -179.143 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -62.28 114.02 2.16 Favored 'Trans proline' 0 C--O 1.214 -0.7 0 C-N-CA 120.44 0.76 . . . . 0.0 110.991 177.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 116.412 -1.756 . . . . 0.0 110.473 -179.868 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 3.6 t . . . . . 0 N--CA 1.492 1.627 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 1.6 t -82.09 163.77 3.05 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 C-N-CA 119.697 -0.801 . . . . 0.0 110.039 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -92.52 -164.86 1.24 Allowed 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 119.55 -0.86 . . . . 0.0 110.93 -179.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.457 ' H ' ' HG1' ' A' ' 4' ' ' THR . 1.1 p -93.05 180.0 5.27 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.501 ' N ' ' OD1' ' A' ' 5' ' ' ASP . 0.0 OUTLIER -92.4 151.46 20.24 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 118.997 -1.081 . . . . 0.0 110.152 178.435 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.517 ' SG ' ' O ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -75.04 165.77 24.72 Favored 'General case' 0 C--N 1.296 -1.75 0 C-N-CA 120.017 -0.673 . . . . 0.0 111.189 178.445 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.0 p -141.67 12.47 2.09 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 119.446 -0.901 . . . . 0.0 110.062 177.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -162.78 179.51 7.6 Favored 'General case' 0 C--N 1.287 -2.126 0 CA-C-N 114.687 -1.142 . . . . 0.0 110.826 178.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.455 ' HB3' ' H ' ' A' ' 30' ' ' LEU . 0.8 OUTLIER -89.81 163.91 14.85 Favored 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 119.252 -0.979 . . . . 0.0 109.741 179.849 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 71.54 14.52 74.92 Favored Glycine 0 N--CA 1.495 2.585 0 C-N-CA 119.028 -1.558 . . . . 0.0 111.777 179.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.7 mm-40 -74.77 -167.43 0.57 Allowed 'General case' 0 N--CA 1.498 1.958 0 C-N-CA 118.977 -1.089 . . . . 0.0 109.991 179.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.477 ' O ' ' O ' ' A' ' 22' ' ' CYS . 0.9 OUTLIER -155.09 -80.31 0.09 Allowed 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 117.693 -1.603 . . . . 0.0 113.554 -179.45 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 92.6 mt -77.03 51.75 0.83 Allowed 'General case' 0 C--N 1.273 -2.755 0 C-N-CA 117.815 -1.554 . . . . 0.0 109.602 -176.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.471 ' H ' ' C ' ' A' ' 12' ' ' ASN . 23.1 p -122.36 -156.07 0.67 Allowed 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.754 176.486 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.517 ' O ' ' SG ' ' A' ' 6' ' ' CYS . 8.6 mt -124.68 124.52 42.36 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 114.784 -1.098 . . . . 0.0 109.917 179.025 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.2 m -108.19 -68.24 0.92 Allowed 'General case' 0 N--CA 1.504 2.227 0 C-N-CA 119.058 -1.057 . . . . 0.0 111.519 -177.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -87.27 91.17 8.63 Favored 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 118.701 -1.2 . . . . 0.0 110.915 -177.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.06 -98.53 1.1 Allowed Glycine 0 N--CA 1.49 2.289 0 C-N-CA 119.632 -1.27 . . . . 0.0 111.598 177.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.406 ' O ' ' OG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -129.83 5.81 5.05 Favored 'General case' 0 N--CA 1.483 1.187 0 CA-C-O 122.293 1.044 . . . . 0.0 110.224 -177.763 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.607 ' N ' ' ND2' ' A' ' 20' ' ' ASN . 1.0 OUTLIER -81.35 130.81 35.19 Favored 'General case' 0 C--N 1.253 -3.605 0 CA-C-N 113.438 -1.71 . . . . 0.0 110.296 178.97 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.6 t -75.38 146.46 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 C-N-CA 119.377 -0.929 . . . . 0.0 110.459 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.477 ' O ' ' O ' ' A' ' 12' ' ' ASN . 21.2 m -143.36 109.95 5.48 Favored 'General case' 0 N--CA 1.505 2.283 0 C-N-CA 118.587 -1.245 . . . . 0.0 110.483 177.31 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.447 ' O ' ' O ' ' A' ' 26' ' ' ASN . . . -175.91 -91.39 0.08 OUTLIER Glycine 0 C--O 1.203 -1.784 0 C-N-CA 118.331 -1.89 . . . . 0.0 112.177 -178.038 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -50.77 120.75 5.05 Favored 'General case' 0 C--N 1.297 -1.677 0 C-N-CA 119.086 -1.046 . . . . 0.0 110.548 -178.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.68 -26.78 21.78 Favored Glycine 0 N--CA 1.481 1.667 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -178.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.447 ' O ' ' O ' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -137.17 -163.81 1.49 Allowed 'General case' 0 C--N 1.313 -0.994 0 C-N-CA 120.148 -0.621 . . . . 0.0 111.122 -179.508 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.534 ' N ' ' O ' ' A' ' 40' ' ' VAL . 16.0 ttpt -142.38 165.46 27.35 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 177.417 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -130.79 163.37 27.48 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 118.893 -1.123 . . . . 0.0 110.494 175.374 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 15.4 mm -151.42 129.47 2.58 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.104 0 CA-C-N 113.176 -1.829 . . . . 0.0 109.186 179.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.455 ' H ' ' HB3' ' A' ' 9' ' ' SER . 29.2 mt -78.06 119.53 21.61 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 118.602 -1.239 . . . . 0.0 109.529 178.245 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 94.64 106.74 2.02 Favored Glycine 0 N--CA 1.478 1.474 0 C-N-CA 119.027 -1.558 . . . . 0.0 110.513 -179.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.559 ' N ' ' O ' ' A' ' 36' ' ' LYS . 18.0 t -74.54 -128.2 0.01 OUTLIER 'General case' 0 C--O 1.197 -1.679 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -73.68 63.4 0.85 Allowed 'General case' 0 C--N 1.256 -3.458 0 CA-C-N 114.337 -1.301 . . . . 0.0 108.342 -175.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 32' ' ' SER . . . 75.08 28.01 63.16 Favored Glycine 0 C--N 1.289 -2.034 0 N-CA-C 108.134 -1.986 . . . . 0.0 108.134 -176.483 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -123.67 -130.09 0.26 Allowed 'General case' 0 C--O 1.212 -0.87 0 C-N-CA 119.197 -1.001 . . . . 0.0 112.323 -176.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.559 ' O ' ' N ' ' A' ' 32' ' ' SER . 3.1 pttm -94.87 -172.22 2.65 Favored 'General case' 0 C--N 1.28 -2.435 0 CA-C-N 113.609 -1.632 . . . . 0.0 113.511 -177.567 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.415 ' OD1' ' N ' ' A' ' 37' ' ' ASN . 1.6 m-20 -52.52 154.53 2.54 Favored 'General case' 0 N--CA 1.502 2.133 0 CA-C-N 114.997 -1.002 . . . . 0.0 112.187 179.342 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.546 ' NE2' ' OG ' ' A' ' 32' ' ' SER . 5.8 tt0 -156.46 155.44 32.06 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 119.626 -0.829 . . . . 0.0 110.407 177.406 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 96.9 m -112.99 98.53 7.22 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 119.897 -0.721 . . . . 0.0 110.642 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.534 ' O ' ' N ' ' A' ' 27' ' ' LYS . 0.2 OUTLIER -98.48 142.78 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.237 0 C-N-CA 118.777 -1.169 . . . . 0.0 111.619 179.844 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.9 t -63.42 150.04 44.54 Favored 'General case' 0 C--N 1.275 -2.636 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.949 179.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 141.6 -147.54 19.12 Favored Glycine 0 N--CA 1.495 2.58 0 C-N-CA 119.697 -1.24 . . . . 0.0 110.428 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -135.62 117.1 14.77 Favored 'General case' 0 N--CA 1.498 1.939 0 C-N-CA 119.798 -0.761 . . . . 0.0 110.349 179.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -113.33 177.17 17.92 Favored Glycine 0 N--CA 1.499 2.888 0 C-N-CA 119.965 -1.112 . . . . 0.0 110.409 -179.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 8.8 t -90.03 127.79 52.3 Favored Pre-proline 0 CA--C 1.566 1.594 0 C-N-CA 119.224 -0.99 . . . . 0.0 110.444 -179.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -59.78 147.84 90.65 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 121.266 1.311 . . . . 0.0 112.019 179.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.63 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 28.0 tt0 -84.35 -37.53 0.64 Allowed Pre-proline 0 CA--C 1.554 1.115 0 C-N-CA 119.674 -0.81 . . . . 0.0 111.896 177.523 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.63 ' CD ' ' N ' ' A' ' 47' ' ' GLU . 4.8 Cg_endo -74.85 -173.25 1.48 Allowed 'Trans proline' 0 C--O 1.213 -0.728 0 C-N-CA 121.1 1.2 . . . . 0.0 111.097 -176.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 116.761 -1.59 . . . . 0.0 109.92 179.122 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 8.9 p . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.405 HG11 ' H ' ' A' ' 3' ' ' TYR . 1.3 t -94.34 175.79 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 C-N-CA 119.643 -0.823 . . . . 0.0 109.475 179.333 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.405 ' H ' HG11 ' A' ' 2' ' ' VAL . 38.4 m-85 -132.18 -174.13 3.35 Favored 'General case' 0 N--CA 1.495 1.789 0 C-N-CA 119.525 -0.87 . . . . 0.0 110.411 179.189 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.71 ' HG1' ' H ' ' A' ' 5' ' ' ASP . 0.1 OUTLIER -101.68 -178.18 3.64 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 178.857 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.71 ' H ' ' HG1' ' A' ' 4' ' ' THR . 0.0 OUTLIER -93.05 154.03 18.36 Favored 'General case' 0 C--N 1.288 -2.078 0 C-N-CA 119.162 -1.015 . . . . 0.0 109.605 178.074 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 3.7 m -73.99 174.89 7.95 Favored 'General case' 0 C--N 1.295 -1.784 0 C-N-CA 118.944 -1.102 . . . . 0.0 110.778 177.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.9 t -155.13 11.88 0.35 Allowed 'General case' 0 C--N 1.276 -2.588 0 CA-C-N 113.554 -1.657 . . . . 0.0 109.806 177.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.419 ' CB ' HE22 ' A' ' 11' ' ' GLN . 4.7 mm-40 -154.82 173.86 15.87 Favored 'General case' 0 C--N 1.29 -1.997 0 CA-C-N 114.313 -1.312 . . . . 0.0 109.498 -177.344 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.465 ' HB3' ' H ' ' A' ' 30' ' ' LEU . 0.9 OUTLIER -89.18 157.26 18.34 Favored 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 119.325 -0.95 . . . . 0.0 109.807 179.205 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 28' ' ' CYS . . . 94.12 -51.49 2.19 Favored Glycine 0 N--CA 1.502 3.054 0 C-N-CA 119.075 -1.536 . . . . 0.0 112.396 178.156 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.449 ' O ' ' OD1' ' A' ' 12' ' ' ASN . 3.9 mp0 -40.24 164.03 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.452 0 C-N-CA 120.29 -0.564 . . . . 0.0 111.91 -176.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.529 ' ND2' ' O ' ' A' ' 26' ' ' ASN . 85.1 m-20 -140.69 -50.45 0.45 Allowed 'General case' 0 N--CA 1.507 2.409 0 C-N-CA 119.149 -1.02 . . . . 0.0 113.413 -177.407 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 14.7 mt -77.35 43.47 0.38 Allowed 'General case' 0 C--N 1.295 -1.787 0 C-N-CA 119.09 -1.044 . . . . 0.0 110.359 -177.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.654 ' SG ' ' N ' ' A' ' 15' ' ' LEU . 14.1 p -123.05 -148.44 0.4 Allowed 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 114.725 -1.125 . . . . 0.0 108.491 176.73 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.654 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 83.3 mt -116.23 98.73 6.76 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 114.497 -1.229 . . . . 0.0 107.866 173.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.469 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 57.6 m -95.9 -51.24 4.55 Favored 'General case' 0 C--N 1.276 -2.595 0 CA-C-N 113.429 -1.714 . . . . 0.0 110.947 -173.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -94.49 94.0 7.97 Favored 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 119.433 -0.907 . . . . 0.0 109.89 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 62.81 -92.7 0.09 OUTLIER Glycine 0 N--CA 1.49 2.242 0 C-N-CA 119.335 -1.412 . . . . 0.0 110.315 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -131.15 3.05 4.31 Favored 'General case' 0 N--CA 1.483 1.219 0 CA-C-O 122.138 0.971 . . . . 0.0 110.114 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 68.6 m-80 -79.34 140.87 37.39 Favored 'General case' 0 C--N 1.258 -3.374 0 CA-C-N 113.409 -1.723 . . . . 0.0 110.544 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.1 t -82.55 135.57 24.61 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 C-N-CA 118.875 -1.13 . . . . 0.0 111.404 -179.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.495 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 0.1 OUTLIER -91.19 151.52 20.91 Favored 'General case' 0 N--CA 1.513 2.708 0 C-N-CA 118.559 -1.256 . . . . 0.0 108.057 169.682 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.459 ' O ' ' OD1' ' A' ' 26' ' ' ASN . . . -118.74 124.93 6.2 Favored Glycine 0 C--O 1.213 -1.211 0 C-N-CA 119.922 -1.132 . . . . 0.0 110.42 -170.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.434 ' C ' ' O ' ' A' ' 23' ' ' GLY . 2.8 tt0 -36.06 132.43 0.52 Allowed 'General case' 0 C--N 1.255 -3.52 0 CA-C-N 112.652 -1.774 . . . . 0.0 110.127 178.073 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 126.6 -30.14 4.3 Favored Glycine 0 N--CA 1.482 1.715 0 N-CA-C 107.716 -2.154 . . . . 0.0 107.716 -175.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.637 ' N ' ' ND2' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -102.13 -159.77 0.75 Allowed 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 177.47 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.51 ' O ' ' O ' ' A' ' 40' ' ' VAL . 4.8 ttpp -152.81 104.5 2.87 Favored 'General case' 0 N--CA 1.498 1.945 0 C-N-CA 119.194 -1.003 . . . . 0.0 111.594 179.593 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.515 ' O ' ' N ' ' A' ' 10' ' ' GLY . 32.5 m -79.43 157.2 27.6 Favored 'General case' 0 C--O 1.201 -1.492 0 C-N-CA 117.617 -1.633 . . . . 0.0 110.071 178.183 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 28.0 mm -140.73 138.1 35.32 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.487 0 CA-C-N 114.825 -1.08 . . . . 0.0 110.173 177.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.465 ' H ' ' HB3' ' A' ' 9' ' ' SER . 21.1 mt -77.72 108.58 11.03 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 119.054 -1.058 . . . . 0.0 109.345 177.205 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.418 ' H ' ' HA ' ' A' ' 37' ' ' ASN . . . 105.47 110.84 3.54 Favored Glycine 0 N--CA 1.484 1.892 0 C-N-CA 119.69 -1.243 . . . . 0.0 110.513 -179.569 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.613 ' N ' ' O ' ' A' ' 36' ' ' LYS . 1.8 t -87.41 -133.92 0.08 Allowed 'General case' 0 C--O 1.203 -1.362 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.329 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -74.33 66.35 1.31 Allowed 'General case' 0 C--N 1.254 -3.582 0 CA-C-N 114.661 -1.154 . . . . 0.0 108.39 -175.525 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 32' ' ' SER . . . 76.93 28.05 59.43 Favored Glycine 0 C--N 1.288 -2.132 0 N-CA-C 108.626 -1.79 . . . . 0.0 108.626 -177.63 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 35.9 mm-40 -130.08 -132.88 0.21 Allowed 'General case' 0 C--O 1.212 -0.887 0 C-N-CA 118.999 -1.08 . . . . 0.0 112.005 -177.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.613 ' O ' ' N ' ' A' ' 32' ' ' SER . 8.8 mmtm -96.74 -164.24 1.13 Allowed 'General case' 0 C--N 1.278 -2.518 0 CA-C-N 112.995 -1.911 . . . . 0.0 112.88 -176.204 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.522 ' OD1' ' N ' ' A' ' 37' ' ' ASN . 0.6 OUTLIER -55.91 157.37 4.46 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.901 178.739 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -154.93 147.03 23.69 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 115.003 -0.998 . . . . 0.0 109.29 176.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.441 ' SG ' ' CB ' ' A' ' 16' ' ' CYS . 1.0 OUTLIER -104.15 91.34 3.9 Favored 'General case' 0 C--N 1.299 -1.604 0 C-N-CA 119.521 -0.872 . . . . 0.0 110.208 -179.984 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.516 ' CG2' ' N ' ' A' ' 41' ' ' THR . 3.4 p -106.76 160.15 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 C-N-CA 118.617 -1.233 . . . . 0.0 110.567 179.299 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.516 ' N ' ' CG2' ' A' ' 40' ' ' VAL . 8.8 t -80.14 154.81 27.79 Favored 'General case' 0 C--N 1.276 -2.606 0 CA-C-N 114.87 -1.059 . . . . 0.0 112.128 -178.613 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 166.94 -120.75 0.93 Allowed Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.906 -1.277 . . . . 0.0 109.906 178.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -142.98 123.74 14.19 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 119.374 -0.93 . . . . 0.0 110.109 179.145 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -142.11 -171.19 12.93 Favored Glycine 0 N--CA 1.489 2.186 1 N-CA-C 131.0 7.16 . . . . 0.0 131.0 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -136.16 154.0 77.06 Favored Pre-proline 0 N--CA 1.492 1.669 0 C-N-CA 119.904 -0.718 . . . . 0.0 109.48 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -56.82 -175.88 0.05 OUTLIER 'Trans proline' 0 C--N 1.324 -0.719 0 C-N-CA 120.994 1.129 . . . . 0.0 110.396 175.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.567 ' CD ' ' H ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -83.82 158.69 61.89 Favored Pre-proline 0 C--N 1.304 -1.397 0 C-N-CA 118.814 -1.154 . . . . 0.0 109.202 178.518 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -55.4 -178.75 0.06 OUTLIER 'Trans proline' 0 C--N 1.325 -0.678 0 C-N-CA 121.119 1.213 . . . . 0.0 110.964 -178.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 116.278 -1.82 . . . . 0.0 110.327 -179.899 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 25.1 m . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.404 HG11 ' H ' ' A' ' 3' ' ' TYR . 1.6 t -90.05 162.59 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 C-N-CA 119.623 -0.831 . . . . 0.0 110.807 -178.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.404 ' H ' HG11 ' A' ' 2' ' ' VAL . 97.0 m-85 -107.77 -163.96 0.93 Allowed 'General case' 0 N--CA 1.495 1.814 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.707 -179.617 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.659 ' HG1' ' H ' ' A' ' 5' ' ' ASP . 0.5 OUTLIER -127.61 -172.91 2.78 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 177.052 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.659 ' H ' ' HG1' ' A' ' 4' ' ' THR . 0.3 OUTLIER -81.3 157.53 25.08 Favored 'General case' 0 C--N 1.288 -2.067 0 C-N-CA 118.358 -1.337 . . . . 0.0 111.332 -178.693 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -75.83 -179.69 4.96 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.242 177.459 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.1 t -138.34 -0.85 1.96 Allowed 'General case' 0 N--CA 1.497 1.892 0 C-N-CA 119.001 -1.08 . . . . 0.0 111.408 178.128 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -163.33 169.17 19.46 Favored 'General case' 0 C--N 1.273 -2.741 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.985 177.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.18 149.37 44.72 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.587 -178.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.59 -12.15 62.98 Favored Glycine 0 N--CA 1.504 3.229 0 C-N-CA 119.473 -1.346 . . . . 0.0 112.458 179.066 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.414 ' CA ' ' OE1' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -66.56 178.18 1.35 Allowed 'General case' 0 N--CA 1.503 2.203 0 C-N-CA 119.181 -1.008 . . . . 0.0 110.961 -179.043 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.568 ' O ' ' O ' ' A' ' 22' ' ' CYS . 44.5 m-20 -143.85 -72.18 0.29 Allowed 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 118.648 -1.221 . . . . 0.0 113.031 -178.472 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 12.9 mt -75.51 48.31 0.44 Allowed 'General case' 0 C--N 1.289 -2.042 0 C-N-CA 119.542 -0.863 . . . . 0.0 110.032 -176.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.479 ' H ' ' C ' ' A' ' 12' ' ' ASN . 31.5 p -122.39 -151.5 0.48 Allowed 'General case' 0 C--N 1.302 -1.5 0 CA-C-N 114.261 -1.336 . . . . 0.0 108.409 176.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 67.6 mt -114.63 110.93 20.52 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-N 115.097 -0.956 . . . . 0.0 108.852 175.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 69.7 m -107.4 -70.41 0.8 Allowed 'General case' 0 C--N 1.285 -2.21 0 CA-C-N 114.437 -1.256 . . . . 0.0 110.243 -175.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -79.03 89.9 4.79 Favored 'General case' 0 C--N 1.297 -1.682 0 C-N-CA 118.829 -1.149 . . . . 0.0 109.472 178.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 70.9 -127.5 15.47 Favored Glycine 0 N--CA 1.483 1.827 0 C-N-CA 119.416 -1.374 . . . . 0.0 110.032 -178.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.404 ' O ' ' OG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -101.63 2.42 38.79 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 122.279 1.038 . . . . 0.0 109.629 179.677 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -78.82 140.73 38.14 Favored 'General case' 0 C--N 1.26 -3.289 0 CA-C-N 113.227 -1.806 . . . . 0.0 110.466 -179.541 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.3 t -80.88 142.47 13.8 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.977 -178.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.568 ' O ' ' O ' ' A' ' 12' ' ' ASN . 0.0 OUTLIER -114.65 161.59 17.9 Favored 'General case' 0 N--CA 1.505 2.319 0 N-CA-C 104.908 -2.256 . . . . 0.0 104.908 168.849 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -137.79 -139.31 3.85 Favored Glycine 0 CA--C 1.483 -1.963 0 C-N-CA 116.809 -2.615 . . . . 0.0 112.134 -175.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -91.57 150.15 21.33 Favored 'General case' 0 C--N 1.253 -3.615 0 CA-C-N 112.343 -1.929 . . . . 0.0 110.543 -174.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.6 -31.96 8.04 Favored Glycine 0 C--N 1.297 -1.634 0 N-CA-C 108.948 -1.661 . . . . 0.0 108.948 -177.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -109.61 -174.74 2.57 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 119.767 -0.773 . . . . 0.0 109.415 179.41 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.403 ' O ' ' O ' ' A' ' 40' ' ' VAL . 51.1 tttp -142.53 114.69 8.29 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 118.994 -1.083 . . . . 0.0 110.01 176.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.472 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 28.9 m -84.38 151.12 24.9 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 117.519 -1.672 . . . . 0.0 110.241 178.008 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 6.3 mm -130.23 125.01 59.05 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.748 0 CA-C-N 113.926 -1.488 . . . . 0.0 109.185 177.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 18.5 mt -76.5 133.58 39.74 Favored 'General case' 0 N--CA 1.498 1.966 0 C-N-CA 118.475 -1.29 . . . . 0.0 110.126 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 36' ' ' LYS . . . -69.44 -96.61 0.05 OUTLIER Glycine 0 N--CA 1.487 2.038 0 C-N-CA 119.162 -1.494 . . . . 0.0 110.219 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.515 ' O ' ' N ' ' A' ' 34' ' ' GLY . 3.4 m -109.96 -127.35 0.27 Allowed 'General case' 0 C--O 1.202 -1.434 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.206 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -73.97 69.29 1.42 Allowed 'General case' 0 C--N 1.255 -3.525 0 CA-C-N 114.703 -1.135 . . . . 0.0 108.723 -174.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 32' ' ' SER . . . 69.52 25.52 75.42 Favored Glycine 0 C--N 1.284 -2.344 0 N-CA-C 107.773 -2.131 . . . . 0.0 107.773 -177.471 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.527 ' O ' ' N ' ' A' ' 37' ' ' ASN . 42.7 mt-10 -91.59 -111.28 0.09 Allowed 'General case' 0 C--N 1.312 -1.044 0 C-N-CA 118.774 -1.17 . . . . 0.0 112.207 -177.083 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.506 ' O ' ' N ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -58.52 76.94 0.01 OUTLIER 'General case' 0 C--N 1.266 -3.035 0 CA-C-N 113.717 -1.583 . . . . 0.0 112.493 -175.905 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.527 ' N ' ' O ' ' A' ' 35' ' ' GLU . 3.2 m-20 -90.7 99.35 12.4 Favored 'General case' 0 C--N 1.289 -2.056 0 CA-C-N 114.378 -1.283 . . . . 0.0 109.106 176.483 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -103.26 148.61 25.61 Favored 'General case' 0 C--N 1.308 -1.217 0 C-N-CA 119.375 -0.93 . . . . 0.0 110.483 -177.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.472 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 1.6 m -103.38 88.5 3.12 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 119.445 -0.902 . . . . 0.0 110.844 -179.335 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.403 ' O ' ' O ' ' A' ' 27' ' ' LYS . 0.2 OUTLIER -97.47 139.68 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 C-N-CA 118.41 -1.316 . . . . 0.0 110.332 179.047 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 15.2 t -53.19 152.92 4.02 Favored 'General case' 0 C--N 1.272 -2.773 0 CA-C-N 113.887 -1.506 . . . . 0.0 111.021 -178.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 152.19 -167.17 31.22 Favored Glycine 0 N--CA 1.49 2.296 0 C-N-CA 119.08 -1.534 . . . . 0.0 110.797 179.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 18.5 mp0 -83.44 -176.77 6.47 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 119.396 -0.922 . . . . 0.0 110.367 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.483 ' CA ' HD22 ' A' ' 12' ' ' ASN . . . 177.76 172.23 42.02 Favored Glycine 0 N--CA 1.486 2.031 1 N-CA-C 129.575 6.59 . . . . 0.0 129.575 179.831 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -128.45 140.87 39.63 Favored Pre-proline 0 N--CA 1.486 1.363 0 C-N-CA 119.291 -0.964 . . . . 0.0 109.925 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -58.54 -163.16 0.02 OUTLIER 'Trans proline' 0 C--O 1.214 -0.692 0 C-N-CA 121.067 1.178 . . . . 0.0 111.059 178.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -119.14 96.01 49.75 Favored Pre-proline 0 C--N 1.305 -1.353 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.409 178.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -68.28 166.58 24.8 Favored 'Trans proline' 0 C--O 1.214 -0.704 0 C-N-CA 120.781 0.987 . . . . 0.0 110.639 -178.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 24.6 pt20 . . . . . 0 N--CA 1.489 1.502 0 CA-C-O 116.37 -1.776 . . . . 0.0 110.277 179.995 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 9.3 m . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.1 t -102.07 169.29 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 C-N-CA 119.849 -0.741 . . . . 0.0 110.319 -179.339 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -100.32 -169.44 1.73 Allowed 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 119.487 -0.885 . . . . 0.0 110.676 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.612 ' OG1' ' N ' ' A' ' 5' ' ' ASP . 0.1 OUTLIER -108.89 -175.42 2.76 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -179.953 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.612 ' N ' ' OG1' ' A' ' 4' ' ' THR . 0.0 OUTLIER -86.13 156.86 20.18 Favored 'General case' 0 C--N 1.293 -1.878 0 C-N-CA 118.982 -1.087 . . . . 0.0 110.619 -179.615 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.6 m -73.43 178.71 4.42 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 119.541 -0.864 . . . . 0.0 110.711 176.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 13.3 t -146.01 4.17 0.95 Allowed 'General case' 0 C--N 1.286 -2.182 0 CA-C-N 114.391 -1.277 . . . . 0.0 110.75 177.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -163.96 170.49 16.6 Favored 'General case' 0 C--N 1.282 -2.358 0 CA-C-N 114.575 -1.193 . . . . 0.0 110.284 178.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.44 ' HB3' ' H ' ' A' ' 30' ' ' LEU . 0.4 OUTLIER -83.31 151.37 25.61 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 119.603 -0.839 . . . . 0.0 109.117 178.479 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.13 -1.99 71.04 Favored Glycine 0 N--CA 1.493 2.447 0 C-N-CA 119.061 -1.542 . . . . 0.0 112.839 179.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.24 -165.24 0.46 Allowed 'General case' 0 N--CA 1.501 2.095 0 C-N-CA 118.752 -1.179 . . . . 0.0 109.723 179.248 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.543 ' OD1' ' N ' ' A' ' 24' ' ' GLN . 12.7 t-20 -150.63 -77.33 0.14 Allowed 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 117.987 -1.485 . . . . 0.0 114.5 -177.324 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.446 ' H ' ' HA ' ' A' ' 46' ' ' PRO . 12.4 mt -76.22 53.91 0.85 Allowed 'General case' 0 C--N 1.273 -2.755 0 C-N-CA 118.557 -1.257 . . . . 0.0 110.857 -175.268 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.638 ' SG ' ' N ' ' A' ' 15' ' ' LEU . 8.8 p -123.53 -152.47 0.51 Allowed 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 114.85 -1.068 . . . . 0.0 108.802 176.012 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.638 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 51.7 mt -112.97 119.6 38.48 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 115.044 -0.98 . . . . 0.0 108.646 176.558 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.406 ' SG ' ' O ' ' A' ' 22' ' ' CYS . 1.6 m -122.47 7.91 9.57 Favored 'General case' 0 N--CA 1.502 2.138 0 C-N-CA 118.634 -1.227 . . . . 0.0 111.15 -176.715 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -157.51 82.2 0.9 Allowed 'General case' 0 C--N 1.298 -1.647 0 C-N-CA 119.412 -0.915 . . . . 0.0 109.35 177.114 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.83 -112.76 3.69 Favored Glycine 0 N--CA 1.485 1.939 0 C-N-CA 119.424 -1.369 . . . . 0.0 109.981 -178.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.48 0.39 14.7 Favored 'General case' 0 CA--C 1.493 -1.249 0 CA-C-O 122.336 1.065 . . . . 0.0 109.551 179.534 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 71.8 m-20 -79.52 128.78 33.79 Favored 'General case' 0 C--N 1.257 -3.435 0 CA-C-N 113.099 -1.864 . . . . 0.0 111.278 -178.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.5 t -69.13 143.99 14.51 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 C-N-CA 118.594 -1.242 . . . . 0.0 108.563 177.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.517 ' O ' ' SG ' ' A' ' 28' ' ' CYS . 0.9 OUTLIER -146.71 128.17 14.99 Favored 'General case' 0 C--N 1.272 -2.768 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 179.642 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.536 ' C ' HD22 ' A' ' 12' ' ' ASN . . . 164.49 -79.85 0.13 Allowed Glycine 0 C--O 1.201 -1.908 0 C-N-CA 117.22 -2.419 . . . . 0.0 112.151 -176.373 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.543 ' N ' ' OD1' ' A' ' 12' ' ' ASN . 0.1 OUTLIER -44.78 125.13 4.76 Favored 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 119.647 -0.821 . . . . 0.0 111.66 -176.753 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.69 -26.2 8.6 Favored Glycine 0 N--CA 1.483 1.808 0 N-CA-C 109.899 -1.28 . . . . 0.0 109.899 -179.287 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.617 ' N ' ' ND2' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -129.53 -175.95 3.75 Favored 'General case' 0 C--N 1.311 -1.074 0 C-N-CA 120.22 -0.592 . . . . 0.0 111.066 -178.871 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.45 ' O ' ' N ' ' A' ' 40' ' ' VAL . 0.0 OUTLIER -120.56 153.83 36.2 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.038 175.187 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.517 ' SG ' ' O ' ' A' ' 22' ' ' CYS . 86.1 m -120.26 146.44 46.08 Favored 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 119.169 -1.013 . . . . 0.0 109.613 174.636 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.416 ' CD1' ' HZ2' ' A' ' 27' ' ' LYS . 2.3 mm -131.99 132.29 61.39 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.953 0 CA-C-N 114.314 -1.312 . . . . 0.0 109.93 179.489 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.44 ' H ' ' HB3' ' A' ' 9' ' ' SER . 14.8 mt -76.56 121.65 23.48 Favored 'General case' 0 N--CA 1.494 1.725 0 C-N-CA 118.327 -1.349 . . . . 0.0 108.891 176.542 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -96.86 -124.69 4.8 Favored Glycine 0 C--O 1.215 -1.069 0 C-N-CA 118.537 -1.792 . . . . 0.0 111.009 -178.33 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.502 ' OG ' ' N ' ' A' ' 33' ' ' ASP . 19.7 p -152.56 -145.81 0.18 Allowed 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 122.571 1.177 . . . . 0.0 111.047 -179.328 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.502 ' N ' ' OG ' ' A' ' 32' ' ' SER . 2.5 m-20 -86.8 68.87 10.24 Favored 'General case' 0 C--N 1.261 -3.262 0 CA-C-N 112.825 -1.988 . . . . 0.0 110.729 -173.64 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 139.62 -9.82 3.16 Favored Glycine 0 C--N 1.276 -2.755 0 N-CA-C 108.14 -1.984 . . . . 0.0 108.14 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.74 ' O ' ' O ' ' A' ' 36' ' ' LYS . 3.5 mm-40 -137.94 11.04 2.87 Favored 'General case' 0 C--O 1.196 -1.721 0 CA-C-N 114.303 -0.948 . . . . 0.0 110.213 -179.813 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.74 ' O ' ' O ' ' A' ' 35' ' ' GLU . 10.2 tttp -31.42 -157.4 0.0 OUTLIER 'General case' 0 C--N 1.262 -3.197 0 O-C-N 126.446 2.341 . . . . 0.0 114.984 -173.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.522 ' OD1' ' N ' ' A' ' 37' ' ' ASN . 0.3 OUTLIER -55.97 114.96 2.14 Favored 'General case' 0 C--N 1.268 -2.964 0 C-N-CA 117.908 -1.517 . . . . 0.0 110.829 -176.639 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -120.78 149.56 42.36 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.144 -0.934 . . . . 0.0 109.727 178.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 3.0 m -100.33 105.73 17.28 Favored 'General case' 0 C--N 1.298 -1.658 0 C-N-CA 119.441 -0.904 . . . . 0.0 110.316 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.656 ' CG2' ' H ' ' A' ' 41' ' ' THR . 7.4 p -99.77 -176.81 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 C-N-CA 118.518 -1.273 . . . . 0.0 110.241 177.479 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.656 ' H ' ' CG2' ' A' ' 40' ' ' VAL . 12.5 t -91.67 160.05 15.56 Favored 'General case' 0 C--N 1.288 -2.068 0 CA-C-N 114.629 -1.169 . . . . 0.0 110.926 179.657 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 138.28 -147.47 19.25 Favored Glycine 0 N--CA 1.496 2.695 1 N-CA-C 131.793 7.477 . . . . 0.0 131.793 179.178 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -108.88 111.46 23.18 Favored 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 119.933 -0.707 . . . . 0.0 110.412 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -130.52 156.56 21.68 Favored Glycine 0 N--CA 1.491 2.363 1 N-CA-C 129.783 6.673 . . . . 0.0 129.783 178.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 5.8 t -111.31 145.2 32.04 Favored Pre-proline 0 N--CA 1.495 1.823 0 C-N-CA 119.59 -0.844 . . . . 0.0 110.197 -178.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.446 ' HA ' ' H ' ' A' ' 13' ' ' LEU . 7.2 Cg_exo -52.44 -176.97 0.02 OUTLIER 'Trans proline' 0 C--O 1.211 -0.854 0 C-N-CA 120.9 1.066 . . . . 0.0 110.351 175.727 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.555 ' CD ' ' H ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -80.1 164.39 52.8 Favored Pre-proline 0 C--N 1.306 -1.322 0 C-N-CA 118.866 -1.134 . . . . 0.0 108.519 178.594 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -57.84 157.81 22.82 Favored 'Trans proline' 0 C--O 1.215 -0.673 0 C-N-CA 121.113 1.209 . . . . 0.0 111.734 -174.165 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 116.268 -1.825 . . . . 0.0 110.405 179.994 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 2.7 m . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.509 ' CG1' ' H ' ' A' ' 3' ' ' TYR . 38.6 t -81.93 174.97 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 C-N-CA 119.402 -0.919 . . . . 0.0 109.973 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.509 ' H ' ' CG1' ' A' ' 2' ' ' VAL . 35.8 m-85 -139.5 -166.24 2.02 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 119.722 -0.791 . . . . 0.0 110.125 -179.381 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -93.09 -174.95 3.71 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 119.679 -0.809 . . . . 0.0 108.858 179.064 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -100.58 154.09 18.85 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 119.03 -1.068 . . . . 0.0 110.441 179.069 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 4.3 m -74.67 174.91 8.43 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-O 122.144 0.973 . . . . 0.0 111.188 178.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -140.26 7.49 2.19 Favored 'General case' 0 C--N 1.285 -2.232 0 CA-C-N 113.549 -1.659 . . . . 0.0 109.471 177.592 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -163.13 162.64 25.72 Favored 'General case' 0 C--N 1.279 -2.481 0 CA-C-N 113.784 -1.553 . . . . 0.0 109.0 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.604 ' OG ' ' N ' ' A' ' 30' ' ' LEU . 0.9 OUTLIER -65.1 -168.11 0.03 OUTLIER 'General case' 0 C--N 1.293 -1.876 0 C-N-CA 118.992 -1.083 . . . . 0.0 110.057 -179.087 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 37.1 6.05 0.0 OUTLIER Glycine 0 N--CA 1.505 3.281 1 N-CA-C 130.124 6.81 . . . . 0.0 130.124 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -74.79 -167.0 0.52 Allowed 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 175.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.474 ' ND2' ' C ' ' A' ' 23' ' ' GLY . 1.4 m-20 -143.01 -70.24 0.33 Allowed 'General case' 0 N--CA 1.5 2.072 0 C-N-CA 117.55 -1.66 . . . . 0.0 114.987 -178.41 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 15.0 mt -77.67 50.45 0.83 Allowed 'General case' 0 C--N 1.27 -2.879 0 C-N-CA 117.244 -1.782 . . . . 0.0 111.111 -174.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.575 ' SG ' ' N ' ' A' ' 15' ' ' LEU . 15.6 p -119.76 -146.48 0.38 Allowed 'General case' 0 C--O 1.207 -1.146 0 CA-C-N 114.948 -1.023 . . . . 0.0 108.397 175.178 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.575 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 7.7 mt -128.85 130.77 47.34 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.822 177.657 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.421 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 7.9 m -139.0 21.47 2.63 Favored 'General case' 0 N--CA 1.498 1.971 0 C-N-CA 119.127 -1.029 . . . . 0.0 110.536 -179.417 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -146.41 55.16 1.14 Allowed 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 177.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.7 -66.92 2.01 Favored Glycine 0 N--CA 1.487 2.063 0 C-N-CA 119.479 -1.344 . . . . 0.0 110.19 -179.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.411 ' O ' ' OG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -144.4 1.72 1.08 Allowed 'General case' 0 C--N 1.309 -1.191 0 C-N-CA 119.445 -0.902 . . . . 0.0 111.57 -179.833 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -90.1 134.91 33.98 Favored 'General case' 0 C--N 1.253 -3.615 0 CA-C-N 114.37 -1.286 . . . . 0.0 110.464 179.033 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.3 t -74.2 144.12 12.79 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 C-N-CA 119.459 -0.897 . . . . 0.0 109.718 179.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.466 ' O ' ' O ' ' A' ' 12' ' ' ASN . 1.2 m -141.82 121.28 13.24 Favored 'General case' 0 C--N 1.29 -1.979 0 C-N-CA 118.857 -1.137 . . . . 0.0 109.384 178.398 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.474 ' C ' ' ND2' ' A' ' 12' ' ' ASN . . . 173.91 -87.69 0.08 OUTLIER Glycine 0 C--O 1.205 -1.664 0 C-N-CA 117.851 -2.119 . . . . 0.0 111.803 -176.223 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -49.8 126.49 14.08 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 119.291 -0.964 . . . . 0.0 110.491 -178.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.52 -26.27 14.68 Favored Glycine 0 N--CA 1.482 1.716 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -178.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.449 ' O ' ' O ' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -138.88 -160.9 1.11 Allowed 'General case' 0 C--N 1.311 -1.087 0 C-N-CA 119.954 -0.699 . . . . 0.0 111.139 -179.855 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.534 ' O ' ' O ' ' A' ' 40' ' ' VAL . 21.1 ttpt -148.5 148.0 29.74 Favored 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 119.66 -0.816 . . . . 0.0 109.88 177.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 87.3 m -99.59 160.45 14.29 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 118.31 -1.356 . . . . 0.0 111.053 178.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 18.5 mm -151.77 90.46 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.274 -2.705 0 CA-C-N 113.574 -1.648 . . . . 0.0 106.711 175.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.604 ' N ' ' OG ' ' A' ' 9' ' ' SER . 3.1 pp -80.6 149.27 29.95 Favored 'General case' 0 C--N 1.288 -2.069 0 C-N-CA 118.051 -1.46 . . . . 0.0 113.359 -173.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.482 ' H ' ' C ' ' A' ' 36' ' ' LYS . . . -144.57 -90.3 0.11 Allowed Glycine 0 N--CA 1.492 2.418 1 N-CA-C 133.816 8.287 . . . . 0.0 133.816 -179.162 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.57 ' HG ' ' H ' ' A' ' 33' ' ' ASP . 59.6 p -149.35 -130.78 0.05 Allowed 'General case' 0 C--O 1.215 -0.75 0 CA-C-O 122.52 1.152 . . . . 0.0 113.459 -175.671 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.57 ' H ' ' HG ' ' A' ' 32' ' ' SER . 5.6 m-20 -79.32 65.75 4.57 Favored 'General case' 0 C--N 1.275 -2.672 0 CA-C-N 112.746 -2.024 . . . . 0.0 111.671 -172.763 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 127.34 -7.88 7.07 Favored Glycine 0 C--N 1.28 -2.552 0 N-CA-C 107.72 -2.152 . . . . 0.0 107.72 179.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.598 ' O ' ' N ' ' A' ' 37' ' ' ASN . 8.0 mt-10 -123.16 -0.54 8.86 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-N 113.618 -1.291 . . . . 0.0 109.931 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.482 ' C ' ' H ' ' A' ' 31' ' ' GLY . 0.1 OUTLIER -34.75 -31.22 0.01 OUTLIER 'General case' 0 C--N 1.27 -2.863 0 CA-C-N 112.734 -2.03 . . . . 0.0 111.397 -174.461 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.598 ' N ' ' O ' ' A' ' 35' ' ' GLU . 58.4 m-80 -160.6 108.01 1.56 Allowed 'General case' 1 C--N 1.242 -4.081 0 CA-C-N 113.895 -1.502 . . . . 0.0 110.937 176.073 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -110.41 145.32 37.79 Favored 'General case' 0 C--N 1.309 -1.183 0 C-N-CA 119.595 -0.842 . . . . 0.0 110.172 178.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 86.5 m -110.84 85.17 2.06 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.715 179.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.534 ' O ' ' O ' ' A' ' 27' ' ' LYS . 1.2 p -97.27 141.74 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 C-N-CA 118.617 -1.233 . . . . 0.0 112.704 -177.52 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.6 t -62.68 140.13 58.69 Favored 'General case' 0 C--N 1.27 -2.876 0 CA-C-N 113.807 -1.542 . . . . 0.0 110.656 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 168.87 -136.06 3.89 Favored Glycine 0 N--CA 1.493 2.456 0 C-N-CA 119.396 -1.383 . . . . 0.0 110.692 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -140.96 113.73 8.3 Favored 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 119.752 -0.779 . . . . 0.0 109.864 -179.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -127.54 171.13 19.01 Favored Glycine 0 N--CA 1.501 3.032 0 C-N-CA 119.725 -1.226 . . . . 0.0 111.247 -178.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -104.83 150.22 38.41 Favored Pre-proline 0 C--N 1.307 -1.254 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 179.6 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -53.51 -164.79 0.01 OUTLIER 'Trans proline' 0 C--O 1.215 -0.641 0 C-N-CA 121.392 1.395 . . . . 0.0 111.765 177.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -131.76 74.54 77.45 Favored Pre-proline 0 C--N 1.308 -1.234 0 CA-C-N 115.086 -0.961 . . . . 0.0 108.648 177.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -60.48 135.02 58.31 Favored 'Trans proline' 0 C--O 1.215 -0.658 0 C-N-CA 121.647 1.565 . . . . 0.0 112.164 -173.174 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 . . . . . 0 N--CA 1.487 1.402 0 CA-C-O 116.261 -1.828 . . . . 0.0 110.291 179.136 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 31.4 m . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.047 0.451 . . . . 0.0 109.799 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.2 t -101.02 6.53 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 CA-C-O 122.043 0.925 . . . . 0.0 110.272 -179.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 -89.61 -178.29 5.51 Favored 'General case' 0 C--N 1.262 -3.235 0 CA-C-N 114.082 -1.417 . . . . 0.0 111.517 -178.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.4 ' H ' ' HG1' ' A' ' 4' ' ' THR . 23.2 p -116.38 -178.5 3.43 Favored 'General case' 0 N--CA 1.486 1.331 0 CA-C-N 114.821 -1.081 . . . . 0.0 108.857 179.19 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.1 154.23 22.18 Favored 'General case' 0 C--N 1.29 -1.998 0 C-N-CA 118.373 -1.331 . . . . 0.0 110.767 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.46 ' SG ' ' O ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -75.37 145.53 41.57 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.116 177.727 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.451 ' O ' ' OG1' ' A' ' 7' ' ' THR . 0.0 OUTLIER -114.69 8.14 16.13 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.703 -0.799 . . . . 0.0 109.506 178.525 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -162.3 171.01 17.94 Favored 'General case' 0 C--N 1.283 -2.287 0 CA-C-N 114.349 -1.296 . . . . 0.0 111.489 179.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -84.47 155.28 22.27 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 114.922 -1.035 . . . . 0.0 110.451 -178.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 87.66 -2.55 86.13 Favored Glycine 0 N--CA 1.498 2.783 0 C-N-CA 119.295 -1.431 . . . . 0.0 111.978 179.064 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -71.53 -174.91 1.18 Allowed 'General case' 0 N--CA 1.505 2.3 0 C-N-CA 119.232 -0.987 . . . . 0.0 110.219 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.537 ' ND2' ' O ' ' A' ' 26' ' ' ASN . 7.1 m120 -146.62 -71.67 0.23 Allowed 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 118.244 -1.382 . . . . 0.0 113.313 -179.106 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 24.6 mt -77.65 50.94 0.87 Allowed 'General case' 0 C--N 1.273 -2.718 0 C-N-CA 118.22 -1.392 . . . . 0.0 110.201 -177.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.423 ' H ' ' C ' ' A' ' 12' ' ' ASN . 30.6 p -119.06 -156.44 0.65 Allowed 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.895 176.738 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.46 ' O ' ' SG ' ' A' ' 6' ' ' CYS . 6.0 mt -123.16 128.67 50.38 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 114.877 -1.056 . . . . 0.0 108.551 175.74 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 93.6 m -115.1 -44.0 3.05 Favored 'General case' 0 N--CA 1.518 2.969 0 C-N-CA 118.221 -1.391 . . . . 0.0 110.61 -179.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -102.19 116.25 32.26 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.058 -1.057 . . . . 0.0 110.057 178.326 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 47.87 -96.95 0.01 OUTLIER Glycine 0 N--CA 1.493 2.443 0 C-N-CA 119.546 -1.311 . . . . 0.0 111.299 179.213 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.432 ' O ' ' OG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -131.44 6.72 4.47 Favored 'General case' 0 N--CA 1.485 1.32 0 CA-C-O 122.556 1.169 . . . . 0.0 110.211 -178.01 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 19.2 m-80 -80.11 132.18 35.89 Favored 'General case' 0 C--N 1.251 -3.674 0 CA-C-N 113.373 -1.739 . . . . 0.0 110.39 178.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.6 t -66.64 151.08 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 119.232 -0.987 . . . . 0.0 110.184 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.496 ' O ' ' O ' ' A' ' 12' ' ' ASN . 0.0 OUTLIER -150.74 112.82 4.57 Favored 'General case' 0 C--N 1.284 -2.28 0 C-N-CA 118.936 -1.106 . . . . 0.0 110.861 -179.882 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 154.77 -45.56 0.55 Allowed Glycine 0 N--CA 1.483 1.771 1 N-CA-C 130.522 6.969 . . . . 0.0 130.522 -177.169 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.539 ' C ' ' H ' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -56.92 133.45 54.68 Favored 'General case' 0 C--N 1.31 -1.134 0 C-N-CA 119.347 -0.941 . . . . 0.0 110.228 179.871 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 73.89 -23.8 1.07 Allowed Glycine 0 C--N 1.298 -1.578 0 C-N-CA 119.264 -1.446 . . . . 0.0 110.149 -179.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.539 ' H ' ' C ' ' A' ' 24' ' ' GLN . 0.0 OUTLIER -111.14 -155.14 0.56 Allowed 'General case' 0 C--O 1.213 -0.849 0 C-N-CA 119.743 -0.783 . . . . 0.0 110.571 -179.311 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.519 ' O ' ' O ' ' A' ' 40' ' ' VAL . 0.3 OUTLIER -157.83 105.91 2.02 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.623 179.389 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.501 ' SG ' ' O ' ' A' ' 38' ' ' GLN . 0.0 OUTLIER -77.21 162.95 26.98 Favored 'General case' 0 CA--C 1.481 -1.68 0 C-N-CA 117.457 -1.697 . . . . 0.0 111.342 -179.055 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 23.7 mm -144.24 119.21 3.82 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.347 0 CA-C-N 112.276 -2.238 . . . . 0.0 108.273 -179.263 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 16.3 mt -78.89 146.55 33.52 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 118.199 -1.4 . . . . 0.0 112.104 -176.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.496 ' O ' ' C ' ' A' ' 35' ' ' GLU . . . -138.69 106.46 0.52 Allowed Glycine 0 C--O 1.199 -2.061 0 N-CA-C 104.527 -3.429 . . . . 0.0 104.527 174.525 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.475 ' O ' ' N ' ' A' ' 34' ' ' GLY . 27.0 t -136.8 2.24 2.61 Favored 'General case' 0 C--N 1.261 -3.251 0 C-N-CA 120.019 -0.673 . . . . 0.0 110.178 -177.345 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -77.58 59.39 1.94 Allowed 'General case' 0 C--N 1.272 -2.793 0 N-CA-C 105.117 -2.179 . . . . 0.0 105.117 -179.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.475 ' N ' ' O ' ' A' ' 32' ' ' SER . . . 74.15 18.55 79.77 Favored Glycine 0 C--N 1.286 -2.246 0 N-CA-C 105.279 -3.128 . . . . 0.0 105.279 -169.825 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.496 ' C ' ' O ' ' A' ' 31' ' ' GLY . 54.2 mt-10 -118.88 -178.3 3.52 Favored 'General case' 0 N--CA 1.425 -1.706 0 CA-C-O 123.131 1.444 . . . . 0.0 111.288 -175.757 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.461 ' C ' ' O ' ' A' ' 31' ' ' GLY . 39.4 pttt -101.02 141.32 34.07 Favored 'General case' 0 C--N 1.246 -3.893 0 CA-C-N 112.011 -2.359 . . . . 0.0 113.919 -179.039 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 65.1 m-20 -63.2 152.77 36.57 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 168.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.501 ' O ' ' SG ' ' A' ' 28' ' ' CYS . 10.2 tt0 -150.77 153.06 34.76 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 117.82 -1.552 . . . . 0.0 112.66 -178.151 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -108.03 114.42 28.31 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 114.602 -1.181 . . . . 0.0 112.004 179.334 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.522 ' CG2' ' N ' ' A' ' 41' ' ' THR . 5.8 p -128.24 158.74 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 C-N-CA 118.579 -1.248 . . . . 0.0 110.172 173.647 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.522 ' N ' ' CG2' ' A' ' 40' ' ' VAL . 0.5 OUTLIER -88.07 138.31 31.56 Favored 'General case' 0 C--N 1.27 -2.862 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.707 -179.876 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 178.48 -153.15 12.28 Favored Glycine 0 N--CA 1.489 2.184 0 C-N-CA 119.43 -1.367 . . . . 0.0 110.411 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -98.97 108.78 21.55 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 119.531 -0.867 . . . . 0.0 110.786 -179.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -129.49 170.28 20.46 Favored Glycine 0 N--CA 1.493 2.445 1 N-CA-C 129.34 6.496 . . . . 0.0 129.34 178.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.2 t -113.61 141.14 25.5 Favored Pre-proline 0 N--CA 1.496 1.843 0 C-N-CA 119.103 -1.039 . . . . 0.0 110.128 -179.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.441 ' O ' ' C ' ' A' ' 47' ' ' GLU . 9.5 Cg_endo -71.72 107.77 2.27 Favored 'Trans proline' 0 C--O 1.213 -0.755 0 C-N-CA 120.989 1.126 . . . . 0.0 110.123 174.675 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.441 ' C ' ' O ' ' A' ' 46' ' ' PRO . 3.6 tm-20 -35.02 97.07 0.12 Allowed Pre-proline 0 N--CA 1.503 2.187 0 C-N-CA 120.056 -0.658 . . . . 0.0 110.673 -179.769 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.412 ' N ' ' O ' ' A' ' 46' ' ' PRO . 1.9 Cg_endo -63.49 113.75 2.23 Favored 'Trans proline' 0 C--O 1.217 -0.565 0 C-N-CA 120.897 1.065 . . . . 0.0 111.351 -174.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.495 1.788 0 CA-C-O 116.269 -1.824 . . . . 0.0 110.083 179.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.411 HG11 ' H ' ' A' ' 3' ' ' TYR . 0.5 OUTLIER -85.46 -166.18 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 C-N-CA 119.642 -0.823 . . . . 0.0 110.573 -178.952 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.411 ' H ' HG11 ' A' ' 2' ' ' VAL . 22.4 m-85 -137.7 -164.71 1.65 Allowed 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.993 -0.683 . . . . 0.0 109.943 -179.323 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -93.98 167.49 11.57 Favored 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 119.266 -0.974 . . . . 0.0 109.281 -179.778 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.485 ' OD1' ' N ' ' A' ' 5' ' ' ASP . 0.0 OUTLIER -84.92 144.49 28.32 Favored 'General case' 0 C--N 1.291 -1.937 0 C-N-CA 118.464 -1.294 . . . . 0.0 109.979 179.599 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -72.11 -178.49 2.44 Favored 'General case' 0 C--N 1.287 -2.136 0 CA-C-O 122.147 0.975 . . . . 0.0 110.542 177.523 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.2 t -159.47 18.31 0.17 Allowed 'General case' 0 C--N 1.272 -2.784 0 CA-C-N 113.538 -1.665 . . . . 0.0 109.263 177.064 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -162.7 -178.46 6.2 Favored 'General case' 0 C--N 1.293 -1.866 0 CA-C-N 114.218 -1.355 . . . . 0.0 110.055 -178.122 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.476 ' HB3' ' H ' ' A' ' 30' ' ' LEU . 0.8 OUTLIER -98.24 166.26 11.48 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.303 -179.787 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.459 ' O ' ' O ' ' A' ' 11' ' ' GLN . . . 84.12 -43.65 3.22 Favored Glycine 0 N--CA 1.509 3.519 0 C-N-CA 119.584 -1.293 . . . . 0.0 113.235 176.819 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.459 ' O ' ' O ' ' A' ' 10' ' ' GLY . 10.9 mt-30 -47.65 178.68 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.563 0 C-N-CA 119.727 -0.789 . . . . 0.0 111.099 -177.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.551 ' O ' ' O ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -144.38 -59.21 0.38 Allowed 'General case' 0 N--CA 1.507 2.418 0 C-N-CA 118.16 -1.416 . . . . 0.0 114.372 -176.31 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.501 ' N ' ' CG ' ' A' ' 12' ' ' ASN . 12.7 mt -76.79 48.07 0.55 Allowed 'General case' 0 C--N 1.27 -2.866 0 C-N-CA 117.156 -1.818 . . . . 0.0 110.995 -176.269 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.586 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 25.0 p -123.38 -160.24 0.89 Allowed 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 176.325 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 70.6 mt -109.03 110.29 21.53 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 176.232 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.586 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 1.9 m -117.62 9.34 13.09 Favored 'General case' 0 N--CA 1.505 2.287 0 C-N-CA 119.19 -1.004 . . . . 0.0 110.345 -176.202 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.419 ' OE2' ' SG ' ' A' ' 22' ' ' CYS . 34.5 mt-10 -141.73 60.78 1.48 Allowed 'General case' 0 C--N 1.288 -2.07 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 177.189 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 79.66 -105.82 2.35 Favored Glycine 0 N--CA 1.484 1.862 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 -177.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.37 -3.22 17.26 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-O 122.232 1.015 . . . . 0.0 109.708 179.165 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 -81.16 133.53 35.47 Favored 'General case' 0 C--N 1.262 -3.2 0 CA-C-N 113.327 -1.76 . . . . 0.0 111.443 -178.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.3 t -70.0 142.3 16.04 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 C-N-CA 119.015 -1.074 . . . . 0.0 109.708 178.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.58 ' O ' ' SG ' ' A' ' 28' ' ' CYS . 0.1 OUTLIER -143.49 119.79 10.88 Favored 'General case' 0 C--N 1.281 -2.39 0 C-N-CA 119.025 -1.07 . . . . 0.0 109.467 177.387 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.445 ' O ' ' O ' ' A' ' 26' ' ' ASN . . . 151.78 -39.55 0.78 Allowed Glycine 0 C--N 1.294 -1.759 1 N-CA-C 130.544 6.978 . . . . 0.0 130.544 -178.806 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -58.28 115.03 2.69 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 118.882 -1.127 . . . . 0.0 110.266 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.49 -23.33 8.73 Favored Glycine 0 C--N 1.3 -1.447 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -178.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.644 ' N ' ' ND2' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -115.31 -168.99 1.48 Allowed 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.638 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.509 ' O ' ' O ' ' A' ' 40' ' ' VAL . 7.4 tttt -148.59 135.94 20.34 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 118.523 -1.271 . . . . 0.0 110.078 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.58 ' SG ' ' O ' ' A' ' 22' ' ' CYS . 2.9 m -95.65 153.72 17.58 Favored 'General case' 0 C--N 1.307 -1.282 0 C-N-CA 118.289 -1.365 . . . . 0.0 111.458 179.513 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 14.9 mm -136.18 130.53 48.15 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.47 0 CA-C-N 114.05 -1.432 . . . . 0.0 109.811 174.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.476 ' H ' ' HB3' ' A' ' 9' ' ' SER . 23.3 mt -73.04 123.82 24.29 Favored 'General case' 0 N--CA 1.496 1.868 0 C-N-CA 119.271 -0.972 . . . . 0.0 108.473 177.795 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -91.66 -118.06 2.26 Favored Glycine 0 N--CA 1.481 1.658 0 C-N-CA 118.573 -1.775 . . . . 0.0 112.181 -176.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 9.1 m -154.14 -147.02 0.2 Allowed 'General case' 0 C--O 1.204 -1.292 0 CA-C-O 122.44 1.114 . . . . 0.0 111.232 -176.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -84.45 65.71 9.08 Favored 'General case' 0 C--N 1.264 -3.149 0 CA-C-N 113.094 -1.867 . . . . 0.0 111.325 -172.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 130.2 -3.94 5.94 Favored Glycine 0 C--N 1.28 -2.578 0 N-CA-C 108.305 -1.918 . . . . 0.0 108.305 179.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.727 ' O ' ' O ' ' A' ' 36' ' ' LYS . 3.7 mm-40 -128.62 9.6 5.99 Favored 'General case' 0 C--O 1.196 -1.734 0 CA-C-N 114.161 -1.02 . . . . 0.0 109.112 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.727 ' O ' ' O ' ' A' ' 35' ' ' GLU . 6.2 mtpp -25.88 -156.12 0.0 OUTLIER 'General case' 0 N--CA 1.523 3.224 0 O-C-N 126.974 2.671 . . . . 0.0 115.089 -174.281 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.558 ' OD1' ' N ' ' A' ' 37' ' ' ASN . 0.2 OUTLIER -57.75 133.68 55.58 Favored 'General case' 0 C--N 1.283 -2.315 0 C-N-CA 118.934 -1.107 . . . . 0.0 111.0 -178.432 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.77 145.93 27.81 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-N 115.267 -0.878 . . . . 0.0 109.64 178.602 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -83.75 116.62 22.78 Favored 'General case' 0 C--N 1.288 -2.106 0 CA-C-N 115.32 -0.854 . . . . 0.0 112.615 -177.624 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.509 ' O ' ' O ' ' A' ' 27' ' ' LYS . 0.9 OUTLIER -119.22 129.69 74.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 CA-C-O 122.606 1.193 . . . . 0.0 110.596 173.707 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 10.1 t -46.98 148.78 1.01 Allowed 'General case' 0 C--N 1.258 -3.378 0 CA-C-N 113.42 -1.718 . . . . 0.0 111.134 -178.032 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.401 ' O ' ' C ' ' A' ' 26' ' ' ASN . . . 149.37 149.66 5.04 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.954 -1.259 . . . . 0.0 109.954 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -80.01 63.4 4.52 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 119.035 -1.066 . . . . 0.0 110.873 -179.323 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -63.36 162.91 32.14 Favored Glycine 0 N--CA 1.49 2.296 0 C-N-CA 119.181 -1.485 . . . . 0.0 109.437 178.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.4 t -79.87 141.04 54.68 Favored Pre-proline 0 N--CA 1.488 1.474 0 C-N-CA 118.514 -1.275 . . . . 0.0 109.835 -179.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.414 ' O ' ' C ' ' A' ' 47' ' ' GLU . 8.4 Cg_endo -67.14 116.46 4.19 Favored 'Trans proline' 0 C--O 1.213 -0.768 0 C-N-CA 121.117 1.211 . . . . 0.0 111.36 178.263 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.414 ' C ' ' O ' ' A' ' 46' ' ' PRO . 0.4 OUTLIER -36.74 101.05 0.21 Allowed Pre-proline 0 N--CA 1.504 2.24 0 C-N-CA 120.284 -0.567 . . . . 0.0 110.929 179.741 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -69.08 104.89 1.28 Allowed 'Trans proline' 0 C--O 1.214 -0.692 0 C-N-CA 120.754 0.969 . . . . 0.0 111.176 -178.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.589 0 C-N-CA 119.209 -0.996 . . . . 0.0 . 179.572 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 33.3 m . . . . . 0 N--CA 1.493 1.68 0 N-CA-C 109.576 -0.528 . . . . 0.0 109.576 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.8 t -95.68 166.54 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 C-N-CA 119.409 -0.917 . . . . 0.0 110.303 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 -130.0 -164.59 1.43 Allowed 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 120.038 -0.665 . . . . 0.0 109.782 179.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -92.83 176.76 6.31 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 119.366 -0.934 . . . . 0.0 108.58 179.069 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.527 ' N ' ' OD1' ' A' ' 5' ' ' ASP . 0.2 OUTLIER -97.02 151.88 19.28 Favored 'General case' 0 C--N 1.294 -1.815 0 C-N-CA 118.889 -1.124 . . . . 0.0 109.554 178.013 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.407 ' N ' ' HB2' ' A' ' 14' ' ' CYS . 1.5 m -70.29 176.76 3.71 Favored 'General case' 0 C--N 1.285 -2.212 0 C-N-CA 119.216 -0.993 . . . . 0.0 110.165 177.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.476 ' H ' HE22 ' A' ' 11' ' ' GLN . 0.1 OUTLIER -153.9 7.72 0.35 Allowed 'General case' 0 C--N 1.274 -2.707 0 CA-C-N 114.112 -1.404 . . . . 0.0 110.474 177.795 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -166.46 173.02 10.28 Favored 'General case' 0 C--N 1.284 -2.248 0 CA-C-N 114.505 -1.225 . . . . 0.0 109.761 -179.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.5 136.19 33.53 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 119.375 -0.93 . . . . 0.0 109.124 -178.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.601 ' CA ' ' HZ3' ' A' ' 27' ' ' LYS . . . 112.13 -30.22 7.83 Favored Glycine 0 N--CA 1.493 2.486 1 N-CA-C 129.642 6.617 . . . . 0.0 129.642 -175.873 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.476 HE22 ' H ' ' A' ' 7' ' ' THR . 0.1 OUTLIER -56.21 -167.19 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.909 0 C-N-CA 119.34 -0.944 . . . . 0.0 109.672 178.7 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.582 ' ND2' ' O ' ' A' ' 23' ' ' GLY . 22.2 t-20 -142.18 -69.2 0.36 Allowed 'General case' 0 N--CA 1.496 1.837 0 C-N-CA 118.472 -1.291 . . . . 0.0 113.766 -176.343 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 14.1 mt -78.38 50.39 0.93 Allowed 'General case' 0 C--N 1.261 -3.258 0 C-N-CA 118.227 -1.389 . . . . 0.0 110.9 -176.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.56 ' SG ' ' N ' ' A' ' 15' ' ' LEU . 13.1 p -114.22 -153.14 0.52 Allowed 'General case' 0 N--CA 1.506 2.371 0 C-N-CA 118.788 -1.165 . . . . 0.0 110.719 177.345 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.56 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 7.7 mt -127.5 137.09 52.56 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 114.068 -1.424 . . . . 0.0 109.751 178.737 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.423 ' SG ' ' CB ' ' A' ' 22' ' ' CYS . 97.5 m -125.11 -77.85 0.59 Allowed 'General case' 0 N--CA 1.513 2.706 0 C-N-CA 118.998 -1.081 . . . . 0.0 111.531 179.504 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -80.07 112.33 17.28 Favored 'General case' 0 C--N 1.299 -1.604 0 C-N-CA 118.345 -1.342 . . . . 0.0 110.282 -178.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 66.06 -107.22 1.86 Allowed Glycine 0 N--CA 1.491 2.308 0 C-N-CA 119.497 -1.335 . . . . 0.0 110.36 -179.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.485 ' O ' ' OG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -134.87 11.43 3.65 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 122.981 1.372 . . . . 0.0 108.896 179.95 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.621 ' N ' HD21 ' A' ' 20' ' ' ASN . 0.8 OUTLIER -76.71 127.95 33.73 Favored 'General case' 0 C--N 1.255 -3.503 0 CA-C-N 112.712 -2.04 . . . . 0.0 109.479 178.366 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.3 t -63.57 146.54 12.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 C-N-CA 118.827 -1.149 . . . . 0.0 110.017 -179.01 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.507 ' O ' ' O ' ' A' ' 12' ' ' ASN . 0.0 OUTLIER -135.51 114.88 12.51 Favored 'General case' 0 C--N 1.299 -1.611 0 C-N-CA 119.164 -1.014 . . . . 0.0 109.773 179.566 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.582 ' O ' ' ND2' ' A' ' 12' ' ' ASN . . . 149.76 -55.14 0.48 Allowed Glycine 0 C--O 1.205 -1.712 1 N-CA-C 129.639 6.615 . . . . 0.0 129.639 -176.916 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.456 ' N ' ' OD1' ' A' ' 12' ' ' ASN . 1.1 tm0? -51.59 121.9 7.19 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 118.325 -1.35 . . . . 0.0 109.923 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.82 -26.34 6.05 Favored Glycine 0 C--N 1.297 -1.592 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 -177.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.489 ' N ' ' O ' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -126.0 -162.21 1.11 Allowed 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 119.974 -0.691 . . . . 0.0 111.263 -179.628 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.601 ' HZ3' ' CA ' ' A' ' 10' ' ' GLY . 0.5 OUTLIER -153.69 124.59 7.29 Favored 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 119.196 -1.002 . . . . 0.0 110.674 177.727 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -81.75 155.93 25.23 Favored 'General case' 0 CA--C 1.483 -1.628 0 C-N-CA 118.31 -1.356 . . . . 0.0 111.876 179.437 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 4.2 mm -133.09 117.54 29.37 Favored 'Isoleucine or valine' 0 C--N 1.256 -3.467 0 CA-C-N 112.201 -2.272 . . . . 0.0 109.2 177.106 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 21.1 mt -77.15 130.77 37.76 Favored 'General case' 0 N--CA 1.505 2.281 0 C-N-CA 118.631 -1.228 . . . . 0.0 111.171 -178.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.485 ' CA ' ' O ' ' A' ' 35' ' ' GLU . . . -120.68 -109.08 2.17 Favored Glycine 0 N--CA 1.48 1.611 1 N-CA-C 132.0 7.56 . . . . 0.0 132.0 176.481 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.644 ' H ' ' N ' ' A' ' 36' ' ' LYS . 9.4 p -167.34 -149.42 0.09 Allowed 'General case' 0 C--N 1.3 -1.574 0 CA-C-O 122.22 1.01 . . . . 0.0 110.136 -178.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.499 ' N ' ' OG ' ' A' ' 32' ' ' SER . 25.7 t0 -81.28 58.68 3.66 Favored 'General case' 0 C--N 1.261 -3.262 0 CA-C-N 113.222 -1.808 . . . . 0.0 109.882 -176.658 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 144.85 -14.47 1.96 Allowed Glycine 0 C--N 1.28 -2.574 0 N-CA-C 107.858 -2.097 . . . . 0.0 107.858 -178.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.669 ' O ' ' O ' ' A' ' 36' ' ' LYS . 13.9 mm-40 -125.02 7.19 7.96 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 114.014 -1.093 . . . . 0.0 109.125 178.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.669 ' O ' ' O ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -31.78 -175.56 0.0 OUTLIER 'General case' 0 N--CA 1.519 2.976 0 CA-C-N 111.459 -2.61 . . . . 0.0 113.694 -177.37 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.558 ' OD1' ' N ' ' A' ' 37' ' ' ASN . 0.1 OUTLIER -61.62 106.17 0.63 Allowed 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 118.0 -1.48 . . . . 0.0 109.132 179.121 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -121.98 151.25 40.99 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 119.67 -0.812 . . . . 0.0 110.916 -178.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -105.13 109.34 21.29 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.777 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.513 ' CG2' ' N ' ' A' ' 41' ' ' THR . 2.3 p -125.59 159.74 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.153 0 C-N-CA 118.869 -1.132 . . . . 0.0 110.06 175.14 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.513 ' N ' ' CG2' ' A' ' 40' ' ' VAL . 3.0 t -69.58 146.96 51.35 Favored 'General case' 0 C--N 1.275 -2.645 0 CA-C-N 115.124 -0.944 . . . . 0.0 111.183 -179.366 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 175.79 160.99 24.31 Favored Glycine 0 N--CA 1.489 2.217 0 C-N-CA 119.28 -1.438 . . . . 0.0 110.494 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -81.28 104.85 12.03 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 119.452 -0.899 . . . . 0.0 110.286 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -123.4 165.28 16.16 Favored Glycine 0 N--CA 1.492 2.395 1 N-CA-C 130.306 6.882 . . . . 0.0 130.306 179.474 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 14.3 t -100.38 142.86 25.43 Favored Pre-proline 0 N--CA 1.49 1.563 0 C-N-CA 119.266 -0.973 . . . . 0.0 110.564 -178.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -53.5 171.88 0.27 Allowed 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 121.246 1.297 . . . . 0.0 111.187 175.178 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.449 ' OE1' ' NE2' ' A' ' 11' ' ' GLN . 12.2 tp10 -101.93 106.57 48.11 Favored Pre-proline 0 CA--C 1.561 1.383 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.72 178.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -62.79 156.67 52.11 Favored 'Trans proline' 0 C--O 1.215 -0.631 0 C-N-CA 120.753 0.969 . . . . 0.0 111.277 -177.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 116.317 -1.801 . . . . 0.0 110.298 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 21.2 m . . . . . 0 N--CA 1.492 1.665 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.6 t -103.18 167.59 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 C-N-CA 119.973 -0.691 . . . . 0.0 109.848 179.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -126.29 -166.6 1.59 Allowed 'General case' 0 N--CA 1.496 1.827 0 C-N-CA 119.946 -0.702 . . . . 0.0 110.917 -178.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.0 p -102.43 179.17 4.38 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.099 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -84.92 152.38 23.56 Favored 'General case' 0 C--N 1.294 -1.836 0 C-N-CA 118.502 -1.279 . . . . 0.0 110.906 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.423 ' N ' ' HB2' ' A' ' 14' ' ' CYS . 0.8 OUTLIER -74.82 -177.49 3.29 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.883 176.582 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.8 t -151.84 11.11 0.56 Allowed 'General case' 0 C--N 1.281 -2.413 0 CA-C-N 114.673 -1.149 . . . . 0.0 110.749 177.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -160.49 158.0 28.53 Favored 'General case' 0 C--N 1.29 -2.008 0 CA-C-N 114.557 -1.201 . . . . 0.0 109.514 -178.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.404 ' HA ' ' H ' ' A' ' 30' ' ' LEU . 0.3 OUTLIER -79.32 138.49 37.74 Favored 'General case' 0 C--N 1.293 -1.856 0 C-N-CA 119.605 -0.838 . . . . 0.0 108.995 -179.116 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.66 ' CA ' ' HZ3' ' A' ' 27' ' ' LYS . . . 107.27 -35.14 5.21 Favored Glycine 0 N--CA 1.5 2.912 1 N-CA-C 129.64 6.616 . . . . 0.0 129.64 -173.72 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 -56.86 -166.21 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.167 0 C-N-CA 119.729 -0.788 . . . . 0.0 110.22 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.475 ' ND2' ' C ' ' A' ' 23' ' ' GLY . 1.4 m-20 -141.37 -66.78 0.41 Allowed 'General case' 0 N--CA 1.508 2.46 0 N-CA-C 115.41 1.633 . . . . 0.0 115.41 -175.633 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 35.7 mt -76.51 51.81 0.75 Allowed 'General case' 0 C--N 1.277 -2.562 0 C-N-CA 118.048 -1.461 . . . . 0.0 111.022 -173.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.423 ' HB2' ' N ' ' A' ' 6' ' ' CYS . 27.3 p -123.62 -154.22 0.6 Allowed 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 114.908 -1.042 . . . . 0.0 108.943 176.285 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 70.8 mt -117.77 116.72 27.57 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 176.155 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.421 ' O ' ' OE1' ' A' ' 17' ' ' GLU . 2.8 m -116.7 -7.06 11.57 Favored 'General case' 0 N--CA 1.5 2.027 0 C-N-CA 118.617 -1.233 . . . . 0.0 111.746 -176.747 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.5 ' OE1' ' SG ' ' A' ' 39' ' ' CYS . 0.3 OUTLIER -127.09 75.49 1.58 Allowed 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 119.245 -0.982 . . . . 0.0 109.255 177.194 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 71.59 -81.26 0.51 Allowed Glycine 0 N--CA 1.489 2.221 0 C-N-CA 119.475 -1.345 . . . . 0.0 110.605 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -135.38 0.88 2.84 Favored 'General case' 0 N--CA 1.486 1.348 0 CA-C-O 121.907 0.86 . . . . 0.0 110.89 -179.24 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.489 ' N ' ' OD1' ' A' ' 20' ' ' ASN . 0.9 OUTLIER -85.13 139.99 31.28 Favored 'General case' 0 C--N 1.257 -3.455 0 CA-C-N 113.824 -1.535 . . . . 0.0 111.234 -179.011 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.2 t -73.79 144.55 12.46 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 C-N-CA 118.704 -1.198 . . . . 0.0 109.867 178.03 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.484 ' O ' ' SG ' ' A' ' 28' ' ' CYS . 3.8 m -149.98 119.95 7.16 Favored 'General case' 0 C--N 1.278 -2.502 0 C-N-CA 118.775 -1.17 . . . . 0.0 108.593 178.07 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.475 ' C ' ' ND2' ' A' ' 12' ' ' ASN . . . 173.09 -84.8 0.08 OUTLIER Glycine 0 C--N 1.3 -1.466 0 C-N-CA 117.688 -2.196 . . . . 0.0 112.055 -176.241 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.504 ' C ' ' H ' ' A' ' 26' ' ' ASN . 25.9 tt0 -42.43 133.68 3.22 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.868 -0.733 . . . . 0.0 111.321 -178.003 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.476 ' C ' HD21 ' A' ' 26' ' ' ASN . . . 76.69 -27.51 1.59 Allowed Glycine 0 N--CA 1.479 1.547 0 C-N-CA 119.679 -1.248 . . . . 0.0 110.083 -179.533 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.518 ' ND2' ' N ' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -128.84 -159.94 0.99 Allowed 'General case' 0 C--N 1.316 -0.871 0 C-N-CA 119.696 -0.802 . . . . 0.0 111.6 -179.039 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.66 ' HZ3' ' CA ' ' A' ' 10' ' ' GLY . 3.4 ttpp -142.98 175.39 9.88 Favored 'General case' 0 N--CA 1.498 1.955 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.815 179.184 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.484 ' SG ' ' O ' ' A' ' 22' ' ' CYS . 57.3 m -138.55 160.66 39.01 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 118.965 -1.094 . . . . 0.0 111.173 176.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 7.8 mm -140.69 97.75 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.13 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 174.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.52 ' CD1' ' C ' ' A' ' 30' ' ' LEU . 0.3 OUTLIER -79.35 130.19 35.2 Favored 'General case' 0 C--N 1.291 -1.944 0 C-N-CA 118.129 -1.428 . . . . 0.0 110.743 -176.216 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.496 ' N ' ' O ' ' A' ' 36' ' ' LYS . . . -50.83 -88.9 0.01 OUTLIER Glycine 0 N--CA 1.489 2.17 0 C-N-CA 120.307 -0.949 . . . . 0.0 111.816 -176.771 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.447 ' O ' ' N ' ' A' ' 34' ' ' GLY . 9.7 t -138.96 -132.15 0.12 Allowed 'General case' 0 C--N 1.309 -1.195 0 C-N-CA 119.425 -0.91 . . . . 0.0 111.526 -177.079 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 81.5 m-20 -74.64 71.14 1.89 Allowed 'General case' 0 C--N 1.258 -3.402 0 CA-C-N 113.577 -1.647 . . . . 0.0 110.108 -170.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 32' ' ' SER . . . 70.23 22.57 77.49 Favored Glycine 0 C--N 1.281 -2.5 0 N-CA-C 107.704 -2.158 . . . . 0.0 107.704 -179.035 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 -93.82 -116.6 0.1 Allowed 'General case' 0 C--N 1.307 -1.256 0 C-N-CA 119.111 -1.035 . . . . 0.0 110.666 -177.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.496 ' O ' ' N ' ' A' ' 31' ' ' GLY . 0.1 OUTLIER -69.36 169.51 12.19 Favored 'General case' 0 C--N 1.26 -3.283 0 CA-C-N 113.913 -1.494 . . . . 0.0 110.608 -178.611 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.652 ' ND2' ' N ' ' A' ' 38' ' ' GLN . 0.2 OUTLIER -178.19 136.11 0.16 Allowed 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 -179.951 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.652 ' N ' ' ND2' ' A' ' 37' ' ' ASN . 10.3 tt0 -131.89 143.29 50.04 Favored 'General case' 0 C--N 1.311 -1.086 0 C-N-CA 119.823 -0.751 . . . . 0.0 110.321 177.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.5 ' SG ' ' OE1' ' A' ' 17' ' ' GLU . 66.2 m -97.93 99.7 11.01 Favored 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 119.539 -0.864 . . . . 0.0 110.01 179.121 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.525 ' O ' ' N ' ' A' ' 27' ' ' LYS . 11.2 p -112.89 155.13 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.334 0 C-N-CA 118.436 -1.306 . . . . 0.0 111.532 179.513 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.4 t -75.0 148.12 40.18 Favored 'General case' 0 C--N 1.265 -3.077 0 CA-C-N 113.836 -1.529 . . . . 0.0 111.292 -179.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 158.72 -179.82 34.1 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 110.119 -1.192 . . . . 0.0 110.119 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -90.8 110.66 21.86 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 119.332 -0.947 . . . . 0.0 110.423 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -128.71 165.76 21.45 Favored Glycine 0 N--CA 1.497 2.701 0 N-CA-C 110.235 -1.146 . . . . 0.0 110.235 179.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -104.5 145.14 30.12 Favored Pre-proline 0 N--CA 1.494 1.774 0 C-N-CA 119.649 -0.82 . . . . 0.0 109.953 -179.649 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -56.47 142.94 89.06 Favored 'Trans proline' 0 C--O 1.216 -0.617 0 C-N-CA 121.232 1.288 . . . . 0.0 111.297 177.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.466 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 6.4 tt0 -64.18 -44.51 77.22 Favored Pre-proline 0 CA--C 1.558 1.261 0 C-N-CA 119.5 -0.88 . . . . 0.0 112.418 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.466 ' HD2' ' N ' ' A' ' 47' ' ' GLU . 5.9 Cg_exo -58.11 99.81 0.1 Allowed 'Trans proline' 0 C--O 1.216 -0.586 0 C-N-CA 120.345 0.697 . . . . 0.0 111.031 -179.309 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.345 0 CA-C-O 116.325 -1.797 . . . . 0.0 110.425 -179.957 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 2.9 m . . . . . 0 N--CA 1.493 1.676 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.0 t -100.56 161.54 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 C-N-CA 119.686 -0.806 . . . . 0.0 110.676 -179.114 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -94.13 -163.69 1.08 Allowed 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 119.714 -0.795 . . . . 0.0 110.07 179.463 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.641 ' HG1' ' N ' ' A' ' 5' ' ' ASP . 0.1 OUTLIER -96.39 179.48 5.01 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.705 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.641 ' N ' ' HG1' ' A' ' 4' ' ' THR . 0.0 OUTLIER -93.77 153.45 18.3 Favored 'General case' 0 C--N 1.289 -2.048 0 C-N-CA 118.92 -1.112 . . . . 0.0 109.858 179.856 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.499 ' SG ' ' OE1' ' A' ' 11' ' ' GLN . 1.2 m -74.13 177.07 5.99 Favored 'General case' 0 C--N 1.291 -1.945 0 C-N-CA 119.406 -0.918 . . . . 0.0 110.515 177.087 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.7 t -152.69 10.84 0.49 Allowed 'General case' 0 C--N 1.279 -2.48 0 CA-C-N 113.924 -1.489 . . . . 0.0 110.151 177.334 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -163.02 167.54 22.27 Favored 'General case' 0 C--N 1.283 -2.318 0 CA-C-N 114.453 -1.248 . . . . 0.0 109.939 178.758 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -84.41 145.16 28.33 Favored 'General case' 0 C--N 1.296 -1.726 0 C-N-CA 119.136 -1.026 . . . . 0.0 108.83 -178.798 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 102.41 -29.46 12.46 Favored Glycine 0 N--CA 1.512 3.706 1 N-CA-C 130.151 6.82 . . . . 0.0 130.151 -175.286 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.499 ' OE1' ' SG ' ' A' ' 6' ' ' CYS . 72.9 mt-30 -58.42 -158.92 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.065 0 C-N-CA 119.83 -0.748 . . . . 0.0 110.756 -179.777 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.527 ' ND2' ' O ' ' A' ' 23' ' ' GLY . 3.0 m-20 -147.41 -67.13 0.26 Allowed 'General case' 0 N--CA 1.503 2.202 0 C-N-CA 118.21 -1.396 . . . . 0.0 114.561 -177.37 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 32.9 mt -77.96 49.33 0.78 Allowed 'General case' 0 C--N 1.274 -2.708 0 C-N-CA 118.434 -1.306 . . . . 0.0 111.218 -174.946 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.401 ' SG ' ' N ' ' A' ' 15' ' ' LEU . 17.5 p -119.41 -154.46 0.57 Allowed 'General case' 0 N--CA 1.497 1.912 0 C-N-CA 119.155 -1.018 . . . . 0.0 110.374 176.484 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.401 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 7.2 mt -125.51 135.2 52.03 Favored 'General case' 0 N--CA 1.485 1.31 0 CA-C-N 114.569 -1.196 . . . . 0.0 110.526 179.764 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.3 m -120.35 -58.76 1.83 Allowed 'General case' 0 N--CA 1.508 2.44 0 C-N-CA 119.274 -0.97 . . . . 0.0 111.228 179.6 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.61 97.18 8.83 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 119.441 -0.903 . . . . 0.0 110.725 -178.499 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 68.77 -113.59 5.35 Favored Glycine 0 N--CA 1.488 2.125 0 C-N-CA 119.444 -1.36 . . . . 0.0 110.815 179.16 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.411 ' O ' ' OG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -113.88 3.71 15.55 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-O 122.133 0.968 . . . . 0.0 110.24 -178.544 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -78.35 129.59 35.17 Favored 'General case' 0 C--N 1.256 -3.469 0 CA-C-N 113.589 -1.641 . . . . 0.0 110.39 -179.979 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -79.32 149.16 5.52 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 C-N-CA 119.473 -0.891 . . . . 0.0 110.227 -179.656 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.477 ' O ' ' O ' ' A' ' 12' ' ' ASN . 15.6 m -143.8 112.58 6.6 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 118.717 -1.193 . . . . 0.0 110.205 179.111 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.527 ' O ' ' ND2' ' A' ' 12' ' ' ASN . . . 178.51 -63.0 0.08 OUTLIER Glycine 0 N--CA 1.484 1.858 1 N-CA-C 130.007 6.763 . . . . 0.0 130.007 -177.274 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -63.54 120.62 12.08 Favored 'General case' 0 C--N 1.311 -1.093 0 C-N-CA 118.466 -1.294 . . . . 0.0 109.842 179.269 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.416 ' C ' ' ND2' ' A' ' 26' ' ' ASN . . . 95.48 -17.2 59.75 Favored Glycine 0 N--CA 1.485 1.918 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 -178.349 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.465 ' O ' ' O ' ' A' ' 23' ' ' GLY . 2.1 m-80 -139.26 -172.87 3.44 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.389 -0.924 . . . . 0.0 110.694 179.07 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.503 ' O ' ' O ' ' A' ' 40' ' ' VAL . 0.0 OUTLIER -138.74 125.68 21.13 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 119.502 -0.879 . . . . 0.0 109.148 177.623 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.49 ' SG ' ' O ' ' A' ' 38' ' ' GLN . 0.1 OUTLIER -82.14 164.9 20.98 Favored 'General case' 0 C--N 1.289 -2.051 0 C-N-CA 116.959 -1.896 . . . . 0.0 109.927 178.206 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 26.8 mm -144.08 125.96 10.54 Favored 'Isoleucine or valine' 0 C--N 1.245 -3.938 0 CA-C-N 113.856 -1.52 . . . . 0.0 108.869 178.74 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 17.7 mt -76.57 131.67 39.06 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 118.51 -1.276 . . . . 0.0 110.135 -179.066 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -95.96 -105.38 2.14 Favored Glycine 0 N--CA 1.491 2.328 0 C-N-CA 118.936 -1.602 . . . . 0.0 111.591 -178.281 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 10.7 t -160.02 -131.71 0.03 OUTLIER 'General case' 0 C--O 1.21 -0.993 0 C-N-CA 118.467 -1.293 . . . . 0.0 112.871 -177.362 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -79.86 73.18 6.62 Favored 'General case' 0 C--N 1.272 -2.791 0 CA-C-N 112.807 -1.997 . . . . 0.0 111.803 -172.241 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 116.49 -8.09 17.76 Favored Glycine 0 C--N 1.273 -2.951 0 N-CA-C 107.362 -2.295 . . . . 0.0 107.362 178.947 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.695 ' O ' ' N ' ' A' ' 37' ' ' ASN . 1.4 mm-40 -123.08 8.49 9.24 Favored 'General case' 0 C--N 1.286 -2.17 0 CA-C-N 113.041 -1.58 . . . . 0.0 107.948 179.22 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -35.4 -18.44 0.0 OUTLIER 'General case' 0 C--N 1.26 -3.311 0 CA-C-N 111.627 -2.533 . . . . 0.0 113.723 -173.588 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.695 ' N ' ' O ' ' A' ' 35' ' ' GLU . 0.3 OUTLIER -153.16 153.46 32.81 Favored 'General case' 0 C--N 1.258 -3.394 0 C-N-CA 118.403 -1.319 . . . . 0.0 113.191 178.058 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.49 ' O ' ' SG ' ' A' ' 28' ' ' CYS . 15.8 tt0 -151.63 164.34 37.11 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 113.976 -1.466 . . . . 0.0 108.24 176.039 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.454 ' N ' ' CG ' ' A' ' 38' ' ' GLN . 29.0 m -127.12 97.43 4.93 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 119.407 -0.917 . . . . 0.0 110.86 -178.308 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.503 ' O ' ' O ' ' A' ' 27' ' ' LYS . 0.4 OUTLIER -111.84 140.79 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.485 0 C-N-CA 118.73 -1.188 . . . . 0.0 112.569 -179.719 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.5 t -56.9 149.35 18.8 Favored 'General case' 0 C--N 1.279 -2.462 0 CA-C-N 113.563 -1.653 . . . . 0.0 111.672 177.943 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 145.16 -130.03 3.71 Favored Glycine 0 N--CA 1.489 2.228 1 N-CA-C 131.116 7.206 . . . . 0.0 131.116 179.622 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 31.9 mm-40 -112.75 106.07 14.34 Favored 'General case' 0 N--CA 1.499 2.007 0 C-N-CA 119.884 -0.726 . . . . 0.0 111.053 -179.044 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -140.02 178.86 19.49 Favored Glycine 0 N--CA 1.493 2.499 0 C-N-CA 119.659 -1.258 . . . . 0.0 110.152 179.377 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -128.61 146.38 59.87 Favored Pre-proline 0 N--CA 1.495 1.815 0 C-N-CA 119.903 -0.719 . . . . 0.0 109.511 179.681 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -57.65 164.06 8.06 Favored 'Trans proline' 0 C--O 1.216 -0.589 0 C-N-CA 121.179 1.253 . . . . 0.0 111.587 -178.809 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 52.3 tp10 -123.73 80.02 55.89 Favored Pre-proline 0 C--N 1.314 -0.968 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.203 179.54 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -62.59 135.79 54.9 Favored 'Trans proline' 0 C--N 1.324 -0.738 0 C-N-CA 121.026 1.151 . . . . 0.0 110.325 179.891 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 116.302 -1.809 . . . . 0.0 110.315 -178.943 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 . . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.588 ' CG1' ' H ' ' A' ' 3' ' ' TYR . 22.0 t -82.69 -178.69 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 C-N-CA 119.884 -0.726 . . . . 0.0 110.652 -178.976 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.588 ' H ' ' CG1' ' A' ' 2' ' ' VAL . 85.1 m-85 -114.89 -166.49 1.12 Allowed 'General case' 0 N--CA 1.5 2.063 0 C-N-CA 120.106 -0.638 . . . . 0.0 110.425 -179.939 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.611 ' HG1' ' N ' ' A' ' 5' ' ' ASP . 0.1 OUTLIER -113.01 -177.82 3.23 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 178.816 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.611 ' N ' ' HG1' ' A' ' 4' ' ' THR . 0.2 OUTLIER -90.33 154.2 19.87 Favored 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 118.681 -1.208 . . . . 0.0 110.746 -179.597 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -75.73 -178.85 4.41 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-N 115.001 -1.0 . . . . 0.0 112.005 178.567 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.4 t -157.15 15.18 0.27 Allowed 'General case' 0 C--N 1.291 -1.978 0 CA-C-N 113.435 -1.712 . . . . 0.0 110.02 177.848 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -161.42 172.01 17.23 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 114.505 -1.225 . . . . 0.0 109.533 -179.261 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.507 ' HB3' ' H ' ' A' ' 30' ' ' LEU . 0.9 OUTLIER -91.64 164.31 13.79 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 119.612 -0.835 . . . . 0.0 110.786 -179.303 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.436 ' O ' ' O ' ' A' ' 11' ' ' GLN . . . 79.69 -25.14 2.99 Favored Glycine 0 N--CA 1.499 2.895 0 C-N-CA 119.541 -1.314 . . . . 0.0 112.906 177.216 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.436 ' O ' ' O ' ' A' ' 10' ' ' GLY . 0.5 OUTLIER -54.93 -171.36 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.065 0 C-N-CA 118.495 -1.282 . . . . 0.0 110.577 -178.499 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.484 ' O ' ' O ' ' A' ' 22' ' ' CYS . 2.1 m-20 -148.4 -66.33 0.24 Allowed 'General case' 0 N--CA 1.501 2.076 0 N-CA-C 115.227 1.565 . . . . 0.0 115.227 -176.978 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 95.5 mt -77.17 49.8 0.71 Allowed 'General case' 0 C--N 1.268 -2.963 0 C-N-CA 117.978 -1.489 . . . . 0.0 111.284 -174.179 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.426 ' H ' ' C ' ' A' ' 12' ' ' ASN . 28.3 p -125.84 -156.42 0.73 Allowed 'General case' 0 C--O 1.207 -1.181 0 CA-C-N 114.988 -1.005 . . . . 0.0 109.082 176.499 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 58.1 mt -115.57 120.22 38.74 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 115.115 -0.948 . . . . 0.0 108.957 176.654 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.0 m -117.56 -61.29 1.72 Allowed 'General case' 0 C--N 1.293 -1.861 0 C-N-CA 119.147 -1.021 . . . . 0.0 110.955 -177.237 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.493 ' CG ' ' SG ' ' A' ' 39' ' ' CYS . 3.1 mm-40 -78.74 90.55 4.63 Favored 'General case' 0 C--N 1.295 -1.783 0 C-N-CA 117.81 -1.556 . . . . 0.0 109.708 179.512 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 71.52 -101.78 1.03 Allowed Glycine 0 N--CA 1.488 2.101 0 C-N-CA 119.481 -1.342 . . . . 0.0 109.904 -179.068 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.42 ' O ' ' OG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -128.66 2.96 5.5 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-O 122.35 1.071 . . . . 0.0 109.873 179.837 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -78.72 136.52 37.43 Favored 'General case' 0 C--N 1.258 -3.376 0 CA-C-N 113.313 -1.767 . . . . 0.0 110.228 -179.887 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.1 t -67.21 145.19 13.96 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 C-N-CA 118.438 -1.305 . . . . 0.0 109.493 178.999 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.529 ' O ' ' SG ' ' A' ' 28' ' ' CYS . 20.0 m -148.72 118.95 7.26 Favored 'General case' 0 C--N 1.277 -2.582 0 C-N-CA 118.426 -1.31 . . . . 0.0 109.333 176.82 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.471 ' O ' ' O ' ' A' ' 26' ' ' ASN . . . 171.64 -82.87 0.08 OUTLIER Glycine 0 C--N 1.291 -1.941 0 C-N-CA 118.557 -1.782 . . . . 0.0 110.395 -176.636 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -55.83 117.46 3.69 Favored 'General case' 0 C--N 1.292 -1.902 0 C-N-CA 119.132 -1.027 . . . . 0.0 109.64 179.058 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 102.26 -26.16 25.2 Favored Glycine 0 N--CA 1.484 1.871 0 N-CA-C 109.077 -1.609 . . . . 0.0 109.077 -177.683 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.471 ' O ' ' O ' ' A' ' 23' ' ' GLY . 0.1 OUTLIER -142.67 -154.83 0.54 Allowed 'General case' 0 C--N 1.309 -1.178 0 C-N-CA 119.943 -0.703 . . . . 0.0 110.147 179.767 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.5 ' N ' ' O ' ' A' ' 40' ' ' VAL . 10.0 tttp -148.21 160.01 43.38 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 176.85 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.529 ' SG ' ' O ' ' A' ' 22' ' ' CYS . 72.1 m -121.47 157.56 30.33 Favored 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 118.923 -1.111 . . . . 0.0 111.828 178.495 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 19.9 mm -146.5 133.76 14.64 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.501 0 CA-C-N 113.375 -1.739 . . . . 0.0 109.945 177.104 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.507 ' H ' ' HB3' ' A' ' 9' ' ' SER . 19.9 mt -76.77 128.8 35.3 Favored 'General case' 0 N--CA 1.505 2.277 0 C-N-CA 119.862 -0.735 . . . . 0.0 109.871 179.135 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -110.42 -123.26 4.51 Favored Glycine 0 N--CA 1.482 1.701 0 C-N-CA 119.128 -1.511 . . . . 0.0 111.227 179.104 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.411 ' N ' ' HA ' ' A' ' 36' ' ' LYS . 22.2 m -155.82 -137.56 0.06 Allowed 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 122.485 1.136 . . . . 0.0 111.941 -178.876 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -80.0 67.12 5.7 Favored 'General case' 0 C--N 1.268 -2.965 0 CA-C-N 112.906 -1.952 . . . . 0.0 112.366 -171.435 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 123.29 -6.15 9.33 Favored Glycine 0 N--CA 1.496 2.649 0 N-CA-C 108.337 -1.905 . . . . 0.0 108.337 177.967 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.674 ' O ' ' O ' ' A' ' 36' ' ' LYS . 14.2 mt-10 -126.29 8.24 7.18 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-N 113.988 -1.106 . . . . 0.0 108.584 179.356 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.674 ' O ' ' O ' ' A' ' 35' ' ' GLU . 8.2 tttm -32.53 -153.55 0.0 OUTLIER 'General case' 0 C--N 1.265 -3.079 0 O-C-N 127.122 2.764 . . . . 0.0 115.215 -174.371 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.511 HD22 ' HZ3' ' A' ' 36' ' ' LYS . 0.4 OUTLIER -64.23 109.38 1.86 Allowed 'General case' 0 C--N 1.268 -2.952 0 C-N-CA 118.629 -1.228 . . . . 0.0 110.736 -177.86 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -109.39 147.19 33.19 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.87 179.691 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.493 ' SG ' ' CG ' ' A' ' 17' ' ' GLU . 15.6 m -96.33 90.45 5.44 Favored 'General case' 0 C--N 1.293 -1.865 0 C-N-CA 119.423 -0.911 . . . . 0.0 110.63 -179.423 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.5 ' O ' ' N ' ' A' ' 27' ' ' LYS . 0.6 OUTLIER -90.08 142.81 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 C-N-CA 118.024 -1.471 . . . . 0.0 111.283 179.932 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -65.33 140.35 58.67 Favored 'General case' 0 C--N 1.274 -2.677 0 CA-C-N 114.225 -1.352 . . . . 0.0 110.831 178.844 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 152.89 -156.15 26.54 Favored Glycine 0 N--CA 1.488 2.11 0 C-N-CA 119.545 -1.312 . . . . 0.0 110.252 -179.903 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -114.29 133.37 55.7 Favored 'General case' 0 N--CA 1.497 1.923 0 C-N-CA 120.033 -0.667 . . . . 0.0 110.399 -179.74 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -137.39 158.69 24.53 Favored Glycine 0 N--CA 1.496 2.638 0 C-N-CA 119.704 -1.236 . . . . 0.0 110.455 -179.943 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 5.8 t -87.21 143.9 35.31 Favored Pre-proline 0 N--CA 1.488 1.456 0 C-N-CA 119.631 -0.827 . . . . 0.0 109.929 -179.858 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -58.16 143.69 96.41 Favored 'Trans proline' 0 C--O 1.218 -0.523 0 C-N-CA 121.006 1.137 . . . . 0.0 111.153 178.195 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -73.22 117.7 62.48 Favored Pre-proline 0 C--N 1.302 -1.458 0 C-N-CA 119.706 -0.798 . . . . 0.0 110.343 -179.819 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -60.04 138.42 81.9 Favored 'Trans proline' 0 C--O 1.215 -0.641 0 C-N-CA 120.38 0.72 . . . . 0.0 110.76 179.576 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.5 0 CA-C-O 116.565 -1.683 . . . . 0.0 110.703 -179.597 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 9.4 m . . . . . 0 N--CA 1.489 1.499 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -79.45 -162.64 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 C-N-CA 119.465 -0.894 . . . . 0.0 109.044 178.484 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -143.15 -178.77 6.01 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 118.845 -1.142 . . . . 0.0 111.591 179.653 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.45 ' H ' ' HG1' ' A' ' 4' ' ' THR . 7.7 p -109.97 -179.58 3.84 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 114.772 -1.104 . . . . 0.0 108.862 -179.328 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.456 ' OD1' ' N ' ' A' ' 5' ' ' ASP . 0.1 OUTLIER -88.15 151.79 22.45 Favored 'General case' 0 C--N 1.291 -1.977 0 C-N-CA 118.344 -1.342 . . . . 0.0 109.351 177.424 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.436 ' N ' ' HB2' ' A' ' 14' ' ' CYS . 0.8 OUTLIER -71.79 -178.12 2.18 Favored 'General case' 0 C--N 1.285 -2.214 0 C-N-CA 119.401 -0.919 . . . . 0.0 110.2 178.894 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.0 t -157.46 17.65 0.27 Allowed 'General case' 0 C--N 1.279 -2.47 0 CA-C-N 114.323 -1.308 . . . . 0.0 110.16 178.662 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.531 ' N ' ' OE1' ' A' ' 8' ' ' GLU . 1.2 pm0 -165.45 169.43 15.61 Favored 'General case' 0 C--N 1.285 -2.236 0 CA-C-N 114.773 -1.103 . . . . 0.0 110.076 179.229 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.456 ' HB3' ' H ' ' A' ' 30' ' ' LEU . 0.3 OUTLIER -84.14 138.56 32.95 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 119.244 -0.983 . . . . 0.0 108.859 -179.525 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.428 ' O ' ' O ' ' A' ' 11' ' ' GLN . . . 104.53 -35.14 5.25 Favored Glycine 0 N--CA 1.501 2.982 1 N-CA-C 130.249 6.859 . . . . 0.0 130.249 -174.976 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.428 ' O ' ' O ' ' A' ' 10' ' ' GLY . 1.2 mt-30 -54.78 -170.03 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.128 0 C-N-CA 119.292 -0.963 . . . . 0.0 109.895 -179.82 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.466 ' O ' ' O ' ' A' ' 22' ' ' CYS . 4.8 m-20 -141.82 -66.92 0.4 Allowed 'General case' 0 N--CA 1.498 1.937 0 C-N-CA 118.055 -1.458 . . . . 0.0 114.631 -176.209 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 13.0 mt -75.67 53.95 0.75 Allowed 'General case' 0 C--N 1.268 -2.943 0 C-N-CA 117.613 -1.635 . . . . 0.0 110.274 -175.777 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.436 ' HB2' ' N ' ' A' ' 6' ' ' CYS . 25.9 p -124.89 -160.64 0.96 Allowed 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.023 175.696 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 52.6 mt -118.1 126.72 52.81 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.147 178.446 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.3 m -110.92 -64.5 1.27 Allowed 'General case' 0 N--CA 1.502 2.131 0 C-N-CA 118.98 -1.088 . . . . 0.0 111.197 179.813 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -89.98 92.32 8.94 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 119.05 -1.06 . . . . 0.0 110.67 -178.875 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.43 -105.39 1.84 Allowed Glycine 0 N--CA 1.489 2.222 0 C-N-CA 119.723 -1.227 . . . . 0.0 111.153 178.601 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.404 ' O ' ' OG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -122.43 3.4 9.69 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 122.417 1.103 . . . . 0.0 109.997 -178.354 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 38.1 m-20 -77.22 138.08 39.22 Favored 'General case' 0 C--N 1.259 -3.35 0 CA-C-N 113.278 -1.783 . . . . 0.0 110.598 -179.841 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.0 t -81.68 146.82 6.74 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 C-N-CA 119.441 -0.904 . . . . 0.0 110.357 179.812 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.466 ' O ' ' O ' ' A' ' 12' ' ' ASN . 20.9 m -144.35 114.21 7.28 Favored 'General case' 0 N--CA 1.5 2.043 0 C-N-CA 118.939 -1.104 . . . . 0.0 109.263 177.362 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.484 ' O ' ' N ' ' A' ' 26' ' ' ASN . . . -179.77 -87.78 0.07 OUTLIER Glycine 0 N--CA 1.479 1.538 0 C-N-CA 117.156 -2.449 . . . . 0.0 113.449 -176.726 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.451 ' C ' ' H ' ' A' ' 26' ' ' ASN . 1.5 tt0 -42.15 129.75 3.68 Favored 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 119.931 -0.708 . . . . 0.0 111.681 -175.947 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 81.19 -30.04 2.74 Favored Glycine 0 N--CA 1.477 1.428 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 -179.09 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.484 ' N ' ' O ' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -122.4 -166.86 1.47 Allowed 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 119.935 -0.706 . . . . 0.0 111.412 -178.839 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.496 ' O ' ' O ' ' A' ' 40' ' ' VAL . 0.6 OUTLIER -153.15 127.11 8.97 Favored 'General case' 0 N--CA 1.505 2.287 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.237 -179.996 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -86.17 168.31 14.11 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 122.728 1.252 . . . . 0.0 112.337 -178.695 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 11.0 mm -146.31 131.89 12.67 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.754 0 CA-C-N 112.52 -2.127 . . . . 0.0 108.09 175.349 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.456 ' H ' ' HB3' ' A' ' 9' ' ' SER . 23.6 mt -75.09 106.32 6.54 Favored 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 117.554 -1.659 . . . . 0.0 108.995 177.629 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.609 ' N ' ' O ' ' A' ' 36' ' ' LYS . . . 114.56 90.95 1.78 Allowed Glycine 0 N--CA 1.488 2.161 1 N-CA-C 130.07 6.788 . . . . 0.0 130.07 -176.78 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.585 ' O ' ' N ' ' A' ' 34' ' ' GLY . 94.0 p -68.25 -120.6 0.0 OUTLIER 'General case' 0 C--O 1.2 -1.534 0 C-N-CA 118.528 -1.269 . . . . 0.0 108.977 -179.805 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.444 ' N ' ' OG ' ' A' ' 32' ' ' SER . 6.5 m-20 -69.06 69.24 0.19 Allowed 'General case' 0 C--N 1.258 -3.407 0 CA-C-N 114.335 -1.302 . . . . 0.0 108.952 -174.419 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.585 ' N ' ' O ' ' A' ' 32' ' ' SER . . . 58.61 33.94 74.33 Favored Glycine 0 C--N 1.285 -2.295 0 N-CA-C 107.621 -2.192 . . . . 0.0 107.621 -176.67 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -109.8 -129.69 0.29 Allowed 'General case' 0 C--O 1.214 -0.777 0 CA-C-O 122.487 1.137 . . . . 0.0 113.268 -175.71 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.609 ' O ' ' N ' ' A' ' 31' ' ' GLY . 28.7 mttp -93.86 -86.21 0.27 Allowed 'General case' 0 C--N 1.273 -2.749 0 CA-C-N 112.777 -2.01 . . . . 0.0 114.077 -172.801 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.598 ' HA ' ' H ' ' A' ' 31' ' ' GLY . 1.1 m-20 -120.57 159.75 24.61 Favored 'General case' 0 C--N 1.269 -2.925 0 CA-C-N 113.514 -1.675 . . . . 0.0 111.228 -176.574 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.495 ' CG ' ' N ' ' A' ' 39' ' ' CYS . 34.2 tt0 -151.94 159.96 43.64 Favored 'General case' 0 C--N 1.312 -1.034 0 C-N-CA 119.051 -1.06 . . . . 0.0 110.329 178.113 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.495 ' N ' ' CG ' ' A' ' 38' ' ' GLN . 91.5 m -131.73 94.28 3.48 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 119.886 -0.726 . . . . 0.0 110.472 -179.902 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.574 ' CG2' ' N ' ' A' ' 41' ' ' THR . 4.4 p -110.02 173.57 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.336 0 C-N-CA 119.105 -1.038 . . . . 0.0 110.217 179.577 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.574 ' N ' ' CG2' ' A' ' 40' ' ' VAL . 8.8 t -84.12 156.49 22.11 Favored 'General case' 0 C--N 1.283 -2.326 0 CA-C-N 115.353 -0.839 . . . . 0.0 111.142 178.727 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 159.39 -140.72 7.02 Favored Glycine 0 N--CA 1.492 2.404 0 C-N-CA 119.681 -1.247 . . . . 0.0 110.497 -179.973 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -146.08 89.56 1.89 Allowed 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 119.529 -0.868 . . . . 0.0 110.459 -179.826 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -97.98 -156.15 29.86 Favored Glycine 0 N--CA 1.492 2.395 0 C-N-CA 119.52 -1.324 . . . . 0.0 110.742 -179.538 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -139.91 153.01 69.23 Favored Pre-proline 0 N--CA 1.492 1.666 0 C-N-CA 119.571 -0.852 . . . . 0.0 110.418 -179.98 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -53.47 153.97 16.53 Favored 'Trans proline' 0 CA--C 1.543 0.965 0 C-N-CA 122.112 1.875 . . . . 0.0 113.035 177.952 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.597 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 9.2 tm-20 -81.87 -42.59 1.04 Allowed Pre-proline 0 N--CA 1.483 1.188 0 CA-C-N 115.937 -0.574 . . . . 0.0 112.292 177.671 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.597 ' CD ' ' N ' ' A' ' 47' ' ' GLU . 1.3 Cg_endo -65.39 167.95 15.58 Favored 'Trans proline' 0 C--O 1.214 -0.691 0 C-N-CA 120.846 1.031 . . . . 0.0 111.234 -174.451 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 116.355 -1.783 . . . . 0.0 110.279 -179.966 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 99.3 t . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.499 ' CG1' ' H ' ' A' ' 3' ' ' TYR . 45.6 t -123.47 172.98 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 C-N-CA 119.926 -0.709 . . . . 0.0 110.055 179.996 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.499 ' H ' ' CG1' ' A' ' 2' ' ' VAL . 10.8 m-85 -144.09 -167.53 2.63 Favored 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 119.896 -0.722 . . . . 0.0 109.89 179.905 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.589 ' OG1' ' N ' ' A' ' 5' ' ' ASP . 0.1 OUTLIER -104.74 -177.64 3.42 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 177.507 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.589 ' N ' ' OG1' ' A' ' 4' ' ' THR . 0.3 OUTLIER -92.1 154.37 18.77 Favored 'General case' 0 C--N 1.291 -1.955 0 C-N-CA 118.626 -1.229 . . . . 0.0 111.169 -179.429 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.482 ' SG ' ' O ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -73.11 170.16 15.51 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.526 177.388 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.419 ' O ' ' OG1' ' A' ' 7' ' ' THR . 0.2 OUTLIER -140.39 7.37 2.16 Favored 'General case' 0 C--N 1.296 -1.761 0 C-N-CA 119.108 -1.037 . . . . 0.0 110.187 176.489 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -163.97 -178.24 5.52 Favored 'General case' 0 C--N 1.288 -2.085 0 CA-C-N 114.449 -1.25 . . . . 0.0 110.198 179.395 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -86.01 164.37 17.41 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.369 -179.24 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.437 ' O ' ' O ' ' A' ' 11' ' ' GLN . . . 83.25 -30.77 3.27 Favored Glycine 0 N--CA 1.49 2.234 0 C-N-CA 119.189 -1.481 . . . . 0.0 111.32 179.531 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.514 ' OE1' ' N ' ' A' ' 11' ' ' GLN . 3.1 mp0 -44.09 168.39 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.068 0 C-N-CA 119.194 -1.002 . . . . 0.0 109.879 179.806 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.484 ' C ' ' H ' ' A' ' 14' ' ' CYS . 2.1 m-20 -141.9 -69.7 0.36 Allowed 'General case' 0 N--CA 1.5 2.051 0 C-N-CA 118.536 -1.266 . . . . 0.0 113.374 -177.647 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 81.7 mt -75.63 46.71 0.37 Allowed 'General case' 0 C--N 1.272 -2.765 0 C-N-CA 118.327 -1.349 . . . . 0.0 110.151 -177.0 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.484 ' H ' ' C ' ' A' ' 12' ' ' ASN . 29.9 p -123.58 -156.93 0.73 Allowed 'General case' 0 C--O 1.205 -1.269 0 CA-C-N 115.265 -0.88 . . . . 0.0 109.597 179.046 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.482 ' O ' ' SG ' ' A' ' 6' ' ' CYS . 71.2 mt -116.09 109.12 17.06 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 114.934 -1.03 . . . . 0.0 108.237 175.687 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.575 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 0.5 OUTLIER -110.31 -51.44 2.87 Favored 'General case' 0 C--N 1.289 -2.054 0 C-N-CA 118.933 -1.107 . . . . 0.0 110.71 -174.673 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.508 ' N ' ' SG ' ' A' ' 16' ' ' CYS . 18.4 tp10 -88.63 75.55 8.26 Favored 'General case' 0 C--N 1.294 -1.816 0 C-N-CA 118.649 -1.221 . . . . 0.0 109.048 177.862 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.38 -121.89 6.61 Favored Glycine 0 N--CA 1.486 2.0 0 C-N-CA 119.143 -1.503 . . . . 0.0 110.013 -178.57 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.81 -1.17 38.27 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 122.026 0.917 . . . . 0.0 110.22 -179.803 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -79.64 133.41 36.4 Favored 'General case' 0 C--N 1.26 -3.309 0 CA-C-N 113.719 -1.582 . . . . 0.0 110.861 -179.137 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.0 t -70.95 141.54 16.73 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.955 0 C-N-CA 118.879 -1.128 . . . . 0.0 109.081 177.71 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.461 ' O ' ' O ' ' A' ' 12' ' ' ASN . 0.1 OUTLIER -148.47 121.39 8.77 Favored 'General case' 0 C--N 1.277 -2.556 0 C-N-CA 118.346 -1.342 . . . . 0.0 109.458 177.304 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.482 ' O ' ' O ' ' A' ' 26' ' ' ASN . . . 175.0 -94.99 0.1 OUTLIER Glycine 0 C--O 1.201 -1.949 0 C-N-CA 118.304 -1.903 . . . . 0.0 111.505 -174.527 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -39.33 129.81 1.74 Allowed 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 120.494 -0.483 . . . . 0.0 111.553 -176.467 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.437 ' O ' ' OD1' ' A' ' 26' ' ' ASN . . . 90.65 -19.36 45.12 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -178.414 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.482 ' O ' ' O ' ' A' ' 23' ' ' GLY . 85.5 m-20 -155.96 -163.13 1.42 Allowed 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -179.862 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.468 ' O ' ' O ' ' A' ' 40' ' ' VAL . 0.0 OUTLIER -156.86 133.13 9.8 Favored 'General case' 0 N--CA 1.496 1.855 0 C-N-CA 117.871 -1.531 . . . . 0.0 111.345 176.143 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.502 ' SG ' ' OD1' ' A' ' 37' ' ' ASN . 0.1 OUTLIER -87.2 161.11 18.22 Favored 'General case' 0 CA--C 1.482 -1.663 0 CA-C-O 123.342 1.544 . . . . 0.0 113.028 179.897 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 31.5 mm -134.47 124.13 44.23 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.265 0 CA-C-N 111.057 -2.792 . . . . 0.0 109.677 -179.764 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 33.2 mt -76.38 121.04 22.46 Favored 'General case' 0 N--CA 1.501 2.121 0 C-N-CA 118.804 -1.159 . . . . 0.0 110.684 -179.42 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 83.4 104.12 0.52 Allowed Glycine 0 C--N 1.302 -1.317 0 C-N-CA 119.224 -1.465 . . . . 0.0 110.846 178.034 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.587 ' O ' ' N ' ' A' ' 34' ' ' GLY . 27.6 t -78.76 -127.46 0.01 OUTLIER 'General case' 0 C--O 1.198 -1.653 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 176.993 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -71.06 66.25 0.39 Allowed 'General case' 0 C--N 1.253 -3.597 0 CA-C-N 114.814 -1.084 . . . . 0.0 108.684 -176.434 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.587 ' N ' ' O ' ' A' ' 32' ' ' SER . . . 69.8 29.47 71.04 Favored Glycine 0 C--N 1.29 -1.989 0 N-CA-C 108.583 -1.807 . . . . 0.0 108.583 -177.245 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -125.7 -124.17 0.25 Allowed 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 118.829 -1.149 . . . . 0.0 113.137 -176.329 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.548 ' O ' ' N ' ' A' ' 32' ' ' SER . 16.2 mtmt -94.96 -173.02 2.85 Favored 'General case' 0 C--N 1.278 -2.506 0 CA-C-N 113.256 -1.793 . . . . 0.0 112.822 -175.517 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.553 ' ND2' ' SG ' ' A' ' 16' ' ' CYS . 1.4 t30 -82.28 151.75 26.63 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 114.859 -1.064 . . . . 0.0 109.076 177.907 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.48 ' O ' ' SG ' ' A' ' 28' ' ' CYS . 22.8 tt0 -145.88 142.76 29.08 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 118.984 -1.087 . . . . 0.0 110.604 178.833 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.575 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 36.0 m -91.1 94.23 9.51 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.063 -178.486 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.468 ' O ' ' O ' ' A' ' 27' ' ' LYS . 1.2 p -105.94 139.22 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 C-N-CA 118.491 -1.284 . . . . 0.0 111.998 179.297 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.436 ' OG1' ' OD1' ' A' ' 26' ' ' ASN . 4.9 t -58.65 143.2 47.33 Favored 'General case' 0 C--N 1.273 -2.76 0 CA-C-N 113.524 -1.671 . . . . 0.0 111.166 178.172 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 158.34 -141.25 7.54 Favored Glycine 0 N--CA 1.487 2.056 0 C-N-CA 119.6 -1.286 . . . . 0.0 110.007 179.671 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -130.5 131.76 45.28 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.837 -0.745 . . . . 0.0 109.816 179.25 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -137.11 -151.1 5.88 Favored Glycine 0 N--CA 1.489 2.198 0 C-N-CA 119.648 -1.263 . . . . 0.0 110.399 -179.515 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -145.48 152.32 49.34 Favored Pre-proline 0 C--N 1.302 -1.491 0 C-N-CA 119.54 -0.864 . . . . 0.0 109.703 179.989 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -56.16 -170.61 0.03 OUTLIER 'Trans proline' 0 C--O 1.214 -0.702 0 C-N-CA 121.124 1.216 . . . . 0.0 110.504 176.565 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -107.54 100.29 33.52 Favored Pre-proline 0 CA--C 1.56 1.352 0 C-N-CA 120.3 -0.56 . . . . 0.0 110.243 178.6 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -62.68 154.71 63.59 Favored 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 120.707 0.938 . . . . 0.0 110.919 -178.045 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 116.303 -1.808 . . . . 0.0 110.35 -179.568 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 7.7 p . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 1.5 t -95.76 160.36 2.81 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 C-N-CA 119.552 -0.859 . . . . 0.0 110.215 179.603 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.462 ' CG ' ' O ' ' A' ' 13' ' ' LEU . 7.3 m-85 -90.44 -164.98 1.25 Allowed 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 119.212 -0.995 . . . . 0.0 109.242 178.699 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.565 ' OG1' ' N ' ' A' ' 5' ' ' ASP . 0.2 OUTLIER -116.65 -176.7 3.02 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 178.9 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.565 ' N ' ' OG1' ' A' ' 4' ' ' THR . 0.2 OUTLIER -79.35 156.17 28.11 Favored 'General case' 0 C--N 1.289 -2.053 0 C-N-CA 118.528 -1.269 . . . . 0.0 110.406 -179.366 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -70.72 152.01 44.27 Favored 'General case' 0 C--N 1.291 -1.967 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.719 176.654 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.415 ' O ' ' CG ' ' A' ' 8' ' ' GLU . 43.0 p -119.36 4.43 11.23 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-O 121.813 0.816 . . . . 0.0 108.96 178.812 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.415 ' CG ' ' O ' ' A' ' 7' ' ' THR . 29.4 mt-10 -161.93 167.47 24.56 Favored 'General case' 0 C--N 1.283 -2.284 0 CA-C-N 113.914 -1.494 . . . . 0.0 111.18 -178.971 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.416 ' HB3' ' H ' ' A' ' 30' ' ' LEU . 0.9 OUTLIER -79.5 156.47 27.79 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 115.038 -0.983 . . . . 0.0 108.868 177.517 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.481 ' N ' ' O ' ' A' ' 28' ' ' CYS . . . 90.51 -13.92 64.15 Favored Glycine 0 N--CA 1.503 3.163 0 C-N-CA 118.739 -1.695 . . . . 0.0 112.45 179.264 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 47.5 mm-40 -61.17 -164.51 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.239 0 C-N-CA 119.139 -1.024 . . . . 0.0 111.073 -178.47 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.529 ' C ' ' H ' ' A' ' 14' ' ' CYS . 7.4 m-20 -160.51 -66.96 0.07 Allowed 'General case' 0 N--CA 1.5 2.057 0 C-N-CA 118.377 -1.329 . . . . 0.0 113.367 179.791 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.462 ' O ' ' CG ' ' A' ' 3' ' ' TYR . 86.1 mt -75.85 41.1 0.2 Allowed 'General case' 0 C--N 1.287 -2.123 0 C-N-CA 119.364 -0.934 . . . . 0.0 110.155 -178.396 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.529 ' H ' ' C ' ' A' ' 12' ' ' ASN . 29.1 p -120.3 -165.83 1.24 Allowed 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.232 178.607 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 47.1 mt -97.19 102.79 14.64 Favored 'General case' 0 C--N 1.294 -1.841 0 C-N-CA 119.248 -0.981 . . . . 0.0 109.441 178.188 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.413 ' CB ' ' SG ' ' A' ' 22' ' ' CYS . 0.5 OUTLIER -95.41 -35.31 11.78 Favored 'General case' 0 C--N 1.281 -2.397 0 CA-C-N 114.262 -1.336 . . . . 0.0 111.139 -176.021 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -114.19 89.65 3.14 Favored 'General case' 0 C--N 1.301 -1.513 0 C-N-CA 119.68 -0.808 . . . . 0.0 110.326 -179.143 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 73.96 -91.26 0.7 Allowed Glycine 0 N--CA 1.488 2.126 0 C-N-CA 119.511 -1.328 . . . . 0.0 110.486 179.418 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.404 ' O ' ' OG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -138.27 4.34 2.44 Favored 'General case' 0 N--CA 1.484 1.232 0 CA-C-O 122.026 0.917 . . . . 0.0 110.89 -178.841 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -85.03 138.89 32.16 Favored 'General case' 0 C--N 1.261 -3.257 0 CA-C-N 113.835 -1.529 . . . . 0.0 111.111 -179.556 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.4 t -77.28 139.5 18.61 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.124 0 C-N-CA 118.95 -1.1 . . . . 0.0 110.032 179.039 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.413 ' SG ' ' CB ' ' A' ' 16' ' ' CYS . 0.8 OUTLIER -80.7 -135.44 0.03 OUTLIER 'General case' 0 C--N 1.278 -2.502 0 C-N-CA 118.722 -1.191 . . . . 0.0 109.333 176.049 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.532 ' O ' ' ND2' ' A' ' 26' ' ' ASN . . . -172.68 107.14 0.24 Allowed Glycine 0 C--N 1.272 -3.028 0 C-N-CA 117.835 -2.126 . . . . 0.0 111.089 179.309 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.461 ' C ' ' O ' ' A' ' 23' ' ' GLY . 2.9 tt0 -34.32 131.92 0.3 Allowed 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 121.632 0.73 . . . . 0.0 110.422 178.665 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 131.23 -31.12 3.21 Favored Glycine 0 C--N 1.291 -1.96 0 N-CA-C 106.512 -2.635 . . . . 0.0 106.512 -174.714 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.589 ' N ' ' ND2' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -96.1 -161.2 0.85 Allowed 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 175.412 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.51 ' N ' ' O ' ' A' ' 40' ' ' VAL . 10.7 ttpp -144.56 113.45 6.8 Favored 'General case' 0 C--N 1.287 -2.116 0 C-N-CA 119.436 -0.906 . . . . 0.0 109.616 177.329 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.566 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 5.3 m -84.31 156.82 21.74 Favored 'General case' 0 CA--C 1.482 -1.662 0 C-N-CA 117.392 -1.723 . . . . 0.0 111.603 -179.665 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.443 ' CD1' ' HZ3' ' A' ' 27' ' ' LYS . 33.2 mm -144.77 125.38 7.89 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.167 0 CA-C-N 113.235 -1.802 . . . . 0.0 109.92 177.943 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.416 ' H ' ' HB3' ' A' ' 9' ' ' SER . 23.4 mt -76.77 121.56 23.5 Favored 'General case' 0 N--CA 1.498 1.964 0 C-N-CA 118.826 -1.15 . . . . 0.0 109.951 178.498 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.439 ' O ' ' O ' ' A' ' 32' ' ' SER . . . 77.65 100.89 0.18 Allowed Glycine 0 C--N 1.303 -1.281 0 C-N-CA 118.468 -1.825 . . . . 0.0 109.855 178.686 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.546 ' O ' ' N ' ' A' ' 34' ' ' GLY . 14.8 m -66.01 -127.78 0.0 OUTLIER 'General case' 0 C--O 1.198 -1.637 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 178.389 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -71.83 64.67 0.49 Allowed 'General case' 0 C--N 1.252 -3.664 0 CA-C-N 114.573 -1.194 . . . . 0.0 108.809 -175.822 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.546 ' N ' ' O ' ' A' ' 32' ' ' SER . . . 72.82 32.46 61.18 Favored Glycine 0 C--N 1.29 -1.988 0 N-CA-C 108.551 -1.82 . . . . 0.0 108.551 -177.252 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -125.7 -125.91 0.24 Allowed 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 118.981 -1.087 . . . . 0.0 112.707 -177.131 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.435 ' O ' ' N ' ' A' ' 32' ' ' SER . 19.9 mttp -97.52 179.93 4.69 Favored 'General case' 0 C--N 1.277 -2.565 0 CA-C-N 113.332 -1.758 . . . . 0.0 113.057 -176.263 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -64.16 152.08 41.64 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.598 175.968 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 43.1 tt0 -161.22 151.61 17.74 Favored 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 119.042 -1.063 . . . . 0.0 110.174 177.098 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.566 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 0.0 OUTLIER -101.84 104.47 15.22 Favored 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 119.55 -0.86 . . . . 0.0 111.607 179.789 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.51 ' O ' ' N ' ' A' ' 27' ' ' LYS . 1.1 p -99.01 137.5 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 C-N-CA 118.307 -1.357 . . . . 0.0 109.994 175.356 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 6.3 t -63.93 145.5 55.73 Favored 'General case' 0 C--N 1.266 -3.039 0 CA-C-N 114.008 -1.451 . . . . 0.0 110.811 -178.752 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 152.29 -146.81 15.81 Favored Glycine 0 N--CA 1.49 2.26 0 C-N-CA 119.459 -1.353 . . . . 0.0 110.64 179.094 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -116.36 129.44 56.25 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 120.083 -0.647 . . . . 0.0 109.797 -179.951 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -145.9 -165.03 11.19 Favored Glycine 0 N--CA 1.494 2.534 0 C-N-CA 119.284 -1.436 . . . . 0.0 110.616 -179.62 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.3 t -120.41 144.92 39.35 Favored Pre-proline 0 N--CA 1.491 1.618 0 C-N-CA 119.933 -0.707 . . . . 0.0 110.147 -179.671 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -64.69 176.27 3.0 Favored 'Trans proline' 0 C--O 1.213 -0.772 0 C-N-CA 120.948 1.099 . . . . 0.0 111.11 175.415 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -116.35 85.76 16.59 Favored Pre-proline 0 C--N 1.313 -0.985 0 C-N-CA 120.307 -0.557 . . . . 0.0 110.967 -179.822 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -63.15 165.86 15.98 Favored 'Trans proline' 0 C--O 1.216 -0.599 0 C-N-CA 120.945 1.097 . . . . 0.0 110.687 179.221 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 116.255 -1.831 . . . . 0.0 110.493 -179.3 . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.488 ' CG1' ' O ' ' A' ' 1' ' ' VAL . 8.2 p . . . . . 0 N--CA 1.489 1.496 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 . . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 1.6 t -78.48 158.97 4.81 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 C-N-CA 119.078 -1.049 . . . . 0.0 109.549 179.479 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -118.35 -171.42 2.07 Favored 'General case' 0 N--CA 1.498 1.942 0 C-N-CA 119.735 -0.786 . . . . 0.0 110.789 -178.337 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.2 p -106.22 -179.87 4.07 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-N 115.304 -0.862 . . . . 0.0 108.838 179.248 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -91.02 149.5 21.81 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 118.572 -1.251 . . . . 0.0 111.134 -179.546 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.513 ' SG ' ' O ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -74.06 178.46 4.99 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.972 178.397 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.2 p -148.68 21.02 1.03 Allowed 'General case' 0 C--N 1.285 -2.2 0 CA-C-N 114.149 -1.387 . . . . 0.0 109.032 175.406 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -160.81 171.89 17.99 Favored 'General case' 0 C--N 1.292 -1.92 0 CA-C-N 114.274 -1.33 . . . . 0.0 110.516 -179.272 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.486 ' O ' ' N ' ' A' ' 11' ' ' GLN . 0.5 OUTLIER -71.32 -176.68 1.55 Allowed 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 119.703 -0.799 . . . . 0.0 109.558 179.785 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.508 ' N ' ' O ' ' A' ' 28' ' ' CYS . . . 28.31 9.39 0.0 OUTLIER Glycine 0 N--CA 1.498 2.819 1 N-CA-C 130.224 6.85 . . . . 0.0 130.224 179.862 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.486 ' N ' ' O ' ' A' ' 9' ' ' SER . 0.0 OUTLIER -60.75 -165.1 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 176.45 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.522 HD21 ' C ' ' A' ' 23' ' ' GLY . 1.4 m-20 -148.76 -70.26 0.21 Allowed 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 117.266 -1.773 . . . . 0.0 114.225 -179.795 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.6 mt -75.74 47.46 0.42 Allowed 'General case' 0 C--N 1.263 -3.174 0 C-N-CA 117.936 -1.505 . . . . 0.0 110.663 -175.543 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.467 ' H ' ' C ' ' A' ' 12' ' ' ASN . 28.0 p -124.74 -156.58 0.73 Allowed 'General case' 0 C--O 1.211 -0.934 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.2 177.182 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.513 ' O ' ' SG ' ' A' ' 6' ' ' CYS . 5.8 mt -115.56 127.29 55.15 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.029 176.199 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.575 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -141.38 21.88 2.21 Favored 'General case' 0 C--N 1.297 -1.703 0 C-N-CA 118.409 -1.316 . . . . 0.0 111.439 -174.516 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -157.03 77.43 0.88 Allowed 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 119.6 -0.84 . . . . 0.0 109.145 176.047 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 77.2 -88.52 0.99 Allowed Glycine 0 N--CA 1.486 1.976 0 C-N-CA 119.386 -1.388 . . . . 0.0 109.881 -178.388 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.48 ' O ' ' OG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -145.56 11.67 1.29 Allowed 'General case' 0 C--N 1.303 -1.432 0 CA-C-O 122.511 1.148 . . . . 0.0 109.988 179.606 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -95.57 138.46 33.21 Favored 'General case' 0 C--N 1.258 -3.392 0 CA-C-N 113.238 -1.801 . . . . 0.0 110.288 178.105 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.4 t -72.64 145.21 12.19 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.059 -178.593 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.473 ' O ' ' O ' ' A' ' 12' ' ' ASN . 6.0 m -144.41 126.13 15.16 Favored 'General case' 0 N--CA 1.499 2.021 0 C-N-CA 118.732 -1.187 . . . . 0.0 109.436 177.212 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.522 ' C ' HD21 ' A' ' 12' ' ' ASN . . . 175.5 -91.05 0.08 OUTLIER Glycine 0 C--O 1.206 -1.604 0 C-N-CA 117.349 -2.358 . . . . 0.0 112.737 -178.043 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -48.9 126.22 11.81 Favored 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 119.453 -0.899 . . . . 0.0 111.007 -176.7 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.18 -29.09 9.22 Favored Glycine 0 N--CA 1.48 1.591 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -178.447 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.436 ' O ' ' O ' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -132.11 -168.95 2.12 Favored 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 120.163 -0.615 . . . . 0.0 110.929 -179.49 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.51 ' O ' ' O ' ' A' ' 40' ' ' VAL . 0.1 OUTLIER -142.71 159.53 42.05 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 177.955 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.508 ' O ' ' N ' ' A' ' 10' ' ' GLY . 74.0 m -127.03 163.27 24.1 Favored 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 118.657 -1.217 . . . . 0.0 111.917 178.666 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 10.8 mm -139.59 130.6 32.67 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.839 0 CA-C-N 113.081 -1.872 . . . . 0.0 109.545 176.494 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 16.7 mt -75.5 117.44 17.29 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 118.091 -1.444 . . . . 0.0 108.31 176.894 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.66 101.77 0.79 Allowed Glycine 0 N--CA 1.482 1.732 0 N-CA-C 108.669 -1.772 . . . . 0.0 108.669 -176.747 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.586 ' N ' ' O ' ' A' ' 36' ' ' LYS . 0.8 OUTLIER -83.3 -134.48 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 119.943 -0.703 . . . . 0.0 109.807 -176.951 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -71.42 64.25 0.4 Allowed 'General case' 0 C--N 1.255 -3.53 0 CA-C-N 114.153 -1.385 . . . . 0.0 108.878 -175.426 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 32' ' ' SER . . . 76.51 27.49 61.24 Favored Glycine 0 C--N 1.285 -2.256 0 N-CA-C 108.124 -1.99 . . . . 0.0 108.124 -176.989 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -126.71 -136.0 0.25 Allowed 'General case' 0 C--O 1.213 -0.857 0 CA-C-O 122.215 1.007 . . . . 0.0 111.41 -177.567 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.586 ' O ' ' N ' ' A' ' 32' ' ' SER . 8.2 mttm -102.89 -154.84 0.5 Allowed 'General case' 0 C--N 1.269 -2.894 0 CA-C-N 113.005 -1.907 . . . . 0.0 112.206 -176.811 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.505 ' OD1' ' N ' ' A' ' 37' ' ' ASN . 0.9 OUTLIER -70.7 141.72 51.55 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 115.063 -0.972 . . . . 0.0 110.542 178.024 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.47 ' CG ' ' N ' ' A' ' 39' ' ' CYS . 36.6 tt0 -143.59 166.9 23.56 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 120.008 -0.677 . . . . 0.0 109.531 179.503 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.575 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 3.8 m -116.93 91.18 3.51 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 119.567 -0.853 . . . . 0.0 110.814 -179.611 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.51 ' O ' ' O ' ' A' ' 27' ' ' LYS . 0.2 OUTLIER -91.17 139.0 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.17 0 C-N-CA 118.235 -1.386 . . . . 0.0 111.432 179.261 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.525 ' HG1' ' N ' ' A' ' 42' ' ' GLY . 11.4 t -49.62 151.69 1.61 Allowed 'General case' 0 C--N 1.271 -2.829 0 CA-C-N 114.124 -1.398 . . . . 0.0 110.806 -178.767 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.525 ' N ' ' HG1' ' A' ' 41' ' ' THR . . . 146.78 -155.27 26.46 Favored Glycine 0 N--CA 1.489 2.209 0 C-N-CA 119.682 -1.247 . . . . 0.0 110.146 -179.378 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 81.4 mt-10 -144.39 143.15 30.79 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 119.497 -0.881 . . . . 0.0 110.282 179.844 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -146.95 -148.12 4.69 Favored Glycine 0 N--CA 1.494 2.53 0 C-N-CA 119.269 -1.443 . . . . 0.0 110.961 -179.525 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -132.56 155.92 80.68 Favored Pre-proline 0 N--CA 1.495 1.814 0 C-N-CA 120.183 -0.607 . . . . 0.0 109.64 -179.206 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -53.04 -168.92 0.01 OUTLIER 'Trans proline' 0 C--O 1.215 -0.657 0 C-N-CA 121.46 1.44 . . . . 0.0 111.44 176.933 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -118.75 86.04 29.12 Favored Pre-proline 0 C--N 1.312 -1.024 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.891 -179.706 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -65.05 169.58 11.78 Favored 'Trans proline' 0 C--N 1.325 -0.695 0 C-N-CA 121.071 1.181 . . . . 0.0 110.831 178.741 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 47.0 mm-40 . . . . . 0 N--CA 1.491 1.575 0 CA-C-O 116.368 -1.777 . . . . 0.0 110.379 -179.849 . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 4.6 t . . . . . 0 N--CA 1.489 1.496 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.3 t -101.64 169.51 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 C-N-CA 119.736 -0.786 . . . . 0.0 110.516 -179.264 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -122.82 -167.74 1.63 Allowed 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 177.601 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.505 ' H ' ' HG1' ' A' ' 4' ' ' THR . 10.4 p -106.07 173.49 6.29 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 119.441 -0.904 . . . . 0.0 109.304 -179.837 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -85.4 147.72 26.35 Favored 'General case' 0 C--N 1.286 -2.176 0 C-N-CA 118.653 -1.219 . . . . 0.0 109.74 179.485 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -75.29 -176.37 3.07 Favored 'General case' 0 C--N 1.285 -2.223 0 C-N-CA 119.547 -0.861 . . . . 0.0 110.336 177.545 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.404 ' O ' ' OG1' ' A' ' 7' ' ' THR . 1.6 t -155.04 12.95 0.38 Allowed 'General case' 0 C--N 1.277 -2.566 0 CA-C-N 114.1 -1.409 . . . . 0.0 110.501 178.696 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -163.82 178.55 7.74 Favored 'General case' 0 C--N 1.282 -2.343 0 CA-C-N 114.647 -1.161 . . . . 0.0 110.088 179.388 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.452 ' O ' ' N ' ' A' ' 11' ' ' GLN . 0.5 OUTLIER -74.66 -160.11 0.1 Allowed 'General case' 0 C--N 1.297 -1.702 0 C-N-CA 119.808 -0.757 . . . . 0.0 109.809 179.864 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 27.79 10.75 0.0 OUTLIER Glycine 0 N--CA 1.5 2.945 1 N-CA-C 130.68 7.032 . . . . 0.0 130.68 178.557 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.456 ' O ' ' OD1' ' A' ' 12' ' ' ASN . 1.3 mt-30 -86.59 -174.68 5.11 Favored 'General case' 0 N--CA 1.499 1.995 0 C-N-CA 119.01 -1.076 . . . . 0.0 108.537 176.726 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.551 ' ND2' ' O ' ' A' ' 26' ' ' ASN . 16.8 m-20 -138.92 -65.63 0.49 Allowed 'General case' 0 N--CA 1.502 2.141 0 C-N-CA 118.247 -1.381 . . . . 0.0 114.675 -174.641 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 21.2 mt -77.94 47.33 0.63 Allowed 'General case' 0 C--N 1.272 -2.796 0 C-N-CA 117.939 -1.504 . . . . 0.0 111.573 -174.946 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 11.0 p -125.35 -167.4 1.68 Allowed 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 119.804 -0.758 . . . . 0.0 109.327 176.732 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 57.2 mt -102.09 116.05 31.86 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 177.06 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 6.5 m -111.4 -42.44 3.89 Favored 'General case' 0 N--CA 1.505 2.285 0 C-N-CA 118.854 -1.138 . . . . 0.0 111.919 -175.642 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.34 92.26 4.86 Favored 'General case' 0 N--CA 1.498 1.952 0 C-N-CA 118.968 -1.093 . . . . 0.0 109.776 178.381 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 76.03 -98.21 1.19 Allowed Glycine 0 N--CA 1.491 2.306 0 C-N-CA 119.319 -1.419 . . . . 0.0 110.308 -179.756 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.416 ' O ' ' OG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -134.89 3.02 3.18 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-O 122.231 1.015 . . . . 0.0 110.451 179.77 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -83.95 139.27 32.69 Favored 'General case' 0 C--N 1.26 -3.303 0 CA-C-N 113.51 -1.677 . . . . 0.0 110.728 -179.358 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.3 t -64.42 142.59 16.68 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.035 0 C-N-CA 118.95 -1.1 . . . . 0.0 110.153 179.511 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.517 ' O ' ' SG ' ' A' ' 28' ' ' CYS . 0.0 OUTLIER -149.72 122.72 8.81 Favored 'General case' 0 C--N 1.28 -2.432 0 C-N-CA 118.659 -1.217 . . . . 0.0 109.403 177.395 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.424 ' O ' ' O ' ' A' ' 26' ' ' ASN . . . 148.91 -33.94 1.14 Allowed Glycine 0 C--N 1.296 -1.678 1 N-CA-C 130.077 6.791 . . . . 0.0 130.077 -177.234 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.466 ' C ' ' H ' ' A' ' 26' ' ' ASN . 0.6 OUTLIER -54.64 116.52 2.74 Favored 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 119.301 -0.959 . . . . 0.0 110.261 179.911 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 78.85 -20.7 4.33 Favored Glycine 0 N--CA 1.479 1.504 0 C-N-CA 119.317 -1.42 . . . . 0.0 109.749 -178.681 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.551 ' O ' ' ND2' ' A' ' 12' ' ' ASN . 0.0 OUTLIER -114.22 -170.53 1.74 Allowed 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 119.933 -0.707 . . . . 0.0 109.876 -179.8 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.525 ' O ' ' O ' ' A' ' 40' ' ' VAL . 0.2 OUTLIER -154.2 118.71 4.87 Favored 'General case' 0 N--CA 1.5 2.045 0 C-N-CA 119.084 -1.046 . . . . 0.0 111.205 -179.969 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.517 ' SG ' ' O ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -81.77 160.98 23.46 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 118.979 -1.088 . . . . 0.0 110.956 -179.174 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 36.5 mm -133.33 126.81 53.11 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 C-N-CA 119.385 -0.926 . . . . 0.0 110.455 179.685 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 13.3 mt -78.57 132.6 37.21 Favored 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 118.612 -1.235 . . . . 0.0 109.935 178.065 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.461 ' O ' ' OG ' ' A' ' 32' ' ' SER . . . -117.72 -112.08 2.58 Favored Glycine 0 C--O 1.216 -0.985 1 N-CA-C 130.954 7.141 . . . . 0.0 130.954 177.331 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.471 ' H ' ' C ' ' A' ' 35' ' ' GLU . 50.0 m -164.08 -129.7 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.248 0 CA-C-O 122.568 1.175 . . . . 0.0 112.484 -177.554 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 38.3 m-20 -80.11 69.95 6.62 Favored 'General case' 0 C--N 1.27 -2.848 0 CA-C-N 112.971 -1.922 . . . . 0.0 111.051 -173.076 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 104.94 2.45 42.4 Favored Glycine 0 C--N 1.278 -2.647 0 N-CA-C 107.111 -2.396 . . . . 0.0 107.111 -179.428 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.693 ' O ' ' O ' ' A' ' 36' ' ' LYS . 3.7 mm-40 -119.54 10.41 11.79 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 113.21 -1.495 . . . . 0.0 108.809 -179.745 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.693 ' O ' ' O ' ' A' ' 35' ' ' GLU . 31.7 mttt -36.23 -157.59 0.0 OUTLIER 'General case' 0 C--N 1.271 -2.836 0 CA-C-N 111.65 -2.523 . . . . 0.0 112.801 -179.439 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.553 ' C ' ' ND2' ' A' ' 37' ' ' ASN . 0.2 OUTLIER -71.66 110.25 6.1 Favored 'General case' 0 C--N 1.28 -2.449 0 C-N-CA 118.983 -1.087 . . . . 0.0 110.156 -179.999 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 tt0 -113.19 140.35 48.01 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.647 179.177 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 77.1 m -91.49 107.65 19.35 Favored 'General case' 0 C--N 1.294 -1.847 0 C-N-CA 119.124 -1.03 . . . . 0.0 111.073 -179.887 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.547 ' CG2' ' N ' ' A' ' 41' ' ' THR . 2.5 p -123.58 162.6 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.5 0 C-N-CA 118.833 -1.147 . . . . 0.0 110.862 177.807 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.547 ' N ' ' CG2' ' A' ' 40' ' ' VAL . 1.3 t -90.0 144.99 25.43 Favored 'General case' 0 C--N 1.284 -2.257 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.805 179.585 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 178.49 -93.4 0.09 OUTLIER Glycine 0 N--CA 1.491 2.344 1 N-CA-C 130.25 6.86 . . . . 0.0 130.25 179.899 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -157.8 93.03 1.24 Allowed 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 119.561 -0.856 . . . . 0.0 110.027 179.399 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -131.62 -178.76 15.67 Favored Glycine 0 N--CA 1.493 2.467 1 N-CA-C 131.711 7.444 . . . . 0.0 131.711 -178.963 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -106.84 118.63 53.73 Favored Pre-proline 0 CA--C 1.561 1.386 0 C-N-CA 120.462 -0.495 . . . . 0.0 111.422 -179.341 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.41 ' O ' ' C ' ' A' ' 47' ' ' GLU . 4.3 Cg_exo -64.46 102.95 0.42 Allowed 'Trans proline' 0 C--O 1.215 -0.652 0 C-N-CA 120.935 1.09 . . . . 0.0 110.784 174.894 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.442 ' OE1' ' OG1' ' A' ' 4' ' ' THR . 6.5 tm-20 -39.64 106.52 0.4 Allowed Pre-proline 0 CA--C 1.56 1.343 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.162 179.603 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.415 ' O ' ' OE2' ' A' ' 47' ' ' GLU . 1.4 Cg_endo -63.93 132.32 34.21 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 120.672 0.914 . . . . 0.0 111.421 -175.563 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 116.341 -1.79 . . . . 0.0 110.182 179.43 . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 3.1 t . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.473 ' CG1' ' H ' ' A' ' 3' ' ' TYR . 23.1 t -85.19 173.34 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 119.009 -1.076 . . . . 0.0 110.047 179.708 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.473 ' H ' ' CG1' ' A' ' 2' ' ' VAL . 23.4 m-85 -96.61 -166.25 1.39 Allowed 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 119.39 -0.924 . . . . 0.0 111.057 -178.013 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 13.8 p -96.9 176.19 6.06 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 119.792 -0.763 . . . . 0.0 109.225 -179.321 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -89.71 144.67 25.79 Favored 'General case' 0 C--N 1.289 -2.052 0 C-N-CA 118.722 -1.191 . . . . 0.0 109.335 178.321 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -73.81 -177.93 3.0 Favored 'General case' 0 C--N 1.286 -2.175 0 CA-C-O 122.144 0.973 . . . . 0.0 111.535 -179.864 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.7 p -154.37 18.56 0.48 Allowed 'General case' 0 C--N 1.283 -2.286 0 CA-C-N 113.476 -1.693 . . . . 0.0 109.076 178.486 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -163.2 177.93 8.64 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-N 114.4 -1.273 . . . . 0.0 110.568 -178.98 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.496 ' O ' ' N ' ' A' ' 11' ' ' GLN . 0.6 OUTLIER -83.91 -158.52 0.32 Allowed 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.985 -179.763 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 22.85 21.41 0.0 OUTLIER Glycine 0 N--CA 1.498 2.779 1 N-CA-C 129.973 6.749 . . . . 0.0 129.973 178.762 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.496 ' N ' ' O ' ' A' ' 9' ' ' SER . 7.7 mt-30 -94.49 -164.18 1.14 Allowed 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 114.492 -0.854 . . . . 0.0 109.575 178.233 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.607 HD22 ' H ' ' A' ' 44' ' ' GLY . 24.7 m-20 -147.57 -62.59 0.27 Allowed 'General case' 0 N--CA 1.501 2.082 0 C-N-CA 118.086 -1.446 . . . . 0.0 114.54 -177.311 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 16.2 mt -76.86 47.43 0.52 Allowed 'General case' 0 C--N 1.269 -2.909 0 C-N-CA 118.127 -1.429 . . . . 0.0 111.795 -174.586 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 7.0 p -129.85 -168.07 1.9 Allowed 'General case' 0 C--N 1.308 -1.203 0 C-N-CA 119.657 -0.817 . . . . 0.0 110.186 175.441 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 35.9 mt -104.41 120.12 40.51 Favored 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 119.586 -0.846 . . . . 0.0 108.935 178.232 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.1 m -119.67 -18.9 8.24 Favored 'General case' 0 N--CA 1.501 2.114 0 C-N-CA 119.163 -1.015 . . . . 0.0 111.816 -176.575 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.11 93.78 4.02 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 119.591 -0.844 . . . . 0.0 109.243 177.677 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 68.84 -101.75 0.83 Allowed Glycine 0 N--CA 1.486 2.001 0 C-N-CA 119.245 -1.455 . . . . 0.0 109.8 -178.268 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.442 ' O ' ' OG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -127.17 4.12 6.41 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 122.541 1.162 . . . . 0.0 109.269 178.931 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -78.09 140.1 39.06 Favored 'General case' 0 C--N 1.262 -3.211 0 CA-C-N 112.811 -1.995 . . . . 0.0 111.203 -179.077 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.1 t -77.27 145.75 9.61 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.19 0 C-N-CA 119.337 -0.945 . . . . 0.0 110.021 178.754 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.494 ' O ' ' SG ' ' A' ' 28' ' ' CYS . 15.0 m -146.57 109.89 4.78 Favored 'General case' 0 C--N 1.288 -2.099 0 C-N-CA 118.99 -1.084 . . . . 0.0 109.185 176.761 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -170.72 -78.75 0.04 OUTLIER Glycine 0 N--CA 1.479 1.523 1 N-CA-C 129.681 6.632 . . . . 0.0 129.681 -175.961 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.34 110.98 2.43 Favored 'General case' 0 C--N 1.311 -1.071 0 C-N-CA 118.308 -1.357 . . . . 0.0 109.309 179.441 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 105.44 -18.93 40.7 Favored Glycine 0 C--N 1.302 -1.359 0 N-CA-C 122.735 3.854 . . . . 0.0 122.735 -171.443 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -132.36 -167.94 1.97 Allowed 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 112.788 -1.706 . . . . 0.0 108.711 179.105 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.475 ' O ' ' O ' ' A' ' 40' ' ' VAL . 12.7 tttt -148.11 122.15 9.46 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 118.52 -1.272 . . . . 0.0 110.502 177.472 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.494 ' SG ' ' O ' ' A' ' 22' ' ' CYS . 19.2 m -86.55 153.58 21.72 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 117.825 -1.55 . . . . 0.0 110.819 178.624 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 13.6 mm -137.2 129.39 42.87 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.647 0 CA-C-N 114.492 -1.231 . . . . 0.0 109.303 175.839 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 17.2 mt -75.55 111.55 10.98 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 118.191 -1.404 . . . . 0.0 108.914 178.001 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.51 100.38 0.96 Allowed Glycine 0 C--N 1.299 -1.526 0 C-N-CA 118.821 -1.657 . . . . 0.0 109.303 -178.275 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.56 ' O ' ' N ' ' A' ' 34' ' ' GLY . 6.7 t -72.19 -130.48 0.0 OUTLIER 'General case' 0 C--O 1.2 -1.519 0 C-N-CA 119.147 -1.021 . . . . 0.0 108.407 -179.01 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -72.07 65.05 0.55 Allowed 'General case' 0 C--N 1.253 -3.603 0 CA-C-N 114.332 -1.303 . . . . 0.0 108.881 -175.697 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.56 ' N ' ' O ' ' A' ' 32' ' ' SER . . . 75.35 26.56 65.58 Favored Glycine 0 C--N 1.289 -2.054 0 N-CA-C 108.521 -1.832 . . . . 0.0 108.521 -177.381 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.426 ' OE2' ' O ' ' A' ' 34' ' ' GLY . 11.0 mm-40 -122.27 -131.3 0.28 Allowed 'General case' 0 C--O 1.214 -0.767 0 C-N-CA 119.251 -0.979 . . . . 0.0 111.873 -177.455 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.519 ' O ' ' N ' ' A' ' 32' ' ' SER . 8.9 mttp -101.72 -168.59 1.57 Allowed 'General case' 0 C--N 1.272 -2.769 0 CA-C-N 113.23 -1.805 . . . . 0.0 112.861 -176.958 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.431 ' OD1' ' N ' ' A' ' 37' ' ' ASN . 2.0 m-20 -64.32 139.55 58.78 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.648 176.65 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 40.2 tt0 -150.51 141.79 23.25 Favored 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 118.998 -1.081 . . . . 0.0 110.111 177.969 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 14.2 m -91.21 91.36 8.18 Favored 'General case' 0 C--N 1.293 -1.861 0 C-N-CA 119.49 -0.884 . . . . 0.0 111.173 -178.362 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.475 ' O ' ' O ' ' A' ' 27' ' ' LYS . 0.6 OUTLIER -95.53 139.69 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 C-N-CA 118.334 -1.347 . . . . 0.0 110.941 178.659 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.8 t -56.8 147.27 23.66 Favored 'General case' 0 C--N 1.271 -2.831 0 CA-C-N 114.085 -1.416 . . . . 0.0 110.918 -179.567 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 159.43 -141.25 7.39 Favored Glycine 0 N--CA 1.487 2.073 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 -179.263 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -146.57 106.44 3.98 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 119.34 -0.944 . . . . 0.0 110.229 179.785 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.607 ' H ' HD22 ' A' ' 12' ' ' ASN . . . -108.46 -156.54 18.46 Favored Glycine 0 N--CA 1.498 2.822 0 C-N-CA 119.834 -1.174 . . . . 0.0 111.1 -178.807 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -132.56 156.12 80.45 Favored Pre-proline 0 N--CA 1.497 1.876 0 C-N-CA 120.104 -0.638 . . . . 0.0 109.853 -178.941 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -53.84 165.33 1.92 Allowed 'Trans proline' 0 C--O 1.216 -0.623 0 C-N-CA 121.373 1.382 . . . . 0.0 111.092 175.828 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.496 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 2.7 tt0 -90.08 -43.49 0.41 Allowed Pre-proline 0 CA--C 1.558 1.259 0 C-N-CA 119.293 -0.963 . . . . 0.0 110.952 177.958 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.496 ' CD ' ' N ' ' A' ' 47' ' ' GLU . 3.9 Cg_endo -72.21 135.63 25.24 Favored 'Trans proline' 0 C--O 1.216 -0.602 0 C-N-CA 120.786 0.991 . . . . 0.0 110.721 176.889 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 5.4 mp0 . . . . . 0 N--CA 1.497 1.887 0 CA-C-O 116.294 -1.812 . . . . 0.0 110.373 179.799 . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 65.5 t . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 4.2 t -79.99 5.1 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 C-N-CA 119.573 -0.851 . . . . 0.0 110.768 -178.936 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -138.32 -172.18 3.22 Favored 'General case' 0 C--N 1.273 -2.75 0 CA-C-N 114.509 -1.223 . . . . 0.0 111.182 179.808 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.6 p -123.22 -167.44 1.6 Allowed 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 114.797 -1.092 . . . . 0.0 108.563 178.314 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -93.54 156.14 16.91 Favored 'General case' 0 C--N 1.288 -2.106 0 C-N-CA 119.05 -1.06 . . . . 0.0 111.434 -177.939 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.447 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 1.7 m -72.23 162.17 29.84 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 114.931 -1.031 . . . . 0.0 110.44 177.286 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.732 ' H ' HE22 ' A' ' 11' ' ' GLN . 0.2 OUTLIER -138.44 8.73 2.66 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 119.46 -0.896 . . . . 0.0 110.034 178.328 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.634 ' H ' ' NE2' ' A' ' 11' ' ' GLN . 11.4 pt-20 -164.75 161.09 20.37 Favored 'General case' 0 C--N 1.281 -2.376 0 CA-C-N 114.29 -1.323 . . . . 0.0 110.379 178.886 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.474 ' HB3' ' H ' ' A' ' 30' ' ' LEU . 0.7 OUTLIER -70.36 150.37 46.37 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.644 -0.823 . . . . 0.0 109.905 -179.783 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 28' ' ' CYS . . . 101.66 -37.01 3.84 Favored Glycine 0 N--CA 1.502 3.085 0 C-N-CA 119.511 -1.328 . . . . 0.0 112.759 178.114 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.732 HE22 ' H ' ' A' ' 7' ' ' THR . 4.5 mt-30 -47.31 176.39 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.521 0 C-N-CA 119.539 -0.865 . . . . 0.0 111.583 -177.63 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.543 ' C ' ' H ' ' A' ' 14' ' ' CYS . 54.7 m-20 -147.93 -60.56 0.26 Allowed 'General case' 0 N--CA 1.502 2.164 0 C-N-CA 118.698 -1.201 . . . . 0.0 113.339 -178.161 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 19.0 mt -76.1 39.71 0.19 Allowed 'General case' 0 C--N 1.29 -2.016 0 C-N-CA 118.752 -1.179 . . . . 0.0 110.273 -177.88 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.587 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 17.2 p -122.27 -164.58 1.18 Allowed 'General case' 0 C--N 1.292 -1.908 0 CA-C-N 115.05 -0.977 . . . . 0.0 108.387 176.555 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 25.4 mt -100.29 99.39 10.05 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-O 122.286 1.041 . . . . 0.0 108.7 177.764 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.587 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 93.2 m -100.91 -61.62 1.35 Allowed 'General case' 0 C--N 1.276 -2.594 0 CA-C-N 113.273 -1.785 . . . . 0.0 110.708 -174.07 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -80.57 90.11 5.7 Favored 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 118.902 -1.119 . . . . 0.0 108.838 178.207 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 69.29 -127.59 21.07 Favored Glycine 0 N--CA 1.484 1.847 0 C-N-CA 118.953 -1.594 . . . . 0.0 109.465 -177.838 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -100.89 0.01 37.65 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 122.179 0.99 . . . . 0.0 109.966 179.688 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 67.7 m-80 -80.02 150.92 30.23 Favored 'General case' 0 C--N 1.261 -3.246 0 CA-C-N 113.483 -1.689 . . . . 0.0 111.256 -179.007 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.4 t -82.92 141.36 15.03 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 C-N-CA 119.566 -0.853 . . . . 0.0 111.477 -179.176 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.602 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 0.1 OUTLIER -77.76 -130.85 0.01 OUTLIER 'General case' 0 N--CA 1.514 2.764 0 C-N-CA 118.765 -1.174 . . . . 0.0 108.867 172.468 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.452 ' O ' ' C ' ' A' ' 24' ' ' GLN . . . -179.71 111.2 0.31 Allowed Glycine 0 C--N 1.275 -2.845 0 C-N-CA 117.96 -2.067 . . . . 0.0 111.617 177.527 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.452 ' C ' ' O ' ' A' ' 23' ' ' GLY . 36.4 tt0 -36.61 129.69 0.77 Allowed 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 119.979 -0.688 . . . . 0.0 109.244 176.13 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 121.31 -25.91 6.85 Favored Glycine 0 N--CA 1.483 1.813 0 N-CA-C 107.532 -2.227 . . . . 0.0 107.532 -175.142 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.625 ' N ' ' ND2' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -107.5 -161.25 0.77 Allowed 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 176.894 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.543 ' O ' ' O ' ' A' ' 40' ' ' VAL . 29.4 tttp -153.7 105.7 2.82 Favored 'General case' 0 N--CA 1.5 2.041 0 C-N-CA 118.799 -1.16 . . . . 0.0 111.918 179.866 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.602 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 3.3 m -78.55 154.81 30.09 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 118.39 -1.324 . . . . 0.0 110.146 178.71 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 8.2 mm -134.3 133.72 55.25 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.152 0 CA-C-N 114.968 -1.014 . . . . 0.0 110.283 175.655 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.474 ' H ' ' HB3' ' A' ' 9' ' ' SER . 17.7 mt -75.64 122.33 23.79 Favored 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 119.123 -1.031 . . . . 0.0 110.038 177.354 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 89.5 107.86 1.19 Allowed Glycine 0 N--CA 1.48 1.585 0 C-N-CA 118.993 -1.575 . . . . 0.0 110.786 178.21 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.601 ' N ' ' O ' ' A' ' 36' ' ' LYS . 4.6 t -84.42 -134.13 0.05 OUTLIER 'General case' 0 C--O 1.201 -1.488 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 178.281 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -72.66 61.51 0.53 Allowed 'General case' 0 C--N 1.254 -3.557 0 CA-C-N 114.807 -1.088 . . . . 0.0 109.353 -175.282 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.505 ' N ' ' O ' ' A' ' 32' ' ' SER . . . 81.57 27.69 46.33 Favored Glycine 0 C--N 1.286 -2.24 0 N-CA-C 108.564 -1.814 . . . . 0.0 108.564 -177.553 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 80.3 mt-10 -129.0 -128.84 0.22 Allowed 'General case' 0 C--O 1.213 -0.855 0 C-N-CA 118.89 -1.124 . . . . 0.0 112.293 -177.405 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.601 ' O ' ' N ' ' A' ' 32' ' ' SER . 16.4 mttp -98.66 -162.93 0.99 Allowed 'General case' 0 C--N 1.277 -2.555 0 CA-C-N 113.207 -1.815 . . . . 0.0 112.802 -176.049 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.499 ' OD1' ' N ' ' A' ' 37' ' ' ASN . 0.1 OUTLIER -65.69 166.35 10.97 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-N 114.922 -1.035 . . . . 0.0 111.498 179.374 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 -160.78 135.86 7.71 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.859 177.581 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.423 ' SG ' ' HB2' ' A' ' 16' ' ' CYS . 1.0 OUTLIER -91.53 108.77 20.13 Favored 'General case' 0 C--N 1.295 -1.787 0 C-N-CA 119.705 -0.798 . . . . 0.0 110.741 -179.557 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.543 ' O ' ' O ' ' A' ' 27' ' ' LYS . 3.7 p -130.95 157.69 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.25 0 C-N-CA 118.219 -1.393 . . . . 0.0 111.359 176.459 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.52 ' N ' ' CG2' ' A' ' 40' ' ' VAL . 14.0 t -73.24 151.03 41.57 Favored 'General case' 0 C--N 1.275 -2.633 0 CA-C-N 114.399 -1.273 . . . . 0.0 111.662 -179.13 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 164.31 -143.13 8.29 Favored Glycine 0 N--CA 1.489 2.2 0 C-N-CA 119.479 -1.343 . . . . 0.0 110.43 179.587 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -120.78 100.26 7.0 Favored 'General case' 0 N--CA 1.495 1.814 0 C-N-CA 120.092 -0.643 . . . . 0.0 109.904 179.588 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -127.28 -155.06 8.7 Favored Glycine 0 N--CA 1.495 2.621 0 N-CA-C 110.255 -1.138 . . . . 0.0 110.255 -179.73 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -144.41 151.05 49.97 Favored Pre-proline 0 N--CA 1.488 1.428 0 C-N-CA 119.431 -0.908 . . . . 0.0 109.954 179.713 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -68.8 141.61 49.83 Favored 'Trans proline' 0 C--O 1.216 -0.612 0 C-N-CA 121.342 1.361 . . . . 0.0 111.336 177.177 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -62.79 118.02 37.81 Favored Pre-proline 0 CA--C 1.56 1.358 0 C-N-CA 119.488 -0.885 . . . . 0.0 109.512 178.506 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -59.93 -176.8 0.13 Allowed 'Trans proline' 0 C--O 1.216 -0.624 0 C-N-CA 120.677 0.918 . . . . 0.0 111.578 -175.901 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 116.312 -1.804 . . . . 0.0 110.402 179.872 . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 98.3 t . . . . . 0 N--CA 1.491 1.624 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.514 ' CG1' ' H ' ' A' ' 3' ' ' TYR . 61.7 t -81.06 173.01 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 C-N-CA 119.481 -0.888 . . . . 0.0 109.983 -179.996 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.514 ' H ' ' CG1' ' A' ' 2' ' ' VAL . 37.8 m-85 -114.39 -165.41 1.01 Allowed 'General case' 0 N--CA 1.493 1.685 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.67 -179.733 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.9 p -99.48 172.27 7.42 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 178.215 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -89.64 154.2 20.15 Favored 'General case' 0 C--N 1.285 -2.207 0 C-N-CA 118.2 -1.4 . . . . 0.0 110.366 -179.632 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.514 ' SG ' ' O ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -73.81 154.73 39.39 Favored 'General case' 0 C--N 1.291 -1.952 0 C-N-CA 119.729 -0.788 . . . . 0.0 110.223 177.35 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.4 t -129.94 14.35 5.79 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-O 122.055 0.931 . . . . 0.0 108.85 177.739 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -162.58 176.94 9.87 Favored 'General case' 0 C--N 1.281 -2.404 0 CA-C-N 113.695 -1.593 . . . . 0.0 109.58 179.488 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.461 ' O ' ' N ' ' A' ' 11' ' ' GLN . 0.5 OUTLIER -72.64 -163.75 0.14 Allowed 'General case' 0 C--N 1.297 -1.693 0 C-N-CA 119.264 -0.974 . . . . 0.0 109.5 -179.506 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.426 ' H ' HD12 ' A' ' 29' ' ' ILE . . . 24.66 19.73 0.0 OUTLIER Glycine 0 N--CA 1.494 2.541 1 N-CA-C 130.218 6.847 . . . . 0.0 130.218 179.264 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.461 ' N ' ' O ' ' A' ' 9' ' ' SER . 7.9 mm-40 -71.09 -163.38 0.08 Allowed 'General case' 0 C--N 1.295 -1.799 0 C-N-CA 119.432 -0.907 . . . . 0.0 109.35 177.241 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.518 ' N ' ' O ' ' A' ' 45' ' ' THR . 26.2 t-20 -148.52 -77.55 0.16 Allowed 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 118.188 -1.405 . . . . 0.0 112.975 -177.876 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 14.1 mt -78.08 42.13 0.39 Allowed 'General case' 0 C--N 1.271 -2.833 0 C-N-CA 118.02 -1.472 . . . . 0.0 110.495 -177.8 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.479 ' H ' ' C ' ' A' ' 12' ' ' ASN . 29.4 p -113.33 -159.88 0.7 Allowed 'General case' 0 N--CA 1.496 1.833 0 C-N-CA 119.483 -0.887 . . . . 0.0 110.129 178.012 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.514 ' O ' ' SG ' ' A' ' 6' ' ' CYS . 3.5 mt -124.82 133.0 53.28 Favored 'General case' 0 N--CA 1.499 2.006 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.518 177.584 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 3.4 m -111.92 -74.42 0.64 Allowed 'General case' 0 N--CA 1.513 2.713 0 C-N-CA 119.064 -1.054 . . . . 0.0 110.308 179.094 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -78.23 125.69 29.72 Favored 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 118.319 -1.352 . . . . 0.0 107.845 177.228 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 28.55 -72.64 0.0 OUTLIER Glycine 0 N--CA 1.502 3.06 1 N-CA-C 128.931 6.332 . . . . 0.0 128.931 -176.7 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -137.53 0.27 2.25 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-O 122.149 0.976 . . . . 0.0 110.324 177.456 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 35.8 m120 -80.27 128.16 33.21 Favored 'General case' 0 C--N 1.261 -3.264 0 CA-C-N 113.557 -1.656 . . . . 0.0 110.448 -179.84 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.1 t -70.34 148.98 10.61 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 C-N-CA 119.282 -0.967 . . . . 0.0 109.954 179.621 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.546 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 0.4 OUTLIER -134.54 101.14 4.86 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 119.0 -1.08 . . . . 0.0 110.699 178.781 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.517 ' O ' ' ND2' ' A' ' 12' ' ' ASN . . . 164.98 -55.4 0.27 Allowed Glycine 0 C--N 1.297 -1.61 1 N-CA-C 131.485 7.354 . . . . 0.0 131.485 179.465 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.503 ' N ' ' OD1' ' A' ' 12' ' ' ASN . 28.7 tt0 -51.47 117.85 2.92 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 118.875 -1.13 . . . . 0.0 110.732 -178.045 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 80.26 -22.37 4.52 Favored Glycine 0 N--CA 1.482 1.711 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -178.506 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.527 ' N ' ' OD1' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -119.8 -159.17 0.77 Allowed 'General case' 0 C--N 1.312 -1.037 0 C-N-CA 120.432 -0.507 . . . . 0.0 109.99 -179.689 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.593 ' N ' ' O ' ' A' ' 40' ' ' VAL . 40.3 tttt -157.98 162.35 38.19 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.654 -179.95 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.546 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -122.97 168.81 11.85 Favored 'General case' 0 CA--C 1.481 -1.706 0 CA-C-O 123.125 1.441 . . . . 0.0 111.638 174.249 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.426 HD12 ' H ' ' A' ' 10' ' ' GLY . 21.6 mm -143.72 130.43 16.95 Favored 'Isoleucine or valine' 0 C--N 1.249 -3.782 0 CA-C-N 111.755 -2.475 . . . . 0.0 108.816 174.324 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 15.2 mt -76.86 126.24 30.64 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 118.275 -1.37 . . . . 0.0 110.016 -179.73 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 36' ' ' LYS . . . -45.24 -73.03 0.3 Allowed Glycine 0 N--CA 1.483 1.794 0 C-N-CA 119.13 -1.51 . . . . 0.0 110.551 179.509 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -125.15 -148.94 0.41 Allowed 'General case' 0 C--O 1.21 -1.002 0 CA-C-O 121.549 0.69 . . . . 0.0 109.19 -179.785 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -77.17 67.47 3.15 Favored 'General case' 0 C--N 1.251 -3.691 0 CA-C-N 114.216 -1.356 . . . . 0.0 110.571 -171.31 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 85.92 21.45 52.88 Favored Glycine 0 C--N 1.282 -2.418 0 N-CA-C 108.518 -1.833 . . . . 0.0 108.518 -179.764 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -104.26 -113.4 0.24 Allowed 'General case' 0 C--N 1.312 -1.056 0 C-N-CA 119.319 -0.952 . . . . 0.0 111.153 -178.365 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.449 ' O ' ' OD1' ' A' ' 37' ' ' ASN . 6.2 mttm -58.91 173.15 0.46 Allowed 'General case' 0 C--N 1.264 -3.137 0 CA-C-N 113.847 -1.524 . . . . 0.0 110.904 -177.819 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.449 ' OD1' ' O ' ' A' ' 36' ' ' LYS . 14.6 m-20 -149.59 162.61 39.85 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.751 -177.805 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.519 ' O ' ' SG ' ' A' ' 28' ' ' CYS . 38.3 tt0 -160.54 147.25 15.53 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 119.383 -0.927 . . . . 0.0 110.488 178.333 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -103.44 107.38 18.19 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 119.885 -0.726 . . . . 0.0 112.378 -179.55 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.593 ' O ' ' N ' ' A' ' 27' ' ' LYS . 0.1 OUTLIER -100.25 141.46 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.571 0 C-N-CA 118.709 -1.196 . . . . 0.0 110.615 174.778 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.9 t -78.79 47.41 0.74 Allowed 'General case' 0 C--N 1.279 -2.471 0 CA-C-N 113.942 -1.481 . . . . 0.0 113.232 -177.882 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -118.47 -124.51 3.37 Favored Glycine 0 N--CA 1.505 3.294 1 N-CA-C 131.198 7.239 . . . . 0.0 131.198 178.172 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -98.1 73.39 2.21 Favored 'General case' 0 N--CA 1.499 1.992 0 C-N-CA 119.412 -0.915 . . . . 0.0 111.215 -178.489 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -92.15 165.22 28.95 Favored Glycine 0 N--CA 1.494 2.559 0 C-N-CA 119.405 -1.378 . . . . 0.0 110.854 -179.597 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.518 ' O ' ' N ' ' A' ' 12' ' ' ASN . 0.5 OUTLIER -129.95 148.3 69.04 Favored Pre-proline 0 N--CA 1.498 1.925 0 C-N-CA 120.128 -0.629 . . . . 0.0 109.721 179.971 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.436 ' O ' ' O ' ' A' ' 45' ' ' THR . 2.7 Cg_exo -52.77 -164.03 0.0 OUTLIER 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 121.414 1.41 . . . . 0.0 111.131 177.717 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -137.39 71.52 52.85 Favored Pre-proline 0 C--N 1.305 -1.353 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.077 178.111 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -68.39 -168.75 0.23 Allowed 'Trans proline' 0 C--N 1.327 -0.585 0 C-N-CA 121.85 1.7 . . . . 0.0 111.882 -174.806 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 . . . . . 0 C--N 1.305 -1.334 0 CA-C-O 116.318 -1.801 . . . . 0.0 110.393 179.474 . . . . . . . . 0 0 . 1 . 031 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 74.6 t . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 . . . . . . . . . 0 0 . 1 . 031 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.0 t -96.0 161.84 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 C-N-CA 119.486 -0.886 . . . . 0.0 110.494 -179.581 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -87.65 -164.53 1.11 Allowed 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 119.909 -0.716 . . . . 0.0 110.417 -179.897 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.2 p -97.59 178.38 5.19 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 119.793 -0.763 . . . . 0.0 108.956 179.742 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -91.17 154.44 19.32 Favored 'General case' 0 C--N 1.297 -1.69 0 C-N-CA 118.796 -1.162 . . . . 0.0 110.322 178.929 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.486 ' SG ' ' O ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -75.13 165.75 24.73 Favored 'General case' 0 C--N 1.299 -1.592 0 C-N-CA 119.886 -0.726 . . . . 0.0 110.899 177.827 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 43.2 p -143.72 17.5 1.81 Allowed 'General case' 0 C--N 1.294 -1.835 0 CA-C-N 114.881 -1.054 . . . . 0.0 108.596 177.123 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -161.15 167.55 25.98 Favored 'General case' 0 C--N 1.288 -2.086 0 CA-C-N 113.64 -1.618 . . . . 0.0 109.853 -179.03 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.515 ' O ' ' N ' ' A' ' 11' ' ' GLN . 0.8 OUTLIER -68.97 -168.37 0.13 Allowed 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 119.043 -1.063 . . . . 0.0 108.765 178.599 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.445 ' H ' HD12 ' A' ' 29' ' ' ILE . . . 24.35 16.89 0.0 OUTLIER Glycine 0 N--CA 1.492 2.421 1 N-CA-C 130.158 6.823 . . . . 0.0 130.158 179.865 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.537 ' NE2' ' OE1' ' A' ' 47' ' ' GLU . 10.8 mt-30 -69.67 -164.97 0.07 Allowed 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 176.218 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.468 ' C ' ' H ' ' A' ' 14' ' ' CYS . 1.7 m-20 -150.43 -70.17 0.18 Allowed 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 117.551 -1.66 . . . . 0.0 113.952 -179.302 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 18.6 mt -77.28 48.96 0.66 Allowed 'General case' 0 C--N 1.272 -2.794 0 C-N-CA 117.705 -1.598 . . . . 0.0 110.189 -176.146 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.468 ' H ' ' C ' ' A' ' 12' ' ' ASN . 26.7 p -125.39 -161.47 1.03 Allowed 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.01 -0.995 . . . . 0.0 109.184 176.517 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.486 ' O ' ' SG ' ' A' ' 6' ' ' CYS . 38.3 mt -112.6 120.84 42.95 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 123.973 0.795 . . . . 0.0 109.131 176.665 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 8.6 m -116.06 -38.54 3.6 Favored 'General case' 0 N--CA 1.503 2.207 0 C-N-CA 119.038 -1.065 . . . . 0.0 111.176 -177.074 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -100.04 76.63 1.94 Allowed 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 119.236 -0.986 . . . . 0.0 110.088 179.236 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 76.1 -94.49 1.01 Allowed Glycine 0 N--CA 1.49 2.282 0 C-N-CA 119.359 -1.401 . . . . 0.0 110.637 179.743 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -125.53 -2.84 7.36 Favored 'General case' 0 N--CA 1.485 1.302 0 CA-C-O 122.058 0.932 . . . . 0.0 110.518 -179.211 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 60.4 m-80 -81.32 136.78 35.78 Favored 'General case' 0 C--N 1.257 -3.452 0 CA-C-N 113.629 -1.623 . . . . 0.0 110.862 -179.248 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.1 t -71.67 147.17 10.95 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 C-N-CA 119.366 -0.934 . . . . 0.0 110.071 179.09 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.441 ' O ' ' O ' ' A' ' 12' ' ' ASN . 6.2 m -149.14 118.56 6.9 Favored 'General case' 0 C--N 1.288 -2.081 0 C-N-CA 118.819 -1.152 . . . . 0.0 108.876 176.486 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.46 ' O ' ' O ' ' A' ' 26' ' ' ASN . . . 179.36 -92.23 0.08 OUTLIER Glycine 0 C--O 1.203 -1.831 0 C-N-CA 117.622 -2.227 . . . . 0.0 112.218 -177.37 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 15.3 tt0 -45.37 131.22 8.31 Favored 'General case' 0 C--N 1.299 -1.612 0 C-N-CA 119.352 -0.939 . . . . 0.0 110.861 -177.472 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.56 -32.15 4.01 Favored Glycine 0 N--CA 1.479 1.515 0 N-CA-C 109.261 -1.536 . . . . 0.0 109.261 -177.819 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.46 ' O ' ' O ' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -129.67 -160.47 1.04 Allowed 'General case' 0 C--N 1.313 -1.0 0 C-N-CA 120.205 -0.598 . . . . 0.0 110.833 -179.801 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.554 ' CG ' ' N ' ' A' ' 28' ' ' CYS . 26.6 tttt -151.51 167.49 27.87 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 177.748 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.554 ' N ' ' CG ' ' A' ' 27' ' ' LYS . 59.6 m -127.62 164.66 21.55 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 119.132 -1.027 . . . . 0.0 111.261 177.001 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.445 HD12 ' H ' ' A' ' 10' ' ' GLY . 20.1 mm -146.2 133.61 15.04 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.278 0 CA-C-N 114.184 -1.371 . . . . 0.0 109.94 176.194 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 18.5 mt -77.42 108.88 10.89 Favored 'General case' 0 N--CA 1.496 1.834 0 C-N-CA 118.952 -1.099 . . . . 0.0 109.381 177.993 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.1 106.78 2.42 Favored Glycine 0 N--CA 1.477 1.403 0 C-N-CA 119.021 -1.561 . . . . 0.0 110.693 179.423 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.532 ' N ' ' O ' ' A' ' 36' ' ' LYS . 1.9 m -76.99 -129.28 0.01 OUTLIER 'General case' 0 C--O 1.2 -1.523 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 178.139 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.494 ' OD1' ' N ' ' A' ' 33' ' ' ASP . 0.6 OUTLIER -74.59 65.88 1.35 Allowed 'General case' 0 C--N 1.25 -3.73 0 CA-C-N 114.702 -1.135 . . . . 0.0 108.512 -175.302 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 32' ' ' SER . . . 75.68 24.23 70.59 Favored Glycine 0 C--N 1.289 -2.05 0 N-CA-C 108.286 -1.926 . . . . 0.0 108.286 -177.433 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -120.3 -134.13 0.31 Allowed 'General case' 0 C--O 1.213 -0.867 0 C-N-CA 119.268 -0.973 . . . . 0.0 111.695 -177.357 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.532 ' O ' ' N ' ' A' ' 32' ' ' SER . 13.6 mmtm -97.49 -168.45 1.69 Allowed 'General case' 0 C--N 1.272 -2.763 0 CA-C-N 113.375 -1.739 . . . . 0.0 113.312 -177.477 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.463 ' OD1' ' N ' ' A' ' 37' ' ' ASN . 1.8 m-20 -59.21 155.18 14.68 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.139 178.249 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -160.58 139.7 10.57 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.94 -0.704 . . . . 0.0 109.64 176.758 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 20.9 m -87.94 103.02 15.29 Favored 'General case' 0 C--N 1.297 -1.677 0 C-N-CA 119.175 -1.01 . . . . 0.0 110.993 -178.772 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.514 ' O ' ' N ' ' A' ' 27' ' ' LYS . 0.4 OUTLIER -100.14 142.07 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.232 0 C-N-CA 118.677 -1.209 . . . . 0.0 111.586 178.837 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.3 t -69.66 141.35 53.63 Favored 'General case' 0 C--N 1.277 -2.584 0 CA-C-N 114.207 -1.36 . . . . 0.0 110.955 179.311 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 157.97 -114.12 0.6 Allowed Glycine 0 N--CA 1.492 2.4 1 N-CA-C 130.492 6.957 . . . . 0.0 130.492 179.686 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -139.43 100.26 3.94 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 119.631 -0.828 . . . . 0.0 109.978 179.286 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -126.46 -175.04 14.0 Favored Glycine 0 N--CA 1.496 2.634 0 N-CA-C 110.33 -1.108 . . . . 0.0 110.33 -179.415 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -137.77 148.47 61.05 Favored Pre-proline 0 N--CA 1.491 1.589 0 C-N-CA 119.84 -0.744 . . . . 0.0 109.78 -179.984 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_exo -48.35 177.2 0.02 OUTLIER 'Trans proline' 0 C--O 1.214 -0.682 0 C-N-CA 121.475 1.45 . . . . 0.0 111.511 179.766 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.585 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 5.1 tp10 -107.02 -41.79 0.14 Allowed Pre-proline 0 CA--C 1.558 1.258 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.747 178.857 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.585 ' CD ' ' N ' ' A' ' 47' ' ' GLU . 4.3 Cg_endo -72.74 130.66 16.08 Favored 'Trans proline' 0 C--O 1.214 -0.688 0 C-N-CA 120.88 1.054 . . . . 0.0 111.165 -176.343 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.691 0 CA-C-O 116.443 -1.742 . . . . 0.0 110.122 179.445 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 43.4 t . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 . . . . . . . . . 0 0 . 1 . 032 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.438 ' CG1' ' H ' ' A' ' 3' ' ' TYR . 6.8 t -79.21 177.76 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 C-N-CA 119.132 -1.027 . . . . 0.0 109.623 179.787 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.438 ' H ' ' CG1' ' A' ' 2' ' ' VAL . 61.1 m-85 -143.07 -172.47 3.68 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.135 -1.026 . . . . 0.0 111.23 -179.794 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.5 ' OG1' ' N ' ' A' ' 5' ' ' ASP . 0.1 OUTLIER -114.45 -165.66 1.03 Allowed 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 115.105 -0.952 . . . . 0.0 108.556 179.232 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.5 ' N ' ' OG1' ' A' ' 4' ' ' THR . 0.7 OUTLIER -92.2 155.05 18.26 Favored 'General case' 0 C--N 1.287 -2.119 0 C-N-CA 118.371 -1.332 . . . . 0.0 110.904 -179.363 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.418 ' N ' ' HB2' ' A' ' 14' ' ' CYS . 0.0 OUTLIER -73.82 171.23 13.74 Favored 'General case' 0 C--N 1.287 -2.148 0 CA-C-N 114.575 -1.193 . . . . 0.0 110.272 178.289 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.5 p -140.94 13.31 2.26 Favored 'General case' 0 C--N 1.294 -1.816 0 C-N-CA 119.367 -0.933 . . . . 0.0 109.687 177.284 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -162.13 174.22 13.25 Favored 'General case' 0 C--N 1.288 -2.108 0 CA-C-N 114.065 -1.425 . . . . 0.0 110.228 179.659 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.43 ' HB3' ' H ' ' A' ' 30' ' ' LEU . 0.7 OUTLIER -85.58 167.2 15.59 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 119.804 -0.758 . . . . 0.0 109.724 -179.945 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' A' ' 28' ' ' CYS . . . 71.34 14.63 74.47 Favored Glycine 0 N--CA 1.503 3.156 0 C-N-CA 119.182 -1.485 . . . . 0.0 112.225 178.693 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -84.52 -174.95 5.56 Favored 'General case' 0 N--CA 1.505 2.298 0 C-N-CA 119.034 -1.066 . . . . 0.0 110.616 179.159 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.519 ' C ' ' H ' ' A' ' 14' ' ' CYS . 10.3 m-20 -153.51 -69.51 0.14 Allowed 'General case' 0 N--CA 1.505 2.299 0 C-N-CA 118.403 -1.319 . . . . 0.0 113.514 -178.048 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 70.2 mt -75.22 45.96 0.3 Allowed 'General case' 0 C--N 1.288 -2.106 0 C-N-CA 118.595 -1.242 . . . . 0.0 109.74 -178.588 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.519 ' H ' ' C ' ' A' ' 12' ' ' ASN . 31.8 p -122.37 -149.5 0.43 Allowed 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 115.233 -0.894 . . . . 0.0 108.884 177.606 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 71.5 mt -120.0 100.18 7.06 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-O 122.25 1.024 . . . . 0.0 109.091 176.347 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.574 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 0.5 OUTLIER -74.21 -69.1 0.47 Allowed 'General case' 0 C--N 1.276 -2.616 0 CA-C-N 113.358 -1.746 . . . . 0.0 110.51 -176.088 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -100.37 95.4 6.74 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 119.029 -1.068 . . . . 0.0 111.302 -179.128 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.17 -95.21 0.84 Allowed Glycine 0 N--CA 1.492 2.398 0 C-N-CA 119.739 -1.219 . . . . 0.0 111.735 177.285 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -127.2 2.49 6.42 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-O 122.061 0.934 . . . . 0.0 110.743 -177.054 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -78.54 129.34 34.71 Favored 'General case' 0 C--N 1.255 -3.501 0 CA-C-N 113.702 -1.59 . . . . 0.0 110.864 -179.868 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.0 t -81.13 138.4 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 118.917 -1.113 . . . . 0.0 110.314 179.113 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.623 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 0.1 OUTLIER -77.94 -135.34 0.02 OUTLIER 'General case' 0 C--N 1.286 -2.184 0 C-N-CA 118.774 -1.171 . . . . 0.0 109.474 172.697 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.539 ' O ' ' ND2' ' A' ' 26' ' ' ASN . . . 179.49 115.83 0.48 Allowed Glycine 0 C--N 1.268 -3.196 0 C-N-CA 117.91 -2.091 . . . . 0.0 111.064 178.973 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.462 ' C ' ' O ' ' A' ' 23' ' ' GLY . 2.3 tt0 -36.22 135.19 0.37 Allowed 'General case' 0 C--N 1.284 -2.24 0 CA-C-N 114.872 -0.664 . . . . 0.0 109.773 176.721 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 116.79 -36.36 3.79 Favored Glycine 0 N--CA 1.486 1.979 0 N-CA-C 107.987 -2.045 . . . . 0.0 107.987 -175.632 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.539 ' ND2' ' O ' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -92.46 -162.46 0.93 Allowed 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 176.557 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.627 ' CB ' ' HZ1' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -151.75 105.25 3.11 Favored 'General case' 0 C--N 1.284 -2.278 0 C-N-CA 118.66 -1.216 . . . . 0.0 110.41 179.284 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.623 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 9.9 m -77.62 159.47 29.19 Favored 'General case' 0 C--O 1.196 -1.725 0 C-N-CA 117.908 -1.517 . . . . 0.0 110.692 -179.595 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.454 HD12 ' HZ2' ' A' ' 27' ' ' LYS . 27.9 mm -141.69 132.41 26.04 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.06 0 CA-C-N 114.005 -1.452 . . . . 0.0 110.207 177.817 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.431 ' CD2' HD22 ' A' ' 37' ' ' ASN . 20.3 mt -77.99 121.71 24.57 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 119.338 -0.945 . . . . 0.0 110.156 177.799 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.71 104.66 0.71 Allowed Glycine 0 N--CA 1.483 1.825 0 C-N-CA 119.23 -1.462 . . . . 0.0 110.603 178.06 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.578 ' O ' ' N ' ' A' ' 34' ' ' GLY . 19.3 m -90.94 -125.64 0.08 Allowed 'General case' 0 C--O 1.196 -1.731 0 C-N-CA 119.211 -0.995 . . . . 0.0 109.062 178.739 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -69.66 63.03 0.18 Allowed 'General case' 0 C--N 1.263 -3.166 0 CA-C-N 114.33 -1.304 . . . . 0.0 109.243 -175.14 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.578 ' N ' ' O ' ' A' ' 32' ' ' SER . . . 69.27 29.34 71.98 Favored Glycine 0 C--N 1.285 -2.28 0 N-CA-C 107.953 -2.059 . . . . 0.0 107.953 -176.336 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -124.93 -132.69 0.26 Allowed 'General case' 0 C--O 1.214 -0.774 0 CA-C-O 122.24 1.019 . . . . 0.0 112.223 -176.753 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.541 ' O ' ' N ' ' A' ' 32' ' ' SER . 53.6 mttp -97.0 -161.69 0.89 Allowed 'General case' 0 C--N 1.275 -2.649 0 CA-C-N 113.062 -1.881 . . . . 0.0 111.744 -177.421 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.58 ' OD1' ' N ' ' A' ' 37' ' ' ASN . 0.1 OUTLIER -75.31 155.83 36.21 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.751 178.243 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -154.75 137.18 15.01 Favored 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 119.492 -0.883 . . . . 0.0 109.368 176.694 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.574 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 2.0 m -78.97 105.99 10.69 Favored 'General case' 0 C--N 1.29 -1.994 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.844 -176.666 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.495 ' O ' ' O ' ' A' ' 27' ' ' LYS . 2.4 p -111.97 143.37 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.354 0 C-N-CA 118.395 -1.322 . . . . 0.0 110.996 175.85 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.2 t -66.24 150.2 49.16 Favored 'General case' 0 C--N 1.269 -2.899 0 CA-C-N 113.626 -1.625 . . . . 0.0 112.251 -178.348 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 165.31 -120.28 0.92 Allowed Glycine 0 N--CA 1.486 2.012 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 178.373 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -160.87 81.78 0.65 Allowed 'General case' 0 C--N 1.299 -1.587 0 C-N-CA 119.408 -0.917 . . . . 0.0 109.447 178.58 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -100.25 -158.88 28.15 Favored Glycine 0 N--CA 1.492 2.43 0 C-N-CA 119.853 -1.165 . . . . 0.0 110.949 -178.035 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -130.35 152.18 79.8 Favored Pre-proline 0 N--CA 1.493 1.681 0 C-N-CA 119.942 -0.703 . . . . 0.0 109.842 -179.759 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -55.85 -175.43 0.04 OUTLIER 'Trans proline' 0 C--O 1.214 -0.712 0 C-N-CA 121.475 1.45 . . . . 0.0 111.2 177.304 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -87.02 123.17 70.66 Favored Pre-proline 0 CA--C 1.558 1.255 0 C-N-CA 119.458 -0.897 . . . . 0.0 109.753 178.587 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -59.76 156.36 38.23 Favored 'Trans proline' 0 C--O 1.216 -0.619 0 C-N-CA 120.403 0.735 . . . . 0.0 111.092 179.942 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 116.234 -1.841 . . . . 0.0 110.381 179.921 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.0 t . . . . . 0 N--CA 1.488 1.437 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.506 ' CE2' HD22 ' A' ' 13' ' ' LEU . 67.8 m-85 -126.05 -166.91 1.63 Allowed 'General case' 0 N--CA 1.499 1.981 0 C-N-CA 119.608 -0.837 . . . . 0.0 110.993 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 7.7 p -105.71 179.92 4.13 Favored 'General case' 0 C--O 1.199 -1.568 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.256 -179.211 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.471 ' OD1' ' N ' ' A' ' 5' ' ' ASP . 0.3 OUTLIER -83.54 156.84 22.6 Favored 'General case' 0 C--N 1.295 -1.802 0 C-N-CA 118.365 -1.334 . . . . 0.0 110.597 179.846 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.468 ' N ' ' HB2' ' A' ' 14' ' ' CYS . 0.1 OUTLIER -75.6 -178.64 4.24 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.666 178.127 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.3 p -123.72 -20.82 5.36 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 114.953 -1.022 . . . . 0.0 109.791 176.615 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.552 ' C ' HD21 ' A' ' 30' ' ' LEU . 2.8 mt-10 -162.52 162.44 27.38 Favored 'General case' 0 C--N 1.276 -2.587 0 CA-C-N 114.236 -1.347 . . . . 0.0 111.712 -178.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.425 ' HA ' ' H ' ' A' ' 30' ' ' LEU . 0.3 OUTLIER -62.87 143.07 57.97 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 115.014 -0.994 . . . . 0.0 108.753 179.439 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.527 ' HA2' ' HE3' ' A' ' 27' ' ' LYS . . . 108.24 -26.76 15.83 Favored Glycine 0 N--CA 1.487 2.094 1 N-CA-C 126.837 5.495 . . . . 0.0 126.837 -171.741 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.407 ' C ' ' OD1' ' A' ' 12' ' ' ASN . 55.0 mt-30 -71.26 -171.38 0.59 Allowed 'General case' 0 N--CA 1.497 1.9 0 CA-C-N 114.642 -0.779 . . . . 0.0 109.889 178.684 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.498 ' O ' ' HA3' ' A' ' 23' ' ' GLY . 4.3 m-20 -135.53 -69.98 0.49 Allowed 'General case' 0 N--CA 1.509 2.477 0 N-CA-C 114.558 1.318 . . . . 0.0 114.558 -175.284 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.506 HD22 ' CE2' ' A' ' 3' ' ' TYR . 50.9 mt -77.45 50.32 0.79 Allowed 'General case' 0 C--N 1.277 -2.565 0 C-N-CA 118.403 -1.319 . . . . 0.0 111.006 -175.774 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.468 ' HB2' ' N ' ' A' ' 6' ' ' CYS . 29.8 p -123.81 -161.02 0.95 Allowed 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 119.577 -0.849 . . . . 0.0 109.98 175.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.436 ' O ' ' SG ' ' A' ' 6' ' ' CYS . 39.9 mt -113.28 121.65 45.07 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.495 176.625 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -128.56 -31.42 2.25 Favored 'General case' 0 N--CA 1.51 2.565 0 C-N-CA 118.899 -1.121 . . . . 0.0 110.48 -179.744 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.418 ' O ' ' N ' ' A' ' 19' ' ' SER . 0.6 OUTLIER -87.16 82.13 7.77 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 119.09 -1.044 . . . . 0.0 108.796 177.708 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 64.94 -81.4 0.07 OUTLIER Glycine 0 N--CA 1.488 2.131 0 C-N-CA 119.23 -1.462 . . . . 0.0 109.593 -178.011 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.418 ' N ' ' O ' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -141.34 0.22 1.48 Allowed 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 122.018 0.914 . . . . 0.0 110.643 178.656 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -83.56 149.11 26.79 Favored 'General case' 0 C--N 1.26 -3.303 0 CA-C-N 113.84 -1.527 . . . . 0.0 110.333 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.5 t -68.56 148.19 11.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 C-N-CA 119.102 -1.039 . . . . 0.0 110.983 -178.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.56 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 0.0 OUTLIER -149.64 107.88 3.76 Favored 'General case' 0 C--N 1.287 -2.125 0 CA-C-N 114.832 -1.076 . . . . 0.0 109.852 -179.789 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.498 ' HA3' ' O ' ' A' ' 12' ' ' ASN . . . 159.47 -45.04 0.44 Allowed Glycine 0 N--CA 1.489 2.183 1 N-CA-C 131.612 7.405 . . . . 0.0 131.612 -177.244 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -53.88 118.81 4.27 Favored 'General case' 0 C--N 1.306 -1.296 0 C-N-CA 118.652 -1.219 . . . . 0.0 110.547 -179.582 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.72 -19.62 6.01 Favored Glycine 0 N--CA 1.48 1.582 0 C-N-CA 119.399 -1.381 . . . . 0.0 110.084 -179.389 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.451 ' O ' ' O ' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -121.15 -169.7 1.89 Allowed 'General case' 0 C--O 1.213 -0.86 0 C-N-CA 119.953 -0.699 . . . . 0.0 110.074 -179.712 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.527 ' HE3' ' HA2' ' A' ' 10' ' ' GLY . 21.0 ttpt -152.47 119.98 6.01 Favored 'General case' 0 N--CA 1.495 1.786 0 C-N-CA 118.573 -1.251 . . . . 0.0 110.978 177.193 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.56 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -83.75 165.63 18.7 Favored 'General case' 0 CA--C 1.476 -1.873 0 C-N-CA 117.6 -1.64 . . . . 0.0 111.805 179.228 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 7.5 mm -131.47 90.3 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.261 -3.252 0 CA-C-N 112.006 -2.361 . . . . 0.0 108.854 175.315 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.552 HD21 ' C ' ' A' ' 8' ' ' GLU . 2.1 pp . . . . . 0 C--N 1.305 -1.358 0 C-N-CA 118.694 -1.202 . . . . 0.0 111.52 -177.664 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 120.615 0.245 . . . . 0.0 110.383 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 23.3 tt0 -161.82 156.0 22.12 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 119.302 -0.959 . . . . 0.0 110.394 176.554 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.51 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 0.1 OUTLIER -103.54 120.9 41.78 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 113.472 0.915 . . . . 0.0 113.472 179.934 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.512 ' CG2' ' N ' ' A' ' 41' ' ' THR . 2.4 p -131.44 158.75 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 CA-C-N 114.751 -1.113 . . . . 0.0 110.477 173.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.512 ' N ' ' CG2' ' A' ' 40' ' ' VAL . 0.0 OUTLIER -83.02 144.04 30.21 Favored 'General case' 0 C--N 1.278 -2.531 0 CA-C-N 114.76 -1.109 . . . . 0.0 111.755 179.995 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 177.94 -124.99 0.97 Allowed Glycine 0 N--CA 1.492 2.369 1 N-CA-C 131.092 7.197 . . . . 0.0 131.092 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -130.96 109.02 10.23 Favored 'General case' 0 N--CA 1.497 1.875 0 C-N-CA 119.998 -0.681 . . . . 0.0 110.058 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -158.12 -162.56 11.88 Favored Glycine 0 N--CA 1.494 2.535 0 C-N-CA 119.044 -1.55 . . . . 0.0 110.962 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -144.04 155.25 58.76 Favored Pre-proline 0 N--CA 1.489 1.508 0 C-N-CA 119.476 -0.89 . . . . 0.0 110.378 -179.135 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -54.46 148.8 41.31 Favored 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 121.836 1.691 . . . . 0.0 111.325 175.22 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.558 1.282 0 C-N-CA 119.462 -0.895 . . . . 0.0 112.57 178.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.486 HG12 ' N ' ' A' ' 3' ' ' TYR . 10.5 t . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.486 ' N ' HG12 ' A' ' 2' ' ' VAL . 44.5 m-85 -97.87 -168.95 1.75 Allowed 'General case' 0 C--N 1.298 -1.636 0 C-N-CA 119.095 -1.042 . . . . 0.0 110.31 -179.524 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.581 ' OG1' ' N ' ' A' ' 5' ' ' ASP . 0.1 OUTLIER -105.31 -178.36 3.63 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 179.543 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.581 ' N ' ' OG1' ' A' ' 4' ' ' THR . 0.3 OUTLIER -88.46 157.43 18.66 Favored 'General case' 0 C--N 1.287 -2.14 0 C-N-CA 118.559 -1.257 . . . . 0.0 110.297 179.543 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.408 ' SG ' ' CB ' ' A' ' 11' ' ' GLN . 1.5 m -73.17 176.7 5.63 Favored 'General case' 0 C--N 1.289 -2.056 0 CA-C-N 115.102 -0.953 . . . . 0.0 111.1 177.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.2 p -123.56 -19.38 5.85 Favored 'General case' 0 C--N 1.289 -2.054 0 CA-C-N 113.792 -1.549 . . . . 0.0 109.793 176.804 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.505 ' C ' HD21 ' A' ' 30' ' ' LEU . 3.5 pt-20 -163.12 163.24 25.81 Favored 'General case' 0 C--N 1.269 -2.917 0 CA-C-N 113.824 -1.535 . . . . 0.0 110.46 178.522 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.436 ' HA ' ' H ' ' A' ' 30' ' ' LEU . 0.7 OUTLIER -66.58 159.93 26.39 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.982 -177.828 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.44 -23.42 32.15 Favored Glycine 0 N--CA 1.507 3.426 0 C-N-CA 119.282 -1.437 . . . . 0.0 112.03 -179.034 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.687 HE21 ' HA ' ' A' ' 47' ' ' GLU . 4.2 mt-30 -62.22 -166.08 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.266 0 C-N-CA 119.765 -0.774 . . . . 0.0 111.163 -178.605 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.528 ' N ' ' O ' ' A' ' 45' ' ' THR . 22.5 t-20 -144.2 -78.94 0.2 Allowed 'General case' 0 N--CA 1.502 2.158 0 N-CA-C 114.629 1.344 . . . . 0.0 114.629 -176.187 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.464 ' O ' ' OE2' ' A' ' 47' ' ' GLU . 87.1 mt -75.25 48.66 0.43 Allowed 'General case' 0 C--N 1.275 -2.672 0 C-N-CA 118.597 -1.241 . . . . 0.0 111.072 -173.73 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.744 ' O ' HG22 ' A' ' 21' ' ' VAL . 7.8 p -120.91 -151.87 0.49 Allowed 'General case' 0 N--CA 1.497 1.92 0 C-N-CA 119.183 -1.007 . . . . 0.0 110.729 177.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.654 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 7.7 mt -123.6 133.21 53.98 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 114.179 -1.373 . . . . 0.0 110.395 179.266 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.7 m -120.59 -68.1 0.93 Allowed 'General case' 0 N--CA 1.503 2.181 0 C-N-CA 119.306 -0.957 . . . . 0.0 110.401 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -84.55 88.0 7.29 Favored 'General case' 0 C--N 1.298 -1.65 0 C-N-CA 119.178 -1.009 . . . . 0.0 110.143 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 70.25 -123.69 12.57 Favored Glycine 0 N--CA 1.487 2.064 0 C-N-CA 119.562 -1.304 . . . . 0.0 111.21 178.602 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.406 ' O ' ' OG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -98.87 1.93 46.19 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 121.871 0.843 . . . . 0.0 110.974 -177.713 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -79.61 128.18 33.07 Favored 'General case' 0 C--N 1.253 -3.611 0 CA-C-N 114.003 -1.453 . . . . 0.0 110.726 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.744 HG22 ' O ' ' A' ' 14' ' ' CYS . 0.9 OUTLIER -78.59 148.75 5.98 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.026 0 C-N-CA 119.088 -1.045 . . . . 0.0 109.495 179.112 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.462 ' O ' ' O ' ' A' ' 12' ' ' ASN . 3.2 m -148.13 122.84 9.89 Favored 'General case' 0 C--N 1.285 -2.218 0 C-N-CA 118.418 -1.313 . . . . 0.0 110.547 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.452 ' O ' ' O ' ' A' ' 26' ' ' ASN . . . 170.66 -87.6 0.09 OUTLIER Glycine 0 C--O 1.197 -2.173 0 C-N-CA 118.425 -1.845 . . . . 0.0 111.76 -177.743 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.447 ' N ' ' OD1' ' A' ' 12' ' ' ASN . 43.2 tt0 -40.08 128.47 2.22 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 120.08 -0.648 . . . . 0.0 111.283 -177.886 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.07 -24.08 17.7 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 109.012 -1.635 . . . . 0.0 109.012 -177.822 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.452 ' O ' ' O ' ' A' ' 23' ' ' GLY . 5.5 m120 -143.79 -162.33 1.44 Allowed 'General case' 0 N--CA 1.493 1.713 0 CA-C-N 114.773 -0.713 . . . . 0.0 109.737 179.311 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.469 ' O ' ' O ' ' A' ' 40' ' ' VAL . 0.5 OUTLIER -139.06 143.48 38.39 Favored 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 119.646 -0.822 . . . . 0.0 109.035 175.786 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -89.66 160.99 16.34 Favored 'General case' 0 C--N 1.298 -1.657 0 C-N-CA 117.719 -1.593 . . . . 0.0 111.101 179.706 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.436 ' O ' HG22 ' A' ' 29' ' ' ILE . 20.1 mm -147.54 94.28 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.255 -3.521 0 CA-C-N 112.523 -2.126 . . . . 0.0 108.496 176.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.505 HD21 ' C ' ' A' ' 8' ' ' GLU . 1.8 pp . . . . . 0 N--CA 1.484 1.236 0 C-N-CA 118.815 -1.154 . . . . 0.0 112.501 -176.761 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 . . . . . 0 N--CA 1.481 1.098 0 CA-C-O 120.656 0.265 . . . . 0.0 111.114 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.414 ' CG ' ' N ' ' A' ' 39' ' ' CYS . 10.8 tt0 -161.71 157.49 24.48 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 119.179 -1.008 . . . . 0.0 111.11 179.574 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.414 ' N ' ' CG ' ' A' ' 38' ' ' GLN . 7.1 m -109.39 94.89 5.27 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.799 178.39 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.469 ' O ' ' O ' ' A' ' 27' ' ' LYS . 0.5 OUTLIER -102.54 145.59 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.568 0 C-N-CA 118.712 -1.195 . . . . 0.0 112.736 -177.892 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.5 t -66.18 143.85 57.01 Favored 'General case' 0 C--N 1.285 -2.235 0 CA-C-N 114.061 -1.427 . . . . 0.0 111.52 177.206 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 152.23 -159.27 28.28 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -179.595 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.401 ' O ' ' CG ' ' A' ' 43' ' ' GLU . 5.8 pt-20 -104.93 113.41 26.99 Favored 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 119.546 -0.861 . . . . 0.0 110.273 179.561 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -114.39 -168.54 16.17 Favored Glycine 0 N--CA 1.5 2.913 0 C-N-CA 120.053 -1.07 . . . . 0.0 110.555 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.528 ' O ' ' N ' ' A' ' 12' ' ' ASN . 0.5 OUTLIER -141.72 148.6 50.32 Favored Pre-proline 0 N--CA 1.493 1.676 0 C-N-CA 119.55 -0.86 . . . . 0.0 110.421 -179.767 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -57.17 167.72 3.16 Favored 'Trans proline' 0 C--O 1.214 -0.683 0 C-N-CA 121.724 1.616 . . . . 0.0 111.949 179.574 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.687 ' HA ' HE21 ' A' ' 11' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.524 0 C-N-CA 119.544 -0.863 . . . . 0.0 109.971 179.684 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 1.5 t . . . . . 0 N--CA 1.486 1.326 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -131.08 -161.91 1.17 Allowed 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 119.865 -0.734 . . . . 0.0 111.301 -178.815 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.07 -176.82 3.54 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.024 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.509 ' N ' ' OD1' ' A' ' 5' ' ' ASP . 0.1 OUTLIER -97.48 156.54 16.44 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.139 -1.025 . . . . 0.0 110.493 178.127 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.503 ' SG ' ' O ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -74.91 151.7 38.89 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.518 177.857 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.475 HG22 ' O ' ' A' ' 7' ' ' THR . 1.4 m -116.65 -3.94 11.73 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 119.68 -0.808 . . . . 0.0 111.114 178.88 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.509 ' HA ' HD12 ' A' ' 30' ' ' LEU . 0.2 OUTLIER -160.34 178.2 9.84 Favored 'General case' 0 C--N 1.275 -2.647 0 CA-C-N 114.785 -1.098 . . . . 0.0 110.906 -179.289 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.401 ' HB3' ' H ' ' A' ' 30' ' ' LEU . 0.3 OUTLIER -79.27 140.64 37.54 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.912 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.572 ' HA2' ' HE3' ' A' ' 27' ' ' LYS . . . 98.65 -16.97 59.03 Favored Glycine 0 N--CA 1.507 3.369 1 N-CA-C 128.641 6.216 . . . . 0.0 128.641 -174.525 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.44 ' O ' ' O ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -51.89 -169.04 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 114.471 -0.864 . . . . 0.0 110.984 179.742 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.473 ' C ' ' H ' ' A' ' 14' ' ' CYS . 15.8 t-20 -140.68 -83.22 0.23 Allowed 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 118.486 -1.286 . . . . 0.0 113.044 -179.07 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.451 ' O ' ' OE2' ' A' ' 47' ' ' GLU . 60.6 mt -75.42 45.28 0.29 Allowed 'General case' 0 C--N 1.276 -2.627 0 C-N-CA 117.71 -1.596 . . . . 0.0 109.916 -175.53 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.486 ' HB2' ' N ' ' A' ' 6' ' ' CYS . 31.1 p -109.23 -158.16 0.64 Allowed 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 119.318 -0.953 . . . . 0.0 109.362 178.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.503 ' O ' ' SG ' ' A' ' 6' ' ' CYS . 6.0 mt -124.09 129.49 50.96 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.336 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 89.8 m -120.91 -65.95 1.1 Allowed 'General case' 0 N--CA 1.502 2.127 0 C-N-CA 119.408 -0.917 . . . . 0.0 111.498 -177.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -79.56 85.48 5.3 Favored 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 118.87 -1.132 . . . . 0.0 110.816 -178.235 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 72.54 -92.55 0.6 Allowed Glycine 0 N--CA 1.491 2.326 0 C-N-CA 119.526 -1.321 . . . . 0.0 110.827 179.171 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.448 ' O ' ' OG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -133.58 4.55 3.65 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-O 122.264 1.031 . . . . 0.0 110.463 -178.931 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 28.0 m-80 -80.54 130.46 35.15 Favored 'General case' 0 C--N 1.254 -3.577 0 CA-C-N 113.485 -1.689 . . . . 0.0 109.787 178.311 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.401 HG22 ' O ' ' A' ' 14' ' ' CYS . 1.4 t -69.8 149.24 10.79 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 C-N-CA 119.195 -1.002 . . . . 0.0 110.547 -179.426 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.452 ' O ' ' O ' ' A' ' 12' ' ' ASN . 12.7 m -145.82 116.17 7.53 Favored 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 118.453 -1.299 . . . . 0.0 110.419 177.451 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 26' ' ' ASN . . . 170.39 -68.08 0.15 Allowed Glycine 0 C--O 1.203 -1.793 0 C-N-CA 118.261 -1.923 . . . . 0.0 112.598 -177.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -56.91 111.61 1.08 Allowed 'General case' 0 C--N 1.298 -1.65 0 C-N-CA 118.917 -1.113 . . . . 0.0 110.827 -177.593 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.418 ' C ' ' ND2' ' A' ' 26' ' ' ASN . . . 99.27 -14.77 60.88 Favored Glycine 0 N--CA 1.484 1.844 0 N-CA-C 109.959 -1.256 . . . . 0.0 109.959 -179.022 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.463 ' O ' ' O ' ' A' ' 23' ' ' GLY . 8.6 m-80 -149.3 -167.72 2.91 Favored 'General case' 0 N--CA 1.494 1.762 0 C-N-CA 119.255 -0.978 . . . . 0.0 111.409 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.572 ' HE3' ' HA2' ' A' ' 10' ' ' GLY . 12.6 tttp -134.61 165.17 25.84 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.155 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.513 ' N ' ' CG ' ' A' ' 27' ' ' LYS . 0.1 OUTLIER -127.4 160.3 31.83 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 118.889 -1.124 . . . . 0.0 110.686 177.968 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.444 HD13 ' O ' ' A' ' 28' ' ' CYS . 7.7 mm -138.85 126.75 27.6 Favored 'Isoleucine or valine' 0 C--N 1.255 -3.506 0 CA-C-N 113.088 -1.869 . . . . 0.0 109.639 177.625 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.509 HD12 ' HA ' ' A' ' 8' ' ' GLU . 19.5 mt . . . . . 0 N--CA 1.495 1.792 0 C-N-CA 118.28 -1.368 . . . . 0.0 110.307 178.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.5 ' N ' ' OD1' ' A' ' 37' ' ' ASN . 0.1 OUTLIER . . . . . 0 N--CA 1.485 1.307 0 CA-C-O 121.258 0.551 . . . . 0.0 111.678 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -159.2 152.92 22.98 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.286 175.629 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 9.6 m -112.14 112.48 24.12 Favored 'General case' 0 C--N 1.298 -1.66 0 C-N-CA 119.729 -0.788 . . . . 0.0 111.737 -177.151 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.465 ' O ' ' O ' ' A' ' 27' ' ' LYS . 1.3 p -123.43 140.82 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.323 0 C-N-CA 118.745 -1.182 . . . . 0.0 112.668 177.823 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.5 t -41.28 157.44 0.02 OUTLIER 'General case' 0 C--N 1.283 -2.304 0 CA-C-N 113.371 -1.74 . . . . 0.0 111.255 178.733 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.433 ' O ' ' OE1' ' A' ' 43' ' ' GLU . . . 150.04 -120.43 1.14 Allowed Glycine 0 N--CA 1.49 2.275 1 N-CA-C 130.274 6.87 . . . . 0.0 130.274 179.557 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.433 ' OE1' ' O ' ' A' ' 42' ' ' GLY . 1.3 tp10 -154.34 104.53 2.6 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 119.37 -0.932 . . . . 0.0 109.974 179.161 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -128.57 179.94 16.29 Favored Glycine 0 N--CA 1.495 2.579 0 C-N-CA 119.867 -1.158 . . . . 0.0 110.695 -179.389 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -130.54 153.65 81.48 Favored Pre-proline 0 N--CA 1.495 1.817 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -53.16 163.97 2.02 Favored 'Trans proline' 0 C--O 1.214 -0.688 0 C-N-CA 121.153 1.236 . . . . 0.0 110.477 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.656 ' H ' ' CD ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.534 0 C-N-CA 118.911 -1.116 . . . . 0.0 109.755 -179.383 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.516 HG12 ' N ' ' A' ' 3' ' ' TYR . 12.8 t . . . . . 0 N--CA 1.484 1.229 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.516 ' N ' HG12 ' A' ' 2' ' ' VAL . 8.4 m-85 -112.29 -166.09 1.05 Allowed 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 119.986 -0.686 . . . . 0.0 109.666 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.431 ' OG1' ' OE1' ' A' ' 47' ' ' GLU . 2.9 p -97.51 177.75 5.41 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 178.719 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.405 ' O ' ' OE2' ' A' ' 47' ' ' GLU . 0.2 OUTLIER -88.46 155.51 19.63 Favored 'General case' 0 C--N 1.293 -1.864 0 C-N-CA 118.458 -1.297 . . . . 0.0 110.066 178.583 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.42 ' SG ' ' O ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -75.4 166.66 23.26 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.693 178.108 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 14.0 p -133.95 2.33 3.37 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 119.431 -0.908 . . . . 0.0 110.39 177.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.496 ' HA ' HD12 ' A' ' 30' ' ' LEU . 0.3 OUTLIER -162.52 -178.7 6.41 Favored 'General case' 0 C--N 1.28 -2.435 0 CA-C-N 114.631 -1.168 . . . . 0.0 111.253 178.894 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -82.27 158.71 23.38 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.535 -178.215 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.498 ' N ' ' O ' ' A' ' 28' ' ' CYS . . . 82.87 -18.0 18.44 Favored Glycine 0 N--CA 1.497 2.706 0 C-N-CA 119.853 -1.165 . . . . 0.0 112.573 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -53.05 170.35 0.08 Allowed 'General case' 0 N--CA 1.501 2.12 0 C-N-CA 119.03 -1.068 . . . . 0.0 110.226 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.504 ' C ' ' H ' ' A' ' 14' ' ' CYS . 1.2 m120 -144.56 -63.42 0.36 Allowed 'General case' 0 N--CA 1.499 2.011 0 C-N-CA 118.317 -1.353 . . . . 0.0 113.433 -179.088 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 49.7 mt -76.5 41.85 0.26 Allowed 'General case' 0 C--N 1.287 -2.136 0 C-N-CA 119.011 -1.076 . . . . 0.0 109.811 -177.769 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.504 ' H ' ' C ' ' A' ' 12' ' ' ASN . 31.6 p -121.94 -157.67 0.74 Allowed 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 114.906 -1.043 . . . . 0.0 108.801 177.728 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.45 HD22 ' O ' ' A' ' 19' ' ' SER . 40.6 mt -108.7 107.12 17.45 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 115.21 -0.904 . . . . 0.0 108.679 175.553 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.407 ' HB2' ' SG ' ' A' ' 39' ' ' CYS . 68.4 m -96.32 -74.29 0.57 Allowed 'General case' 0 C--N 1.278 -2.532 0 CA-C-N 114.167 -1.379 . . . . 0.0 111.235 -174.798 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -84.73 115.62 22.79 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 118.601 -1.239 . . . . 0.0 110.102 179.373 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 66.42 -107.69 2.09 Favored Glycine 0 N--CA 1.489 2.193 0 C-N-CA 119.324 -1.417 . . . . 0.0 110.448 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.45 ' O ' HD22 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -134.6 4.68 3.38 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-O 122.197 0.999 . . . . 0.0 110.185 -179.804 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -79.13 152.87 30.51 Favored 'General case' 0 C--N 1.261 -3.281 0 CA-C-N 113.431 -1.713 . . . . 0.0 110.607 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.2 t -85.9 142.39 13.2 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 C-N-CA 119.195 -1.002 . . . . 0.0 112.117 -177.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.454 ' O ' ' O ' ' A' ' 12' ' ' ASN . 0.1 OUTLIER -99.96 150.32 22.53 Favored 'General case' 0 N--CA 1.508 2.457 0 CA-C-N 114.964 -1.016 . . . . 0.0 108.94 169.295 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.448 ' O ' ' C ' ' A' ' 24' ' ' GLN . . . -113.81 110.81 2.51 Favored Glycine 0 CA--C 1.482 -2.031 0 C-N-CA 119.652 -1.261 . . . . 0.0 110.487 -169.118 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.448 ' C ' ' O ' ' A' ' 23' ' ' GLY . 0.2 OUTLIER -32.93 117.29 0.25 Allowed 'General case' 0 C--N 1.252 -3.64 0 CA-C-N 111.974 -2.113 . . . . 0.0 109.941 175.933 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 146.28 -25.69 1.71 Allowed Glycine 0 C--N 1.283 -2.401 0 N-CA-C 105.005 -3.238 . . . . 0.0 105.005 -174.245 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.539 ' OD1' ' N ' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -110.72 -172.39 2.02 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 113.208 -1.496 . . . . 0.0 107.292 175.056 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.462 ' O ' ' O ' ' A' ' 40' ' ' VAL . 21.9 tttm -144.18 108.86 4.9 Favored 'General case' 0 N--CA 1.502 2.133 0 C-N-CA 118.512 -1.275 . . . . 0.0 110.933 178.217 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.562 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 3.6 m -84.17 152.2 24.41 Favored 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 117.722 -1.591 . . . . 0.0 110.136 178.075 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.448 HD12 ' HZ1' ' A' ' 27' ' ' LYS . 2.1 mm -127.68 131.0 70.38 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.288 0 CA-C-N 114.382 -1.281 . . . . 0.0 109.39 177.212 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.496 HD12 ' HA ' ' A' ' 8' ' ' GLU . 17.5 mt . . . . . 0 N--CA 1.497 1.909 0 C-N-CA 118.471 -1.292 . . . . 0.0 110.162 178.474 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.0 p30 . . . . . 0 C--O 1.214 -0.778 0 CA-C-O 121.558 0.694 . . . . 0.0 111.815 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -155.37 149.72 26.01 Favored 'General case' 0 C--N 1.295 -1.782 0 CA-C-N 114.828 -1.078 . . . . 0.0 108.982 176.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.562 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 1.3 m -107.92 93.32 4.47 Favored 'General case' 0 C--N 1.296 -1.741 0 C-N-CA 119.608 -0.837 . . . . 0.0 111.2 -177.507 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.462 ' O ' ' O ' ' A' ' 27' ' ' LYS . 0.9 OUTLIER -107.7 143.41 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.31 0 C-N-CA 118.816 -1.154 . . . . 0.0 110.759 179.027 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.413 ' O ' HG22 ' A' ' 40' ' ' VAL . 7.1 t -50.94 157.89 0.77 Allowed 'General case' 0 C--N 1.274 -2.697 0 CA-C-N 114.31 -1.314 . . . . 0.0 111.036 -178.366 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 153.52 -154.97 25.86 Favored Glycine 0 N--CA 1.492 2.424 0 C-N-CA 119.528 -1.32 . . . . 0.0 110.748 179.523 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -122.83 67.52 0.97 Allowed 'General case' 0 N--CA 1.498 1.947 0 C-N-CA 120.039 -0.664 . . . . 0.0 110.215 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -74.01 173.34 50.56 Favored Glycine 0 N--CA 1.491 2.346 0 C-N-CA 119.425 -1.369 . . . . 0.0 110.523 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -106.22 145.56 31.21 Favored Pre-proline 0 N--CA 1.491 1.616 0 C-N-CA 119.679 -0.808 . . . . 0.0 109.527 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -62.63 130.85 31.15 Favored 'Trans proline' 0 C--O 1.216 -0.615 0 C-N-CA 120.901 1.067 . . . . 0.0 110.872 176.669 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.431 ' OE1' ' OG1' ' A' ' 4' ' ' THR . 1.0 OUTLIER . . . . . 0 C--N 1.3 -1.566 0 C-N-CA 119.547 -0.861 . . . . 0.0 110.362 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.51 HG12 ' H ' ' A' ' 3' ' ' TYR . 2.7 t . . . . . 0 N--CA 1.496 1.872 0 CA-C-O 120.696 0.284 . . . . 0.0 111.143 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.51 ' H ' HG12 ' A' ' 2' ' ' VAL . 52.1 m-85 -123.94 -173.69 2.81 Favored 'General case' 0 N--CA 1.5 2.026 0 C-N-CA 119.931 -0.707 . . . . 0.0 110.652 179.72 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -101.52 173.0 6.63 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 115.171 -0.922 . . . . 0.0 108.557 178.241 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.531 ' N ' ' OD1' ' A' ' 5' ' ' ASP . 0.0 OUTLIER -91.06 152.23 20.72 Favored 'General case' 0 C--N 1.294 -1.826 0 C-N-CA 118.489 -1.285 . . . . 0.0 108.877 176.684 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.412 ' N ' ' HB2' ' A' ' 14' ' ' CYS . 1.3 m -75.41 179.88 4.95 Favored 'General case' 0 C--N 1.29 -2.018 0 C-N-CA 119.221 -0.992 . . . . 0.0 111.019 179.154 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.1 t -150.56 16.84 0.8 Allowed 'General case' 0 C--N 1.281 -2.412 0 CA-C-N 113.601 -1.636 . . . . 0.0 109.393 177.824 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -159.42 175.08 13.75 Favored 'General case' 0 C--N 1.29 -1.991 0 CA-C-N 114.443 -1.253 . . . . 0.0 110.643 -178.743 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -76.88 -170.27 1.56 Allowed 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.265 179.506 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.572 ' HA2' ' O ' ' A' ' 28' ' ' CYS . . . 26.1 18.23 0.0 OUTLIER Glycine 0 N--CA 1.503 3.126 1 N-CA-C 130.913 7.125 . . . . 0.0 130.913 178.974 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -87.76 -166.88 1.71 Allowed 'General case' 0 N--CA 1.503 2.216 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 176.406 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.496 ' C ' ' H ' ' A' ' 14' ' ' CYS . 10.6 m120 -151.48 -55.5 0.14 Allowed 'General case' 0 N--CA 1.503 2.183 0 N-CA-C 116.612 2.078 . . . . 0.0 116.612 -178.366 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.453 HD22 ' CZ ' ' A' ' 3' ' ' TYR . 24.3 mt -75.79 41.7 0.22 Allowed 'General case' 0 C--N 1.29 -1.981 0 C-N-CA 118.134 -1.426 . . . . 0.0 110.716 -174.469 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.699 ' O ' HG22 ' A' ' 21' ' ' VAL . 30.5 p -124.21 -148.23 0.39 Allowed 'General case' 0 C--N 1.288 -2.073 0 CA-C-N 114.817 -1.083 . . . . 0.0 108.298 176.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.437 HD12 ' OD1' ' A' ' 5' ' ' ASP . 6.2 mt -119.21 110.72 17.35 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 176.038 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.435 ' HB2' ' SG ' ' A' ' 39' ' ' CYS . 55.9 m -104.56 -61.51 1.45 Allowed 'General case' 0 C--N 1.281 -2.396 0 CA-C-N 114.009 -1.45 . . . . 0.0 112.085 -172.66 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -96.27 94.52 7.52 Favored 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 118.76 -1.176 . . . . 0.0 110.392 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 73.15 -108.93 2.64 Favored Glycine 0 N--CA 1.492 2.378 0 C-N-CA 119.467 -1.349 . . . . 0.0 110.788 179.396 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -119.29 1.82 11.31 Favored 'General case' 0 CA--C 1.492 -1.286 0 CA-C-O 122.34 1.067 . . . . 0.0 109.896 -179.358 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -78.52 127.74 32.58 Favored 'General case' 0 C--N 1.257 -3.454 0 CA-C-N 113.204 -1.816 . . . . 0.0 109.758 179.634 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.699 HG22 ' O ' ' A' ' 14' ' ' CYS . 0.9 OUTLIER -78.33 137.97 21.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 C-N-CA 118.961 -1.096 . . . . 0.0 110.103 179.736 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.549 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 0.1 OUTLIER -86.66 146.22 26.39 Favored 'General case' 0 C--N 1.283 -2.289 0 C-N-CA 118.29 -1.364 . . . . 0.0 109.589 173.186 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.444 ' O ' ' C ' ' A' ' 24' ' ' GLN . . . -116.07 104.42 1.27 Allowed Glycine 0 C--N 1.296 -1.656 0 N-CA-C 108.809 -1.716 . . . . 0.0 108.809 -174.193 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.444 ' C ' ' O ' ' A' ' 23' ' ' GLY . 1.4 tm0? -31.86 124.52 0.27 Allowed 'General case' 0 C--N 1.26 -3.29 0 CA-C-N 112.632 -1.784 . . . . 0.0 110.941 179.186 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 140.79 -23.25 2.64 Favored Glycine 0 C--N 1.29 -1.972 0 N-CA-C 105.139 -3.184 . . . . 0.0 105.139 -173.818 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.663 ' ND2' ' N ' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -111.41 -162.29 0.79 Allowed 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 112.907 -1.647 . . . . 0.0 107.282 175.601 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.538 ' O ' ' N ' ' A' ' 40' ' ' VAL . 14.9 tttp -144.6 147.54 33.27 Favored 'General case' 0 C--N 1.297 -1.703 0 C-N-CA 118.661 -1.216 . . . . 0.0 109.949 175.317 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.572 ' O ' ' HA2' ' A' ' 10' ' ' GLY . 56.6 m -111.99 157.53 20.61 Favored 'General case' 0 CA--C 1.483 -1.603 0 C-N-CA 118.711 -1.195 . . . . 0.0 109.775 177.29 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 11.3 mm -140.05 126.96 23.24 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.7 0 CA-C-N 114.629 -1.169 . . . . 0.0 109.954 175.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' A' ' 30' ' ' LEU . 15.3 mt . . . . . 0 N--CA 1.496 1.856 0 C-N-CA 118.671 -1.212 . . . . 0.0 110.094 178.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.495 ' OD1' ' N ' ' A' ' 38' ' ' GLN . 62.7 t-20 . . . . . 0 C--O 1.216 -0.672 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.495 ' N ' ' OD1' ' A' ' 37' ' ' ASN . 23.5 tt0 -140.59 155.75 46.48 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 119.447 -0.901 . . . . 0.0 110.773 -179.636 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.435 ' SG ' ' HB2' ' A' ' 16' ' ' CYS . 1.5 m -101.47 89.03 3.6 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 119.662 -0.815 . . . . 0.0 110.843 -179.191 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.538 ' N ' ' O ' ' A' ' 27' ' ' LYS . 0.3 OUTLIER -94.87 141.71 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.675 0 C-N-CA 118.299 -1.36 . . . . 0.0 112.029 179.835 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.413 ' O ' HG22 ' A' ' 40' ' ' VAL . 3.5 t -54.13 145.4 17.22 Favored 'General case' 0 C--N 1.276 -2.59 0 CA-C-N 114.661 -1.154 . . . . 0.0 110.633 -179.527 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 157.81 -173.43 35.12 Favored Glycine 0 N--CA 1.494 2.536 0 C-N-CA 119.164 -1.493 . . . . 0.0 110.778 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -111.23 122.16 47.16 Favored 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 120.081 -0.648 . . . . 0.0 110.362 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -138.41 -145.28 4.8 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 179.543 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -139.81 153.2 69.66 Favored Pre-proline 0 N--CA 1.491 1.607 0 C-N-CA 119.59 -0.844 . . . . 0.0 109.997 179.43 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -60.48 -169.25 0.05 OUTLIER 'Trans proline' 0 C--O 1.216 -0.622 0 C-N-CA 121.417 1.412 . . . . 0.0 111.515 178.19 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.437 ' OE2' ' O ' ' A' ' 5' ' ' ASP . 3.8 tt0 . . . . . 0 C--N 1.312 -1.036 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.043 179.09 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.42 HG12 ' N ' ' A' ' 3' ' ' TYR . 3.6 t . . . . . 0 N--CA 1.489 1.498 0 CA-C-O 121.06 0.457 . . . . 0.0 110.081 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.42 ' N ' HG12 ' A' ' 2' ' ' VAL . 24.5 m-85 -150.56 -169.91 3.51 Favored 'General case' 0 C--N 1.297 -1.7 0 C-N-CA 119.774 -0.77 . . . . 0.0 109.808 179.115 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.552 ' OG1' ' N ' ' A' ' 5' ' ' ASP . 0.0 OUTLIER -109.76 174.97 5.62 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 177.891 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.552 ' N ' ' OG1' ' A' ' 4' ' ' THR . 0.2 OUTLIER -84.2 151.24 24.96 Favored 'General case' 0 C--N 1.28 -2.456 0 C-N-CA 118.106 -1.438 . . . . 0.0 110.322 -178.199 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.506 ' O ' HG23 ' A' ' 7' ' ' THR . 0.1 OUTLIER -76.65 -176.79 3.94 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-O 122.147 0.975 . . . . 0.0 111.756 178.62 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.506 HG23 ' O ' ' A' ' 6' ' ' CYS . 1.3 p -157.02 15.87 0.28 Allowed 'General case' 0 C--N 1.283 -2.292 0 CA-C-N 113.391 -1.731 . . . . 0.0 109.709 177.594 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -163.24 174.3 12.27 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-N 114.935 -1.03 . . . . 0.0 111.513 179.247 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.412 ' HB3' ' H ' ' A' ' 30' ' ' LEU . 0.4 OUTLIER -88.38 170.06 11.27 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.175 -178.21 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.456 ' O ' ' O ' ' A' ' 11' ' ' GLN . . . 73.44 -33.54 0.82 Allowed Glycine 0 N--CA 1.504 3.197 0 C-N-CA 119.668 -1.253 . . . . 0.0 112.378 177.684 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.456 ' O ' ' O ' ' A' ' 10' ' ' GLY . 43.1 mt-30 -51.8 -173.6 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.241 0 C-N-CA 119.507 -0.877 . . . . 0.0 110.153 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.502 ' C ' ' H ' ' A' ' 14' ' ' CYS . 1.6 m120 -158.85 -51.88 0.06 Allowed 'General case' 0 N--CA 1.503 2.176 0 C-N-CA 117.043 -1.863 . . . . 0.0 115.29 -179.199 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 67.1 mt -76.49 40.1 0.22 Allowed 'General case' 0 C--N 1.288 -2.091 0 C-N-CA 118.642 -1.223 . . . . 0.0 110.639 -175.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.502 ' H ' ' C ' ' A' ' 12' ' ' ASN . 10.0 p -124.76 -158.36 0.82 Allowed 'General case' 0 C--N 1.29 -1.995 0 CA-C-N 114.502 -1.226 . . . . 0.0 108.831 178.21 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 6.6 mt -109.91 116.17 31.15 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 119.65 -0.82 . . . . 0.0 110.662 178.519 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -111.93 -68.96 0.89 Allowed 'General case' 0 C--N 1.295 -1.786 0 CA-C-N 114.403 -1.271 . . . . 0.0 110.838 -177.792 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -79.38 99.01 6.97 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 119.585 -0.846 . . . . 0.0 110.376 -179.41 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.0 -113.56 5.48 Favored Glycine 0 N--CA 1.486 1.975 0 C-N-CA 119.408 -1.377 . . . . 0.0 110.451 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.422 ' O ' ' OG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -111.71 3.78 18.05 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-O 122.43 1.11 . . . . 0.0 109.694 -179.544 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -78.5 129.27 34.67 Favored 'General case' 0 C--N 1.256 -3.491 0 CA-C-N 113.229 -1.805 . . . . 0.0 110.248 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.443 HG22 ' O ' ' A' ' 14' ' ' CYS . 0.9 OUTLIER -78.36 144.06 11.77 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 C-N-CA 118.993 -1.083 . . . . 0.0 110.349 179.93 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.6 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 0.1 OUTLIER -90.97 143.97 26.15 Favored 'General case' 0 C--N 1.286 -2.166 0 C-N-CA 118.813 -1.155 . . . . 0.0 110.621 173.325 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.658 ' O ' ' N ' ' A' ' 25' ' ' GLY . . . -113.63 110.47 2.46 Favored Glycine 0 CA--C 1.486 -1.779 0 N-CA-C 107.844 -2.102 . . . . 0.0 107.844 -174.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -37.36 -5.2 0.0 OUTLIER 'General case' 0 C--N 1.254 -3.565 0 CA-C-N 112.521 -1.84 . . . . 0.0 114.491 178.576 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.658 ' N ' ' O ' ' A' ' 23' ' ' GLY . . . -69.27 -9.57 61.02 Favored Glycine 0 C--N 1.263 -3.498 0 N-CA-C 106.695 -2.562 . . . . 0.0 106.695 173.332 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 47.2 m-20 -135.41 -167.3 1.99 Allowed 'General case' 0 N--CA 1.485 1.309 0 CA-C-N 113.594 -1.303 . . . . 0.0 108.069 178.206 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.555 ' N ' ' O ' ' A' ' 40' ' ' VAL . 0.2 OUTLIER -123.12 166.84 14.51 Favored 'General case' 0 N--CA 1.503 2.217 0 C-N-CA 119.578 -0.849 . . . . 0.0 110.923 179.756 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.6 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 0.6 OUTLIER -136.34 154.89 50.71 Favored 'General case' 0 CA--C 1.472 -2.023 0 CA-C-O 122.203 1.002 . . . . 0.0 110.016 175.492 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 26.4 mm -145.56 127.78 9.19 Favored 'Isoleucine or valine' 1 C--N 1.24 -4.182 0 CA-C-N 113.083 -1.872 . . . . 0.0 109.528 177.098 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.412 ' H ' ' HB3' ' A' ' 9' ' ' SER . 17.6 mt . . . . . 0 N--CA 1.49 1.559 0 C-N-CA 118.467 -1.293 . . . . 0.0 110.429 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.548 ' N ' ' OD1' ' A' ' 37' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.474 0.756 0 CA-C-O 120.817 0.342 . . . . 0.0 110.176 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -156.74 152.41 26.97 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 119.143 -1.023 . . . . 0.0 110.511 176.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.575 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 0.9 OUTLIER -125.42 87.65 2.74 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.562 -179.793 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.555 ' O ' ' N ' ' A' ' 27' ' ' LYS . 2.4 p -111.35 146.77 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.621 0 C-N-CA 118.447 -1.301 . . . . 0.0 112.773 -179.289 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.407 ' N ' ' CG2' ' A' ' 40' ' ' VAL . 6.1 t -43.76 161.48 0.02 OUTLIER 'General case' 0 C--N 1.285 -2.226 0 CA-C-N 113.328 -1.76 . . . . 0.0 112.035 178.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 120.93 143.55 6.76 Favored Glycine 0 N--CA 1.497 2.76 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -84.57 131.86 34.58 Favored 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 119.188 -1.005 . . . . 0.0 111.1 -178.017 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -131.79 -156.2 8.3 Favored Glycine 0 N--CA 1.496 2.668 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 179.469 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.503 ' O ' HG23 ' A' ' 45' ' ' THR . 14.4 t -102.48 127.87 29.45 Favored Pre-proline 0 N--CA 1.493 1.681 0 C-N-CA 119.476 -0.89 . . . . 0.0 110.351 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.431 ' O ' ' C ' ' A' ' 47' ' ' GLU . 1.4 Cg_endo -64.69 115.02 2.99 Favored 'Trans proline' 0 C--O 1.214 -0.687 0 C-N-CA 120.591 0.861 . . . . 0.0 110.822 178.56 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.431 ' C ' ' O ' ' A' ' 46' ' ' PRO . 1.2 tt0 . . . . . 0 N--CA 1.503 2.212 0 C-N-CA 120.229 -0.588 . . . . 0.0 110.702 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.491 HG12 ' H ' ' A' ' 3' ' ' TYR . 3.4 t . . . . . 0 N--CA 1.489 1.491 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.491 ' H ' HG12 ' A' ' 2' ' ' VAL . 33.1 m-85 -107.72 -167.38 1.25 Allowed 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 119.879 -0.729 . . . . 0.0 110.505 -179.46 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -96.9 176.91 5.8 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 178.831 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.537 ' N ' ' OD1' ' A' ' 5' ' ' ASP . 0.4 OUTLIER -89.96 157.09 18.0 Favored 'General case' 0 C--N 1.293 -1.856 0 C-N-CA 118.099 -1.441 . . . . 0.0 109.19 176.984 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.496 ' SG ' ' O ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -75.58 165.89 24.39 Favored 'General case' 0 C--N 1.285 -2.223 0 C-N-CA 119.745 -0.782 . . . . 0.0 110.708 178.571 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.506 HG22 HE22 ' A' ' 11' ' ' GLN . 2.0 t -130.94 3.5 4.42 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.231 177.778 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -162.34 161.55 27.53 Favored 'General case' 0 C--N 1.28 -2.456 0 CA-C-N 113.671 -1.604 . . . . 0.0 110.414 -179.672 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.462 ' HA ' ' H ' ' A' ' 30' ' ' LEU . 0.6 OUTLIER -77.24 154.84 32.61 Favored 'General case' 0 C--N 1.291 -1.962 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.323 -179.43 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.436 ' O ' ' O ' ' A' ' 11' ' ' GLN . . . 96.21 -33.47 5.59 Favored Glycine 0 N--CA 1.501 2.984 0 C-N-CA 119.27 -1.443 . . . . 0.0 112.296 -179.641 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.624 HE21 ' HA ' ' A' ' 47' ' ' GLU . 37.1 mt-30 -51.72 -176.63 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.181 0 C-N-CA 119.128 -1.029 . . . . 0.0 110.698 -178.475 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.517 ' O ' ' O ' ' A' ' 22' ' ' CYS . 0.4 OUTLIER -144.64 -64.4 0.35 Allowed 'General case' 0 N--CA 1.5 2.059 0 C-N-CA 118.45 -1.3 . . . . 0.0 113.97 -176.202 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 85.2 mt -76.87 50.05 0.69 Allowed 'General case' 0 C--N 1.271 -2.809 0 C-N-CA 117.596 -1.642 . . . . 0.0 110.101 -176.532 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.564 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 29.7 p -125.56 -152.01 0.5 Allowed 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.011 -0.995 . . . . 0.0 108.684 177.59 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.534 HD22 ' O ' ' A' ' 19' ' ' SER . 76.0 mt -117.37 117.23 28.94 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 115.179 -0.919 . . . . 0.0 108.918 176.365 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.564 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 1.5 m -126.36 17.35 7.67 Favored 'General case' 0 N--CA 1.498 1.958 0 C-N-CA 118.81 -1.156 . . . . 0.0 111.036 -176.294 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -152.3 83.3 1.25 Allowed 'General case' 0 C--N 1.295 -1.795 0 C-N-CA 119.662 -0.815 . . . . 0.0 108.9 178.239 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 67.32 -85.11 0.13 Allowed Glycine 0 N--CA 1.486 1.989 0 C-N-CA 119.193 -1.479 . . . . 0.0 109.727 -178.179 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.534 ' O ' HD22 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -140.42 -2.18 1.44 Allowed 'General case' 0 N--CA 1.486 1.361 0 CA-C-O 121.891 0.853 . . . . 0.0 111.14 179.363 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -82.88 144.99 29.69 Favored 'General case' 0 C--N 1.258 -3.402 0 CA-C-N 114.189 -1.369 . . . . 0.0 111.057 -179.249 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.2 t -71.96 144.8 12.83 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.523 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.545 ' O ' ' SG ' ' A' ' 28' ' ' CYS . 0.7 OUTLIER -146.4 127.47 14.64 Favored 'General case' 0 C--N 1.279 -2.487 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 177.353 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.512 ' C ' ' H ' ' A' ' 25' ' ' GLY . . . 166.82 -83.81 0.1 OUTLIER Glycine 0 N--CA 1.482 1.703 0 C-N-CA 116.465 -2.778 . . . . 0.0 113.764 -175.489 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -72.66 17.39 0.11 Allowed 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 118.712 -1.195 . . . . 0.0 112.691 -173.858 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.512 ' H ' ' C ' ' A' ' 23' ' ' GLY . . . -126.86 -11.35 3.59 Favored Glycine 0 C--N 1.264 -3.422 0 N-CA-C 107.937 -2.065 . . . . 0.0 107.937 173.669 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.44 ' O ' ' O ' ' A' ' 23' ' ' GLY . 1.5 m-80 -158.22 -146.65 0.16 Allowed 'General case' 0 C--O 1.213 -0.834 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 -177.786 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.579 ' N ' ' O ' ' A' ' 40' ' ' VAL . 0.0 OUTLIER -141.34 138.44 33.08 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 175.45 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.545 ' SG ' ' O ' ' A' ' 22' ' ' CYS . 36.3 m -101.82 148.6 25.11 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 118.108 -1.437 . . . . 0.0 111.808 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 35.1 mm -140.32 90.1 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.263 -3.156 0 CA-C-N 112.918 -1.947 . . . . 0.0 106.878 175.179 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.681 ' C ' HD12 ' A' ' 30' ' ' LEU . 0.4 OUTLIER . . . . . 0 C--N 1.305 -1.34 0 C-N-CA 118.955 -1.098 . . . . 0.0 110.296 -176.245 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.833 ' N ' HD21 ' A' ' 37' ' ' ASN . 0.5 OUTLIER . . . . . 0 N--CA 1.482 1.134 0 CA-C-O 121.098 0.475 . . . . 0.0 110.938 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.461 ' CG ' ' N ' ' A' ' 39' ' ' CYS . 13.7 tt0 -157.38 157.61 34.37 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 119.26 -0.976 . . . . 0.0 110.973 179.468 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.461 ' N ' ' CG ' ' A' ' 38' ' ' GLN . 82.0 m -115.82 74.33 0.89 Allowed 'General case' 0 N--CA 1.492 1.669 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.453 178.403 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.579 ' O ' ' N ' ' A' ' 27' ' ' LYS . 0.2 OUTLIER -81.01 143.21 12.69 Favored 'Isoleucine or valine' 0 C--O 1.193 -1.873 0 C-N-CA 118.684 -1.206 . . . . 0.0 111.548 -177.75 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.5 t -64.1 140.18 58.84 Favored 'General case' 0 C--N 1.272 -2.777 0 CA-C-N 114.596 -1.184 . . . . 0.0 111.551 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 163.8 -140.92 6.76 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 178.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -145.86 113.43 6.34 Favored 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 119.272 -0.971 . . . . 0.0 110.32 179.593 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -114.37 -163.37 14.58 Favored Glycine 0 N--CA 1.498 2.812 0 C-N-CA 119.966 -1.111 . . . . 0.0 110.89 -179.249 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -131.1 153.02 81.63 Favored Pre-proline 0 N--CA 1.498 1.97 0 C-N-CA 120.04 -0.664 . . . . 0.0 109.627 -179.612 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -54.12 160.18 6.65 Favored 'Trans proline' 0 C--O 1.216 -0.621 0 C-N-CA 121.604 1.536 . . . . 0.0 112.177 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.624 ' HA ' HE21 ' A' ' 11' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.25 0 C-N-CA 119.519 -0.872 . . . . 0.0 108.796 178.44 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.472 HG12 ' N ' ' A' ' 3' ' ' TYR . 6.0 t . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.472 ' N ' HG12 ' A' ' 2' ' ' VAL . 25.1 m-85 -130.04 -167.62 1.84 Allowed 'General case' 0 N--CA 1.497 1.89 0 C-N-CA 119.779 -0.768 . . . . 0.0 109.948 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.0 p -98.42 176.95 5.51 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 119.541 -0.864 . . . . 0.0 108.866 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -88.06 153.07 21.56 Favored 'General case' 0 C--N 1.29 -1.979 0 C-N-CA 118.468 -1.293 . . . . 0.0 110.79 179.609 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.528 ' SG ' ' CB ' ' A' ' 11' ' ' GLN . 1.2 m -74.39 179.13 4.76 Favored 'General case' 0 C--N 1.287 -2.127 0 CA-C-N 114.754 -1.112 . . . . 0.0 111.564 176.743 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -152.81 13.41 0.53 Allowed 'General case' 0 C--N 1.29 -2.018 0 CA-C-N 113.657 -1.61 . . . . 0.0 110.015 176.404 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.596 ' CG ' ' NE2' ' A' ' 11' ' ' GLN . 0.9 OUTLIER -163.5 -171.81 2.7 Favored 'General case' 0 C--N 1.286 -2.157 0 CA-C-N 114.511 -1.222 . . . . 0.0 109.947 179.271 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.496 ' HB3' ' H ' ' A' ' 30' ' ' LEU . 0.8 OUTLIER -99.91 172.99 6.89 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 119.911 -0.716 . . . . 0.0 110.707 -178.007 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.488 ' H ' HD13 ' A' ' 29' ' ' ILE . . . 63.57 22.21 65.64 Favored Glycine 0 N--CA 1.502 3.063 0 C-N-CA 119.978 -1.106 . . . . 0.0 112.661 176.709 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.596 ' NE2' ' CG ' ' A' ' 8' ' ' GLU . 0.0 OUTLIER -89.2 -166.53 1.62 Allowed 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 118.95 -1.1 . . . . 0.0 111.213 178.804 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.836 ' OD1' ' HA2' ' A' ' 23' ' ' GLY . 2.0 m-20 -153.76 -70.37 0.14 Allowed 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 118.81 -1.156 . . . . 0.0 113.265 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.408 ' HA ' HD23 ' A' ' 13' ' ' LEU . 94.4 mt -77.97 45.6 0.53 Allowed 'General case' 0 C--N 1.282 -2.343 0 C-N-CA 118.64 -1.224 . . . . 0.0 111.291 -176.235 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.476 ' SG ' ' N ' ' A' ' 15' ' ' LEU . 15.3 p -123.82 -154.88 0.63 Allowed 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 174.784 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.535 HD22 ' O ' ' A' ' 19' ' ' SER . 63.3 mt -116.62 109.8 17.69 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-N 114.654 -1.157 . . . . 0.0 108.406 176.665 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.404 ' HA ' ' ND2' ' A' ' 37' ' ' ASN . 4.7 m -104.89 -58.97 1.81 Allowed 'General case' 0 C--N 1.288 -2.099 0 C-N-CA 118.939 -1.104 . . . . 0.0 111.027 -175.53 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -83.79 85.45 7.29 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 118.363 -1.335 . . . . 0.0 109.233 177.77 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.53 -116.8 5.28 Favored Glycine 0 N--CA 1.489 2.191 0 C-N-CA 119.384 -1.388 . . . . 0.0 110.317 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.535 ' O ' HD22 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -109.74 1.41 19.41 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-O 122.261 1.029 . . . . 0.0 109.91 -179.581 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 32.2 m120 -79.32 139.03 37.93 Favored 'General case' 0 C--N 1.26 -3.324 0 CA-C-N 113.244 -1.798 . . . . 0.0 111.081 -178.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.6 t -74.09 142.45 14.79 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 C-N-CA 118.987 -1.085 . . . . 0.0 110.206 179.164 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.515 ' O ' ' SG ' ' A' ' 28' ' ' CYS . 4.0 m -145.55 99.25 3.26 Favored 'General case' 0 C--N 1.284 -2.264 0 C-N-CA 118.873 -1.131 . . . . 0.0 109.408 177.538 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.836 ' HA2' ' OD1' ' A' ' 12' ' ' ASN . . . -161.91 -78.33 0.03 OUTLIER Glycine 0 C--N 1.297 -1.631 1 N-CA-C 131.482 7.353 . . . . 0.0 131.482 -177.489 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.527 ' O ' ' ND2' ' A' ' 26' ' ' ASN . 21.6 tt0 -45.9 124.56 5.43 Favored 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 119.506 -0.877 . . . . 0.0 111.188 -178.86 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.66 -26.15 2.77 Favored Glycine 0 N--CA 1.478 1.454 0 C-N-CA 119.61 -1.281 . . . . 0.0 110.255 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.548 ' ND2' ' N ' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -110.21 -167.58 1.21 Allowed 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 119.54 -0.864 . . . . 0.0 110.726 -178.92 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.537 ' O ' ' O ' ' A' ' 40' ' ' VAL . 16.6 tttt -148.08 166.08 28.87 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 119.466 -0.894 . . . . 0.0 110.056 179.2 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.515 ' SG ' ' O ' ' A' ' 22' ' ' CYS . 59.0 m -136.06 158.89 43.31 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.261 -0.975 . . . . 0.0 110.147 176.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.488 HD13 ' H ' ' A' ' 10' ' ' GLY . 22.3 mm -142.68 136.73 27.53 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.505 0 CA-C-N 114.793 -1.094 . . . . 0.0 110.536 177.229 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.496 ' H ' ' HB3' ' A' ' 9' ' ' SER . 18.1 mt . . . . . 0 N--CA 1.485 1.288 0 C-N-CA 119.943 -0.703 . . . . 0.0 110.967 177.34 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.492 ' OD1' ' N ' ' A' ' 38' ' ' GLN . 45.2 t-20 . . . . . 0 N--CA 1.439 -0.991 0 CA-C-O 121.165 0.507 . . . . 0.0 110.737 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.492 ' N ' ' OD1' ' A' ' 37' ' ' ASN . 13.1 tt0 -127.04 143.16 51.36 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 114.93 -1.032 . . . . 0.0 108.994 176.061 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 66.6 m -96.28 108.19 20.64 Favored 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 119.212 -0.995 . . . . 0.0 111.136 -178.707 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.537 ' O ' ' O ' ' A' ' 27' ' ' LYS . 0.2 OUTLIER -110.26 142.26 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.407 0 C-N-CA 118.908 -1.117 . . . . 0.0 111.285 177.007 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.415 ' O ' HG22 ' A' ' 40' ' ' VAL . 15.1 t -70.25 151.48 45.28 Favored 'General case' 0 C--N 1.273 -2.76 0 CA-C-N 114.692 -1.14 . . . . 0.0 110.314 178.749 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.444 ' H ' ' HA ' ' A' ' 26' ' ' ASN . . . 144.37 -116.54 0.96 Allowed Glycine 0 N--CA 1.493 2.472 1 N-CA-C 130.847 7.099 . . . . 0.0 130.847 -178.962 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 -116.26 72.61 0.82 Allowed 'General case' 0 N--CA 1.5 2.065 0 C-N-CA 119.957 -0.697 . . . . 0.0 110.556 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.441 ' O ' ' ND2' ' A' ' 12' ' ' ASN . . . -107.67 151.16 16.95 Favored Glycine 0 N--CA 1.497 2.704 0 C-N-CA 119.795 -1.193 . . . . 0.0 110.53 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -117.61 152.53 49.79 Favored Pre-proline 0 N--CA 1.496 1.839 0 C-N-CA 120.097 -0.641 . . . . 0.0 109.532 179.687 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -53.36 161.47 3.88 Favored 'Trans proline' 0 C--O 1.215 -0.629 0 C-N-CA 121.287 1.324 . . . . 0.0 111.137 177.436 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 . . . . . 0 C--N 1.307 -1.246 0 C-N-CA 118.987 -1.085 . . . . 0.0 111.048 178.022 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.48 1.075 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -82.53 -170.82 3.15 Favored 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 118.961 -1.096 . . . . 0.0 110.791 -179.422 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.51 ' OG1' ' N ' ' A' ' 5' ' ' ASP . 0.0 OUTLIER -118.76 -169.07 1.65 Allowed 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.35 179.608 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.51 ' N ' ' OG1' ' A' ' 4' ' ' THR . 0.0 OUTLIER -90.46 151.81 21.23 Favored 'General case' 0 C--N 1.288 -2.073 0 C-N-CA 118.774 -1.17 . . . . 0.0 111.903 -176.649 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.497 ' O ' HG23 ' A' ' 7' ' ' THR . 0.7 OUTLIER -75.57 179.48 5.3 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-N 114.215 -1.357 . . . . 0.0 112.28 177.348 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.497 HG23 ' O ' ' A' ' 6' ' ' CYS . 5.3 p -159.09 16.26 0.17 Allowed 'General case' 0 C--N 1.285 -2.204 0 CA-C-N 112.979 -1.919 . . . . 0.0 109.342 177.636 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.402 ' CG ' ' O ' ' A' ' 7' ' ' THR . 33.1 mt-10 -160.96 168.07 25.29 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 114.949 -1.023 . . . . 0.0 110.704 -178.179 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.48 ' HB3' ' H ' ' A' ' 30' ' ' LEU . 0.7 OUTLIER -88.33 159.42 18.08 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.06 -179.892 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.444 ' O ' ' O ' ' A' ' 11' ' ' GLN . . . 82.99 -28.47 3.64 Favored Glycine 0 N--CA 1.501 2.971 0 C-N-CA 119.446 -1.359 . . . . 0.0 112.531 177.862 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.453 ' O ' ' OD1' ' A' ' 12' ' ' ASN . 31.3 mt-30 -49.55 -178.59 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.13 0 C-N-CA 119.496 -0.882 . . . . 0.0 110.817 -179.059 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.688 ' C ' ' HA3' ' A' ' 23' ' ' GLY . 13.2 m-20 -143.68 -67.83 0.34 Allowed 'General case' 0 N--CA 1.501 2.108 0 C-N-CA 118.493 -1.283 . . . . 0.0 114.289 -176.031 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 94.2 mt -77.78 48.28 0.68 Allowed 'General case' 0 C--N 1.275 -2.638 0 C-N-CA 118.803 -1.159 . . . . 0.0 111.399 -175.019 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 29.4 p -122.93 -159.35 0.83 Allowed 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 119.677 -0.809 . . . . 0.0 110.566 176.214 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 64.7 mt -117.17 121.93 42.62 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.958 177.81 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 63.5 m -110.18 -73.47 0.68 Allowed 'General case' 0 N--CA 1.5 2.07 0 C-N-CA 119.028 -1.069 . . . . 0.0 110.883 -179.301 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -79.69 93.23 5.5 Favored 'General case' 0 C--N 1.295 -1.767 0 C-N-CA 118.828 -1.149 . . . . 0.0 110.185 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 72.83 -118.9 6.66 Favored Glycine 0 N--CA 1.488 2.143 0 C-N-CA 119.494 -1.336 . . . . 0.0 110.73 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.42 ' O ' ' OG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -110.65 4.59 20.3 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-O 122.286 1.041 . . . . 0.0 109.947 -178.918 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 61.5 m-80 -78.37 135.24 37.42 Favored 'General case' 0 C--N 1.259 -3.366 0 CA-C-N 113.2 -1.818 . . . . 0.0 110.742 -179.09 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.1 t -75.67 144.67 11.7 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 C-N-CA 119.451 -0.9 . . . . 0.0 110.754 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.463 ' O ' ' O ' ' A' ' 12' ' ' ASN . 53.8 m -141.68 99.78 3.62 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 118.768 -1.173 . . . . 0.0 110.137 176.701 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.688 ' HA3' ' C ' ' A' ' 12' ' ' ASN . . . -176.14 -42.05 0.06 OUTLIER Glycine 0 N--CA 1.487 2.043 1 N-CA-C 129.921 6.728 . . . . 0.0 129.921 -178.012 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 12.1 tt0 -86.33 118.19 25.61 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 118.879 -1.128 . . . . 0.0 109.117 177.239 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.42 -22.6 29.24 Favored Glycine 0 C--N 1.294 -1.802 0 N-CA-C 108.719 -1.753 . . . . 0.0 108.719 -176.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.455 ' O ' ' O ' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -131.72 164.79 25.17 Favored 'General case' 0 C--O 1.209 -1.077 0 C-N-CA 120.021 -0.672 . . . . 0.0 110.035 179.156 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.539 ' O ' ' O ' ' A' ' 40' ' ' VAL . 10.0 ttpt -122.12 147.87 45.6 Favored 'General case' 0 N--CA 1.506 2.37 0 C-N-CA 119.752 -0.779 . . . . 0.0 110.189 178.493 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.436 ' SG ' ' O ' ' A' ' 38' ' ' GLN . 0.7 OUTLIER -109.37 163.1 13.71 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 118.289 -1.364 . . . . 0.0 111.282 176.917 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 18.8 mm -145.49 130.07 12.3 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.355 0 CA-C-N 112.286 -2.234 . . . . 0.0 109.462 177.564 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.48 ' H ' ' HB3' ' A' ' 9' ' ' SER . 24.3 mt . . . . . 0 C--N 1.302 -1.457 0 C-N-CA 118.518 -1.273 . . . . 0.0 109.39 178.55 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.794 ' N ' HD21 ' A' ' 37' ' ' ASN . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 121.349 0.595 . . . . 0.0 111.994 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.436 ' O ' ' SG ' ' A' ' 28' ' ' CYS . 7.3 tt0 -154.76 161.16 41.61 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.771 177.728 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.426 ' H ' ' HG3' ' A' ' 38' ' ' GLN . 62.6 m -128.3 84.08 2.21 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 120.037 -0.665 . . . . 0.0 110.445 -179.159 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.539 ' O ' ' O ' ' A' ' 27' ' ' LYS . 0.2 OUTLIER -91.69 139.17 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.606 0 C-N-CA 118.124 -1.43 . . . . 0.0 112.317 -178.722 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.42 ' O ' HG22 ' A' ' 40' ' ' VAL . 3.9 t -47.61 163.17 0.05 Allowed 'General case' 0 C--N 1.277 -2.583 0 CA-C-N 114.137 -1.392 . . . . 0.0 111.599 -178.786 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 130.36 -150.5 19.21 Favored Glycine 0 N--CA 1.492 2.43 1 N-CA-C 130.289 6.875 . . . . 0.0 130.289 -179.335 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -123.72 141.86 51.62 Favored 'General case' 0 N--CA 1.498 1.934 0 C-N-CA 119.88 -0.728 . . . . 0.0 109.958 178.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -161.4 -177.56 34.59 Favored Glycine 0 N--CA 1.487 2.085 0 C-N-CA 119.224 -1.465 . . . . 0.0 110.614 -179.586 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.424 ' O ' ' O ' ' A' ' 46' ' ' PRO . 0.4 OUTLIER -101.86 154.8 37.08 Favored Pre-proline 0 N--CA 1.49 1.559 0 C-N-CA 119.849 -0.741 . . . . 0.0 109.388 -179.701 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.424 ' O ' ' O ' ' A' ' 45' ' ' THR . 4.6 Cg_exo -54.96 -159.81 0.01 OUTLIER 'Trans proline' 0 C--O 1.213 -0.757 0 C-N-CA 121.273 1.315 . . . . 0.0 110.708 176.416 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 . . . . . 0 C--N 1.306 -1.325 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.062 179.63 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.1 t . . . . . 0 N--CA 1.479 1.005 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -103.75 -167.19 1.34 Allowed 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 119.443 -0.903 . . . . 0.0 111.02 -178.409 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.96 174.13 7.09 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.278 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -94.52 150.83 19.86 Favored 'General case' 0 C--N 1.296 -1.73 0 C-N-CA 118.737 -1.185 . . . . 0.0 109.833 179.182 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.518 ' SG ' ' O ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -75.86 165.94 24.26 Favored 'General case' 0 C--N 1.292 -1.93 0 C-N-CA 119.655 -0.818 . . . . 0.0 111.028 178.919 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 34.2 p -135.96 12.02 3.36 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-N 114.61 -1.177 . . . . 0.0 108.871 175.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -162.54 175.43 11.46 Favored 'General case' 0 C--N 1.284 -2.248 0 CA-C-N 114.321 -1.309 . . . . 0.0 111.729 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -85.33 154.46 21.88 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 114.816 -1.084 . . . . 0.0 110.296 -179.266 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.449 ' O ' ' O ' ' A' ' 11' ' ' GLN . . . 89.42 -21.21 30.02 Favored Glycine 0 N--CA 1.502 3.077 0 C-N-CA 119.261 -1.447 . . . . 0.0 112.855 178.124 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.449 ' O ' ' O ' ' A' ' 10' ' ' GLY . 5.2 mp0 -49.66 179.35 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.338 0 C-N-CA 118.588 -1.245 . . . . 0.0 110.187 -179.012 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.603 ' O ' ' HA3' ' A' ' 23' ' ' GLY . 15.6 t-20 -138.12 -76.49 0.38 Allowed 'General case' 0 N--CA 1.497 1.879 0 C-N-CA 118.963 -1.095 . . . . 0.0 112.438 -178.105 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 83.1 mt -78.36 47.34 0.68 Allowed 'General case' 0 C--N 1.264 -3.149 0 C-N-CA 117.968 -1.493 . . . . 0.0 110.594 -177.039 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.41 ' HB2' ' N ' ' A' ' 6' ' ' CYS . 31.9 p -117.03 -157.13 0.65 Allowed 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 119.482 -0.887 . . . . 0.0 110.13 177.492 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.518 ' O ' ' SG ' ' A' ' 6' ' ' CYS . 4.6 mt -122.8 127.98 49.83 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.371 177.266 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 82.8 m -116.35 -64.61 1.29 Allowed 'General case' 0 N--CA 1.511 2.604 0 C-N-CA 119.287 -0.965 . . . . 0.0 110.951 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 85.3 mt-10 -79.23 76.35 5.77 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 119.08 -1.048 . . . . 0.0 110.287 -178.677 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 73.77 -108.57 2.54 Favored Glycine 0 N--CA 1.488 2.144 0 C-N-CA 119.481 -1.342 . . . . 0.0 111.123 179.074 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -108.2 0.26 21.36 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 122.119 0.962 . . . . 0.0 110.773 -177.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 72.9 m-20 -79.66 127.01 31.65 Favored 'General case' 0 C--N 1.256 -3.481 0 CA-C-N 113.838 -1.528 . . . . 0.0 110.435 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.2 t -66.68 148.69 11.98 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 C-N-CA 118.835 -1.146 . . . . 0.0 109.168 178.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.513 ' O ' ' O ' ' A' ' 12' ' ' ASN . 0.0 OUTLIER -143.55 113.59 7.24 Favored 'General case' 0 C--N 1.289 -2.053 0 C-N-CA 118.802 -1.159 . . . . 0.0 110.754 -178.574 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.603 ' HA3' ' O ' ' A' ' 12' ' ' ASN . . . 162.08 -57.59 0.3 Allowed Glycine 0 N--CA 1.483 1.824 1 N-CA-C 130.29 6.876 . . . . 0.0 130.29 -178.01 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.582 ' HA ' HD21 ' A' ' 12' ' ' ASN . 15.8 tt0 -61.47 126.69 28.27 Favored 'General case' 0 C--N 1.31 -1.137 0 C-N-CA 119.037 -1.065 . . . . 0.0 110.51 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.41 -25.56 8.0 Favored Glycine 0 N--CA 1.482 1.708 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -178.232 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.484 ' OD1' ' N ' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -123.11 -167.18 1.56 Allowed 'General case' 0 C--N 1.316 -0.867 0 C-N-CA 120.322 -0.551 . . . . 0.0 110.021 179.992 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.56 ' HZ1' HD11 ' A' ' 29' ' ' ILE . 15.4 tttp -145.65 115.93 7.51 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 178.136 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.51 ' SG ' ' O ' ' A' ' 38' ' ' GLN . 0.1 OUTLIER -80.11 163.72 23.91 Favored 'General case' 0 CA--C 1.477 -1.828 0 C-N-CA 117.528 -1.669 . . . . 0.0 112.415 178.503 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.56 HD11 ' HZ1' ' A' ' 27' ' ' LYS . 18.1 mm -149.39 124.7 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.265 -3.076 0 CA-C-N 111.982 -2.372 . . . . 0.0 108.218 178.503 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 26.9 mt . . . . . 0 N--CA 1.49 1.544 0 C-N-CA 118.337 -1.345 . . . . 0.0 110.421 -178.505 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.426 ' ND2' ' N ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.209 0 CA-C-O 120.498 0.189 . . . . 0.0 110.647 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.51 ' O ' ' SG ' ' A' ' 28' ' ' CYS . 42.1 tt0 -157.33 152.83 26.44 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 118.791 -1.164 . . . . 0.0 111.223 178.379 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -113.1 107.24 15.67 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 115.226 -0.897 . . . . 0.0 112.058 178.804 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.483 ' CG2' ' N ' ' A' ' 41' ' ' THR . 1.6 p -110.45 155.99 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 C-N-CA 119.01 -1.076 . . . . 0.0 109.494 174.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.483 ' N ' ' CG2' ' A' ' 40' ' ' VAL . 6.0 t -78.87 152.28 31.32 Favored 'General case' 0 C--N 1.279 -2.479 0 CA-C-N 114.814 -1.084 . . . . 0.0 112.202 -177.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 153.28 -113.87 0.6 Allowed Glycine 0 N--CA 1.491 2.331 1 N-CA-C 128.945 6.338 . . . . 0.0 128.945 -179.529 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -154.62 101.34 2.32 Favored 'General case' 0 N--CA 1.494 1.753 0 C-N-CA 119.299 -0.961 . . . . 0.0 110.268 177.755 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -114.73 -165.69 15.1 Favored Glycine 0 N--CA 1.496 2.656 0 C-N-CA 120.013 -1.089 . . . . 0.0 110.579 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -134.32 148.25 66.94 Favored Pre-proline 0 N--CA 1.489 1.513 0 C-N-CA 119.965 -0.694 . . . . 0.0 110.152 -179.431 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -59.74 143.64 99.59 Favored 'Trans proline' 0 C--O 1.211 -0.83 0 C-N-CA 121.314 1.343 . . . . 0.0 110.997 176.432 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 . . . . . 0 CA--C 1.565 1.523 0 C-N-CA 119.628 -0.829 . . . . 0.0 110.588 -179.721 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.1 t . . . . . 0 N--CA 1.481 1.088 0 CA-C-O 121.065 0.459 . . . . 0.0 110.498 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -100.48 -165.07 1.17 Allowed 'General case' 0 N--CA 1.492 1.648 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.283 179.223 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -94.18 -179.58 4.99 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.125 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 5' ' ' ASP . 0.2 OUTLIER -93.05 154.65 17.99 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 118.462 -1.295 . . . . 0.0 110.781 179.478 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.404 ' N ' ' HB2' ' A' ' 14' ' ' CYS . 1.9 m -75.41 179.17 5.38 Favored 'General case' 0 C--N 1.294 -1.841 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.056 178.226 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.3 p -134.24 -2.54 2.81 Favored 'General case' 0 C--N 1.29 -2.019 0 CA-C-N 113.904 -1.498 . . . . 0.0 109.924 176.312 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -162.84 157.04 20.83 Favored 'General case' 0 C--N 1.279 -2.493 0 CA-C-N 114.237 -1.347 . . . . 0.0 110.053 179.417 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.585 ' OG ' ' N ' ' A' ' 30' ' ' LEU . 1.4 m -62.59 -175.79 0.09 Allowed 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 119.73 -0.788 . . . . 0.0 110.496 179.237 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.442 ' O ' ' O ' ' A' ' 11' ' ' GLN . . . 73.64 -42.58 1.07 Allowed Glycine 0 N--CA 1.5 2.919 0 C-N-CA 120.111 -1.042 . . . . 0.0 112.9 178.173 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.442 ' O ' ' O ' ' A' ' 10' ' ' GLY . 2.5 mp0 -53.79 -173.02 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.607 0 C-N-CA 119.022 -1.071 . . . . 0.0 110.222 -177.936 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.506 ' ND2' ' O ' ' A' ' 26' ' ' ASN . 11.4 m-20 -151.59 -57.63 0.15 Allowed 'General case' 0 N--CA 1.503 2.212 0 C-N-CA 117.691 -1.604 . . . . 0.0 114.707 -177.044 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.425 HD23 ' HA ' ' A' ' 13' ' ' LEU . 15.0 mt -75.7 49.75 0.53 Allowed 'General case' 0 C--N 1.287 -2.133 0 C-N-CA 118.989 -1.085 . . . . 0.0 110.107 -176.175 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.593 ' SG ' ' N ' ' A' ' 15' ' ' LEU . 19.5 p -130.37 -142.31 0.24 Allowed 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 114.662 -1.154 . . . . 0.0 108.821 176.207 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.646 HD22 ' O ' ' A' ' 19' ' ' SER . 88.1 mt -122.9 108.8 13.39 Favored 'General case' 0 C--N 1.288 -2.083 0 CA-C-N 114.592 -1.185 . . . . 0.0 109.365 176.523 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.426 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 8.6 m -111.22 -46.74 3.27 Favored 'General case' 0 C--N 1.288 -2.068 0 CA-C-N 113.941 -1.481 . . . . 0.0 110.598 -175.382 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -87.82 73.88 9.16 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 119.17 -1.012 . . . . 0.0 109.307 178.26 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 73.39 -107.61 2.28 Favored Glycine 0 N--CA 1.489 2.195 0 C-N-CA 119.304 -1.427 . . . . 0.0 109.938 -178.785 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.646 ' O ' HD22 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -111.31 -0.13 16.49 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-O 122.337 1.065 . . . . 0.0 109.89 179.897 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -82.75 145.62 29.46 Favored 'General case' 0 C--N 1.261 -3.256 0 CA-C-N 113.201 -1.818 . . . . 0.0 111.467 -179.34 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.4 t -84.17 142.2 13.7 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.258 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.503 ' O ' ' O ' ' A' ' 12' ' ' ASN . 0.0 OUTLIER -109.85 146.44 35.07 Favored 'General case' 0 N--CA 1.504 2.229 0 N-CA-C 106.012 -1.848 . . . . 0.0 106.012 168.637 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -105.13 -154.58 22.29 Favored Glycine 0 CA--C 1.49 -1.491 0 C-N-CA 118.256 -1.926 . . . . 0.0 111.13 -173.271 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.473 ' C ' ' H ' ' A' ' 26' ' ' ASN . 4.0 tt0 -92.82 170.89 9.34 Favored 'General case' 0 C--N 1.246 -3.926 0 CA-C-N 112.075 -2.063 . . . . 0.0 109.55 -177.25 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.415 ' H ' ' HG2' ' A' ' 24' ' ' GLN . . . 81.06 -35.32 2.36 Favored Glycine 0 N--CA 1.48 1.616 0 N-CA-C 108.595 -1.802 . . . . 0.0 108.595 -177.464 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.506 ' O ' ' ND2' ' A' ' 12' ' ' ASN . 0.0 OUTLIER -100.49 173.77 6.41 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 177.542 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.563 ' CE ' HD11 ' A' ' 29' ' ' ILE . 0.1 OUTLIER -128.76 131.53 47.85 Favored 'General case' 0 N--CA 1.502 2.155 0 C-N-CA 119.461 -0.896 . . . . 0.0 111.057 -179.388 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.425 ' O ' ' N ' ' A' ' 10' ' ' GLY . 81.3 m -93.01 153.71 18.56 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 118.359 -1.336 . . . . 0.0 110.067 176.813 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.563 HD11 ' CE ' ' A' ' 27' ' ' LYS . 30.3 mm -140.77 81.04 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.265 -3.091 0 CA-C-N 114.142 -1.39 . . . . 0.0 108.869 176.512 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.617 ' C ' HD12 ' A' ' 30' ' ' LEU . 1.1 pp . . . . . 0 C--N 1.304 -1.403 0 C-N-CA 119.257 -0.977 . . . . 0.0 110.998 -178.138 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.413 ' OD1' ' N ' ' A' ' 37' ' ' ASN . 4.3 m-20 . . . . . 0 N--CA 1.482 1.135 0 CA-C-O 121.141 0.495 . . . . 0.0 111.903 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.471 ' CG ' ' N ' ' A' ' 39' ' ' CYS . 7.0 tt0 -161.45 157.91 25.82 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.099 177.824 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.471 ' N ' ' CG ' ' A' ' 38' ' ' GLN . 0.9 OUTLIER -117.52 92.04 3.74 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 120.124 -0.63 . . . . 0.0 109.649 178.892 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.485 ' O ' ' O ' ' A' ' 27' ' ' LYS . 0.6 OUTLIER -101.23 134.33 41.76 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.267 0 C-N-CA 118.482 -1.287 . . . . 0.0 112.476 -178.417 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.427 ' O ' HG22 ' A' ' 40' ' ' VAL . 6.0 t -57.15 157.17 6.35 Favored 'General case' 0 C--N 1.273 -2.743 0 CA-C-N 113.044 -1.889 . . . . 0.0 111.019 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 148.69 -104.59 0.28 Allowed Glycine 0 N--CA 1.492 2.427 1 N-CA-C 130.866 7.106 . . . . 0.0 130.866 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -160.13 106.55 1.58 Allowed 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 119.441 -0.904 . . . . 0.0 110.368 -179.557 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -146.28 -174.63 18.59 Favored Glycine 0 N--CA 1.493 2.496 0 C-N-CA 119.548 -1.311 . . . . 0.0 110.437 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.7 t -107.47 144.77 29.89 Favored Pre-proline 0 N--CA 1.492 1.632 0 C-N-CA 119.781 -0.768 . . . . 0.0 110.37 -179.392 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -63.76 132.48 35.2 Favored 'Trans proline' 0 C--O 1.214 -0.699 0 C-N-CA 120.904 1.07 . . . . 0.0 110.53 174.807 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.488 1.451 0 C-N-CA 119.515 -0.874 . . . . 0.0 110.703 -179.143 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 1.6 t . . . . . 0 N--CA 1.484 1.238 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -92.52 -164.86 1.24 Allowed 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 119.55 -0.86 . . . . 0.0 110.93 -179.375 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.1 p -93.05 180.0 5.27 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.501 ' N ' ' OD1' ' A' ' 5' ' ' ASP . 0.0 OUTLIER -92.4 151.46 20.24 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 118.997 -1.081 . . . . 0.0 110.152 178.435 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.517 ' SG ' ' O ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -75.04 165.77 24.72 Favored 'General case' 0 C--N 1.296 -1.75 0 C-N-CA 120.017 -0.673 . . . . 0.0 111.189 178.445 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.0 p -141.67 12.47 2.09 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 119.446 -0.901 . . . . 0.0 110.062 177.269 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -162.78 179.51 7.6 Favored 'General case' 0 C--N 1.287 -2.126 0 CA-C-N 114.687 -1.142 . . . . 0.0 110.826 178.246 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.462 ' HB3' ' H ' ' A' ' 30' ' ' LEU . 0.8 OUTLIER -89.81 163.91 14.85 Favored 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 119.252 -0.979 . . . . 0.0 109.741 179.849 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 71.54 14.52 74.92 Favored Glycine 0 N--CA 1.495 2.585 0 C-N-CA 119.028 -1.558 . . . . 0.0 111.777 179.563 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.7 mm-40 -74.77 -167.43 0.57 Allowed 'General case' 0 N--CA 1.498 1.958 0 C-N-CA 118.977 -1.089 . . . . 0.0 109.991 179.261 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.477 ' O ' ' O ' ' A' ' 22' ' ' CYS . 0.9 OUTLIER -155.09 -80.31 0.09 Allowed 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 117.693 -1.603 . . . . 0.0 113.554 -179.45 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 92.6 mt -77.03 51.75 0.83 Allowed 'General case' 0 C--N 1.273 -2.755 0 C-N-CA 117.815 -1.554 . . . . 0.0 109.602 -176.667 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.419 ' HB2' ' N ' ' A' ' 6' ' ' CYS . 23.1 p -122.36 -156.07 0.67 Allowed 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.754 176.486 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.517 ' O ' ' SG ' ' A' ' 6' ' ' CYS . 8.6 mt -124.68 124.52 42.36 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 114.784 -1.098 . . . . 0.0 109.917 179.025 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.2 m -108.19 -68.24 0.92 Allowed 'General case' 0 N--CA 1.504 2.227 0 C-N-CA 119.058 -1.057 . . . . 0.0 111.519 -177.829 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -87.27 91.17 8.63 Favored 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 118.701 -1.2 . . . . 0.0 110.915 -177.857 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.06 -98.53 1.1 Allowed Glycine 0 N--CA 1.49 2.289 0 C-N-CA 119.632 -1.27 . . . . 0.0 111.598 177.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.406 ' O ' ' OG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -129.83 5.81 5.05 Favored 'General case' 0 N--CA 1.483 1.187 0 CA-C-O 122.293 1.044 . . . . 0.0 110.224 -177.763 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.457 ' N ' ' OD1' ' A' ' 20' ' ' ASN . 4.1 m-20 -81.35 130.81 35.19 Favored 'General case' 0 C--N 1.253 -3.605 0 CA-C-N 113.438 -1.71 . . . . 0.0 110.296 178.97 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.6 t -75.38 146.46 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 C-N-CA 119.377 -0.929 . . . . 0.0 110.459 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.477 ' O ' ' O ' ' A' ' 12' ' ' ASN . 21.2 m -143.36 109.95 5.48 Favored 'General case' 0 N--CA 1.505 2.283 0 C-N-CA 118.587 -1.245 . . . . 0.0 110.483 177.31 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.447 ' O ' ' O ' ' A' ' 26' ' ' ASN . . . -175.91 -91.39 0.08 OUTLIER Glycine 0 C--O 1.203 -1.784 0 C-N-CA 118.331 -1.89 . . . . 0.0 112.177 -178.038 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -50.77 120.75 5.05 Favored 'General case' 0 C--N 1.297 -1.677 0 C-N-CA 119.086 -1.046 . . . . 0.0 110.548 -178.78 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.68 -26.78 21.78 Favored Glycine 0 N--CA 1.481 1.667 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -178.071 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.447 ' O ' ' O ' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -137.17 -163.81 1.49 Allowed 'General case' 0 C--N 1.313 -0.994 0 C-N-CA 120.148 -0.621 . . . . 0.0 111.122 -179.508 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.561 ' NZ ' HD11 ' A' ' 29' ' ' ILE . 16.0 ttpt -142.38 165.46 27.35 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 177.417 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -130.79 163.37 27.48 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 118.893 -1.123 . . . . 0.0 110.494 175.374 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.561 HD11 ' NZ ' ' A' ' 27' ' ' LYS . 15.4 mm -151.42 129.47 2.58 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.104 0 CA-C-N 113.176 -1.829 . . . . 0.0 109.186 179.434 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.462 ' H ' ' HB3' ' A' ' 9' ' ' SER . 29.2 mt . . . . . 0 C--N 1.303 -1.454 0 C-N-CA 118.602 -1.239 . . . . 0.0 109.529 178.245 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.846 HD21 ' N ' ' A' ' 37' ' ' ASN . 0.5 OUTLIER . . . . . 0 N--CA 1.502 2.133 0 CA-C-O 121.062 0.458 . . . . 0.0 112.187 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -156.46 155.44 32.06 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 119.626 -0.829 . . . . 0.0 110.407 177.406 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 96.9 m -112.99 98.53 7.22 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 119.897 -0.721 . . . . 0.0 110.642 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.534 ' O ' ' N ' ' A' ' 27' ' ' LYS . 0.2 OUTLIER -98.48 142.78 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.237 0 C-N-CA 118.777 -1.169 . . . . 0.0 111.619 179.844 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.411 ' O ' HG22 ' A' ' 40' ' ' VAL . 1.9 t -63.42 150.04 44.54 Favored 'General case' 0 C--N 1.275 -2.636 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.949 179.685 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.416 ' H ' ' HA ' ' A' ' 26' ' ' ASN . . . 141.6 -147.54 19.12 Favored Glycine 0 N--CA 1.495 2.58 0 C-N-CA 119.697 -1.24 . . . . 0.0 110.428 -179.747 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -135.62 117.1 14.77 Favored 'General case' 0 N--CA 1.498 1.939 0 C-N-CA 119.798 -0.761 . . . . 0.0 110.349 179.61 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -113.33 177.17 17.92 Favored Glycine 0 N--CA 1.499 2.888 0 C-N-CA 119.965 -1.112 . . . . 0.0 110.409 -179.329 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.481 ' O ' HG23 ' A' ' 45' ' ' THR . 8.8 t -90.03 127.79 52.3 Favored Pre-proline 0 CA--C 1.566 1.594 0 C-N-CA 119.224 -0.99 . . . . 0.0 110.444 -179.681 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -59.78 147.84 90.65 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 121.266 1.311 . . . . 0.0 112.019 179.336 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.435 ' OE1' ' O ' ' A' ' 5' ' ' ASP . 28.0 tt0 . . . . . 0 CA--C 1.554 1.115 0 C-N-CA 119.674 -0.81 . . . . 0.0 111.896 177.523 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.404 HG12 ' H ' ' A' ' 3' ' ' TYR . 1.3 t . . . . . 0 N--CA 1.481 1.083 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.404 ' H ' HG12 ' A' ' 2' ' ' VAL . 38.4 m-85 -132.18 -174.13 3.35 Favored 'General case' 0 N--CA 1.495 1.789 0 C-N-CA 119.525 -0.87 . . . . 0.0 110.411 179.189 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.575 ' OG1' ' N ' ' A' ' 5' ' ' ASP . 0.1 OUTLIER -101.68 -178.18 3.64 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 178.857 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.575 ' N ' ' OG1' ' A' ' 4' ' ' THR . 0.0 OUTLIER -93.05 154.03 18.36 Favored 'General case' 0 C--N 1.288 -2.078 0 C-N-CA 119.162 -1.015 . . . . 0.0 109.605 178.074 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.418 ' SG ' ' HB2' ' A' ' 11' ' ' GLN . 3.7 m -73.99 174.89 7.95 Favored 'General case' 0 C--N 1.295 -1.784 0 C-N-CA 118.944 -1.102 . . . . 0.0 110.778 177.543 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.9 t -155.13 11.88 0.35 Allowed 'General case' 0 C--N 1.276 -2.588 0 CA-C-N 113.554 -1.657 . . . . 0.0 109.806 177.108 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -154.82 173.86 15.87 Favored 'General case' 0 C--N 1.29 -1.997 0 CA-C-N 114.313 -1.312 . . . . 0.0 109.498 -177.344 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.478 ' HB3' ' H ' ' A' ' 30' ' ' LEU . 0.9 OUTLIER -89.18 157.26 18.34 Favored 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 119.325 -0.95 . . . . 0.0 109.807 179.205 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 28' ' ' CYS . . . 94.12 -51.49 2.19 Favored Glycine 0 N--CA 1.502 3.054 0 C-N-CA 119.075 -1.536 . . . . 0.0 112.396 178.156 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.462 ' H ' ' CD ' ' A' ' 11' ' ' GLN . 23.3 mp0 -40.24 164.03 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.452 0 C-N-CA 120.29 -0.564 . . . . 0.0 111.91 -176.985 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.497 ' ND2' ' O ' ' A' ' 26' ' ' ASN . 85.1 m-20 -140.69 -50.45 0.45 Allowed 'General case' 0 N--CA 1.507 2.409 0 C-N-CA 119.149 -1.02 . . . . 0.0 113.413 -177.407 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.428 HD12 ' HB3' ' A' ' 46' ' ' PRO . 14.7 mt -77.35 43.47 0.38 Allowed 'General case' 0 C--N 1.295 -1.787 0 C-N-CA 119.09 -1.044 . . . . 0.0 110.359 -177.389 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.654 ' SG ' ' N ' ' A' ' 15' ' ' LEU . 14.1 p -123.05 -148.44 0.4 Allowed 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 114.725 -1.125 . . . . 0.0 108.491 176.73 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.654 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 83.3 mt -116.23 98.73 6.76 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 114.497 -1.229 . . . . 0.0 107.866 173.904 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.469 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 57.6 m -95.9 -51.24 4.55 Favored 'General case' 0 C--N 1.276 -2.595 0 CA-C-N 113.429 -1.714 . . . . 0.0 110.947 -173.761 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -94.49 94.0 7.97 Favored 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 119.433 -0.907 . . . . 0.0 109.89 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 62.81 -92.7 0.09 OUTLIER Glycine 0 N--CA 1.49 2.242 0 C-N-CA 119.335 -1.412 . . . . 0.0 110.315 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.45 ' O ' HD22 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -131.15 3.05 4.31 Favored 'General case' 0 N--CA 1.483 1.219 0 CA-C-O 122.138 0.971 . . . . 0.0 110.114 -179.901 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 68.6 m-80 -79.34 140.87 37.39 Favored 'General case' 0 C--N 1.258 -3.374 0 CA-C-N 113.409 -1.723 . . . . 0.0 110.544 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.1 t -82.55 135.57 24.61 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 C-N-CA 118.875 -1.13 . . . . 0.0 111.404 -179.375 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.495 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 0.1 OUTLIER -91.19 151.52 20.91 Favored 'General case' 0 N--CA 1.513 2.708 0 C-N-CA 118.559 -1.256 . . . . 0.0 108.057 169.682 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.459 ' O ' ' OD1' ' A' ' 26' ' ' ASN . . . -118.74 124.93 6.2 Favored Glycine 0 C--O 1.213 -1.211 0 C-N-CA 119.922 -1.132 . . . . 0.0 110.42 -170.729 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.434 ' C ' ' O ' ' A' ' 23' ' ' GLY . 10.5 tt0 -36.06 132.43 0.52 Allowed 'General case' 0 C--N 1.255 -3.52 0 CA-C-N 112.652 -1.774 . . . . 0.0 110.127 178.073 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 126.6 -30.14 4.3 Favored Glycine 0 N--CA 1.482 1.715 0 N-CA-C 107.716 -2.154 . . . . 0.0 107.716 -175.844 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.637 ' ND2' ' N ' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -102.13 -159.77 0.75 Allowed 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 177.47 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.765 ' NZ ' HD11 ' A' ' 29' ' ' ILE . 4.8 ttpp -152.81 104.5 2.87 Favored 'General case' 0 N--CA 1.498 1.945 0 C-N-CA 119.194 -1.003 . . . . 0.0 111.594 179.593 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.515 ' O ' ' N ' ' A' ' 10' ' ' GLY . 32.5 m -79.43 157.2 27.6 Favored 'General case' 0 C--O 1.201 -1.492 0 C-N-CA 117.617 -1.633 . . . . 0.0 110.071 178.183 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.765 HD11 ' NZ ' ' A' ' 27' ' ' LYS . 28.0 mm -140.73 138.1 35.32 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.487 0 CA-C-N 114.825 -1.08 . . . . 0.0 110.173 177.414 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.478 ' H ' ' HB3' ' A' ' 9' ' ' SER . 21.1 mt . . . . . 0 N--CA 1.493 1.709 0 C-N-CA 119.054 -1.058 . . . . 0.0 109.345 177.205 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.522 ' N ' ' OD1' ' A' ' 37' ' ' ASN . 0.6 OUTLIER . . . . . 0 N--CA 1.495 1.787 0 CA-C-O 121.374 0.607 . . . . 0.0 111.901 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -154.93 147.03 23.69 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 115.003 -0.998 . . . . 0.0 109.29 176.724 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.465 ' SG ' ' HB2' ' A' ' 16' ' ' CYS . 1.0 OUTLIER -104.15 91.34 3.9 Favored 'General case' 0 C--N 1.299 -1.604 0 C-N-CA 119.521 -0.872 . . . . 0.0 110.208 -179.984 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.573 HG22 ' N ' ' A' ' 41' ' ' THR . 3.4 p -106.76 160.15 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 C-N-CA 118.617 -1.233 . . . . 0.0 110.567 179.299 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.573 ' N ' HG22 ' A' ' 40' ' ' VAL . 8.8 t -80.14 154.81 27.79 Favored 'General case' 0 C--N 1.276 -2.606 0 CA-C-N 114.87 -1.059 . . . . 0.0 112.128 -178.613 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 166.94 -120.75 0.93 Allowed Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.906 -1.277 . . . . 0.0 109.906 178.666 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -142.98 123.74 14.19 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 119.374 -0.93 . . . . 0.0 110.109 179.145 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -142.11 -171.19 12.93 Favored Glycine 0 N--CA 1.489 2.186 1 N-CA-C 131.0 7.16 . . . . 0.0 131.0 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -136.16 154.0 77.06 Favored Pre-proline 0 N--CA 1.492 1.669 0 C-N-CA 119.904 -0.718 . . . . 0.0 109.48 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.428 ' HB3' HD12 ' A' ' 13' ' ' LEU . 5.8 Cg_exo -56.82 -175.88 0.05 OUTLIER 'Trans proline' 0 C--N 1.324 -0.719 0 C-N-CA 120.994 1.129 . . . . 0.0 110.396 175.794 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.656 ' H ' ' CD ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.304 -1.397 0 C-N-CA 118.814 -1.154 . . . . 0.0 109.202 178.518 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 1.6 t . . . . . 0 N--CA 1.485 1.318 0 CA-C-O 120.914 0.388 . . . . 0.0 110.807 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -107.77 -163.96 0.93 Allowed 'General case' 0 N--CA 1.495 1.814 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.707 -179.617 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.565 ' OG1' ' N ' ' A' ' 5' ' ' ASP . 0.5 OUTLIER -127.61 -172.91 2.78 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 177.052 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.565 ' N ' ' OG1' ' A' ' 4' ' ' THR . 0.3 OUTLIER -81.3 157.53 25.08 Favored 'General case' 0 C--N 1.288 -2.067 0 C-N-CA 118.358 -1.337 . . . . 0.0 111.332 -178.693 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.402 ' N ' ' HB2' ' A' ' 14' ' ' CYS . 0.0 OUTLIER -75.83 -179.69 4.96 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.242 177.459 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.1 t -138.34 -0.85 1.96 Allowed 'General case' 0 N--CA 1.497 1.892 0 C-N-CA 119.001 -1.08 . . . . 0.0 111.408 178.128 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.463 ' HA ' HD12 ' A' ' 30' ' ' LEU . 8.8 pt-20 -163.33 169.17 19.46 Favored 'General case' 0 C--N 1.273 -2.741 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.985 177.913 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.18 149.37 44.72 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.587 -178.837 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.59 -12.15 62.98 Favored Glycine 0 N--CA 1.504 3.229 0 C-N-CA 119.473 -1.346 . . . . 0.0 112.458 179.066 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.414 ' OE1' ' CA ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -66.56 178.18 1.35 Allowed 'General case' 0 N--CA 1.503 2.203 0 C-N-CA 119.181 -1.008 . . . . 0.0 110.961 -179.043 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.72 HD21 ' HA3' ' A' ' 44' ' ' GLY . 44.5 m-20 -143.85 -72.18 0.29 Allowed 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 118.648 -1.221 . . . . 0.0 113.031 -178.472 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.425 HD12 ' HB3' ' A' ' 46' ' ' PRO . 12.9 mt -75.51 48.31 0.44 Allowed 'General case' 0 C--N 1.289 -2.042 0 C-N-CA 119.542 -0.863 . . . . 0.0 110.032 -176.488 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.438 ' H ' ' C ' ' A' ' 12' ' ' ASN . 31.5 p -122.39 -151.5 0.48 Allowed 'General case' 0 C--N 1.302 -1.5 0 CA-C-N 114.261 -1.336 . . . . 0.0 108.409 176.696 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.45 HD22 ' O ' ' A' ' 19' ' ' SER . 67.6 mt -114.63 110.93 20.52 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-N 115.097 -0.956 . . . . 0.0 108.852 175.808 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 69.7 m -107.4 -70.41 0.8 Allowed 'General case' 0 C--N 1.285 -2.21 0 CA-C-N 114.437 -1.256 . . . . 0.0 110.243 -175.639 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -79.03 89.9 4.79 Favored 'General case' 0 C--N 1.297 -1.682 0 C-N-CA 118.829 -1.149 . . . . 0.0 109.472 178.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 70.9 -127.5 15.47 Favored Glycine 0 N--CA 1.483 1.827 0 C-N-CA 119.416 -1.374 . . . . 0.0 110.032 -178.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.45 ' O ' HD22 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -101.63 2.42 38.79 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 122.279 1.038 . . . . 0.0 109.629 179.677 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -78.82 140.73 38.14 Favored 'General case' 0 C--N 1.26 -3.289 0 CA-C-N 113.227 -1.806 . . . . 0.0 110.466 -179.541 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.3 t -80.88 142.47 13.8 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.977 -178.303 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.568 ' O ' ' O ' ' A' ' 12' ' ' ASN . 0.0 OUTLIER -114.65 161.59 17.9 Favored 'General case' 0 N--CA 1.505 2.319 0 N-CA-C 104.908 -2.256 . . . . 0.0 104.908 168.849 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -137.79 -139.31 3.85 Favored Glycine 0 CA--C 1.483 -1.963 0 C-N-CA 116.809 -2.615 . . . . 0.0 112.134 -175.433 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 50.0 tp60 -91.57 150.15 21.33 Favored 'General case' 0 C--N 1.253 -3.615 0 CA-C-N 112.343 -1.929 . . . . 0.0 110.543 -174.371 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.6 -31.96 8.04 Favored Glycine 0 C--N 1.297 -1.634 0 N-CA-C 108.948 -1.661 . . . . 0.0 108.948 -177.817 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -109.61 -174.74 2.57 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 119.767 -0.773 . . . . 0.0 109.415 179.41 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.403 ' O ' ' O ' ' A' ' 40' ' ' VAL . 51.1 tttp -142.53 114.69 8.29 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 118.994 -1.083 . . . . 0.0 110.01 176.856 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.472 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 28.9 m -84.38 151.12 24.9 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 117.519 -1.672 . . . . 0.0 110.241 178.008 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 6.3 mm -130.23 125.01 59.05 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.748 0 CA-C-N 113.926 -1.488 . . . . 0.0 109.185 177.32 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.463 HD12 ' HA ' ' A' ' 8' ' ' GLU . 18.5 mt . . . . . 0 N--CA 1.498 1.966 0 C-N-CA 118.475 -1.29 . . . . 0.0 110.126 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 . . . . . 0 N--CA 1.484 1.238 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -103.26 148.61 25.61 Favored 'General case' 0 C--N 1.308 -1.217 0 C-N-CA 119.375 -0.93 . . . . 0.0 110.483 -177.609 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.472 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 1.6 m -103.38 88.5 3.12 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 119.445 -0.902 . . . . 0.0 110.844 -179.335 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.418 HG22 ' O ' ' A' ' 41' ' ' THR . 0.2 OUTLIER -97.47 139.68 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 C-N-CA 118.41 -1.316 . . . . 0.0 110.332 179.047 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.418 ' O ' HG22 ' A' ' 40' ' ' VAL . 15.2 t -53.19 152.92 4.02 Favored 'General case' 0 C--N 1.272 -2.773 0 CA-C-N 113.887 -1.506 . . . . 0.0 111.021 -178.811 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 152.19 -167.17 31.22 Favored Glycine 0 N--CA 1.49 2.296 0 C-N-CA 119.08 -1.534 . . . . 0.0 110.797 179.332 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 18.5 mp0 -83.44 -176.77 6.47 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 119.396 -0.922 . . . . 0.0 110.367 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.72 ' HA3' HD21 ' A' ' 12' ' ' ASN . . . 177.76 172.23 42.02 Favored Glycine 0 N--CA 1.486 2.031 1 N-CA-C 129.575 6.59 . . . . 0.0 129.575 179.831 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -128.45 140.87 39.63 Favored Pre-proline 0 N--CA 1.486 1.363 0 C-N-CA 119.291 -0.964 . . . . 0.0 109.925 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.425 ' HB3' HD12 ' A' ' 13' ' ' LEU . 4.9 Cg_exo -58.54 -163.16 0.02 OUTLIER 'Trans proline' 0 C--O 1.214 -0.692 0 C-N-CA 121.067 1.178 . . . . 0.0 111.059 178.124 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 . . . . . 0 C--N 1.305 -1.353 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.409 178.614 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.1 t . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 110.319 -0.252 . . . . 0.0 110.319 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.479 ' CE2' HD22 ' A' ' 13' ' ' LEU . 28.0 m-85 -100.32 -169.44 1.73 Allowed 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 119.487 -0.885 . . . . 0.0 110.676 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.612 ' OG1' ' N ' ' A' ' 5' ' ' ASP . 0.1 OUTLIER -108.89 -175.42 2.76 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -179.953 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.612 ' N ' ' OG1' ' A' ' 4' ' ' THR . 0.0 OUTLIER -86.13 156.86 20.18 Favored 'General case' 0 C--N 1.293 -1.878 0 C-N-CA 118.982 -1.087 . . . . 0.0 110.619 -179.615 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.6 m -73.43 178.71 4.42 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 119.541 -0.864 . . . . 0.0 110.711 176.731 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 13.3 t -146.01 4.17 0.95 Allowed 'General case' 0 C--N 1.286 -2.182 0 CA-C-N 114.391 -1.277 . . . . 0.0 110.75 177.475 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.425 ' HA ' HD12 ' A' ' 30' ' ' LEU . 2.3 mt-10 -163.96 170.49 16.6 Favored 'General case' 0 C--N 1.282 -2.358 0 CA-C-N 114.575 -1.193 . . . . 0.0 110.284 178.922 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.445 ' HB3' ' H ' ' A' ' 30' ' ' LEU . 0.4 OUTLIER -83.31 151.37 25.61 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 119.603 -0.839 . . . . 0.0 109.117 178.479 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.13 -1.99 71.04 Favored Glycine 0 N--CA 1.493 2.447 0 C-N-CA 119.061 -1.542 . . . . 0.0 112.839 179.047 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.24 -165.24 0.46 Allowed 'General case' 0 N--CA 1.501 2.095 0 C-N-CA 118.752 -1.179 . . . . 0.0 109.723 179.248 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.543 ' OD1' ' N ' ' A' ' 24' ' ' GLN . 12.7 t-20 -150.63 -77.33 0.14 Allowed 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 117.987 -1.485 . . . . 0.0 114.5 -177.324 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.538 ' H ' ' HA ' ' A' ' 46' ' ' PRO . 12.4 mt -76.22 53.91 0.85 Allowed 'General case' 0 C--N 1.273 -2.755 0 C-N-CA 118.557 -1.257 . . . . 0.0 110.857 -175.268 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.638 ' SG ' ' N ' ' A' ' 15' ' ' LEU . 8.8 p -123.53 -152.47 0.51 Allowed 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 114.85 -1.068 . . . . 0.0 108.802 176.012 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.638 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 51.7 mt -112.97 119.6 38.48 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 115.044 -0.98 . . . . 0.0 108.646 176.558 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.406 ' SG ' ' O ' ' A' ' 22' ' ' CYS . 1.6 m -122.47 7.91 9.57 Favored 'General case' 0 N--CA 1.502 2.138 0 C-N-CA 118.634 -1.227 . . . . 0.0 111.15 -176.715 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -157.51 82.2 0.9 Allowed 'General case' 0 C--N 1.298 -1.647 0 C-N-CA 119.412 -0.915 . . . . 0.0 109.35 177.114 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.83 -112.76 3.69 Favored Glycine 0 N--CA 1.485 1.939 0 C-N-CA 119.424 -1.369 . . . . 0.0 109.981 -178.774 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.48 0.39 14.7 Favored 'General case' 0 CA--C 1.493 -1.249 0 CA-C-O 122.336 1.065 . . . . 0.0 109.551 179.534 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 71.8 m-20 -79.52 128.78 33.79 Favored 'General case' 0 C--N 1.257 -3.435 0 CA-C-N 113.099 -1.864 . . . . 0.0 111.278 -178.46 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.5 t -69.13 143.99 14.51 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 C-N-CA 118.594 -1.242 . . . . 0.0 108.563 177.311 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.517 ' O ' ' SG ' ' A' ' 28' ' ' CYS . 0.9 OUTLIER -146.71 128.17 14.99 Favored 'General case' 0 C--N 1.272 -2.768 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 179.642 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.464 ' O ' ' O ' ' A' ' 26' ' ' ASN . . . 164.49 -79.85 0.13 Allowed Glycine 0 C--O 1.201 -1.908 0 C-N-CA 117.22 -2.419 . . . . 0.0 112.151 -176.373 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.543 ' N ' ' OD1' ' A' ' 12' ' ' ASN . 0.1 OUTLIER -44.78 125.13 4.76 Favored 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 119.647 -0.821 . . . . 0.0 111.66 -176.753 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.69 -26.2 8.6 Favored Glycine 0 N--CA 1.483 1.808 0 N-CA-C 109.899 -1.28 . . . . 0.0 109.899 -179.287 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.464 ' O ' ' O ' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -129.53 -175.95 3.75 Favored 'General case' 0 C--N 1.311 -1.074 0 C-N-CA 120.22 -0.592 . . . . 0.0 111.066 -178.871 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.45 ' O ' ' N ' ' A' ' 40' ' ' VAL . 0.0 OUTLIER -120.56 153.83 36.2 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.038 175.187 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.517 ' SG ' ' O ' ' A' ' 22' ' ' CYS . 86.1 m -120.26 146.44 46.08 Favored 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 119.169 -1.013 . . . . 0.0 109.613 174.636 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.44 HD13 ' O ' ' A' ' 28' ' ' CYS . 2.3 mm -131.99 132.29 61.39 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.953 0 CA-C-N 114.314 -1.312 . . . . 0.0 109.93 179.489 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.445 ' H ' ' HB3' ' A' ' 9' ' ' SER . 14.8 mt . . . . . 0 N--CA 1.494 1.725 0 C-N-CA 118.327 -1.349 . . . . 0.0 108.891 176.542 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.522 ' N ' ' OD1' ' A' ' 37' ' ' ASN . 0.3 OUTLIER . . . . . 0 C--O 1.215 -0.717 0 CA-C-O 120.966 0.412 . . . . 0.0 110.829 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -120.78 149.56 42.36 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.144 -0.934 . . . . 0.0 109.727 178.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 3.0 m -100.33 105.73 17.28 Favored 'General case' 0 C--N 1.298 -1.658 0 C-N-CA 119.441 -0.904 . . . . 0.0 110.316 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.915 HG22 ' H ' ' A' ' 41' ' ' THR . 7.4 p -99.77 -176.81 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 C-N-CA 118.518 -1.273 . . . . 0.0 110.241 177.479 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.915 ' H ' HG22 ' A' ' 40' ' ' VAL . 12.5 t -91.67 160.05 15.56 Favored 'General case' 0 C--N 1.288 -2.068 0 CA-C-N 114.629 -1.169 . . . . 0.0 110.926 179.657 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 138.28 -147.47 19.25 Favored Glycine 0 N--CA 1.496 2.695 1 N-CA-C 131.793 7.477 . . . . 0.0 131.793 179.178 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -108.88 111.46 23.18 Favored 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 119.933 -0.707 . . . . 0.0 110.412 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -130.52 156.56 21.68 Favored Glycine 0 N--CA 1.491 2.363 1 N-CA-C 129.783 6.673 . . . . 0.0 129.783 178.858 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.462 HG23 ' O ' ' A' ' 46' ' ' PRO . 5.8 t -111.31 145.2 32.04 Favored Pre-proline 0 N--CA 1.495 1.823 0 C-N-CA 119.59 -0.844 . . . . 0.0 110.197 -178.807 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.538 ' HA ' ' H ' ' A' ' 13' ' ' LEU . 7.2 Cg_exo -52.44 -176.97 0.02 OUTLIER 'Trans proline' 0 C--O 1.211 -0.854 0 C-N-CA 120.9 1.066 . . . . 0.0 110.351 175.727 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.652 ' H ' ' CD ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.306 -1.322 0 C-N-CA 118.866 -1.134 . . . . 0.0 108.519 178.594 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.681 HG12 ' N ' ' A' ' 3' ' ' TYR . 38.6 t . . . . . 0 N--CA 1.489 1.497 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.681 ' N ' HG12 ' A' ' 2' ' ' VAL . 35.8 m-85 -139.5 -166.24 2.02 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 119.722 -0.791 . . . . 0.0 110.125 -179.381 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -93.09 -174.95 3.71 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 119.679 -0.809 . . . . 0.0 108.858 179.064 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -100.58 154.09 18.85 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 119.03 -1.068 . . . . 0.0 110.441 179.069 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.42 ' N ' ' HB2' ' A' ' 14' ' ' CYS . 4.3 m -74.67 174.91 8.43 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-O 122.144 0.973 . . . . 0.0 111.188 178.776 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -140.26 7.49 2.19 Favored 'General case' 0 C--N 1.285 -2.232 0 CA-C-N 113.549 -1.659 . . . . 0.0 109.471 177.592 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -163.13 162.64 25.72 Favored 'General case' 0 C--N 1.279 -2.481 0 CA-C-N 113.784 -1.553 . . . . 0.0 109.0 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.604 ' OG ' ' N ' ' A' ' 30' ' ' LEU . 0.9 OUTLIER -65.1 -168.11 0.03 OUTLIER 'General case' 0 C--N 1.293 -1.876 0 C-N-CA 118.992 -1.083 . . . . 0.0 110.057 -179.087 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.508 ' H ' HD13 ' A' ' 29' ' ' ILE . . . 37.1 6.05 0.0 OUTLIER Glycine 0 N--CA 1.505 3.281 1 N-CA-C 130.124 6.81 . . . . 0.0 130.124 -179.831 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -74.79 -167.0 0.52 Allowed 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 175.747 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.466 ' O ' ' O ' ' A' ' 22' ' ' CYS . 0.7 OUTLIER -143.01 -70.24 0.33 Allowed 'General case' 0 N--CA 1.5 2.072 0 C-N-CA 117.55 -1.66 . . . . 0.0 114.987 -178.41 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.538 HD12 ' HB3' ' A' ' 46' ' ' PRO . 15.0 mt -77.67 50.45 0.83 Allowed 'General case' 0 C--N 1.27 -2.879 0 C-N-CA 117.244 -1.782 . . . . 0.0 111.111 -174.505 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.575 ' SG ' ' N ' ' A' ' 15' ' ' LEU . 15.6 p -119.76 -146.48 0.38 Allowed 'General case' 0 C--O 1.207 -1.146 0 CA-C-N 114.948 -1.023 . . . . 0.0 108.397 175.178 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.575 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 7.7 mt -128.85 130.77 47.34 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.822 177.657 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.421 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 7.9 m -139.0 21.47 2.63 Favored 'General case' 0 N--CA 1.498 1.971 0 C-N-CA 119.127 -1.029 . . . . 0.0 110.536 -179.417 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -146.41 55.16 1.14 Allowed 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 177.735 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.7 -66.92 2.01 Favored Glycine 0 N--CA 1.487 2.063 0 C-N-CA 119.479 -1.344 . . . . 0.0 110.19 -179.273 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.411 ' O ' ' OG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -144.4 1.72 1.08 Allowed 'General case' 0 C--N 1.309 -1.191 0 C-N-CA 119.445 -0.902 . . . . 0.0 111.57 -179.833 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -90.1 134.91 33.98 Favored 'General case' 0 C--N 1.253 -3.615 0 CA-C-N 114.37 -1.286 . . . . 0.0 110.464 179.033 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.567 HG22 ' O ' ' A' ' 14' ' ' CYS . 1.3 t -74.2 144.12 12.79 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 C-N-CA 119.459 -0.897 . . . . 0.0 109.718 179.693 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.466 ' O ' ' O ' ' A' ' 12' ' ' ASN . 1.2 m -141.82 121.28 13.24 Favored 'General case' 0 C--N 1.29 -1.979 0 C-N-CA 118.857 -1.137 . . . . 0.0 109.384 178.398 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.449 ' O ' ' O ' ' A' ' 26' ' ' ASN . . . 173.91 -87.69 0.08 OUTLIER Glycine 0 C--O 1.205 -1.664 0 C-N-CA 117.851 -2.119 . . . . 0.0 111.803 -176.223 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -49.8 126.49 14.08 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 119.291 -0.964 . . . . 0.0 110.491 -178.408 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.52 -26.27 14.68 Favored Glycine 0 N--CA 1.482 1.716 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -178.38 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.449 ' O ' ' O ' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -138.88 -160.9 1.11 Allowed 'General case' 0 C--N 1.311 -1.087 0 C-N-CA 119.954 -0.699 . . . . 0.0 111.139 -179.855 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.534 ' O ' ' O ' ' A' ' 40' ' ' VAL . 21.1 ttpt -148.5 148.0 29.74 Favored 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 119.66 -0.816 . . . . 0.0 109.88 177.899 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.442 ' O ' ' HA2' ' A' ' 10' ' ' GLY . 87.3 m -99.59 160.45 14.29 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 118.31 -1.356 . . . . 0.0 111.053 178.511 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.508 HD13 ' H ' ' A' ' 10' ' ' GLY . 18.5 mm -151.77 90.46 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.274 -2.705 0 CA-C-N 113.574 -1.648 . . . . 0.0 106.711 175.693 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.681 ' C ' HD12 ' A' ' 30' ' ' LEU . 3.1 pp . . . . . 0 C--N 1.288 -2.069 0 C-N-CA 118.051 -1.46 . . . . 0.0 113.359 -173.802 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.562 ' HA ' ' HA ' ' A' ' 30' ' ' LEU . 58.4 m-80 . . . . . 0 C--O 1.216 -0.665 0 CA-C-O 120.246 0.07 . . . . 0.0 110.937 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -110.41 145.32 37.79 Favored 'General case' 0 C--N 1.309 -1.183 0 C-N-CA 119.595 -0.842 . . . . 0.0 110.172 178.374 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 86.5 m -110.84 85.17 2.06 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.715 179.668 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.534 ' O ' ' O ' ' A' ' 27' ' ' LYS . 1.2 p -97.27 141.74 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 C-N-CA 118.617 -1.233 . . . . 0.0 112.704 -177.52 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.6 t -62.68 140.13 58.69 Favored 'General case' 0 C--N 1.27 -2.876 0 CA-C-N 113.807 -1.542 . . . . 0.0 110.656 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 168.87 -136.06 3.89 Favored Glycine 0 N--CA 1.493 2.456 0 C-N-CA 119.396 -1.383 . . . . 0.0 110.692 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -140.96 113.73 8.3 Favored 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 119.752 -0.779 . . . . 0.0 109.864 -179.731 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -127.54 171.13 19.01 Favored Glycine 0 N--CA 1.501 3.032 0 C-N-CA 119.725 -1.226 . . . . 0.0 111.247 -178.862 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -104.83 150.22 38.41 Favored Pre-proline 0 C--N 1.307 -1.254 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 179.6 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.538 ' HB3' HD12 ' A' ' 13' ' ' LEU . 3.4 Cg_exo -53.51 -164.79 0.01 OUTLIER 'Trans proline' 0 C--O 1.215 -0.641 0 C-N-CA 121.392 1.395 . . . . 0.0 111.765 177.342 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 . . . . . 0 C--N 1.308 -1.234 0 CA-C-N 115.086 -0.961 . . . . 0.0 108.648 177.553 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.2 t . . . . . 0 N--CA 1.489 1.494 0 CA-C-O 122.043 0.925 . . . . 0.0 110.272 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.459 ' CZ ' HD22 ' A' ' 13' ' ' LEU . 36.4 m-85 -89.61 -178.29 5.51 Favored 'General case' 0 C--N 1.262 -3.235 0 CA-C-N 114.082 -1.417 . . . . 0.0 111.517 -178.563 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 23.2 p -116.38 -178.5 3.43 Favored 'General case' 0 N--CA 1.486 1.331 0 CA-C-N 114.821 -1.081 . . . . 0.0 108.857 179.19 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.1 154.23 22.18 Favored 'General case' 0 C--N 1.29 -1.998 0 C-N-CA 118.373 -1.331 . . . . 0.0 110.767 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.46 ' SG ' ' O ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -75.37 145.53 41.57 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.116 177.727 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.451 ' O ' ' OG1' ' A' ' 7' ' ' THR . 0.0 OUTLIER -114.69 8.14 16.13 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.703 -0.799 . . . . 0.0 109.506 178.525 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -162.3 171.01 17.94 Favored 'General case' 0 C--N 1.283 -2.287 0 CA-C-N 114.349 -1.296 . . . . 0.0 111.489 179.616 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -84.47 155.28 22.27 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 114.922 -1.035 . . . . 0.0 110.451 -178.901 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 87.66 -2.55 86.13 Favored Glycine 0 N--CA 1.498 2.783 0 C-N-CA 119.295 -1.431 . . . . 0.0 111.978 179.064 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -71.53 -174.91 1.18 Allowed 'General case' 0 N--CA 1.505 2.3 0 C-N-CA 119.232 -0.987 . . . . 0.0 110.219 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.741 ' O ' ' HA3' ' A' ' 23' ' ' GLY . 7.1 m120 -146.62 -71.67 0.23 Allowed 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 118.244 -1.382 . . . . 0.0 113.313 -179.106 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.699 HD12 ' HB3' ' A' ' 46' ' ' PRO . 24.6 mt -77.65 50.94 0.87 Allowed 'General case' 0 C--N 1.273 -2.718 0 C-N-CA 118.22 -1.392 . . . . 0.0 110.201 -177.618 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.432 ' HB2' ' N ' ' A' ' 6' ' ' CYS . 30.6 p -119.06 -156.44 0.65 Allowed 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.895 176.738 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.46 ' O ' ' SG ' ' A' ' 6' ' ' CYS . 6.0 mt -123.16 128.67 50.38 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 114.877 -1.056 . . . . 0.0 108.551 175.74 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 93.6 m -115.1 -44.0 3.05 Favored 'General case' 0 N--CA 1.518 2.969 0 C-N-CA 118.221 -1.391 . . . . 0.0 110.61 -179.382 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -102.19 116.25 32.26 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.058 -1.057 . . . . 0.0 110.057 178.326 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 47.87 -96.95 0.01 OUTLIER Glycine 0 N--CA 1.493 2.443 0 C-N-CA 119.546 -1.311 . . . . 0.0 111.299 179.213 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -131.44 6.72 4.47 Favored 'General case' 0 N--CA 1.485 1.32 0 CA-C-O 122.556 1.169 . . . . 0.0 110.211 -178.01 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 19.2 m-80 -80.11 132.18 35.89 Favored 'General case' 0 C--N 1.251 -3.674 0 CA-C-N 113.373 -1.739 . . . . 0.0 110.39 178.674 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.6 t -66.64 151.08 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 119.232 -0.987 . . . . 0.0 110.184 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.496 ' O ' ' O ' ' A' ' 12' ' ' ASN . 0.0 OUTLIER -150.74 112.82 4.57 Favored 'General case' 0 C--N 1.284 -2.28 0 C-N-CA 118.936 -1.106 . . . . 0.0 110.861 -179.882 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.741 ' HA3' ' O ' ' A' ' 12' ' ' ASN . . . 154.77 -45.56 0.55 Allowed Glycine 0 N--CA 1.483 1.771 1 N-CA-C 130.522 6.969 . . . . 0.0 130.522 -177.169 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.504 ' C ' ' H ' ' A' ' 26' ' ' ASN . 6.2 tp60 -56.92 133.45 54.68 Favored 'General case' 0 C--N 1.31 -1.134 0 C-N-CA 119.347 -0.941 . . . . 0.0 110.228 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 73.89 -23.8 1.07 Allowed Glycine 0 C--N 1.298 -1.578 0 C-N-CA 119.264 -1.446 . . . . 0.0 110.149 -179.423 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.537 ' O ' ' ND2' ' A' ' 12' ' ' ASN . 0.0 OUTLIER -111.14 -155.14 0.56 Allowed 'General case' 0 C--O 1.213 -0.849 0 C-N-CA 119.743 -0.783 . . . . 0.0 110.571 -179.311 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.612 ' CE ' HD11 ' A' ' 29' ' ' ILE . 0.3 OUTLIER -157.83 105.91 2.02 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.623 179.389 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.501 ' SG ' ' O ' ' A' ' 38' ' ' GLN . 0.0 OUTLIER -77.21 162.95 26.98 Favored 'General case' 0 CA--C 1.481 -1.68 0 C-N-CA 117.457 -1.697 . . . . 0.0 111.342 -179.055 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.612 HD11 ' CE ' ' A' ' 27' ' ' LYS . 23.7 mm -144.24 119.21 3.82 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.347 0 CA-C-N 112.276 -2.238 . . . . 0.0 108.273 -179.263 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 16.3 mt . . . . . 0 N--CA 1.488 1.444 0 C-N-CA 118.199 -1.4 . . . . 0.0 112.104 -176.707 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 65.1 m-20 . . . . . 0 N--CA 1.493 1.682 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.501 ' O ' ' SG ' ' A' ' 28' ' ' CYS . 61.1 tt0 -150.77 153.06 34.76 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 117.82 -1.552 . . . . 0.0 112.66 -178.151 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -108.03 114.42 28.31 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 114.602 -1.181 . . . . 0.0 112.004 179.334 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.596 HG22 ' N ' ' A' ' 41' ' ' THR . 5.8 p -128.24 158.74 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 C-N-CA 118.579 -1.248 . . . . 0.0 110.172 173.647 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.596 ' N ' HG22 ' A' ' 40' ' ' VAL . 0.5 OUTLIER -88.07 138.31 31.56 Favored 'General case' 0 C--N 1.27 -2.862 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.707 -179.876 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 178.48 -153.15 12.28 Favored Glycine 0 N--CA 1.489 2.184 0 C-N-CA 119.43 -1.367 . . . . 0.0 110.411 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -98.97 108.78 21.55 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 119.531 -0.867 . . . . 0.0 110.786 -179.463 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -129.49 170.28 20.46 Favored Glycine 0 N--CA 1.493 2.445 1 N-CA-C 129.34 6.496 . . . . 0.0 129.34 178.814 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.2 t -113.61 141.14 25.5 Favored Pre-proline 0 N--CA 1.496 1.843 0 C-N-CA 119.103 -1.039 . . . . 0.0 110.128 -179.544 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.699 ' HB3' HD12 ' A' ' 13' ' ' LEU . 9.5 Cg_endo -71.72 107.77 2.27 Favored 'Trans proline' 0 C--O 1.213 -0.755 0 C-N-CA 120.989 1.126 . . . . 0.0 110.123 174.675 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.441 ' C ' ' O ' ' A' ' 46' ' ' PRO . 3.6 tm-20 . . . . . 0 N--CA 1.503 2.187 0 C-N-CA 120.056 -0.658 . . . . 0.0 110.673 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.572 HG12 ' H ' ' A' ' 3' ' ' TYR . 0.5 OUTLIER . . . . . 0 N--CA 1.478 0.95 0 CA-C-O 120.936 0.398 . . . . 0.0 110.573 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.572 ' H ' HG12 ' A' ' 2' ' ' VAL . 22.4 m-85 -137.7 -164.71 1.65 Allowed 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.993 -0.683 . . . . 0.0 109.943 -179.323 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -93.98 167.49 11.57 Favored 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 119.266 -0.974 . . . . 0.0 109.281 -179.778 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.485 ' OD1' ' N ' ' A' ' 5' ' ' ASP . 0.0 OUTLIER -84.92 144.49 28.32 Favored 'General case' 0 C--N 1.291 -1.937 0 C-N-CA 118.464 -1.294 . . . . 0.0 109.979 179.599 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -72.11 -178.49 2.44 Favored 'General case' 0 C--N 1.287 -2.136 0 CA-C-O 122.147 0.975 . . . . 0.0 110.542 177.523 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.2 t -159.47 18.31 0.17 Allowed 'General case' 0 C--N 1.272 -2.784 0 CA-C-N 113.538 -1.665 . . . . 0.0 109.263 177.064 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -162.7 -178.46 6.2 Favored 'General case' 0 C--N 1.293 -1.866 0 CA-C-N 114.218 -1.355 . . . . 0.0 110.055 -178.122 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.493 ' HB3' ' H ' ' A' ' 30' ' ' LEU . 0.8 OUTLIER -98.24 166.26 11.48 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.303 -179.787 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.459 ' O ' ' O ' ' A' ' 11' ' ' GLN . . . 84.12 -43.65 3.22 Favored Glycine 0 N--CA 1.509 3.519 0 C-N-CA 119.584 -1.293 . . . . 0.0 113.235 176.819 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.459 ' O ' ' O ' ' A' ' 10' ' ' GLY . 56.4 mt-30 -47.65 178.68 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.563 0 C-N-CA 119.727 -0.789 . . . . 0.0 111.099 -177.869 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.551 ' O ' ' O ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -144.38 -59.21 0.38 Allowed 'General case' 0 N--CA 1.507 2.418 0 C-N-CA 118.16 -1.416 . . . . 0.0 114.372 -176.31 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.501 ' N ' ' CG ' ' A' ' 12' ' ' ASN . 12.7 mt -76.79 48.07 0.55 Allowed 'General case' 0 C--N 1.27 -2.866 0 C-N-CA 117.156 -1.818 . . . . 0.0 110.995 -176.269 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.586 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 25.0 p -123.38 -160.24 0.89 Allowed 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 176.325 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.496 HD22 ' O ' ' A' ' 19' ' ' SER . 70.6 mt -109.03 110.29 21.53 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 176.232 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.586 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 1.9 m -117.62 9.34 13.09 Favored 'General case' 0 N--CA 1.505 2.287 0 C-N-CA 119.19 -1.004 . . . . 0.0 110.345 -176.202 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.419 ' OE2' ' SG ' ' A' ' 22' ' ' CYS . 34.5 mt-10 -141.73 60.78 1.48 Allowed 'General case' 0 C--N 1.288 -2.07 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 177.189 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 79.66 -105.82 2.35 Favored Glycine 0 N--CA 1.484 1.862 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 -177.5 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.496 ' O ' HD22 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -109.37 -3.22 17.26 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-O 122.232 1.015 . . . . 0.0 109.708 179.165 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 -81.16 133.53 35.47 Favored 'General case' 0 C--N 1.262 -3.2 0 CA-C-N 113.327 -1.76 . . . . 0.0 111.443 -178.478 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.417 ' HA ' HD23 ' A' ' 15' ' ' LEU . 2.3 t -70.0 142.3 16.04 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 C-N-CA 119.015 -1.074 . . . . 0.0 109.708 178.588 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.58 ' O ' ' SG ' ' A' ' 28' ' ' CYS . 0.1 OUTLIER -143.49 119.79 10.88 Favored 'General case' 0 C--N 1.281 -2.39 0 C-N-CA 119.025 -1.07 . . . . 0.0 109.467 177.387 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.445 ' O ' ' O ' ' A' ' 26' ' ' ASN . . . 151.78 -39.55 0.78 Allowed Glycine 0 C--N 1.294 -1.759 1 N-CA-C 130.544 6.978 . . . . 0.0 130.544 -178.806 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -58.28 115.03 2.69 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 118.882 -1.127 . . . . 0.0 110.266 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.49 -23.33 8.73 Favored Glycine 0 C--N 1.3 -1.447 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -178.356 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.48 ' N ' ' OD1' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -115.31 -168.99 1.48 Allowed 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.638 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.529 ' HE3' HD11 ' A' ' 29' ' ' ILE . 7.4 tttt -148.59 135.94 20.34 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 118.523 -1.271 . . . . 0.0 110.078 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.58 ' SG ' ' O ' ' A' ' 22' ' ' CYS . 2.9 m -95.65 153.72 17.58 Favored 'General case' 0 C--N 1.307 -1.282 0 C-N-CA 118.289 -1.365 . . . . 0.0 111.458 179.513 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.529 HD11 ' HE3' ' A' ' 27' ' ' LYS . 14.9 mm -136.18 130.53 48.15 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.47 0 CA-C-N 114.05 -1.432 . . . . 0.0 109.811 174.678 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.493 ' H ' ' HB3' ' A' ' 9' ' ' SER . 23.3 mt . . . . . 0 N--CA 1.496 1.868 0 C-N-CA 119.271 -0.972 . . . . 0.0 108.473 177.795 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.558 ' N ' ' OD1' ' A' ' 37' ' ' ASN . 0.2 OUTLIER . . . . . 0 C--O 1.215 -0.719 0 CA-C-O 121.294 0.568 . . . . 0.0 111.0 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.77 145.93 27.81 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-N 115.267 -0.878 . . . . 0.0 109.64 178.602 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -83.75 116.62 22.78 Favored 'General case' 0 C--N 1.288 -2.106 0 CA-C-N 115.32 -0.854 . . . . 0.0 112.615 -177.624 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.509 ' O ' ' O ' ' A' ' 27' ' ' LYS . 0.9 OUTLIER -119.22 129.69 74.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 CA-C-O 122.606 1.193 . . . . 0.0 110.596 173.707 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 10.1 t -46.98 148.78 1.01 Allowed 'General case' 0 C--N 1.258 -3.378 0 CA-C-N 113.42 -1.718 . . . . 0.0 111.134 -178.032 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.401 ' O ' ' C ' ' A' ' 26' ' ' ASN . . . 149.37 149.66 5.04 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.954 -1.259 . . . . 0.0 109.954 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -80.01 63.4 4.52 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 119.035 -1.066 . . . . 0.0 110.873 -179.323 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -63.36 162.91 32.14 Favored Glycine 0 N--CA 1.49 2.296 0 C-N-CA 119.181 -1.485 . . . . 0.0 109.437 178.546 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.4 t -79.87 141.04 54.68 Favored Pre-proline 0 N--CA 1.488 1.474 0 C-N-CA 118.514 -1.275 . . . . 0.0 109.835 -179.307 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.436 ' HB3' HD12 ' A' ' 13' ' ' LEU . 8.4 Cg_endo -67.14 116.46 4.19 Favored 'Trans proline' 0 C--O 1.213 -0.768 0 C-N-CA 121.117 1.211 . . . . 0.0 111.36 178.263 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.414 ' C ' ' O ' ' A' ' 46' ' ' PRO . 0.4 OUTLIER . . . . . 0 N--CA 1.504 2.24 0 C-N-CA 120.284 -0.567 . . . . 0.0 110.929 179.741 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.408 HG12 ' H ' ' A' ' 3' ' ' TYR . 2.8 t . . . . . 0 N--CA 1.489 1.48 0 CA-C-O 120.866 0.365 . . . . 0.0 110.303 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.415 ' CZ ' HD22 ' A' ' 13' ' ' LEU . 45.5 m-85 -130.0 -164.59 1.43 Allowed 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 120.038 -0.665 . . . . 0.0 109.782 179.437 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -92.83 176.76 6.31 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 119.366 -0.934 . . . . 0.0 108.58 179.069 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.527 ' N ' ' OD1' ' A' ' 5' ' ' ASP . 0.2 OUTLIER -97.02 151.88 19.28 Favored 'General case' 0 C--N 1.294 -1.815 0 C-N-CA 118.889 -1.124 . . . . 0.0 109.554 178.013 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.428 ' N ' ' HB2' ' A' ' 14' ' ' CYS . 1.5 m -70.29 176.76 3.71 Favored 'General case' 0 C--N 1.285 -2.212 0 C-N-CA 119.216 -0.993 . . . . 0.0 110.165 177.902 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.419 ' O ' ' OG1' ' A' ' 7' ' ' THR . 0.1 OUTLIER -153.9 7.72 0.35 Allowed 'General case' 0 C--N 1.274 -2.707 0 CA-C-N 114.112 -1.404 . . . . 0.0 110.474 177.795 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -166.46 173.02 10.28 Favored 'General case' 0 C--N 1.284 -2.248 0 CA-C-N 114.505 -1.225 . . . . 0.0 109.761 -179.813 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.5 136.19 33.53 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 119.375 -0.93 . . . . 0.0 109.124 -178.92 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.696 ' HA2' ' NZ ' ' A' ' 27' ' ' LYS . . . 112.13 -30.22 7.83 Favored Glycine 0 N--CA 1.493 2.486 1 N-CA-C 129.642 6.617 . . . . 0.0 129.642 -175.873 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -56.21 -167.19 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.909 0 C-N-CA 119.34 -0.944 . . . . 0.0 109.672 178.7 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.602 ' O ' ' HA3' ' A' ' 23' ' ' GLY . 22.2 t-20 -142.18 -69.2 0.36 Allowed 'General case' 0 N--CA 1.496 1.837 0 C-N-CA 118.472 -1.291 . . . . 0.0 113.766 -176.343 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.557 HD12 ' HB3' ' A' ' 46' ' ' PRO . 14.1 mt -78.38 50.39 0.93 Allowed 'General case' 0 C--N 1.261 -3.258 0 C-N-CA 118.227 -1.389 . . . . 0.0 110.9 -176.899 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.56 ' SG ' ' N ' ' A' ' 15' ' ' LEU . 13.1 p -114.22 -153.14 0.52 Allowed 'General case' 0 N--CA 1.506 2.371 0 C-N-CA 118.788 -1.165 . . . . 0.0 110.719 177.345 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.56 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 7.7 mt -127.5 137.09 52.56 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 114.068 -1.424 . . . . 0.0 109.751 178.737 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.423 ' SG ' ' CB ' ' A' ' 22' ' ' CYS . 97.5 m -125.11 -77.85 0.59 Allowed 'General case' 0 N--CA 1.513 2.706 0 C-N-CA 118.998 -1.081 . . . . 0.0 111.531 179.504 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -80.07 112.33 17.28 Favored 'General case' 0 C--N 1.299 -1.604 0 C-N-CA 118.345 -1.342 . . . . 0.0 110.282 -178.141 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 66.06 -107.22 1.86 Allowed Glycine 0 N--CA 1.491 2.308 0 C-N-CA 119.497 -1.335 . . . . 0.0 110.36 -179.465 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.485 ' O ' ' OG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -134.87 11.43 3.65 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 122.981 1.372 . . . . 0.0 108.896 179.95 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -76.71 127.95 33.73 Favored 'General case' 0 C--N 1.255 -3.503 0 CA-C-N 112.712 -2.04 . . . . 0.0 109.479 178.366 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.3 t -63.57 146.54 12.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 C-N-CA 118.827 -1.149 . . . . 0.0 110.017 -179.01 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.507 ' O ' ' O ' ' A' ' 12' ' ' ASN . 0.0 OUTLIER -135.51 114.88 12.51 Favored 'General case' 0 C--N 1.299 -1.611 0 C-N-CA 119.164 -1.014 . . . . 0.0 109.773 179.566 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.602 ' HA3' ' O ' ' A' ' 12' ' ' ASN . . . 149.76 -55.14 0.48 Allowed Glycine 0 C--O 1.205 -1.712 1 N-CA-C 129.639 6.615 . . . . 0.0 129.639 -176.916 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.456 ' N ' ' OD1' ' A' ' 12' ' ' ASN . 1.1 tm0? -51.59 121.9 7.19 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 118.325 -1.35 . . . . 0.0 109.923 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.82 -26.34 6.05 Favored Glycine 0 C--N 1.297 -1.592 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 -177.709 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.489 ' N ' ' O ' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -126.0 -162.21 1.11 Allowed 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 119.974 -0.691 . . . . 0.0 111.263 -179.628 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.696 ' NZ ' ' HA2' ' A' ' 10' ' ' GLY . 0.5 OUTLIER -153.69 124.59 7.29 Favored 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 119.196 -1.002 . . . . 0.0 110.674 177.727 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.432 ' O ' HD13 ' A' ' 29' ' ' ILE . 0.1 OUTLIER -81.75 155.93 25.23 Favored 'General case' 0 CA--C 1.483 -1.628 0 C-N-CA 118.31 -1.356 . . . . 0.0 111.876 179.437 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.432 HD13 ' O ' ' A' ' 28' ' ' CYS . 4.2 mm -133.09 117.54 29.37 Favored 'Isoleucine or valine' 0 C--N 1.256 -3.467 0 CA-C-N 112.201 -2.272 . . . . 0.0 109.2 177.106 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 21.1 mt . . . . . 0 N--CA 1.505 2.281 0 C-N-CA 118.631 -1.228 . . . . 0.0 111.171 -178.867 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.734 ' N ' HD21 ' A' ' 37' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.797 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -121.98 151.25 40.99 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 119.67 -0.812 . . . . 0.0 110.916 -178.238 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -105.13 109.34 21.29 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.777 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.513 HG22 ' N ' ' A' ' 41' ' ' THR . 2.3 p -125.59 159.74 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.153 0 C-N-CA 118.869 -1.132 . . . . 0.0 110.06 175.14 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.513 ' N ' HG22 ' A' ' 40' ' ' VAL . 3.0 t -69.58 146.96 51.35 Favored 'General case' 0 C--N 1.275 -2.645 0 CA-C-N 115.124 -0.944 . . . . 0.0 111.183 -179.366 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 175.79 160.99 24.31 Favored Glycine 0 N--CA 1.489 2.217 0 C-N-CA 119.28 -1.438 . . . . 0.0 110.494 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -81.28 104.85 12.03 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 119.452 -0.899 . . . . 0.0 110.286 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -123.4 165.28 16.16 Favored Glycine 0 N--CA 1.492 2.395 1 N-CA-C 130.306 6.882 . . . . 0.0 130.306 179.474 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 14.3 t -100.38 142.86 25.43 Favored Pre-proline 0 N--CA 1.49 1.563 0 C-N-CA 119.266 -0.973 . . . . 0.0 110.564 -178.932 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.557 ' HB3' HD12 ' A' ' 13' ' ' LEU . 11.2 Cg_exo -53.5 171.88 0.27 Allowed 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 121.246 1.297 . . . . 0.0 111.187 175.178 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 . . . . . 0 CA--C 1.561 1.383 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.72 178.882 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.413 HG12 ' H ' ' A' ' 3' ' ' TYR . 2.6 t . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.413 ' H ' HG12 ' A' ' 2' ' ' VAL . 59.2 m-85 -126.29 -166.6 1.59 Allowed 'General case' 0 N--CA 1.496 1.827 0 C-N-CA 119.946 -0.702 . . . . 0.0 110.917 -178.819 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.0 p -102.43 179.17 4.38 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.099 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.469 ' OD1' HD12 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -84.92 152.38 23.56 Favored 'General case' 0 C--N 1.294 -1.836 0 C-N-CA 118.502 -1.279 . . . . 0.0 110.906 -179.751 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.447 ' N ' ' HB2' ' A' ' 14' ' ' CYS . 0.8 OUTLIER -74.82 -177.49 3.29 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.883 176.582 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.8 t -151.84 11.11 0.56 Allowed 'General case' 0 C--N 1.281 -2.413 0 CA-C-N 114.673 -1.149 . . . . 0.0 110.749 177.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -160.49 158.0 28.53 Favored 'General case' 0 C--N 1.29 -2.008 0 CA-C-N 114.557 -1.201 . . . . 0.0 109.514 -178.89 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.482 ' HA ' ' H ' ' A' ' 30' ' ' LEU . 0.3 OUTLIER -79.32 138.49 37.74 Favored 'General case' 0 C--N 1.293 -1.856 0 C-N-CA 119.605 -0.838 . . . . 0.0 108.995 -179.116 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.884 ' HA2' ' NZ ' ' A' ' 27' ' ' LYS . . . 107.27 -35.14 5.21 Favored Glycine 0 N--CA 1.5 2.912 1 N-CA-C 129.64 6.616 . . . . 0.0 129.64 -173.72 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -56.86 -166.21 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.167 0 C-N-CA 119.729 -0.788 . . . . 0.0 110.22 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.475 ' ND2' ' C ' ' A' ' 23' ' ' GLY . 1.4 m-20 -141.37 -66.78 0.41 Allowed 'General case' 0 N--CA 1.508 2.46 0 N-CA-C 115.41 1.633 . . . . 0.0 115.41 -175.633 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.457 HD23 ' HA ' ' A' ' 13' ' ' LEU . 35.7 mt -76.51 51.81 0.75 Allowed 'General case' 0 C--N 1.277 -2.562 0 C-N-CA 118.048 -1.461 . . . . 0.0 111.022 -173.781 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.447 ' HB2' ' N ' ' A' ' 6' ' ' CYS . 27.3 p -123.62 -154.22 0.6 Allowed 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 114.908 -1.042 . . . . 0.0 108.943 176.285 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.469 HD12 ' OD1' ' A' ' 5' ' ' ASP . 70.8 mt -117.77 116.72 27.57 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 176.155 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.421 ' O ' ' OE1' ' A' ' 17' ' ' GLU . 2.8 m -116.7 -7.06 11.57 Favored 'General case' 0 N--CA 1.5 2.027 0 C-N-CA 118.617 -1.233 . . . . 0.0 111.746 -176.747 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.5 ' OE1' ' SG ' ' A' ' 39' ' ' CYS . 0.3 OUTLIER -127.09 75.49 1.58 Allowed 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 119.245 -0.982 . . . . 0.0 109.255 177.194 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 71.59 -81.26 0.51 Allowed Glycine 0 N--CA 1.489 2.221 0 C-N-CA 119.475 -1.345 . . . . 0.0 110.605 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -135.38 0.88 2.84 Favored 'General case' 0 N--CA 1.486 1.348 0 CA-C-O 121.907 0.86 . . . . 0.0 110.89 -179.24 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.489 ' OD1' ' N ' ' A' ' 20' ' ' ASN . 0.9 OUTLIER -85.13 139.99 31.28 Favored 'General case' 0 C--N 1.257 -3.455 0 CA-C-N 113.824 -1.535 . . . . 0.0 111.234 -179.011 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.2 t -73.79 144.55 12.46 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 C-N-CA 118.704 -1.198 . . . . 0.0 109.867 178.03 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.484 ' O ' ' SG ' ' A' ' 28' ' ' CYS . 3.8 m -149.98 119.95 7.16 Favored 'General case' 0 C--N 1.278 -2.502 0 C-N-CA 118.775 -1.17 . . . . 0.0 108.593 178.07 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.475 ' C ' ' ND2' ' A' ' 12' ' ' ASN . . . 173.09 -84.8 0.08 OUTLIER Glycine 0 C--N 1.3 -1.466 0 C-N-CA 117.688 -2.196 . . . . 0.0 112.055 -176.241 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.485 ' C ' ' H ' ' A' ' 26' ' ' ASN . 25.9 tt0 -42.43 133.68 3.22 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.868 -0.733 . . . . 0.0 111.321 -178.003 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 76.69 -27.51 1.59 Allowed Glycine 0 N--CA 1.479 1.547 0 C-N-CA 119.679 -1.248 . . . . 0.0 110.083 -179.533 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.485 ' H ' ' C ' ' A' ' 24' ' ' GLN . 0.0 OUTLIER -128.84 -159.94 0.99 Allowed 'General case' 0 C--N 1.316 -0.871 0 C-N-CA 119.696 -0.802 . . . . 0.0 111.6 -179.039 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.884 ' NZ ' ' HA2' ' A' ' 10' ' ' GLY . 3.4 ttpp -142.98 175.39 9.88 Favored 'General case' 0 N--CA 1.498 1.955 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.815 179.184 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.484 ' SG ' ' O ' ' A' ' 22' ' ' CYS . 57.3 m -138.55 160.66 39.01 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 118.965 -1.094 . . . . 0.0 111.173 176.766 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 7.8 mm -140.69 97.75 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.13 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 174.539 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.76 ' C ' HD12 ' A' ' 30' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--N 1.291 -1.944 0 C-N-CA 118.129 -1.428 . . . . 0.0 110.743 -176.216 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.502 ' OD1' ' N ' ' A' ' 38' ' ' GLN . 46.0 t-20 . . . . . 0 C--O 1.217 -0.656 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.502 ' N ' ' OD1' ' A' ' 37' ' ' ASN . 64.5 tt0 -131.89 143.29 50.04 Favored 'General case' 0 C--N 1.311 -1.086 0 C-N-CA 119.823 -0.751 . . . . 0.0 110.321 177.904 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.5 ' SG ' ' OE1' ' A' ' 17' ' ' GLU . 66.2 m -97.93 99.7 11.01 Favored 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 119.539 -0.864 . . . . 0.0 110.01 179.121 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.525 ' O ' ' N ' ' A' ' 27' ' ' LYS . 11.2 p -112.89 155.13 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.334 0 C-N-CA 118.436 -1.306 . . . . 0.0 111.532 179.513 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.488 ' N ' HG22 ' A' ' 40' ' ' VAL . 2.4 t -75.0 148.12 40.18 Favored 'General case' 0 C--N 1.265 -3.077 0 CA-C-N 113.836 -1.529 . . . . 0.0 111.292 -179.178 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 158.72 -179.82 34.1 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 110.119 -1.192 . . . . 0.0 110.119 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -90.8 110.66 21.86 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 119.332 -0.947 . . . . 0.0 110.423 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -128.71 165.76 21.45 Favored Glycine 0 N--CA 1.497 2.701 0 N-CA-C 110.235 -1.146 . . . . 0.0 110.235 179.726 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -104.5 145.14 30.12 Favored Pre-proline 0 N--CA 1.494 1.774 0 C-N-CA 119.649 -0.82 . . . . 0.0 109.953 -179.649 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -56.47 142.94 89.06 Favored 'Trans proline' 0 C--O 1.216 -0.617 0 C-N-CA 121.232 1.288 . . . . 0.0 111.297 177.296 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 . . . . . 0 CA--C 1.558 1.261 0 C-N-CA 119.5 -0.88 . . . . 0.0 112.418 -179.795 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.0 t . . . . . 0 N--CA 1.488 1.439 0 CA-C-O 121.043 0.449 . . . . 0.0 110.676 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.726 ' CE2' HD22 ' A' ' 13' ' ' LEU . 23.8 m-85 -94.13 -163.69 1.08 Allowed 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 119.714 -0.795 . . . . 0.0 110.07 179.463 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.583 ' OG1' ' N ' ' A' ' 5' ' ' ASP . 0.1 OUTLIER -96.39 179.48 5.01 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.705 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.583 ' N ' ' OG1' ' A' ' 4' ' ' THR . 0.0 OUTLIER -93.77 153.45 18.3 Favored 'General case' 0 C--N 1.289 -2.048 0 C-N-CA 118.92 -1.112 . . . . 0.0 109.858 179.856 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.499 ' SG ' ' OE1' ' A' ' 11' ' ' GLN . 1.2 m -74.13 177.07 5.99 Favored 'General case' 0 C--N 1.291 -1.945 0 C-N-CA 119.406 -0.918 . . . . 0.0 110.515 177.087 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.417 ' O ' HG23 ' A' ' 7' ' ' THR . 2.7 t -152.69 10.84 0.49 Allowed 'General case' 0 C--N 1.279 -2.48 0 CA-C-N 113.924 -1.489 . . . . 0.0 110.151 177.334 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -163.02 167.54 22.27 Favored 'General case' 0 C--N 1.283 -2.318 0 CA-C-N 114.453 -1.248 . . . . 0.0 109.939 178.758 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -84.41 145.16 28.33 Favored 'General case' 0 C--N 1.296 -1.726 0 C-N-CA 119.136 -1.026 . . . . 0.0 108.83 -178.798 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 102.41 -29.46 12.46 Favored Glycine 0 N--CA 1.512 3.706 1 N-CA-C 130.151 6.82 . . . . 0.0 130.151 -175.286 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.499 ' OE1' ' SG ' ' A' ' 6' ' ' CYS . 72.9 mt-30 -58.42 -158.92 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.065 0 C-N-CA 119.83 -0.748 . . . . 0.0 110.756 -179.777 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.635 ' O ' ' HA3' ' A' ' 23' ' ' GLY . 0.4 OUTLIER -147.41 -67.13 0.26 Allowed 'General case' 0 N--CA 1.503 2.202 0 C-N-CA 118.21 -1.396 . . . . 0.0 114.561 -177.37 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.726 HD22 ' CE2' ' A' ' 3' ' ' TYR . 32.9 mt -77.96 49.33 0.78 Allowed 'General case' 0 C--N 1.274 -2.708 0 C-N-CA 118.434 -1.306 . . . . 0.0 111.218 -174.946 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.695 ' O ' HG22 ' A' ' 21' ' ' VAL . 17.5 p -119.41 -154.46 0.57 Allowed 'General case' 0 N--CA 1.497 1.912 0 C-N-CA 119.155 -1.018 . . . . 0.0 110.374 176.484 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.401 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 7.2 mt -125.51 135.2 52.03 Favored 'General case' 0 N--CA 1.485 1.31 0 CA-C-N 114.569 -1.196 . . . . 0.0 110.526 179.764 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.3 m -120.35 -58.76 1.83 Allowed 'General case' 0 N--CA 1.508 2.44 0 C-N-CA 119.274 -0.97 . . . . 0.0 111.228 179.6 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.61 97.18 8.83 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 119.441 -0.903 . . . . 0.0 110.725 -178.499 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 68.77 -113.59 5.35 Favored Glycine 0 N--CA 1.488 2.125 0 C-N-CA 119.444 -1.36 . . . . 0.0 110.815 179.16 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.88 3.71 15.55 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-O 122.133 0.968 . . . . 0.0 110.24 -178.544 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -78.35 129.59 35.17 Favored 'General case' 0 C--N 1.256 -3.469 0 CA-C-N 113.589 -1.641 . . . . 0.0 110.39 -179.979 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.695 HG22 ' O ' ' A' ' 14' ' ' CYS . 0.9 OUTLIER -79.32 149.16 5.52 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 C-N-CA 119.473 -0.891 . . . . 0.0 110.227 -179.656 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.477 ' O ' ' O ' ' A' ' 12' ' ' ASN . 15.6 m -143.8 112.58 6.6 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 118.717 -1.193 . . . . 0.0 110.205 179.111 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.635 ' HA3' ' O ' ' A' ' 12' ' ' ASN . . . 178.51 -63.0 0.08 OUTLIER Glycine 0 N--CA 1.484 1.858 1 N-CA-C 130.007 6.763 . . . . 0.0 130.007 -177.274 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -63.54 120.62 12.08 Favored 'General case' 0 C--N 1.311 -1.093 0 C-N-CA 118.466 -1.294 . . . . 0.0 109.842 179.269 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 95.48 -17.2 59.75 Favored Glycine 0 N--CA 1.485 1.918 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 -178.349 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.465 ' O ' ' O ' ' A' ' 23' ' ' GLY . 6.5 m120 -139.26 -172.87 3.44 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.389 -0.924 . . . . 0.0 110.694 179.07 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.747 ' NZ ' HD11 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -138.74 125.68 21.13 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 119.502 -0.879 . . . . 0.0 109.148 177.623 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.49 ' SG ' ' O ' ' A' ' 38' ' ' GLN . 0.1 OUTLIER -82.14 164.9 20.98 Favored 'General case' 0 C--N 1.289 -2.051 0 C-N-CA 116.959 -1.896 . . . . 0.0 109.927 178.206 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.747 HD11 ' NZ ' ' A' ' 27' ' ' LYS . 26.8 mm -144.08 125.96 10.54 Favored 'Isoleucine or valine' 0 C--N 1.245 -3.938 0 CA-C-N 113.856 -1.52 . . . . 0.0 108.869 178.74 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 17.7 mt . . . . . 0 N--CA 1.495 1.783 0 C-N-CA 118.51 -1.276 . . . . 0.0 110.135 -179.066 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.215 -0.743 0 CA-C-O 121.89 0.852 . . . . 0.0 113.191 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.49 ' O ' ' SG ' ' A' ' 28' ' ' CYS . 15.8 tt0 -151.63 164.34 37.11 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 113.976 -1.466 . . . . 0.0 108.24 176.039 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.454 ' N ' ' CG ' ' A' ' 38' ' ' GLN . 29.0 m -127.12 97.43 4.93 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 119.407 -0.917 . . . . 0.0 110.86 -178.308 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.503 ' O ' ' O ' ' A' ' 27' ' ' LYS . 0.4 OUTLIER -111.84 140.79 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.485 0 C-N-CA 118.73 -1.188 . . . . 0.0 112.569 -179.719 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.426 ' O ' HG22 ' A' ' 40' ' ' VAL . 9.5 t -56.9 149.35 18.8 Favored 'General case' 0 C--N 1.279 -2.462 0 CA-C-N 113.563 -1.653 . . . . 0.0 111.672 177.943 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 145.16 -130.03 3.71 Favored Glycine 0 N--CA 1.489 2.228 1 N-CA-C 131.116 7.206 . . . . 0.0 131.116 179.622 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 31.9 mm-40 -112.75 106.07 14.34 Favored 'General case' 0 N--CA 1.499 2.007 0 C-N-CA 119.884 -0.726 . . . . 0.0 111.053 -179.044 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -140.02 178.86 19.49 Favored Glycine 0 N--CA 1.493 2.499 0 C-N-CA 119.659 -1.258 . . . . 0.0 110.152 179.377 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -128.61 146.38 59.87 Favored Pre-proline 0 N--CA 1.495 1.815 0 C-N-CA 119.903 -0.719 . . . . 0.0 109.511 179.681 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -57.65 164.06 8.06 Favored 'Trans proline' 0 C--O 1.216 -0.589 0 C-N-CA 121.179 1.253 . . . . 0.0 111.587 -178.809 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 52.3 tp10 . . . . . 0 C--N 1.314 -0.968 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.203 179.54 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.826 HG12 ' H ' ' A' ' 3' ' ' TYR . 22.0 t . . . . . 0 N--CA 1.493 1.719 0 CA-C-O 120.657 0.265 . . . . 0.0 110.652 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.826 ' H ' HG12 ' A' ' 2' ' ' VAL . 85.1 m-85 -114.89 -166.49 1.12 Allowed 'General case' 0 N--CA 1.5 2.063 0 C-N-CA 120.106 -0.638 . . . . 0.0 110.425 -179.939 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.599 ' OG1' ' N ' ' A' ' 5' ' ' ASP . 0.1 OUTLIER -113.01 -177.82 3.23 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 178.816 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.599 ' N ' ' OG1' ' A' ' 4' ' ' THR . 0.2 OUTLIER -90.33 154.2 19.87 Favored 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 118.681 -1.208 . . . . 0.0 110.746 -179.597 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -75.73 -178.85 4.41 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-N 115.001 -1.0 . . . . 0.0 112.005 178.567 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.4 t -157.15 15.18 0.27 Allowed 'General case' 0 C--N 1.291 -1.978 0 CA-C-N 113.435 -1.712 . . . . 0.0 110.02 177.848 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -161.42 172.01 17.23 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 114.505 -1.225 . . . . 0.0 109.533 -179.261 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.534 ' HB3' ' H ' ' A' ' 30' ' ' LEU . 0.9 OUTLIER -91.64 164.31 13.79 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 119.612 -0.835 . . . . 0.0 110.786 -179.303 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.436 ' O ' ' O ' ' A' ' 11' ' ' GLN . . . 79.69 -25.14 2.99 Favored Glycine 0 N--CA 1.499 2.895 0 C-N-CA 119.541 -1.314 . . . . 0.0 112.906 177.216 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.436 ' O ' ' O ' ' A' ' 10' ' ' GLY . 0.5 OUTLIER -54.93 -171.36 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.065 0 C-N-CA 118.495 -1.282 . . . . 0.0 110.577 -178.499 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.484 ' O ' ' O ' ' A' ' 22' ' ' CYS . 2.1 m-20 -148.4 -66.33 0.24 Allowed 'General case' 0 N--CA 1.501 2.076 0 N-CA-C 115.227 1.565 . . . . 0.0 115.227 -176.978 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 95.5 mt -77.17 49.8 0.71 Allowed 'General case' 0 C--N 1.268 -2.963 0 C-N-CA 117.978 -1.489 . . . . 0.0 111.284 -174.179 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 28.3 p -125.84 -156.42 0.73 Allowed 'General case' 0 C--O 1.207 -1.181 0 CA-C-N 114.988 -1.005 . . . . 0.0 109.082 176.499 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.573 HD12 ' OD1' ' A' ' 5' ' ' ASP . 58.1 mt -115.57 120.22 38.74 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 115.115 -0.948 . . . . 0.0 108.957 176.654 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.0 m -117.56 -61.29 1.72 Allowed 'General case' 0 C--N 1.293 -1.861 0 C-N-CA 119.147 -1.021 . . . . 0.0 110.955 -177.237 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.493 ' CG ' ' SG ' ' A' ' 39' ' ' CYS . 3.1 mm-40 -78.74 90.55 4.63 Favored 'General case' 0 C--N 1.295 -1.783 0 C-N-CA 117.81 -1.556 . . . . 0.0 109.708 179.512 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 71.52 -101.78 1.03 Allowed Glycine 0 N--CA 1.488 2.101 0 C-N-CA 119.481 -1.342 . . . . 0.0 109.904 -179.068 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.483 ' O ' HD22 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -128.66 2.96 5.5 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-O 122.35 1.071 . . . . 0.0 109.873 179.837 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -78.72 136.52 37.43 Favored 'General case' 0 C--N 1.258 -3.376 0 CA-C-N 113.313 -1.767 . . . . 0.0 110.228 -179.887 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.1 t -67.21 145.19 13.96 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 C-N-CA 118.438 -1.305 . . . . 0.0 109.493 178.999 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.529 ' O ' ' SG ' ' A' ' 28' ' ' CYS . 20.0 m -148.72 118.95 7.26 Favored 'General case' 0 C--N 1.277 -2.582 0 C-N-CA 118.426 -1.31 . . . . 0.0 109.333 176.82 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.471 ' O ' ' O ' ' A' ' 26' ' ' ASN . . . 171.64 -82.87 0.08 OUTLIER Glycine 0 C--N 1.291 -1.941 0 C-N-CA 118.557 -1.782 . . . . 0.0 110.395 -176.636 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -55.83 117.46 3.69 Favored 'General case' 0 C--N 1.292 -1.902 0 C-N-CA 119.132 -1.027 . . . . 0.0 109.64 179.058 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 102.26 -26.16 25.2 Favored Glycine 0 N--CA 1.484 1.871 0 N-CA-C 109.077 -1.609 . . . . 0.0 109.077 -177.683 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.471 ' O ' ' O ' ' A' ' 23' ' ' GLY . 0.1 OUTLIER -142.67 -154.83 0.54 Allowed 'General case' 0 C--N 1.309 -1.178 0 C-N-CA 119.943 -0.703 . . . . 0.0 110.147 179.767 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.5 ' N ' ' O ' ' A' ' 40' ' ' VAL . 10.0 tttp -148.21 160.01 43.38 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 176.85 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.529 ' SG ' ' O ' ' A' ' 22' ' ' CYS . 72.1 m -121.47 157.56 30.33 Favored 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 118.923 -1.111 . . . . 0.0 111.828 178.495 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 19.9 mm -146.5 133.76 14.64 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.501 0 CA-C-N 113.375 -1.739 . . . . 0.0 109.945 177.104 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.534 ' H ' ' HB3' ' A' ' 9' ' ' SER . 19.9 mt . . . . . 0 N--CA 1.505 2.277 0 C-N-CA 119.862 -0.735 . . . . 0.0 109.871 179.135 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.507 ' N ' ' OD1' ' A' ' 37' ' ' ASN . 0.4 OUTLIER . . . . . 0 C--O 1.217 -0.638 0 CA-C-O 120.806 0.336 . . . . 0.0 110.736 . . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -109.39 147.19 33.19 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.87 179.691 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.493 ' SG ' ' CG ' ' A' ' 17' ' ' GLU . 15.6 m -96.33 90.45 5.44 Favored 'General case' 0 C--N 1.293 -1.865 0 C-N-CA 119.423 -0.911 . . . . 0.0 110.63 -179.423 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.5 ' O ' ' N ' ' A' ' 27' ' ' LYS . 0.6 OUTLIER -90.08 142.81 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 C-N-CA 118.024 -1.471 . . . . 0.0 111.283 179.932 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -65.33 140.35 58.67 Favored 'General case' 0 C--N 1.274 -2.677 0 CA-C-N 114.225 -1.352 . . . . 0.0 110.831 178.844 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 152.89 -156.15 26.54 Favored Glycine 0 N--CA 1.488 2.11 0 C-N-CA 119.545 -1.312 . . . . 0.0 110.252 -179.903 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -114.29 133.37 55.7 Favored 'General case' 0 N--CA 1.497 1.923 0 C-N-CA 120.033 -0.667 . . . . 0.0 110.399 -179.74 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -137.39 158.69 24.53 Favored Glycine 0 N--CA 1.496 2.638 0 C-N-CA 119.704 -1.236 . . . . 0.0 110.455 -179.943 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 5.8 t -87.21 143.9 35.31 Favored Pre-proline 0 N--CA 1.488 1.456 0 C-N-CA 119.631 -0.827 . . . . 0.0 109.929 -179.858 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -58.16 143.69 96.41 Favored 'Trans proline' 0 C--O 1.218 -0.523 0 C-N-CA 121.006 1.137 . . . . 0.0 111.153 178.195 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.548 ' OE1' HG23 ' A' ' 4' ' ' THR . 1.9 tm-20 . . . . . 0 C--N 1.302 -1.458 0 C-N-CA 119.706 -0.798 . . . . 0.0 110.343 -179.819 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.532 HG12 ' H ' ' A' ' 3' ' ' TYR . 0.6 OUTLIER . . . . . 0 N--CA 1.476 0.844 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 . . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.532 ' H ' HG12 ' A' ' 2' ' ' VAL . 95.0 m-85 -143.15 -178.77 6.01 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 118.845 -1.142 . . . . 0.0 111.591 179.653 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 7.7 p -109.97 -179.58 3.84 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 114.772 -1.104 . . . . 0.0 108.862 -179.328 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.456 ' OD1' ' N ' ' A' ' 5' ' ' ASP . 0.1 OUTLIER -88.15 151.79 22.45 Favored 'General case' 0 C--N 1.291 -1.977 0 C-N-CA 118.344 -1.342 . . . . 0.0 109.351 177.424 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.465 ' N ' ' HB2' ' A' ' 14' ' ' CYS . 0.8 OUTLIER -71.79 -178.12 2.18 Favored 'General case' 0 C--N 1.285 -2.214 0 C-N-CA 119.401 -0.919 . . . . 0.0 110.2 178.894 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.0 t -157.46 17.65 0.27 Allowed 'General case' 0 C--N 1.279 -2.47 0 CA-C-N 114.323 -1.308 . . . . 0.0 110.16 178.662 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.531 ' N ' ' OE1' ' A' ' 8' ' ' GLU . 1.2 pm0 -165.45 169.43 15.61 Favored 'General case' 0 C--N 1.285 -2.236 0 CA-C-N 114.773 -1.103 . . . . 0.0 110.076 179.229 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.48 ' HB3' ' H ' ' A' ' 30' ' ' LEU . 0.3 OUTLIER -84.14 138.56 32.95 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 119.244 -0.983 . . . . 0.0 108.859 -179.525 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.542 ' HA2' ' HE3' ' A' ' 27' ' ' LYS . . . 104.53 -35.14 5.25 Favored Glycine 0 N--CA 1.501 2.982 1 N-CA-C 130.249 6.859 . . . . 0.0 130.249 -174.976 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.428 ' O ' ' O ' ' A' ' 10' ' ' GLY . 7.3 mt-30 -54.78 -170.03 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.128 0 C-N-CA 119.292 -0.963 . . . . 0.0 109.895 -179.82 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.466 ' O ' ' O ' ' A' ' 22' ' ' CYS . 4.8 m-20 -141.82 -66.92 0.4 Allowed 'General case' 0 N--CA 1.498 1.937 0 C-N-CA 118.055 -1.458 . . . . 0.0 114.631 -176.209 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.485 HD22 ' CZ ' ' A' ' 3' ' ' TYR . 13.0 mt -75.67 53.95 0.75 Allowed 'General case' 0 C--N 1.268 -2.943 0 C-N-CA 117.613 -1.635 . . . . 0.0 110.274 -175.777 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.465 ' HB2' ' N ' ' A' ' 6' ' ' CYS . 25.9 p -124.89 -160.64 0.96 Allowed 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.023 175.696 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 52.6 mt -118.1 126.72 52.81 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.147 178.446 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.3 m -110.92 -64.5 1.27 Allowed 'General case' 0 N--CA 1.502 2.131 0 C-N-CA 118.98 -1.088 . . . . 0.0 111.197 179.813 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -89.98 92.32 8.94 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 119.05 -1.06 . . . . 0.0 110.67 -178.875 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.43 -105.39 1.84 Allowed Glycine 0 N--CA 1.489 2.222 0 C-N-CA 119.723 -1.227 . . . . 0.0 111.153 178.601 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.404 ' O ' ' OG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -122.43 3.4 9.69 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 122.417 1.103 . . . . 0.0 109.997 -178.354 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 38.1 m-20 -77.22 138.08 39.22 Favored 'General case' 0 C--N 1.259 -3.35 0 CA-C-N 113.278 -1.783 . . . . 0.0 110.598 -179.841 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.0 t -81.68 146.82 6.74 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 C-N-CA 119.441 -0.904 . . . . 0.0 110.357 179.812 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.466 ' O ' ' O ' ' A' ' 12' ' ' ASN . 20.9 m -144.35 114.21 7.28 Favored 'General case' 0 N--CA 1.5 2.043 0 C-N-CA 118.939 -1.104 . . . . 0.0 109.263 177.362 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.484 ' O ' ' N ' ' A' ' 26' ' ' ASN . . . -179.77 -87.78 0.07 OUTLIER Glycine 0 N--CA 1.479 1.538 0 C-N-CA 117.156 -2.449 . . . . 0.0 113.449 -176.726 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.426 ' C ' ' H ' ' A' ' 26' ' ' ASN . 1.5 tt0 -42.15 129.75 3.68 Favored 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 119.931 -0.708 . . . . 0.0 111.681 -175.947 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 81.19 -30.04 2.74 Favored Glycine 0 N--CA 1.477 1.428 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 -179.09 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.484 ' N ' ' O ' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -122.4 -166.86 1.47 Allowed 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 119.935 -0.706 . . . . 0.0 111.412 -178.839 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.542 ' HE3' ' HA2' ' A' ' 10' ' ' GLY . 0.6 OUTLIER -153.15 127.11 8.97 Favored 'General case' 0 N--CA 1.505 2.287 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.237 -179.996 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -86.17 168.31 14.11 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 122.728 1.252 . . . . 0.0 112.337 -178.695 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 11.0 mm -146.31 131.89 12.67 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.754 0 CA-C-N 112.52 -2.127 . . . . 0.0 108.09 175.349 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.48 ' H ' ' HB3' ' A' ' 9' ' ' SER . 23.6 mt . . . . . 0 C--N 1.298 -1.643 0 C-N-CA 117.554 -1.659 . . . . 0.0 108.995 177.629 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.465 ' N ' ' OD1' ' A' ' 37' ' ' ASN . 1.1 m-20 . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 120.692 0.282 . . . . 0.0 111.228 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.495 ' CG ' ' N ' ' A' ' 39' ' ' CYS . 34.2 tt0 -151.94 159.96 43.64 Favored 'General case' 0 C--N 1.312 -1.034 0 C-N-CA 119.051 -1.06 . . . . 0.0 110.329 178.113 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.495 ' N ' ' CG ' ' A' ' 38' ' ' GLN . 91.5 m -131.73 94.28 3.48 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 119.886 -0.726 . . . . 0.0 110.472 -179.902 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.676 HG22 ' N ' ' A' ' 41' ' ' THR . 4.4 p -110.02 173.57 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.336 0 C-N-CA 119.105 -1.038 . . . . 0.0 110.217 179.577 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.676 ' N ' HG22 ' A' ' 40' ' ' VAL . 8.8 t -84.12 156.49 22.11 Favored 'General case' 0 C--N 1.283 -2.326 0 CA-C-N 115.353 -0.839 . . . . 0.0 111.142 178.727 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 159.39 -140.72 7.02 Favored Glycine 0 N--CA 1.492 2.404 0 C-N-CA 119.681 -1.247 . . . . 0.0 110.497 -179.973 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -146.08 89.56 1.89 Allowed 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 119.529 -0.868 . . . . 0.0 110.459 -179.826 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -97.98 -156.15 29.86 Favored Glycine 0 N--CA 1.492 2.395 0 C-N-CA 119.52 -1.324 . . . . 0.0 110.742 -179.538 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -139.91 153.01 69.23 Favored Pre-proline 0 N--CA 1.492 1.666 0 C-N-CA 119.571 -0.852 . . . . 0.0 110.418 -179.98 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.455 ' HB3' HD12 ' A' ' 13' ' ' LEU . 5.2 Cg_exo -53.47 153.97 16.53 Favored 'Trans proline' 0 CA--C 1.543 0.965 0 C-N-CA 122.112 1.875 . . . . 0.0 113.035 177.952 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.2 tm-20 . . . . . 0 N--CA 1.483 1.188 0 CA-C-N 115.937 -0.574 . . . . 0.0 112.292 177.671 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.684 HG12 ' N ' ' A' ' 3' ' ' TYR . 45.6 t . . . . . 0 N--CA 1.497 1.917 0 CA-C-O 120.995 0.426 . . . . 0.0 110.055 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.684 ' N ' HG12 ' A' ' 2' ' ' VAL . 10.8 m-85 -144.09 -167.53 2.63 Favored 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 119.896 -0.722 . . . . 0.0 109.89 179.905 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.589 ' OG1' ' N ' ' A' ' 5' ' ' ASP . 0.1 OUTLIER -104.74 -177.64 3.42 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 177.507 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.589 ' N ' ' OG1' ' A' ' 4' ' ' THR . 0.3 OUTLIER -92.1 154.37 18.77 Favored 'General case' 0 C--N 1.291 -1.955 0 C-N-CA 118.626 -1.229 . . . . 0.0 111.169 -179.429 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.482 ' SG ' ' O ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -73.11 170.16 15.51 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.526 177.388 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.39 7.37 2.16 Favored 'General case' 0 C--N 1.296 -1.761 0 C-N-CA 119.108 -1.037 . . . . 0.0 110.187 176.489 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.411 ' HA ' HD12 ' A' ' 30' ' ' LEU . 0.3 OUTLIER -163.97 -178.24 5.52 Favored 'General case' 0 C--N 1.288 -2.085 0 CA-C-N 114.449 -1.25 . . . . 0.0 110.198 179.395 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -86.01 164.37 17.41 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.369 -179.24 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.437 ' O ' ' O ' ' A' ' 11' ' ' GLN . . . 83.25 -30.77 3.27 Favored Glycine 0 N--CA 1.49 2.234 0 C-N-CA 119.189 -1.481 . . . . 0.0 111.32 179.531 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.514 ' OE1' ' N ' ' A' ' 11' ' ' GLN . 3.1 mp0 -44.09 168.39 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.068 0 C-N-CA 119.194 -1.002 . . . . 0.0 109.879 179.806 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.461 ' O ' ' O ' ' A' ' 22' ' ' CYS . 2.1 m-20 -141.9 -69.7 0.36 Allowed 'General case' 0 N--CA 1.5 2.051 0 C-N-CA 118.536 -1.266 . . . . 0.0 113.374 -177.647 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 81.7 mt -75.63 46.71 0.37 Allowed 'General case' 0 C--N 1.272 -2.765 0 C-N-CA 118.327 -1.349 . . . . 0.0 110.151 -177.0 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.442 ' HB2' ' N ' ' A' ' 6' ' ' CYS . 29.9 p -123.58 -156.93 0.73 Allowed 'General case' 0 C--O 1.205 -1.269 0 CA-C-N 115.265 -0.88 . . . . 0.0 109.597 179.046 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.482 ' O ' ' SG ' ' A' ' 6' ' ' CYS . 71.2 mt -116.09 109.12 17.06 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 114.934 -1.03 . . . . 0.0 108.237 175.687 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.575 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 0.5 OUTLIER -110.31 -51.44 2.87 Favored 'General case' 0 C--N 1.289 -2.054 0 C-N-CA 118.933 -1.107 . . . . 0.0 110.71 -174.673 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.508 ' N ' ' SG ' ' A' ' 16' ' ' CYS . 18.4 tp10 -88.63 75.55 8.26 Favored 'General case' 0 C--N 1.294 -1.816 0 C-N-CA 118.649 -1.221 . . . . 0.0 109.048 177.862 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.38 -121.89 6.61 Favored Glycine 0 N--CA 1.486 2.0 0 C-N-CA 119.143 -1.503 . . . . 0.0 110.013 -178.57 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.425 ' O ' HD22 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -99.81 -1.17 38.27 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 122.026 0.917 . . . . 0.0 110.22 -179.803 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -79.64 133.41 36.4 Favored 'General case' 0 C--N 1.26 -3.309 0 CA-C-N 113.719 -1.582 . . . . 0.0 110.861 -179.137 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.0 t -70.95 141.54 16.73 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.955 0 C-N-CA 118.879 -1.128 . . . . 0.0 109.081 177.71 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.461 ' O ' ' O ' ' A' ' 12' ' ' ASN . 0.1 OUTLIER -148.47 121.39 8.77 Favored 'General case' 0 C--N 1.277 -2.556 0 C-N-CA 118.346 -1.342 . . . . 0.0 109.458 177.304 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.482 ' O ' ' O ' ' A' ' 26' ' ' ASN . . . 175.0 -94.99 0.1 OUTLIER Glycine 0 C--O 1.201 -1.949 0 C-N-CA 118.304 -1.903 . . . . 0.0 111.505 -174.527 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -39.33 129.81 1.74 Allowed 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 120.494 -0.483 . . . . 0.0 111.553 -176.467 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.437 ' O ' ' OD1' ' A' ' 26' ' ' ASN . . . 90.65 -19.36 45.12 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -178.414 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.482 ' O ' ' O ' ' A' ' 23' ' ' GLY . 85.5 m-20 -155.96 -163.13 1.42 Allowed 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -179.862 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.676 ' NZ ' HD11 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -156.86 133.13 9.8 Favored 'General case' 0 N--CA 1.496 1.855 0 C-N-CA 117.871 -1.531 . . . . 0.0 111.345 176.143 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.502 ' SG ' ' OD1' ' A' ' 37' ' ' ASN . 0.1 OUTLIER -87.2 161.11 18.22 Favored 'General case' 0 CA--C 1.482 -1.663 0 CA-C-O 123.342 1.544 . . . . 0.0 113.028 179.897 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.676 HD11 ' NZ ' ' A' ' 27' ' ' LYS . 31.5 mm -134.47 124.13 44.23 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.265 0 CA-C-N 111.057 -2.792 . . . . 0.0 109.677 -179.764 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.411 HD12 ' HA ' ' A' ' 8' ' ' GLU . 33.2 mt . . . . . 0 N--CA 1.501 2.121 0 C-N-CA 118.804 -1.159 . . . . 0.0 110.684 -179.42 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.502 ' OD1' ' SG ' ' A' ' 28' ' ' CYS . 1.4 t30 . . . . . 0 C--O 1.214 -0.776 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.48 ' O ' ' SG ' ' A' ' 28' ' ' CYS . 22.8 tt0 -145.88 142.76 29.08 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 118.984 -1.087 . . . . 0.0 110.604 178.833 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.575 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 36.0 m -91.1 94.23 9.51 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.063 -178.486 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.468 ' O ' ' O ' ' A' ' 27' ' ' LYS . 1.2 p -105.94 139.22 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 C-N-CA 118.491 -1.284 . . . . 0.0 111.998 179.297 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.426 ' O ' HG22 ' A' ' 40' ' ' VAL . 4.9 t -58.65 143.2 47.33 Favored 'General case' 0 C--N 1.273 -2.76 0 CA-C-N 113.524 -1.671 . . . . 0.0 111.166 178.172 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 158.34 -141.25 7.54 Favored Glycine 0 N--CA 1.487 2.056 0 C-N-CA 119.6 -1.286 . . . . 0.0 110.007 179.671 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -130.5 131.76 45.28 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.837 -0.745 . . . . 0.0 109.816 179.25 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -137.11 -151.1 5.88 Favored Glycine 0 N--CA 1.489 2.198 0 C-N-CA 119.648 -1.263 . . . . 0.0 110.399 -179.515 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -145.48 152.32 49.34 Favored Pre-proline 0 C--N 1.302 -1.491 0 C-N-CA 119.54 -0.864 . . . . 0.0 109.703 179.989 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -56.16 -170.61 0.03 OUTLIER 'Trans proline' 0 C--O 1.214 -0.702 0 C-N-CA 121.124 1.216 . . . . 0.0 110.504 176.565 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 . . . . . 0 CA--C 1.56 1.352 0 C-N-CA 120.3 -0.56 . . . . 0.0 110.243 178.6 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 1.5 t . . . . . 0 N--CA 1.481 1.12 0 CA-C-O 120.818 0.342 . . . . 0.0 110.215 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.462 ' CG ' ' O ' ' A' ' 13' ' ' LEU . 7.3 m-85 -90.44 -164.98 1.25 Allowed 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 119.212 -0.995 . . . . 0.0 109.242 178.699 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.584 HG23 ' OE2' ' A' ' 47' ' ' GLU . 0.2 OUTLIER -116.65 -176.7 3.02 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 178.9 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.565 ' N ' ' OG1' ' A' ' 4' ' ' THR . 0.2 OUTLIER -79.35 156.17 28.11 Favored 'General case' 0 C--N 1.289 -2.053 0 C-N-CA 118.528 -1.269 . . . . 0.0 110.406 -179.366 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.405 ' N ' ' HB2' ' A' ' 14' ' ' CYS . 0.1 OUTLIER -70.72 152.01 44.27 Favored 'General case' 0 C--N 1.291 -1.967 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.719 176.654 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.415 ' O ' ' CG ' ' A' ' 8' ' ' GLU . 43.0 p -119.36 4.43 11.23 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-O 121.813 0.816 . . . . 0.0 108.96 178.812 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.415 ' CG ' ' O ' ' A' ' 7' ' ' THR . 29.4 mt-10 -161.93 167.47 24.56 Favored 'General case' 0 C--N 1.283 -2.284 0 CA-C-N 113.914 -1.494 . . . . 0.0 111.18 -178.971 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.422 ' HB3' ' H ' ' A' ' 30' ' ' LEU . 0.9 OUTLIER -79.5 156.47 27.79 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 115.038 -0.983 . . . . 0.0 108.868 177.517 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 28' ' ' CYS . . . 90.51 -13.92 64.15 Favored Glycine 0 N--CA 1.503 3.163 0 C-N-CA 118.739 -1.695 . . . . 0.0 112.45 179.264 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 47.5 mm-40 -61.17 -164.51 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.239 0 C-N-CA 119.139 -1.024 . . . . 0.0 111.073 -178.47 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.495 ' C ' ' H ' ' A' ' 14' ' ' CYS . 7.4 m-20 -160.51 -66.96 0.07 Allowed 'General case' 0 N--CA 1.5 2.057 0 C-N-CA 118.377 -1.329 . . . . 0.0 113.367 179.791 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.462 ' O ' ' CG ' ' A' ' 3' ' ' TYR . 86.1 mt -75.85 41.1 0.2 Allowed 'General case' 0 C--N 1.287 -2.123 0 C-N-CA 119.364 -0.934 . . . . 0.0 110.155 -178.396 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.495 ' H ' ' C ' ' A' ' 12' ' ' ASN . 29.1 p -120.3 -165.83 1.24 Allowed 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.232 178.607 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.567 HD22 ' O ' ' A' ' 19' ' ' SER . 47.1 mt -97.19 102.79 14.64 Favored 'General case' 0 C--N 1.294 -1.841 0 C-N-CA 119.248 -0.981 . . . . 0.0 109.441 178.188 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.413 ' CB ' ' SG ' ' A' ' 22' ' ' CYS . 0.5 OUTLIER -95.41 -35.31 11.78 Favored 'General case' 0 C--N 1.281 -2.397 0 CA-C-N 114.262 -1.336 . . . . 0.0 111.139 -176.021 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -114.19 89.65 3.14 Favored 'General case' 0 C--N 1.301 -1.513 0 C-N-CA 119.68 -0.808 . . . . 0.0 110.326 -179.143 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 73.96 -91.26 0.7 Allowed Glycine 0 N--CA 1.488 2.126 0 C-N-CA 119.511 -1.328 . . . . 0.0 110.486 179.418 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.567 ' O ' HD22 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -138.27 4.34 2.44 Favored 'General case' 0 N--CA 1.484 1.232 0 CA-C-O 122.026 0.917 . . . . 0.0 110.89 -178.841 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -85.03 138.89 32.16 Favored 'General case' 0 C--N 1.261 -3.257 0 CA-C-N 113.835 -1.529 . . . . 0.0 111.111 -179.556 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.54 HG12 ' O ' ' A' ' 22' ' ' CYS . 2.4 t -77.28 139.5 18.61 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.124 0 C-N-CA 118.95 -1.1 . . . . 0.0 110.032 179.039 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.54 ' O ' HG12 ' A' ' 21' ' ' VAL . 0.8 OUTLIER -80.7 -135.44 0.03 OUTLIER 'General case' 0 C--N 1.278 -2.502 0 C-N-CA 118.722 -1.191 . . . . 0.0 109.333 176.049 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.532 ' O ' ' ND2' ' A' ' 26' ' ' ASN . . . -172.68 107.14 0.24 Allowed Glycine 0 C--N 1.272 -3.028 0 C-N-CA 117.835 -2.126 . . . . 0.0 111.089 179.309 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.461 ' C ' ' O ' ' A' ' 23' ' ' GLY . 2.9 tt0 -34.32 131.92 0.3 Allowed 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 121.632 0.73 . . . . 0.0 110.422 178.665 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 131.23 -31.12 3.21 Favored Glycine 0 C--N 1.291 -1.96 0 N-CA-C 106.512 -2.635 . . . . 0.0 106.512 -174.714 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.589 ' ND2' ' N ' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -96.1 -161.2 0.85 Allowed 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 175.412 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.697 ' NZ ' HD11 ' A' ' 29' ' ' ILE . 10.7 ttpp -144.56 113.45 6.8 Favored 'General case' 0 C--N 1.287 -2.116 0 C-N-CA 119.436 -0.906 . . . . 0.0 109.616 177.329 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.566 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 5.3 m -84.31 156.82 21.74 Favored 'General case' 0 CA--C 1.482 -1.662 0 C-N-CA 117.392 -1.723 . . . . 0.0 111.603 -179.665 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.697 HD11 ' NZ ' ' A' ' 27' ' ' LYS . 33.2 mm -144.77 125.38 7.89 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.167 0 CA-C-N 113.235 -1.802 . . . . 0.0 109.92 177.943 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.422 ' H ' ' HB3' ' A' ' 9' ' ' SER . 23.4 mt . . . . . 0 N--CA 1.498 1.964 0 C-N-CA 118.826 -1.15 . . . . 0.0 109.951 178.498 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 . . . . . 0 N--CA 1.488 1.455 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 43.1 tt0 -161.22 151.61 17.74 Favored 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 119.042 -1.063 . . . . 0.0 110.174 177.098 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.566 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 0.0 OUTLIER -101.84 104.47 15.22 Favored 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 119.55 -0.86 . . . . 0.0 111.607 179.789 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.51 ' O ' ' N ' ' A' ' 27' ' ' LYS . 1.1 p -99.01 137.5 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 C-N-CA 118.307 -1.357 . . . . 0.0 109.994 175.356 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 6.3 t -63.93 145.5 55.73 Favored 'General case' 0 C--N 1.266 -3.039 0 CA-C-N 114.008 -1.451 . . . . 0.0 110.811 -178.752 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 152.29 -146.81 15.81 Favored Glycine 0 N--CA 1.49 2.26 0 C-N-CA 119.459 -1.353 . . . . 0.0 110.64 179.094 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -116.36 129.44 56.25 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 120.083 -0.647 . . . . 0.0 109.797 -179.951 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -145.9 -165.03 11.19 Favored Glycine 0 N--CA 1.494 2.534 0 C-N-CA 119.284 -1.436 . . . . 0.0 110.616 -179.62 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.3 t -120.41 144.92 39.35 Favored Pre-proline 0 N--CA 1.491 1.618 0 C-N-CA 119.933 -0.707 . . . . 0.0 110.147 -179.671 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.447 ' HB3' HD12 ' A' ' 13' ' ' LEU . 1.2 Cg_endo -64.69 176.27 3.0 Favored 'Trans proline' 0 C--O 1.213 -0.772 0 C-N-CA 120.948 1.099 . . . . 0.0 111.11 175.415 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.584 ' OE2' HG23 ' A' ' 4' ' ' THR . 2.8 tt0 . . . . . 0 C--N 1.313 -0.985 0 C-N-CA 120.307 -0.557 . . . . 0.0 110.967 -179.822 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 1.6 t . . . . . 0 N--CA 1.477 0.898 0 N-CA-C 109.549 -0.538 . . . . 0.0 109.549 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.427 ' CZ ' HD22 ' A' ' 13' ' ' LEU . 42.8 m-85 -118.35 -171.42 2.07 Favored 'General case' 0 N--CA 1.498 1.942 0 C-N-CA 119.735 -0.786 . . . . 0.0 110.789 -178.337 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.2 p -106.22 -179.87 4.07 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-N 115.304 -0.862 . . . . 0.0 108.838 179.248 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -91.02 149.5 21.81 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 118.572 -1.251 . . . . 0.0 111.134 -179.546 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.513 ' SG ' ' O ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -74.06 178.46 4.99 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.972 178.397 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.2 p -148.68 21.02 1.03 Allowed 'General case' 0 C--N 1.285 -2.2 0 CA-C-N 114.149 -1.387 . . . . 0.0 109.032 175.406 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -160.81 171.89 17.99 Favored 'General case' 0 C--N 1.292 -1.92 0 CA-C-N 114.274 -1.33 . . . . 0.0 110.516 -179.272 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.486 ' O ' ' N ' ' A' ' 11' ' ' GLN . 0.5 OUTLIER -71.32 -176.68 1.55 Allowed 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 119.703 -0.799 . . . . 0.0 109.558 179.785 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.678 ' HA2' ' O ' ' A' ' 28' ' ' CYS . . . 28.31 9.39 0.0 OUTLIER Glycine 0 N--CA 1.498 2.819 1 N-CA-C 130.224 6.85 . . . . 0.0 130.224 179.862 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.486 ' N ' ' O ' ' A' ' 9' ' ' SER . 0.0 OUTLIER -60.75 -165.1 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 176.45 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.473 ' O ' ' O ' ' A' ' 22' ' ' CYS . 0.3 OUTLIER -148.76 -70.26 0.21 Allowed 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 117.266 -1.773 . . . . 0.0 114.225 -179.795 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.427 HD22 ' CZ ' ' A' ' 3' ' ' TYR . 7.6 mt -75.74 47.46 0.42 Allowed 'General case' 0 C--N 1.263 -3.174 0 C-N-CA 117.936 -1.505 . . . . 0.0 110.663 -175.543 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.542 ' O ' HG22 ' A' ' 21' ' ' VAL . 28.0 p -124.74 -156.58 0.73 Allowed 'General case' 0 C--O 1.211 -0.934 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.2 177.182 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.513 ' O ' ' SG ' ' A' ' 6' ' ' CYS . 5.8 mt -115.56 127.29 55.15 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.029 176.199 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.575 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -141.38 21.88 2.21 Favored 'General case' 0 C--N 1.297 -1.703 0 C-N-CA 118.409 -1.316 . . . . 0.0 111.439 -174.516 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -157.03 77.43 0.88 Allowed 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 119.6 -0.84 . . . . 0.0 109.145 176.047 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 77.2 -88.52 0.99 Allowed Glycine 0 N--CA 1.486 1.976 0 C-N-CA 119.386 -1.388 . . . . 0.0 109.881 -178.388 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.48 ' O ' ' OG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -145.56 11.67 1.29 Allowed 'General case' 0 C--N 1.303 -1.432 0 CA-C-O 122.511 1.148 . . . . 0.0 109.988 179.606 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -95.57 138.46 33.21 Favored 'General case' 0 C--N 1.258 -3.392 0 CA-C-N 113.238 -1.801 . . . . 0.0 110.288 178.105 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.542 HG22 ' O ' ' A' ' 14' ' ' CYS . 1.4 t -72.64 145.21 12.19 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.059 -178.593 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.473 ' O ' ' O ' ' A' ' 12' ' ' ASN . 6.0 m -144.41 126.13 15.16 Favored 'General case' 0 N--CA 1.499 2.021 0 C-N-CA 118.732 -1.187 . . . . 0.0 109.436 177.212 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.436 ' O ' ' O ' ' A' ' 26' ' ' ASN . . . 175.5 -91.05 0.08 OUTLIER Glycine 0 C--O 1.206 -1.604 0 C-N-CA 117.349 -2.358 . . . . 0.0 112.737 -178.043 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -48.9 126.22 11.81 Favored 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 119.453 -0.899 . . . . 0.0 111.007 -176.7 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.18 -29.09 9.22 Favored Glycine 0 N--CA 1.48 1.591 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -178.447 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.436 ' O ' ' O ' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -132.11 -168.95 2.12 Favored 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 120.163 -0.615 . . . . 0.0 110.929 -179.49 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.51 ' O ' ' O ' ' A' ' 40' ' ' VAL . 0.1 OUTLIER -142.71 159.53 42.05 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 177.955 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.678 ' O ' ' HA2' ' A' ' 10' ' ' GLY . 74.0 m -127.03 163.27 24.1 Favored 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 118.657 -1.217 . . . . 0.0 111.917 178.666 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 10.8 mm -139.59 130.6 32.67 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.839 0 CA-C-N 113.081 -1.872 . . . . 0.0 109.545 176.494 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.454 HD23 ' HA ' ' A' ' 30' ' ' LEU . 16.7 mt . . . . . 0 N--CA 1.491 1.598 0 C-N-CA 118.091 -1.444 . . . . 0.0 108.31 176.894 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.505 ' N ' ' OD1' ' A' ' 37' ' ' ASN . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 120.935 0.398 . . . . 0.0 110.542 . . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.47 ' CG ' ' N ' ' A' ' 39' ' ' CYS . 36.6 tt0 -143.59 166.9 23.56 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 120.008 -0.677 . . . . 0.0 109.531 179.503 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.575 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 3.8 m -116.93 91.18 3.51 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 119.567 -0.853 . . . . 0.0 110.814 -179.611 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.51 ' O ' ' O ' ' A' ' 27' ' ' LYS . 0.2 OUTLIER -91.17 139.0 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.17 0 C-N-CA 118.235 -1.386 . . . . 0.0 111.432 179.261 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.421 ' O ' HG22 ' A' ' 40' ' ' VAL . 11.4 t -49.62 151.69 1.61 Allowed 'General case' 0 C--N 1.271 -2.829 0 CA-C-N 114.124 -1.398 . . . . 0.0 110.806 -178.767 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 146.78 -155.27 26.46 Favored Glycine 0 N--CA 1.489 2.209 0 C-N-CA 119.682 -1.247 . . . . 0.0 110.146 -179.378 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 81.4 mt-10 -144.39 143.15 30.79 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 119.497 -0.881 . . . . 0.0 110.282 179.844 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -146.95 -148.12 4.69 Favored Glycine 0 N--CA 1.494 2.53 0 C-N-CA 119.269 -1.443 . . . . 0.0 110.961 -179.525 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -132.56 155.92 80.68 Favored Pre-proline 0 N--CA 1.495 1.814 0 C-N-CA 120.183 -0.607 . . . . 0.0 109.64 -179.206 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -53.04 -168.92 0.01 OUTLIER 'Trans proline' 0 C--O 1.215 -0.657 0 C-N-CA 121.46 1.44 . . . . 0.0 111.44 176.933 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 . . . . . 0 C--N 1.312 -1.024 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.891 -179.706 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.545 HG12 ' N ' ' A' ' 3' ' ' TYR . 11.3 t . . . . . 0 N--CA 1.493 1.679 0 CA-C-O 120.777 0.323 . . . . 0.0 110.516 . . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.545 ' N ' HG12 ' A' ' 2' ' ' VAL . 37.0 m-85 -122.82 -167.74 1.63 Allowed 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 177.601 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.442 ' OG1' ' OE1' ' A' ' 47' ' ' GLU . 10.4 p -106.07 173.49 6.29 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 119.441 -0.904 . . . . 0.0 109.304 -179.837 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -85.4 147.72 26.35 Favored 'General case' 0 C--N 1.286 -2.176 0 C-N-CA 118.653 -1.219 . . . . 0.0 109.74 179.485 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -75.29 -176.37 3.07 Favored 'General case' 0 C--N 1.285 -2.223 0 C-N-CA 119.547 -0.861 . . . . 0.0 110.336 177.545 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.404 ' O ' ' OG1' ' A' ' 7' ' ' THR . 1.6 t -155.04 12.95 0.38 Allowed 'General case' 0 C--N 1.277 -2.566 0 CA-C-N 114.1 -1.409 . . . . 0.0 110.501 178.696 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -163.82 178.55 7.74 Favored 'General case' 0 C--N 1.282 -2.343 0 CA-C-N 114.647 -1.161 . . . . 0.0 110.088 179.388 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.452 ' O ' ' N ' ' A' ' 11' ' ' GLN . 0.5 OUTLIER -74.66 -160.11 0.1 Allowed 'General case' 0 C--N 1.297 -1.702 0 C-N-CA 119.808 -0.757 . . . . 0.0 109.809 179.864 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.709 ' HA2' ' CE ' ' A' ' 27' ' ' LYS . . . 27.79 10.75 0.0 OUTLIER Glycine 0 N--CA 1.5 2.945 1 N-CA-C 130.68 7.032 . . . . 0.0 130.68 178.557 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.456 ' O ' ' OD1' ' A' ' 12' ' ' ASN . 1.3 mt-30 -86.59 -174.68 5.11 Favored 'General case' 0 N--CA 1.499 1.995 0 C-N-CA 119.01 -1.076 . . . . 0.0 108.537 176.726 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.551 ' ND2' ' O ' ' A' ' 26' ' ' ASN . 16.8 m-20 -138.92 -65.63 0.49 Allowed 'General case' 0 N--CA 1.502 2.141 0 C-N-CA 118.247 -1.381 . . . . 0.0 114.675 -174.641 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.438 HD23 ' HA ' ' A' ' 13' ' ' LEU . 21.2 mt -77.94 47.33 0.63 Allowed 'General case' 0 C--N 1.272 -2.796 0 C-N-CA 117.939 -1.504 . . . . 0.0 111.573 -174.946 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 11.0 p -125.35 -167.4 1.68 Allowed 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 119.804 -0.758 . . . . 0.0 109.327 176.732 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.585 HD22 ' O ' ' A' ' 19' ' ' SER . 57.2 mt -102.09 116.05 31.86 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 177.06 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 6.5 m -111.4 -42.44 3.89 Favored 'General case' 0 N--CA 1.505 2.285 0 C-N-CA 118.854 -1.138 . . . . 0.0 111.919 -175.642 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.34 92.26 4.86 Favored 'General case' 0 N--CA 1.498 1.952 0 C-N-CA 118.968 -1.093 . . . . 0.0 109.776 178.381 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 76.03 -98.21 1.19 Allowed Glycine 0 N--CA 1.491 2.306 0 C-N-CA 119.319 -1.419 . . . . 0.0 110.308 -179.756 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.585 ' O ' HD22 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -134.89 3.02 3.18 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-O 122.231 1.015 . . . . 0.0 110.451 179.77 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -83.95 139.27 32.69 Favored 'General case' 0 C--N 1.26 -3.303 0 CA-C-N 113.51 -1.677 . . . . 0.0 110.728 -179.358 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.434 ' HA ' HD23 ' A' ' 15' ' ' LEU . 2.3 t -64.42 142.59 16.68 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.035 0 C-N-CA 118.95 -1.1 . . . . 0.0 110.153 179.511 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.517 ' O ' ' SG ' ' A' ' 28' ' ' CYS . 0.0 OUTLIER -149.72 122.72 8.81 Favored 'General case' 0 C--N 1.28 -2.432 0 C-N-CA 118.659 -1.217 . . . . 0.0 109.403 177.395 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.428 ' HA3' ' O ' ' A' ' 12' ' ' ASN . . . 148.91 -33.94 1.14 Allowed Glycine 0 C--N 1.296 -1.678 1 N-CA-C 130.077 6.791 . . . . 0.0 130.077 -177.234 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.444 ' C ' ' H ' ' A' ' 26' ' ' ASN . 0.6 OUTLIER -54.64 116.52 2.74 Favored 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 119.301 -0.959 . . . . 0.0 110.261 179.911 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 78.85 -20.7 4.33 Favored Glycine 0 N--CA 1.479 1.504 0 C-N-CA 119.317 -1.42 . . . . 0.0 109.749 -178.681 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.551 ' O ' ' ND2' ' A' ' 12' ' ' ASN . 0.0 OUTLIER -114.22 -170.53 1.74 Allowed 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 119.933 -0.707 . . . . 0.0 109.876 -179.8 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.709 ' CE ' ' HA2' ' A' ' 10' ' ' GLY . 0.2 OUTLIER -154.2 118.71 4.87 Favored 'General case' 0 N--CA 1.5 2.045 0 C-N-CA 119.084 -1.046 . . . . 0.0 111.205 -179.969 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.517 ' SG ' ' O ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -81.77 160.98 23.46 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 118.979 -1.088 . . . . 0.0 110.956 -179.174 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.537 HD11 ' CE ' ' A' ' 27' ' ' LYS . 36.5 mm -133.33 126.81 53.11 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 C-N-CA 119.385 -0.926 . . . . 0.0 110.455 179.685 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 13.3 mt . . . . . 0 N--CA 1.497 1.91 0 C-N-CA 118.612 -1.235 . . . . 0.0 109.935 178.065 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.403 ' C ' ' OD1' ' A' ' 37' ' ' ASN . 48.6 t-20 . . . . . 0 N--CA 1.432 -1.364 0 CA-C-O 121.12 0.486 . . . . 0.0 110.156 . . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 tt0 -113.19 140.35 48.01 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.647 179.177 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 77.1 m -91.49 107.65 19.35 Favored 'General case' 0 C--N 1.294 -1.847 0 C-N-CA 119.124 -1.03 . . . . 0.0 111.073 -179.887 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.578 HG22 ' N ' ' A' ' 41' ' ' THR . 2.5 p -123.58 162.6 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.5 0 C-N-CA 118.833 -1.147 . . . . 0.0 110.862 177.807 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.578 ' N ' HG22 ' A' ' 40' ' ' VAL . 1.3 t -90.0 144.99 25.43 Favored 'General case' 0 C--N 1.284 -2.257 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.805 179.585 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 178.49 -93.4 0.09 OUTLIER Glycine 0 N--CA 1.491 2.344 1 N-CA-C 130.25 6.86 . . . . 0.0 130.25 179.899 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -157.8 93.03 1.24 Allowed 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 119.561 -0.856 . . . . 0.0 110.027 179.399 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.528 ' HA3' ' HG3' ' A' ' 27' ' ' LYS . . . -131.62 -178.76 15.67 Favored Glycine 0 N--CA 1.493 2.467 1 N-CA-C 131.711 7.444 . . . . 0.0 131.711 -178.963 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -106.84 118.63 53.73 Favored Pre-proline 0 CA--C 1.561 1.386 0 C-N-CA 120.462 -0.495 . . . . 0.0 111.422 -179.341 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.41 ' O ' ' C ' ' A' ' 47' ' ' GLU . 4.3 Cg_exo -64.46 102.95 0.42 Allowed 'Trans proline' 0 C--O 1.215 -0.652 0 C-N-CA 120.935 1.09 . . . . 0.0 110.784 174.894 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.442 ' OE1' ' OG1' ' A' ' 4' ' ' THR . 6.5 tm-20 . . . . . 0 CA--C 1.56 1.343 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.162 179.603 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.638 HG12 ' N ' ' A' ' 3' ' ' TYR . 23.1 t . . . . . 0 N--CA 1.488 1.455 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 . . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.638 ' N ' HG12 ' A' ' 2' ' ' VAL . 23.4 m-85 -96.61 -166.25 1.39 Allowed 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 119.39 -0.924 . . . . 0.0 111.057 -178.013 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 13.8 p -96.9 176.19 6.06 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 119.792 -0.763 . . . . 0.0 109.225 -179.321 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -89.71 144.67 25.79 Favored 'General case' 0 C--N 1.289 -2.052 0 C-N-CA 118.722 -1.191 . . . . 0.0 109.335 178.321 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -73.81 -177.93 3.0 Favored 'General case' 0 C--N 1.286 -2.175 0 CA-C-O 122.144 0.973 . . . . 0.0 111.535 -179.864 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.7 p -154.37 18.56 0.48 Allowed 'General case' 0 C--N 1.283 -2.286 0 CA-C-N 113.476 -1.693 . . . . 0.0 109.076 178.486 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -163.2 177.93 8.64 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-N 114.4 -1.273 . . . . 0.0 110.568 -178.98 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.496 ' O ' ' N ' ' A' ' 11' ' ' GLN . 0.6 OUTLIER -83.91 -158.52 0.32 Allowed 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.985 -179.763 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.529 ' HA2' ' HE3' ' A' ' 27' ' ' LYS . . . 22.85 21.41 0.0 OUTLIER Glycine 0 N--CA 1.498 2.779 1 N-CA-C 129.973 6.749 . . . . 0.0 129.973 178.762 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.496 ' N ' ' O ' ' A' ' 9' ' ' SER . 7.7 mt-30 -94.49 -164.18 1.14 Allowed 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 114.492 -0.854 . . . . 0.0 109.575 178.233 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.74 HD21 ' H ' ' A' ' 44' ' ' GLY . 24.7 m-20 -147.57 -62.59 0.27 Allowed 'General case' 0 N--CA 1.501 2.082 0 C-N-CA 118.086 -1.446 . . . . 0.0 114.54 -177.311 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.437 HD22 ' CZ ' ' A' ' 3' ' ' TYR . 16.2 mt -76.86 47.43 0.52 Allowed 'General case' 0 C--N 1.269 -2.909 0 C-N-CA 118.127 -1.429 . . . . 0.0 111.795 -174.586 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 7.0 p -129.85 -168.07 1.9 Allowed 'General case' 0 C--N 1.308 -1.203 0 C-N-CA 119.657 -0.817 . . . . 0.0 110.186 175.441 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 35.9 mt -104.41 120.12 40.51 Favored 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 119.586 -0.846 . . . . 0.0 108.935 178.232 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.1 m -119.67 -18.9 8.24 Favored 'General case' 0 N--CA 1.501 2.114 0 C-N-CA 119.163 -1.015 . . . . 0.0 111.816 -176.575 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.11 93.78 4.02 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 119.591 -0.844 . . . . 0.0 109.243 177.677 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 68.84 -101.75 0.83 Allowed Glycine 0 N--CA 1.486 2.001 0 C-N-CA 119.245 -1.455 . . . . 0.0 109.8 -178.268 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.442 ' O ' ' OG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -127.17 4.12 6.41 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 122.541 1.162 . . . . 0.0 109.269 178.931 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -78.09 140.1 39.06 Favored 'General case' 0 C--N 1.262 -3.211 0 CA-C-N 112.811 -1.995 . . . . 0.0 111.203 -179.077 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.1 t -77.27 145.75 9.61 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.19 0 C-N-CA 119.337 -0.945 . . . . 0.0 110.021 178.754 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.494 ' O ' ' SG ' ' A' ' 28' ' ' CYS . 15.0 m -146.57 109.89 4.78 Favored 'General case' 0 C--N 1.288 -2.099 0 C-N-CA 118.99 -1.084 . . . . 0.0 109.185 176.761 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.577 ' HA2' ' OD1' ' A' ' 12' ' ' ASN . . . -170.72 -78.75 0.04 OUTLIER Glycine 0 N--CA 1.479 1.523 1 N-CA-C 129.681 6.632 . . . . 0.0 129.681 -175.961 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.34 110.98 2.43 Favored 'General case' 0 C--N 1.311 -1.071 0 C-N-CA 118.308 -1.357 . . . . 0.0 109.309 179.441 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 105.44 -18.93 40.7 Favored Glycine 0 C--N 1.302 -1.359 0 N-CA-C 122.735 3.854 . . . . 0.0 122.735 -171.443 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.413 ' HA ' ' H ' ' A' ' 42' ' ' GLY . 0.0 OUTLIER -132.36 -167.94 1.97 Allowed 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 112.788 -1.706 . . . . 0.0 108.711 179.105 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.529 ' HE3' ' HA2' ' A' ' 10' ' ' GLY . 12.7 tttt -148.11 122.15 9.46 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 118.52 -1.272 . . . . 0.0 110.502 177.472 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.494 ' SG ' ' O ' ' A' ' 22' ' ' CYS . 19.2 m -86.55 153.58 21.72 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 117.825 -1.55 . . . . 0.0 110.819 178.624 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 13.6 mm -137.2 129.39 42.87 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.647 0 CA-C-N 114.492 -1.231 . . . . 0.0 109.303 175.839 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.461 HD23 ' HA ' ' A' ' 30' ' ' LEU . 17.2 mt . . . . . 0 N--CA 1.49 1.575 0 C-N-CA 118.191 -1.404 . . . . 0.0 108.914 178.001 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.431 ' OD1' ' N ' ' A' ' 37' ' ' ASN . 2.0 m-20 . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 . . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 40.2 tt0 -150.51 141.79 23.25 Favored 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 118.998 -1.081 . . . . 0.0 110.111 177.969 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 14.2 m -91.21 91.36 8.18 Favored 'General case' 0 C--N 1.293 -1.861 0 C-N-CA 119.49 -0.884 . . . . 0.0 111.173 -178.362 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.475 ' O ' ' O ' ' A' ' 27' ' ' LYS . 0.6 OUTLIER -95.53 139.69 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 C-N-CA 118.334 -1.347 . . . . 0.0 110.941 178.659 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.413 ' O ' HG22 ' A' ' 40' ' ' VAL . 8.8 t -56.8 147.27 23.66 Favored 'General case' 0 C--N 1.271 -2.831 0 CA-C-N 114.085 -1.416 . . . . 0.0 110.918 -179.567 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.413 ' H ' ' HA ' ' A' ' 26' ' ' ASN . . . 159.43 -141.25 7.39 Favored Glycine 0 N--CA 1.487 2.073 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 -179.263 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -146.57 106.44 3.98 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 119.34 -0.944 . . . . 0.0 110.229 179.785 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.74 ' H ' HD21 ' A' ' 12' ' ' ASN . . . -108.46 -156.54 18.46 Favored Glycine 0 N--CA 1.498 2.822 0 C-N-CA 119.834 -1.174 . . . . 0.0 111.1 -178.807 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -132.56 156.12 80.45 Favored Pre-proline 0 N--CA 1.497 1.876 0 C-N-CA 120.104 -0.638 . . . . 0.0 109.853 -178.941 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -53.84 165.33 1.92 Allowed 'Trans proline' 0 C--O 1.216 -0.623 0 C-N-CA 121.373 1.382 . . . . 0.0 111.092 175.828 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 . . . . . 0 CA--C 1.558 1.259 0 C-N-CA 119.293 -0.963 . . . . 0.0 110.952 177.958 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 4.2 t . . . . . 0 N--CA 1.485 1.314 0 CA-C-O 121.586 0.708 . . . . 0.0 110.768 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.463 ' CZ ' HD22 ' A' ' 13' ' ' LEU . 94.7 m-85 -138.32 -172.18 3.22 Favored 'General case' 0 C--N 1.273 -2.75 0 CA-C-N 114.509 -1.223 . . . . 0.0 111.182 179.808 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.6 p -123.22 -167.44 1.6 Allowed 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 114.797 -1.092 . . . . 0.0 108.563 178.314 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.428 ' OD1' HD12 ' A' ' 15' ' ' LEU . 0.1 OUTLIER -93.54 156.14 16.91 Favored 'General case' 0 C--N 1.288 -2.106 0 C-N-CA 119.05 -1.06 . . . . 0.0 111.434 -177.939 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.447 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 1.7 m -72.23 162.17 29.84 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 114.931 -1.031 . . . . 0.0 110.44 177.286 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.454 ' O ' ' OG1' ' A' ' 7' ' ' THR . 0.2 OUTLIER -138.44 8.73 2.66 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 119.46 -0.896 . . . . 0.0 110.034 178.328 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -164.75 161.09 20.37 Favored 'General case' 0 C--N 1.281 -2.376 0 CA-C-N 114.29 -1.323 . . . . 0.0 110.379 178.886 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.484 ' HB3' ' H ' ' A' ' 30' ' ' LEU . 0.7 OUTLIER -70.36 150.37 46.37 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.644 -0.823 . . . . 0.0 109.905 -179.783 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.426 ' O ' ' O ' ' A' ' 11' ' ' GLN . . . 101.66 -37.01 3.84 Favored Glycine 0 N--CA 1.502 3.085 0 C-N-CA 119.511 -1.328 . . . . 0.0 112.759 178.114 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.426 ' O ' ' O ' ' A' ' 10' ' ' GLY . 24.7 mt-30 -47.31 176.39 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.521 0 C-N-CA 119.539 -0.865 . . . . 0.0 111.583 -177.63 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.514 ' C ' ' H ' ' A' ' 14' ' ' CYS . 54.7 m-20 -147.93 -60.56 0.26 Allowed 'General case' 0 N--CA 1.502 2.164 0 C-N-CA 118.698 -1.201 . . . . 0.0 113.339 -178.161 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.495 HD12 ' HB3' ' A' ' 46' ' ' PRO . 19.0 mt -76.1 39.71 0.19 Allowed 'General case' 0 C--N 1.29 -2.016 0 C-N-CA 118.752 -1.179 . . . . 0.0 110.273 -177.88 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.587 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 17.2 p -122.27 -164.58 1.18 Allowed 'General case' 0 C--N 1.292 -1.908 0 CA-C-N 115.05 -0.977 . . . . 0.0 108.387 176.555 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.428 HD12 ' OD1' ' A' ' 5' ' ' ASP . 25.4 mt -100.29 99.39 10.05 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-O 122.286 1.041 . . . . 0.0 108.7 177.764 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.587 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 93.2 m -100.91 -61.62 1.35 Allowed 'General case' 0 C--N 1.276 -2.594 0 CA-C-N 113.273 -1.785 . . . . 0.0 110.708 -174.07 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -80.57 90.11 5.7 Favored 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 118.902 -1.119 . . . . 0.0 108.838 178.207 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 69.29 -127.59 21.07 Favored Glycine 0 N--CA 1.484 1.847 0 C-N-CA 118.953 -1.594 . . . . 0.0 109.465 -177.838 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -100.89 0.01 37.65 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 122.179 0.99 . . . . 0.0 109.966 179.688 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 67.7 m-80 -80.02 150.92 30.23 Favored 'General case' 0 C--N 1.261 -3.246 0 CA-C-N 113.483 -1.689 . . . . 0.0 111.256 -179.007 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.545 HG12 ' O ' ' A' ' 22' ' ' CYS . 2.4 t -82.92 141.36 15.03 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 C-N-CA 119.566 -0.853 . . . . 0.0 111.477 -179.176 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.602 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 0.1 OUTLIER -77.76 -130.85 0.01 OUTLIER 'General case' 0 N--CA 1.514 2.764 0 C-N-CA 118.765 -1.174 . . . . 0.0 108.867 172.468 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.588 ' O ' ' ND2' ' A' ' 26' ' ' ASN . . . -179.71 111.2 0.31 Allowed Glycine 0 C--N 1.275 -2.845 0 C-N-CA 117.96 -2.067 . . . . 0.0 111.617 177.527 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.452 ' C ' ' O ' ' A' ' 23' ' ' GLY . 36.4 tt0 -36.61 129.69 0.77 Allowed 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 119.979 -0.688 . . . . 0.0 109.244 176.13 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 121.31 -25.91 6.85 Favored Glycine 0 N--CA 1.483 1.813 0 N-CA-C 107.532 -2.227 . . . . 0.0 107.532 -175.142 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.588 ' ND2' ' O ' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -107.5 -161.25 0.77 Allowed 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 176.894 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.543 ' O ' ' O ' ' A' ' 40' ' ' VAL . 29.4 tttp -153.7 105.7 2.82 Favored 'General case' 0 N--CA 1.5 2.041 0 C-N-CA 118.799 -1.16 . . . . 0.0 111.918 179.866 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.619 ' O ' HD13 ' A' ' 29' ' ' ILE . 3.3 m -78.55 154.81 30.09 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 118.39 -1.324 . . . . 0.0 110.146 178.71 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.619 HD13 ' O ' ' A' ' 28' ' ' CYS . 8.2 mm -134.3 133.72 55.25 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.152 0 CA-C-N 114.968 -1.014 . . . . 0.0 110.283 175.655 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.484 ' H ' ' HB3' ' A' ' 9' ' ' SER . 17.7 mt . . . . . 0 N--CA 1.497 1.885 0 C-N-CA 119.123 -1.031 . . . . 0.0 110.038 177.354 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.499 ' N ' ' OD1' ' A' ' 37' ' ' ASN . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 121.187 0.518 . . . . 0.0 111.498 . . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 -160.78 135.86 7.71 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.859 177.581 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.476 ' SG ' ' HB2' ' A' ' 16' ' ' CYS . 1.0 OUTLIER -91.53 108.77 20.13 Favored 'General case' 0 C--N 1.295 -1.787 0 C-N-CA 119.705 -0.798 . . . . 0.0 110.741 -179.557 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.561 HG22 ' N ' ' A' ' 41' ' ' THR . 3.7 p -130.95 157.69 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.25 0 C-N-CA 118.219 -1.393 . . . . 0.0 111.359 176.459 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.561 ' N ' HG22 ' A' ' 40' ' ' VAL . 14.0 t -73.24 151.03 41.57 Favored 'General case' 0 C--N 1.275 -2.633 0 CA-C-N 114.399 -1.273 . . . . 0.0 111.662 -179.13 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 164.31 -143.13 8.29 Favored Glycine 0 N--CA 1.489 2.2 0 C-N-CA 119.479 -1.343 . . . . 0.0 110.43 179.587 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -120.78 100.26 7.0 Favored 'General case' 0 N--CA 1.495 1.814 0 C-N-CA 120.092 -0.643 . . . . 0.0 109.904 179.588 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -127.28 -155.06 8.7 Favored Glycine 0 N--CA 1.495 2.621 0 N-CA-C 110.255 -1.138 . . . . 0.0 110.255 -179.73 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -144.41 151.05 49.97 Favored Pre-proline 0 N--CA 1.488 1.428 0 C-N-CA 119.431 -0.908 . . . . 0.0 109.954 179.713 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.495 ' HB3' HD12 ' A' ' 13' ' ' LEU . 9.3 Cg_endo -68.8 141.61 49.83 Favored 'Trans proline' 0 C--O 1.216 -0.612 0 C-N-CA 121.342 1.361 . . . . 0.0 111.336 177.177 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 . . . . . 0 CA--C 1.56 1.358 0 C-N-CA 119.488 -0.885 . . . . 0.0 109.512 178.506 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.674 HG12 ' N ' ' A' ' 3' ' ' TYR . 61.7 t . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 120.938 0.399 . . . . 0.0 109.983 . . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.674 ' N ' HG12 ' A' ' 2' ' ' VAL . 37.8 m-85 -114.39 -165.41 1.01 Allowed 'General case' 0 N--CA 1.493 1.685 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.67 -179.733 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.9 p -99.48 172.27 7.42 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 178.215 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -89.64 154.2 20.15 Favored 'General case' 0 C--N 1.285 -2.207 0 C-N-CA 118.2 -1.4 . . . . 0.0 110.366 -179.632 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.514 ' SG ' ' O ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -73.81 154.73 39.39 Favored 'General case' 0 C--N 1.291 -1.952 0 C-N-CA 119.729 -0.788 . . . . 0.0 110.223 177.35 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.4 t -129.94 14.35 5.79 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-O 122.055 0.931 . . . . 0.0 108.85 177.739 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.498 ' HG2' HE21 ' A' ' 11' ' ' GLN . 11.6 pt-20 -162.58 176.94 9.87 Favored 'General case' 0 C--N 1.281 -2.404 0 CA-C-N 113.695 -1.593 . . . . 0.0 109.58 179.488 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.461 ' O ' ' N ' ' A' ' 11' ' ' GLN . 0.5 OUTLIER -72.64 -163.75 0.14 Allowed 'General case' 0 C--N 1.297 -1.693 0 C-N-CA 119.264 -0.974 . . . . 0.0 109.5 -179.506 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.602 ' H ' HD13 ' A' ' 29' ' ' ILE . . . 24.66 19.73 0.0 OUTLIER Glycine 0 N--CA 1.494 2.541 1 N-CA-C 130.218 6.847 . . . . 0.0 130.218 179.264 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.498 HE21 ' HG2' ' A' ' 8' ' ' GLU . 7.9 mm-40 -71.09 -163.38 0.08 Allowed 'General case' 0 C--N 1.295 -1.799 0 C-N-CA 119.432 -0.907 . . . . 0.0 109.35 177.241 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.57 ' O ' ' HA3' ' A' ' 23' ' ' GLY . 26.2 t-20 -148.52 -77.55 0.16 Allowed 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 118.188 -1.405 . . . . 0.0 112.975 -177.876 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.428 HD12 ' HB3' ' A' ' 46' ' ' PRO . 14.1 mt -78.08 42.13 0.39 Allowed 'General case' 0 C--N 1.271 -2.833 0 C-N-CA 118.02 -1.472 . . . . 0.0 110.495 -177.8 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.42 ' H ' ' C ' ' A' ' 12' ' ' ASN . 29.4 p -113.33 -159.88 0.7 Allowed 'General case' 0 N--CA 1.496 1.833 0 C-N-CA 119.483 -0.887 . . . . 0.0 110.129 178.012 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.514 ' O ' ' SG ' ' A' ' 6' ' ' CYS . 3.5 mt -124.82 133.0 53.28 Favored 'General case' 0 N--CA 1.499 2.006 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.518 177.584 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 3.4 m -111.92 -74.42 0.64 Allowed 'General case' 0 N--CA 1.513 2.713 0 C-N-CA 119.064 -1.054 . . . . 0.0 110.308 179.094 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -78.23 125.69 29.72 Favored 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 118.319 -1.352 . . . . 0.0 107.845 177.228 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 28.55 -72.64 0.0 OUTLIER Glycine 0 N--CA 1.502 3.06 1 N-CA-C 128.931 6.332 . . . . 0.0 128.931 -176.7 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -137.53 0.27 2.25 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-O 122.149 0.976 . . . . 0.0 110.324 177.456 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 35.8 m120 -80.27 128.16 33.21 Favored 'General case' 0 C--N 1.261 -3.264 0 CA-C-N 113.557 -1.656 . . . . 0.0 110.448 -179.84 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.1 t -70.34 148.98 10.61 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 C-N-CA 119.282 -0.967 . . . . 0.0 109.954 179.621 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.546 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 0.4 OUTLIER -134.54 101.14 4.86 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 119.0 -1.08 . . . . 0.0 110.699 178.781 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.57 ' HA3' ' O ' ' A' ' 12' ' ' ASN . . . 164.98 -55.4 0.27 Allowed Glycine 0 C--N 1.297 -1.61 1 N-CA-C 131.485 7.354 . . . . 0.0 131.485 179.465 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.503 ' N ' ' OD1' ' A' ' 12' ' ' ASN . 28.7 tt0 -51.47 117.85 2.92 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 118.875 -1.13 . . . . 0.0 110.732 -178.045 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 80.26 -22.37 4.52 Favored Glycine 0 N--CA 1.482 1.711 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -178.506 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.527 ' N ' ' OD1' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -119.8 -159.17 0.77 Allowed 'General case' 0 C--N 1.312 -1.037 0 C-N-CA 120.432 -0.507 . . . . 0.0 109.99 -179.689 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.593 ' N ' ' O ' ' A' ' 40' ' ' VAL . 40.3 tttt -157.98 162.35 38.19 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.654 -179.95 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.546 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -122.97 168.81 11.85 Favored 'General case' 0 CA--C 1.481 -1.706 0 CA-C-O 123.125 1.441 . . . . 0.0 111.638 174.249 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.602 HD13 ' H ' ' A' ' 10' ' ' GLY . 21.6 mm -143.72 130.43 16.95 Favored 'Isoleucine or valine' 0 C--N 1.249 -3.782 0 CA-C-N 111.755 -2.475 . . . . 0.0 108.816 174.324 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.412 ' HA ' HD23 ' A' ' 30' ' ' LEU . 15.2 mt . . . . . 0 N--CA 1.49 1.54 0 C-N-CA 118.275 -1.37 . . . . 0.0 110.016 -179.73 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 14.6 m-20 . . . . . 0 N--CA 1.485 1.306 0 N-CA-C 109.751 -0.462 . . . . 0.0 109.751 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.519 ' O ' ' SG ' ' A' ' 28' ' ' CYS . 38.3 tt0 -160.54 147.25 15.53 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 119.383 -0.927 . . . . 0.0 110.488 178.333 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -103.44 107.38 18.19 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 119.885 -0.726 . . . . 0.0 112.378 -179.55 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.593 ' O ' ' N ' ' A' ' 27' ' ' LYS . 0.1 OUTLIER -100.25 141.46 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.571 0 C-N-CA 118.709 -1.196 . . . . 0.0 110.615 174.778 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.634 HG23 ' O ' ' A' ' 41' ' ' THR . 8.9 t -78.79 47.41 0.74 Allowed 'General case' 0 C--N 1.279 -2.471 0 CA-C-N 113.942 -1.481 . . . . 0.0 113.232 -177.882 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -118.47 -124.51 3.37 Favored Glycine 0 N--CA 1.505 3.294 1 N-CA-C 131.198 7.239 . . . . 0.0 131.198 178.172 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -98.1 73.39 2.21 Favored 'General case' 0 N--CA 1.499 1.992 0 C-N-CA 119.412 -0.915 . . . . 0.0 111.215 -178.489 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -92.15 165.22 28.95 Favored Glycine 0 N--CA 1.494 2.559 0 C-N-CA 119.405 -1.378 . . . . 0.0 110.854 -179.597 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.518 ' O ' ' N ' ' A' ' 12' ' ' ASN . 0.5 OUTLIER -129.95 148.3 69.04 Favored Pre-proline 0 N--CA 1.498 1.925 0 C-N-CA 120.128 -0.629 . . . . 0.0 109.721 179.971 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.436 ' O ' ' O ' ' A' ' 45' ' ' THR . 2.7 Cg_exo -52.77 -164.03 0.0 OUTLIER 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 121.414 1.41 . . . . 0.0 111.131 177.717 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 . . . . . 0 C--N 1.305 -1.353 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.077 178.111 . . . . . . . . 0 0 . 1 . 031 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.0 t . . . . . 0 N--CA 1.486 1.37 0 CA-C-O 121.057 0.456 . . . . 0.0 110.494 . . . . . . . . . 0 0 . 1 . 031 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -87.65 -164.53 1.11 Allowed 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 119.909 -0.716 . . . . 0.0 110.417 -179.897 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.2 p -97.59 178.38 5.19 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 119.793 -0.763 . . . . 0.0 108.956 179.742 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -91.17 154.44 19.32 Favored 'General case' 0 C--N 1.297 -1.69 0 C-N-CA 118.796 -1.162 . . . . 0.0 110.322 178.929 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.486 ' SG ' ' O ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -75.13 165.75 24.73 Favored 'General case' 0 C--N 1.299 -1.592 0 C-N-CA 119.886 -0.726 . . . . 0.0 110.899 177.827 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 43.2 p -143.72 17.5 1.81 Allowed 'General case' 0 C--N 1.294 -1.835 0 CA-C-N 114.881 -1.054 . . . . 0.0 108.596 177.123 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -161.15 167.55 25.98 Favored 'General case' 0 C--N 1.288 -2.086 0 CA-C-N 113.64 -1.618 . . . . 0.0 109.853 -179.03 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.515 ' O ' ' N ' ' A' ' 11' ' ' GLN . 0.8 OUTLIER -68.97 -168.37 0.13 Allowed 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 119.043 -1.063 . . . . 0.0 108.765 178.599 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.702 ' H ' HD13 ' A' ' 29' ' ' ILE . . . 24.35 16.89 0.0 OUTLIER Glycine 0 N--CA 1.492 2.421 1 N-CA-C 130.158 6.823 . . . . 0.0 130.158 179.865 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.528 ' NE2' ' OE1' ' A' ' 47' ' ' GLU . 10.8 mt-30 -69.67 -164.97 0.07 Allowed 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 176.218 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.442 ' OD1' ' O ' ' A' ' 11' ' ' GLN . 1.7 m-20 -150.43 -70.17 0.18 Allowed 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 117.551 -1.66 . . . . 0.0 113.952 -179.302 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.5 HD12 ' HB3' ' A' ' 46' ' ' PRO . 18.6 mt -77.28 48.96 0.66 Allowed 'General case' 0 C--N 1.272 -2.794 0 C-N-CA 117.705 -1.598 . . . . 0.0 110.189 -176.146 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.439 ' HB2' ' N ' ' A' ' 6' ' ' CYS . 26.7 p -125.39 -161.47 1.03 Allowed 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.01 -0.995 . . . . 0.0 109.184 176.517 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.486 ' O ' ' SG ' ' A' ' 6' ' ' CYS . 38.3 mt -112.6 120.84 42.95 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 123.973 0.795 . . . . 0.0 109.131 176.665 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 8.6 m -116.06 -38.54 3.6 Favored 'General case' 0 N--CA 1.503 2.207 0 C-N-CA 119.038 -1.065 . . . . 0.0 111.176 -177.074 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -100.04 76.63 1.94 Allowed 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 119.236 -0.986 . . . . 0.0 110.088 179.236 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 76.1 -94.49 1.01 Allowed Glycine 0 N--CA 1.49 2.282 0 C-N-CA 119.359 -1.401 . . . . 0.0 110.637 179.743 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -125.53 -2.84 7.36 Favored 'General case' 0 N--CA 1.485 1.302 0 CA-C-O 122.058 0.932 . . . . 0.0 110.518 -179.211 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 60.4 m-80 -81.32 136.78 35.78 Favored 'General case' 0 C--N 1.257 -3.452 0 CA-C-N 113.629 -1.623 . . . . 0.0 110.862 -179.248 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.1 t -71.67 147.17 10.95 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 C-N-CA 119.366 -0.934 . . . . 0.0 110.071 179.09 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.441 ' O ' ' O ' ' A' ' 12' ' ' ASN . 6.2 m -149.14 118.56 6.9 Favored 'General case' 0 C--N 1.288 -2.081 0 C-N-CA 118.819 -1.152 . . . . 0.0 108.876 176.486 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.46 ' O ' ' O ' ' A' ' 26' ' ' ASN . . . 179.36 -92.23 0.08 OUTLIER Glycine 0 C--O 1.203 -1.831 0 C-N-CA 117.622 -2.227 . . . . 0.0 112.218 -177.37 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 15.3 tt0 -45.37 131.22 8.31 Favored 'General case' 0 C--N 1.299 -1.612 0 C-N-CA 119.352 -0.939 . . . . 0.0 110.861 -177.472 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.56 -32.15 4.01 Favored Glycine 0 N--CA 1.479 1.515 0 N-CA-C 109.261 -1.536 . . . . 0.0 109.261 -177.819 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.46 ' O ' ' O ' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -129.67 -160.47 1.04 Allowed 'General case' 0 C--N 1.313 -1.0 0 C-N-CA 120.205 -0.598 . . . . 0.0 110.833 -179.801 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.554 ' CG ' ' N ' ' A' ' 28' ' ' CYS . 26.6 tttt -151.51 167.49 27.87 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 177.748 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.639 ' O ' ' HA2' ' A' ' 10' ' ' GLY . 59.6 m -127.62 164.66 21.55 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 119.132 -1.027 . . . . 0.0 111.261 177.001 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.702 HD13 ' H ' ' A' ' 10' ' ' GLY . 20.1 mm -146.2 133.61 15.04 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.278 0 CA-C-N 114.184 -1.371 . . . . 0.0 109.94 176.194 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 18.5 mt . . . . . 0 N--CA 1.496 1.834 0 C-N-CA 118.952 -1.099 . . . . 0.0 109.381 177.993 . . . . . . . . 0 0 . 1 . 031 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.79 HD21 ' N ' ' A' ' 37' ' ' ASN . 0.6 OUTLIER . . . . . 0 N--CA 1.496 1.835 0 CA-C-O 121.007 0.432 . . . . 0.0 111.139 . . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 26.3 tt0 -160.58 139.7 10.57 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.94 -0.704 . . . . 0.0 109.64 176.758 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 20.9 m -87.94 103.02 15.29 Favored 'General case' 0 C--N 1.297 -1.677 0 C-N-CA 119.175 -1.01 . . . . 0.0 110.993 -178.772 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.514 ' O ' ' N ' ' A' ' 27' ' ' LYS . 0.4 OUTLIER -100.14 142.07 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.232 0 C-N-CA 118.677 -1.209 . . . . 0.0 111.586 178.837 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.3 t -69.66 141.35 53.63 Favored 'General case' 0 C--N 1.277 -2.584 0 CA-C-N 114.207 -1.36 . . . . 0.0 110.955 179.311 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 157.97 -114.12 0.6 Allowed Glycine 0 N--CA 1.492 2.4 1 N-CA-C 130.492 6.957 . . . . 0.0 130.492 179.686 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -139.43 100.26 3.94 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 119.631 -0.828 . . . . 0.0 109.978 179.286 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -126.46 -175.04 14.0 Favored Glycine 0 N--CA 1.496 2.634 0 N-CA-C 110.33 -1.108 . . . . 0.0 110.33 -179.415 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -137.77 148.47 61.05 Favored Pre-proline 0 N--CA 1.491 1.589 0 C-N-CA 119.84 -0.744 . . . . 0.0 109.78 -179.984 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.5 ' HB3' HD12 ' A' ' 13' ' ' LEU . 10.4 Cg_exo -48.35 177.2 0.02 OUTLIER 'Trans proline' 0 C--O 1.214 -0.682 0 C-N-CA 121.475 1.45 . . . . 0.0 111.511 179.766 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.528 ' OE1' ' NE2' ' A' ' 11' ' ' GLN . 5.1 tp10 . . . . . 0 CA--C 1.558 1.258 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.747 178.857 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.707 HG12 ' H ' ' A' ' 3' ' ' TYR . 6.8 t . . . . . 0 N--CA 1.489 1.513 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 . . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.707 ' H ' HG12 ' A' ' 2' ' ' VAL . 61.1 m-85 -143.07 -172.47 3.68 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.135 -1.026 . . . . 0.0 111.23 -179.794 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.5 ' OG1' ' N ' ' A' ' 5' ' ' ASP . 0.1 OUTLIER -114.45 -165.66 1.03 Allowed 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 115.105 -0.952 . . . . 0.0 108.556 179.232 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.5 ' N ' ' OG1' ' A' ' 4' ' ' THR . 0.7 OUTLIER -92.2 155.05 18.26 Favored 'General case' 0 C--N 1.287 -2.119 0 C-N-CA 118.371 -1.332 . . . . 0.0 110.904 -179.363 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.447 ' N ' ' HB2' ' A' ' 14' ' ' CYS . 0.0 OUTLIER -73.82 171.23 13.74 Favored 'General case' 0 C--N 1.287 -2.148 0 CA-C-N 114.575 -1.193 . . . . 0.0 110.272 178.289 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.5 p -140.94 13.31 2.26 Favored 'General case' 0 C--N 1.294 -1.816 0 C-N-CA 119.367 -0.933 . . . . 0.0 109.687 177.284 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -162.13 174.22 13.25 Favored 'General case' 0 C--N 1.288 -2.108 0 CA-C-N 114.065 -1.425 . . . . 0.0 110.228 179.659 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.448 ' HB3' ' H ' ' A' ' 30' ' ' LEU . 0.7 OUTLIER -85.58 167.2 15.59 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 119.804 -0.758 . . . . 0.0 109.724 -179.945 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 28' ' ' CYS . . . 71.34 14.63 74.47 Favored Glycine 0 N--CA 1.503 3.156 0 C-N-CA 119.182 -1.485 . . . . 0.0 112.225 178.693 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -84.52 -174.95 5.56 Favored 'General case' 0 N--CA 1.505 2.298 0 C-N-CA 119.034 -1.066 . . . . 0.0 110.616 179.159 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.481 ' C ' ' H ' ' A' ' 14' ' ' CYS . 10.3 m-20 -153.51 -69.51 0.14 Allowed 'General case' 0 N--CA 1.505 2.299 0 C-N-CA 118.403 -1.319 . . . . 0.0 113.514 -178.048 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.494 HD13 ' CZ ' ' A' ' 3' ' ' TYR . 70.2 mt -75.22 45.96 0.3 Allowed 'General case' 0 C--N 1.288 -2.106 0 C-N-CA 118.595 -1.242 . . . . 0.0 109.74 -178.588 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.481 ' H ' ' C ' ' A' ' 12' ' ' ASN . 31.8 p -122.37 -149.5 0.43 Allowed 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 115.233 -0.894 . . . . 0.0 108.884 177.606 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.445 HD23 ' HA ' ' A' ' 15' ' ' LEU . 71.5 mt -120.0 100.18 7.06 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-O 122.25 1.024 . . . . 0.0 109.091 176.347 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.574 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 0.5 OUTLIER -74.21 -69.1 0.47 Allowed 'General case' 0 C--N 1.276 -2.616 0 CA-C-N 113.358 -1.746 . . . . 0.0 110.51 -176.088 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -100.37 95.4 6.74 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 119.029 -1.068 . . . . 0.0 111.302 -179.128 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.17 -95.21 0.84 Allowed Glycine 0 N--CA 1.492 2.398 0 C-N-CA 119.739 -1.219 . . . . 0.0 111.735 177.285 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -127.2 2.49 6.42 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-O 122.061 0.934 . . . . 0.0 110.743 -177.054 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 13.8 m-20 -78.54 129.34 34.71 Favored 'General case' 0 C--N 1.255 -3.501 0 CA-C-N 113.702 -1.59 . . . . 0.0 110.864 -179.868 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.581 HG12 ' O ' ' A' ' 22' ' ' CYS . 2.0 t -81.13 138.4 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 118.917 -1.113 . . . . 0.0 110.314 179.113 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.623 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 0.1 OUTLIER -77.94 -135.34 0.02 OUTLIER 'General case' 0 C--N 1.286 -2.184 0 C-N-CA 118.774 -1.171 . . . . 0.0 109.474 172.697 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.539 ' O ' ' ND2' ' A' ' 26' ' ' ASN . . . 179.49 115.83 0.48 Allowed Glycine 0 C--N 1.268 -3.196 0 C-N-CA 117.91 -2.091 . . . . 0.0 111.064 178.973 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.462 ' C ' ' O ' ' A' ' 23' ' ' GLY . 22.9 tt0 -36.22 135.19 0.37 Allowed 'General case' 0 C--N 1.284 -2.24 0 CA-C-N 114.872 -0.664 . . . . 0.0 109.773 176.721 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 116.79 -36.36 3.79 Favored Glycine 0 N--CA 1.486 1.979 0 N-CA-C 107.987 -2.045 . . . . 0.0 107.987 -175.632 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.539 ' ND2' ' O ' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -92.46 -162.46 0.93 Allowed 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 176.557 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.642 ' CE ' HD11 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -151.75 105.25 3.11 Favored 'General case' 0 C--N 1.284 -2.278 0 C-N-CA 118.66 -1.216 . . . . 0.0 110.41 179.284 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.623 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 9.9 m -77.62 159.47 29.19 Favored 'General case' 0 C--O 1.196 -1.725 0 C-N-CA 117.908 -1.517 . . . . 0.0 110.692 -179.595 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.642 HD11 ' CE ' ' A' ' 27' ' ' LYS . 27.9 mm -141.69 132.41 26.04 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.06 0 CA-C-N 114.005 -1.452 . . . . 0.0 110.207 177.817 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.448 ' H ' ' HB3' ' A' ' 9' ' ' SER . 20.3 mt . . . . . 0 N--CA 1.492 1.671 0 C-N-CA 119.338 -0.945 . . . . 0.0 110.156 177.799 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.867 ' N ' HD21 ' A' ' 37' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.257 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 . . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -154.75 137.18 15.01 Favored 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 119.492 -0.883 . . . . 0.0 109.368 176.694 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.574 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 2.0 m -78.97 105.99 10.69 Favored 'General case' 0 C--N 1.29 -1.994 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.844 -176.666 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.495 ' O ' ' O ' ' A' ' 27' ' ' LYS . 2.4 p -111.97 143.37 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.354 0 C-N-CA 118.395 -1.322 . . . . 0.0 110.996 175.85 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.2 t -66.24 150.2 49.16 Favored 'General case' 0 C--N 1.269 -2.899 0 CA-C-N 113.626 -1.625 . . . . 0.0 112.251 -178.348 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 165.31 -120.28 0.92 Allowed Glycine 0 N--CA 1.486 2.012 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 178.373 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -160.87 81.78 0.65 Allowed 'General case' 0 C--N 1.299 -1.587 0 C-N-CA 119.408 -0.917 . . . . 0.0 109.447 178.58 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -100.25 -158.88 28.15 Favored Glycine 0 N--CA 1.492 2.43 0 C-N-CA 119.853 -1.165 . . . . 0.0 110.949 -178.035 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -130.35 152.18 79.8 Favored Pre-proline 0 N--CA 1.493 1.681 0 C-N-CA 119.942 -0.703 . . . . 0.0 109.842 -179.759 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -55.85 -175.43 0.04 OUTLIER 'Trans proline' 0 C--O 1.214 -0.712 0 C-N-CA 121.475 1.45 . . . . 0.0 111.2 177.304 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 . . . . . 0 CA--C 1.558 1.255 0 C-N-CA 119.458 -0.897 . . . . 0.0 109.753 178.587 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 5.2 t . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.0 t -106.52 164.8 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.51 178.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.506 ' CE2' HD22 ' A' ' 13' ' ' LEU . 67.8 m-85 -126.05 -166.91 1.63 Allowed 'General case' 0 N--CA 1.499 1.981 0 C-N-CA 119.608 -0.837 . . . . 0.0 110.993 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 7.7 p -105.71 179.92 4.13 Favored 'General case' 0 C--O 1.199 -1.568 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.256 -179.211 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.471 ' OD1' ' N ' ' A' ' 5' ' ' ASP . 0.3 OUTLIER -83.54 156.84 22.6 Favored 'General case' 0 C--N 1.295 -1.802 0 C-N-CA 118.365 -1.334 . . . . 0.0 110.597 179.846 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.468 ' N ' ' HB2' ' A' ' 14' ' ' CYS . 0.1 OUTLIER -75.6 -178.64 4.24 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.666 178.127 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.3 p -123.72 -20.82 5.36 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 114.953 -1.022 . . . . 0.0 109.791 176.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.552 ' C ' HD21 ' A' ' 30' ' ' LEU . 2.8 mt-10 -162.52 162.44 27.38 Favored 'General case' 0 C--N 1.276 -2.587 0 CA-C-N 114.236 -1.347 . . . . 0.0 111.712 -178.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.425 ' HA ' ' H ' ' A' ' 30' ' ' LEU . 0.3 OUTLIER -62.87 143.07 57.97 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 115.014 -0.994 . . . . 0.0 108.753 179.439 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.527 ' HA2' ' HE3' ' A' ' 27' ' ' LYS . . . 108.24 -26.76 15.83 Favored Glycine 0 N--CA 1.487 2.094 1 N-CA-C 126.837 5.495 . . . . 0.0 126.837 -171.741 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.407 ' C ' ' OD1' ' A' ' 12' ' ' ASN . 55.0 mt-30 -71.26 -171.38 0.59 Allowed 'General case' 0 N--CA 1.497 1.9 0 CA-C-N 114.642 -0.779 . . . . 0.0 109.889 178.684 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.498 ' O ' ' HA3' ' A' ' 23' ' ' GLY . 4.3 m-20 -135.53 -69.98 0.49 Allowed 'General case' 0 N--CA 1.509 2.477 0 N-CA-C 114.558 1.318 . . . . 0.0 114.558 -175.284 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.506 HD22 ' CE2' ' A' ' 3' ' ' TYR . 50.9 mt -77.45 50.32 0.79 Allowed 'General case' 0 C--N 1.277 -2.565 0 C-N-CA 118.403 -1.319 . . . . 0.0 111.006 -175.774 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.468 ' HB2' ' N ' ' A' ' 6' ' ' CYS . 29.8 p -123.81 -161.02 0.95 Allowed 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 119.577 -0.849 . . . . 0.0 109.98 175.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.436 ' O ' ' SG ' ' A' ' 6' ' ' CYS . 39.9 mt -113.28 121.65 45.07 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.495 176.625 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -128.56 -31.42 2.25 Favored 'General case' 0 N--CA 1.51 2.565 0 C-N-CA 118.899 -1.121 . . . . 0.0 110.48 -179.744 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.418 ' O ' ' N ' ' A' ' 19' ' ' SER . 0.6 OUTLIER -87.16 82.13 7.77 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 119.09 -1.044 . . . . 0.0 108.796 177.708 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 64.94 -81.4 0.07 OUTLIER Glycine 0 N--CA 1.488 2.131 0 C-N-CA 119.23 -1.462 . . . . 0.0 109.593 -178.011 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.418 ' N ' ' O ' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -141.34 0.22 1.48 Allowed 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 122.018 0.914 . . . . 0.0 110.643 178.656 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -83.56 149.11 26.79 Favored 'General case' 0 C--N 1.26 -3.303 0 CA-C-N 113.84 -1.527 . . . . 0.0 110.333 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.5 t -68.56 148.19 11.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 C-N-CA 119.102 -1.039 . . . . 0.0 110.983 -178.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.56 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 0.0 OUTLIER -149.64 107.88 3.76 Favored 'General case' 0 C--N 1.287 -2.125 0 CA-C-N 114.832 -1.076 . . . . 0.0 109.852 -179.789 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.498 ' HA3' ' O ' ' A' ' 12' ' ' ASN . . . 159.47 -45.04 0.44 Allowed Glycine 0 N--CA 1.489 2.183 1 N-CA-C 131.612 7.405 . . . . 0.0 131.612 -177.244 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -53.88 118.81 4.27 Favored 'General case' 0 C--N 1.306 -1.296 0 C-N-CA 118.652 -1.219 . . . . 0.0 110.547 -179.582 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.72 -19.62 6.01 Favored Glycine 0 N--CA 1.48 1.582 0 C-N-CA 119.399 -1.381 . . . . 0.0 110.084 -179.389 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.451 ' O ' ' O ' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -121.15 -169.7 1.89 Allowed 'General case' 0 C--O 1.213 -0.86 0 C-N-CA 119.953 -0.699 . . . . 0.0 110.074 -179.712 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.527 ' HE3' ' HA2' ' A' ' 10' ' ' GLY . 21.0 ttpt -152.47 119.98 6.01 Favored 'General case' 0 N--CA 1.495 1.786 0 C-N-CA 118.573 -1.251 . . . . 0.0 110.978 177.193 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.56 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -83.75 165.63 18.7 Favored 'General case' 0 CA--C 1.476 -1.873 0 C-N-CA 117.6 -1.64 . . . . 0.0 111.805 179.228 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 7.5 mm -131.47 90.3 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.261 -3.252 0 CA-C-N 112.006 -2.361 . . . . 0.0 108.854 175.315 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.552 HD21 ' C ' ' A' ' 8' ' ' GLU . 2.1 pp -79.91 123.29 27.64 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 118.694 -1.202 . . . . 0.0 111.52 -177.664 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.544 ' N ' ' OD1' ' A' ' 37' ' ' ASN . . . 59.38 90.49 0.02 OUTLIER Glycine 0 N--CA 1.477 1.433 0 C-N-CA 118.992 -1.575 . . . . 0.0 109.509 179.523 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.555 ' O ' ' N ' ' A' ' 34' ' ' GLY . 67.6 m -68.45 -124.2 0.0 OUTLIER 'General case' 0 C--O 1.199 -1.557 0 C-N-CA 118.468 -1.293 . . . . 0.0 108.469 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -73.94 67.99 1.3 Allowed 'General case' 0 C--N 1.249 -3.802 0 CA-C-N 114.379 -1.282 . . . . 0.0 108.583 -174.221 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.555 ' N ' ' O ' ' A' ' 32' ' ' SER . . . 67.51 27.34 73.55 Favored Glycine 0 C--N 1.29 -2.019 0 N-CA-C 108.0 -2.04 . . . . 0.0 108.0 -177.206 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -116.47 -134.54 0.34 Allowed 'General case' 0 C--O 1.214 -0.773 0 CA-C-O 122.365 1.079 . . . . 0.0 112.599 -176.489 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 8.1 mtmp? -93.61 176.21 6.45 Favored 'General case' 0 C--N 1.271 -2.83 0 CA-C-N 112.96 -1.927 . . . . 0.0 113.603 -174.567 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.544 ' OD1' ' N ' ' A' ' 31' ' ' GLY . 3.5 m-20 -103.36 152.69 21.29 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 114.556 -1.202 . . . . 0.0 110.383 177.656 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 23.3 tt0 -161.82 156.0 22.12 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 119.302 -0.959 . . . . 0.0 110.394 176.554 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.51 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 0.1 OUTLIER -103.54 120.9 41.78 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 113.472 0.915 . . . . 0.0 113.472 179.934 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.512 ' CG2' ' N ' ' A' ' 41' ' ' THR . 2.4 p -131.44 158.75 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 CA-C-N 114.751 -1.113 . . . . 0.0 110.477 173.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.512 ' N ' ' CG2' ' A' ' 40' ' ' VAL . 0.0 OUTLIER -83.02 144.04 30.21 Favored 'General case' 0 C--N 1.278 -2.531 0 CA-C-N 114.76 -1.109 . . . . 0.0 111.755 179.995 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 177.94 -124.99 0.97 Allowed Glycine 0 N--CA 1.492 2.369 1 N-CA-C 131.092 7.197 . . . . 0.0 131.092 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -130.96 109.02 10.23 Favored 'General case' 0 N--CA 1.497 1.875 0 C-N-CA 119.998 -0.681 . . . . 0.0 110.058 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -158.12 -162.56 11.88 Favored Glycine 0 N--CA 1.494 2.535 0 C-N-CA 119.044 -1.55 . . . . 0.0 110.962 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -144.04 155.25 58.76 Favored Pre-proline 0 N--CA 1.489 1.508 0 C-N-CA 119.476 -0.89 . . . . 0.0 110.378 -179.135 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -54.46 148.8 41.31 Favored 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 121.836 1.691 . . . . 0.0 111.325 175.22 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.58 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 0.6 OUTLIER -82.7 -37.27 0.75 Allowed Pre-proline 0 CA--C 1.558 1.282 0 C-N-CA 119.462 -0.895 . . . . 0.0 112.57 178.793 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.58 ' CD ' ' N ' ' A' ' 47' ' ' GLU . 5.7 Cg_exo -61.37 141.04 91.19 Favored 'Trans proline' 0 C--O 1.214 -0.685 0 C-N-CA 120.458 0.772 . . . . 0.0 110.969 -177.528 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.5 pp0? . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 116.367 -1.778 . . . . 0.0 110.489 -179.732 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 1.9 p . . . . . 0 N--CA 1.489 1.513 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.486 HG12 ' N ' ' A' ' 3' ' ' TYR . 10.5 t -116.6 168.03 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 177.654 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.486 ' N ' HG12 ' A' ' 2' ' ' VAL . 44.5 m-85 -97.87 -168.95 1.75 Allowed 'General case' 0 C--N 1.298 -1.636 0 C-N-CA 119.095 -1.042 . . . . 0.0 110.31 -179.524 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.581 ' OG1' ' N ' ' A' ' 5' ' ' ASP . 0.1 OUTLIER -105.31 -178.36 3.63 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 179.543 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.581 ' N ' ' OG1' ' A' ' 4' ' ' THR . 0.3 OUTLIER -88.46 157.43 18.66 Favored 'General case' 0 C--N 1.287 -2.14 0 C-N-CA 118.559 -1.257 . . . . 0.0 110.297 179.543 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.408 ' SG ' ' CB ' ' A' ' 11' ' ' GLN . 1.5 m -73.17 176.7 5.63 Favored 'General case' 0 C--N 1.289 -2.056 0 CA-C-N 115.102 -0.953 . . . . 0.0 111.1 177.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.2 p -123.56 -19.38 5.85 Favored 'General case' 0 C--N 1.289 -2.054 0 CA-C-N 113.792 -1.549 . . . . 0.0 109.793 176.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.505 ' C ' HD21 ' A' ' 30' ' ' LEU . 3.5 pt-20 -163.12 163.24 25.81 Favored 'General case' 0 C--N 1.269 -2.917 0 CA-C-N 113.824 -1.535 . . . . 0.0 110.46 178.522 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.436 ' HA ' ' H ' ' A' ' 30' ' ' LEU . 0.7 OUTLIER -66.58 159.93 26.39 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.982 -177.828 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.44 -23.42 32.15 Favored Glycine 0 N--CA 1.507 3.426 0 C-N-CA 119.282 -1.437 . . . . 0.0 112.03 -179.034 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.687 HE21 ' HA ' ' A' ' 47' ' ' GLU . 4.2 mt-30 -62.22 -166.08 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.266 0 C-N-CA 119.765 -0.774 . . . . 0.0 111.163 -178.605 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.528 ' N ' ' O ' ' A' ' 45' ' ' THR . 22.5 t-20 -144.2 -78.94 0.2 Allowed 'General case' 0 N--CA 1.502 2.158 0 N-CA-C 114.629 1.344 . . . . 0.0 114.629 -176.187 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.464 ' O ' ' OE2' ' A' ' 47' ' ' GLU . 87.1 mt -75.25 48.66 0.43 Allowed 'General case' 0 C--N 1.275 -2.672 0 C-N-CA 118.597 -1.241 . . . . 0.0 111.072 -173.73 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.744 ' O ' HG22 ' A' ' 21' ' ' VAL . 7.8 p -120.91 -151.87 0.49 Allowed 'General case' 0 N--CA 1.497 1.92 0 C-N-CA 119.183 -1.007 . . . . 0.0 110.729 177.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.654 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 7.7 mt -123.6 133.21 53.98 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 114.179 -1.373 . . . . 0.0 110.395 179.266 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.7 m -120.59 -68.1 0.93 Allowed 'General case' 0 N--CA 1.503 2.181 0 C-N-CA 119.306 -0.957 . . . . 0.0 110.401 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -84.55 88.0 7.29 Favored 'General case' 0 C--N 1.298 -1.65 0 C-N-CA 119.178 -1.009 . . . . 0.0 110.143 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 70.25 -123.69 12.57 Favored Glycine 0 N--CA 1.487 2.064 0 C-N-CA 119.562 -1.304 . . . . 0.0 111.21 178.602 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.406 ' O ' ' OG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -98.87 1.93 46.19 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 121.871 0.843 . . . . 0.0 110.974 -177.713 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -79.61 128.18 33.07 Favored 'General case' 0 C--N 1.253 -3.611 0 CA-C-N 114.003 -1.453 . . . . 0.0 110.726 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.744 HG22 ' O ' ' A' ' 14' ' ' CYS . 0.9 OUTLIER -78.59 148.75 5.98 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.026 0 C-N-CA 119.088 -1.045 . . . . 0.0 109.495 179.112 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.462 ' O ' ' O ' ' A' ' 12' ' ' ASN . 3.2 m -148.13 122.84 9.89 Favored 'General case' 0 C--N 1.285 -2.218 0 C-N-CA 118.418 -1.313 . . . . 0.0 110.547 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.452 ' O ' ' O ' ' A' ' 26' ' ' ASN . . . 170.66 -87.6 0.09 OUTLIER Glycine 0 C--O 1.197 -2.173 0 C-N-CA 118.425 -1.845 . . . . 0.0 111.76 -177.743 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.447 ' N ' ' OD1' ' A' ' 12' ' ' ASN . 43.2 tt0 -40.08 128.47 2.22 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 120.08 -0.648 . . . . 0.0 111.283 -177.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.07 -24.08 17.7 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 109.012 -1.635 . . . . 0.0 109.012 -177.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.452 ' O ' ' O ' ' A' ' 23' ' ' GLY . 5.5 m120 -143.79 -162.33 1.44 Allowed 'General case' 0 N--CA 1.493 1.713 0 CA-C-N 114.773 -0.713 . . . . 0.0 109.737 179.311 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.469 ' O ' ' O ' ' A' ' 40' ' ' VAL . 0.5 OUTLIER -139.06 143.48 38.39 Favored 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 119.646 -0.822 . . . . 0.0 109.035 175.786 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -89.66 160.99 16.34 Favored 'General case' 0 C--N 1.298 -1.657 0 C-N-CA 117.719 -1.593 . . . . 0.0 111.101 179.706 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.436 ' O ' HG22 ' A' ' 29' ' ' ILE . 20.1 mm -147.54 94.28 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.255 -3.521 0 CA-C-N 112.523 -2.126 . . . . 0.0 108.496 176.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.505 HD21 ' C ' ' A' ' 8' ' ' GLU . 1.8 pp -94.38 134.18 37.16 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 118.815 -1.154 . . . . 0.0 112.501 -176.761 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.529 ' N ' ' OD1' ' A' ' 37' ' ' ASN . . . 55.64 92.66 0.01 OUTLIER Glycine 0 N--CA 1.48 1.622 0 C-N-CA 119.322 -1.418 . . . . 0.0 110.279 177.607 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.54 ' O ' ' N ' ' A' ' 34' ' ' GLY . 15.2 m -75.51 -128.54 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 118.688 -1.205 . . . . 0.0 108.604 179.2 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.435 ' OD1' ' OE2' ' A' ' 35' ' ' GLU . 10.4 p-10 -75.05 68.29 1.83 Allowed 'General case' 0 C--N 1.252 -3.657 0 CA-C-N 114.415 -1.266 . . . . 0.0 108.765 -173.261 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.54 ' N ' ' O ' ' A' ' 32' ' ' SER . . . 70.52 28.66 70.77 Favored Glycine 0 C--N 1.289 -2.05 0 N-CA-C 108.383 -1.887 . . . . 0.0 108.383 -177.751 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.435 ' OE2' ' OD1' ' A' ' 33' ' ' ASP . 13.3 mt-10 -120.42 -136.58 0.33 Allowed 'General case' 0 C--O 1.214 -0.769 0 C-N-CA 118.97 -1.092 . . . . 0.0 112.378 -177.193 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 6.1 mmtp -94.56 -179.14 4.79 Favored 'General case' 0 C--N 1.266 -3.025 0 CA-C-N 113.025 -1.898 . . . . 0.0 113.616 -173.02 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.529 ' OD1' ' N ' ' A' ' 31' ' ' GLY . 6.7 m-20 -104.56 160.46 14.92 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-N 114.43 -1.259 . . . . 0.0 111.114 179.224 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.414 ' CG ' ' N ' ' A' ' 39' ' ' CYS . 10.8 tt0 -161.71 157.49 24.48 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 119.179 -1.008 . . . . 0.0 111.11 179.574 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.414 ' N ' ' CG ' ' A' ' 38' ' ' GLN . 7.1 m -109.39 94.89 5.27 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.799 178.39 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.469 ' O ' ' O ' ' A' ' 27' ' ' LYS . 0.5 OUTLIER -102.54 145.59 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.568 0 C-N-CA 118.712 -1.195 . . . . 0.0 112.736 -177.892 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.5 t -66.18 143.85 57.01 Favored 'General case' 0 C--N 1.285 -2.235 0 CA-C-N 114.061 -1.427 . . . . 0.0 111.52 177.206 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 152.23 -159.27 28.28 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -179.595 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.401 ' O ' ' CG ' ' A' ' 43' ' ' GLU . 5.8 pt-20 -104.93 113.41 26.99 Favored 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 119.546 -0.861 . . . . 0.0 110.273 179.561 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -114.39 -168.54 16.17 Favored Glycine 0 N--CA 1.5 2.913 0 C-N-CA 120.053 -1.07 . . . . 0.0 110.555 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.528 ' O ' ' N ' ' A' ' 12' ' ' ASN . 0.5 OUTLIER -141.72 148.6 50.32 Favored Pre-proline 0 N--CA 1.493 1.676 0 C-N-CA 119.55 -0.86 . . . . 0.0 110.421 -179.767 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -57.17 167.72 3.16 Favored 'Trans proline' 0 C--O 1.214 -0.683 0 C-N-CA 121.724 1.616 . . . . 0.0 111.949 179.574 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.687 ' HA ' HE21 ' A' ' 11' ' ' GLN . 0.0 OUTLIER -79.64 159.06 72.57 Favored Pre-proline 0 N--CA 1.489 1.524 0 C-N-CA 119.544 -0.863 . . . . 0.0 109.971 179.684 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -62.79 173.22 3.89 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 121.424 1.416 . . . . 0.0 111.868 -178.288 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 . . . . . 0 N--CA 1.495 1.812 0 CA-C-O 116.364 -1.779 . . . . 0.0 110.024 178.977 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 24.9 m . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 1.5 t -79.81 169.03 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 C-N-CA 119.436 -0.906 . . . . 0.0 110.044 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -131.08 -161.91 1.17 Allowed 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 119.865 -0.734 . . . . 0.0 111.301 -178.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.07 -176.82 3.54 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.024 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.509 ' N ' ' OD1' ' A' ' 5' ' ' ASP . 0.1 OUTLIER -97.48 156.54 16.44 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.139 -1.025 . . . . 0.0 110.493 178.127 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.503 ' SG ' ' O ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -74.91 151.7 38.89 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.518 177.857 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.475 HG22 ' O ' ' A' ' 7' ' ' THR . 1.4 m -116.65 -3.94 11.73 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 119.68 -0.808 . . . . 0.0 111.114 178.88 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.509 ' HA ' HD12 ' A' ' 30' ' ' LEU . 0.2 OUTLIER -160.34 178.2 9.84 Favored 'General case' 0 C--N 1.275 -2.647 0 CA-C-N 114.785 -1.098 . . . . 0.0 110.906 -179.289 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.401 ' HB3' ' H ' ' A' ' 30' ' ' LEU . 0.3 OUTLIER -79.27 140.64 37.54 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.912 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.572 ' HA2' ' HE3' ' A' ' 27' ' ' LYS . . . 98.65 -16.97 59.03 Favored Glycine 0 N--CA 1.507 3.369 1 N-CA-C 128.641 6.216 . . . . 0.0 128.641 -174.525 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.44 ' O ' ' O ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -51.89 -169.04 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 114.471 -0.864 . . . . 0.0 110.984 179.742 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.473 ' C ' ' H ' ' A' ' 14' ' ' CYS . 15.8 t-20 -140.68 -83.22 0.23 Allowed 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 118.486 -1.286 . . . . 0.0 113.044 -179.07 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.451 ' O ' ' OE2' ' A' ' 47' ' ' GLU . 60.6 mt -75.42 45.28 0.29 Allowed 'General case' 0 C--N 1.276 -2.627 0 C-N-CA 117.71 -1.596 . . . . 0.0 109.916 -175.53 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.486 ' HB2' ' N ' ' A' ' 6' ' ' CYS . 31.1 p -109.23 -158.16 0.64 Allowed 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 119.318 -0.953 . . . . 0.0 109.362 178.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.503 ' O ' ' SG ' ' A' ' 6' ' ' CYS . 6.0 mt -124.09 129.49 50.96 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.336 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 89.8 m -120.91 -65.95 1.1 Allowed 'General case' 0 N--CA 1.502 2.127 0 C-N-CA 119.408 -0.917 . . . . 0.0 111.498 -177.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -79.56 85.48 5.3 Favored 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 118.87 -1.132 . . . . 0.0 110.816 -178.235 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 72.54 -92.55 0.6 Allowed Glycine 0 N--CA 1.491 2.326 0 C-N-CA 119.526 -1.321 . . . . 0.0 110.827 179.171 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.448 ' O ' ' OG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -133.58 4.55 3.65 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-O 122.264 1.031 . . . . 0.0 110.463 -178.931 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 28.0 m-80 -80.54 130.46 35.15 Favored 'General case' 0 C--N 1.254 -3.577 0 CA-C-N 113.485 -1.689 . . . . 0.0 109.787 178.311 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.401 HG22 ' O ' ' A' ' 14' ' ' CYS . 1.4 t -69.8 149.24 10.79 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 C-N-CA 119.195 -1.002 . . . . 0.0 110.547 -179.426 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.452 ' O ' ' O ' ' A' ' 12' ' ' ASN . 12.7 m -145.82 116.17 7.53 Favored 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 118.453 -1.299 . . . . 0.0 110.419 177.451 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 26' ' ' ASN . . . 170.39 -68.08 0.15 Allowed Glycine 0 C--O 1.203 -1.793 0 C-N-CA 118.261 -1.923 . . . . 0.0 112.598 -177.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -56.91 111.61 1.08 Allowed 'General case' 0 C--N 1.298 -1.65 0 C-N-CA 118.917 -1.113 . . . . 0.0 110.827 -177.593 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.418 ' C ' ' ND2' ' A' ' 26' ' ' ASN . . . 99.27 -14.77 60.88 Favored Glycine 0 N--CA 1.484 1.844 0 N-CA-C 109.959 -1.256 . . . . 0.0 109.959 -179.022 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.463 ' O ' ' O ' ' A' ' 23' ' ' GLY . 8.6 m-80 -149.3 -167.72 2.91 Favored 'General case' 0 N--CA 1.494 1.762 0 C-N-CA 119.255 -0.978 . . . . 0.0 111.409 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.572 ' HE3' ' HA2' ' A' ' 10' ' ' GLY . 12.6 tttp -134.61 165.17 25.84 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.155 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.513 ' N ' ' CG ' ' A' ' 27' ' ' LYS . 0.1 OUTLIER -127.4 160.3 31.83 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 118.889 -1.124 . . . . 0.0 110.686 177.968 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.444 HD13 ' O ' ' A' ' 28' ' ' CYS . 7.7 mm -138.85 126.75 27.6 Favored 'Isoleucine or valine' 0 C--N 1.255 -3.506 0 CA-C-N 113.088 -1.869 . . . . 0.0 109.639 177.625 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.509 HD12 ' HA ' ' A' ' 8' ' ' GLU . 19.5 mt -78.2 124.43 28.06 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 118.28 -1.368 . . . . 0.0 110.307 178.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 79.65 100.56 0.27 Allowed Glycine 0 C--N 1.302 -1.341 0 C-N-CA 118.996 -1.573 . . . . 0.0 110.229 178.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.558 ' O ' ' N ' ' A' ' 34' ' ' GLY . 89.8 p -80.87 -123.41 0.02 OUTLIER 'General case' 0 C--O 1.202 -1.413 0 C-N-CA 118.455 -1.298 . . . . 0.0 108.858 179.288 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.447 ' N ' ' OG ' ' A' ' 32' ' ' SER . 1.1 m-20 -73.76 64.04 0.91 Allowed 'General case' 0 C--N 1.256 -3.488 0 CA-C-N 114.577 -1.192 . . . . 0.0 109.444 -172.581 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.558 ' N ' ' O ' ' A' ' 32' ' ' SER . . . 74.06 29.42 62.7 Favored Glycine 0 C--N 1.288 -2.103 0 N-CA-C 108.48 -1.848 . . . . 0.0 108.48 -177.654 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 59.7 mm-40 -127.53 -134.25 0.24 Allowed 'General case' 0 C--O 1.213 -0.826 0 C-N-CA 118.773 -1.171 . . . . 0.0 112.495 -177.456 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 10.5 mtmm -98.17 -167.3 1.49 Allowed 'General case' 0 C--N 1.276 -2.623 0 CA-C-N 112.671 -2.059 . . . . 0.0 113.199 -175.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.5 ' N ' ' OD1' ' A' ' 37' ' ' ASN . 0.1 OUTLIER -59.75 157.23 12.43 Favored 'General case' 0 N--CA 1.485 1.307 0 CA-C-N 114.492 -1.231 . . . . 0.0 111.678 178.116 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -159.2 152.92 22.98 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.286 175.629 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 9.6 m -112.14 112.48 24.12 Favored 'General case' 0 C--N 1.298 -1.66 0 C-N-CA 119.729 -0.788 . . . . 0.0 111.737 -177.151 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.465 ' O ' ' O ' ' A' ' 27' ' ' LYS . 1.3 p -123.43 140.82 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.323 0 C-N-CA 118.745 -1.182 . . . . 0.0 112.668 177.823 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.5 t -41.28 157.44 0.02 OUTLIER 'General case' 0 C--N 1.283 -2.304 0 CA-C-N 113.371 -1.74 . . . . 0.0 111.255 178.733 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.433 ' O ' ' OE1' ' A' ' 43' ' ' GLU . . . 150.04 -120.43 1.14 Allowed Glycine 0 N--CA 1.49 2.275 1 N-CA-C 130.274 6.87 . . . . 0.0 130.274 179.557 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.433 ' OE1' ' O ' ' A' ' 42' ' ' GLY . 1.3 tp10 -154.34 104.53 2.6 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 119.37 -0.932 . . . . 0.0 109.974 179.161 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -128.57 179.94 16.29 Favored Glycine 0 N--CA 1.495 2.579 0 C-N-CA 119.867 -1.158 . . . . 0.0 110.695 -179.389 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -130.54 153.65 81.48 Favored Pre-proline 0 N--CA 1.495 1.817 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -53.16 163.97 2.02 Favored 'Trans proline' 0 C--O 1.214 -0.688 0 C-N-CA 121.153 1.236 . . . . 0.0 110.477 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.656 ' H ' ' CD ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -76.13 155.98 84.15 Favored Pre-proline 0 N--CA 1.49 1.534 0 C-N-CA 118.911 -1.116 . . . . 0.0 109.755 -179.383 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -52.69 127.67 25.38 Favored 'Trans proline' 0 C--O 1.214 -0.691 0 C-N-CA 121.497 1.465 . . . . 0.0 111.877 -177.041 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 . . . . . 0 N--CA 1.488 1.472 0 CA-C-O 116.297 -1.811 . . . . 0.0 110.227 179.343 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.571 HG13 ' O ' ' A' ' 1' ' ' VAL . 8.7 p . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.516 HG12 ' N ' ' A' ' 3' ' ' TYR . 12.8 t -136.03 169.27 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 C-N-CA 119.696 -0.802 . . . . 0.0 110.019 179.366 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.516 ' N ' HG12 ' A' ' 2' ' ' VAL . 8.4 m-85 -112.29 -166.09 1.05 Allowed 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 119.986 -0.686 . . . . 0.0 109.666 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.431 ' OG1' ' OE1' ' A' ' 47' ' ' GLU . 2.9 p -97.51 177.75 5.41 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 178.719 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.405 ' O ' ' OE2' ' A' ' 47' ' ' GLU . 0.2 OUTLIER -88.46 155.51 19.63 Favored 'General case' 0 C--N 1.293 -1.864 0 C-N-CA 118.458 -1.297 . . . . 0.0 110.066 178.583 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.42 ' SG ' ' O ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -75.4 166.66 23.26 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.693 178.108 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 14.0 p -133.95 2.33 3.37 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 119.431 -0.908 . . . . 0.0 110.39 177.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.496 ' HA ' HD12 ' A' ' 30' ' ' LEU . 0.3 OUTLIER -162.52 -178.7 6.41 Favored 'General case' 0 C--N 1.28 -2.435 0 CA-C-N 114.631 -1.168 . . . . 0.0 111.253 178.894 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -82.27 158.71 23.38 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.535 -178.215 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.498 ' N ' ' O ' ' A' ' 28' ' ' CYS . . . 82.87 -18.0 18.44 Favored Glycine 0 N--CA 1.497 2.706 0 C-N-CA 119.853 -1.165 . . . . 0.0 112.573 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -53.05 170.35 0.08 Allowed 'General case' 0 N--CA 1.501 2.12 0 C-N-CA 119.03 -1.068 . . . . 0.0 110.226 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.504 ' C ' ' H ' ' A' ' 14' ' ' CYS . 1.2 m120 -144.56 -63.42 0.36 Allowed 'General case' 0 N--CA 1.499 2.011 0 C-N-CA 118.317 -1.353 . . . . 0.0 113.433 -179.088 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 49.7 mt -76.5 41.85 0.26 Allowed 'General case' 0 C--N 1.287 -2.136 0 C-N-CA 119.011 -1.076 . . . . 0.0 109.811 -177.769 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.504 ' H ' ' C ' ' A' ' 12' ' ' ASN . 31.6 p -121.94 -157.67 0.74 Allowed 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 114.906 -1.043 . . . . 0.0 108.801 177.728 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.45 HD22 ' O ' ' A' ' 19' ' ' SER . 40.6 mt -108.7 107.12 17.45 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 115.21 -0.904 . . . . 0.0 108.679 175.553 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.407 ' HB2' ' SG ' ' A' ' 39' ' ' CYS . 68.4 m -96.32 -74.29 0.57 Allowed 'General case' 0 C--N 1.278 -2.532 0 CA-C-N 114.167 -1.379 . . . . 0.0 111.235 -174.798 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -84.73 115.62 22.79 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 118.601 -1.239 . . . . 0.0 110.102 179.373 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 66.42 -107.69 2.09 Favored Glycine 0 N--CA 1.489 2.193 0 C-N-CA 119.324 -1.417 . . . . 0.0 110.448 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.45 ' O ' HD22 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -134.6 4.68 3.38 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-O 122.197 0.999 . . . . 0.0 110.185 -179.804 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -79.13 152.87 30.51 Favored 'General case' 0 C--N 1.261 -3.281 0 CA-C-N 113.431 -1.713 . . . . 0.0 110.607 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.2 t -85.9 142.39 13.2 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 C-N-CA 119.195 -1.002 . . . . 0.0 112.117 -177.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.454 ' O ' ' O ' ' A' ' 12' ' ' ASN . 0.1 OUTLIER -99.96 150.32 22.53 Favored 'General case' 0 N--CA 1.508 2.457 0 CA-C-N 114.964 -1.016 . . . . 0.0 108.94 169.295 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.448 ' O ' ' C ' ' A' ' 24' ' ' GLN . . . -113.81 110.81 2.51 Favored Glycine 0 CA--C 1.482 -2.031 0 C-N-CA 119.652 -1.261 . . . . 0.0 110.487 -169.118 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.448 ' C ' ' O ' ' A' ' 23' ' ' GLY . 0.2 OUTLIER -32.93 117.29 0.25 Allowed 'General case' 0 C--N 1.252 -3.64 0 CA-C-N 111.974 -2.113 . . . . 0.0 109.941 175.933 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 146.28 -25.69 1.71 Allowed Glycine 0 C--N 1.283 -2.401 0 N-CA-C 105.005 -3.238 . . . . 0.0 105.005 -174.245 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.539 ' N ' ' OD1' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -110.72 -172.39 2.02 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 113.208 -1.496 . . . . 0.0 107.292 175.056 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.462 ' O ' ' O ' ' A' ' 40' ' ' VAL . 21.9 tttm -144.18 108.86 4.9 Favored 'General case' 0 N--CA 1.502 2.133 0 C-N-CA 118.512 -1.275 . . . . 0.0 110.933 178.217 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.562 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 3.6 m -84.17 152.2 24.41 Favored 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 117.722 -1.591 . . . . 0.0 110.136 178.075 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.448 HD12 ' HZ1' ' A' ' 27' ' ' LYS . 2.1 mm -127.68 131.0 70.38 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.288 0 CA-C-N 114.382 -1.281 . . . . 0.0 109.39 177.212 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.496 HD12 ' HA ' ' A' ' 8' ' ' GLU . 17.5 mt -79.03 136.3 37.15 Favored 'General case' 0 N--CA 1.497 1.909 0 C-N-CA 118.471 -1.292 . . . . 0.0 110.162 178.474 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.457 ' H ' ' C ' ' A' ' 36' ' ' LYS . . . -43.89 -78.08 0.08 OUTLIER Glycine 0 N--CA 1.487 2.06 0 C-N-CA 118.868 -1.634 . . . . 0.0 109.553 177.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.909 ' H ' ' CA ' ' A' ' 35' ' ' GLU . 1.0 OUTLIER 80.65 -54.35 0.33 Allowed 'General case' 0 CA--C 1.474 -1.975 0 CA-C-O 121.6 0.714 . . . . 0.0 109.137 177.968 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.516 ' N ' ' OG ' ' A' ' 32' ' ' SER . 1.1 t70 -78.34 4.75 12.12 Favored 'General case' 0 C--N 1.249 -3.785 0 N-CA-C 104.882 -2.266 . . . . 0.0 104.882 171.262 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.752 ' O ' ' N ' ' A' ' 36' ' ' LYS . . . -171.04 24.58 0.09 OUTLIER Glycine 0 C--N 1.29 -2.012 0 CA-C-N 111.005 -2.816 . . . . 0.0 107.949 177.634 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.909 ' CA ' ' H ' ' A' ' 32' ' ' SER . 1.8 tm-20 10.79 33.13 0.0 OUTLIER 'General case' 1 N--CA 1.56 5.061 0 CA-C-O 123.301 1.524 . . . . 0.0 115.004 -176.366 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.752 ' N ' ' O ' ' A' ' 34' ' ' GLY . 18.2 mtpt -84.96 -153.63 0.17 Allowed 'General case' 1 C--N 1.216 -5.201 0 CA-C-N 112.136 -2.302 . . . . 0.0 107.733 174.322 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -163.89 154.66 15.7 Favored 'General case' 0 C--N 1.277 -2.548 0 C-N-CA 119.244 -0.982 . . . . 0.0 111.815 178.614 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -155.37 149.72 26.01 Favored 'General case' 0 C--N 1.295 -1.782 0 CA-C-N 114.828 -1.078 . . . . 0.0 108.982 176.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.562 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 1.3 m -107.92 93.32 4.47 Favored 'General case' 0 C--N 1.296 -1.741 0 C-N-CA 119.608 -0.837 . . . . 0.0 111.2 -177.507 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.462 ' O ' ' O ' ' A' ' 27' ' ' LYS . 0.9 OUTLIER -107.7 143.41 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.31 0 C-N-CA 118.816 -1.154 . . . . 0.0 110.759 179.027 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.413 ' O ' HG22 ' A' ' 40' ' ' VAL . 7.1 t -50.94 157.89 0.77 Allowed 'General case' 0 C--N 1.274 -2.697 0 CA-C-N 114.31 -1.314 . . . . 0.0 111.036 -178.366 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 153.52 -154.97 25.86 Favored Glycine 0 N--CA 1.492 2.424 0 C-N-CA 119.528 -1.32 . . . . 0.0 110.748 179.523 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -122.83 67.52 0.97 Allowed 'General case' 0 N--CA 1.498 1.947 0 C-N-CA 120.039 -0.664 . . . . 0.0 110.215 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -74.01 173.34 50.56 Favored Glycine 0 N--CA 1.491 2.346 0 C-N-CA 119.425 -1.369 . . . . 0.0 110.523 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -106.22 145.56 31.21 Favored Pre-proline 0 N--CA 1.491 1.616 0 C-N-CA 119.679 -0.808 . . . . 0.0 109.527 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -62.63 130.85 31.15 Favored 'Trans proline' 0 C--O 1.216 -0.615 0 C-N-CA 120.901 1.067 . . . . 0.0 110.872 176.669 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.431 ' OE1' ' OG1' ' A' ' 4' ' ' THR . 1.0 OUTLIER -51.66 116.07 7.37 Favored Pre-proline 0 C--N 1.3 -1.566 0 C-N-CA 119.547 -0.861 . . . . 0.0 110.362 -179.992 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -60.44 105.46 0.3 Allowed 'Trans proline' 0 C--O 1.216 -0.606 0 C-N-CA 120.419 0.746 . . . . 0.0 111.013 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 . . . . . 0 N--CA 1.489 1.506 0 CA-C-O 116.46 -1.733 . . . . 0.0 110.436 -179.839 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.51 HG12 ' H ' ' A' ' 3' ' ' TYR . 2.7 t -103.05 171.13 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 C-N-CA 119.835 -0.746 . . . . 0.0 111.143 -178.027 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.51 ' H ' HG12 ' A' ' 2' ' ' VAL . 52.1 m-85 -123.94 -173.69 2.81 Favored 'General case' 0 N--CA 1.5 2.026 0 C-N-CA 119.931 -0.707 . . . . 0.0 110.652 179.72 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -101.52 173.0 6.63 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 115.171 -0.922 . . . . 0.0 108.557 178.241 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.531 ' N ' ' OD1' ' A' ' 5' ' ' ASP . 0.0 OUTLIER -91.06 152.23 20.72 Favored 'General case' 0 C--N 1.294 -1.826 0 C-N-CA 118.489 -1.285 . . . . 0.0 108.877 176.684 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.412 ' N ' ' HB2' ' A' ' 14' ' ' CYS . 1.3 m -75.41 179.88 4.95 Favored 'General case' 0 C--N 1.29 -2.018 0 C-N-CA 119.221 -0.992 . . . . 0.0 111.019 179.154 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.1 t -150.56 16.84 0.8 Allowed 'General case' 0 C--N 1.281 -2.412 0 CA-C-N 113.601 -1.636 . . . . 0.0 109.393 177.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -159.42 175.08 13.75 Favored 'General case' 0 C--N 1.29 -1.991 0 CA-C-N 114.443 -1.253 . . . . 0.0 110.643 -178.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -76.88 -170.27 1.56 Allowed 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.265 179.506 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.572 ' HA2' ' O ' ' A' ' 28' ' ' CYS . . . 26.1 18.23 0.0 OUTLIER Glycine 0 N--CA 1.503 3.126 1 N-CA-C 130.913 7.125 . . . . 0.0 130.913 178.974 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -87.76 -166.88 1.71 Allowed 'General case' 0 N--CA 1.503 2.216 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 176.406 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.496 ' C ' ' H ' ' A' ' 14' ' ' CYS . 10.6 m120 -151.48 -55.5 0.14 Allowed 'General case' 0 N--CA 1.503 2.183 0 N-CA-C 116.612 2.078 . . . . 0.0 116.612 -178.366 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.453 HD22 ' CZ ' ' A' ' 3' ' ' TYR . 24.3 mt -75.79 41.7 0.22 Allowed 'General case' 0 C--N 1.29 -1.981 0 C-N-CA 118.134 -1.426 . . . . 0.0 110.716 -174.469 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.699 ' O ' HG22 ' A' ' 21' ' ' VAL . 30.5 p -124.21 -148.23 0.39 Allowed 'General case' 0 C--N 1.288 -2.073 0 CA-C-N 114.817 -1.083 . . . . 0.0 108.298 176.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.437 HD12 ' OD1' ' A' ' 5' ' ' ASP . 6.2 mt -119.21 110.72 17.35 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 176.038 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.435 ' HB2' ' SG ' ' A' ' 39' ' ' CYS . 55.9 m -104.56 -61.51 1.45 Allowed 'General case' 0 C--N 1.281 -2.396 0 CA-C-N 114.009 -1.45 . . . . 0.0 112.085 -172.66 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -96.27 94.52 7.52 Favored 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 118.76 -1.176 . . . . 0.0 110.392 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 73.15 -108.93 2.64 Favored Glycine 0 N--CA 1.492 2.378 0 C-N-CA 119.467 -1.349 . . . . 0.0 110.788 179.396 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -119.29 1.82 11.31 Favored 'General case' 0 CA--C 1.492 -1.286 0 CA-C-O 122.34 1.067 . . . . 0.0 109.896 -179.358 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -78.52 127.74 32.58 Favored 'General case' 0 C--N 1.257 -3.454 0 CA-C-N 113.204 -1.816 . . . . 0.0 109.758 179.634 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.699 HG22 ' O ' ' A' ' 14' ' ' CYS . 0.9 OUTLIER -78.33 137.97 21.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 C-N-CA 118.961 -1.096 . . . . 0.0 110.103 179.736 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.549 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 0.1 OUTLIER -86.66 146.22 26.39 Favored 'General case' 0 C--N 1.283 -2.289 0 C-N-CA 118.29 -1.364 . . . . 0.0 109.589 173.186 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.444 ' O ' ' C ' ' A' ' 24' ' ' GLN . . . -116.07 104.42 1.27 Allowed Glycine 0 C--N 1.296 -1.656 0 N-CA-C 108.809 -1.716 . . . . 0.0 108.809 -174.193 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.444 ' C ' ' O ' ' A' ' 23' ' ' GLY . 1.4 tm0? -31.86 124.52 0.27 Allowed 'General case' 0 C--N 1.26 -3.29 0 CA-C-N 112.632 -1.784 . . . . 0.0 110.941 179.186 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 140.79 -23.25 2.64 Favored Glycine 0 C--N 1.29 -1.972 0 N-CA-C 105.139 -3.184 . . . . 0.0 105.139 -173.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.663 ' ND2' ' N ' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -111.41 -162.29 0.79 Allowed 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 112.907 -1.647 . . . . 0.0 107.282 175.601 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.538 ' O ' ' N ' ' A' ' 40' ' ' VAL . 14.9 tttp -144.6 147.54 33.27 Favored 'General case' 0 C--N 1.297 -1.703 0 C-N-CA 118.661 -1.216 . . . . 0.0 109.949 175.317 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.572 ' O ' ' HA2' ' A' ' 10' ' ' GLY . 56.6 m -111.99 157.53 20.61 Favored 'General case' 0 CA--C 1.483 -1.603 0 C-N-CA 118.711 -1.195 . . . . 0.0 109.775 177.29 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 11.3 mm -140.05 126.96 23.24 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.7 0 CA-C-N 114.629 -1.169 . . . . 0.0 109.954 175.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' A' ' 30' ' ' LEU . 15.3 mt -76.76 115.0 16.13 Favored 'General case' 0 N--CA 1.496 1.856 0 C-N-CA 118.671 -1.212 . . . . 0.0 110.094 178.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.737 ' HA3' ' HB2' ' A' ' 36' ' ' LYS . . . -33.83 -68.76 0.19 Allowed Glycine 0 N--CA 1.493 2.494 1 N-CA-C 128.899 6.32 . . . . 0.0 128.899 -179.402 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.493 ' O ' ' N ' ' A' ' 34' ' ' GLY . 0.8 OUTLIER -139.28 -137.99 0.13 Allowed 'General case' 0 C--O 1.203 -1.342 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 178.119 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.62 68.46 1.65 Allowed 'General case' 0 C--N 1.253 -3.612 0 CA-C-O 122.568 1.175 . . . . 0.0 109.398 -173.445 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.493 ' N ' ' O ' ' A' ' 32' ' ' SER . . . 74.28 27.43 65.98 Favored Glycine 0 C--N 1.285 -2.259 0 N-CA-C 108.073 -2.011 . . . . 0.0 108.073 -178.453 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.439 ' O ' ' O ' ' A' ' 36' ' ' LYS . 21.8 mt-10 -106.0 -117.28 0.24 Allowed 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 119.336 -0.946 . . . . 0.0 111.684 -177.227 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.737 ' HB2' ' HA3' ' A' ' 31' ' ' GLY . 0.9 OUTLIER -45.39 175.47 0.0 OUTLIER 'General case' 0 C--N 1.264 -3.119 0 CA-C-N 113.79 -1.55 . . . . 0.0 112.054 -177.556 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.495 ' OD1' ' N ' ' A' ' 38' ' ' GLN . 62.7 t-20 -174.67 133.28 0.36 Allowed 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 -178.361 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.495 ' N ' ' OD1' ' A' ' 37' ' ' ASN . 23.5 tt0 -140.59 155.75 46.48 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 119.447 -0.901 . . . . 0.0 110.773 -179.636 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.435 ' SG ' ' HB2' ' A' ' 16' ' ' CYS . 1.5 m -101.47 89.03 3.6 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 119.662 -0.815 . . . . 0.0 110.843 -179.191 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.538 ' N ' ' O ' ' A' ' 27' ' ' LYS . 0.3 OUTLIER -94.87 141.71 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.675 0 C-N-CA 118.299 -1.36 . . . . 0.0 112.029 179.835 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.413 ' O ' HG22 ' A' ' 40' ' ' VAL . 3.5 t -54.13 145.4 17.22 Favored 'General case' 0 C--N 1.276 -2.59 0 CA-C-N 114.661 -1.154 . . . . 0.0 110.633 -179.527 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 157.81 -173.43 35.12 Favored Glycine 0 N--CA 1.494 2.536 0 C-N-CA 119.164 -1.493 . . . . 0.0 110.778 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -111.23 122.16 47.16 Favored 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 120.081 -0.648 . . . . 0.0 110.362 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -138.41 -145.28 4.8 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 179.543 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -139.81 153.2 69.66 Favored Pre-proline 0 N--CA 1.491 1.607 0 C-N-CA 119.59 -0.844 . . . . 0.0 109.997 179.43 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -60.48 -169.25 0.05 OUTLIER 'Trans proline' 0 C--O 1.216 -0.622 0 C-N-CA 121.417 1.412 . . . . 0.0 111.515 178.19 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.437 ' OE2' ' O ' ' A' ' 5' ' ' ASP . 3.8 tt0 -126.97 77.06 75.52 Favored Pre-proline 0 C--N 1.312 -1.036 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.043 179.09 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -59.91 123.98 14.36 Favored 'Trans proline' 0 C--O 1.214 -0.713 0 C-N-CA 121.303 1.336 . . . . 0.0 111.412 -176.431 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 116.43 -1.748 . . . . 0.0 110.22 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.401 HG12 ' N ' ' A' ' 2' ' ' VAL . 39.6 t . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.42 HG12 ' N ' ' A' ' 3' ' ' TYR . 3.6 t -81.92 164.48 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 C-N-CA 119.087 -1.045 . . . . 0.0 110.081 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.42 ' N ' HG12 ' A' ' 2' ' ' VAL . 24.5 m-85 -150.56 -169.91 3.51 Favored 'General case' 0 C--N 1.297 -1.7 0 C-N-CA 119.774 -0.77 . . . . 0.0 109.808 179.115 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.552 ' OG1' ' N ' ' A' ' 5' ' ' ASP . 0.0 OUTLIER -109.76 174.97 5.62 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 177.891 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.552 ' N ' ' OG1' ' A' ' 4' ' ' THR . 0.2 OUTLIER -84.2 151.24 24.96 Favored 'General case' 0 C--N 1.28 -2.456 0 C-N-CA 118.106 -1.438 . . . . 0.0 110.322 -178.199 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.506 ' O ' HG23 ' A' ' 7' ' ' THR . 0.1 OUTLIER -76.65 -176.79 3.94 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-O 122.147 0.975 . . . . 0.0 111.756 178.62 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.506 HG23 ' O ' ' A' ' 6' ' ' CYS . 1.3 p -157.02 15.87 0.28 Allowed 'General case' 0 C--N 1.283 -2.292 0 CA-C-N 113.391 -1.731 . . . . 0.0 109.709 177.594 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -163.24 174.3 12.27 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-N 114.935 -1.03 . . . . 0.0 111.513 179.247 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.412 ' HB3' ' H ' ' A' ' 30' ' ' LEU . 0.4 OUTLIER -88.38 170.06 11.27 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.175 -178.21 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.456 ' O ' ' O ' ' A' ' 11' ' ' GLN . . . 73.44 -33.54 0.82 Allowed Glycine 0 N--CA 1.504 3.197 0 C-N-CA 119.668 -1.253 . . . . 0.0 112.378 177.684 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.456 ' O ' ' O ' ' A' ' 10' ' ' GLY . 43.1 mt-30 -51.8 -173.6 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.241 0 C-N-CA 119.507 -0.877 . . . . 0.0 110.153 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.502 ' C ' ' H ' ' A' ' 14' ' ' CYS . 1.6 m120 -158.85 -51.88 0.06 Allowed 'General case' 0 N--CA 1.503 2.176 0 C-N-CA 117.043 -1.863 . . . . 0.0 115.29 -179.199 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 67.1 mt -76.49 40.1 0.22 Allowed 'General case' 0 C--N 1.288 -2.091 0 C-N-CA 118.642 -1.223 . . . . 0.0 110.639 -175.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.502 ' H ' ' C ' ' A' ' 12' ' ' ASN . 10.0 p -124.76 -158.36 0.82 Allowed 'General case' 0 C--N 1.29 -1.995 0 CA-C-N 114.502 -1.226 . . . . 0.0 108.831 178.21 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 6.6 mt -109.91 116.17 31.15 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 119.65 -0.82 . . . . 0.0 110.662 178.519 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -111.93 -68.96 0.89 Allowed 'General case' 0 C--N 1.295 -1.786 0 CA-C-N 114.403 -1.271 . . . . 0.0 110.838 -177.792 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -79.38 99.01 6.97 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 119.585 -0.846 . . . . 0.0 110.376 -179.41 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.0 -113.56 5.48 Favored Glycine 0 N--CA 1.486 1.975 0 C-N-CA 119.408 -1.377 . . . . 0.0 110.451 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.422 ' O ' ' OG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -111.71 3.78 18.05 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-O 122.43 1.11 . . . . 0.0 109.694 -179.544 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -78.5 129.27 34.67 Favored 'General case' 0 C--N 1.256 -3.491 0 CA-C-N 113.229 -1.805 . . . . 0.0 110.248 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.443 HG22 ' O ' ' A' ' 14' ' ' CYS . 0.9 OUTLIER -78.36 144.06 11.77 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 C-N-CA 118.993 -1.083 . . . . 0.0 110.349 179.93 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.6 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 0.1 OUTLIER -90.97 143.97 26.15 Favored 'General case' 0 C--N 1.286 -2.166 0 C-N-CA 118.813 -1.155 . . . . 0.0 110.621 173.325 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.658 ' O ' ' N ' ' A' ' 25' ' ' GLY . . . -113.63 110.47 2.46 Favored Glycine 0 CA--C 1.486 -1.779 0 N-CA-C 107.844 -2.102 . . . . 0.0 107.844 -174.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -37.36 -5.2 0.0 OUTLIER 'General case' 0 C--N 1.254 -3.565 0 CA-C-N 112.521 -1.84 . . . . 0.0 114.491 178.576 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.658 ' N ' ' O ' ' A' ' 23' ' ' GLY . . . -69.27 -9.57 61.02 Favored Glycine 0 C--N 1.263 -3.498 0 N-CA-C 106.695 -2.562 . . . . 0.0 106.695 173.332 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 47.2 m-20 -135.41 -167.3 1.99 Allowed 'General case' 0 N--CA 1.485 1.309 0 CA-C-N 113.594 -1.303 . . . . 0.0 108.069 178.206 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.555 ' N ' ' O ' ' A' ' 40' ' ' VAL . 0.2 OUTLIER -123.12 166.84 14.51 Favored 'General case' 0 N--CA 1.503 2.217 0 C-N-CA 119.578 -0.849 . . . . 0.0 110.923 179.756 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.6 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 0.6 OUTLIER -136.34 154.89 50.71 Favored 'General case' 0 CA--C 1.472 -2.023 0 CA-C-O 122.203 1.002 . . . . 0.0 110.016 175.492 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 26.4 mm -145.56 127.78 9.19 Favored 'Isoleucine or valine' 1 C--N 1.24 -4.182 0 CA-C-N 113.083 -1.872 . . . . 0.0 109.528 177.098 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.412 ' H ' ' HB3' ' A' ' 9' ' ' SER . 17.6 mt -78.36 132.96 37.61 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 118.467 -1.293 . . . . 0.0 110.429 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.507 ' N ' ' O ' ' A' ' 36' ' ' LYS . . . -45.1 -75.52 0.17 Allowed Glycine 0 N--CA 1.486 1.973 0 C-N-CA 119.106 -1.521 . . . . 0.0 109.94 178.471 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.431 ' O ' ' N ' ' A' ' 34' ' ' GLY . 4.7 t -139.0 -137.68 0.13 Allowed 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 119.621 -0.832 . . . . 0.0 110.041 179.085 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -75.63 70.14 2.42 Favored 'General case' 0 C--N 1.252 -3.651 0 CA-C-N 113.783 -1.553 . . . . 0.0 110.415 -170.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' A' ' 32' ' ' SER . . . 75.24 21.7 77.43 Favored Glycine 0 C--N 1.281 -2.486 0 N-CA-C 108.242 -1.943 . . . . 0.0 108.242 -179.644 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 70.5 mt-10 -98.01 -115.07 0.14 Allowed 'General case' 0 C--N 1.307 -1.259 0 C-N-CA 119.171 -1.011 . . . . 0.0 110.593 -178.337 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.507 ' O ' ' N ' ' A' ' 31' ' ' GLY . 1.3 mtpp -62.79 167.23 4.76 Favored 'General case' 0 C--N 1.26 -3.313 0 CA-C-N 114.304 -1.317 . . . . 0.0 110.369 -178.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.548 ' N ' ' OD1' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -143.94 165.57 27.36 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.176 179.575 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -156.74 152.41 26.97 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 119.143 -1.023 . . . . 0.0 110.511 176.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.575 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 0.9 OUTLIER -125.42 87.65 2.74 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.562 -179.793 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.555 ' O ' ' N ' ' A' ' 27' ' ' LYS . 2.4 p -111.35 146.77 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.621 0 C-N-CA 118.447 -1.301 . . . . 0.0 112.773 -179.289 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.407 ' N ' ' CG2' ' A' ' 40' ' ' VAL . 6.1 t -43.76 161.48 0.02 OUTLIER 'General case' 0 C--N 1.285 -2.226 0 CA-C-N 113.328 -1.76 . . . . 0.0 112.035 178.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 120.93 143.55 6.76 Favored Glycine 0 N--CA 1.497 2.76 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -84.57 131.86 34.58 Favored 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 119.188 -1.005 . . . . 0.0 111.1 -178.017 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -131.79 -156.2 8.3 Favored Glycine 0 N--CA 1.496 2.668 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 179.469 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.503 ' O ' HG23 ' A' ' 45' ' ' THR . 14.4 t -102.48 127.87 29.45 Favored Pre-proline 0 N--CA 1.493 1.681 0 C-N-CA 119.476 -0.89 . . . . 0.0 110.351 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.431 ' O ' ' C ' ' A' ' 47' ' ' GLU . 1.4 Cg_endo -64.69 115.02 2.99 Favored 'Trans proline' 0 C--O 1.214 -0.687 0 C-N-CA 120.591 0.861 . . . . 0.0 110.822 178.56 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.431 ' C ' ' O ' ' A' ' 46' ' ' PRO . 1.2 tt0 -36.01 98.52 0.15 Allowed Pre-proline 0 N--CA 1.503 2.212 0 C-N-CA 120.229 -0.588 . . . . 0.0 110.702 -179.658 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -58.42 104.3 0.18 Allowed 'Trans proline' 0 C--O 1.215 -0.635 0 C-N-CA 120.778 0.985 . . . . 0.0 110.967 -177.001 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 . . . . . 0 C--N 1.302 -1.458 0 CA-C-O 116.251 -1.833 . . . . 0.0 110.41 -179.06 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 2.2 t . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.491 HG12 ' H ' ' A' ' 3' ' ' TYR . 3.4 t -84.28 169.12 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 C-N-CA 119.336 -0.945 . . . . 0.0 109.961 179.6 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.491 ' H ' HG12 ' A' ' 2' ' ' VAL . 33.1 m-85 -107.72 -167.38 1.25 Allowed 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 119.879 -0.729 . . . . 0.0 110.505 -179.46 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -96.9 176.91 5.8 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 178.831 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.537 ' N ' ' OD1' ' A' ' 5' ' ' ASP . 0.4 OUTLIER -89.96 157.09 18.0 Favored 'General case' 0 C--N 1.293 -1.856 0 C-N-CA 118.099 -1.441 . . . . 0.0 109.19 176.984 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.496 ' SG ' ' O ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -75.58 165.89 24.39 Favored 'General case' 0 C--N 1.285 -2.223 0 C-N-CA 119.745 -0.782 . . . . 0.0 110.708 178.571 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.779 ' H ' HE22 ' A' ' 11' ' ' GLN . 2.0 t -130.94 3.5 4.42 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.231 177.778 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.582 ' H ' HE22 ' A' ' 11' ' ' GLN . 2.7 mm-40 -162.34 161.55 27.53 Favored 'General case' 0 C--N 1.28 -2.456 0 CA-C-N 113.671 -1.604 . . . . 0.0 110.414 -179.672 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.462 ' HA ' ' H ' ' A' ' 30' ' ' LEU . 0.6 OUTLIER -77.24 154.84 32.61 Favored 'General case' 0 C--N 1.291 -1.962 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.323 -179.43 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.436 ' O ' ' O ' ' A' ' 11' ' ' GLN . . . 96.21 -33.47 5.59 Favored Glycine 0 N--CA 1.501 2.984 0 C-N-CA 119.27 -1.443 . . . . 0.0 112.296 -179.641 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.779 HE22 ' H ' ' A' ' 7' ' ' THR . 8.8 mt-30 -51.72 -176.63 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.181 0 C-N-CA 119.128 -1.029 . . . . 0.0 110.698 -178.475 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.517 ' O ' ' O ' ' A' ' 22' ' ' CYS . 0.4 OUTLIER -144.64 -64.4 0.35 Allowed 'General case' 0 N--CA 1.5 2.059 0 C-N-CA 118.45 -1.3 . . . . 0.0 113.97 -176.202 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 85.2 mt -76.87 50.05 0.69 Allowed 'General case' 0 C--N 1.271 -2.809 0 C-N-CA 117.596 -1.642 . . . . 0.0 110.101 -176.532 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.564 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 29.7 p -125.56 -152.01 0.5 Allowed 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.011 -0.995 . . . . 0.0 108.684 177.59 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.534 HD22 ' O ' ' A' ' 19' ' ' SER . 76.0 mt -117.37 117.23 28.94 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 115.179 -0.919 . . . . 0.0 108.918 176.365 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.564 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 1.5 m -126.36 17.35 7.67 Favored 'General case' 0 N--CA 1.498 1.958 0 C-N-CA 118.81 -1.156 . . . . 0.0 111.036 -176.294 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -152.3 83.3 1.25 Allowed 'General case' 0 C--N 1.295 -1.795 0 C-N-CA 119.662 -0.815 . . . . 0.0 108.9 178.239 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 67.32 -85.11 0.13 Allowed Glycine 0 N--CA 1.486 1.989 0 C-N-CA 119.193 -1.479 . . . . 0.0 109.727 -178.179 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.534 ' O ' HD22 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -140.42 -2.18 1.44 Allowed 'General case' 0 N--CA 1.486 1.361 0 CA-C-O 121.891 0.853 . . . . 0.0 111.14 179.363 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -82.88 144.99 29.69 Favored 'General case' 0 C--N 1.258 -3.402 0 CA-C-N 114.189 -1.369 . . . . 0.0 111.057 -179.249 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.2 t -71.96 144.8 12.83 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.523 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.545 ' O ' ' SG ' ' A' ' 28' ' ' CYS . 0.7 OUTLIER -146.4 127.47 14.64 Favored 'General case' 0 C--N 1.279 -2.487 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 177.353 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.512 ' C ' ' H ' ' A' ' 25' ' ' GLY . . . 166.82 -83.81 0.1 OUTLIER Glycine 0 N--CA 1.482 1.703 0 C-N-CA 116.465 -2.778 . . . . 0.0 113.764 -175.489 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -72.66 17.39 0.11 Allowed 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 118.712 -1.195 . . . . 0.0 112.691 -173.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.512 ' H ' ' C ' ' A' ' 23' ' ' GLY . . . -126.86 -11.35 3.59 Favored Glycine 0 C--N 1.264 -3.422 0 N-CA-C 107.937 -2.065 . . . . 0.0 107.937 173.669 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.44 ' O ' ' O ' ' A' ' 23' ' ' GLY . 1.5 m-80 -158.22 -146.65 0.16 Allowed 'General case' 0 C--O 1.213 -0.834 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 -177.786 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.579 ' N ' ' O ' ' A' ' 40' ' ' VAL . 0.0 OUTLIER -141.34 138.44 33.08 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 175.45 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.545 ' SG ' ' O ' ' A' ' 22' ' ' CYS . 36.3 m -101.82 148.6 25.11 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 118.108 -1.437 . . . . 0.0 111.808 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 35.1 mm -140.32 90.1 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.263 -3.156 0 CA-C-N 112.918 -1.947 . . . . 0.0 106.878 175.179 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.681 ' C ' HD12 ' A' ' 30' ' ' LEU . 0.4 OUTLIER -78.41 130.79 36.51 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 118.955 -1.098 . . . . 0.0 110.296 -176.245 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.499 ' H ' ' HA ' ' A' ' 37' ' ' ASN . . . 60.02 86.75 0.03 OUTLIER Glycine 0 N--CA 1.483 1.796 0 C-N-CA 119.044 -1.55 . . . . 0.0 109.466 -178.062 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.566 ' O ' ' N ' ' A' ' 34' ' ' GLY . 67.8 m -68.32 -122.94 0.0 OUTLIER 'General case' 0 C--O 1.196 -1.715 0 C-N-CA 118.594 -1.242 . . . . 0.0 108.564 -179.505 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -73.54 66.88 1.04 Allowed 'General case' 0 C--N 1.252 -3.646 0 CA-C-N 114.523 -1.217 . . . . 0.0 108.518 -174.111 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.566 ' N ' ' O ' ' A' ' 32' ' ' SER . . . 66.08 26.95 72.54 Favored Glycine 0 C--N 1.286 -2.2 0 N-CA-C 107.741 -2.143 . . . . 0.0 107.741 -176.57 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -113.62 -136.67 0.37 Allowed 'General case' 0 C--O 1.216 -0.702 0 CA-C-O 122.418 1.104 . . . . 0.0 112.042 -176.571 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 6.2 mmmt -93.46 -176.12 4.01 Favored 'General case' 0 C--N 1.267 -2.997 0 CA-C-N 112.938 -1.937 . . . . 0.0 112.181 -176.355 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.499 ' HA ' ' H ' ' A' ' 31' ' ' GLY . 1.6 m-20 -90.95 162.79 14.6 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.938 178.427 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.461 ' CG ' ' N ' ' A' ' 39' ' ' CYS . 13.7 tt0 -157.38 157.61 34.37 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 119.26 -0.976 . . . . 0.0 110.973 179.468 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.461 ' N ' ' CG ' ' A' ' 38' ' ' GLN . 82.0 m -115.82 74.33 0.89 Allowed 'General case' 0 N--CA 1.492 1.669 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.453 178.403 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.579 ' O ' ' N ' ' A' ' 27' ' ' LYS . 0.2 OUTLIER -81.01 143.21 12.69 Favored 'Isoleucine or valine' 0 C--O 1.193 -1.873 0 C-N-CA 118.684 -1.206 . . . . 0.0 111.548 -177.75 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.5 t -64.1 140.18 58.84 Favored 'General case' 0 C--N 1.272 -2.777 0 CA-C-N 114.596 -1.184 . . . . 0.0 111.551 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 163.8 -140.92 6.76 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 178.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -145.86 113.43 6.34 Favored 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 119.272 -0.971 . . . . 0.0 110.32 179.593 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -114.37 -163.37 14.58 Favored Glycine 0 N--CA 1.498 2.812 0 C-N-CA 119.966 -1.111 . . . . 0.0 110.89 -179.249 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -131.1 153.02 81.63 Favored Pre-proline 0 N--CA 1.498 1.97 0 C-N-CA 120.04 -0.664 . . . . 0.0 109.627 -179.612 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -54.12 160.18 6.65 Favored 'Trans proline' 0 C--O 1.216 -0.621 0 C-N-CA 121.604 1.536 . . . . 0.0 112.177 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.623 ' H ' ' CD ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -74.19 148.01 86.04 Favored Pre-proline 0 N--CA 1.484 1.25 0 C-N-CA 119.519 -0.872 . . . . 0.0 108.796 178.44 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_endo -61.41 123.04 12.01 Favored 'Trans proline' 0 C--O 1.214 -0.677 0 C-N-CA 120.991 1.127 . . . . 0.0 111.783 -175.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 116.308 -1.806 . . . . 0.0 110.115 178.96 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 3.9 t . . . . . 0 N--CA 1.488 1.474 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.472 HG12 ' N ' ' A' ' 3' ' ' TYR . 6.0 t -119.22 169.0 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 C-N-CA 120.016 -0.674 . . . . 0.0 109.51 178.861 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.472 ' N ' HG12 ' A' ' 2' ' ' VAL . 25.1 m-85 -130.04 -167.62 1.84 Allowed 'General case' 0 N--CA 1.497 1.89 0 C-N-CA 119.779 -0.768 . . . . 0.0 109.948 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.0 p -98.42 176.95 5.51 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 119.541 -0.864 . . . . 0.0 108.866 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -88.06 153.07 21.56 Favored 'General case' 0 C--N 1.29 -1.979 0 C-N-CA 118.468 -1.293 . . . . 0.0 110.79 179.609 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.528 ' SG ' ' CB ' ' A' ' 11' ' ' GLN . 1.2 m -74.39 179.13 4.76 Favored 'General case' 0 C--N 1.287 -2.127 0 CA-C-N 114.754 -1.112 . . . . 0.0 111.564 176.743 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -152.81 13.41 0.53 Allowed 'General case' 0 C--N 1.29 -2.018 0 CA-C-N 113.657 -1.61 . . . . 0.0 110.015 176.404 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.596 ' CG ' ' NE2' ' A' ' 11' ' ' GLN . 0.9 OUTLIER -163.5 -171.81 2.7 Favored 'General case' 0 C--N 1.286 -2.157 0 CA-C-N 114.511 -1.222 . . . . 0.0 109.947 179.271 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.496 ' HB3' ' H ' ' A' ' 30' ' ' LEU . 0.8 OUTLIER -99.91 172.99 6.89 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 119.911 -0.716 . . . . 0.0 110.707 -178.007 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.488 ' H ' HD13 ' A' ' 29' ' ' ILE . . . 63.57 22.21 65.64 Favored Glycine 0 N--CA 1.502 3.063 0 C-N-CA 119.978 -1.106 . . . . 0.0 112.661 176.709 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.596 ' NE2' ' CG ' ' A' ' 8' ' ' GLU . 0.0 OUTLIER -89.2 -166.53 1.62 Allowed 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 118.95 -1.1 . . . . 0.0 111.213 178.804 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.836 ' OD1' ' HA2' ' A' ' 23' ' ' GLY . 2.0 m-20 -153.76 -70.37 0.14 Allowed 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 118.81 -1.156 . . . . 0.0 113.265 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.408 ' HA ' HD23 ' A' ' 13' ' ' LEU . 94.4 mt -77.97 45.6 0.53 Allowed 'General case' 0 C--N 1.282 -2.343 0 C-N-CA 118.64 -1.224 . . . . 0.0 111.291 -176.235 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.476 ' SG ' ' N ' ' A' ' 15' ' ' LEU . 15.3 p -123.82 -154.88 0.63 Allowed 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 174.784 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.535 HD22 ' O ' ' A' ' 19' ' ' SER . 63.3 mt -116.62 109.8 17.69 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-N 114.654 -1.157 . . . . 0.0 108.406 176.665 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.404 ' HA ' ' ND2' ' A' ' 37' ' ' ASN . 4.7 m -104.89 -58.97 1.81 Allowed 'General case' 0 C--N 1.288 -2.099 0 C-N-CA 118.939 -1.104 . . . . 0.0 111.027 -175.53 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -83.79 85.45 7.29 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 118.363 -1.335 . . . . 0.0 109.233 177.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.53 -116.8 5.28 Favored Glycine 0 N--CA 1.489 2.191 0 C-N-CA 119.384 -1.388 . . . . 0.0 110.317 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.535 ' O ' HD22 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -109.74 1.41 19.41 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-O 122.261 1.029 . . . . 0.0 109.91 -179.581 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 32.2 m120 -79.32 139.03 37.93 Favored 'General case' 0 C--N 1.26 -3.324 0 CA-C-N 113.244 -1.798 . . . . 0.0 111.081 -178.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.6 t -74.09 142.45 14.79 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 C-N-CA 118.987 -1.085 . . . . 0.0 110.206 179.164 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.515 ' O ' ' SG ' ' A' ' 28' ' ' CYS . 4.0 m -145.55 99.25 3.26 Favored 'General case' 0 C--N 1.284 -2.264 0 C-N-CA 118.873 -1.131 . . . . 0.0 109.408 177.538 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.836 ' HA2' ' OD1' ' A' ' 12' ' ' ASN . . . -161.91 -78.33 0.03 OUTLIER Glycine 0 C--N 1.297 -1.631 1 N-CA-C 131.482 7.353 . . . . 0.0 131.482 -177.489 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.527 ' O ' ' ND2' ' A' ' 26' ' ' ASN . 21.6 tt0 -45.9 124.56 5.43 Favored 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 119.506 -0.877 . . . . 0.0 111.188 -178.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.66 -26.15 2.77 Favored Glycine 0 N--CA 1.478 1.454 0 C-N-CA 119.61 -1.281 . . . . 0.0 110.255 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.548 ' ND2' ' N ' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -110.21 -167.58 1.21 Allowed 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 119.54 -0.864 . . . . 0.0 110.726 -178.92 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.537 ' O ' ' O ' ' A' ' 40' ' ' VAL . 16.6 tttt -148.08 166.08 28.87 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 119.466 -0.894 . . . . 0.0 110.056 179.2 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.515 ' SG ' ' O ' ' A' ' 22' ' ' CYS . 59.0 m -136.06 158.89 43.31 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.261 -0.975 . . . . 0.0 110.147 176.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.488 HD13 ' H ' ' A' ' 10' ' ' GLY . 22.3 mm -142.68 136.73 27.53 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.505 0 CA-C-N 114.793 -1.094 . . . . 0.0 110.536 177.229 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.496 ' H ' ' HB3' ' A' ' 9' ' ' SER . 18.1 mt -77.48 147.35 35.92 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 119.943 -0.703 . . . . 0.0 110.967 177.34 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.402 ' H ' ' C ' ' A' ' 36' ' ' LYS . . . -125.44 -112.13 1.87 Allowed Glycine 0 N--CA 1.475 1.246 0 CA-C-N 114.538 -1.21 . . . . 0.0 110.163 175.649 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.482 ' O ' ' CA ' ' A' ' 36' ' ' LYS . 7.5 m -152.91 -136.56 0.06 Allowed 'General case' 0 C--N 1.311 -1.108 0 CA-C-O 122.567 1.175 . . . . 0.0 111.967 -178.195 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -84.77 69.03 10.65 Favored 'General case' 0 C--N 1.265 -3.077 0 CA-C-N 113.001 -1.909 . . . . 0.0 110.635 -173.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 139.87 -12.28 3.13 Favored Glycine 0 C--N 1.277 -2.725 0 N-CA-C 108.227 -1.949 . . . . 0.0 108.227 179.512 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.662 ' O ' ' N ' ' A' ' 37' ' ' ASN . 6.3 mt-10 -138.36 14.63 2.79 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-O 122.663 1.22 . . . . 0.0 108.321 179.486 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.482 ' CA ' ' O ' ' A' ' 32' ' ' SER . 0.0 OUTLIER -35.21 -20.07 0.0 OUTLIER 'General case' 0 C--N 1.249 -3.765 0 CA-C-N 111.402 -2.636 . . . . 0.0 113.209 -175.504 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.662 ' N ' ' O ' ' A' ' 35' ' ' GLU . 45.2 t-20 -174.37 131.37 0.37 Allowed 'General case' 0 C--N 1.253 -3.61 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.737 178.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.492 ' N ' ' OD1' ' A' ' 37' ' ' ASN . 13.1 tt0 -127.04 143.16 51.36 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 114.93 -1.032 . . . . 0.0 108.994 176.061 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 66.6 m -96.28 108.19 20.64 Favored 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 119.212 -0.995 . . . . 0.0 111.136 -178.707 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.537 ' O ' ' O ' ' A' ' 27' ' ' LYS . 0.2 OUTLIER -110.26 142.26 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.407 0 C-N-CA 118.908 -1.117 . . . . 0.0 111.285 177.007 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.415 ' O ' HG22 ' A' ' 40' ' ' VAL . 15.1 t -70.25 151.48 45.28 Favored 'General case' 0 C--N 1.273 -2.76 0 CA-C-N 114.692 -1.14 . . . . 0.0 110.314 178.749 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.444 ' H ' ' HA ' ' A' ' 26' ' ' ASN . . . 144.37 -116.54 0.96 Allowed Glycine 0 N--CA 1.493 2.472 1 N-CA-C 130.847 7.099 . . . . 0.0 130.847 -178.962 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 -116.26 72.61 0.82 Allowed 'General case' 0 N--CA 1.5 2.065 0 C-N-CA 119.957 -0.697 . . . . 0.0 110.556 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.441 ' O ' ' ND2' ' A' ' 12' ' ' ASN . . . -107.67 151.16 16.95 Favored Glycine 0 N--CA 1.497 2.704 0 C-N-CA 119.795 -1.193 . . . . 0.0 110.53 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -117.61 152.53 49.79 Favored Pre-proline 0 N--CA 1.496 1.839 0 C-N-CA 120.097 -0.641 . . . . 0.0 109.532 179.687 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -53.36 161.47 3.88 Favored 'Trans proline' 0 C--O 1.215 -0.629 0 C-N-CA 121.287 1.324 . . . . 0.0 111.137 177.436 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.477 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 2.6 tt0 -73.8 -45.8 6.97 Favored Pre-proline 0 C--N 1.307 -1.246 0 C-N-CA 118.987 -1.085 . . . . 0.0 111.048 178.022 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.477 ' HD2' ' N ' ' A' ' 47' ' ' GLU . 1.9 Cg_endo -64.98 139.92 63.76 Favored 'Trans proline' 0 C--O 1.214 -0.7 0 C-N-CA 120.429 0.753 . . . . 0.0 110.585 175.636 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 116.384 -1.77 . . . . 0.0 110.435 -179.882 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.525 HG13 ' O ' ' A' ' 1' ' ' VAL . 7.9 p . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -102.88 159.76 4.46 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 C-N-CA 119.937 -0.705 . . . . 0.0 109.767 179.421 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -82.53 -170.82 3.15 Favored 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 118.961 -1.096 . . . . 0.0 110.791 -179.422 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.51 ' OG1' ' N ' ' A' ' 5' ' ' ASP . 0.0 OUTLIER -118.76 -169.07 1.65 Allowed 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.35 179.608 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.51 ' N ' ' OG1' ' A' ' 4' ' ' THR . 0.0 OUTLIER -90.46 151.81 21.23 Favored 'General case' 0 C--N 1.288 -2.073 0 C-N-CA 118.774 -1.17 . . . . 0.0 111.903 -176.649 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.497 ' O ' HG23 ' A' ' 7' ' ' THR . 0.7 OUTLIER -75.57 179.48 5.3 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-N 114.215 -1.357 . . . . 0.0 112.28 177.348 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.497 HG23 ' O ' ' A' ' 6' ' ' CYS . 5.3 p -159.09 16.26 0.17 Allowed 'General case' 0 C--N 1.285 -2.204 0 CA-C-N 112.979 -1.919 . . . . 0.0 109.342 177.636 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.402 ' CG ' ' O ' ' A' ' 7' ' ' THR . 33.1 mt-10 -160.96 168.07 25.29 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 114.949 -1.023 . . . . 0.0 110.704 -178.179 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.48 ' HB3' ' H ' ' A' ' 30' ' ' LEU . 0.7 OUTLIER -88.33 159.42 18.08 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.06 -179.892 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.444 ' O ' ' O ' ' A' ' 11' ' ' GLN . . . 82.99 -28.47 3.64 Favored Glycine 0 N--CA 1.501 2.971 0 C-N-CA 119.446 -1.359 . . . . 0.0 112.531 177.862 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.453 ' O ' ' OD1' ' A' ' 12' ' ' ASN . 31.3 mt-30 -49.55 -178.59 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.13 0 C-N-CA 119.496 -0.882 . . . . 0.0 110.817 -179.059 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.688 ' C ' ' HA3' ' A' ' 23' ' ' GLY . 13.2 m-20 -143.68 -67.83 0.34 Allowed 'General case' 0 N--CA 1.501 2.108 0 C-N-CA 118.493 -1.283 . . . . 0.0 114.289 -176.031 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 94.2 mt -77.78 48.28 0.68 Allowed 'General case' 0 C--N 1.275 -2.638 0 C-N-CA 118.803 -1.159 . . . . 0.0 111.399 -175.019 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 29.4 p -122.93 -159.35 0.83 Allowed 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 119.677 -0.809 . . . . 0.0 110.566 176.214 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 64.7 mt -117.17 121.93 42.62 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.958 177.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 63.5 m -110.18 -73.47 0.68 Allowed 'General case' 0 N--CA 1.5 2.07 0 C-N-CA 119.028 -1.069 . . . . 0.0 110.883 -179.301 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -79.69 93.23 5.5 Favored 'General case' 0 C--N 1.295 -1.767 0 C-N-CA 118.828 -1.149 . . . . 0.0 110.185 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 72.83 -118.9 6.66 Favored Glycine 0 N--CA 1.488 2.143 0 C-N-CA 119.494 -1.336 . . . . 0.0 110.73 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.42 ' O ' ' OG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -110.65 4.59 20.3 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-O 122.286 1.041 . . . . 0.0 109.947 -178.918 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 61.5 m-80 -78.37 135.24 37.42 Favored 'General case' 0 C--N 1.259 -3.366 0 CA-C-N 113.2 -1.818 . . . . 0.0 110.742 -179.09 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.1 t -75.67 144.67 11.7 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 C-N-CA 119.451 -0.9 . . . . 0.0 110.754 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.463 ' O ' ' O ' ' A' ' 12' ' ' ASN . 53.8 m -141.68 99.78 3.62 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 118.768 -1.173 . . . . 0.0 110.137 176.701 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.688 ' HA3' ' C ' ' A' ' 12' ' ' ASN . . . -176.14 -42.05 0.06 OUTLIER Glycine 0 N--CA 1.487 2.043 1 N-CA-C 129.921 6.728 . . . . 0.0 129.921 -178.012 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 12.1 tt0 -86.33 118.19 25.61 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 118.879 -1.128 . . . . 0.0 109.117 177.239 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.42 -22.6 29.24 Favored Glycine 0 C--N 1.294 -1.802 0 N-CA-C 108.719 -1.753 . . . . 0.0 108.719 -176.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.455 ' O ' ' O ' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -131.72 164.79 25.17 Favored 'General case' 0 C--O 1.209 -1.077 0 C-N-CA 120.021 -0.672 . . . . 0.0 110.035 179.156 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.539 ' O ' ' O ' ' A' ' 40' ' ' VAL . 10.0 ttpt -122.12 147.87 45.6 Favored 'General case' 0 N--CA 1.506 2.37 0 C-N-CA 119.752 -0.779 . . . . 0.0 110.189 178.493 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.436 ' SG ' ' O ' ' A' ' 38' ' ' GLN . 0.7 OUTLIER -109.37 163.1 13.71 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 118.289 -1.364 . . . . 0.0 111.282 176.917 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 18.8 mm -145.49 130.07 12.3 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.355 0 CA-C-N 112.286 -2.234 . . . . 0.0 109.462 177.564 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.48 ' H ' ' HB3' ' A' ' 9' ' ' SER . 24.3 mt -77.41 115.9 17.56 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 118.518 -1.273 . . . . 0.0 109.39 178.55 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.441 ' H ' ' HA ' ' A' ' 37' ' ' ASN . . . 96.93 107.03 2.42 Favored Glycine 0 N--CA 1.479 1.518 0 C-N-CA 119.116 -1.516 . . . . 0.0 110.308 -179.416 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.561 ' N ' ' O ' ' A' ' 36' ' ' LYS . 8.9 t -76.14 -129.61 0.01 OUTLIER 'General case' 0 C--O 1.199 -1.581 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 178.25 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.408 ' OD2' ' O ' ' A' ' 33' ' ' ASP . 6.7 p-10 -74.23 65.12 1.15 Allowed 'General case' 0 C--N 1.252 -3.673 0 CA-C-N 114.902 -1.045 . . . . 0.0 108.636 -175.61 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 32' ' ' SER . . . 76.1 28.95 59.46 Favored Glycine 0 C--N 1.289 -2.056 0 N-CA-C 108.602 -1.799 . . . . 0.0 108.602 -177.518 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -127.0 -128.94 0.23 Allowed 'General case' 0 C--O 1.214 -0.783 0 C-N-CA 118.992 -1.083 . . . . 0.0 112.499 -177.386 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.561 ' O ' ' N ' ' A' ' 32' ' ' SER . 21.3 mtmt -95.36 -171.66 2.45 Favored 'General case' 0 C--N 1.277 -2.554 0 CA-C-N 113.241 -1.8 . . . . 0.0 113.145 -176.797 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.458 ' OD1' ' N ' ' A' ' 37' ' ' ASN . 1.3 m120 -49.28 161.02 0.19 Allowed 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 114.851 -1.068 . . . . 0.0 111.994 179.349 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.436 ' O ' ' SG ' ' A' ' 28' ' ' CYS . 7.0 tt0 -154.76 161.16 41.61 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.771 177.728 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.426 ' H ' ' HG3' ' A' ' 38' ' ' GLN . 62.6 m -128.3 84.08 2.21 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 120.037 -0.665 . . . . 0.0 110.445 -179.159 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.539 ' O ' ' O ' ' A' ' 27' ' ' LYS . 0.2 OUTLIER -91.69 139.17 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.606 0 C-N-CA 118.124 -1.43 . . . . 0.0 112.317 -178.722 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.42 ' O ' HG22 ' A' ' 40' ' ' VAL . 3.9 t -47.61 163.17 0.05 Allowed 'General case' 0 C--N 1.277 -2.583 0 CA-C-N 114.137 -1.392 . . . . 0.0 111.599 -178.786 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 130.36 -150.5 19.21 Favored Glycine 0 N--CA 1.492 2.43 1 N-CA-C 130.289 6.875 . . . . 0.0 130.289 -179.335 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -123.72 141.86 51.62 Favored 'General case' 0 N--CA 1.498 1.934 0 C-N-CA 119.88 -0.728 . . . . 0.0 109.958 178.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -161.4 -177.56 34.59 Favored Glycine 0 N--CA 1.487 2.085 0 C-N-CA 119.224 -1.465 . . . . 0.0 110.614 -179.586 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.424 ' O ' ' O ' ' A' ' 46' ' ' PRO . 0.4 OUTLIER -101.86 154.8 37.08 Favored Pre-proline 0 N--CA 1.49 1.559 0 C-N-CA 119.849 -0.741 . . . . 0.0 109.388 -179.701 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.424 ' O ' ' O ' ' A' ' 45' ' ' THR . 4.6 Cg_exo -54.96 -159.81 0.01 OUTLIER 'Trans proline' 0 C--O 1.213 -0.757 0 C-N-CA 121.273 1.315 . . . . 0.0 110.708 176.416 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -112.22 88.71 10.92 Favored Pre-proline 0 C--N 1.306 -1.325 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.062 179.63 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -66.27 117.94 5.11 Favored 'Trans proline' 0 C--O 1.216 -0.604 0 C-N-CA 120.913 1.075 . . . . 0.0 110.779 177.525 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 . . . . . 0 C--N 1.302 -1.477 0 CA-C-O 116.337 -1.792 . . . . 0.0 110.493 -179.724 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 5.7 m . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.418 ' H ' HG23 ' A' ' 2' ' ' VAL . 2.1 t -79.3 161.97 4.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 C-N-CA 118.994 -1.082 . . . . 0.0 109.262 179.157 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -103.75 -167.19 1.34 Allowed 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 119.443 -0.903 . . . . 0.0 111.02 -178.409 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.96 174.13 7.09 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.278 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -94.52 150.83 19.86 Favored 'General case' 0 C--N 1.296 -1.73 0 C-N-CA 118.737 -1.185 . . . . 0.0 109.833 179.182 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.518 ' SG ' ' O ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -75.86 165.94 24.26 Favored 'General case' 0 C--N 1.292 -1.93 0 C-N-CA 119.655 -0.818 . . . . 0.0 111.028 178.919 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 34.2 p -135.96 12.02 3.36 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-N 114.61 -1.177 . . . . 0.0 108.871 175.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -162.54 175.43 11.46 Favored 'General case' 0 C--N 1.284 -2.248 0 CA-C-N 114.321 -1.309 . . . . 0.0 111.729 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -85.33 154.46 21.88 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 114.816 -1.084 . . . . 0.0 110.296 -179.266 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.449 ' O ' ' O ' ' A' ' 11' ' ' GLN . . . 89.42 -21.21 30.02 Favored Glycine 0 N--CA 1.502 3.077 0 C-N-CA 119.261 -1.447 . . . . 0.0 112.855 178.124 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.449 ' O ' ' O ' ' A' ' 10' ' ' GLY . 5.2 mp0 -49.66 179.35 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.338 0 C-N-CA 118.588 -1.245 . . . . 0.0 110.187 -179.012 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.603 ' O ' ' HA3' ' A' ' 23' ' ' GLY . 15.6 t-20 -138.12 -76.49 0.38 Allowed 'General case' 0 N--CA 1.497 1.879 0 C-N-CA 118.963 -1.095 . . . . 0.0 112.438 -178.105 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 83.1 mt -78.36 47.34 0.68 Allowed 'General case' 0 C--N 1.264 -3.149 0 C-N-CA 117.968 -1.493 . . . . 0.0 110.594 -177.039 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.41 ' HB2' ' N ' ' A' ' 6' ' ' CYS . 31.9 p -117.03 -157.13 0.65 Allowed 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 119.482 -0.887 . . . . 0.0 110.13 177.492 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.518 ' O ' ' SG ' ' A' ' 6' ' ' CYS . 4.6 mt -122.8 127.98 49.83 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.371 177.266 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 82.8 m -116.35 -64.61 1.29 Allowed 'General case' 0 N--CA 1.511 2.604 0 C-N-CA 119.287 -0.965 . . . . 0.0 110.951 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 85.3 mt-10 -79.23 76.35 5.77 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 119.08 -1.048 . . . . 0.0 110.287 -178.677 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 73.77 -108.57 2.54 Favored Glycine 0 N--CA 1.488 2.144 0 C-N-CA 119.481 -1.342 . . . . 0.0 111.123 179.074 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -108.2 0.26 21.36 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 122.119 0.962 . . . . 0.0 110.773 -177.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 72.9 m-20 -79.66 127.01 31.65 Favored 'General case' 0 C--N 1.256 -3.481 0 CA-C-N 113.838 -1.528 . . . . 0.0 110.435 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.2 t -66.68 148.69 11.98 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 C-N-CA 118.835 -1.146 . . . . 0.0 109.168 178.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.513 ' O ' ' O ' ' A' ' 12' ' ' ASN . 0.0 OUTLIER -143.55 113.59 7.24 Favored 'General case' 0 C--N 1.289 -2.053 0 C-N-CA 118.802 -1.159 . . . . 0.0 110.754 -178.574 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.603 ' HA3' ' O ' ' A' ' 12' ' ' ASN . . . 162.08 -57.59 0.3 Allowed Glycine 0 N--CA 1.483 1.824 1 N-CA-C 130.29 6.876 . . . . 0.0 130.29 -178.01 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.582 ' HA ' HD21 ' A' ' 12' ' ' ASN . 15.8 tt0 -61.47 126.69 28.27 Favored 'General case' 0 C--N 1.31 -1.137 0 C-N-CA 119.037 -1.065 . . . . 0.0 110.51 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.41 -25.56 8.0 Favored Glycine 0 N--CA 1.482 1.708 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -178.232 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.484 ' OD1' ' N ' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -123.11 -167.18 1.56 Allowed 'General case' 0 C--N 1.316 -0.867 0 C-N-CA 120.322 -0.551 . . . . 0.0 110.021 179.992 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.56 ' HZ1' HD11 ' A' ' 29' ' ' ILE . 15.4 tttp -145.65 115.93 7.51 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 178.136 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.51 ' SG ' ' O ' ' A' ' 38' ' ' GLN . 0.1 OUTLIER -80.11 163.72 23.91 Favored 'General case' 0 CA--C 1.477 -1.828 0 C-N-CA 117.528 -1.669 . . . . 0.0 112.415 178.503 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.56 HD11 ' HZ1' ' A' ' 27' ' ' LYS . 18.1 mm -149.39 124.7 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.265 -3.076 0 CA-C-N 111.982 -2.372 . . . . 0.0 108.218 178.503 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.499 HD22 HD22 ' A' ' 37' ' ' ASN . 26.9 mt -77.33 137.44 38.76 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 118.337 -1.345 . . . . 0.0 110.421 -178.505 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.53 ' C ' ' H ' ' A' ' 33' ' ' ASP . . . -85.81 -86.93 0.99 Allowed Glycine 0 N--CA 1.492 2.419 0 C-N-CA 117.982 -2.056 . . . . 0.0 108.338 177.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.521 ' O ' ' N ' ' A' ' 34' ' ' GLY . 0.6 OUTLIER 73.87 -18.91 0.37 Allowed 'General case' 0 C--O 1.195 -1.788 0 C-N-CA 119.516 -0.873 . . . . 0.0 111.76 175.408 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.53 ' H ' ' C ' ' A' ' 31' ' ' GLY . 24.8 t0 -77.57 63.87 2.78 Favored 'General case' 0 C--N 1.256 -3.488 0 N-CA-C 106.544 -1.65 . . . . 0.0 106.544 -176.179 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 32' ' ' SER . . . 66.48 26.13 72.75 Favored Glycine 0 C--N 1.286 -2.199 0 N-CA-C 104.416 -3.474 . . . . 0.0 104.416 -171.213 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -140.86 170.78 15.1 Favored 'General case' 0 N--CA 1.419 -1.991 0 CA-C-O 123.345 1.545 . . . . 0.0 110.993 -174.734 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.75 170.09 9.02 Favored 'General case' 1 C--N 1.227 -4.752 0 CA-C-N 111.592 -2.549 . . . . 0.0 111.566 178.791 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.499 HD22 HD22 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -54.93 169.46 0.23 Allowed 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.647 174.676 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.51 ' O ' ' SG ' ' A' ' 28' ' ' CYS . 42.1 tt0 -157.33 152.83 26.44 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 118.791 -1.164 . . . . 0.0 111.223 178.379 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -113.1 107.24 15.67 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 115.226 -0.897 . . . . 0.0 112.058 178.804 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.483 ' CG2' ' N ' ' A' ' 41' ' ' THR . 1.6 p -110.45 155.99 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 C-N-CA 119.01 -1.076 . . . . 0.0 109.494 174.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.483 ' N ' ' CG2' ' A' ' 40' ' ' VAL . 6.0 t -78.87 152.28 31.32 Favored 'General case' 0 C--N 1.279 -2.479 0 CA-C-N 114.814 -1.084 . . . . 0.0 112.202 -177.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 153.28 -113.87 0.6 Allowed Glycine 0 N--CA 1.491 2.331 1 N-CA-C 128.945 6.338 . . . . 0.0 128.945 -179.529 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -154.62 101.34 2.32 Favored 'General case' 0 N--CA 1.494 1.753 0 C-N-CA 119.299 -0.961 . . . . 0.0 110.268 177.755 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -114.73 -165.69 15.1 Favored Glycine 0 N--CA 1.496 2.656 0 C-N-CA 120.013 -1.089 . . . . 0.0 110.579 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -134.32 148.25 66.94 Favored Pre-proline 0 N--CA 1.489 1.513 0 C-N-CA 119.965 -0.694 . . . . 0.0 110.152 -179.431 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -59.74 143.64 99.59 Favored 'Trans proline' 0 C--O 1.211 -0.83 0 C-N-CA 121.314 1.343 . . . . 0.0 110.997 176.432 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -72.31 117.65 60.51 Favored Pre-proline 0 CA--C 1.565 1.523 0 C-N-CA 119.628 -0.829 . . . . 0.0 110.588 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_endo -68.3 117.76 5.17 Favored 'Trans proline' 0 C--O 1.216 -0.596 0 C-N-CA 120.822 1.015 . . . . 0.0 111.17 178.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.494 1.768 0 CA-C-O 116.372 -1.775 . . . . 0.0 110.365 179.457 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 2.2 t . . . . . 0 N--CA 1.488 1.464 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.1 t -92.93 160.96 2.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 C-N-CA 119.205 -0.998 . . . . 0.0 110.498 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -100.48 -165.07 1.17 Allowed 'General case' 0 N--CA 1.492 1.648 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.283 179.223 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -94.18 -179.58 4.99 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.125 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 5' ' ' ASP . 0.2 OUTLIER -93.05 154.65 17.99 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 118.462 -1.295 . . . . 0.0 110.781 179.478 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.404 ' N ' ' HB2' ' A' ' 14' ' ' CYS . 1.9 m -75.41 179.17 5.38 Favored 'General case' 0 C--N 1.294 -1.841 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.056 178.226 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.3 p -134.24 -2.54 2.81 Favored 'General case' 0 C--N 1.29 -2.019 0 CA-C-N 113.904 -1.498 . . . . 0.0 109.924 176.312 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -162.84 157.04 20.83 Favored 'General case' 0 C--N 1.279 -2.493 0 CA-C-N 114.237 -1.347 . . . . 0.0 110.053 179.417 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.585 ' OG ' ' N ' ' A' ' 30' ' ' LEU . 1.4 m -62.59 -175.79 0.09 Allowed 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 119.73 -0.788 . . . . 0.0 110.496 179.237 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.442 ' O ' ' O ' ' A' ' 11' ' ' GLN . . . 73.64 -42.58 1.07 Allowed Glycine 0 N--CA 1.5 2.919 0 C-N-CA 120.111 -1.042 . . . . 0.0 112.9 178.173 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.442 ' O ' ' O ' ' A' ' 10' ' ' GLY . 2.5 mp0 -53.79 -173.02 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.607 0 C-N-CA 119.022 -1.071 . . . . 0.0 110.222 -177.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.506 ' ND2' ' O ' ' A' ' 26' ' ' ASN . 11.4 m-20 -151.59 -57.63 0.15 Allowed 'General case' 0 N--CA 1.503 2.212 0 C-N-CA 117.691 -1.604 . . . . 0.0 114.707 -177.044 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.425 HD23 ' HA ' ' A' ' 13' ' ' LEU . 15.0 mt -75.7 49.75 0.53 Allowed 'General case' 0 C--N 1.287 -2.133 0 C-N-CA 118.989 -1.085 . . . . 0.0 110.107 -176.175 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.593 ' SG ' ' N ' ' A' ' 15' ' ' LEU . 19.5 p -130.37 -142.31 0.24 Allowed 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 114.662 -1.154 . . . . 0.0 108.821 176.207 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.646 HD22 ' O ' ' A' ' 19' ' ' SER . 88.1 mt -122.9 108.8 13.39 Favored 'General case' 0 C--N 1.288 -2.083 0 CA-C-N 114.592 -1.185 . . . . 0.0 109.365 176.523 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.426 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 8.6 m -111.22 -46.74 3.27 Favored 'General case' 0 C--N 1.288 -2.068 0 CA-C-N 113.941 -1.481 . . . . 0.0 110.598 -175.382 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -87.82 73.88 9.16 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 119.17 -1.012 . . . . 0.0 109.307 178.26 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 73.39 -107.61 2.28 Favored Glycine 0 N--CA 1.489 2.195 0 C-N-CA 119.304 -1.427 . . . . 0.0 109.938 -178.785 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.646 ' O ' HD22 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -111.31 -0.13 16.49 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-O 122.337 1.065 . . . . 0.0 109.89 179.897 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -82.75 145.62 29.46 Favored 'General case' 0 C--N 1.261 -3.256 0 CA-C-N 113.201 -1.818 . . . . 0.0 111.467 -179.34 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.4 t -84.17 142.2 13.7 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.258 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.503 ' O ' ' O ' ' A' ' 12' ' ' ASN . 0.0 OUTLIER -109.85 146.44 35.07 Favored 'General case' 0 N--CA 1.504 2.229 0 N-CA-C 106.012 -1.848 . . . . 0.0 106.012 168.637 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -105.13 -154.58 22.29 Favored Glycine 0 CA--C 1.49 -1.491 0 C-N-CA 118.256 -1.926 . . . . 0.0 111.13 -173.271 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.473 ' C ' ' H ' ' A' ' 26' ' ' ASN . 4.0 tt0 -92.82 170.89 9.34 Favored 'General case' 0 C--N 1.246 -3.926 0 CA-C-N 112.075 -2.063 . . . . 0.0 109.55 -177.25 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.415 ' H ' ' HG2' ' A' ' 24' ' ' GLN . . . 81.06 -35.32 2.36 Favored Glycine 0 N--CA 1.48 1.616 0 N-CA-C 108.595 -1.802 . . . . 0.0 108.595 -177.464 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.506 ' O ' ' ND2' ' A' ' 12' ' ' ASN . 0.0 OUTLIER -100.49 173.77 6.41 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 177.542 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.563 ' CE ' HD11 ' A' ' 29' ' ' ILE . 0.1 OUTLIER -128.76 131.53 47.85 Favored 'General case' 0 N--CA 1.502 2.155 0 C-N-CA 119.461 -0.896 . . . . 0.0 111.057 -179.388 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.425 ' O ' ' N ' ' A' ' 10' ' ' GLY . 81.3 m -93.01 153.71 18.56 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 118.359 -1.336 . . . . 0.0 110.067 176.813 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.563 HD11 ' CE ' ' A' ' 27' ' ' LYS . 30.3 mm -140.77 81.04 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.265 -3.091 0 CA-C-N 114.142 -1.39 . . . . 0.0 108.869 176.512 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.617 ' C ' HD12 ' A' ' 30' ' ' LEU . 1.1 pp -78.51 133.76 37.37 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 119.257 -0.977 . . . . 0.0 110.998 -178.138 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.406 ' O ' ' O ' ' A' ' 32' ' ' SER . . . 57.15 89.58 0.01 OUTLIER Glycine 0 N--CA 1.477 1.428 0 C-N-CA 118.483 -1.818 . . . . 0.0 108.585 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.512 ' O ' ' N ' ' A' ' 34' ' ' GLY . 1.7 t -67.13 -134.0 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.468 0 C-N-CA 118.825 -1.15 . . . . 0.0 108.463 -178.0 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -75.14 65.38 1.52 Allowed 'General case' 1 C--N 1.243 -4.038 0 CA-C-N 114.727 -1.124 . . . . 0.0 108.783 -174.347 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' A' ' 32' ' ' SER . . . 78.21 25.69 61.16 Favored Glycine 0 C--N 1.286 -2.232 0 N-CA-C 108.348 -1.901 . . . . 0.0 108.348 -177.583 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -121.44 -135.19 0.31 Allowed 'General case' 0 C--O 1.215 -0.762 0 CA-C-O 122.306 1.05 . . . . 0.0 112.147 -177.086 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.413 ' O ' ' N ' ' A' ' 32' ' ' SER . 13.7 mmtm -94.39 -173.34 3.03 Favored 'General case' 0 C--N 1.272 -2.783 0 CA-C-N 113.037 -1.892 . . . . 0.0 112.787 -175.31 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.413 ' OD1' ' N ' ' A' ' 37' ' ' ASN . 4.3 m-20 -101.32 164.7 11.65 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.903 179.59 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.471 ' CG ' ' N ' ' A' ' 39' ' ' CYS . 7.0 tt0 -161.45 157.91 25.82 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.099 177.824 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.471 ' N ' ' CG ' ' A' ' 38' ' ' GLN . 0.9 OUTLIER -117.52 92.04 3.74 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 120.124 -0.63 . . . . 0.0 109.649 178.892 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.485 ' O ' ' O ' ' A' ' 27' ' ' LYS . 0.6 OUTLIER -101.23 134.33 41.76 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.267 0 C-N-CA 118.482 -1.287 . . . . 0.0 112.476 -178.417 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.427 ' O ' HG22 ' A' ' 40' ' ' VAL . 6.0 t -57.15 157.17 6.35 Favored 'General case' 0 C--N 1.273 -2.743 0 CA-C-N 113.044 -1.889 . . . . 0.0 111.019 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 148.69 -104.59 0.28 Allowed Glycine 0 N--CA 1.492 2.427 1 N-CA-C 130.866 7.106 . . . . 0.0 130.866 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -160.13 106.55 1.58 Allowed 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 119.441 -0.904 . . . . 0.0 110.368 -179.557 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -146.28 -174.63 18.59 Favored Glycine 0 N--CA 1.493 2.496 0 C-N-CA 119.548 -1.311 . . . . 0.0 110.437 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.7 t -107.47 144.77 29.89 Favored Pre-proline 0 N--CA 1.492 1.632 0 C-N-CA 119.781 -0.768 . . . . 0.0 110.37 -179.392 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -63.76 132.48 35.2 Favored 'Trans proline' 0 C--O 1.214 -0.699 0 C-N-CA 120.904 1.07 . . . . 0.0 110.53 174.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -53.15 114.79 6.45 Favored Pre-proline 0 N--CA 1.488 1.451 0 C-N-CA 119.515 -0.874 . . . . 0.0 110.703 -179.143 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -62.28 114.02 2.16 Favored 'Trans proline' 0 C--O 1.214 -0.7 0 C-N-CA 120.44 0.76 . . . . 0.0 110.991 177.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 116.412 -1.756 . . . . 0.0 110.473 -179.868 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 3.6 t . . . . . 0 N--CA 1.492 1.627 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.43 ' H ' HG23 ' A' ' 2' ' ' VAL . 1.6 t -82.09 163.77 3.05 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 C-N-CA 119.697 -0.801 . . . . 0.0 110.039 179.788 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -92.52 -164.86 1.24 Allowed 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 119.55 -0.86 . . . . 0.0 110.93 -179.375 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.1 p -93.05 180.0 5.27 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.501 ' N ' ' OD1' ' A' ' 5' ' ' ASP . 0.0 OUTLIER -92.4 151.46 20.24 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 118.997 -1.081 . . . . 0.0 110.152 178.435 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.517 ' SG ' ' O ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -75.04 165.77 24.72 Favored 'General case' 0 C--N 1.296 -1.75 0 C-N-CA 120.017 -0.673 . . . . 0.0 111.189 178.445 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.0 p -141.67 12.47 2.09 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 119.446 -0.901 . . . . 0.0 110.062 177.269 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -162.78 179.51 7.6 Favored 'General case' 0 C--N 1.287 -2.126 0 CA-C-N 114.687 -1.142 . . . . 0.0 110.826 178.246 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.462 ' HB3' ' H ' ' A' ' 30' ' ' LEU . 0.8 OUTLIER -89.81 163.91 14.85 Favored 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 119.252 -0.979 . . . . 0.0 109.741 179.849 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 71.54 14.52 74.92 Favored Glycine 0 N--CA 1.495 2.585 0 C-N-CA 119.028 -1.558 . . . . 0.0 111.777 179.563 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.7 mm-40 -74.77 -167.43 0.57 Allowed 'General case' 0 N--CA 1.498 1.958 0 C-N-CA 118.977 -1.089 . . . . 0.0 109.991 179.261 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.477 ' O ' ' O ' ' A' ' 22' ' ' CYS . 0.9 OUTLIER -155.09 -80.31 0.09 Allowed 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 117.693 -1.603 . . . . 0.0 113.554 -179.45 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 92.6 mt -77.03 51.75 0.83 Allowed 'General case' 0 C--N 1.273 -2.755 0 C-N-CA 117.815 -1.554 . . . . 0.0 109.602 -176.667 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.419 ' HB2' ' N ' ' A' ' 6' ' ' CYS . 23.1 p -122.36 -156.07 0.67 Allowed 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.754 176.486 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.517 ' O ' ' SG ' ' A' ' 6' ' ' CYS . 8.6 mt -124.68 124.52 42.36 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 114.784 -1.098 . . . . 0.0 109.917 179.025 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.2 m -108.19 -68.24 0.92 Allowed 'General case' 0 N--CA 1.504 2.227 0 C-N-CA 119.058 -1.057 . . . . 0.0 111.519 -177.829 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -87.27 91.17 8.63 Favored 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 118.701 -1.2 . . . . 0.0 110.915 -177.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.06 -98.53 1.1 Allowed Glycine 0 N--CA 1.49 2.289 0 C-N-CA 119.632 -1.27 . . . . 0.0 111.598 177.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.406 ' O ' ' OG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -129.83 5.81 5.05 Favored 'General case' 0 N--CA 1.483 1.187 0 CA-C-O 122.293 1.044 . . . . 0.0 110.224 -177.763 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.457 ' OD1' ' N ' ' A' ' 20' ' ' ASN . 4.1 m-20 -81.35 130.81 35.19 Favored 'General case' 0 C--N 1.253 -3.605 0 CA-C-N 113.438 -1.71 . . . . 0.0 110.296 178.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.6 t -75.38 146.46 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 C-N-CA 119.377 -0.929 . . . . 0.0 110.459 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.477 ' O ' ' O ' ' A' ' 12' ' ' ASN . 21.2 m -143.36 109.95 5.48 Favored 'General case' 0 N--CA 1.505 2.283 0 C-N-CA 118.587 -1.245 . . . . 0.0 110.483 177.31 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.447 ' O ' ' O ' ' A' ' 26' ' ' ASN . . . -175.91 -91.39 0.08 OUTLIER Glycine 0 C--O 1.203 -1.784 0 C-N-CA 118.331 -1.89 . . . . 0.0 112.177 -178.038 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -50.77 120.75 5.05 Favored 'General case' 0 C--N 1.297 -1.677 0 C-N-CA 119.086 -1.046 . . . . 0.0 110.548 -178.78 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.68 -26.78 21.78 Favored Glycine 0 N--CA 1.481 1.667 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -178.071 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.447 ' O ' ' O ' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -137.17 -163.81 1.49 Allowed 'General case' 0 C--N 1.313 -0.994 0 C-N-CA 120.148 -0.621 . . . . 0.0 111.122 -179.508 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.561 ' NZ ' HD11 ' A' ' 29' ' ' ILE . 16.0 ttpt -142.38 165.46 27.35 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 177.417 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -130.79 163.37 27.48 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 118.893 -1.123 . . . . 0.0 110.494 175.374 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.561 HD11 ' NZ ' ' A' ' 27' ' ' LYS . 15.4 mm -151.42 129.47 2.58 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.104 0 CA-C-N 113.176 -1.829 . . . . 0.0 109.186 179.434 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.462 ' H ' ' HB3' ' A' ' 9' ' ' SER . 29.2 mt -78.06 119.53 21.61 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 118.602 -1.239 . . . . 0.0 109.529 178.245 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.45 ' H ' ' HA ' ' A' ' 37' ' ' ASN . . . 94.64 106.74 2.02 Favored Glycine 0 N--CA 1.478 1.474 0 C-N-CA 119.027 -1.558 . . . . 0.0 110.513 -179.553 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.559 ' N ' ' O ' ' A' ' 36' ' ' LYS . 18.0 t -74.54 -128.2 0.01 OUTLIER 'General case' 0 C--O 1.197 -1.679 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -73.68 63.4 0.85 Allowed 'General case' 0 C--N 1.256 -3.458 0 CA-C-N 114.337 -1.301 . . . . 0.0 108.342 -175.773 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.555 ' N ' ' O ' ' A' ' 32' ' ' SER . . . 75.08 28.01 63.16 Favored Glycine 0 C--N 1.289 -2.034 0 N-CA-C 108.134 -1.986 . . . . 0.0 108.134 -176.483 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -123.67 -130.09 0.26 Allowed 'General case' 0 C--O 1.212 -0.87 0 C-N-CA 119.197 -1.001 . . . . 0.0 112.323 -176.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.559 ' O ' ' N ' ' A' ' 32' ' ' SER . 3.1 pttm -94.87 -172.22 2.65 Favored 'General case' 0 C--N 1.28 -2.435 0 CA-C-N 113.609 -1.632 . . . . 0.0 113.511 -177.567 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.45 ' HA ' ' H ' ' A' ' 31' ' ' GLY . 1.6 m-20 -52.52 154.53 2.54 Favored 'General case' 0 N--CA 1.502 2.133 0 CA-C-N 114.997 -1.002 . . . . 0.0 112.187 179.342 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -156.46 155.44 32.06 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 119.626 -0.829 . . . . 0.0 110.407 177.406 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 96.9 m -112.99 98.53 7.22 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 119.897 -0.721 . . . . 0.0 110.642 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.534 ' O ' ' N ' ' A' ' 27' ' ' LYS . 0.2 OUTLIER -98.48 142.78 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.237 0 C-N-CA 118.777 -1.169 . . . . 0.0 111.619 179.844 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.411 ' O ' HG22 ' A' ' 40' ' ' VAL . 1.9 t -63.42 150.04 44.54 Favored 'General case' 0 C--N 1.275 -2.636 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.949 179.685 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.416 ' H ' ' HA ' ' A' ' 26' ' ' ASN . . . 141.6 -147.54 19.12 Favored Glycine 0 N--CA 1.495 2.58 0 C-N-CA 119.697 -1.24 . . . . 0.0 110.428 -179.747 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -135.62 117.1 14.77 Favored 'General case' 0 N--CA 1.498 1.939 0 C-N-CA 119.798 -0.761 . . . . 0.0 110.349 179.61 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -113.33 177.17 17.92 Favored Glycine 0 N--CA 1.499 2.888 0 C-N-CA 119.965 -1.112 . . . . 0.0 110.409 -179.329 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.481 ' O ' HG23 ' A' ' 45' ' ' THR . 8.8 t -90.03 127.79 52.3 Favored Pre-proline 0 CA--C 1.566 1.594 0 C-N-CA 119.224 -0.99 . . . . 0.0 110.444 -179.681 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -59.78 147.84 90.65 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 121.266 1.311 . . . . 0.0 112.019 179.336 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.63 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 28.0 tt0 -84.35 -37.53 0.64 Allowed Pre-proline 0 CA--C 1.554 1.115 0 C-N-CA 119.674 -0.81 . . . . 0.0 111.896 177.523 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.63 ' CD ' ' N ' ' A' ' 47' ' ' GLU . 4.8 Cg_endo -74.85 -173.25 1.48 Allowed 'Trans proline' 0 C--O 1.213 -0.728 0 C-N-CA 121.1 1.2 . . . . 0.0 111.097 -176.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 116.761 -1.59 . . . . 0.0 109.92 179.122 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 8.9 p . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.404 HG12 ' H ' ' A' ' 3' ' ' TYR . 1.3 t -94.34 175.79 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 C-N-CA 119.643 -0.823 . . . . 0.0 109.475 179.333 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.404 ' H ' HG12 ' A' ' 2' ' ' VAL . 38.4 m-85 -132.18 -174.13 3.35 Favored 'General case' 0 N--CA 1.495 1.789 0 C-N-CA 119.525 -0.87 . . . . 0.0 110.411 179.189 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.575 ' OG1' ' N ' ' A' ' 5' ' ' ASP . 0.1 OUTLIER -101.68 -178.18 3.64 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 178.857 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.575 ' N ' ' OG1' ' A' ' 4' ' ' THR . 0.0 OUTLIER -93.05 154.03 18.36 Favored 'General case' 0 C--N 1.288 -2.078 0 C-N-CA 119.162 -1.015 . . . . 0.0 109.605 178.074 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.418 ' SG ' ' HB2' ' A' ' 11' ' ' GLN . 3.7 m -73.99 174.89 7.95 Favored 'General case' 0 C--N 1.295 -1.784 0 C-N-CA 118.944 -1.102 . . . . 0.0 110.778 177.543 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.9 t -155.13 11.88 0.35 Allowed 'General case' 0 C--N 1.276 -2.588 0 CA-C-N 113.554 -1.657 . . . . 0.0 109.806 177.108 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -154.82 173.86 15.87 Favored 'General case' 0 C--N 1.29 -1.997 0 CA-C-N 114.313 -1.312 . . . . 0.0 109.498 -177.344 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.478 ' HB3' ' H ' ' A' ' 30' ' ' LEU . 0.9 OUTLIER -89.18 157.26 18.34 Favored 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 119.325 -0.95 . . . . 0.0 109.807 179.205 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 28' ' ' CYS . . . 94.12 -51.49 2.19 Favored Glycine 0 N--CA 1.502 3.054 0 C-N-CA 119.075 -1.536 . . . . 0.0 112.396 178.156 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.462 ' H ' ' CD ' ' A' ' 11' ' ' GLN . 23.3 mp0 -40.24 164.03 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.452 0 C-N-CA 120.29 -0.564 . . . . 0.0 111.91 -176.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.497 ' ND2' ' O ' ' A' ' 26' ' ' ASN . 85.1 m-20 -140.69 -50.45 0.45 Allowed 'General case' 0 N--CA 1.507 2.409 0 C-N-CA 119.149 -1.02 . . . . 0.0 113.413 -177.407 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.428 HD12 ' HB3' ' A' ' 46' ' ' PRO . 14.7 mt -77.35 43.47 0.38 Allowed 'General case' 0 C--N 1.295 -1.787 0 C-N-CA 119.09 -1.044 . . . . 0.0 110.359 -177.389 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.654 ' SG ' ' N ' ' A' ' 15' ' ' LEU . 14.1 p -123.05 -148.44 0.4 Allowed 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 114.725 -1.125 . . . . 0.0 108.491 176.73 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.654 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 83.3 mt -116.23 98.73 6.76 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 114.497 -1.229 . . . . 0.0 107.866 173.904 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.469 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 57.6 m -95.9 -51.24 4.55 Favored 'General case' 0 C--N 1.276 -2.595 0 CA-C-N 113.429 -1.714 . . . . 0.0 110.947 -173.761 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -94.49 94.0 7.97 Favored 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 119.433 -0.907 . . . . 0.0 109.89 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 62.81 -92.7 0.09 OUTLIER Glycine 0 N--CA 1.49 2.242 0 C-N-CA 119.335 -1.412 . . . . 0.0 110.315 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.45 ' O ' HD22 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -131.15 3.05 4.31 Favored 'General case' 0 N--CA 1.483 1.219 0 CA-C-O 122.138 0.971 . . . . 0.0 110.114 -179.901 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 68.6 m-80 -79.34 140.87 37.39 Favored 'General case' 0 C--N 1.258 -3.374 0 CA-C-N 113.409 -1.723 . . . . 0.0 110.544 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.1 t -82.55 135.57 24.61 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 C-N-CA 118.875 -1.13 . . . . 0.0 111.404 -179.375 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.495 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 0.1 OUTLIER -91.19 151.52 20.91 Favored 'General case' 0 N--CA 1.513 2.708 0 C-N-CA 118.559 -1.256 . . . . 0.0 108.057 169.682 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.459 ' O ' ' OD1' ' A' ' 26' ' ' ASN . . . -118.74 124.93 6.2 Favored Glycine 0 C--O 1.213 -1.211 0 C-N-CA 119.922 -1.132 . . . . 0.0 110.42 -170.729 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.434 ' C ' ' O ' ' A' ' 23' ' ' GLY . 10.5 tt0 -36.06 132.43 0.52 Allowed 'General case' 0 C--N 1.255 -3.52 0 CA-C-N 112.652 -1.774 . . . . 0.0 110.127 178.073 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 126.6 -30.14 4.3 Favored Glycine 0 N--CA 1.482 1.715 0 N-CA-C 107.716 -2.154 . . . . 0.0 107.716 -175.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.637 ' ND2' ' N ' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -102.13 -159.77 0.75 Allowed 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 177.47 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.765 ' NZ ' HD11 ' A' ' 29' ' ' ILE . 4.8 ttpp -152.81 104.5 2.87 Favored 'General case' 0 N--CA 1.498 1.945 0 C-N-CA 119.194 -1.003 . . . . 0.0 111.594 179.593 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.515 ' O ' ' N ' ' A' ' 10' ' ' GLY . 32.5 m -79.43 157.2 27.6 Favored 'General case' 0 C--O 1.201 -1.492 0 C-N-CA 117.617 -1.633 . . . . 0.0 110.071 178.183 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.765 HD11 ' NZ ' ' A' ' 27' ' ' LYS . 28.0 mm -140.73 138.1 35.32 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.487 0 CA-C-N 114.825 -1.08 . . . . 0.0 110.173 177.414 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.478 ' H ' ' HB3' ' A' ' 9' ' ' SER . 21.1 mt -77.72 108.58 11.03 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 119.054 -1.058 . . . . 0.0 109.345 177.205 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.47 ' H ' ' HA ' ' A' ' 37' ' ' ASN . . . 105.47 110.84 3.54 Favored Glycine 0 N--CA 1.484 1.892 0 C-N-CA 119.69 -1.243 . . . . 0.0 110.513 -179.569 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.613 ' N ' ' O ' ' A' ' 36' ' ' LYS . 1.8 t -87.41 -133.92 0.08 Allowed 'General case' 0 C--O 1.203 -1.362 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.329 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -74.33 66.35 1.31 Allowed 'General case' 0 C--N 1.254 -3.582 0 CA-C-N 114.661 -1.154 . . . . 0.0 108.39 -175.525 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 32' ' ' SER . . . 76.93 28.05 59.43 Favored Glycine 0 C--N 1.288 -2.132 0 N-CA-C 108.626 -1.79 . . . . 0.0 108.626 -177.63 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 35.9 mm-40 -130.08 -132.88 0.21 Allowed 'General case' 0 C--O 1.212 -0.887 0 C-N-CA 118.999 -1.08 . . . . 0.0 112.005 -177.478 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.613 ' O ' ' N ' ' A' ' 32' ' ' SER . 8.8 mmtm -96.74 -164.24 1.13 Allowed 'General case' 0 C--N 1.278 -2.518 0 CA-C-N 112.995 -1.911 . . . . 0.0 112.88 -176.204 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.522 ' N ' ' OD1' ' A' ' 37' ' ' ASN . 0.6 OUTLIER -55.91 157.37 4.46 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.901 178.739 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -154.93 147.03 23.69 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 115.003 -0.998 . . . . 0.0 109.29 176.724 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.465 ' SG ' ' HB2' ' A' ' 16' ' ' CYS . 1.0 OUTLIER -104.15 91.34 3.9 Favored 'General case' 0 C--N 1.299 -1.604 0 C-N-CA 119.521 -0.872 . . . . 0.0 110.208 -179.984 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.573 HG22 ' N ' ' A' ' 41' ' ' THR . 3.4 p -106.76 160.15 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 C-N-CA 118.617 -1.233 . . . . 0.0 110.567 179.299 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.573 ' N ' HG22 ' A' ' 40' ' ' VAL . 8.8 t -80.14 154.81 27.79 Favored 'General case' 0 C--N 1.276 -2.606 0 CA-C-N 114.87 -1.059 . . . . 0.0 112.128 -178.613 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 166.94 -120.75 0.93 Allowed Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.906 -1.277 . . . . 0.0 109.906 178.666 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -142.98 123.74 14.19 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 119.374 -0.93 . . . . 0.0 110.109 179.145 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -142.11 -171.19 12.93 Favored Glycine 0 N--CA 1.489 2.186 1 N-CA-C 131.0 7.16 . . . . 0.0 131.0 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -136.16 154.0 77.06 Favored Pre-proline 0 N--CA 1.492 1.669 0 C-N-CA 119.904 -0.718 . . . . 0.0 109.48 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.428 ' HB3' HD12 ' A' ' 13' ' ' LEU . 5.8 Cg_exo -56.82 -175.88 0.05 OUTLIER 'Trans proline' 0 C--N 1.324 -0.719 0 C-N-CA 120.994 1.129 . . . . 0.0 110.396 175.794 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.656 ' H ' ' CD ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -83.82 158.69 61.89 Favored Pre-proline 0 C--N 1.304 -1.397 0 C-N-CA 118.814 -1.154 . . . . 0.0 109.202 178.518 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -55.4 -178.75 0.06 OUTLIER 'Trans proline' 0 C--N 1.325 -0.678 0 C-N-CA 121.119 1.213 . . . . 0.0 110.964 -178.38 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 116.278 -1.82 . . . . 0.0 110.327 -179.899 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 25.1 m . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 1.6 t -90.05 162.59 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 C-N-CA 119.623 -0.831 . . . . 0.0 110.807 -178.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -107.77 -163.96 0.93 Allowed 'General case' 0 N--CA 1.495 1.814 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.707 -179.617 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.565 ' OG1' ' N ' ' A' ' 5' ' ' ASP . 0.5 OUTLIER -127.61 -172.91 2.78 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 177.052 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.565 ' N ' ' OG1' ' A' ' 4' ' ' THR . 0.3 OUTLIER -81.3 157.53 25.08 Favored 'General case' 0 C--N 1.288 -2.067 0 C-N-CA 118.358 -1.337 . . . . 0.0 111.332 -178.693 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.402 ' N ' ' HB2' ' A' ' 14' ' ' CYS . 0.0 OUTLIER -75.83 -179.69 4.96 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.242 177.459 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.1 t -138.34 -0.85 1.96 Allowed 'General case' 0 N--CA 1.497 1.892 0 C-N-CA 119.001 -1.08 . . . . 0.0 111.408 178.128 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.463 ' HA ' HD12 ' A' ' 30' ' ' LEU . 8.8 pt-20 -163.33 169.17 19.46 Favored 'General case' 0 C--N 1.273 -2.741 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.985 177.913 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.18 149.37 44.72 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.587 -178.837 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.59 -12.15 62.98 Favored Glycine 0 N--CA 1.504 3.229 0 C-N-CA 119.473 -1.346 . . . . 0.0 112.458 179.066 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.414 ' OE1' ' CA ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -66.56 178.18 1.35 Allowed 'General case' 0 N--CA 1.503 2.203 0 C-N-CA 119.181 -1.008 . . . . 0.0 110.961 -179.043 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.72 HD21 ' HA3' ' A' ' 44' ' ' GLY . 44.5 m-20 -143.85 -72.18 0.29 Allowed 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 118.648 -1.221 . . . . 0.0 113.031 -178.472 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.425 HD12 ' HB3' ' A' ' 46' ' ' PRO . 12.9 mt -75.51 48.31 0.44 Allowed 'General case' 0 C--N 1.289 -2.042 0 C-N-CA 119.542 -0.863 . . . . 0.0 110.032 -176.488 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.438 ' H ' ' C ' ' A' ' 12' ' ' ASN . 31.5 p -122.39 -151.5 0.48 Allowed 'General case' 0 C--N 1.302 -1.5 0 CA-C-N 114.261 -1.336 . . . . 0.0 108.409 176.696 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.45 HD22 ' O ' ' A' ' 19' ' ' SER . 67.6 mt -114.63 110.93 20.52 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-N 115.097 -0.956 . . . . 0.0 108.852 175.808 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 69.7 m -107.4 -70.41 0.8 Allowed 'General case' 0 C--N 1.285 -2.21 0 CA-C-N 114.437 -1.256 . . . . 0.0 110.243 -175.639 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -79.03 89.9 4.79 Favored 'General case' 0 C--N 1.297 -1.682 0 C-N-CA 118.829 -1.149 . . . . 0.0 109.472 178.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 70.9 -127.5 15.47 Favored Glycine 0 N--CA 1.483 1.827 0 C-N-CA 119.416 -1.374 . . . . 0.0 110.032 -178.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.45 ' O ' HD22 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -101.63 2.42 38.79 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 122.279 1.038 . . . . 0.0 109.629 179.677 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -78.82 140.73 38.14 Favored 'General case' 0 C--N 1.26 -3.289 0 CA-C-N 113.227 -1.806 . . . . 0.0 110.466 -179.541 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.3 t -80.88 142.47 13.8 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.977 -178.303 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.568 ' O ' ' O ' ' A' ' 12' ' ' ASN . 0.0 OUTLIER -114.65 161.59 17.9 Favored 'General case' 0 N--CA 1.505 2.319 0 N-CA-C 104.908 -2.256 . . . . 0.0 104.908 168.849 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -137.79 -139.31 3.85 Favored Glycine 0 CA--C 1.483 -1.963 0 C-N-CA 116.809 -2.615 . . . . 0.0 112.134 -175.433 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 50.0 tp60 -91.57 150.15 21.33 Favored 'General case' 0 C--N 1.253 -3.615 0 CA-C-N 112.343 -1.929 . . . . 0.0 110.543 -174.371 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.6 -31.96 8.04 Favored Glycine 0 C--N 1.297 -1.634 0 N-CA-C 108.948 -1.661 . . . . 0.0 108.948 -177.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -109.61 -174.74 2.57 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 119.767 -0.773 . . . . 0.0 109.415 179.41 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.403 ' O ' ' O ' ' A' ' 40' ' ' VAL . 51.1 tttp -142.53 114.69 8.29 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 118.994 -1.083 . . . . 0.0 110.01 176.856 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.472 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 28.9 m -84.38 151.12 24.9 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 117.519 -1.672 . . . . 0.0 110.241 178.008 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 6.3 mm -130.23 125.01 59.05 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.748 0 CA-C-N 113.926 -1.488 . . . . 0.0 109.185 177.32 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.463 HD12 ' HA ' ' A' ' 8' ' ' GLU . 18.5 mt -76.5 133.58 39.74 Favored 'General case' 0 N--CA 1.498 1.966 0 C-N-CA 118.475 -1.29 . . . . 0.0 110.126 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 36' ' ' LYS . . . -69.44 -96.61 0.05 OUTLIER Glycine 0 N--CA 1.487 2.038 0 C-N-CA 119.162 -1.494 . . . . 0.0 110.219 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.515 ' O ' ' N ' ' A' ' 34' ' ' GLY . 3.4 m -109.96 -127.35 0.27 Allowed 'General case' 0 C--O 1.202 -1.434 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.206 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -73.97 69.29 1.42 Allowed 'General case' 0 C--N 1.255 -3.525 0 CA-C-N 114.703 -1.135 . . . . 0.0 108.723 -174.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 32' ' ' SER . . . 69.52 25.52 75.42 Favored Glycine 0 C--N 1.284 -2.344 0 N-CA-C 107.773 -2.131 . . . . 0.0 107.773 -177.471 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.527 ' O ' ' N ' ' A' ' 37' ' ' ASN . 42.7 mt-10 -91.59 -111.28 0.09 Allowed 'General case' 0 C--N 1.312 -1.044 0 C-N-CA 118.774 -1.17 . . . . 0.0 112.207 -177.083 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.506 ' O ' ' N ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -58.52 76.94 0.01 OUTLIER 'General case' 0 C--N 1.266 -3.035 0 CA-C-N 113.717 -1.583 . . . . 0.0 112.493 -175.905 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.527 ' N ' ' O ' ' A' ' 35' ' ' GLU . 3.2 m-20 -90.7 99.35 12.4 Favored 'General case' 0 C--N 1.289 -2.056 0 CA-C-N 114.378 -1.283 . . . . 0.0 109.106 176.483 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -103.26 148.61 25.61 Favored 'General case' 0 C--N 1.308 -1.217 0 C-N-CA 119.375 -0.93 . . . . 0.0 110.483 -177.609 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.472 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 1.6 m -103.38 88.5 3.12 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 119.445 -0.902 . . . . 0.0 110.844 -179.335 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.418 HG22 ' O ' ' A' ' 41' ' ' THR . 0.2 OUTLIER -97.47 139.68 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 C-N-CA 118.41 -1.316 . . . . 0.0 110.332 179.047 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.418 ' O ' HG22 ' A' ' 40' ' ' VAL . 15.2 t -53.19 152.92 4.02 Favored 'General case' 0 C--N 1.272 -2.773 0 CA-C-N 113.887 -1.506 . . . . 0.0 111.021 -178.811 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 152.19 -167.17 31.22 Favored Glycine 0 N--CA 1.49 2.296 0 C-N-CA 119.08 -1.534 . . . . 0.0 110.797 179.332 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 18.5 mp0 -83.44 -176.77 6.47 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 119.396 -0.922 . . . . 0.0 110.367 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.72 ' HA3' HD21 ' A' ' 12' ' ' ASN . . . 177.76 172.23 42.02 Favored Glycine 0 N--CA 1.486 2.031 1 N-CA-C 129.575 6.59 . . . . 0.0 129.575 179.831 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -128.45 140.87 39.63 Favored Pre-proline 0 N--CA 1.486 1.363 0 C-N-CA 119.291 -0.964 . . . . 0.0 109.925 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.425 ' HB3' HD12 ' A' ' 13' ' ' LEU . 4.9 Cg_exo -58.54 -163.16 0.02 OUTLIER 'Trans proline' 0 C--O 1.214 -0.692 0 C-N-CA 121.067 1.178 . . . . 0.0 111.059 178.124 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -119.14 96.01 49.75 Favored Pre-proline 0 C--N 1.305 -1.353 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.409 178.614 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -68.28 166.58 24.8 Favored 'Trans proline' 0 C--O 1.214 -0.704 0 C-N-CA 120.781 0.987 . . . . 0.0 110.639 -178.583 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 24.6 pt20 . . . . . 0 N--CA 1.489 1.502 0 CA-C-O 116.37 -1.776 . . . . 0.0 110.277 179.995 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 9.3 m . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.1 t -102.07 169.29 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 C-N-CA 119.849 -0.741 . . . . 0.0 110.319 -179.339 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.479 ' CE2' HD22 ' A' ' 13' ' ' LEU . 28.0 m-85 -100.32 -169.44 1.73 Allowed 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 119.487 -0.885 . . . . 0.0 110.676 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.612 ' OG1' ' N ' ' A' ' 5' ' ' ASP . 0.1 OUTLIER -108.89 -175.42 2.76 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -179.953 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.612 ' N ' ' OG1' ' A' ' 4' ' ' THR . 0.0 OUTLIER -86.13 156.86 20.18 Favored 'General case' 0 C--N 1.293 -1.878 0 C-N-CA 118.982 -1.087 . . . . 0.0 110.619 -179.615 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.6 m -73.43 178.71 4.42 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 119.541 -0.864 . . . . 0.0 110.711 176.731 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 13.3 t -146.01 4.17 0.95 Allowed 'General case' 0 C--N 1.286 -2.182 0 CA-C-N 114.391 -1.277 . . . . 0.0 110.75 177.475 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.425 ' HA ' HD12 ' A' ' 30' ' ' LEU . 2.3 mt-10 -163.96 170.49 16.6 Favored 'General case' 0 C--N 1.282 -2.358 0 CA-C-N 114.575 -1.193 . . . . 0.0 110.284 178.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.445 ' HB3' ' H ' ' A' ' 30' ' ' LEU . 0.4 OUTLIER -83.31 151.37 25.61 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 119.603 -0.839 . . . . 0.0 109.117 178.479 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.13 -1.99 71.04 Favored Glycine 0 N--CA 1.493 2.447 0 C-N-CA 119.061 -1.542 . . . . 0.0 112.839 179.047 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.24 -165.24 0.46 Allowed 'General case' 0 N--CA 1.501 2.095 0 C-N-CA 118.752 -1.179 . . . . 0.0 109.723 179.248 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.543 ' OD1' ' N ' ' A' ' 24' ' ' GLN . 12.7 t-20 -150.63 -77.33 0.14 Allowed 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 117.987 -1.485 . . . . 0.0 114.5 -177.324 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.538 ' H ' ' HA ' ' A' ' 46' ' ' PRO . 12.4 mt -76.22 53.91 0.85 Allowed 'General case' 0 C--N 1.273 -2.755 0 C-N-CA 118.557 -1.257 . . . . 0.0 110.857 -175.268 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.638 ' SG ' ' N ' ' A' ' 15' ' ' LEU . 8.8 p -123.53 -152.47 0.51 Allowed 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 114.85 -1.068 . . . . 0.0 108.802 176.012 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.638 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 51.7 mt -112.97 119.6 38.48 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 115.044 -0.98 . . . . 0.0 108.646 176.558 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.406 ' SG ' ' O ' ' A' ' 22' ' ' CYS . 1.6 m -122.47 7.91 9.57 Favored 'General case' 0 N--CA 1.502 2.138 0 C-N-CA 118.634 -1.227 . . . . 0.0 111.15 -176.715 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -157.51 82.2 0.9 Allowed 'General case' 0 C--N 1.298 -1.647 0 C-N-CA 119.412 -0.915 . . . . 0.0 109.35 177.114 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.83 -112.76 3.69 Favored Glycine 0 N--CA 1.485 1.939 0 C-N-CA 119.424 -1.369 . . . . 0.0 109.981 -178.774 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.48 0.39 14.7 Favored 'General case' 0 CA--C 1.493 -1.249 0 CA-C-O 122.336 1.065 . . . . 0.0 109.551 179.534 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 71.8 m-20 -79.52 128.78 33.79 Favored 'General case' 0 C--N 1.257 -3.435 0 CA-C-N 113.099 -1.864 . . . . 0.0 111.278 -178.46 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.5 t -69.13 143.99 14.51 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 C-N-CA 118.594 -1.242 . . . . 0.0 108.563 177.311 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.517 ' O ' ' SG ' ' A' ' 28' ' ' CYS . 0.9 OUTLIER -146.71 128.17 14.99 Favored 'General case' 0 C--N 1.272 -2.768 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 179.642 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.464 ' O ' ' O ' ' A' ' 26' ' ' ASN . . . 164.49 -79.85 0.13 Allowed Glycine 0 C--O 1.201 -1.908 0 C-N-CA 117.22 -2.419 . . . . 0.0 112.151 -176.373 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.543 ' N ' ' OD1' ' A' ' 12' ' ' ASN . 0.1 OUTLIER -44.78 125.13 4.76 Favored 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 119.647 -0.821 . . . . 0.0 111.66 -176.753 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.69 -26.2 8.6 Favored Glycine 0 N--CA 1.483 1.808 0 N-CA-C 109.899 -1.28 . . . . 0.0 109.899 -179.287 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.464 ' O ' ' O ' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -129.53 -175.95 3.75 Favored 'General case' 0 C--N 1.311 -1.074 0 C-N-CA 120.22 -0.592 . . . . 0.0 111.066 -178.871 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.45 ' O ' ' N ' ' A' ' 40' ' ' VAL . 0.0 OUTLIER -120.56 153.83 36.2 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.038 175.187 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.517 ' SG ' ' O ' ' A' ' 22' ' ' CYS . 86.1 m -120.26 146.44 46.08 Favored 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 119.169 -1.013 . . . . 0.0 109.613 174.636 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.44 HD13 ' O ' ' A' ' 28' ' ' CYS . 2.3 mm -131.99 132.29 61.39 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.953 0 CA-C-N 114.314 -1.312 . . . . 0.0 109.93 179.489 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.445 ' H ' ' HB3' ' A' ' 9' ' ' SER . 14.8 mt -76.56 121.65 23.48 Favored 'General case' 0 N--CA 1.494 1.725 0 C-N-CA 118.327 -1.349 . . . . 0.0 108.891 176.542 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -96.86 -124.69 4.8 Favored Glycine 0 C--O 1.215 -1.069 0 C-N-CA 118.537 -1.792 . . . . 0.0 111.009 -178.33 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.502 ' OG ' ' N ' ' A' ' 33' ' ' ASP . 19.7 p -152.56 -145.81 0.18 Allowed 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 122.571 1.177 . . . . 0.0 111.047 -179.328 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.502 ' N ' ' OG ' ' A' ' 32' ' ' SER . 2.5 m-20 -86.8 68.87 10.24 Favored 'General case' 0 C--N 1.261 -3.262 0 CA-C-N 112.825 -1.988 . . . . 0.0 110.729 -173.64 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 139.62 -9.82 3.16 Favored Glycine 0 C--N 1.276 -2.755 0 N-CA-C 108.14 -1.984 . . . . 0.0 108.14 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.74 ' O ' ' O ' ' A' ' 36' ' ' LYS . 3.5 mm-40 -137.94 11.04 2.87 Favored 'General case' 0 C--O 1.196 -1.721 0 CA-C-N 114.303 -0.948 . . . . 0.0 110.213 -179.813 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.74 ' O ' ' O ' ' A' ' 35' ' ' GLU . 10.2 tttp -31.42 -157.4 0.0 OUTLIER 'General case' 0 C--N 1.262 -3.197 0 O-C-N 126.446 2.341 . . . . 0.0 114.984 -173.815 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.522 ' N ' ' OD1' ' A' ' 37' ' ' ASN . 0.3 OUTLIER -55.97 114.96 2.14 Favored 'General case' 0 C--N 1.268 -2.964 0 C-N-CA 117.908 -1.517 . . . . 0.0 110.829 -176.639 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -120.78 149.56 42.36 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.144 -0.934 . . . . 0.0 109.727 178.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 3.0 m -100.33 105.73 17.28 Favored 'General case' 0 C--N 1.298 -1.658 0 C-N-CA 119.441 -0.904 . . . . 0.0 110.316 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.915 HG22 ' H ' ' A' ' 41' ' ' THR . 7.4 p -99.77 -176.81 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 C-N-CA 118.518 -1.273 . . . . 0.0 110.241 177.479 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.915 ' H ' HG22 ' A' ' 40' ' ' VAL . 12.5 t -91.67 160.05 15.56 Favored 'General case' 0 C--N 1.288 -2.068 0 CA-C-N 114.629 -1.169 . . . . 0.0 110.926 179.657 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 138.28 -147.47 19.25 Favored Glycine 0 N--CA 1.496 2.695 1 N-CA-C 131.793 7.477 . . . . 0.0 131.793 179.178 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -108.88 111.46 23.18 Favored 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 119.933 -0.707 . . . . 0.0 110.412 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -130.52 156.56 21.68 Favored Glycine 0 N--CA 1.491 2.363 1 N-CA-C 129.783 6.673 . . . . 0.0 129.783 178.858 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.462 HG23 ' O ' ' A' ' 46' ' ' PRO . 5.8 t -111.31 145.2 32.04 Favored Pre-proline 0 N--CA 1.495 1.823 0 C-N-CA 119.59 -0.844 . . . . 0.0 110.197 -178.807 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.538 ' HA ' ' H ' ' A' ' 13' ' ' LEU . 7.2 Cg_exo -52.44 -176.97 0.02 OUTLIER 'Trans proline' 0 C--O 1.211 -0.854 0 C-N-CA 120.9 1.066 . . . . 0.0 110.351 175.727 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.652 ' H ' ' CD ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -80.1 164.39 52.8 Favored Pre-proline 0 C--N 1.306 -1.322 0 C-N-CA 118.866 -1.134 . . . . 0.0 108.519 178.594 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -57.84 157.81 22.82 Favored 'Trans proline' 0 C--O 1.215 -0.673 0 C-N-CA 121.113 1.209 . . . . 0.0 111.734 -174.165 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 116.268 -1.825 . . . . 0.0 110.405 179.994 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 2.7 m . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.681 HG12 ' N ' ' A' ' 3' ' ' TYR . 38.6 t -81.93 174.97 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 C-N-CA 119.402 -0.919 . . . . 0.0 109.973 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.681 ' N ' HG12 ' A' ' 2' ' ' VAL . 35.8 m-85 -139.5 -166.24 2.02 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 119.722 -0.791 . . . . 0.0 110.125 -179.381 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -93.09 -174.95 3.71 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 119.679 -0.809 . . . . 0.0 108.858 179.064 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -100.58 154.09 18.85 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 119.03 -1.068 . . . . 0.0 110.441 179.069 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.42 ' N ' ' HB2' ' A' ' 14' ' ' CYS . 4.3 m -74.67 174.91 8.43 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-O 122.144 0.973 . . . . 0.0 111.188 178.776 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -140.26 7.49 2.19 Favored 'General case' 0 C--N 1.285 -2.232 0 CA-C-N 113.549 -1.659 . . . . 0.0 109.471 177.592 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -163.13 162.64 25.72 Favored 'General case' 0 C--N 1.279 -2.481 0 CA-C-N 113.784 -1.553 . . . . 0.0 109.0 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.604 ' OG ' ' N ' ' A' ' 30' ' ' LEU . 0.9 OUTLIER -65.1 -168.11 0.03 OUTLIER 'General case' 0 C--N 1.293 -1.876 0 C-N-CA 118.992 -1.083 . . . . 0.0 110.057 -179.087 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.508 ' H ' HD13 ' A' ' 29' ' ' ILE . . . 37.1 6.05 0.0 OUTLIER Glycine 0 N--CA 1.505 3.281 1 N-CA-C 130.124 6.81 . . . . 0.0 130.124 -179.831 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -74.79 -167.0 0.52 Allowed 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 175.747 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.466 ' O ' ' O ' ' A' ' 22' ' ' CYS . 0.7 OUTLIER -143.01 -70.24 0.33 Allowed 'General case' 0 N--CA 1.5 2.072 0 C-N-CA 117.55 -1.66 . . . . 0.0 114.987 -178.41 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.538 HD12 ' HB3' ' A' ' 46' ' ' PRO . 15.0 mt -77.67 50.45 0.83 Allowed 'General case' 0 C--N 1.27 -2.879 0 C-N-CA 117.244 -1.782 . . . . 0.0 111.111 -174.505 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.575 ' SG ' ' N ' ' A' ' 15' ' ' LEU . 15.6 p -119.76 -146.48 0.38 Allowed 'General case' 0 C--O 1.207 -1.146 0 CA-C-N 114.948 -1.023 . . . . 0.0 108.397 175.178 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.575 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 7.7 mt -128.85 130.77 47.34 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.822 177.657 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.421 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 7.9 m -139.0 21.47 2.63 Favored 'General case' 0 N--CA 1.498 1.971 0 C-N-CA 119.127 -1.029 . . . . 0.0 110.536 -179.417 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -146.41 55.16 1.14 Allowed 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 177.735 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.7 -66.92 2.01 Favored Glycine 0 N--CA 1.487 2.063 0 C-N-CA 119.479 -1.344 . . . . 0.0 110.19 -179.273 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.411 ' O ' ' OG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -144.4 1.72 1.08 Allowed 'General case' 0 C--N 1.309 -1.191 0 C-N-CA 119.445 -0.902 . . . . 0.0 111.57 -179.833 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -90.1 134.91 33.98 Favored 'General case' 0 C--N 1.253 -3.615 0 CA-C-N 114.37 -1.286 . . . . 0.0 110.464 179.033 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.567 HG22 ' O ' ' A' ' 14' ' ' CYS . 1.3 t -74.2 144.12 12.79 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 C-N-CA 119.459 -0.897 . . . . 0.0 109.718 179.693 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.466 ' O ' ' O ' ' A' ' 12' ' ' ASN . 1.2 m -141.82 121.28 13.24 Favored 'General case' 0 C--N 1.29 -1.979 0 C-N-CA 118.857 -1.137 . . . . 0.0 109.384 178.398 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.449 ' O ' ' O ' ' A' ' 26' ' ' ASN . . . 173.91 -87.69 0.08 OUTLIER Glycine 0 C--O 1.205 -1.664 0 C-N-CA 117.851 -2.119 . . . . 0.0 111.803 -176.223 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -49.8 126.49 14.08 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 119.291 -0.964 . . . . 0.0 110.491 -178.408 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.52 -26.27 14.68 Favored Glycine 0 N--CA 1.482 1.716 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -178.38 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.449 ' O ' ' O ' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -138.88 -160.9 1.11 Allowed 'General case' 0 C--N 1.311 -1.087 0 C-N-CA 119.954 -0.699 . . . . 0.0 111.139 -179.855 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.534 ' O ' ' O ' ' A' ' 40' ' ' VAL . 21.1 ttpt -148.5 148.0 29.74 Favored 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 119.66 -0.816 . . . . 0.0 109.88 177.899 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.442 ' O ' ' HA2' ' A' ' 10' ' ' GLY . 87.3 m -99.59 160.45 14.29 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 118.31 -1.356 . . . . 0.0 111.053 178.511 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.508 HD13 ' H ' ' A' ' 10' ' ' GLY . 18.5 mm -151.77 90.46 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.274 -2.705 0 CA-C-N 113.574 -1.648 . . . . 0.0 106.711 175.693 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.681 ' C ' HD12 ' A' ' 30' ' ' LEU . 3.1 pp -80.6 149.27 29.95 Favored 'General case' 0 C--N 1.288 -2.069 0 C-N-CA 118.051 -1.46 . . . . 0.0 113.359 -173.802 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.51 ' H ' ' C ' ' A' ' 36' ' ' LYS . . . -144.57 -90.3 0.11 Allowed Glycine 0 N--CA 1.492 2.418 1 N-CA-C 133.816 8.287 . . . . 0.0 133.816 -179.162 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.528 ' OG ' ' N ' ' A' ' 33' ' ' ASP . 59.6 p -149.35 -130.78 0.05 Allowed 'General case' 0 C--O 1.215 -0.75 0 CA-C-O 122.52 1.152 . . . . 0.0 113.459 -175.671 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.528 ' N ' ' OG ' ' A' ' 32' ' ' SER . 5.6 m-20 -79.32 65.75 4.57 Favored 'General case' 0 C--N 1.275 -2.672 0 CA-C-N 112.746 -2.024 . . . . 0.0 111.671 -172.763 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 127.34 -7.88 7.07 Favored Glycine 0 C--N 1.28 -2.552 0 N-CA-C 107.72 -2.152 . . . . 0.0 107.72 179.103 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.598 ' O ' ' N ' ' A' ' 37' ' ' ASN . 8.0 mt-10 -123.16 -0.54 8.86 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-N 113.618 -1.291 . . . . 0.0 109.931 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.51 ' C ' ' H ' ' A' ' 31' ' ' GLY . 0.1 OUTLIER -34.75 -31.22 0.01 OUTLIER 'General case' 0 C--N 1.27 -2.863 0 CA-C-N 112.734 -2.03 . . . . 0.0 111.397 -174.461 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.598 ' N ' ' O ' ' A' ' 35' ' ' GLU . 58.4 m-80 -160.6 108.01 1.56 Allowed 'General case' 1 C--N 1.242 -4.081 0 CA-C-N 113.895 -1.502 . . . . 0.0 110.937 176.073 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -110.41 145.32 37.79 Favored 'General case' 0 C--N 1.309 -1.183 0 C-N-CA 119.595 -0.842 . . . . 0.0 110.172 178.374 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 86.5 m -110.84 85.17 2.06 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.715 179.668 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.534 ' O ' ' O ' ' A' ' 27' ' ' LYS . 1.2 p -97.27 141.74 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 C-N-CA 118.617 -1.233 . . . . 0.0 112.704 -177.52 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.6 t -62.68 140.13 58.69 Favored 'General case' 0 C--N 1.27 -2.876 0 CA-C-N 113.807 -1.542 . . . . 0.0 110.656 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 168.87 -136.06 3.89 Favored Glycine 0 N--CA 1.493 2.456 0 C-N-CA 119.396 -1.383 . . . . 0.0 110.692 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -140.96 113.73 8.3 Favored 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 119.752 -0.779 . . . . 0.0 109.864 -179.731 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -127.54 171.13 19.01 Favored Glycine 0 N--CA 1.501 3.032 0 C-N-CA 119.725 -1.226 . . . . 0.0 111.247 -178.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -104.83 150.22 38.41 Favored Pre-proline 0 C--N 1.307 -1.254 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 179.6 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.538 ' HB3' HD12 ' A' ' 13' ' ' LEU . 3.4 Cg_exo -53.51 -164.79 0.01 OUTLIER 'Trans proline' 0 C--O 1.215 -0.641 0 C-N-CA 121.392 1.395 . . . . 0.0 111.765 177.342 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -131.76 74.54 77.45 Favored Pre-proline 0 C--N 1.308 -1.234 0 CA-C-N 115.086 -0.961 . . . . 0.0 108.648 177.553 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -60.48 135.02 58.31 Favored 'Trans proline' 0 C--O 1.215 -0.658 0 C-N-CA 121.647 1.565 . . . . 0.0 112.164 -173.174 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 . . . . . 0 N--CA 1.487 1.402 0 CA-C-O 116.261 -1.828 . . . . 0.0 110.291 179.136 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.494 HG23 ' O ' ' A' ' 1' ' ' VAL . 31.4 m . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.047 0.451 . . . . 0.0 109.799 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.2 t -101.02 6.53 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 CA-C-O 122.043 0.925 . . . . 0.0 110.272 -179.707 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.459 ' CZ ' HD22 ' A' ' 13' ' ' LEU . 36.4 m-85 -89.61 -178.29 5.51 Favored 'General case' 0 C--N 1.262 -3.235 0 CA-C-N 114.082 -1.417 . . . . 0.0 111.517 -178.563 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 23.2 p -116.38 -178.5 3.43 Favored 'General case' 0 N--CA 1.486 1.331 0 CA-C-N 114.821 -1.081 . . . . 0.0 108.857 179.19 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.1 154.23 22.18 Favored 'General case' 0 C--N 1.29 -1.998 0 C-N-CA 118.373 -1.331 . . . . 0.0 110.767 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.46 ' SG ' ' O ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -75.37 145.53 41.57 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.116 177.727 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.451 ' O ' ' OG1' ' A' ' 7' ' ' THR . 0.0 OUTLIER -114.69 8.14 16.13 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.703 -0.799 . . . . 0.0 109.506 178.525 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -162.3 171.01 17.94 Favored 'General case' 0 C--N 1.283 -2.287 0 CA-C-N 114.349 -1.296 . . . . 0.0 111.489 179.616 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -84.47 155.28 22.27 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 114.922 -1.035 . . . . 0.0 110.451 -178.901 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 87.66 -2.55 86.13 Favored Glycine 0 N--CA 1.498 2.783 0 C-N-CA 119.295 -1.431 . . . . 0.0 111.978 179.064 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -71.53 -174.91 1.18 Allowed 'General case' 0 N--CA 1.505 2.3 0 C-N-CA 119.232 -0.987 . . . . 0.0 110.219 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.741 ' O ' ' HA3' ' A' ' 23' ' ' GLY . 7.1 m120 -146.62 -71.67 0.23 Allowed 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 118.244 -1.382 . . . . 0.0 113.313 -179.106 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.699 HD12 ' HB3' ' A' ' 46' ' ' PRO . 24.6 mt -77.65 50.94 0.87 Allowed 'General case' 0 C--N 1.273 -2.718 0 C-N-CA 118.22 -1.392 . . . . 0.0 110.201 -177.618 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.432 ' HB2' ' N ' ' A' ' 6' ' ' CYS . 30.6 p -119.06 -156.44 0.65 Allowed 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.895 176.738 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.46 ' O ' ' SG ' ' A' ' 6' ' ' CYS . 6.0 mt -123.16 128.67 50.38 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 114.877 -1.056 . . . . 0.0 108.551 175.74 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 93.6 m -115.1 -44.0 3.05 Favored 'General case' 0 N--CA 1.518 2.969 0 C-N-CA 118.221 -1.391 . . . . 0.0 110.61 -179.382 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -102.19 116.25 32.26 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.058 -1.057 . . . . 0.0 110.057 178.326 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 47.87 -96.95 0.01 OUTLIER Glycine 0 N--CA 1.493 2.443 0 C-N-CA 119.546 -1.311 . . . . 0.0 111.299 179.213 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -131.44 6.72 4.47 Favored 'General case' 0 N--CA 1.485 1.32 0 CA-C-O 122.556 1.169 . . . . 0.0 110.211 -178.01 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 19.2 m-80 -80.11 132.18 35.89 Favored 'General case' 0 C--N 1.251 -3.674 0 CA-C-N 113.373 -1.739 . . . . 0.0 110.39 178.674 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.6 t -66.64 151.08 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 119.232 -0.987 . . . . 0.0 110.184 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.496 ' O ' ' O ' ' A' ' 12' ' ' ASN . 0.0 OUTLIER -150.74 112.82 4.57 Favored 'General case' 0 C--N 1.284 -2.28 0 C-N-CA 118.936 -1.106 . . . . 0.0 110.861 -179.882 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.741 ' HA3' ' O ' ' A' ' 12' ' ' ASN . . . 154.77 -45.56 0.55 Allowed Glycine 0 N--CA 1.483 1.771 1 N-CA-C 130.522 6.969 . . . . 0.0 130.522 -177.169 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.504 ' C ' ' H ' ' A' ' 26' ' ' ASN . 6.2 tp60 -56.92 133.45 54.68 Favored 'General case' 0 C--N 1.31 -1.134 0 C-N-CA 119.347 -0.941 . . . . 0.0 110.228 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 73.89 -23.8 1.07 Allowed Glycine 0 C--N 1.298 -1.578 0 C-N-CA 119.264 -1.446 . . . . 0.0 110.149 -179.423 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.537 ' O ' ' ND2' ' A' ' 12' ' ' ASN . 0.0 OUTLIER -111.14 -155.14 0.56 Allowed 'General case' 0 C--O 1.213 -0.849 0 C-N-CA 119.743 -0.783 . . . . 0.0 110.571 -179.311 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.612 ' CE ' HD11 ' A' ' 29' ' ' ILE . 0.3 OUTLIER -157.83 105.91 2.02 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.623 179.389 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.501 ' SG ' ' O ' ' A' ' 38' ' ' GLN . 0.0 OUTLIER -77.21 162.95 26.98 Favored 'General case' 0 CA--C 1.481 -1.68 0 C-N-CA 117.457 -1.697 . . . . 0.0 111.342 -179.055 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.612 HD11 ' CE ' ' A' ' 27' ' ' LYS . 23.7 mm -144.24 119.21 3.82 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.347 0 CA-C-N 112.276 -2.238 . . . . 0.0 108.273 -179.263 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 16.3 mt -78.89 146.55 33.52 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 118.199 -1.4 . . . . 0.0 112.104 -176.707 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.496 ' O ' ' C ' ' A' ' 35' ' ' GLU . . . -138.69 106.46 0.52 Allowed Glycine 0 C--O 1.199 -2.061 0 N-CA-C 104.527 -3.429 . . . . 0.0 104.527 174.525 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.528 ' O ' ' N ' ' A' ' 34' ' ' GLY . 27.0 t -136.8 2.24 2.61 Favored 'General case' 0 C--N 1.261 -3.251 0 C-N-CA 120.019 -0.673 . . . . 0.0 110.178 -177.345 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -77.58 59.39 1.94 Allowed 'General case' 0 C--N 1.272 -2.793 0 N-CA-C 105.117 -2.179 . . . . 0.0 105.117 -179.045 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 32' ' ' SER . . . 74.15 18.55 79.77 Favored Glycine 0 C--N 1.286 -2.246 0 N-CA-C 105.279 -3.128 . . . . 0.0 105.279 -169.825 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.496 ' C ' ' O ' ' A' ' 31' ' ' GLY . 54.2 mt-10 -118.88 -178.3 3.52 Favored 'General case' 0 N--CA 1.425 -1.706 0 CA-C-O 123.131 1.444 . . . . 0.0 111.288 -175.757 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.461 ' C ' ' O ' ' A' ' 31' ' ' GLY . 39.4 pttt -101.02 141.32 34.07 Favored 'General case' 0 C--N 1.246 -3.893 0 CA-C-N 112.011 -2.359 . . . . 0.0 113.919 -179.039 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.415 ' HA ' ' H ' ' A' ' 31' ' ' GLY . 65.1 m-20 -63.2 152.77 36.57 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 168.783 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.501 ' O ' ' SG ' ' A' ' 28' ' ' CYS . 61.1 tt0 -150.77 153.06 34.76 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 117.82 -1.552 . . . . 0.0 112.66 -178.151 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -108.03 114.42 28.31 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 114.602 -1.181 . . . . 0.0 112.004 179.334 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.596 HG22 ' N ' ' A' ' 41' ' ' THR . 5.8 p -128.24 158.74 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 C-N-CA 118.579 -1.248 . . . . 0.0 110.172 173.647 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.596 ' N ' HG22 ' A' ' 40' ' ' VAL . 0.5 OUTLIER -88.07 138.31 31.56 Favored 'General case' 0 C--N 1.27 -2.862 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.707 -179.876 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 178.48 -153.15 12.28 Favored Glycine 0 N--CA 1.489 2.184 0 C-N-CA 119.43 -1.367 . . . . 0.0 110.411 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -98.97 108.78 21.55 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 119.531 -0.867 . . . . 0.0 110.786 -179.463 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -129.49 170.28 20.46 Favored Glycine 0 N--CA 1.493 2.445 1 N-CA-C 129.34 6.496 . . . . 0.0 129.34 178.814 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.2 t -113.61 141.14 25.5 Favored Pre-proline 0 N--CA 1.496 1.843 0 C-N-CA 119.103 -1.039 . . . . 0.0 110.128 -179.544 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.699 ' HB3' HD12 ' A' ' 13' ' ' LEU . 9.5 Cg_endo -71.72 107.77 2.27 Favored 'Trans proline' 0 C--O 1.213 -0.755 0 C-N-CA 120.989 1.126 . . . . 0.0 110.123 174.675 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.441 ' C ' ' O ' ' A' ' 46' ' ' PRO . 3.6 tm-20 -35.02 97.07 0.12 Allowed Pre-proline 0 N--CA 1.503 2.187 0 C-N-CA 120.056 -0.658 . . . . 0.0 110.673 -179.769 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.412 ' N ' ' O ' ' A' ' 46' ' ' PRO . 1.9 Cg_endo -63.49 113.75 2.23 Favored 'Trans proline' 0 C--O 1.217 -0.565 0 C-N-CA 120.897 1.065 . . . . 0.0 111.351 -174.871 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.495 1.788 0 CA-C-O 116.269 -1.824 . . . . 0.0 110.083 179.344 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.572 HG12 ' H ' ' A' ' 3' ' ' TYR . 0.5 OUTLIER -85.46 -166.18 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 C-N-CA 119.642 -0.823 . . . . 0.0 110.573 -178.952 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.572 ' H ' HG12 ' A' ' 2' ' ' VAL . 22.4 m-85 -137.7 -164.71 1.65 Allowed 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.993 -0.683 . . . . 0.0 109.943 -179.323 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -93.98 167.49 11.57 Favored 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 119.266 -0.974 . . . . 0.0 109.281 -179.778 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.485 ' OD1' ' N ' ' A' ' 5' ' ' ASP . 0.0 OUTLIER -84.92 144.49 28.32 Favored 'General case' 0 C--N 1.291 -1.937 0 C-N-CA 118.464 -1.294 . . . . 0.0 109.979 179.599 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -72.11 -178.49 2.44 Favored 'General case' 0 C--N 1.287 -2.136 0 CA-C-O 122.147 0.975 . . . . 0.0 110.542 177.523 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.2 t -159.47 18.31 0.17 Allowed 'General case' 0 C--N 1.272 -2.784 0 CA-C-N 113.538 -1.665 . . . . 0.0 109.263 177.064 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -162.7 -178.46 6.2 Favored 'General case' 0 C--N 1.293 -1.866 0 CA-C-N 114.218 -1.355 . . . . 0.0 110.055 -178.122 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.493 ' HB3' ' H ' ' A' ' 30' ' ' LEU . 0.8 OUTLIER -98.24 166.26 11.48 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.303 -179.787 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.459 ' O ' ' O ' ' A' ' 11' ' ' GLN . . . 84.12 -43.65 3.22 Favored Glycine 0 N--CA 1.509 3.519 0 C-N-CA 119.584 -1.293 . . . . 0.0 113.235 176.819 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.459 ' O ' ' O ' ' A' ' 10' ' ' GLY . 56.4 mt-30 -47.65 178.68 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.563 0 C-N-CA 119.727 -0.789 . . . . 0.0 111.099 -177.869 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.551 ' O ' ' O ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -144.38 -59.21 0.38 Allowed 'General case' 0 N--CA 1.507 2.418 0 C-N-CA 118.16 -1.416 . . . . 0.0 114.372 -176.31 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.501 ' N ' ' CG ' ' A' ' 12' ' ' ASN . 12.7 mt -76.79 48.07 0.55 Allowed 'General case' 0 C--N 1.27 -2.866 0 C-N-CA 117.156 -1.818 . . . . 0.0 110.995 -176.269 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.586 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 25.0 p -123.38 -160.24 0.89 Allowed 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 176.325 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.496 HD22 ' O ' ' A' ' 19' ' ' SER . 70.6 mt -109.03 110.29 21.53 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 176.232 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.586 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 1.9 m -117.62 9.34 13.09 Favored 'General case' 0 N--CA 1.505 2.287 0 C-N-CA 119.19 -1.004 . . . . 0.0 110.345 -176.202 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.419 ' OE2' ' SG ' ' A' ' 22' ' ' CYS . 34.5 mt-10 -141.73 60.78 1.48 Allowed 'General case' 0 C--N 1.288 -2.07 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 177.189 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 79.66 -105.82 2.35 Favored Glycine 0 N--CA 1.484 1.862 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 -177.5 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.496 ' O ' HD22 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -109.37 -3.22 17.26 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-O 122.232 1.015 . . . . 0.0 109.708 179.165 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 -81.16 133.53 35.47 Favored 'General case' 0 C--N 1.262 -3.2 0 CA-C-N 113.327 -1.76 . . . . 0.0 111.443 -178.478 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.417 ' HA ' HD23 ' A' ' 15' ' ' LEU . 2.3 t -70.0 142.3 16.04 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 C-N-CA 119.015 -1.074 . . . . 0.0 109.708 178.588 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.58 ' O ' ' SG ' ' A' ' 28' ' ' CYS . 0.1 OUTLIER -143.49 119.79 10.88 Favored 'General case' 0 C--N 1.281 -2.39 0 C-N-CA 119.025 -1.07 . . . . 0.0 109.467 177.387 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.445 ' O ' ' O ' ' A' ' 26' ' ' ASN . . . 151.78 -39.55 0.78 Allowed Glycine 0 C--N 1.294 -1.759 1 N-CA-C 130.544 6.978 . . . . 0.0 130.544 -178.806 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -58.28 115.03 2.69 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 118.882 -1.127 . . . . 0.0 110.266 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.49 -23.33 8.73 Favored Glycine 0 C--N 1.3 -1.447 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -178.356 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.48 ' N ' ' OD1' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -115.31 -168.99 1.48 Allowed 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.638 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.529 ' HE3' HD11 ' A' ' 29' ' ' ILE . 7.4 tttt -148.59 135.94 20.34 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 118.523 -1.271 . . . . 0.0 110.078 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.58 ' SG ' ' O ' ' A' ' 22' ' ' CYS . 2.9 m -95.65 153.72 17.58 Favored 'General case' 0 C--N 1.307 -1.282 0 C-N-CA 118.289 -1.365 . . . . 0.0 111.458 179.513 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.529 HD11 ' HE3' ' A' ' 27' ' ' LYS . 14.9 mm -136.18 130.53 48.15 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.47 0 CA-C-N 114.05 -1.432 . . . . 0.0 109.811 174.678 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.493 ' H ' ' HB3' ' A' ' 9' ' ' SER . 23.3 mt -73.04 123.82 24.29 Favored 'General case' 0 N--CA 1.496 1.868 0 C-N-CA 119.271 -0.972 . . . . 0.0 108.473 177.795 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -91.66 -118.06 2.26 Favored Glycine 0 N--CA 1.481 1.658 0 C-N-CA 118.573 -1.775 . . . . 0.0 112.181 -176.543 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 9.1 m -154.14 -147.02 0.2 Allowed 'General case' 0 C--O 1.204 -1.292 0 CA-C-O 122.44 1.114 . . . . 0.0 111.232 -176.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -84.45 65.71 9.08 Favored 'General case' 0 C--N 1.264 -3.149 0 CA-C-N 113.094 -1.867 . . . . 0.0 111.325 -172.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 130.2 -3.94 5.94 Favored Glycine 0 C--N 1.28 -2.578 0 N-CA-C 108.305 -1.918 . . . . 0.0 108.305 179.712 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.727 ' O ' ' O ' ' A' ' 36' ' ' LYS . 3.7 mm-40 -128.62 9.6 5.99 Favored 'General case' 0 C--O 1.196 -1.734 0 CA-C-N 114.161 -1.02 . . . . 0.0 109.112 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.727 ' O ' ' O ' ' A' ' 35' ' ' GLU . 6.2 mtpp -25.88 -156.12 0.0 OUTLIER 'General case' 0 N--CA 1.523 3.224 0 O-C-N 126.974 2.671 . . . . 0.0 115.089 -174.281 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.558 ' N ' ' OD1' ' A' ' 37' ' ' ASN . 0.2 OUTLIER -57.75 133.68 55.58 Favored 'General case' 0 C--N 1.283 -2.315 0 C-N-CA 118.934 -1.107 . . . . 0.0 111.0 -178.432 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.77 145.93 27.81 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-N 115.267 -0.878 . . . . 0.0 109.64 178.602 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -83.75 116.62 22.78 Favored 'General case' 0 C--N 1.288 -2.106 0 CA-C-N 115.32 -0.854 . . . . 0.0 112.615 -177.624 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.509 ' O ' ' O ' ' A' ' 27' ' ' LYS . 0.9 OUTLIER -119.22 129.69 74.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 CA-C-O 122.606 1.193 . . . . 0.0 110.596 173.707 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 10.1 t -46.98 148.78 1.01 Allowed 'General case' 0 C--N 1.258 -3.378 0 CA-C-N 113.42 -1.718 . . . . 0.0 111.134 -178.032 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.401 ' O ' ' C ' ' A' ' 26' ' ' ASN . . . 149.37 149.66 5.04 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.954 -1.259 . . . . 0.0 109.954 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -80.01 63.4 4.52 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 119.035 -1.066 . . . . 0.0 110.873 -179.323 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -63.36 162.91 32.14 Favored Glycine 0 N--CA 1.49 2.296 0 C-N-CA 119.181 -1.485 . . . . 0.0 109.437 178.546 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.4 t -79.87 141.04 54.68 Favored Pre-proline 0 N--CA 1.488 1.474 0 C-N-CA 118.514 -1.275 . . . . 0.0 109.835 -179.307 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.436 ' HB3' HD12 ' A' ' 13' ' ' LEU . 8.4 Cg_endo -67.14 116.46 4.19 Favored 'Trans proline' 0 C--O 1.213 -0.768 0 C-N-CA 121.117 1.211 . . . . 0.0 111.36 178.263 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.414 ' C ' ' O ' ' A' ' 46' ' ' PRO . 0.4 OUTLIER -36.74 101.05 0.21 Allowed Pre-proline 0 N--CA 1.504 2.24 0 C-N-CA 120.284 -0.567 . . . . 0.0 110.929 179.741 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -69.08 104.89 1.28 Allowed 'Trans proline' 0 C--O 1.214 -0.692 0 C-N-CA 120.754 0.969 . . . . 0.0 111.176 -178.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.589 0 C-N-CA 119.209 -0.996 . . . . 0.0 . 179.572 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.607 HG23 ' O ' ' A' ' 1' ' ' VAL . 33.3 m . . . . . 0 N--CA 1.493 1.68 0 N-CA-C 109.576 -0.528 . . . . 0.0 109.576 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.408 HG12 ' H ' ' A' ' 3' ' ' TYR . 2.8 t -95.68 166.54 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 C-N-CA 119.409 -0.917 . . . . 0.0 110.303 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.415 ' CZ ' HD22 ' A' ' 13' ' ' LEU . 45.5 m-85 -130.0 -164.59 1.43 Allowed 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 120.038 -0.665 . . . . 0.0 109.782 179.437 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -92.83 176.76 6.31 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 119.366 -0.934 . . . . 0.0 108.58 179.069 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.527 ' N ' ' OD1' ' A' ' 5' ' ' ASP . 0.2 OUTLIER -97.02 151.88 19.28 Favored 'General case' 0 C--N 1.294 -1.815 0 C-N-CA 118.889 -1.124 . . . . 0.0 109.554 178.013 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.428 ' N ' ' HB2' ' A' ' 14' ' ' CYS . 1.5 m -70.29 176.76 3.71 Favored 'General case' 0 C--N 1.285 -2.212 0 C-N-CA 119.216 -0.993 . . . . 0.0 110.165 177.902 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.419 ' O ' ' OG1' ' A' ' 7' ' ' THR . 0.1 OUTLIER -153.9 7.72 0.35 Allowed 'General case' 0 C--N 1.274 -2.707 0 CA-C-N 114.112 -1.404 . . . . 0.0 110.474 177.795 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -166.46 173.02 10.28 Favored 'General case' 0 C--N 1.284 -2.248 0 CA-C-N 114.505 -1.225 . . . . 0.0 109.761 -179.813 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.5 136.19 33.53 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 119.375 -0.93 . . . . 0.0 109.124 -178.92 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.696 ' HA2' ' NZ ' ' A' ' 27' ' ' LYS . . . 112.13 -30.22 7.83 Favored Glycine 0 N--CA 1.493 2.486 1 N-CA-C 129.642 6.617 . . . . 0.0 129.642 -175.873 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -56.21 -167.19 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.909 0 C-N-CA 119.34 -0.944 . . . . 0.0 109.672 178.7 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.602 ' O ' ' HA3' ' A' ' 23' ' ' GLY . 22.2 t-20 -142.18 -69.2 0.36 Allowed 'General case' 0 N--CA 1.496 1.837 0 C-N-CA 118.472 -1.291 . . . . 0.0 113.766 -176.343 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.557 HD12 ' HB3' ' A' ' 46' ' ' PRO . 14.1 mt -78.38 50.39 0.93 Allowed 'General case' 0 C--N 1.261 -3.258 0 C-N-CA 118.227 -1.389 . . . . 0.0 110.9 -176.899 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.56 ' SG ' ' N ' ' A' ' 15' ' ' LEU . 13.1 p -114.22 -153.14 0.52 Allowed 'General case' 0 N--CA 1.506 2.371 0 C-N-CA 118.788 -1.165 . . . . 0.0 110.719 177.345 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.56 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 7.7 mt -127.5 137.09 52.56 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 114.068 -1.424 . . . . 0.0 109.751 178.737 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.423 ' SG ' ' CB ' ' A' ' 22' ' ' CYS . 97.5 m -125.11 -77.85 0.59 Allowed 'General case' 0 N--CA 1.513 2.706 0 C-N-CA 118.998 -1.081 . . . . 0.0 111.531 179.504 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -80.07 112.33 17.28 Favored 'General case' 0 C--N 1.299 -1.604 0 C-N-CA 118.345 -1.342 . . . . 0.0 110.282 -178.141 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 66.06 -107.22 1.86 Allowed Glycine 0 N--CA 1.491 2.308 0 C-N-CA 119.497 -1.335 . . . . 0.0 110.36 -179.465 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.485 ' O ' ' OG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -134.87 11.43 3.65 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 122.981 1.372 . . . . 0.0 108.896 179.95 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -76.71 127.95 33.73 Favored 'General case' 0 C--N 1.255 -3.503 0 CA-C-N 112.712 -2.04 . . . . 0.0 109.479 178.366 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.3 t -63.57 146.54 12.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 C-N-CA 118.827 -1.149 . . . . 0.0 110.017 -179.01 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.507 ' O ' ' O ' ' A' ' 12' ' ' ASN . 0.0 OUTLIER -135.51 114.88 12.51 Favored 'General case' 0 C--N 1.299 -1.611 0 C-N-CA 119.164 -1.014 . . . . 0.0 109.773 179.566 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.602 ' HA3' ' O ' ' A' ' 12' ' ' ASN . . . 149.76 -55.14 0.48 Allowed Glycine 0 C--O 1.205 -1.712 1 N-CA-C 129.639 6.615 . . . . 0.0 129.639 -176.916 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.456 ' N ' ' OD1' ' A' ' 12' ' ' ASN . 1.1 tm0? -51.59 121.9 7.19 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 118.325 -1.35 . . . . 0.0 109.923 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.82 -26.34 6.05 Favored Glycine 0 C--N 1.297 -1.592 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 -177.709 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.489 ' N ' ' O ' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -126.0 -162.21 1.11 Allowed 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 119.974 -0.691 . . . . 0.0 111.263 -179.628 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.696 ' NZ ' ' HA2' ' A' ' 10' ' ' GLY . 0.5 OUTLIER -153.69 124.59 7.29 Favored 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 119.196 -1.002 . . . . 0.0 110.674 177.727 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.432 ' O ' HD13 ' A' ' 29' ' ' ILE . 0.1 OUTLIER -81.75 155.93 25.23 Favored 'General case' 0 CA--C 1.483 -1.628 0 C-N-CA 118.31 -1.356 . . . . 0.0 111.876 179.437 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.432 HD13 ' O ' ' A' ' 28' ' ' CYS . 4.2 mm -133.09 117.54 29.37 Favored 'Isoleucine or valine' 0 C--N 1.256 -3.467 0 CA-C-N 112.201 -2.272 . . . . 0.0 109.2 177.106 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 21.1 mt -77.15 130.77 37.76 Favored 'General case' 0 N--CA 1.505 2.281 0 C-N-CA 118.631 -1.228 . . . . 0.0 111.171 -178.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 1.005 ' HA3' ' O ' ' A' ' 35' ' ' GLU . . . -120.68 -109.08 2.17 Favored Glycine 0 N--CA 1.48 1.611 1 N-CA-C 132.0 7.56 . . . . 0.0 132.0 176.481 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.719 ' H ' ' N ' ' A' ' 36' ' ' LYS . 9.4 p -167.34 -149.42 0.09 Allowed 'General case' 0 C--N 1.3 -1.574 0 CA-C-O 122.22 1.01 . . . . 0.0 110.136 -178.899 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.499 ' N ' ' OG ' ' A' ' 32' ' ' SER . 25.7 t0 -81.28 58.68 3.66 Favored 'General case' 0 C--N 1.261 -3.262 0 CA-C-N 113.222 -1.808 . . . . 0.0 109.882 -176.658 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 144.85 -14.47 1.96 Allowed Glycine 0 C--N 1.28 -2.574 0 N-CA-C 107.858 -2.097 . . . . 0.0 107.858 -178.342 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 1.005 ' O ' ' HA3' ' A' ' 31' ' ' GLY . 13.9 mm-40 -125.02 7.19 7.96 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 114.014 -1.093 . . . . 0.0 109.125 178.931 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.719 ' N ' ' H ' ' A' ' 32' ' ' SER . 0.0 OUTLIER -31.78 -175.56 0.0 OUTLIER 'General case' 0 N--CA 1.519 2.976 0 CA-C-N 111.459 -2.61 . . . . 0.0 113.694 -177.37 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.558 ' N ' ' OD1' ' A' ' 37' ' ' ASN . 0.1 OUTLIER -61.62 106.17 0.63 Allowed 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 118.0 -1.48 . . . . 0.0 109.132 179.121 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -121.98 151.25 40.99 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 119.67 -0.812 . . . . 0.0 110.916 -178.238 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -105.13 109.34 21.29 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.777 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.513 HG22 ' N ' ' A' ' 41' ' ' THR . 2.3 p -125.59 159.74 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.153 0 C-N-CA 118.869 -1.132 . . . . 0.0 110.06 175.14 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.513 ' N ' HG22 ' A' ' 40' ' ' VAL . 3.0 t -69.58 146.96 51.35 Favored 'General case' 0 C--N 1.275 -2.645 0 CA-C-N 115.124 -0.944 . . . . 0.0 111.183 -179.366 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 175.79 160.99 24.31 Favored Glycine 0 N--CA 1.489 2.217 0 C-N-CA 119.28 -1.438 . . . . 0.0 110.494 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -81.28 104.85 12.03 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 119.452 -0.899 . . . . 0.0 110.286 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -123.4 165.28 16.16 Favored Glycine 0 N--CA 1.492 2.395 1 N-CA-C 130.306 6.882 . . . . 0.0 130.306 179.474 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 14.3 t -100.38 142.86 25.43 Favored Pre-proline 0 N--CA 1.49 1.563 0 C-N-CA 119.266 -0.973 . . . . 0.0 110.564 -178.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.557 ' HB3' HD12 ' A' ' 13' ' ' LEU . 11.2 Cg_exo -53.5 171.88 0.27 Allowed 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 121.246 1.297 . . . . 0.0 111.187 175.178 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -101.93 106.57 48.11 Favored Pre-proline 0 CA--C 1.561 1.383 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.72 178.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -62.79 156.67 52.11 Favored 'Trans proline' 0 C--O 1.215 -0.631 0 C-N-CA 120.753 0.969 . . . . 0.0 111.277 -177.696 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 116.317 -1.801 . . . . 0.0 110.298 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 21.2 m . . . . . 0 N--CA 1.492 1.665 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.413 HG12 ' H ' ' A' ' 3' ' ' TYR . 2.6 t -103.18 167.59 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 C-N-CA 119.973 -0.691 . . . . 0.0 109.848 179.739 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.413 ' H ' HG12 ' A' ' 2' ' ' VAL . 59.2 m-85 -126.29 -166.6 1.59 Allowed 'General case' 0 N--CA 1.496 1.827 0 C-N-CA 119.946 -0.702 . . . . 0.0 110.917 -178.819 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.0 p -102.43 179.17 4.38 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.099 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.469 ' OD1' HD12 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -84.92 152.38 23.56 Favored 'General case' 0 C--N 1.294 -1.836 0 C-N-CA 118.502 -1.279 . . . . 0.0 110.906 -179.751 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.447 ' N ' ' HB2' ' A' ' 14' ' ' CYS . 0.8 OUTLIER -74.82 -177.49 3.29 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.883 176.582 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.8 t -151.84 11.11 0.56 Allowed 'General case' 0 C--N 1.281 -2.413 0 CA-C-N 114.673 -1.149 . . . . 0.0 110.749 177.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -160.49 158.0 28.53 Favored 'General case' 0 C--N 1.29 -2.008 0 CA-C-N 114.557 -1.201 . . . . 0.0 109.514 -178.89 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.482 ' HA ' ' H ' ' A' ' 30' ' ' LEU . 0.3 OUTLIER -79.32 138.49 37.74 Favored 'General case' 0 C--N 1.293 -1.856 0 C-N-CA 119.605 -0.838 . . . . 0.0 108.995 -179.116 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.884 ' HA2' ' NZ ' ' A' ' 27' ' ' LYS . . . 107.27 -35.14 5.21 Favored Glycine 0 N--CA 1.5 2.912 1 N-CA-C 129.64 6.616 . . . . 0.0 129.64 -173.72 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -56.86 -166.21 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.167 0 C-N-CA 119.729 -0.788 . . . . 0.0 110.22 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.475 ' ND2' ' C ' ' A' ' 23' ' ' GLY . 1.4 m-20 -141.37 -66.78 0.41 Allowed 'General case' 0 N--CA 1.508 2.46 0 N-CA-C 115.41 1.633 . . . . 0.0 115.41 -175.633 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.457 HD23 ' HA ' ' A' ' 13' ' ' LEU . 35.7 mt -76.51 51.81 0.75 Allowed 'General case' 0 C--N 1.277 -2.562 0 C-N-CA 118.048 -1.461 . . . . 0.0 111.022 -173.781 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.447 ' HB2' ' N ' ' A' ' 6' ' ' CYS . 27.3 p -123.62 -154.22 0.6 Allowed 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 114.908 -1.042 . . . . 0.0 108.943 176.285 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.469 HD12 ' OD1' ' A' ' 5' ' ' ASP . 70.8 mt -117.77 116.72 27.57 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 176.155 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.421 ' O ' ' OE1' ' A' ' 17' ' ' GLU . 2.8 m -116.7 -7.06 11.57 Favored 'General case' 0 N--CA 1.5 2.027 0 C-N-CA 118.617 -1.233 . . . . 0.0 111.746 -176.747 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.5 ' OE1' ' SG ' ' A' ' 39' ' ' CYS . 0.3 OUTLIER -127.09 75.49 1.58 Allowed 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 119.245 -0.982 . . . . 0.0 109.255 177.194 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 71.59 -81.26 0.51 Allowed Glycine 0 N--CA 1.489 2.221 0 C-N-CA 119.475 -1.345 . . . . 0.0 110.605 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -135.38 0.88 2.84 Favored 'General case' 0 N--CA 1.486 1.348 0 CA-C-O 121.907 0.86 . . . . 0.0 110.89 -179.24 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.489 ' OD1' ' N ' ' A' ' 20' ' ' ASN . 0.9 OUTLIER -85.13 139.99 31.28 Favored 'General case' 0 C--N 1.257 -3.455 0 CA-C-N 113.824 -1.535 . . . . 0.0 111.234 -179.011 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.2 t -73.79 144.55 12.46 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 C-N-CA 118.704 -1.198 . . . . 0.0 109.867 178.03 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.484 ' O ' ' SG ' ' A' ' 28' ' ' CYS . 3.8 m -149.98 119.95 7.16 Favored 'General case' 0 C--N 1.278 -2.502 0 C-N-CA 118.775 -1.17 . . . . 0.0 108.593 178.07 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.475 ' C ' ' ND2' ' A' ' 12' ' ' ASN . . . 173.09 -84.8 0.08 OUTLIER Glycine 0 C--N 1.3 -1.466 0 C-N-CA 117.688 -2.196 . . . . 0.0 112.055 -176.241 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.485 ' C ' ' H ' ' A' ' 26' ' ' ASN . 25.9 tt0 -42.43 133.68 3.22 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.868 -0.733 . . . . 0.0 111.321 -178.003 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 76.69 -27.51 1.59 Allowed Glycine 0 N--CA 1.479 1.547 0 C-N-CA 119.679 -1.248 . . . . 0.0 110.083 -179.533 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.485 ' H ' ' C ' ' A' ' 24' ' ' GLN . 0.0 OUTLIER -128.84 -159.94 0.99 Allowed 'General case' 0 C--N 1.316 -0.871 0 C-N-CA 119.696 -0.802 . . . . 0.0 111.6 -179.039 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.884 ' NZ ' ' HA2' ' A' ' 10' ' ' GLY . 3.4 ttpp -142.98 175.39 9.88 Favored 'General case' 0 N--CA 1.498 1.955 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.815 179.184 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.484 ' SG ' ' O ' ' A' ' 22' ' ' CYS . 57.3 m -138.55 160.66 39.01 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 118.965 -1.094 . . . . 0.0 111.173 176.766 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 7.8 mm -140.69 97.75 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.13 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 174.539 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.76 ' C ' HD12 ' A' ' 30' ' ' LEU . 0.3 OUTLIER -79.35 130.19 35.2 Favored 'General case' 0 C--N 1.291 -1.944 0 C-N-CA 118.129 -1.428 . . . . 0.0 110.743 -176.216 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.496 ' N ' ' O ' ' A' ' 36' ' ' LYS . . . -50.83 -88.9 0.01 OUTLIER Glycine 0 N--CA 1.489 2.17 0 C-N-CA 120.307 -0.949 . . . . 0.0 111.816 -176.771 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.447 ' O ' ' N ' ' A' ' 34' ' ' GLY . 9.7 t -138.96 -132.15 0.12 Allowed 'General case' 0 C--N 1.309 -1.195 0 C-N-CA 119.425 -0.91 . . . . 0.0 111.526 -177.079 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 81.5 m-20 -74.64 71.14 1.89 Allowed 'General case' 0 C--N 1.258 -3.402 0 CA-C-N 113.577 -1.647 . . . . 0.0 110.108 -170.617 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 32' ' ' SER . . . 70.23 22.57 77.49 Favored Glycine 0 C--N 1.281 -2.5 0 N-CA-C 107.704 -2.158 . . . . 0.0 107.704 -179.035 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 -93.82 -116.6 0.1 Allowed 'General case' 0 C--N 1.307 -1.256 0 C-N-CA 119.111 -1.035 . . . . 0.0 110.666 -177.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.496 ' O ' ' N ' ' A' ' 31' ' ' GLY . 0.1 OUTLIER -69.36 169.51 12.19 Favored 'General case' 0 C--N 1.26 -3.283 0 CA-C-N 113.913 -1.494 . . . . 0.0 110.608 -178.611 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.502 ' OD1' ' N ' ' A' ' 38' ' ' GLN . 46.0 t-20 -178.19 136.11 0.16 Allowed 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.502 ' N ' ' OD1' ' A' ' 37' ' ' ASN . 64.5 tt0 -131.89 143.29 50.04 Favored 'General case' 0 C--N 1.311 -1.086 0 C-N-CA 119.823 -0.751 . . . . 0.0 110.321 177.904 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.5 ' SG ' ' OE1' ' A' ' 17' ' ' GLU . 66.2 m -97.93 99.7 11.01 Favored 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 119.539 -0.864 . . . . 0.0 110.01 179.121 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.525 ' O ' ' N ' ' A' ' 27' ' ' LYS . 11.2 p -112.89 155.13 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.334 0 C-N-CA 118.436 -1.306 . . . . 0.0 111.532 179.513 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.488 ' N ' HG22 ' A' ' 40' ' ' VAL . 2.4 t -75.0 148.12 40.18 Favored 'General case' 0 C--N 1.265 -3.077 0 CA-C-N 113.836 -1.529 . . . . 0.0 111.292 -179.178 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 158.72 -179.82 34.1 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 110.119 -1.192 . . . . 0.0 110.119 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -90.8 110.66 21.86 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 119.332 -0.947 . . . . 0.0 110.423 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -128.71 165.76 21.45 Favored Glycine 0 N--CA 1.497 2.701 0 N-CA-C 110.235 -1.146 . . . . 0.0 110.235 179.726 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -104.5 145.14 30.12 Favored Pre-proline 0 N--CA 1.494 1.774 0 C-N-CA 119.649 -0.82 . . . . 0.0 109.953 -179.649 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -56.47 142.94 89.06 Favored 'Trans proline' 0 C--O 1.216 -0.617 0 C-N-CA 121.232 1.288 . . . . 0.0 111.297 177.296 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.5 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 6.4 tt0 -64.18 -44.51 77.22 Favored Pre-proline 0 CA--C 1.558 1.261 0 C-N-CA 119.5 -0.88 . . . . 0.0 112.418 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.5 ' HD2' ' N ' ' A' ' 47' ' ' GLU . 5.9 Cg_exo -58.11 99.81 0.1 Allowed 'Trans proline' 0 C--O 1.216 -0.586 0 C-N-CA 120.345 0.697 . . . . 0.0 111.031 -179.309 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.345 0 CA-C-O 116.325 -1.797 . . . . 0.0 110.425 -179.957 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 2.9 m . . . . . 0 N--CA 1.493 1.676 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.0 t -100.56 161.54 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 C-N-CA 119.686 -0.806 . . . . 0.0 110.676 -179.114 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.726 ' CE2' HD22 ' A' ' 13' ' ' LEU . 23.8 m-85 -94.13 -163.69 1.08 Allowed 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 119.714 -0.795 . . . . 0.0 110.07 179.463 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.583 ' OG1' ' N ' ' A' ' 5' ' ' ASP . 0.1 OUTLIER -96.39 179.48 5.01 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.705 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.583 ' N ' ' OG1' ' A' ' 4' ' ' THR . 0.0 OUTLIER -93.77 153.45 18.3 Favored 'General case' 0 C--N 1.289 -2.048 0 C-N-CA 118.92 -1.112 . . . . 0.0 109.858 179.856 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.499 ' SG ' ' OE1' ' A' ' 11' ' ' GLN . 1.2 m -74.13 177.07 5.99 Favored 'General case' 0 C--N 1.291 -1.945 0 C-N-CA 119.406 -0.918 . . . . 0.0 110.515 177.087 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.417 ' O ' HG23 ' A' ' 7' ' ' THR . 2.7 t -152.69 10.84 0.49 Allowed 'General case' 0 C--N 1.279 -2.48 0 CA-C-N 113.924 -1.489 . . . . 0.0 110.151 177.334 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -163.02 167.54 22.27 Favored 'General case' 0 C--N 1.283 -2.318 0 CA-C-N 114.453 -1.248 . . . . 0.0 109.939 178.758 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -84.41 145.16 28.33 Favored 'General case' 0 C--N 1.296 -1.726 0 C-N-CA 119.136 -1.026 . . . . 0.0 108.83 -178.798 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 102.41 -29.46 12.46 Favored Glycine 0 N--CA 1.512 3.706 1 N-CA-C 130.151 6.82 . . . . 0.0 130.151 -175.286 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.499 ' OE1' ' SG ' ' A' ' 6' ' ' CYS . 72.9 mt-30 -58.42 -158.92 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.065 0 C-N-CA 119.83 -0.748 . . . . 0.0 110.756 -179.777 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.635 ' O ' ' HA3' ' A' ' 23' ' ' GLY . 0.4 OUTLIER -147.41 -67.13 0.26 Allowed 'General case' 0 N--CA 1.503 2.202 0 C-N-CA 118.21 -1.396 . . . . 0.0 114.561 -177.37 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.726 HD22 ' CE2' ' A' ' 3' ' ' TYR . 32.9 mt -77.96 49.33 0.78 Allowed 'General case' 0 C--N 1.274 -2.708 0 C-N-CA 118.434 -1.306 . . . . 0.0 111.218 -174.946 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.695 ' O ' HG22 ' A' ' 21' ' ' VAL . 17.5 p -119.41 -154.46 0.57 Allowed 'General case' 0 N--CA 1.497 1.912 0 C-N-CA 119.155 -1.018 . . . . 0.0 110.374 176.484 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.401 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 7.2 mt -125.51 135.2 52.03 Favored 'General case' 0 N--CA 1.485 1.31 0 CA-C-N 114.569 -1.196 . . . . 0.0 110.526 179.764 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.3 m -120.35 -58.76 1.83 Allowed 'General case' 0 N--CA 1.508 2.44 0 C-N-CA 119.274 -0.97 . . . . 0.0 111.228 179.6 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.61 97.18 8.83 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 119.441 -0.903 . . . . 0.0 110.725 -178.499 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 68.77 -113.59 5.35 Favored Glycine 0 N--CA 1.488 2.125 0 C-N-CA 119.444 -1.36 . . . . 0.0 110.815 179.16 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.88 3.71 15.55 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-O 122.133 0.968 . . . . 0.0 110.24 -178.544 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -78.35 129.59 35.17 Favored 'General case' 0 C--N 1.256 -3.469 0 CA-C-N 113.589 -1.641 . . . . 0.0 110.39 -179.979 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.695 HG22 ' O ' ' A' ' 14' ' ' CYS . 0.9 OUTLIER -79.32 149.16 5.52 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 C-N-CA 119.473 -0.891 . . . . 0.0 110.227 -179.656 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.477 ' O ' ' O ' ' A' ' 12' ' ' ASN . 15.6 m -143.8 112.58 6.6 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 118.717 -1.193 . . . . 0.0 110.205 179.111 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.635 ' HA3' ' O ' ' A' ' 12' ' ' ASN . . . 178.51 -63.0 0.08 OUTLIER Glycine 0 N--CA 1.484 1.858 1 N-CA-C 130.007 6.763 . . . . 0.0 130.007 -177.274 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -63.54 120.62 12.08 Favored 'General case' 0 C--N 1.311 -1.093 0 C-N-CA 118.466 -1.294 . . . . 0.0 109.842 179.269 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 95.48 -17.2 59.75 Favored Glycine 0 N--CA 1.485 1.918 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 -178.349 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.465 ' O ' ' O ' ' A' ' 23' ' ' GLY . 6.5 m120 -139.26 -172.87 3.44 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.389 -0.924 . . . . 0.0 110.694 179.07 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.747 ' NZ ' HD11 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -138.74 125.68 21.13 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 119.502 -0.879 . . . . 0.0 109.148 177.623 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.49 ' SG ' ' O ' ' A' ' 38' ' ' GLN . 0.1 OUTLIER -82.14 164.9 20.98 Favored 'General case' 0 C--N 1.289 -2.051 0 C-N-CA 116.959 -1.896 . . . . 0.0 109.927 178.206 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.747 HD11 ' NZ ' ' A' ' 27' ' ' LYS . 26.8 mm -144.08 125.96 10.54 Favored 'Isoleucine or valine' 0 C--N 1.245 -3.938 0 CA-C-N 113.856 -1.52 . . . . 0.0 108.869 178.74 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 17.7 mt -76.57 131.67 39.06 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 118.51 -1.276 . . . . 0.0 110.135 -179.066 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.423 ' H ' ' C ' ' A' ' 36' ' ' LYS . . . -95.96 -105.38 2.14 Favored Glycine 0 N--CA 1.491 2.328 0 C-N-CA 118.936 -1.602 . . . . 0.0 111.591 -178.281 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.437 ' H ' ' C ' ' A' ' 35' ' ' GLU . 10.7 t -160.02 -131.71 0.03 OUTLIER 'General case' 0 C--O 1.21 -0.993 0 C-N-CA 118.467 -1.293 . . . . 0.0 112.871 -177.362 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -79.86 73.18 6.62 Favored 'General case' 0 C--N 1.272 -2.791 0 CA-C-N 112.807 -1.997 . . . . 0.0 111.803 -172.241 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 116.49 -8.09 17.76 Favored Glycine 0 C--N 1.273 -2.951 0 N-CA-C 107.362 -2.295 . . . . 0.0 107.362 178.947 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.695 ' O ' ' N ' ' A' ' 37' ' ' ASN . 1.4 mm-40 -123.08 8.49 9.24 Favored 'General case' 0 C--N 1.286 -2.17 0 CA-C-N 113.041 -1.58 . . . . 0.0 107.948 179.22 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.423 ' C ' ' H ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -35.4 -18.44 0.0 OUTLIER 'General case' 0 C--N 1.26 -3.311 0 CA-C-N 111.627 -2.533 . . . . 0.0 113.723 -173.588 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.695 ' N ' ' O ' ' A' ' 35' ' ' GLU . 0.3 OUTLIER -153.16 153.46 32.81 Favored 'General case' 0 C--N 1.258 -3.394 0 C-N-CA 118.403 -1.319 . . . . 0.0 113.191 178.058 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.49 ' O ' ' SG ' ' A' ' 28' ' ' CYS . 15.8 tt0 -151.63 164.34 37.11 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 113.976 -1.466 . . . . 0.0 108.24 176.039 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.454 ' N ' ' CG ' ' A' ' 38' ' ' GLN . 29.0 m -127.12 97.43 4.93 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 119.407 -0.917 . . . . 0.0 110.86 -178.308 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.503 ' O ' ' O ' ' A' ' 27' ' ' LYS . 0.4 OUTLIER -111.84 140.79 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.485 0 C-N-CA 118.73 -1.188 . . . . 0.0 112.569 -179.719 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.426 ' O ' HG22 ' A' ' 40' ' ' VAL . 9.5 t -56.9 149.35 18.8 Favored 'General case' 0 C--N 1.279 -2.462 0 CA-C-N 113.563 -1.653 . . . . 0.0 111.672 177.943 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 145.16 -130.03 3.71 Favored Glycine 0 N--CA 1.489 2.228 1 N-CA-C 131.116 7.206 . . . . 0.0 131.116 179.622 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 31.9 mm-40 -112.75 106.07 14.34 Favored 'General case' 0 N--CA 1.499 2.007 0 C-N-CA 119.884 -0.726 . . . . 0.0 111.053 -179.044 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -140.02 178.86 19.49 Favored Glycine 0 N--CA 1.493 2.499 0 C-N-CA 119.659 -1.258 . . . . 0.0 110.152 179.377 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -128.61 146.38 59.87 Favored Pre-proline 0 N--CA 1.495 1.815 0 C-N-CA 119.903 -0.719 . . . . 0.0 109.511 179.681 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -57.65 164.06 8.06 Favored 'Trans proline' 0 C--O 1.216 -0.589 0 C-N-CA 121.179 1.253 . . . . 0.0 111.587 -178.809 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 52.3 tp10 -123.73 80.02 55.89 Favored Pre-proline 0 C--N 1.314 -0.968 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.203 179.54 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -62.59 135.79 54.9 Favored 'Trans proline' 0 C--N 1.324 -0.738 0 C-N-CA 121.026 1.151 . . . . 0.0 110.325 179.891 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 116.302 -1.809 . . . . 0.0 110.315 -178.943 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.408 ' O ' HG22 ' A' ' 1' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 . . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.826 HG12 ' H ' ' A' ' 3' ' ' TYR . 22.0 t -82.69 -178.69 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 C-N-CA 119.884 -0.726 . . . . 0.0 110.652 -178.976 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.826 ' H ' HG12 ' A' ' 2' ' ' VAL . 85.1 m-85 -114.89 -166.49 1.12 Allowed 'General case' 0 N--CA 1.5 2.063 0 C-N-CA 120.106 -0.638 . . . . 0.0 110.425 -179.939 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.599 ' OG1' ' N ' ' A' ' 5' ' ' ASP . 0.1 OUTLIER -113.01 -177.82 3.23 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 178.816 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.599 ' N ' ' OG1' ' A' ' 4' ' ' THR . 0.2 OUTLIER -90.33 154.2 19.87 Favored 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 118.681 -1.208 . . . . 0.0 110.746 -179.597 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -75.73 -178.85 4.41 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-N 115.001 -1.0 . . . . 0.0 112.005 178.567 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.4 t -157.15 15.18 0.27 Allowed 'General case' 0 C--N 1.291 -1.978 0 CA-C-N 113.435 -1.712 . . . . 0.0 110.02 177.848 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -161.42 172.01 17.23 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 114.505 -1.225 . . . . 0.0 109.533 -179.261 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.534 ' HB3' ' H ' ' A' ' 30' ' ' LEU . 0.9 OUTLIER -91.64 164.31 13.79 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 119.612 -0.835 . . . . 0.0 110.786 -179.303 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.436 ' O ' ' O ' ' A' ' 11' ' ' GLN . . . 79.69 -25.14 2.99 Favored Glycine 0 N--CA 1.499 2.895 0 C-N-CA 119.541 -1.314 . . . . 0.0 112.906 177.216 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.436 ' O ' ' O ' ' A' ' 10' ' ' GLY . 0.5 OUTLIER -54.93 -171.36 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.065 0 C-N-CA 118.495 -1.282 . . . . 0.0 110.577 -178.499 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.484 ' O ' ' O ' ' A' ' 22' ' ' CYS . 2.1 m-20 -148.4 -66.33 0.24 Allowed 'General case' 0 N--CA 1.501 2.076 0 N-CA-C 115.227 1.565 . . . . 0.0 115.227 -176.978 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 95.5 mt -77.17 49.8 0.71 Allowed 'General case' 0 C--N 1.268 -2.963 0 C-N-CA 117.978 -1.489 . . . . 0.0 111.284 -174.179 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 28.3 p -125.84 -156.42 0.73 Allowed 'General case' 0 C--O 1.207 -1.181 0 CA-C-N 114.988 -1.005 . . . . 0.0 109.082 176.499 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.573 HD12 ' OD1' ' A' ' 5' ' ' ASP . 58.1 mt -115.57 120.22 38.74 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 115.115 -0.948 . . . . 0.0 108.957 176.654 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.0 m -117.56 -61.29 1.72 Allowed 'General case' 0 C--N 1.293 -1.861 0 C-N-CA 119.147 -1.021 . . . . 0.0 110.955 -177.237 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.493 ' CG ' ' SG ' ' A' ' 39' ' ' CYS . 3.1 mm-40 -78.74 90.55 4.63 Favored 'General case' 0 C--N 1.295 -1.783 0 C-N-CA 117.81 -1.556 . . . . 0.0 109.708 179.512 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 71.52 -101.78 1.03 Allowed Glycine 0 N--CA 1.488 2.101 0 C-N-CA 119.481 -1.342 . . . . 0.0 109.904 -179.068 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.483 ' O ' HD22 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -128.66 2.96 5.5 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-O 122.35 1.071 . . . . 0.0 109.873 179.837 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -78.72 136.52 37.43 Favored 'General case' 0 C--N 1.258 -3.376 0 CA-C-N 113.313 -1.767 . . . . 0.0 110.228 -179.887 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.1 t -67.21 145.19 13.96 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 C-N-CA 118.438 -1.305 . . . . 0.0 109.493 178.999 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.529 ' O ' ' SG ' ' A' ' 28' ' ' CYS . 20.0 m -148.72 118.95 7.26 Favored 'General case' 0 C--N 1.277 -2.582 0 C-N-CA 118.426 -1.31 . . . . 0.0 109.333 176.82 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.471 ' O ' ' O ' ' A' ' 26' ' ' ASN . . . 171.64 -82.87 0.08 OUTLIER Glycine 0 C--N 1.291 -1.941 0 C-N-CA 118.557 -1.782 . . . . 0.0 110.395 -176.636 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -55.83 117.46 3.69 Favored 'General case' 0 C--N 1.292 -1.902 0 C-N-CA 119.132 -1.027 . . . . 0.0 109.64 179.058 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 102.26 -26.16 25.2 Favored Glycine 0 N--CA 1.484 1.871 0 N-CA-C 109.077 -1.609 . . . . 0.0 109.077 -177.683 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.471 ' O ' ' O ' ' A' ' 23' ' ' GLY . 0.1 OUTLIER -142.67 -154.83 0.54 Allowed 'General case' 0 C--N 1.309 -1.178 0 C-N-CA 119.943 -0.703 . . . . 0.0 110.147 179.767 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.5 ' N ' ' O ' ' A' ' 40' ' ' VAL . 10.0 tttp -148.21 160.01 43.38 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 176.85 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.529 ' SG ' ' O ' ' A' ' 22' ' ' CYS . 72.1 m -121.47 157.56 30.33 Favored 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 118.923 -1.111 . . . . 0.0 111.828 178.495 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 19.9 mm -146.5 133.76 14.64 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.501 0 CA-C-N 113.375 -1.739 . . . . 0.0 109.945 177.104 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.534 ' H ' ' HB3' ' A' ' 9' ' ' SER . 19.9 mt -76.77 128.8 35.3 Favored 'General case' 0 N--CA 1.505 2.277 0 C-N-CA 119.862 -0.735 . . . . 0.0 109.871 179.135 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -110.42 -123.26 4.51 Favored Glycine 0 N--CA 1.482 1.701 0 C-N-CA 119.128 -1.511 . . . . 0.0 111.227 179.104 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.484 ' N ' ' HA ' ' A' ' 36' ' ' LYS . 22.2 m -155.82 -137.56 0.06 Allowed 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 122.485 1.136 . . . . 0.0 111.941 -178.876 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -80.0 67.12 5.7 Favored 'General case' 0 C--N 1.268 -2.965 0 CA-C-N 112.906 -1.952 . . . . 0.0 112.366 -171.435 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 123.29 -6.15 9.33 Favored Glycine 0 N--CA 1.496 2.649 0 N-CA-C 108.337 -1.905 . . . . 0.0 108.337 177.967 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.674 ' O ' ' O ' ' A' ' 36' ' ' LYS . 14.2 mt-10 -126.29 8.24 7.18 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-N 113.988 -1.106 . . . . 0.0 108.584 179.356 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.674 ' O ' ' O ' ' A' ' 35' ' ' GLU . 8.2 tttm -32.53 -153.55 0.0 OUTLIER 'General case' 0 C--N 1.265 -3.079 0 O-C-N 127.122 2.764 . . . . 0.0 115.215 -174.371 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.507 ' N ' ' OD1' ' A' ' 37' ' ' ASN . 0.4 OUTLIER -64.23 109.38 1.86 Allowed 'General case' 0 C--N 1.268 -2.952 0 C-N-CA 118.629 -1.228 . . . . 0.0 110.736 -177.86 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -109.39 147.19 33.19 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.87 179.691 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.493 ' SG ' ' CG ' ' A' ' 17' ' ' GLU . 15.6 m -96.33 90.45 5.44 Favored 'General case' 0 C--N 1.293 -1.865 0 C-N-CA 119.423 -0.911 . . . . 0.0 110.63 -179.423 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.5 ' O ' ' N ' ' A' ' 27' ' ' LYS . 0.6 OUTLIER -90.08 142.81 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 C-N-CA 118.024 -1.471 . . . . 0.0 111.283 179.932 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -65.33 140.35 58.67 Favored 'General case' 0 C--N 1.274 -2.677 0 CA-C-N 114.225 -1.352 . . . . 0.0 110.831 178.844 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 152.89 -156.15 26.54 Favored Glycine 0 N--CA 1.488 2.11 0 C-N-CA 119.545 -1.312 . . . . 0.0 110.252 -179.903 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -114.29 133.37 55.7 Favored 'General case' 0 N--CA 1.497 1.923 0 C-N-CA 120.033 -0.667 . . . . 0.0 110.399 -179.74 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -137.39 158.69 24.53 Favored Glycine 0 N--CA 1.496 2.638 0 C-N-CA 119.704 -1.236 . . . . 0.0 110.455 -179.943 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 5.8 t -87.21 143.9 35.31 Favored Pre-proline 0 N--CA 1.488 1.456 0 C-N-CA 119.631 -0.827 . . . . 0.0 109.929 -179.858 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -58.16 143.69 96.41 Favored 'Trans proline' 0 C--O 1.218 -0.523 0 C-N-CA 121.006 1.137 . . . . 0.0 111.153 178.195 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.548 ' OE1' HG23 ' A' ' 4' ' ' THR . 1.9 tm-20 -73.22 117.7 62.48 Favored Pre-proline 0 C--N 1.302 -1.458 0 C-N-CA 119.706 -0.798 . . . . 0.0 110.343 -179.819 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -60.04 138.42 81.9 Favored 'Trans proline' 0 C--O 1.215 -0.641 0 C-N-CA 120.38 0.72 . . . . 0.0 110.76 179.576 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.5 0 CA-C-O 116.565 -1.683 . . . . 0.0 110.703 -179.597 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 9.4 m . . . . . 0 N--CA 1.489 1.499 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.532 HG12 ' H ' ' A' ' 3' ' ' TYR . 0.6 OUTLIER -79.45 -162.64 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 C-N-CA 119.465 -0.894 . . . . 0.0 109.044 178.484 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.532 ' H ' HG12 ' A' ' 2' ' ' VAL . 95.0 m-85 -143.15 -178.77 6.01 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 118.845 -1.142 . . . . 0.0 111.591 179.653 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 7.7 p -109.97 -179.58 3.84 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 114.772 -1.104 . . . . 0.0 108.862 -179.328 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.456 ' OD1' ' N ' ' A' ' 5' ' ' ASP . 0.1 OUTLIER -88.15 151.79 22.45 Favored 'General case' 0 C--N 1.291 -1.977 0 C-N-CA 118.344 -1.342 . . . . 0.0 109.351 177.424 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.465 ' N ' ' HB2' ' A' ' 14' ' ' CYS . 0.8 OUTLIER -71.79 -178.12 2.18 Favored 'General case' 0 C--N 1.285 -2.214 0 C-N-CA 119.401 -0.919 . . . . 0.0 110.2 178.894 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.0 t -157.46 17.65 0.27 Allowed 'General case' 0 C--N 1.279 -2.47 0 CA-C-N 114.323 -1.308 . . . . 0.0 110.16 178.662 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.531 ' N ' ' OE1' ' A' ' 8' ' ' GLU . 1.2 pm0 -165.45 169.43 15.61 Favored 'General case' 0 C--N 1.285 -2.236 0 CA-C-N 114.773 -1.103 . . . . 0.0 110.076 179.229 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.48 ' HB3' ' H ' ' A' ' 30' ' ' LEU . 0.3 OUTLIER -84.14 138.56 32.95 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 119.244 -0.983 . . . . 0.0 108.859 -179.525 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.542 ' HA2' ' HE3' ' A' ' 27' ' ' LYS . . . 104.53 -35.14 5.25 Favored Glycine 0 N--CA 1.501 2.982 1 N-CA-C 130.249 6.859 . . . . 0.0 130.249 -174.976 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.428 ' O ' ' O ' ' A' ' 10' ' ' GLY . 7.3 mt-30 -54.78 -170.03 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.128 0 C-N-CA 119.292 -0.963 . . . . 0.0 109.895 -179.82 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.466 ' O ' ' O ' ' A' ' 22' ' ' CYS . 4.8 m-20 -141.82 -66.92 0.4 Allowed 'General case' 0 N--CA 1.498 1.937 0 C-N-CA 118.055 -1.458 . . . . 0.0 114.631 -176.209 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.485 HD22 ' CZ ' ' A' ' 3' ' ' TYR . 13.0 mt -75.67 53.95 0.75 Allowed 'General case' 0 C--N 1.268 -2.943 0 C-N-CA 117.613 -1.635 . . . . 0.0 110.274 -175.777 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.465 ' HB2' ' N ' ' A' ' 6' ' ' CYS . 25.9 p -124.89 -160.64 0.96 Allowed 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.023 175.696 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 52.6 mt -118.1 126.72 52.81 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.147 178.446 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.3 m -110.92 -64.5 1.27 Allowed 'General case' 0 N--CA 1.502 2.131 0 C-N-CA 118.98 -1.088 . . . . 0.0 111.197 179.813 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -89.98 92.32 8.94 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 119.05 -1.06 . . . . 0.0 110.67 -178.875 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.43 -105.39 1.84 Allowed Glycine 0 N--CA 1.489 2.222 0 C-N-CA 119.723 -1.227 . . . . 0.0 111.153 178.601 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.404 ' O ' ' OG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -122.43 3.4 9.69 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 122.417 1.103 . . . . 0.0 109.997 -178.354 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 38.1 m-20 -77.22 138.08 39.22 Favored 'General case' 0 C--N 1.259 -3.35 0 CA-C-N 113.278 -1.783 . . . . 0.0 110.598 -179.841 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.0 t -81.68 146.82 6.74 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 C-N-CA 119.441 -0.904 . . . . 0.0 110.357 179.812 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.466 ' O ' ' O ' ' A' ' 12' ' ' ASN . 20.9 m -144.35 114.21 7.28 Favored 'General case' 0 N--CA 1.5 2.043 0 C-N-CA 118.939 -1.104 . . . . 0.0 109.263 177.362 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.484 ' O ' ' N ' ' A' ' 26' ' ' ASN . . . -179.77 -87.78 0.07 OUTLIER Glycine 0 N--CA 1.479 1.538 0 C-N-CA 117.156 -2.449 . . . . 0.0 113.449 -176.726 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.426 ' C ' ' H ' ' A' ' 26' ' ' ASN . 1.5 tt0 -42.15 129.75 3.68 Favored 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 119.931 -0.708 . . . . 0.0 111.681 -175.947 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 81.19 -30.04 2.74 Favored Glycine 0 N--CA 1.477 1.428 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 -179.09 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.484 ' N ' ' O ' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -122.4 -166.86 1.47 Allowed 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 119.935 -0.706 . . . . 0.0 111.412 -178.839 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.542 ' HE3' ' HA2' ' A' ' 10' ' ' GLY . 0.6 OUTLIER -153.15 127.11 8.97 Favored 'General case' 0 N--CA 1.505 2.287 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.237 -179.996 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -86.17 168.31 14.11 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 122.728 1.252 . . . . 0.0 112.337 -178.695 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 11.0 mm -146.31 131.89 12.67 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.754 0 CA-C-N 112.52 -2.127 . . . . 0.0 108.09 175.349 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.48 ' H ' ' HB3' ' A' ' 9' ' ' SER . 23.6 mt -75.09 106.32 6.54 Favored 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 117.554 -1.659 . . . . 0.0 108.995 177.629 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.62 ' H ' ' HA ' ' A' ' 37' ' ' ASN . . . 114.56 90.95 1.78 Allowed Glycine 0 N--CA 1.488 2.161 1 N-CA-C 130.07 6.788 . . . . 0.0 130.07 -176.78 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.585 ' O ' ' N ' ' A' ' 34' ' ' GLY . 94.0 p -68.25 -120.6 0.0 OUTLIER 'General case' 0 C--O 1.2 -1.534 0 C-N-CA 118.528 -1.269 . . . . 0.0 108.977 -179.805 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.453 ' N ' ' OG ' ' A' ' 32' ' ' SER . 6.5 m-20 -69.06 69.24 0.19 Allowed 'General case' 0 C--N 1.258 -3.407 0 CA-C-N 114.335 -1.302 . . . . 0.0 108.952 -174.419 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.585 ' N ' ' O ' ' A' ' 32' ' ' SER . . . 58.61 33.94 74.33 Favored Glycine 0 C--N 1.285 -2.295 0 N-CA-C 107.621 -2.192 . . . . 0.0 107.621 -176.67 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -109.8 -129.69 0.29 Allowed 'General case' 0 C--O 1.214 -0.777 0 CA-C-O 122.487 1.137 . . . . 0.0 113.268 -175.71 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.609 ' O ' ' N ' ' A' ' 31' ' ' GLY . 28.7 mttp -93.86 -86.21 0.27 Allowed 'General case' 0 C--N 1.273 -2.749 0 CA-C-N 112.777 -2.01 . . . . 0.0 114.077 -172.801 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.62 ' HA ' ' H ' ' A' ' 31' ' ' GLY . 1.1 m-20 -120.57 159.75 24.61 Favored 'General case' 0 C--N 1.269 -2.925 0 CA-C-N 113.514 -1.675 . . . . 0.0 111.228 -176.574 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.495 ' CG ' ' N ' ' A' ' 39' ' ' CYS . 34.2 tt0 -151.94 159.96 43.64 Favored 'General case' 0 C--N 1.312 -1.034 0 C-N-CA 119.051 -1.06 . . . . 0.0 110.329 178.113 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.495 ' N ' ' CG ' ' A' ' 38' ' ' GLN . 91.5 m -131.73 94.28 3.48 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 119.886 -0.726 . . . . 0.0 110.472 -179.902 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.676 HG22 ' N ' ' A' ' 41' ' ' THR . 4.4 p -110.02 173.57 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.336 0 C-N-CA 119.105 -1.038 . . . . 0.0 110.217 179.577 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.676 ' N ' HG22 ' A' ' 40' ' ' VAL . 8.8 t -84.12 156.49 22.11 Favored 'General case' 0 C--N 1.283 -2.326 0 CA-C-N 115.353 -0.839 . . . . 0.0 111.142 178.727 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 159.39 -140.72 7.02 Favored Glycine 0 N--CA 1.492 2.404 0 C-N-CA 119.681 -1.247 . . . . 0.0 110.497 -179.973 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -146.08 89.56 1.89 Allowed 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 119.529 -0.868 . . . . 0.0 110.459 -179.826 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -97.98 -156.15 29.86 Favored Glycine 0 N--CA 1.492 2.395 0 C-N-CA 119.52 -1.324 . . . . 0.0 110.742 -179.538 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -139.91 153.01 69.23 Favored Pre-proline 0 N--CA 1.492 1.666 0 C-N-CA 119.571 -0.852 . . . . 0.0 110.418 -179.98 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.455 ' HB3' HD12 ' A' ' 13' ' ' LEU . 5.2 Cg_exo -53.47 153.97 16.53 Favored 'Trans proline' 0 CA--C 1.543 0.965 0 C-N-CA 122.112 1.875 . . . . 0.0 113.035 177.952 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.597 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 9.2 tm-20 -81.87 -42.59 1.04 Allowed Pre-proline 0 N--CA 1.483 1.188 0 CA-C-N 115.937 -0.574 . . . . 0.0 112.292 177.671 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.597 ' CD ' ' N ' ' A' ' 47' ' ' GLU . 1.3 Cg_endo -65.39 167.95 15.58 Favored 'Trans proline' 0 C--O 1.214 -0.691 0 C-N-CA 120.846 1.031 . . . . 0.0 111.234 -174.451 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 116.355 -1.783 . . . . 0.0 110.279 -179.966 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 99.3 t . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.684 HG12 ' N ' ' A' ' 3' ' ' TYR . 45.6 t -123.47 172.98 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 C-N-CA 119.926 -0.709 . . . . 0.0 110.055 179.996 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.684 ' N ' HG12 ' A' ' 2' ' ' VAL . 10.8 m-85 -144.09 -167.53 2.63 Favored 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 119.896 -0.722 . . . . 0.0 109.89 179.905 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.589 ' OG1' ' N ' ' A' ' 5' ' ' ASP . 0.1 OUTLIER -104.74 -177.64 3.42 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 177.507 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.589 ' N ' ' OG1' ' A' ' 4' ' ' THR . 0.3 OUTLIER -92.1 154.37 18.77 Favored 'General case' 0 C--N 1.291 -1.955 0 C-N-CA 118.626 -1.229 . . . . 0.0 111.169 -179.429 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.482 ' SG ' ' O ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -73.11 170.16 15.51 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.526 177.388 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.39 7.37 2.16 Favored 'General case' 0 C--N 1.296 -1.761 0 C-N-CA 119.108 -1.037 . . . . 0.0 110.187 176.489 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.411 ' HA ' HD12 ' A' ' 30' ' ' LEU . 0.3 OUTLIER -163.97 -178.24 5.52 Favored 'General case' 0 C--N 1.288 -2.085 0 CA-C-N 114.449 -1.25 . . . . 0.0 110.198 179.395 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -86.01 164.37 17.41 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.369 -179.24 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.437 ' O ' ' O ' ' A' ' 11' ' ' GLN . . . 83.25 -30.77 3.27 Favored Glycine 0 N--CA 1.49 2.234 0 C-N-CA 119.189 -1.481 . . . . 0.0 111.32 179.531 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.514 ' OE1' ' N ' ' A' ' 11' ' ' GLN . 3.1 mp0 -44.09 168.39 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.068 0 C-N-CA 119.194 -1.002 . . . . 0.0 109.879 179.806 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.461 ' O ' ' O ' ' A' ' 22' ' ' CYS . 2.1 m-20 -141.9 -69.7 0.36 Allowed 'General case' 0 N--CA 1.5 2.051 0 C-N-CA 118.536 -1.266 . . . . 0.0 113.374 -177.647 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 81.7 mt -75.63 46.71 0.37 Allowed 'General case' 0 C--N 1.272 -2.765 0 C-N-CA 118.327 -1.349 . . . . 0.0 110.151 -177.0 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.442 ' HB2' ' N ' ' A' ' 6' ' ' CYS . 29.9 p -123.58 -156.93 0.73 Allowed 'General case' 0 C--O 1.205 -1.269 0 CA-C-N 115.265 -0.88 . . . . 0.0 109.597 179.046 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.482 ' O ' ' SG ' ' A' ' 6' ' ' CYS . 71.2 mt -116.09 109.12 17.06 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 114.934 -1.03 . . . . 0.0 108.237 175.687 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.575 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 0.5 OUTLIER -110.31 -51.44 2.87 Favored 'General case' 0 C--N 1.289 -2.054 0 C-N-CA 118.933 -1.107 . . . . 0.0 110.71 -174.673 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.508 ' N ' ' SG ' ' A' ' 16' ' ' CYS . 18.4 tp10 -88.63 75.55 8.26 Favored 'General case' 0 C--N 1.294 -1.816 0 C-N-CA 118.649 -1.221 . . . . 0.0 109.048 177.862 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.38 -121.89 6.61 Favored Glycine 0 N--CA 1.486 2.0 0 C-N-CA 119.143 -1.503 . . . . 0.0 110.013 -178.57 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.425 ' O ' HD22 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -99.81 -1.17 38.27 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 122.026 0.917 . . . . 0.0 110.22 -179.803 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -79.64 133.41 36.4 Favored 'General case' 0 C--N 1.26 -3.309 0 CA-C-N 113.719 -1.582 . . . . 0.0 110.861 -179.137 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.0 t -70.95 141.54 16.73 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.955 0 C-N-CA 118.879 -1.128 . . . . 0.0 109.081 177.71 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.461 ' O ' ' O ' ' A' ' 12' ' ' ASN . 0.1 OUTLIER -148.47 121.39 8.77 Favored 'General case' 0 C--N 1.277 -2.556 0 C-N-CA 118.346 -1.342 . . . . 0.0 109.458 177.304 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.482 ' O ' ' O ' ' A' ' 26' ' ' ASN . . . 175.0 -94.99 0.1 OUTLIER Glycine 0 C--O 1.201 -1.949 0 C-N-CA 118.304 -1.903 . . . . 0.0 111.505 -174.527 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -39.33 129.81 1.74 Allowed 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 120.494 -0.483 . . . . 0.0 111.553 -176.467 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.437 ' O ' ' OD1' ' A' ' 26' ' ' ASN . . . 90.65 -19.36 45.12 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -178.414 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.482 ' O ' ' O ' ' A' ' 23' ' ' GLY . 85.5 m-20 -155.96 -163.13 1.42 Allowed 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -179.862 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.676 ' NZ ' HD11 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -156.86 133.13 9.8 Favored 'General case' 0 N--CA 1.496 1.855 0 C-N-CA 117.871 -1.531 . . . . 0.0 111.345 176.143 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.502 ' SG ' ' OD1' ' A' ' 37' ' ' ASN . 0.1 OUTLIER -87.2 161.11 18.22 Favored 'General case' 0 CA--C 1.482 -1.663 0 CA-C-O 123.342 1.544 . . . . 0.0 113.028 179.897 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.676 HD11 ' NZ ' ' A' ' 27' ' ' LYS . 31.5 mm -134.47 124.13 44.23 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.265 0 CA-C-N 111.057 -2.792 . . . . 0.0 109.677 -179.764 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.411 HD12 ' HA ' ' A' ' 8' ' ' GLU . 33.2 mt -76.38 121.04 22.46 Favored 'General case' 0 N--CA 1.501 2.121 0 C-N-CA 118.804 -1.159 . . . . 0.0 110.684 -179.42 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 83.4 104.12 0.52 Allowed Glycine 0 C--N 1.302 -1.317 0 C-N-CA 119.224 -1.465 . . . . 0.0 110.846 178.034 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.587 ' O ' ' N ' ' A' ' 34' ' ' GLY . 27.6 t -78.76 -127.46 0.01 OUTLIER 'General case' 0 C--O 1.198 -1.653 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 176.993 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -71.06 66.25 0.39 Allowed 'General case' 0 C--N 1.253 -3.597 0 CA-C-N 114.814 -1.084 . . . . 0.0 108.684 -176.434 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.587 ' N ' ' O ' ' A' ' 32' ' ' SER . . . 69.8 29.47 71.04 Favored Glycine 0 C--N 1.29 -1.989 0 N-CA-C 108.583 -1.807 . . . . 0.0 108.583 -177.245 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -125.7 -124.17 0.25 Allowed 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 118.829 -1.149 . . . . 0.0 113.137 -176.329 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.548 ' O ' ' N ' ' A' ' 32' ' ' SER . 16.2 mtmt -94.96 -173.02 2.85 Favored 'General case' 0 C--N 1.278 -2.506 0 CA-C-N 113.256 -1.793 . . . . 0.0 112.822 -175.517 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.502 ' OD1' ' SG ' ' A' ' 28' ' ' CYS . 1.4 t30 -82.28 151.75 26.63 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 114.859 -1.064 . . . . 0.0 109.076 177.907 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.48 ' O ' ' SG ' ' A' ' 28' ' ' CYS . 22.8 tt0 -145.88 142.76 29.08 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 118.984 -1.087 . . . . 0.0 110.604 178.833 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.575 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 36.0 m -91.1 94.23 9.51 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.063 -178.486 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.468 ' O ' ' O ' ' A' ' 27' ' ' LYS . 1.2 p -105.94 139.22 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 C-N-CA 118.491 -1.284 . . . . 0.0 111.998 179.297 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.426 ' O ' HG22 ' A' ' 40' ' ' VAL . 4.9 t -58.65 143.2 47.33 Favored 'General case' 0 C--N 1.273 -2.76 0 CA-C-N 113.524 -1.671 . . . . 0.0 111.166 178.172 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 158.34 -141.25 7.54 Favored Glycine 0 N--CA 1.487 2.056 0 C-N-CA 119.6 -1.286 . . . . 0.0 110.007 179.671 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -130.5 131.76 45.28 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.837 -0.745 . . . . 0.0 109.816 179.25 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -137.11 -151.1 5.88 Favored Glycine 0 N--CA 1.489 2.198 0 C-N-CA 119.648 -1.263 . . . . 0.0 110.399 -179.515 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -145.48 152.32 49.34 Favored Pre-proline 0 C--N 1.302 -1.491 0 C-N-CA 119.54 -0.864 . . . . 0.0 109.703 179.989 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -56.16 -170.61 0.03 OUTLIER 'Trans proline' 0 C--O 1.214 -0.702 0 C-N-CA 121.124 1.216 . . . . 0.0 110.504 176.565 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -107.54 100.29 33.52 Favored Pre-proline 0 CA--C 1.56 1.352 0 C-N-CA 120.3 -0.56 . . . . 0.0 110.243 178.6 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -62.68 154.71 63.59 Favored 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 120.707 0.938 . . . . 0.0 110.919 -178.045 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 116.303 -1.808 . . . . 0.0 110.35 -179.568 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.423 HG13 ' O ' ' A' ' 1' ' ' VAL . 7.7 p . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 . . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 1.5 t -95.76 160.36 2.81 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 C-N-CA 119.552 -0.859 . . . . 0.0 110.215 179.603 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.462 ' CG ' ' O ' ' A' ' 13' ' ' LEU . 7.3 m-85 -90.44 -164.98 1.25 Allowed 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 119.212 -0.995 . . . . 0.0 109.242 178.699 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.584 HG23 ' OE2' ' A' ' 47' ' ' GLU . 0.2 OUTLIER -116.65 -176.7 3.02 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 178.9 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.565 ' N ' ' OG1' ' A' ' 4' ' ' THR . 0.2 OUTLIER -79.35 156.17 28.11 Favored 'General case' 0 C--N 1.289 -2.053 0 C-N-CA 118.528 -1.269 . . . . 0.0 110.406 -179.366 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.405 ' N ' ' HB2' ' A' ' 14' ' ' CYS . 0.1 OUTLIER -70.72 152.01 44.27 Favored 'General case' 0 C--N 1.291 -1.967 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.719 176.654 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.415 ' O ' ' CG ' ' A' ' 8' ' ' GLU . 43.0 p -119.36 4.43 11.23 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-O 121.813 0.816 . . . . 0.0 108.96 178.812 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.415 ' CG ' ' O ' ' A' ' 7' ' ' THR . 29.4 mt-10 -161.93 167.47 24.56 Favored 'General case' 0 C--N 1.283 -2.284 0 CA-C-N 113.914 -1.494 . . . . 0.0 111.18 -178.971 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.422 ' HB3' ' H ' ' A' ' 30' ' ' LEU . 0.9 OUTLIER -79.5 156.47 27.79 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 115.038 -0.983 . . . . 0.0 108.868 177.517 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 28' ' ' CYS . . . 90.51 -13.92 64.15 Favored Glycine 0 N--CA 1.503 3.163 0 C-N-CA 118.739 -1.695 . . . . 0.0 112.45 179.264 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 47.5 mm-40 -61.17 -164.51 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.239 0 C-N-CA 119.139 -1.024 . . . . 0.0 111.073 -178.47 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.495 ' C ' ' H ' ' A' ' 14' ' ' CYS . 7.4 m-20 -160.51 -66.96 0.07 Allowed 'General case' 0 N--CA 1.5 2.057 0 C-N-CA 118.377 -1.329 . . . . 0.0 113.367 179.791 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.462 ' O ' ' CG ' ' A' ' 3' ' ' TYR . 86.1 mt -75.85 41.1 0.2 Allowed 'General case' 0 C--N 1.287 -2.123 0 C-N-CA 119.364 -0.934 . . . . 0.0 110.155 -178.396 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.495 ' H ' ' C ' ' A' ' 12' ' ' ASN . 29.1 p -120.3 -165.83 1.24 Allowed 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.232 178.607 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.567 HD22 ' O ' ' A' ' 19' ' ' SER . 47.1 mt -97.19 102.79 14.64 Favored 'General case' 0 C--N 1.294 -1.841 0 C-N-CA 119.248 -0.981 . . . . 0.0 109.441 178.188 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.413 ' CB ' ' SG ' ' A' ' 22' ' ' CYS . 0.5 OUTLIER -95.41 -35.31 11.78 Favored 'General case' 0 C--N 1.281 -2.397 0 CA-C-N 114.262 -1.336 . . . . 0.0 111.139 -176.021 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -114.19 89.65 3.14 Favored 'General case' 0 C--N 1.301 -1.513 0 C-N-CA 119.68 -0.808 . . . . 0.0 110.326 -179.143 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 73.96 -91.26 0.7 Allowed Glycine 0 N--CA 1.488 2.126 0 C-N-CA 119.511 -1.328 . . . . 0.0 110.486 179.418 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.567 ' O ' HD22 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -138.27 4.34 2.44 Favored 'General case' 0 N--CA 1.484 1.232 0 CA-C-O 122.026 0.917 . . . . 0.0 110.89 -178.841 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -85.03 138.89 32.16 Favored 'General case' 0 C--N 1.261 -3.257 0 CA-C-N 113.835 -1.529 . . . . 0.0 111.111 -179.556 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.54 HG12 ' O ' ' A' ' 22' ' ' CYS . 2.4 t -77.28 139.5 18.61 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.124 0 C-N-CA 118.95 -1.1 . . . . 0.0 110.032 179.039 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.54 ' O ' HG12 ' A' ' 21' ' ' VAL . 0.8 OUTLIER -80.7 -135.44 0.03 OUTLIER 'General case' 0 C--N 1.278 -2.502 0 C-N-CA 118.722 -1.191 . . . . 0.0 109.333 176.049 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.532 ' O ' ' ND2' ' A' ' 26' ' ' ASN . . . -172.68 107.14 0.24 Allowed Glycine 0 C--N 1.272 -3.028 0 C-N-CA 117.835 -2.126 . . . . 0.0 111.089 179.309 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.461 ' C ' ' O ' ' A' ' 23' ' ' GLY . 2.9 tt0 -34.32 131.92 0.3 Allowed 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 121.632 0.73 . . . . 0.0 110.422 178.665 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 131.23 -31.12 3.21 Favored Glycine 0 C--N 1.291 -1.96 0 N-CA-C 106.512 -2.635 . . . . 0.0 106.512 -174.714 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.589 ' ND2' ' N ' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -96.1 -161.2 0.85 Allowed 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 175.412 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.697 ' NZ ' HD11 ' A' ' 29' ' ' ILE . 10.7 ttpp -144.56 113.45 6.8 Favored 'General case' 0 C--N 1.287 -2.116 0 C-N-CA 119.436 -0.906 . . . . 0.0 109.616 177.329 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.566 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 5.3 m -84.31 156.82 21.74 Favored 'General case' 0 CA--C 1.482 -1.662 0 C-N-CA 117.392 -1.723 . . . . 0.0 111.603 -179.665 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.697 HD11 ' NZ ' ' A' ' 27' ' ' LYS . 33.2 mm -144.77 125.38 7.89 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.167 0 CA-C-N 113.235 -1.802 . . . . 0.0 109.92 177.943 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.422 ' H ' ' HB3' ' A' ' 9' ' ' SER . 23.4 mt -76.77 121.56 23.5 Favored 'General case' 0 N--CA 1.498 1.964 0 C-N-CA 118.826 -1.15 . . . . 0.0 109.951 178.498 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.439 ' O ' ' O ' ' A' ' 32' ' ' SER . . . 77.65 100.89 0.18 Allowed Glycine 0 C--N 1.303 -1.281 0 C-N-CA 118.468 -1.825 . . . . 0.0 109.855 178.686 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.575 ' O ' ' N ' ' A' ' 34' ' ' GLY . 14.8 m -66.01 -127.78 0.0 OUTLIER 'General case' 0 C--O 1.198 -1.637 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 178.389 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -71.83 64.67 0.49 Allowed 'General case' 0 C--N 1.252 -3.664 0 CA-C-N 114.573 -1.194 . . . . 0.0 108.809 -175.822 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.575 ' N ' ' O ' ' A' ' 32' ' ' SER . . . 72.82 32.46 61.18 Favored Glycine 0 C--N 1.29 -1.988 0 N-CA-C 108.551 -1.82 . . . . 0.0 108.551 -177.252 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -125.7 -125.91 0.24 Allowed 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 118.981 -1.087 . . . . 0.0 112.707 -177.131 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.435 ' O ' ' N ' ' A' ' 32' ' ' SER . 19.9 mttp -97.52 179.93 4.69 Favored 'General case' 0 C--N 1.277 -2.565 0 CA-C-N 113.332 -1.758 . . . . 0.0 113.057 -176.263 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.4 ' HA ' ' H ' ' A' ' 31' ' ' GLY . 7.3 m-20 -64.16 152.08 41.64 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.598 175.968 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 43.1 tt0 -161.22 151.61 17.74 Favored 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 119.042 -1.063 . . . . 0.0 110.174 177.098 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.566 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 0.0 OUTLIER -101.84 104.47 15.22 Favored 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 119.55 -0.86 . . . . 0.0 111.607 179.789 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.51 ' O ' ' N ' ' A' ' 27' ' ' LYS . 1.1 p -99.01 137.5 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 C-N-CA 118.307 -1.357 . . . . 0.0 109.994 175.356 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 6.3 t -63.93 145.5 55.73 Favored 'General case' 0 C--N 1.266 -3.039 0 CA-C-N 114.008 -1.451 . . . . 0.0 110.811 -178.752 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 152.29 -146.81 15.81 Favored Glycine 0 N--CA 1.49 2.26 0 C-N-CA 119.459 -1.353 . . . . 0.0 110.64 179.094 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -116.36 129.44 56.25 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 120.083 -0.647 . . . . 0.0 109.797 -179.951 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -145.9 -165.03 11.19 Favored Glycine 0 N--CA 1.494 2.534 0 C-N-CA 119.284 -1.436 . . . . 0.0 110.616 -179.62 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.3 t -120.41 144.92 39.35 Favored Pre-proline 0 N--CA 1.491 1.618 0 C-N-CA 119.933 -0.707 . . . . 0.0 110.147 -179.671 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.447 ' HB3' HD12 ' A' ' 13' ' ' LEU . 1.2 Cg_endo -64.69 176.27 3.0 Favored 'Trans proline' 0 C--O 1.213 -0.772 0 C-N-CA 120.948 1.099 . . . . 0.0 111.11 175.415 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.584 ' OE2' HG23 ' A' ' 4' ' ' THR . 2.8 tt0 -116.35 85.76 16.59 Favored Pre-proline 0 C--N 1.313 -0.985 0 C-N-CA 120.307 -0.557 . . . . 0.0 110.967 -179.822 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -63.15 165.86 15.98 Favored 'Trans proline' 0 C--O 1.216 -0.599 0 C-N-CA 120.945 1.097 . . . . 0.0 110.687 179.221 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 116.255 -1.831 . . . . 0.0 110.493 -179.3 . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.741 HG13 ' O ' ' A' ' 1' ' ' VAL . 8.2 p . . . . . 0 N--CA 1.489 1.496 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 . . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.421 ' H ' HG23 ' A' ' 2' ' ' VAL . 1.6 t -78.48 158.97 4.81 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 C-N-CA 119.078 -1.049 . . . . 0.0 109.549 179.479 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.427 ' CZ ' HD22 ' A' ' 13' ' ' LEU . 42.8 m-85 -118.35 -171.42 2.07 Favored 'General case' 0 N--CA 1.498 1.942 0 C-N-CA 119.735 -0.786 . . . . 0.0 110.789 -178.337 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.2 p -106.22 -179.87 4.07 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-N 115.304 -0.862 . . . . 0.0 108.838 179.248 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -91.02 149.5 21.81 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 118.572 -1.251 . . . . 0.0 111.134 -179.546 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.513 ' SG ' ' O ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -74.06 178.46 4.99 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.972 178.397 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.2 p -148.68 21.02 1.03 Allowed 'General case' 0 C--N 1.285 -2.2 0 CA-C-N 114.149 -1.387 . . . . 0.0 109.032 175.406 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -160.81 171.89 17.99 Favored 'General case' 0 C--N 1.292 -1.92 0 CA-C-N 114.274 -1.33 . . . . 0.0 110.516 -179.272 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.486 ' O ' ' N ' ' A' ' 11' ' ' GLN . 0.5 OUTLIER -71.32 -176.68 1.55 Allowed 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 119.703 -0.799 . . . . 0.0 109.558 179.785 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.678 ' HA2' ' O ' ' A' ' 28' ' ' CYS . . . 28.31 9.39 0.0 OUTLIER Glycine 0 N--CA 1.498 2.819 1 N-CA-C 130.224 6.85 . . . . 0.0 130.224 179.862 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.486 ' N ' ' O ' ' A' ' 9' ' ' SER . 0.0 OUTLIER -60.75 -165.1 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 176.45 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.473 ' O ' ' O ' ' A' ' 22' ' ' CYS . 0.3 OUTLIER -148.76 -70.26 0.21 Allowed 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 117.266 -1.773 . . . . 0.0 114.225 -179.795 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.427 HD22 ' CZ ' ' A' ' 3' ' ' TYR . 7.6 mt -75.74 47.46 0.42 Allowed 'General case' 0 C--N 1.263 -3.174 0 C-N-CA 117.936 -1.505 . . . . 0.0 110.663 -175.543 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.542 ' O ' HG22 ' A' ' 21' ' ' VAL . 28.0 p -124.74 -156.58 0.73 Allowed 'General case' 0 C--O 1.211 -0.934 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.2 177.182 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.513 ' O ' ' SG ' ' A' ' 6' ' ' CYS . 5.8 mt -115.56 127.29 55.15 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.029 176.199 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.575 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -141.38 21.88 2.21 Favored 'General case' 0 C--N 1.297 -1.703 0 C-N-CA 118.409 -1.316 . . . . 0.0 111.439 -174.516 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -157.03 77.43 0.88 Allowed 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 119.6 -0.84 . . . . 0.0 109.145 176.047 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 77.2 -88.52 0.99 Allowed Glycine 0 N--CA 1.486 1.976 0 C-N-CA 119.386 -1.388 . . . . 0.0 109.881 -178.388 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.48 ' O ' ' OG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -145.56 11.67 1.29 Allowed 'General case' 0 C--N 1.303 -1.432 0 CA-C-O 122.511 1.148 . . . . 0.0 109.988 179.606 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -95.57 138.46 33.21 Favored 'General case' 0 C--N 1.258 -3.392 0 CA-C-N 113.238 -1.801 . . . . 0.0 110.288 178.105 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.542 HG22 ' O ' ' A' ' 14' ' ' CYS . 1.4 t -72.64 145.21 12.19 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.059 -178.593 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.473 ' O ' ' O ' ' A' ' 12' ' ' ASN . 6.0 m -144.41 126.13 15.16 Favored 'General case' 0 N--CA 1.499 2.021 0 C-N-CA 118.732 -1.187 . . . . 0.0 109.436 177.212 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.436 ' O ' ' O ' ' A' ' 26' ' ' ASN . . . 175.5 -91.05 0.08 OUTLIER Glycine 0 C--O 1.206 -1.604 0 C-N-CA 117.349 -2.358 . . . . 0.0 112.737 -178.043 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -48.9 126.22 11.81 Favored 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 119.453 -0.899 . . . . 0.0 111.007 -176.7 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.18 -29.09 9.22 Favored Glycine 0 N--CA 1.48 1.591 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -178.447 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.436 ' O ' ' O ' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -132.11 -168.95 2.12 Favored 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 120.163 -0.615 . . . . 0.0 110.929 -179.49 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.51 ' O ' ' O ' ' A' ' 40' ' ' VAL . 0.1 OUTLIER -142.71 159.53 42.05 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 177.955 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.678 ' O ' ' HA2' ' A' ' 10' ' ' GLY . 74.0 m -127.03 163.27 24.1 Favored 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 118.657 -1.217 . . . . 0.0 111.917 178.666 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 10.8 mm -139.59 130.6 32.67 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.839 0 CA-C-N 113.081 -1.872 . . . . 0.0 109.545 176.494 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.454 HD23 ' HA ' ' A' ' 30' ' ' LEU . 16.7 mt -75.5 117.44 17.29 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 118.091 -1.444 . . . . 0.0 108.31 176.894 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.66 101.77 0.79 Allowed Glycine 0 N--CA 1.482 1.732 0 N-CA-C 108.669 -1.772 . . . . 0.0 108.669 -176.747 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.586 ' N ' ' O ' ' A' ' 36' ' ' LYS . 0.8 OUTLIER -83.3 -134.48 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 119.943 -0.703 . . . . 0.0 109.807 -176.951 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.411 ' H ' ' HB2' ' A' ' 32' ' ' SER . 16.0 t70 -71.42 64.25 0.4 Allowed 'General case' 0 C--N 1.255 -3.53 0 CA-C-N 114.153 -1.385 . . . . 0.0 108.878 -175.426 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 32' ' ' SER . . . 76.51 27.49 61.24 Favored Glycine 0 C--N 1.285 -2.256 0 N-CA-C 108.124 -1.99 . . . . 0.0 108.124 -176.989 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -126.71 -136.0 0.25 Allowed 'General case' 0 C--O 1.213 -0.857 0 CA-C-O 122.215 1.007 . . . . 0.0 111.41 -177.567 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.586 ' O ' ' N ' ' A' ' 32' ' ' SER . 8.2 mttm -102.89 -154.84 0.5 Allowed 'General case' 0 C--N 1.269 -2.894 0 CA-C-N 113.005 -1.907 . . . . 0.0 112.206 -176.811 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.505 ' N ' ' OD1' ' A' ' 37' ' ' ASN . 0.9 OUTLIER -70.7 141.72 51.55 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 115.063 -0.972 . . . . 0.0 110.542 178.024 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.47 ' CG ' ' N ' ' A' ' 39' ' ' CYS . 36.6 tt0 -143.59 166.9 23.56 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 120.008 -0.677 . . . . 0.0 109.531 179.503 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.575 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 3.8 m -116.93 91.18 3.51 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 119.567 -0.853 . . . . 0.0 110.814 -179.611 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.51 ' O ' ' O ' ' A' ' 27' ' ' LYS . 0.2 OUTLIER -91.17 139.0 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.17 0 C-N-CA 118.235 -1.386 . . . . 0.0 111.432 179.261 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.421 ' O ' HG22 ' A' ' 40' ' ' VAL . 11.4 t -49.62 151.69 1.61 Allowed 'General case' 0 C--N 1.271 -2.829 0 CA-C-N 114.124 -1.398 . . . . 0.0 110.806 -178.767 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 146.78 -155.27 26.46 Favored Glycine 0 N--CA 1.489 2.209 0 C-N-CA 119.682 -1.247 . . . . 0.0 110.146 -179.378 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 81.4 mt-10 -144.39 143.15 30.79 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 119.497 -0.881 . . . . 0.0 110.282 179.844 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -146.95 -148.12 4.69 Favored Glycine 0 N--CA 1.494 2.53 0 C-N-CA 119.269 -1.443 . . . . 0.0 110.961 -179.525 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -132.56 155.92 80.68 Favored Pre-proline 0 N--CA 1.495 1.814 0 C-N-CA 120.183 -0.607 . . . . 0.0 109.64 -179.206 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -53.04 -168.92 0.01 OUTLIER 'Trans proline' 0 C--O 1.215 -0.657 0 C-N-CA 121.46 1.44 . . . . 0.0 111.44 176.933 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -118.75 86.04 29.12 Favored Pre-proline 0 C--N 1.312 -1.024 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.891 -179.706 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -65.05 169.58 11.78 Favored 'Trans proline' 0 C--N 1.325 -0.695 0 C-N-CA 121.071 1.181 . . . . 0.0 110.831 178.741 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 47.0 mm-40 . . . . . 0 N--CA 1.491 1.575 0 CA-C-O 116.368 -1.777 . . . . 0.0 110.379 -179.849 . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 4.6 t . . . . . 0 N--CA 1.489 1.496 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.545 HG12 ' N ' ' A' ' 3' ' ' TYR . 11.3 t -101.64 169.51 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 C-N-CA 119.736 -0.786 . . . . 0.0 110.516 -179.264 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.545 ' N ' HG12 ' A' ' 2' ' ' VAL . 37.0 m-85 -122.82 -167.74 1.63 Allowed 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 177.601 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.442 ' OG1' ' OE1' ' A' ' 47' ' ' GLU . 10.4 p -106.07 173.49 6.29 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 119.441 -0.904 . . . . 0.0 109.304 -179.837 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -85.4 147.72 26.35 Favored 'General case' 0 C--N 1.286 -2.176 0 C-N-CA 118.653 -1.219 . . . . 0.0 109.74 179.485 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -75.29 -176.37 3.07 Favored 'General case' 0 C--N 1.285 -2.223 0 C-N-CA 119.547 -0.861 . . . . 0.0 110.336 177.545 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.404 ' O ' ' OG1' ' A' ' 7' ' ' THR . 1.6 t -155.04 12.95 0.38 Allowed 'General case' 0 C--N 1.277 -2.566 0 CA-C-N 114.1 -1.409 . . . . 0.0 110.501 178.696 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -163.82 178.55 7.74 Favored 'General case' 0 C--N 1.282 -2.343 0 CA-C-N 114.647 -1.161 . . . . 0.0 110.088 179.388 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.452 ' O ' ' N ' ' A' ' 11' ' ' GLN . 0.5 OUTLIER -74.66 -160.11 0.1 Allowed 'General case' 0 C--N 1.297 -1.702 0 C-N-CA 119.808 -0.757 . . . . 0.0 109.809 179.864 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.709 ' HA2' ' CE ' ' A' ' 27' ' ' LYS . . . 27.79 10.75 0.0 OUTLIER Glycine 0 N--CA 1.5 2.945 1 N-CA-C 130.68 7.032 . . . . 0.0 130.68 178.557 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.456 ' O ' ' OD1' ' A' ' 12' ' ' ASN . 1.3 mt-30 -86.59 -174.68 5.11 Favored 'General case' 0 N--CA 1.499 1.995 0 C-N-CA 119.01 -1.076 . . . . 0.0 108.537 176.726 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.551 ' ND2' ' O ' ' A' ' 26' ' ' ASN . 16.8 m-20 -138.92 -65.63 0.49 Allowed 'General case' 0 N--CA 1.502 2.141 0 C-N-CA 118.247 -1.381 . . . . 0.0 114.675 -174.641 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.438 HD23 ' HA ' ' A' ' 13' ' ' LEU . 21.2 mt -77.94 47.33 0.63 Allowed 'General case' 0 C--N 1.272 -2.796 0 C-N-CA 117.939 -1.504 . . . . 0.0 111.573 -174.946 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 11.0 p -125.35 -167.4 1.68 Allowed 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 119.804 -0.758 . . . . 0.0 109.327 176.732 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.585 HD22 ' O ' ' A' ' 19' ' ' SER . 57.2 mt -102.09 116.05 31.86 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 177.06 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 6.5 m -111.4 -42.44 3.89 Favored 'General case' 0 N--CA 1.505 2.285 0 C-N-CA 118.854 -1.138 . . . . 0.0 111.919 -175.642 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.34 92.26 4.86 Favored 'General case' 0 N--CA 1.498 1.952 0 C-N-CA 118.968 -1.093 . . . . 0.0 109.776 178.381 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 76.03 -98.21 1.19 Allowed Glycine 0 N--CA 1.491 2.306 0 C-N-CA 119.319 -1.419 . . . . 0.0 110.308 -179.756 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.585 ' O ' HD22 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -134.89 3.02 3.18 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-O 122.231 1.015 . . . . 0.0 110.451 179.77 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -83.95 139.27 32.69 Favored 'General case' 0 C--N 1.26 -3.303 0 CA-C-N 113.51 -1.677 . . . . 0.0 110.728 -179.358 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.434 ' HA ' HD23 ' A' ' 15' ' ' LEU . 2.3 t -64.42 142.59 16.68 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.035 0 C-N-CA 118.95 -1.1 . . . . 0.0 110.153 179.511 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.517 ' O ' ' SG ' ' A' ' 28' ' ' CYS . 0.0 OUTLIER -149.72 122.72 8.81 Favored 'General case' 0 C--N 1.28 -2.432 0 C-N-CA 118.659 -1.217 . . . . 0.0 109.403 177.395 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.428 ' HA3' ' O ' ' A' ' 12' ' ' ASN . . . 148.91 -33.94 1.14 Allowed Glycine 0 C--N 1.296 -1.678 1 N-CA-C 130.077 6.791 . . . . 0.0 130.077 -177.234 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.444 ' C ' ' H ' ' A' ' 26' ' ' ASN . 0.6 OUTLIER -54.64 116.52 2.74 Favored 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 119.301 -0.959 . . . . 0.0 110.261 179.911 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 78.85 -20.7 4.33 Favored Glycine 0 N--CA 1.479 1.504 0 C-N-CA 119.317 -1.42 . . . . 0.0 109.749 -178.681 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.551 ' O ' ' ND2' ' A' ' 12' ' ' ASN . 0.0 OUTLIER -114.22 -170.53 1.74 Allowed 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 119.933 -0.707 . . . . 0.0 109.876 -179.8 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.709 ' CE ' ' HA2' ' A' ' 10' ' ' GLY . 0.2 OUTLIER -154.2 118.71 4.87 Favored 'General case' 0 N--CA 1.5 2.045 0 C-N-CA 119.084 -1.046 . . . . 0.0 111.205 -179.969 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.517 ' SG ' ' O ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -81.77 160.98 23.46 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 118.979 -1.088 . . . . 0.0 110.956 -179.174 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.537 HD11 ' CE ' ' A' ' 27' ' ' LYS . 36.5 mm -133.33 126.81 53.11 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 C-N-CA 119.385 -0.926 . . . . 0.0 110.455 179.685 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 13.3 mt -78.57 132.6 37.21 Favored 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 118.612 -1.235 . . . . 0.0 109.935 178.065 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.939 ' HA3' ' O ' ' A' ' 35' ' ' GLU . . . -117.72 -112.08 2.58 Favored Glycine 0 C--O 1.216 -0.985 1 N-CA-C 130.954 7.141 . . . . 0.0 130.954 177.331 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.506 ' H ' ' C ' ' A' ' 35' ' ' GLU . 50.0 m -164.08 -129.7 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.248 0 CA-C-O 122.568 1.175 . . . . 0.0 112.484 -177.554 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 38.3 m-20 -80.11 69.95 6.62 Favored 'General case' 0 C--N 1.27 -2.848 0 CA-C-N 112.971 -1.922 . . . . 0.0 111.051 -173.076 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 104.94 2.45 42.4 Favored Glycine 0 C--N 1.278 -2.647 0 N-CA-C 107.111 -2.396 . . . . 0.0 107.111 -179.428 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.939 ' O ' ' HA3' ' A' ' 31' ' ' GLY . 3.7 mm-40 -119.54 10.41 11.79 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 113.21 -1.495 . . . . 0.0 108.809 -179.745 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.693 ' O ' ' O ' ' A' ' 35' ' ' GLU . 31.7 mttt -36.23 -157.59 0.0 OUTLIER 'General case' 0 C--N 1.271 -2.836 0 CA-C-N 111.65 -2.523 . . . . 0.0 112.801 -179.439 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.403 ' C ' ' OD1' ' A' ' 37' ' ' ASN . 48.6 t-20 -71.66 110.25 6.1 Favored 'General case' 0 C--N 1.28 -2.449 0 C-N-CA 118.983 -1.087 . . . . 0.0 110.156 -179.999 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 tt0 -113.19 140.35 48.01 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.647 179.177 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 77.1 m -91.49 107.65 19.35 Favored 'General case' 0 C--N 1.294 -1.847 0 C-N-CA 119.124 -1.03 . . . . 0.0 111.073 -179.887 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.578 HG22 ' N ' ' A' ' 41' ' ' THR . 2.5 p -123.58 162.6 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.5 0 C-N-CA 118.833 -1.147 . . . . 0.0 110.862 177.807 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.578 ' N ' HG22 ' A' ' 40' ' ' VAL . 1.3 t -90.0 144.99 25.43 Favored 'General case' 0 C--N 1.284 -2.257 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.805 179.585 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 178.49 -93.4 0.09 OUTLIER Glycine 0 N--CA 1.491 2.344 1 N-CA-C 130.25 6.86 . . . . 0.0 130.25 179.899 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -157.8 93.03 1.24 Allowed 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 119.561 -0.856 . . . . 0.0 110.027 179.399 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.528 ' HA3' ' HG3' ' A' ' 27' ' ' LYS . . . -131.62 -178.76 15.67 Favored Glycine 0 N--CA 1.493 2.467 1 N-CA-C 131.711 7.444 . . . . 0.0 131.711 -178.963 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -106.84 118.63 53.73 Favored Pre-proline 0 CA--C 1.561 1.386 0 C-N-CA 120.462 -0.495 . . . . 0.0 111.422 -179.341 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.41 ' O ' ' C ' ' A' ' 47' ' ' GLU . 4.3 Cg_exo -64.46 102.95 0.42 Allowed 'Trans proline' 0 C--O 1.215 -0.652 0 C-N-CA 120.935 1.09 . . . . 0.0 110.784 174.894 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.442 ' OE1' ' OG1' ' A' ' 4' ' ' THR . 6.5 tm-20 -39.64 106.52 0.4 Allowed Pre-proline 0 CA--C 1.56 1.343 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.162 179.603 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.415 ' O ' ' OE2' ' A' ' 47' ' ' GLU . 1.4 Cg_endo -63.93 132.32 34.21 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 120.672 0.914 . . . . 0.0 111.421 -175.563 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 116.341 -1.79 . . . . 0.0 110.182 179.43 . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 3.1 t . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.638 HG12 ' N ' ' A' ' 3' ' ' TYR . 23.1 t -85.19 173.34 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 119.009 -1.076 . . . . 0.0 110.047 179.708 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.638 ' N ' HG12 ' A' ' 2' ' ' VAL . 23.4 m-85 -96.61 -166.25 1.39 Allowed 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 119.39 -0.924 . . . . 0.0 111.057 -178.013 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 13.8 p -96.9 176.19 6.06 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 119.792 -0.763 . . . . 0.0 109.225 -179.321 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -89.71 144.67 25.79 Favored 'General case' 0 C--N 1.289 -2.052 0 C-N-CA 118.722 -1.191 . . . . 0.0 109.335 178.321 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -73.81 -177.93 3.0 Favored 'General case' 0 C--N 1.286 -2.175 0 CA-C-O 122.144 0.973 . . . . 0.0 111.535 -179.864 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.7 p -154.37 18.56 0.48 Allowed 'General case' 0 C--N 1.283 -2.286 0 CA-C-N 113.476 -1.693 . . . . 0.0 109.076 178.486 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -163.2 177.93 8.64 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-N 114.4 -1.273 . . . . 0.0 110.568 -178.98 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.496 ' O ' ' N ' ' A' ' 11' ' ' GLN . 0.6 OUTLIER -83.91 -158.52 0.32 Allowed 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.985 -179.763 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.529 ' HA2' ' HE3' ' A' ' 27' ' ' LYS . . . 22.85 21.41 0.0 OUTLIER Glycine 0 N--CA 1.498 2.779 1 N-CA-C 129.973 6.749 . . . . 0.0 129.973 178.762 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.496 ' N ' ' O ' ' A' ' 9' ' ' SER . 7.7 mt-30 -94.49 -164.18 1.14 Allowed 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 114.492 -0.854 . . . . 0.0 109.575 178.233 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.74 HD21 ' H ' ' A' ' 44' ' ' GLY . 24.7 m-20 -147.57 -62.59 0.27 Allowed 'General case' 0 N--CA 1.501 2.082 0 C-N-CA 118.086 -1.446 . . . . 0.0 114.54 -177.311 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.437 HD22 ' CZ ' ' A' ' 3' ' ' TYR . 16.2 mt -76.86 47.43 0.52 Allowed 'General case' 0 C--N 1.269 -2.909 0 C-N-CA 118.127 -1.429 . . . . 0.0 111.795 -174.586 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 7.0 p -129.85 -168.07 1.9 Allowed 'General case' 0 C--N 1.308 -1.203 0 C-N-CA 119.657 -0.817 . . . . 0.0 110.186 175.441 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 35.9 mt -104.41 120.12 40.51 Favored 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 119.586 -0.846 . . . . 0.0 108.935 178.232 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.1 m -119.67 -18.9 8.24 Favored 'General case' 0 N--CA 1.501 2.114 0 C-N-CA 119.163 -1.015 . . . . 0.0 111.816 -176.575 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.11 93.78 4.02 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 119.591 -0.844 . . . . 0.0 109.243 177.677 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 68.84 -101.75 0.83 Allowed Glycine 0 N--CA 1.486 2.001 0 C-N-CA 119.245 -1.455 . . . . 0.0 109.8 -178.268 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.442 ' O ' ' OG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -127.17 4.12 6.41 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 122.541 1.162 . . . . 0.0 109.269 178.931 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -78.09 140.1 39.06 Favored 'General case' 0 C--N 1.262 -3.211 0 CA-C-N 112.811 -1.995 . . . . 0.0 111.203 -179.077 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.1 t -77.27 145.75 9.61 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.19 0 C-N-CA 119.337 -0.945 . . . . 0.0 110.021 178.754 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.494 ' O ' ' SG ' ' A' ' 28' ' ' CYS . 15.0 m -146.57 109.89 4.78 Favored 'General case' 0 C--N 1.288 -2.099 0 C-N-CA 118.99 -1.084 . . . . 0.0 109.185 176.761 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.577 ' HA2' ' OD1' ' A' ' 12' ' ' ASN . . . -170.72 -78.75 0.04 OUTLIER Glycine 0 N--CA 1.479 1.523 1 N-CA-C 129.681 6.632 . . . . 0.0 129.681 -175.961 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.34 110.98 2.43 Favored 'General case' 0 C--N 1.311 -1.071 0 C-N-CA 118.308 -1.357 . . . . 0.0 109.309 179.441 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 105.44 -18.93 40.7 Favored Glycine 0 C--N 1.302 -1.359 0 N-CA-C 122.735 3.854 . . . . 0.0 122.735 -171.443 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.413 ' HA ' ' H ' ' A' ' 42' ' ' GLY . 0.0 OUTLIER -132.36 -167.94 1.97 Allowed 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 112.788 -1.706 . . . . 0.0 108.711 179.105 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.529 ' HE3' ' HA2' ' A' ' 10' ' ' GLY . 12.7 tttt -148.11 122.15 9.46 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 118.52 -1.272 . . . . 0.0 110.502 177.472 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.494 ' SG ' ' O ' ' A' ' 22' ' ' CYS . 19.2 m -86.55 153.58 21.72 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 117.825 -1.55 . . . . 0.0 110.819 178.624 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 13.6 mm -137.2 129.39 42.87 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.647 0 CA-C-N 114.492 -1.231 . . . . 0.0 109.303 175.839 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.461 HD23 ' HA ' ' A' ' 30' ' ' LEU . 17.2 mt -75.55 111.55 10.98 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 118.191 -1.404 . . . . 0.0 108.914 178.001 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.51 100.38 0.96 Allowed Glycine 0 C--N 1.299 -1.526 0 C-N-CA 118.821 -1.657 . . . . 0.0 109.303 -178.275 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.56 ' O ' ' N ' ' A' ' 34' ' ' GLY . 6.7 t -72.19 -130.48 0.0 OUTLIER 'General case' 0 C--O 1.2 -1.519 0 C-N-CA 119.147 -1.021 . . . . 0.0 108.407 -179.01 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -72.07 65.05 0.55 Allowed 'General case' 0 C--N 1.253 -3.603 0 CA-C-N 114.332 -1.303 . . . . 0.0 108.881 -175.697 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.56 ' N ' ' O ' ' A' ' 32' ' ' SER . . . 75.35 26.56 65.58 Favored Glycine 0 C--N 1.289 -2.054 0 N-CA-C 108.521 -1.832 . . . . 0.0 108.521 -177.381 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.426 ' OE2' ' O ' ' A' ' 34' ' ' GLY . 11.0 mm-40 -122.27 -131.3 0.28 Allowed 'General case' 0 C--O 1.214 -0.767 0 C-N-CA 119.251 -0.979 . . . . 0.0 111.873 -177.455 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.519 ' O ' ' N ' ' A' ' 32' ' ' SER . 8.9 mttp -101.72 -168.59 1.57 Allowed 'General case' 0 C--N 1.272 -2.769 0 CA-C-N 113.23 -1.805 . . . . 0.0 112.861 -176.958 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.431 ' OD1' ' N ' ' A' ' 37' ' ' ASN . 2.0 m-20 -64.32 139.55 58.78 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.648 176.65 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 40.2 tt0 -150.51 141.79 23.25 Favored 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 118.998 -1.081 . . . . 0.0 110.111 177.969 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 14.2 m -91.21 91.36 8.18 Favored 'General case' 0 C--N 1.293 -1.861 0 C-N-CA 119.49 -0.884 . . . . 0.0 111.173 -178.362 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.475 ' O ' ' O ' ' A' ' 27' ' ' LYS . 0.6 OUTLIER -95.53 139.69 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 C-N-CA 118.334 -1.347 . . . . 0.0 110.941 178.659 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.413 ' O ' HG22 ' A' ' 40' ' ' VAL . 8.8 t -56.8 147.27 23.66 Favored 'General case' 0 C--N 1.271 -2.831 0 CA-C-N 114.085 -1.416 . . . . 0.0 110.918 -179.567 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.413 ' H ' ' HA ' ' A' ' 26' ' ' ASN . . . 159.43 -141.25 7.39 Favored Glycine 0 N--CA 1.487 2.073 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 -179.263 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -146.57 106.44 3.98 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 119.34 -0.944 . . . . 0.0 110.229 179.785 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.74 ' H ' HD21 ' A' ' 12' ' ' ASN . . . -108.46 -156.54 18.46 Favored Glycine 0 N--CA 1.498 2.822 0 C-N-CA 119.834 -1.174 . . . . 0.0 111.1 -178.807 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -132.56 156.12 80.45 Favored Pre-proline 0 N--CA 1.497 1.876 0 C-N-CA 120.104 -0.638 . . . . 0.0 109.853 -178.941 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -53.84 165.33 1.92 Allowed 'Trans proline' 0 C--O 1.216 -0.623 0 C-N-CA 121.373 1.382 . . . . 0.0 111.092 175.828 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.496 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 2.7 tt0 -90.08 -43.49 0.41 Allowed Pre-proline 0 CA--C 1.558 1.259 0 C-N-CA 119.293 -0.963 . . . . 0.0 110.952 177.958 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.496 ' CD ' ' N ' ' A' ' 47' ' ' GLU . 3.9 Cg_endo -72.21 135.63 25.24 Favored 'Trans proline' 0 C--O 1.216 -0.602 0 C-N-CA 120.786 0.991 . . . . 0.0 110.721 176.889 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 5.4 mp0 . . . . . 0 N--CA 1.497 1.887 0 CA-C-O 116.294 -1.812 . . . . 0.0 110.373 179.799 . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.778 HG12 ' H ' ' A' ' 3' ' ' TYR . 65.5 t . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 . . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 4.2 t -79.99 5.1 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 C-N-CA 119.573 -0.851 . . . . 0.0 110.768 -178.936 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.778 ' H ' HG12 ' A' ' 1' ' ' VAL . 94.7 m-85 -138.32 -172.18 3.22 Favored 'General case' 0 C--N 1.273 -2.75 0 CA-C-N 114.509 -1.223 . . . . 0.0 111.182 179.808 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.6 p -123.22 -167.44 1.6 Allowed 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 114.797 -1.092 . . . . 0.0 108.563 178.314 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.428 ' OD1' HD12 ' A' ' 15' ' ' LEU . 0.1 OUTLIER -93.54 156.14 16.91 Favored 'General case' 0 C--N 1.288 -2.106 0 C-N-CA 119.05 -1.06 . . . . 0.0 111.434 -177.939 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.447 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 1.7 m -72.23 162.17 29.84 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 114.931 -1.031 . . . . 0.0 110.44 177.286 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.454 ' O ' ' OG1' ' A' ' 7' ' ' THR . 0.2 OUTLIER -138.44 8.73 2.66 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 119.46 -0.896 . . . . 0.0 110.034 178.328 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -164.75 161.09 20.37 Favored 'General case' 0 C--N 1.281 -2.376 0 CA-C-N 114.29 -1.323 . . . . 0.0 110.379 178.886 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.484 ' HB3' ' H ' ' A' ' 30' ' ' LEU . 0.7 OUTLIER -70.36 150.37 46.37 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.644 -0.823 . . . . 0.0 109.905 -179.783 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.426 ' O ' ' O ' ' A' ' 11' ' ' GLN . . . 101.66 -37.01 3.84 Favored Glycine 0 N--CA 1.502 3.085 0 C-N-CA 119.511 -1.328 . . . . 0.0 112.759 178.114 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.426 ' O ' ' O ' ' A' ' 10' ' ' GLY . 24.7 mt-30 -47.31 176.39 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.521 0 C-N-CA 119.539 -0.865 . . . . 0.0 111.583 -177.63 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.514 ' C ' ' H ' ' A' ' 14' ' ' CYS . 54.7 m-20 -147.93 -60.56 0.26 Allowed 'General case' 0 N--CA 1.502 2.164 0 C-N-CA 118.698 -1.201 . . . . 0.0 113.339 -178.161 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.495 HD12 ' HB3' ' A' ' 46' ' ' PRO . 19.0 mt -76.1 39.71 0.19 Allowed 'General case' 0 C--N 1.29 -2.016 0 C-N-CA 118.752 -1.179 . . . . 0.0 110.273 -177.88 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.587 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 17.2 p -122.27 -164.58 1.18 Allowed 'General case' 0 C--N 1.292 -1.908 0 CA-C-N 115.05 -0.977 . . . . 0.0 108.387 176.555 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.428 HD12 ' OD1' ' A' ' 5' ' ' ASP . 25.4 mt -100.29 99.39 10.05 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-O 122.286 1.041 . . . . 0.0 108.7 177.764 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.587 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 93.2 m -100.91 -61.62 1.35 Allowed 'General case' 0 C--N 1.276 -2.594 0 CA-C-N 113.273 -1.785 . . . . 0.0 110.708 -174.07 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -80.57 90.11 5.7 Favored 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 118.902 -1.119 . . . . 0.0 108.838 178.207 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 69.29 -127.59 21.07 Favored Glycine 0 N--CA 1.484 1.847 0 C-N-CA 118.953 -1.594 . . . . 0.0 109.465 -177.838 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -100.89 0.01 37.65 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 122.179 0.99 . . . . 0.0 109.966 179.688 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 67.7 m-80 -80.02 150.92 30.23 Favored 'General case' 0 C--N 1.261 -3.246 0 CA-C-N 113.483 -1.689 . . . . 0.0 111.256 -179.007 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.545 HG12 ' O ' ' A' ' 22' ' ' CYS . 2.4 t -82.92 141.36 15.03 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 C-N-CA 119.566 -0.853 . . . . 0.0 111.477 -179.176 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.602 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 0.1 OUTLIER -77.76 -130.85 0.01 OUTLIER 'General case' 0 N--CA 1.514 2.764 0 C-N-CA 118.765 -1.174 . . . . 0.0 108.867 172.468 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.588 ' O ' ' ND2' ' A' ' 26' ' ' ASN . . . -179.71 111.2 0.31 Allowed Glycine 0 C--N 1.275 -2.845 0 C-N-CA 117.96 -2.067 . . . . 0.0 111.617 177.527 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.452 ' C ' ' O ' ' A' ' 23' ' ' GLY . 36.4 tt0 -36.61 129.69 0.77 Allowed 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 119.979 -0.688 . . . . 0.0 109.244 176.13 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 121.31 -25.91 6.85 Favored Glycine 0 N--CA 1.483 1.813 0 N-CA-C 107.532 -2.227 . . . . 0.0 107.532 -175.142 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.588 ' ND2' ' O ' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -107.5 -161.25 0.77 Allowed 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 176.894 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.543 ' O ' ' O ' ' A' ' 40' ' ' VAL . 29.4 tttp -153.7 105.7 2.82 Favored 'General case' 0 N--CA 1.5 2.041 0 C-N-CA 118.799 -1.16 . . . . 0.0 111.918 179.866 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.619 ' O ' HD13 ' A' ' 29' ' ' ILE . 3.3 m -78.55 154.81 30.09 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 118.39 -1.324 . . . . 0.0 110.146 178.71 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.619 HD13 ' O ' ' A' ' 28' ' ' CYS . 8.2 mm -134.3 133.72 55.25 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.152 0 CA-C-N 114.968 -1.014 . . . . 0.0 110.283 175.655 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.484 ' H ' ' HB3' ' A' ' 9' ' ' SER . 17.7 mt -75.64 122.33 23.79 Favored 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 119.123 -1.031 . . . . 0.0 110.038 177.354 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 89.5 107.86 1.19 Allowed Glycine 0 N--CA 1.48 1.585 0 C-N-CA 118.993 -1.575 . . . . 0.0 110.786 178.21 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.601 ' N ' ' O ' ' A' ' 36' ' ' LYS . 4.6 t -84.42 -134.13 0.05 OUTLIER 'General case' 0 C--O 1.201 -1.488 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 178.281 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -72.66 61.51 0.53 Allowed 'General case' 0 C--N 1.254 -3.557 0 CA-C-N 114.807 -1.088 . . . . 0.0 109.353 -175.282 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.558 ' N ' ' O ' ' A' ' 32' ' ' SER . . . 81.57 27.69 46.33 Favored Glycine 0 C--N 1.286 -2.24 0 N-CA-C 108.564 -1.814 . . . . 0.0 108.564 -177.553 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 80.3 mt-10 -129.0 -128.84 0.22 Allowed 'General case' 0 C--O 1.213 -0.855 0 C-N-CA 118.89 -1.124 . . . . 0.0 112.293 -177.405 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.601 ' O ' ' N ' ' A' ' 32' ' ' SER . 16.4 mttp -98.66 -162.93 0.99 Allowed 'General case' 0 C--N 1.277 -2.555 0 CA-C-N 113.207 -1.815 . . . . 0.0 112.802 -176.049 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.499 ' N ' ' OD1' ' A' ' 37' ' ' ASN . 0.1 OUTLIER -65.69 166.35 10.97 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-N 114.922 -1.035 . . . . 0.0 111.498 179.374 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 -160.78 135.86 7.71 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.859 177.581 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.476 ' SG ' ' HB2' ' A' ' 16' ' ' CYS . 1.0 OUTLIER -91.53 108.77 20.13 Favored 'General case' 0 C--N 1.295 -1.787 0 C-N-CA 119.705 -0.798 . . . . 0.0 110.741 -179.557 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.561 HG22 ' N ' ' A' ' 41' ' ' THR . 3.7 p -130.95 157.69 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.25 0 C-N-CA 118.219 -1.393 . . . . 0.0 111.359 176.459 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.561 ' N ' HG22 ' A' ' 40' ' ' VAL . 14.0 t -73.24 151.03 41.57 Favored 'General case' 0 C--N 1.275 -2.633 0 CA-C-N 114.399 -1.273 . . . . 0.0 111.662 -179.13 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 164.31 -143.13 8.29 Favored Glycine 0 N--CA 1.489 2.2 0 C-N-CA 119.479 -1.343 . . . . 0.0 110.43 179.587 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -120.78 100.26 7.0 Favored 'General case' 0 N--CA 1.495 1.814 0 C-N-CA 120.092 -0.643 . . . . 0.0 109.904 179.588 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -127.28 -155.06 8.7 Favored Glycine 0 N--CA 1.495 2.621 0 N-CA-C 110.255 -1.138 . . . . 0.0 110.255 -179.73 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -144.41 151.05 49.97 Favored Pre-proline 0 N--CA 1.488 1.428 0 C-N-CA 119.431 -0.908 . . . . 0.0 109.954 179.713 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.495 ' HB3' HD12 ' A' ' 13' ' ' LEU . 9.3 Cg_endo -68.8 141.61 49.83 Favored 'Trans proline' 0 C--O 1.216 -0.612 0 C-N-CA 121.342 1.361 . . . . 0.0 111.336 177.177 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -62.79 118.02 37.81 Favored Pre-proline 0 CA--C 1.56 1.358 0 C-N-CA 119.488 -0.885 . . . . 0.0 109.512 178.506 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -59.93 -176.8 0.13 Allowed 'Trans proline' 0 C--O 1.216 -0.624 0 C-N-CA 120.677 0.918 . . . . 0.0 111.578 -175.901 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 116.312 -1.804 . . . . 0.0 110.402 179.872 . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 98.3 t . . . . . 0 N--CA 1.491 1.624 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.674 HG12 ' N ' ' A' ' 3' ' ' TYR . 61.7 t -81.06 173.01 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 C-N-CA 119.481 -0.888 . . . . 0.0 109.983 -179.996 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.674 ' N ' HG12 ' A' ' 2' ' ' VAL . 37.8 m-85 -114.39 -165.41 1.01 Allowed 'General case' 0 N--CA 1.493 1.685 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.67 -179.733 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.9 p -99.48 172.27 7.42 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 178.215 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -89.64 154.2 20.15 Favored 'General case' 0 C--N 1.285 -2.207 0 C-N-CA 118.2 -1.4 . . . . 0.0 110.366 -179.632 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.514 ' SG ' ' O ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -73.81 154.73 39.39 Favored 'General case' 0 C--N 1.291 -1.952 0 C-N-CA 119.729 -0.788 . . . . 0.0 110.223 177.35 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.4 t -129.94 14.35 5.79 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-O 122.055 0.931 . . . . 0.0 108.85 177.739 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.498 ' HG2' HE21 ' A' ' 11' ' ' GLN . 11.6 pt-20 -162.58 176.94 9.87 Favored 'General case' 0 C--N 1.281 -2.404 0 CA-C-N 113.695 -1.593 . . . . 0.0 109.58 179.488 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.461 ' O ' ' N ' ' A' ' 11' ' ' GLN . 0.5 OUTLIER -72.64 -163.75 0.14 Allowed 'General case' 0 C--N 1.297 -1.693 0 C-N-CA 119.264 -0.974 . . . . 0.0 109.5 -179.506 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.602 ' H ' HD13 ' A' ' 29' ' ' ILE . . . 24.66 19.73 0.0 OUTLIER Glycine 0 N--CA 1.494 2.541 1 N-CA-C 130.218 6.847 . . . . 0.0 130.218 179.264 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.498 HE21 ' HG2' ' A' ' 8' ' ' GLU . 7.9 mm-40 -71.09 -163.38 0.08 Allowed 'General case' 0 C--N 1.295 -1.799 0 C-N-CA 119.432 -0.907 . . . . 0.0 109.35 177.241 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.57 ' O ' ' HA3' ' A' ' 23' ' ' GLY . 26.2 t-20 -148.52 -77.55 0.16 Allowed 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 118.188 -1.405 . . . . 0.0 112.975 -177.876 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.428 HD12 ' HB3' ' A' ' 46' ' ' PRO . 14.1 mt -78.08 42.13 0.39 Allowed 'General case' 0 C--N 1.271 -2.833 0 C-N-CA 118.02 -1.472 . . . . 0.0 110.495 -177.8 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.42 ' H ' ' C ' ' A' ' 12' ' ' ASN . 29.4 p -113.33 -159.88 0.7 Allowed 'General case' 0 N--CA 1.496 1.833 0 C-N-CA 119.483 -0.887 . . . . 0.0 110.129 178.012 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.514 ' O ' ' SG ' ' A' ' 6' ' ' CYS . 3.5 mt -124.82 133.0 53.28 Favored 'General case' 0 N--CA 1.499 2.006 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.518 177.584 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 3.4 m -111.92 -74.42 0.64 Allowed 'General case' 0 N--CA 1.513 2.713 0 C-N-CA 119.064 -1.054 . . . . 0.0 110.308 179.094 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -78.23 125.69 29.72 Favored 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 118.319 -1.352 . . . . 0.0 107.845 177.228 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 28.55 -72.64 0.0 OUTLIER Glycine 0 N--CA 1.502 3.06 1 N-CA-C 128.931 6.332 . . . . 0.0 128.931 -176.7 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -137.53 0.27 2.25 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-O 122.149 0.976 . . . . 0.0 110.324 177.456 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 35.8 m120 -80.27 128.16 33.21 Favored 'General case' 0 C--N 1.261 -3.264 0 CA-C-N 113.557 -1.656 . . . . 0.0 110.448 -179.84 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.1 t -70.34 148.98 10.61 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 C-N-CA 119.282 -0.967 . . . . 0.0 109.954 179.621 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.546 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 0.4 OUTLIER -134.54 101.14 4.86 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 119.0 -1.08 . . . . 0.0 110.699 178.781 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.57 ' HA3' ' O ' ' A' ' 12' ' ' ASN . . . 164.98 -55.4 0.27 Allowed Glycine 0 C--N 1.297 -1.61 1 N-CA-C 131.485 7.354 . . . . 0.0 131.485 179.465 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.503 ' N ' ' OD1' ' A' ' 12' ' ' ASN . 28.7 tt0 -51.47 117.85 2.92 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 118.875 -1.13 . . . . 0.0 110.732 -178.045 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 80.26 -22.37 4.52 Favored Glycine 0 N--CA 1.482 1.711 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -178.506 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.527 ' N ' ' OD1' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -119.8 -159.17 0.77 Allowed 'General case' 0 C--N 1.312 -1.037 0 C-N-CA 120.432 -0.507 . . . . 0.0 109.99 -179.689 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.593 ' N ' ' O ' ' A' ' 40' ' ' VAL . 40.3 tttt -157.98 162.35 38.19 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.654 -179.95 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.546 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -122.97 168.81 11.85 Favored 'General case' 0 CA--C 1.481 -1.706 0 CA-C-O 123.125 1.441 . . . . 0.0 111.638 174.249 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.602 HD13 ' H ' ' A' ' 10' ' ' GLY . 21.6 mm -143.72 130.43 16.95 Favored 'Isoleucine or valine' 0 C--N 1.249 -3.782 0 CA-C-N 111.755 -2.475 . . . . 0.0 108.816 174.324 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.412 ' HA ' HD23 ' A' ' 30' ' ' LEU . 15.2 mt -76.86 126.24 30.64 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 118.275 -1.37 . . . . 0.0 110.016 -179.73 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 36' ' ' LYS . . . -45.24 -73.03 0.3 Allowed Glycine 0 N--CA 1.483 1.794 0 C-N-CA 119.13 -1.51 . . . . 0.0 110.551 179.509 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -125.15 -148.94 0.41 Allowed 'General case' 0 C--O 1.21 -1.002 0 CA-C-O 121.549 0.69 . . . . 0.0 109.19 -179.785 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -77.17 67.47 3.15 Favored 'General case' 0 C--N 1.251 -3.691 0 CA-C-N 114.216 -1.356 . . . . 0.0 110.571 -171.31 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 85.92 21.45 52.88 Favored Glycine 0 C--N 1.282 -2.418 0 N-CA-C 108.518 -1.833 . . . . 0.0 108.518 -179.764 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -104.26 -113.4 0.24 Allowed 'General case' 0 C--N 1.312 -1.056 0 C-N-CA 119.319 -0.952 . . . . 0.0 111.153 -178.365 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.449 ' O ' ' OD1' ' A' ' 37' ' ' ASN . 6.2 mttm -58.91 173.15 0.46 Allowed 'General case' 0 C--N 1.264 -3.137 0 CA-C-N 113.847 -1.524 . . . . 0.0 110.904 -177.819 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.449 ' OD1' ' O ' ' A' ' 36' ' ' LYS . 14.6 m-20 -149.59 162.61 39.85 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.751 -177.805 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.519 ' O ' ' SG ' ' A' ' 28' ' ' CYS . 38.3 tt0 -160.54 147.25 15.53 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 119.383 -0.927 . . . . 0.0 110.488 178.333 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -103.44 107.38 18.19 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 119.885 -0.726 . . . . 0.0 112.378 -179.55 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.593 ' O ' ' N ' ' A' ' 27' ' ' LYS . 0.1 OUTLIER -100.25 141.46 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.571 0 C-N-CA 118.709 -1.196 . . . . 0.0 110.615 174.778 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.634 HG23 ' O ' ' A' ' 41' ' ' THR . 8.9 t -78.79 47.41 0.74 Allowed 'General case' 0 C--N 1.279 -2.471 0 CA-C-N 113.942 -1.481 . . . . 0.0 113.232 -177.882 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -118.47 -124.51 3.37 Favored Glycine 0 N--CA 1.505 3.294 1 N-CA-C 131.198 7.239 . . . . 0.0 131.198 178.172 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -98.1 73.39 2.21 Favored 'General case' 0 N--CA 1.499 1.992 0 C-N-CA 119.412 -0.915 . . . . 0.0 111.215 -178.489 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -92.15 165.22 28.95 Favored Glycine 0 N--CA 1.494 2.559 0 C-N-CA 119.405 -1.378 . . . . 0.0 110.854 -179.597 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.518 ' O ' ' N ' ' A' ' 12' ' ' ASN . 0.5 OUTLIER -129.95 148.3 69.04 Favored Pre-proline 0 N--CA 1.498 1.925 0 C-N-CA 120.128 -0.629 . . . . 0.0 109.721 179.971 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.436 ' O ' ' O ' ' A' ' 45' ' ' THR . 2.7 Cg_exo -52.77 -164.03 0.0 OUTLIER 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 121.414 1.41 . . . . 0.0 111.131 177.717 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -137.39 71.52 52.85 Favored Pre-proline 0 C--N 1.305 -1.353 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.077 178.111 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -68.39 -168.75 0.23 Allowed 'Trans proline' 0 C--N 1.327 -0.585 0 C-N-CA 121.85 1.7 . . . . 0.0 111.882 -174.806 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.5 mt-30 . . . . . 0 C--N 1.305 -1.334 0 CA-C-O 116.318 -1.801 . . . . 0.0 110.393 179.474 . . . . . . . . 0 0 . 1 . 031 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 74.6 t . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 . . . . . . . . . 0 0 . 1 . 031 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.0 t -96.0 161.84 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 C-N-CA 119.486 -0.886 . . . . 0.0 110.494 -179.581 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -87.65 -164.53 1.11 Allowed 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 119.909 -0.716 . . . . 0.0 110.417 -179.897 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.2 p -97.59 178.38 5.19 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 119.793 -0.763 . . . . 0.0 108.956 179.742 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -91.17 154.44 19.32 Favored 'General case' 0 C--N 1.297 -1.69 0 C-N-CA 118.796 -1.162 . . . . 0.0 110.322 178.929 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.486 ' SG ' ' O ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -75.13 165.75 24.73 Favored 'General case' 0 C--N 1.299 -1.592 0 C-N-CA 119.886 -0.726 . . . . 0.0 110.899 177.827 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 43.2 p -143.72 17.5 1.81 Allowed 'General case' 0 C--N 1.294 -1.835 0 CA-C-N 114.881 -1.054 . . . . 0.0 108.596 177.123 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -161.15 167.55 25.98 Favored 'General case' 0 C--N 1.288 -2.086 0 CA-C-N 113.64 -1.618 . . . . 0.0 109.853 -179.03 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.515 ' O ' ' N ' ' A' ' 11' ' ' GLN . 0.8 OUTLIER -68.97 -168.37 0.13 Allowed 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 119.043 -1.063 . . . . 0.0 108.765 178.599 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.702 ' H ' HD13 ' A' ' 29' ' ' ILE . . . 24.35 16.89 0.0 OUTLIER Glycine 0 N--CA 1.492 2.421 1 N-CA-C 130.158 6.823 . . . . 0.0 130.158 179.865 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.528 ' NE2' ' OE1' ' A' ' 47' ' ' GLU . 10.8 mt-30 -69.67 -164.97 0.07 Allowed 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 176.218 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.442 ' OD1' ' O ' ' A' ' 11' ' ' GLN . 1.7 m-20 -150.43 -70.17 0.18 Allowed 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 117.551 -1.66 . . . . 0.0 113.952 -179.302 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.5 HD12 ' HB3' ' A' ' 46' ' ' PRO . 18.6 mt -77.28 48.96 0.66 Allowed 'General case' 0 C--N 1.272 -2.794 0 C-N-CA 117.705 -1.598 . . . . 0.0 110.189 -176.146 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.439 ' HB2' ' N ' ' A' ' 6' ' ' CYS . 26.7 p -125.39 -161.47 1.03 Allowed 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.01 -0.995 . . . . 0.0 109.184 176.517 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.486 ' O ' ' SG ' ' A' ' 6' ' ' CYS . 38.3 mt -112.6 120.84 42.95 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 123.973 0.795 . . . . 0.0 109.131 176.665 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 8.6 m -116.06 -38.54 3.6 Favored 'General case' 0 N--CA 1.503 2.207 0 C-N-CA 119.038 -1.065 . . . . 0.0 111.176 -177.074 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -100.04 76.63 1.94 Allowed 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 119.236 -0.986 . . . . 0.0 110.088 179.236 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 76.1 -94.49 1.01 Allowed Glycine 0 N--CA 1.49 2.282 0 C-N-CA 119.359 -1.401 . . . . 0.0 110.637 179.743 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -125.53 -2.84 7.36 Favored 'General case' 0 N--CA 1.485 1.302 0 CA-C-O 122.058 0.932 . . . . 0.0 110.518 -179.211 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 60.4 m-80 -81.32 136.78 35.78 Favored 'General case' 0 C--N 1.257 -3.452 0 CA-C-N 113.629 -1.623 . . . . 0.0 110.862 -179.248 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.1 t -71.67 147.17 10.95 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 C-N-CA 119.366 -0.934 . . . . 0.0 110.071 179.09 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.441 ' O ' ' O ' ' A' ' 12' ' ' ASN . 6.2 m -149.14 118.56 6.9 Favored 'General case' 0 C--N 1.288 -2.081 0 C-N-CA 118.819 -1.152 . . . . 0.0 108.876 176.486 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.46 ' O ' ' O ' ' A' ' 26' ' ' ASN . . . 179.36 -92.23 0.08 OUTLIER Glycine 0 C--O 1.203 -1.831 0 C-N-CA 117.622 -2.227 . . . . 0.0 112.218 -177.37 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 15.3 tt0 -45.37 131.22 8.31 Favored 'General case' 0 C--N 1.299 -1.612 0 C-N-CA 119.352 -0.939 . . . . 0.0 110.861 -177.472 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.56 -32.15 4.01 Favored Glycine 0 N--CA 1.479 1.515 0 N-CA-C 109.261 -1.536 . . . . 0.0 109.261 -177.819 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.46 ' O ' ' O ' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -129.67 -160.47 1.04 Allowed 'General case' 0 C--N 1.313 -1.0 0 C-N-CA 120.205 -0.598 . . . . 0.0 110.833 -179.801 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.554 ' CG ' ' N ' ' A' ' 28' ' ' CYS . 26.6 tttt -151.51 167.49 27.87 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 177.748 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.639 ' O ' ' HA2' ' A' ' 10' ' ' GLY . 59.6 m -127.62 164.66 21.55 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 119.132 -1.027 . . . . 0.0 111.261 177.001 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.702 HD13 ' H ' ' A' ' 10' ' ' GLY . 20.1 mm -146.2 133.61 15.04 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.278 0 CA-C-N 114.184 -1.371 . . . . 0.0 109.94 176.194 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 18.5 mt -77.42 108.88 10.89 Favored 'General case' 0 N--CA 1.496 1.834 0 C-N-CA 118.952 -1.099 . . . . 0.0 109.381 177.993 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.422 ' H ' ' HA ' ' A' ' 37' ' ' ASN . . . 97.1 106.78 2.42 Favored Glycine 0 N--CA 1.477 1.403 0 C-N-CA 119.021 -1.561 . . . . 0.0 110.693 179.423 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.532 ' N ' ' O ' ' A' ' 36' ' ' LYS . 1.9 m -76.99 -129.28 0.01 OUTLIER 'General case' 0 C--O 1.2 -1.523 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 178.139 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.494 ' N ' ' OD1' ' A' ' 33' ' ' ASP . 0.6 OUTLIER -74.59 65.88 1.35 Allowed 'General case' 0 C--N 1.25 -3.73 0 CA-C-N 114.702 -1.135 . . . . 0.0 108.512 -175.302 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 32' ' ' SER . . . 75.68 24.23 70.59 Favored Glycine 0 C--N 1.289 -2.05 0 N-CA-C 108.286 -1.926 . . . . 0.0 108.286 -177.433 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -120.3 -134.13 0.31 Allowed 'General case' 0 C--O 1.213 -0.867 0 C-N-CA 119.268 -0.973 . . . . 0.0 111.695 -177.357 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.532 ' O ' ' N ' ' A' ' 32' ' ' SER . 13.6 mmtm -97.49 -168.45 1.69 Allowed 'General case' 0 C--N 1.272 -2.763 0 CA-C-N 113.375 -1.739 . . . . 0.0 113.312 -177.477 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.463 ' N ' ' OD1' ' A' ' 37' ' ' ASN . 1.8 m-20 -59.21 155.18 14.68 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.139 178.249 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 26.3 tt0 -160.58 139.7 10.57 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.94 -0.704 . . . . 0.0 109.64 176.758 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 20.9 m -87.94 103.02 15.29 Favored 'General case' 0 C--N 1.297 -1.677 0 C-N-CA 119.175 -1.01 . . . . 0.0 110.993 -178.772 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.514 ' O ' ' N ' ' A' ' 27' ' ' LYS . 0.4 OUTLIER -100.14 142.07 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.232 0 C-N-CA 118.677 -1.209 . . . . 0.0 111.586 178.837 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.3 t -69.66 141.35 53.63 Favored 'General case' 0 C--N 1.277 -2.584 0 CA-C-N 114.207 -1.36 . . . . 0.0 110.955 179.311 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 157.97 -114.12 0.6 Allowed Glycine 0 N--CA 1.492 2.4 1 N-CA-C 130.492 6.957 . . . . 0.0 130.492 179.686 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -139.43 100.26 3.94 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 119.631 -0.828 . . . . 0.0 109.978 179.286 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -126.46 -175.04 14.0 Favored Glycine 0 N--CA 1.496 2.634 0 N-CA-C 110.33 -1.108 . . . . 0.0 110.33 -179.415 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -137.77 148.47 61.05 Favored Pre-proline 0 N--CA 1.491 1.589 0 C-N-CA 119.84 -0.744 . . . . 0.0 109.78 -179.984 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.5 ' HB3' HD12 ' A' ' 13' ' ' LEU . 10.4 Cg_exo -48.35 177.2 0.02 OUTLIER 'Trans proline' 0 C--O 1.214 -0.682 0 C-N-CA 121.475 1.45 . . . . 0.0 111.511 179.766 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.591 ' H ' ' CD ' ' A' ' 48' ' ' PRO . 5.1 tp10 -107.02 -41.79 0.14 Allowed Pre-proline 0 CA--C 1.558 1.258 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.747 178.857 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.591 ' CD ' ' H ' ' A' ' 47' ' ' GLU . 4.3 Cg_endo -72.74 130.66 16.08 Favored 'Trans proline' 0 C--O 1.214 -0.688 0 C-N-CA 120.88 1.054 . . . . 0.0 111.165 -176.343 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.691 0 CA-C-O 116.443 -1.742 . . . . 0.0 110.122 179.445 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 43.4 t . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 . . . . . . . . . 0 0 . 1 . 032 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.707 HG12 ' H ' ' A' ' 3' ' ' TYR . 6.8 t -79.21 177.76 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 C-N-CA 119.132 -1.027 . . . . 0.0 109.623 179.787 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.707 ' H ' HG12 ' A' ' 2' ' ' VAL . 61.1 m-85 -143.07 -172.47 3.68 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.135 -1.026 . . . . 0.0 111.23 -179.794 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.5 ' OG1' ' N ' ' A' ' 5' ' ' ASP . 0.1 OUTLIER -114.45 -165.66 1.03 Allowed 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 115.105 -0.952 . . . . 0.0 108.556 179.232 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.5 ' N ' ' OG1' ' A' ' 4' ' ' THR . 0.7 OUTLIER -92.2 155.05 18.26 Favored 'General case' 0 C--N 1.287 -2.119 0 C-N-CA 118.371 -1.332 . . . . 0.0 110.904 -179.363 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.447 ' N ' ' HB2' ' A' ' 14' ' ' CYS . 0.0 OUTLIER -73.82 171.23 13.74 Favored 'General case' 0 C--N 1.287 -2.148 0 CA-C-N 114.575 -1.193 . . . . 0.0 110.272 178.289 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.5 p -140.94 13.31 2.26 Favored 'General case' 0 C--N 1.294 -1.816 0 C-N-CA 119.367 -0.933 . . . . 0.0 109.687 177.284 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -162.13 174.22 13.25 Favored 'General case' 0 C--N 1.288 -2.108 0 CA-C-N 114.065 -1.425 . . . . 0.0 110.228 179.659 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.448 ' HB3' ' H ' ' A' ' 30' ' ' LEU . 0.7 OUTLIER -85.58 167.2 15.59 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 119.804 -0.758 . . . . 0.0 109.724 -179.945 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 28' ' ' CYS . . . 71.34 14.63 74.47 Favored Glycine 0 N--CA 1.503 3.156 0 C-N-CA 119.182 -1.485 . . . . 0.0 112.225 178.693 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -84.52 -174.95 5.56 Favored 'General case' 0 N--CA 1.505 2.298 0 C-N-CA 119.034 -1.066 . . . . 0.0 110.616 179.159 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.481 ' C ' ' H ' ' A' ' 14' ' ' CYS . 10.3 m-20 -153.51 -69.51 0.14 Allowed 'General case' 0 N--CA 1.505 2.299 0 C-N-CA 118.403 -1.319 . . . . 0.0 113.514 -178.048 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.494 HD13 ' CZ ' ' A' ' 3' ' ' TYR . 70.2 mt -75.22 45.96 0.3 Allowed 'General case' 0 C--N 1.288 -2.106 0 C-N-CA 118.595 -1.242 . . . . 0.0 109.74 -178.588 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.481 ' H ' ' C ' ' A' ' 12' ' ' ASN . 31.8 p -122.37 -149.5 0.43 Allowed 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 115.233 -0.894 . . . . 0.0 108.884 177.606 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.445 HD23 ' HA ' ' A' ' 15' ' ' LEU . 71.5 mt -120.0 100.18 7.06 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-O 122.25 1.024 . . . . 0.0 109.091 176.347 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.574 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 0.5 OUTLIER -74.21 -69.1 0.47 Allowed 'General case' 0 C--N 1.276 -2.616 0 CA-C-N 113.358 -1.746 . . . . 0.0 110.51 -176.088 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -100.37 95.4 6.74 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 119.029 -1.068 . . . . 0.0 111.302 -179.128 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.17 -95.21 0.84 Allowed Glycine 0 N--CA 1.492 2.398 0 C-N-CA 119.739 -1.219 . . . . 0.0 111.735 177.285 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -127.2 2.49 6.42 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-O 122.061 0.934 . . . . 0.0 110.743 -177.054 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 13.8 m-20 -78.54 129.34 34.71 Favored 'General case' 0 C--N 1.255 -3.501 0 CA-C-N 113.702 -1.59 . . . . 0.0 110.864 -179.868 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.581 HG12 ' O ' ' A' ' 22' ' ' CYS . 2.0 t -81.13 138.4 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 118.917 -1.113 . . . . 0.0 110.314 179.113 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.623 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 0.1 OUTLIER -77.94 -135.34 0.02 OUTLIER 'General case' 0 C--N 1.286 -2.184 0 C-N-CA 118.774 -1.171 . . . . 0.0 109.474 172.697 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.539 ' O ' ' ND2' ' A' ' 26' ' ' ASN . . . 179.49 115.83 0.48 Allowed Glycine 0 C--N 1.268 -3.196 0 C-N-CA 117.91 -2.091 . . . . 0.0 111.064 178.973 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.462 ' C ' ' O ' ' A' ' 23' ' ' GLY . 22.9 tt0 -36.22 135.19 0.37 Allowed 'General case' 0 C--N 1.284 -2.24 0 CA-C-N 114.872 -0.664 . . . . 0.0 109.773 176.721 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 116.79 -36.36 3.79 Favored Glycine 0 N--CA 1.486 1.979 0 N-CA-C 107.987 -2.045 . . . . 0.0 107.987 -175.632 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.539 ' ND2' ' O ' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -92.46 -162.46 0.93 Allowed 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 176.557 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.642 ' CE ' HD11 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -151.75 105.25 3.11 Favored 'General case' 0 C--N 1.284 -2.278 0 C-N-CA 118.66 -1.216 . . . . 0.0 110.41 179.284 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.623 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 9.9 m -77.62 159.47 29.19 Favored 'General case' 0 C--O 1.196 -1.725 0 C-N-CA 117.908 -1.517 . . . . 0.0 110.692 -179.595 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.642 HD11 ' CE ' ' A' ' 27' ' ' LYS . 27.9 mm -141.69 132.41 26.04 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.06 0 CA-C-N 114.005 -1.452 . . . . 0.0 110.207 177.817 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.448 ' H ' ' HB3' ' A' ' 9' ' ' SER . 20.3 mt -77.99 121.71 24.57 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 119.338 -0.945 . . . . 0.0 110.156 177.799 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.71 104.66 0.71 Allowed Glycine 0 N--CA 1.483 1.825 0 C-N-CA 119.23 -1.462 . . . . 0.0 110.603 178.06 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.578 ' O ' ' N ' ' A' ' 34' ' ' GLY . 19.3 m -90.94 -125.64 0.08 Allowed 'General case' 0 C--O 1.196 -1.731 0 C-N-CA 119.211 -0.995 . . . . 0.0 109.062 178.739 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -69.66 63.03 0.18 Allowed 'General case' 0 C--N 1.263 -3.166 0 CA-C-N 114.33 -1.304 . . . . 0.0 109.243 -175.14 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.578 ' N ' ' O ' ' A' ' 32' ' ' SER . . . 69.27 29.34 71.98 Favored Glycine 0 C--N 1.285 -2.28 0 N-CA-C 107.953 -2.059 . . . . 0.0 107.953 -176.336 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -124.93 -132.69 0.26 Allowed 'General case' 0 C--O 1.214 -0.774 0 CA-C-O 122.24 1.019 . . . . 0.0 112.223 -176.753 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.541 ' O ' ' N ' ' A' ' 32' ' ' SER . 53.6 mttp -97.0 -161.69 0.89 Allowed 'General case' 0 C--N 1.275 -2.649 0 CA-C-N 113.062 -1.881 . . . . 0.0 111.744 -177.421 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.58 ' N ' ' OD1' ' A' ' 37' ' ' ASN . 0.1 OUTLIER -75.31 155.83 36.21 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.751 178.243 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -154.75 137.18 15.01 Favored 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 119.492 -0.883 . . . . 0.0 109.368 176.694 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.574 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 2.0 m -78.97 105.99 10.69 Favored 'General case' 0 C--N 1.29 -1.994 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.844 -176.666 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.495 ' O ' ' O ' ' A' ' 27' ' ' LYS . 2.4 p -111.97 143.37 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.354 0 C-N-CA 118.395 -1.322 . . . . 0.0 110.996 175.85 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.2 t -66.24 150.2 49.16 Favored 'General case' 0 C--N 1.269 -2.899 0 CA-C-N 113.626 -1.625 . . . . 0.0 112.251 -178.348 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 165.31 -120.28 0.92 Allowed Glycine 0 N--CA 1.486 2.012 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 178.373 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -160.87 81.78 0.65 Allowed 'General case' 0 C--N 1.299 -1.587 0 C-N-CA 119.408 -0.917 . . . . 0.0 109.447 178.58 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -100.25 -158.88 28.15 Favored Glycine 0 N--CA 1.492 2.43 0 C-N-CA 119.853 -1.165 . . . . 0.0 110.949 -178.035 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -130.35 152.18 79.8 Favored Pre-proline 0 N--CA 1.493 1.681 0 C-N-CA 119.942 -0.703 . . . . 0.0 109.842 -179.759 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -55.85 -175.43 0.04 OUTLIER 'Trans proline' 0 C--O 1.214 -0.712 0 C-N-CA 121.475 1.45 . . . . 0.0 111.2 177.304 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -87.02 123.17 70.66 Favored Pre-proline 0 CA--C 1.558 1.255 0 C-N-CA 119.458 -0.897 . . . . 0.0 109.753 178.587 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -59.76 156.36 38.23 Favored 'Trans proline' 0 C--O 1.216 -0.619 0 C-N-CA 120.403 0.735 . . . . 0.0 111.092 179.942 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 116.234 -1.841 . . . . 0.0 110.381 179.921 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.0 t . . . . . 0 N--CA 1.488 1.437 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.506 ' CE2' HD22 ' A' ' 13' ' ' LEU . 67.8 m-85 -126.05 -166.91 1.63 Allowed 'General case' 0 N--CA 1.499 1.981 0 C-N-CA 119.608 -0.837 . . . . 0.0 110.993 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 7.7 p -105.71 179.92 4.13 Favored 'General case' 0 C--O 1.199 -1.568 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.256 -179.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.471 ' OD1' ' N ' ' A' ' 5' ' ' ASP . 0.3 OUTLIER -83.54 156.84 22.6 Favored 'General case' 0 C--N 1.295 -1.802 0 C-N-CA 118.365 -1.334 . . . . 0.0 110.597 179.846 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.468 ' N ' ' HB2' ' A' ' 14' ' ' CYS . 0.1 OUTLIER -75.6 -178.64 4.24 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.666 178.127 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.467 HG23 HE22 ' A' ' 11' ' ' GLN . 1.3 p -123.72 -20.82 5.36 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 114.953 -1.022 . . . . 0.0 109.791 176.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.552 ' C ' HD21 ' A' ' 30' ' ' LEU . 2.8 mt-10 -162.52 162.44 27.38 Favored 'General case' 0 C--N 1.276 -2.587 0 CA-C-N 114.236 -1.347 . . . . 0.0 111.712 -178.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.425 ' HA ' ' H ' ' A' ' 30' ' ' LEU . 0.3 OUTLIER -62.87 143.07 57.97 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 115.014 -0.994 . . . . 0.0 108.753 179.439 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.527 ' HA2' ' HE3' ' A' ' 27' ' ' LYS . . . 108.24 -26.76 15.83 Favored Glycine 0 N--CA 1.487 2.094 1 N-CA-C 126.837 5.495 . . . . 0.0 126.837 -171.741 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.467 HE22 HG23 ' A' ' 7' ' ' THR . 11.0 mt-30 -71.26 -171.38 0.59 Allowed 'General case' 0 N--CA 1.497 1.9 0 CA-C-N 114.642 -0.779 . . . . 0.0 109.889 178.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.498 ' O ' ' HA3' ' A' ' 23' ' ' GLY . 4.3 m-20 -135.53 -69.98 0.49 Allowed 'General case' 0 N--CA 1.509 2.477 0 N-CA-C 114.558 1.318 . . . . 0.0 114.558 -175.284 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.506 HD22 ' CE2' ' A' ' 3' ' ' TYR . 50.9 mt -77.45 50.32 0.79 Allowed 'General case' 0 C--N 1.277 -2.565 0 C-N-CA 118.403 -1.319 . . . . 0.0 111.006 -175.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.468 ' HB2' ' N ' ' A' ' 6' ' ' CYS . 29.8 p -123.81 -161.02 0.95 Allowed 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 119.577 -0.849 . . . . 0.0 109.98 175.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.436 ' O ' ' SG ' ' A' ' 6' ' ' CYS . 39.9 mt -113.28 121.65 45.07 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.495 176.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -128.56 -31.42 2.25 Favored 'General case' 0 N--CA 1.51 2.565 0 C-N-CA 118.899 -1.121 . . . . 0.0 110.48 -179.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.418 ' O ' ' N ' ' A' ' 19' ' ' SER . 0.6 OUTLIER -87.16 82.13 7.77 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 119.09 -1.044 . . . . 0.0 108.796 177.708 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 64.94 -81.4 0.07 OUTLIER Glycine 0 N--CA 1.488 2.131 0 C-N-CA 119.23 -1.462 . . . . 0.0 109.593 -178.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.418 ' N ' ' O ' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -141.34 0.22 1.48 Allowed 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 122.018 0.914 . . . . 0.0 110.643 178.656 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -83.56 149.11 26.79 Favored 'General case' 0 C--N 1.26 -3.303 0 CA-C-N 113.84 -1.527 . . . . 0.0 110.333 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.5 t -68.56 148.19 11.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 C-N-CA 119.102 -1.039 . . . . 0.0 110.983 -178.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.56 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 0.0 OUTLIER -149.64 107.88 3.76 Favored 'General case' 0 C--N 1.287 -2.125 0 CA-C-N 114.832 -1.076 . . . . 0.0 109.852 -179.789 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.498 ' HA3' ' O ' ' A' ' 12' ' ' ASN . . . 159.47 -45.04 0.44 Allowed Glycine 0 N--CA 1.489 2.183 1 N-CA-C 131.612 7.405 . . . . 0.0 131.612 -177.244 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -53.88 118.81 4.27 Favored 'General case' 0 C--N 1.306 -1.296 0 C-N-CA 118.652 -1.219 . . . . 0.0 110.547 -179.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.72 -19.62 6.01 Favored Glycine 0 N--CA 1.48 1.582 0 C-N-CA 119.399 -1.381 . . . . 0.0 110.084 -179.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.451 ' O ' ' O ' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -121.15 -169.7 1.89 Allowed 'General case' 0 C--O 1.213 -0.86 0 C-N-CA 119.953 -0.699 . . . . 0.0 110.074 -179.712 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.527 ' HE3' ' HA2' ' A' ' 10' ' ' GLY . 21.0 ttpt -152.47 119.98 6.01 Favored 'General case' 0 N--CA 1.495 1.786 0 C-N-CA 118.573 -1.251 . . . . 0.0 110.978 177.193 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.56 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -83.75 165.63 18.7 Favored 'General case' 0 CA--C 1.476 -1.873 0 C-N-CA 117.6 -1.64 . . . . 0.0 111.805 179.228 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 7.5 mm -131.47 90.3 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.261 -3.252 0 CA-C-N 112.006 -2.361 . . . . 0.0 108.854 175.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.552 HD21 ' C ' ' A' ' 8' ' ' GLU . 2.1 pp . . . . . 0 C--N 1.305 -1.358 0 C-N-CA 118.694 -1.202 . . . . 0.0 111.52 -177.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 120.615 0.245 . . . . 0.0 110.383 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 23.3 tt0 -161.82 156.0 22.12 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 119.302 -0.959 . . . . 0.0 110.394 176.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.51 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 0.1 OUTLIER -103.54 120.9 41.78 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 113.472 0.915 . . . . 0.0 113.472 179.934 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.512 ' CG2' ' N ' ' A' ' 41' ' ' THR . 2.4 p -131.44 158.75 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 CA-C-N 114.751 -1.113 . . . . 0.0 110.477 173.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.512 ' N ' ' CG2' ' A' ' 40' ' ' VAL . 0.0 OUTLIER -83.02 144.04 30.21 Favored 'General case' 0 C--N 1.278 -2.531 0 CA-C-N 114.76 -1.109 . . . . 0.0 111.755 179.995 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 177.94 -124.99 0.97 Allowed Glycine 0 N--CA 1.492 2.369 1 N-CA-C 131.092 7.197 . . . . 0.0 131.092 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -130.96 109.02 10.23 Favored 'General case' 0 N--CA 1.497 1.875 0 C-N-CA 119.998 -0.681 . . . . 0.0 110.058 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -158.12 -162.56 11.88 Favored Glycine 0 N--CA 1.494 2.535 0 C-N-CA 119.044 -1.55 . . . . 0.0 110.962 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -144.04 155.25 58.76 Favored Pre-proline 0 N--CA 1.489 1.508 0 C-N-CA 119.476 -0.89 . . . . 0.0 110.378 -179.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -54.46 148.8 41.31 Favored 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 121.836 1.691 . . . . 0.0 111.325 175.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.558 1.282 0 C-N-CA 119.462 -0.895 . . . . 0.0 112.57 178.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.486 HG12 ' N ' ' A' ' 3' ' ' TYR . 10.5 t . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.486 ' N ' HG12 ' A' ' 2' ' ' VAL . 44.5 m-85 -97.87 -168.95 1.75 Allowed 'General case' 0 C--N 1.298 -1.636 0 C-N-CA 119.095 -1.042 . . . . 0.0 110.31 -179.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.581 ' OG1' ' N ' ' A' ' 5' ' ' ASP . 0.1 OUTLIER -105.31 -178.36 3.63 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 179.543 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.581 ' N ' ' OG1' ' A' ' 4' ' ' THR . 0.3 OUTLIER -88.46 157.43 18.66 Favored 'General case' 0 C--N 1.287 -2.14 0 C-N-CA 118.559 -1.257 . . . . 0.0 110.297 179.543 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.408 ' SG ' ' CB ' ' A' ' 11' ' ' GLN . 1.5 m -73.17 176.7 5.63 Favored 'General case' 0 C--N 1.289 -2.056 0 CA-C-N 115.102 -0.953 . . . . 0.0 111.1 177.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.857 ' H ' HE22 ' A' ' 11' ' ' GLN . 1.2 p -123.56 -19.38 5.85 Favored 'General case' 0 C--N 1.289 -2.054 0 CA-C-N 113.792 -1.549 . . . . 0.0 109.793 176.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.505 ' C ' HD21 ' A' ' 30' ' ' LEU . 3.5 pt-20 -163.12 163.24 25.81 Favored 'General case' 0 C--N 1.269 -2.917 0 CA-C-N 113.824 -1.535 . . . . 0.0 110.46 178.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.436 ' HA ' ' H ' ' A' ' 30' ' ' LEU . 0.7 OUTLIER -66.58 159.93 26.39 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.982 -177.828 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.44 -23.42 32.15 Favored Glycine 0 N--CA 1.507 3.426 0 C-N-CA 119.282 -1.437 . . . . 0.0 112.03 -179.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.857 HE22 ' H ' ' A' ' 7' ' ' THR . 2.5 mt-30 -62.22 -166.08 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.266 0 C-N-CA 119.765 -0.774 . . . . 0.0 111.163 -178.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.528 ' N ' ' O ' ' A' ' 45' ' ' THR . 22.5 t-20 -144.2 -78.94 0.2 Allowed 'General case' 0 N--CA 1.502 2.158 0 N-CA-C 114.629 1.344 . . . . 0.0 114.629 -176.187 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.464 ' O ' ' OE2' ' A' ' 47' ' ' GLU . 87.1 mt -75.25 48.66 0.43 Allowed 'General case' 0 C--N 1.275 -2.672 0 C-N-CA 118.597 -1.241 . . . . 0.0 111.072 -173.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.744 ' O ' HG22 ' A' ' 21' ' ' VAL . 7.8 p -120.91 -151.87 0.49 Allowed 'General case' 0 N--CA 1.497 1.92 0 C-N-CA 119.183 -1.007 . . . . 0.0 110.729 177.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.654 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 7.7 mt -123.6 133.21 53.98 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 114.179 -1.373 . . . . 0.0 110.395 179.266 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.7 m -120.59 -68.1 0.93 Allowed 'General case' 0 N--CA 1.503 2.181 0 C-N-CA 119.306 -0.957 . . . . 0.0 110.401 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -84.55 88.0 7.29 Favored 'General case' 0 C--N 1.298 -1.65 0 C-N-CA 119.178 -1.009 . . . . 0.0 110.143 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 70.25 -123.69 12.57 Favored Glycine 0 N--CA 1.487 2.064 0 C-N-CA 119.562 -1.304 . . . . 0.0 111.21 178.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.406 ' O ' ' OG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -98.87 1.93 46.19 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 121.871 0.843 . . . . 0.0 110.974 -177.713 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -79.61 128.18 33.07 Favored 'General case' 0 C--N 1.253 -3.611 0 CA-C-N 114.003 -1.453 . . . . 0.0 110.726 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.744 HG22 ' O ' ' A' ' 14' ' ' CYS . 0.9 OUTLIER -78.59 148.75 5.98 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.026 0 C-N-CA 119.088 -1.045 . . . . 0.0 109.495 179.112 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.462 ' O ' ' O ' ' A' ' 12' ' ' ASN . 3.2 m -148.13 122.84 9.89 Favored 'General case' 0 C--N 1.285 -2.218 0 C-N-CA 118.418 -1.313 . . . . 0.0 110.547 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.452 ' O ' ' O ' ' A' ' 26' ' ' ASN . . . 170.66 -87.6 0.09 OUTLIER Glycine 0 C--O 1.197 -2.173 0 C-N-CA 118.425 -1.845 . . . . 0.0 111.76 -177.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.447 ' N ' ' OD1' ' A' ' 12' ' ' ASN . 43.2 tt0 -40.08 128.47 2.22 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 120.08 -0.648 . . . . 0.0 111.283 -177.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.623 ' C ' HD22 ' A' ' 26' ' ' ASN . . . 90.07 -24.08 17.7 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 109.012 -1.635 . . . . 0.0 109.012 -177.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.623 HD22 ' C ' ' A' ' 25' ' ' GLY . 2.3 m-80 -143.79 -162.33 1.44 Allowed 'General case' 0 N--CA 1.493 1.713 0 CA-C-N 114.773 -0.713 . . . . 0.0 109.737 179.311 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.469 ' O ' ' O ' ' A' ' 40' ' ' VAL . 0.5 OUTLIER -139.06 143.48 38.39 Favored 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 119.646 -0.822 . . . . 0.0 109.035 175.786 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -89.66 160.99 16.34 Favored 'General case' 0 C--N 1.298 -1.657 0 C-N-CA 117.719 -1.593 . . . . 0.0 111.101 179.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.436 HG22 ' O ' ' A' ' 29' ' ' ILE . 20.1 mm -147.54 94.28 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.255 -3.521 0 CA-C-N 112.523 -2.126 . . . . 0.0 108.496 176.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.505 HD21 ' C ' ' A' ' 8' ' ' GLU . 1.8 pp . . . . . 0 N--CA 1.484 1.236 0 C-N-CA 118.815 -1.154 . . . . 0.0 112.501 -176.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 . . . . . 0 N--CA 1.481 1.098 0 CA-C-O 120.656 0.265 . . . . 0.0 111.114 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.414 ' CG ' ' N ' ' A' ' 39' ' ' CYS . 10.8 tt0 -161.71 157.49 24.48 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 119.179 -1.008 . . . . 0.0 111.11 179.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.414 ' N ' ' CG ' ' A' ' 38' ' ' GLN . 7.1 m -109.39 94.89 5.27 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.799 178.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.469 ' O ' ' O ' ' A' ' 27' ' ' LYS . 0.5 OUTLIER -102.54 145.59 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.568 0 C-N-CA 118.712 -1.195 . . . . 0.0 112.736 -177.892 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.5 t -66.18 143.85 57.01 Favored 'General case' 0 C--N 1.285 -2.235 0 CA-C-N 114.061 -1.427 . . . . 0.0 111.52 177.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 152.23 -159.27 28.28 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -179.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.401 ' O ' ' CG ' ' A' ' 43' ' ' GLU . 5.8 pt-20 -104.93 113.41 26.99 Favored 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 119.546 -0.861 . . . . 0.0 110.273 179.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -114.39 -168.54 16.17 Favored Glycine 0 N--CA 1.5 2.913 0 C-N-CA 120.053 -1.07 . . . . 0.0 110.555 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.528 ' O ' ' N ' ' A' ' 12' ' ' ASN . 0.5 OUTLIER -141.72 148.6 50.32 Favored Pre-proline 0 N--CA 1.493 1.676 0 C-N-CA 119.55 -0.86 . . . . 0.0 110.421 -179.767 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -57.17 167.72 3.16 Favored 'Trans proline' 0 C--O 1.214 -0.683 0 C-N-CA 121.724 1.616 . . . . 0.0 111.949 179.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.639 ' CD ' ' H ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.524 0 C-N-CA 119.544 -0.863 . . . . 0.0 109.971 179.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 1.5 t . . . . . 0 N--CA 1.486 1.326 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -131.08 -161.91 1.17 Allowed 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 119.865 -0.734 . . . . 0.0 111.301 -178.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.07 -176.82 3.54 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.024 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.509 ' N ' ' OD1' ' A' ' 5' ' ' ASP . 0.1 OUTLIER -97.48 156.54 16.44 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.139 -1.025 . . . . 0.0 110.493 178.127 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.503 ' SG ' ' O ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -74.91 151.7 38.89 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.518 177.857 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.475 HG22 ' O ' ' A' ' 7' ' ' THR . 1.4 m -116.65 -3.94 11.73 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 119.68 -0.808 . . . . 0.0 111.114 178.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.509 ' HA ' HD12 ' A' ' 30' ' ' LEU . 0.2 OUTLIER -160.34 178.2 9.84 Favored 'General case' 0 C--N 1.275 -2.647 0 CA-C-N 114.785 -1.098 . . . . 0.0 110.906 -179.289 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.401 ' HB3' ' H ' ' A' ' 30' ' ' LEU . 0.3 OUTLIER -79.27 140.64 37.54 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.912 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.572 ' HA2' ' HE3' ' A' ' 27' ' ' LYS . . . 98.65 -16.97 59.03 Favored Glycine 0 N--CA 1.507 3.369 1 N-CA-C 128.641 6.216 . . . . 0.0 128.641 -174.525 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.44 ' O ' ' O ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -51.89 -169.04 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 114.471 -0.864 . . . . 0.0 110.984 179.742 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.473 ' C ' ' H ' ' A' ' 14' ' ' CYS . 15.8 t-20 -140.68 -83.22 0.23 Allowed 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 118.486 -1.286 . . . . 0.0 113.044 -179.07 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.451 ' O ' ' OE2' ' A' ' 47' ' ' GLU . 60.6 mt -75.42 45.28 0.29 Allowed 'General case' 0 C--N 1.276 -2.627 0 C-N-CA 117.71 -1.596 . . . . 0.0 109.916 -175.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.486 ' HB2' ' N ' ' A' ' 6' ' ' CYS . 31.1 p -109.23 -158.16 0.64 Allowed 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 119.318 -0.953 . . . . 0.0 109.362 178.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.503 ' O ' ' SG ' ' A' ' 6' ' ' CYS . 6.0 mt -124.09 129.49 50.96 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.336 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 89.8 m -120.91 -65.95 1.1 Allowed 'General case' 0 N--CA 1.502 2.127 0 C-N-CA 119.408 -0.917 . . . . 0.0 111.498 -177.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -79.56 85.48 5.3 Favored 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 118.87 -1.132 . . . . 0.0 110.816 -178.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 72.54 -92.55 0.6 Allowed Glycine 0 N--CA 1.491 2.326 0 C-N-CA 119.526 -1.321 . . . . 0.0 110.827 179.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.448 ' O ' ' OG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -133.58 4.55 3.65 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-O 122.264 1.031 . . . . 0.0 110.463 -178.931 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 28.0 m-80 -80.54 130.46 35.15 Favored 'General case' 0 C--N 1.254 -3.577 0 CA-C-N 113.485 -1.689 . . . . 0.0 109.787 178.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.401 HG22 ' O ' ' A' ' 14' ' ' CYS . 1.4 t -69.8 149.24 10.79 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 C-N-CA 119.195 -1.002 . . . . 0.0 110.547 -179.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.452 ' O ' ' O ' ' A' ' 12' ' ' ASN . 12.7 m -145.82 116.17 7.53 Favored 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 118.453 -1.299 . . . . 0.0 110.419 177.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 26' ' ' ASN . . . 170.39 -68.08 0.15 Allowed Glycine 0 C--O 1.203 -1.793 0 C-N-CA 118.261 -1.923 . . . . 0.0 112.598 -177.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -56.91 111.61 1.08 Allowed 'General case' 0 C--N 1.298 -1.65 0 C-N-CA 118.917 -1.113 . . . . 0.0 110.827 -177.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.418 ' C ' ' ND2' ' A' ' 26' ' ' ASN . . . 99.27 -14.77 60.88 Favored Glycine 0 N--CA 1.484 1.844 0 N-CA-C 109.959 -1.256 . . . . 0.0 109.959 -179.022 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.463 ' O ' ' O ' ' A' ' 23' ' ' GLY . 8.6 m-80 -149.3 -167.72 2.91 Favored 'General case' 0 N--CA 1.494 1.762 0 C-N-CA 119.255 -0.978 . . . . 0.0 111.409 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.572 ' HE3' ' HA2' ' A' ' 10' ' ' GLY . 12.6 tttp -134.61 165.17 25.84 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.155 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.513 ' N ' ' CG ' ' A' ' 27' ' ' LYS . 0.1 OUTLIER -127.4 160.3 31.83 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 118.889 -1.124 . . . . 0.0 110.686 177.968 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.444 HD13 ' O ' ' A' ' 28' ' ' CYS . 7.7 mm -138.85 126.75 27.6 Favored 'Isoleucine or valine' 0 C--N 1.255 -3.506 0 CA-C-N 113.088 -1.869 . . . . 0.0 109.639 177.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.509 HD12 ' HA ' ' A' ' 8' ' ' GLU . 19.5 mt . . . . . 0 N--CA 1.495 1.792 0 C-N-CA 118.28 -1.368 . . . . 0.0 110.307 178.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.5 ' OD1' ' N ' ' A' ' 37' ' ' ASN . 0.1 OUTLIER . . . . . 0 N--CA 1.485 1.307 0 CA-C-O 121.258 0.551 . . . . 0.0 111.678 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -159.2 152.92 22.98 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.286 175.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 9.6 m -112.14 112.48 24.12 Favored 'General case' 0 C--N 1.298 -1.66 0 C-N-CA 119.729 -0.788 . . . . 0.0 111.737 -177.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.465 ' O ' ' O ' ' A' ' 27' ' ' LYS . 1.3 p -123.43 140.82 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.323 0 C-N-CA 118.745 -1.182 . . . . 0.0 112.668 177.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.5 t -41.28 157.44 0.02 OUTLIER 'General case' 0 C--N 1.283 -2.304 0 CA-C-N 113.371 -1.74 . . . . 0.0 111.255 178.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.433 ' O ' ' OE1' ' A' ' 43' ' ' GLU . . . 150.04 -120.43 1.14 Allowed Glycine 0 N--CA 1.49 2.275 1 N-CA-C 130.274 6.87 . . . . 0.0 130.274 179.557 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.433 ' OE1' ' O ' ' A' ' 42' ' ' GLY . 1.3 tp10 -154.34 104.53 2.6 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 119.37 -0.932 . . . . 0.0 109.974 179.161 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -128.57 179.94 16.29 Favored Glycine 0 N--CA 1.495 2.579 0 C-N-CA 119.867 -1.158 . . . . 0.0 110.695 -179.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -130.54 153.65 81.48 Favored Pre-proline 0 N--CA 1.495 1.817 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -53.16 163.97 2.02 Favored 'Trans proline' 0 C--O 1.214 -0.688 0 C-N-CA 121.153 1.236 . . . . 0.0 110.477 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.656 ' CD ' ' H ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.534 0 C-N-CA 118.911 -1.116 . . . . 0.0 109.755 -179.383 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.516 HG12 ' N ' ' A' ' 3' ' ' TYR . 12.8 t . . . . . 0 N--CA 1.484 1.229 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.516 ' N ' HG12 ' A' ' 2' ' ' VAL . 8.4 m-85 -112.29 -166.09 1.05 Allowed 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 119.986 -0.686 . . . . 0.0 109.666 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.431 ' OG1' ' OE1' ' A' ' 47' ' ' GLU . 2.9 p -97.51 177.75 5.41 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 178.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.405 ' O ' ' OE2' ' A' ' 47' ' ' GLU . 0.2 OUTLIER -88.46 155.51 19.63 Favored 'General case' 0 C--N 1.293 -1.864 0 C-N-CA 118.458 -1.297 . . . . 0.0 110.066 178.583 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.42 ' SG ' ' O ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -75.4 166.66 23.26 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.693 178.108 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 14.0 p -133.95 2.33 3.37 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 119.431 -0.908 . . . . 0.0 110.39 177.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.496 ' HA ' HD12 ' A' ' 30' ' ' LEU . 0.3 OUTLIER -162.52 -178.7 6.41 Favored 'General case' 0 C--N 1.28 -2.435 0 CA-C-N 114.631 -1.168 . . . . 0.0 111.253 178.894 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -82.27 158.71 23.38 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.535 -178.215 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.498 ' N ' ' O ' ' A' ' 28' ' ' CYS . . . 82.87 -18.0 18.44 Favored Glycine 0 N--CA 1.497 2.706 0 C-N-CA 119.853 -1.165 . . . . 0.0 112.573 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -53.05 170.35 0.08 Allowed 'General case' 0 N--CA 1.501 2.12 0 C-N-CA 119.03 -1.068 . . . . 0.0 110.226 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.504 ' C ' ' H ' ' A' ' 14' ' ' CYS . 22.0 m-20 -144.56 -63.42 0.36 Allowed 'General case' 0 N--CA 1.499 2.011 0 C-N-CA 118.317 -1.353 . . . . 0.0 113.433 -179.088 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 49.7 mt -76.5 41.85 0.26 Allowed 'General case' 0 C--N 1.287 -2.136 0 C-N-CA 119.011 -1.076 . . . . 0.0 109.811 -177.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.504 ' H ' ' C ' ' A' ' 12' ' ' ASN . 31.6 p -121.94 -157.67 0.74 Allowed 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 114.906 -1.043 . . . . 0.0 108.801 177.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.45 HD22 ' O ' ' A' ' 19' ' ' SER . 40.6 mt -108.7 107.12 17.45 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 115.21 -0.904 . . . . 0.0 108.679 175.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.407 ' HB2' ' SG ' ' A' ' 39' ' ' CYS . 68.4 m -96.32 -74.29 0.57 Allowed 'General case' 0 C--N 1.278 -2.532 0 CA-C-N 114.167 -1.379 . . . . 0.0 111.235 -174.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -84.73 115.62 22.79 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 118.601 -1.239 . . . . 0.0 110.102 179.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 66.42 -107.69 2.09 Favored Glycine 0 N--CA 1.489 2.193 0 C-N-CA 119.324 -1.417 . . . . 0.0 110.448 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.45 ' O ' HD22 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -134.6 4.68 3.38 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-O 122.197 0.999 . . . . 0.0 110.185 -179.804 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -79.13 152.87 30.51 Favored 'General case' 0 C--N 1.261 -3.281 0 CA-C-N 113.431 -1.713 . . . . 0.0 110.607 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.2 t -85.9 142.39 13.2 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 C-N-CA 119.195 -1.002 . . . . 0.0 112.117 -177.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.454 ' O ' ' O ' ' A' ' 12' ' ' ASN . 0.1 OUTLIER -99.96 150.32 22.53 Favored 'General case' 0 N--CA 1.508 2.457 0 CA-C-N 114.964 -1.016 . . . . 0.0 108.94 169.295 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.448 ' O ' ' C ' ' A' ' 24' ' ' GLN . . . -113.81 110.81 2.51 Favored Glycine 0 CA--C 1.482 -2.031 0 C-N-CA 119.652 -1.261 . . . . 0.0 110.487 -169.118 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.497 HE21 ' HG3' ' A' ' 46' ' ' PRO . 4.2 tt0 -32.93 117.29 0.25 Allowed 'General case' 0 C--N 1.252 -3.64 0 CA-C-N 111.974 -2.113 . . . . 0.0 109.941 175.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 146.28 -25.69 1.71 Allowed Glycine 0 C--N 1.283 -2.401 0 N-CA-C 105.005 -3.238 . . . . 0.0 105.005 -174.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.539 ' N ' ' OD1' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -110.72 -172.39 2.02 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 113.208 -1.496 . . . . 0.0 107.292 175.056 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.462 ' O ' ' O ' ' A' ' 40' ' ' VAL . 21.9 tttm -144.18 108.86 4.9 Favored 'General case' 0 N--CA 1.502 2.133 0 C-N-CA 118.512 -1.275 . . . . 0.0 110.933 178.217 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.562 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 3.6 m -84.17 152.2 24.41 Favored 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 117.722 -1.591 . . . . 0.0 110.136 178.075 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.448 HD12 ' HZ1' ' A' ' 27' ' ' LYS . 2.1 mm -127.68 131.0 70.38 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.288 0 CA-C-N 114.382 -1.281 . . . . 0.0 109.39 177.212 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.496 HD12 ' HA ' ' A' ' 8' ' ' GLU . 17.5 mt . . . . . 0 N--CA 1.497 1.909 0 C-N-CA 118.471 -1.292 . . . . 0.0 110.162 178.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.0 p30 . . . . . 0 C--O 1.214 -0.778 0 CA-C-O 121.558 0.694 . . . . 0.0 111.815 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -155.37 149.72 26.01 Favored 'General case' 0 C--N 1.295 -1.782 0 CA-C-N 114.828 -1.078 . . . . 0.0 108.982 176.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.562 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 1.3 m -107.92 93.32 4.47 Favored 'General case' 0 C--N 1.296 -1.741 0 C-N-CA 119.608 -0.837 . . . . 0.0 111.2 -177.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.462 ' O ' ' O ' ' A' ' 27' ' ' LYS . 0.9 OUTLIER -107.7 143.41 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.31 0 C-N-CA 118.816 -1.154 . . . . 0.0 110.759 179.027 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.413 ' O ' HG22 ' A' ' 40' ' ' VAL . 7.1 t -50.94 157.89 0.77 Allowed 'General case' 0 C--N 1.274 -2.697 0 CA-C-N 114.31 -1.314 . . . . 0.0 111.036 -178.366 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 153.52 -154.97 25.86 Favored Glycine 0 N--CA 1.492 2.424 0 C-N-CA 119.528 -1.32 . . . . 0.0 110.748 179.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -122.83 67.52 0.97 Allowed 'General case' 0 N--CA 1.498 1.947 0 C-N-CA 120.039 -0.664 . . . . 0.0 110.215 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -74.01 173.34 50.56 Favored Glycine 0 N--CA 1.491 2.346 0 C-N-CA 119.425 -1.369 . . . . 0.0 110.523 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -106.22 145.56 31.21 Favored Pre-proline 0 N--CA 1.491 1.616 0 C-N-CA 119.679 -0.808 . . . . 0.0 109.527 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.497 ' HG3' HE21 ' A' ' 24' ' ' GLN . 1.7 Cg_endo -62.63 130.85 31.15 Favored 'Trans proline' 0 C--O 1.216 -0.615 0 C-N-CA 120.901 1.067 . . . . 0.0 110.872 176.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.431 ' OE1' ' OG1' ' A' ' 4' ' ' THR . 1.0 OUTLIER . . . . . 0 C--N 1.3 -1.566 0 C-N-CA 119.547 -0.861 . . . . 0.0 110.362 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.51 HG12 ' H ' ' A' ' 3' ' ' TYR . 2.7 t . . . . . 0 N--CA 1.496 1.872 0 CA-C-O 120.696 0.284 . . . . 0.0 111.143 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.51 ' H ' HG12 ' A' ' 2' ' ' VAL . 52.1 m-85 -123.94 -173.69 2.81 Favored 'General case' 0 N--CA 1.5 2.026 0 C-N-CA 119.931 -0.707 . . . . 0.0 110.652 179.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -101.52 173.0 6.63 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 115.171 -0.922 . . . . 0.0 108.557 178.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.531 ' N ' ' OD1' ' A' ' 5' ' ' ASP . 0.0 OUTLIER -91.06 152.23 20.72 Favored 'General case' 0 C--N 1.294 -1.826 0 C-N-CA 118.489 -1.285 . . . . 0.0 108.877 176.684 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.412 ' N ' ' HB2' ' A' ' 14' ' ' CYS . 1.3 m -75.41 179.88 4.95 Favored 'General case' 0 C--N 1.29 -2.018 0 C-N-CA 119.221 -0.992 . . . . 0.0 111.019 179.154 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.1 t -150.56 16.84 0.8 Allowed 'General case' 0 C--N 1.281 -2.412 0 CA-C-N 113.601 -1.636 . . . . 0.0 109.393 177.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -159.42 175.08 13.75 Favored 'General case' 0 C--N 1.29 -1.991 0 CA-C-N 114.443 -1.253 . . . . 0.0 110.643 -178.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -76.88 -170.27 1.56 Allowed 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.265 179.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.572 ' HA2' ' O ' ' A' ' 28' ' ' CYS . . . 26.1 18.23 0.0 OUTLIER Glycine 0 N--CA 1.503 3.126 1 N-CA-C 130.913 7.125 . . . . 0.0 130.913 178.974 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -87.76 -166.88 1.71 Allowed 'General case' 0 N--CA 1.503 2.216 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 176.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.496 ' C ' ' H ' ' A' ' 14' ' ' CYS . 10.6 m120 -151.48 -55.5 0.14 Allowed 'General case' 0 N--CA 1.503 2.183 0 N-CA-C 116.612 2.078 . . . . 0.0 116.612 -178.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.453 HD22 ' CZ ' ' A' ' 3' ' ' TYR . 24.3 mt -75.79 41.7 0.22 Allowed 'General case' 0 C--N 1.29 -1.981 0 C-N-CA 118.134 -1.426 . . . . 0.0 110.716 -174.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.699 ' O ' HG22 ' A' ' 21' ' ' VAL . 30.5 p -124.21 -148.23 0.39 Allowed 'General case' 0 C--N 1.288 -2.073 0 CA-C-N 114.817 -1.083 . . . . 0.0 108.298 176.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.437 HD12 ' OD1' ' A' ' 5' ' ' ASP . 6.2 mt -119.21 110.72 17.35 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 176.038 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.435 ' HB2' ' SG ' ' A' ' 39' ' ' CYS . 55.9 m -104.56 -61.51 1.45 Allowed 'General case' 0 C--N 1.281 -2.396 0 CA-C-N 114.009 -1.45 . . . . 0.0 112.085 -172.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -96.27 94.52 7.52 Favored 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 118.76 -1.176 . . . . 0.0 110.392 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 73.15 -108.93 2.64 Favored Glycine 0 N--CA 1.492 2.378 0 C-N-CA 119.467 -1.349 . . . . 0.0 110.788 179.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -119.29 1.82 11.31 Favored 'General case' 0 CA--C 1.492 -1.286 0 CA-C-O 122.34 1.067 . . . . 0.0 109.896 -179.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -78.52 127.74 32.58 Favored 'General case' 0 C--N 1.257 -3.454 0 CA-C-N 113.204 -1.816 . . . . 0.0 109.758 179.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.699 HG22 ' O ' ' A' ' 14' ' ' CYS . 0.9 OUTLIER -78.33 137.97 21.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 C-N-CA 118.961 -1.096 . . . . 0.0 110.103 179.736 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.549 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 0.1 OUTLIER -86.66 146.22 26.39 Favored 'General case' 0 C--N 1.283 -2.289 0 C-N-CA 118.29 -1.364 . . . . 0.0 109.589 173.186 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.488 ' O ' ' ND2' ' A' ' 26' ' ' ASN . . . -116.07 104.42 1.27 Allowed Glycine 0 C--N 1.296 -1.656 0 N-CA-C 108.809 -1.716 . . . . 0.0 108.809 -174.193 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.485 HE21 ' C ' ' A' ' 24' ' ' GLN . 0.0 OUTLIER -31.86 124.52 0.27 Allowed 'General case' 0 C--N 1.26 -3.29 0 CA-C-N 112.632 -1.784 . . . . 0.0 110.941 179.186 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 140.79 -23.25 2.64 Favored Glycine 0 C--N 1.29 -1.972 0 N-CA-C 105.139 -3.184 . . . . 0.0 105.139 -173.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.509 ' OD1' ' N ' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -111.41 -162.29 0.79 Allowed 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 112.907 -1.647 . . . . 0.0 107.282 175.601 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.538 ' O ' ' N ' ' A' ' 40' ' ' VAL . 14.9 tttp -144.6 147.54 33.27 Favored 'General case' 0 C--N 1.297 -1.703 0 C-N-CA 118.661 -1.216 . . . . 0.0 109.949 175.317 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.572 ' O ' ' HA2' ' A' ' 10' ' ' GLY . 56.6 m -111.99 157.53 20.61 Favored 'General case' 0 CA--C 1.483 -1.603 0 C-N-CA 118.711 -1.195 . . . . 0.0 109.775 177.29 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 11.3 mm -140.05 126.96 23.24 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.7 0 CA-C-N 114.629 -1.169 . . . . 0.0 109.954 175.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' A' ' 30' ' ' LEU . 15.3 mt . . . . . 0 N--CA 1.496 1.856 0 C-N-CA 118.671 -1.212 . . . . 0.0 110.094 178.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 1.029 HD22 ' N ' ' A' ' 38' ' ' GLN . 0.3 OUTLIER . . . . . 0 C--O 1.216 -0.672 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 1.029 ' N ' HD22 ' A' ' 37' ' ' ASN . 23.5 tt0 -140.59 155.75 46.48 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 119.447 -0.901 . . . . 0.0 110.773 -179.636 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.435 ' SG ' ' HB2' ' A' ' 16' ' ' CYS . 1.5 m -101.47 89.03 3.6 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 119.662 -0.815 . . . . 0.0 110.843 -179.191 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.538 ' N ' ' O ' ' A' ' 27' ' ' LYS . 0.3 OUTLIER -94.87 141.71 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.675 0 C-N-CA 118.299 -1.36 . . . . 0.0 112.029 179.835 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.413 ' O ' HG22 ' A' ' 40' ' ' VAL . 3.5 t -54.13 145.4 17.22 Favored 'General case' 0 C--N 1.276 -2.59 0 CA-C-N 114.661 -1.154 . . . . 0.0 110.633 -179.527 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 157.81 -173.43 35.12 Favored Glycine 0 N--CA 1.494 2.536 0 C-N-CA 119.164 -1.493 . . . . 0.0 110.778 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -111.23 122.16 47.16 Favored 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 120.081 -0.648 . . . . 0.0 110.362 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -138.41 -145.28 4.8 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 179.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -139.81 153.2 69.66 Favored Pre-proline 0 N--CA 1.491 1.607 0 C-N-CA 119.59 -0.844 . . . . 0.0 109.997 179.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -60.48 -169.25 0.05 OUTLIER 'Trans proline' 0 C--O 1.216 -0.622 0 C-N-CA 121.417 1.412 . . . . 0.0 111.515 178.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.437 ' OE2' ' O ' ' A' ' 5' ' ' ASP . 3.8 tt0 . . . . . 0 C--N 1.312 -1.036 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.043 179.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.42 HG12 ' N ' ' A' ' 3' ' ' TYR . 3.6 t . . . . . 0 N--CA 1.489 1.498 0 CA-C-O 121.06 0.457 . . . . 0.0 110.081 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.42 ' N ' HG12 ' A' ' 2' ' ' VAL . 24.5 m-85 -150.56 -169.91 3.51 Favored 'General case' 0 C--N 1.297 -1.7 0 C-N-CA 119.774 -0.77 . . . . 0.0 109.808 179.115 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.552 ' OG1' ' N ' ' A' ' 5' ' ' ASP . 0.0 OUTLIER -109.76 174.97 5.62 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 177.891 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.552 ' N ' ' OG1' ' A' ' 4' ' ' THR . 0.2 OUTLIER -84.2 151.24 24.96 Favored 'General case' 0 C--N 1.28 -2.456 0 C-N-CA 118.106 -1.438 . . . . 0.0 110.322 -178.199 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.506 ' O ' HG23 ' A' ' 7' ' ' THR . 0.1 OUTLIER -76.65 -176.79 3.94 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-O 122.147 0.975 . . . . 0.0 111.756 178.62 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.506 HG23 ' O ' ' A' ' 6' ' ' CYS . 1.3 p -157.02 15.87 0.28 Allowed 'General case' 0 C--N 1.283 -2.292 0 CA-C-N 113.391 -1.731 . . . . 0.0 109.709 177.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.449 ' N ' HE22 ' A' ' 11' ' ' GLN . 2.0 mt-10 -163.24 174.3 12.27 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-N 114.935 -1.03 . . . . 0.0 111.513 179.247 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.412 ' HB3' ' H ' ' A' ' 30' ' ' LEU . 0.4 OUTLIER -88.38 170.06 11.27 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.175 -178.21 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.456 ' O ' ' O ' ' A' ' 11' ' ' GLN . . . 73.44 -33.54 0.82 Allowed Glycine 0 N--CA 1.504 3.197 0 C-N-CA 119.668 -1.253 . . . . 0.0 112.378 177.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.456 ' O ' ' O ' ' A' ' 10' ' ' GLY . 12.4 mt-30 -51.8 -173.6 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.241 0 C-N-CA 119.507 -0.877 . . . . 0.0 110.153 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.502 ' C ' ' H ' ' A' ' 14' ' ' CYS . 1.6 m120 -158.85 -51.88 0.06 Allowed 'General case' 0 N--CA 1.503 2.176 0 C-N-CA 117.043 -1.863 . . . . 0.0 115.29 -179.199 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 67.1 mt -76.49 40.1 0.22 Allowed 'General case' 0 C--N 1.288 -2.091 0 C-N-CA 118.642 -1.223 . . . . 0.0 110.639 -175.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.502 ' H ' ' C ' ' A' ' 12' ' ' ASN . 10.0 p -124.76 -158.36 0.82 Allowed 'General case' 0 C--N 1.29 -1.995 0 CA-C-N 114.502 -1.226 . . . . 0.0 108.831 178.21 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 6.6 mt -109.91 116.17 31.15 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 119.65 -0.82 . . . . 0.0 110.662 178.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -111.93 -68.96 0.89 Allowed 'General case' 0 C--N 1.295 -1.786 0 CA-C-N 114.403 -1.271 . . . . 0.0 110.838 -177.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -79.38 99.01 6.97 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 119.585 -0.846 . . . . 0.0 110.376 -179.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.0 -113.56 5.48 Favored Glycine 0 N--CA 1.486 1.975 0 C-N-CA 119.408 -1.377 . . . . 0.0 110.451 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.422 ' O ' ' OG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -111.71 3.78 18.05 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-O 122.43 1.11 . . . . 0.0 109.694 -179.544 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -78.5 129.27 34.67 Favored 'General case' 0 C--N 1.256 -3.491 0 CA-C-N 113.229 -1.805 . . . . 0.0 110.248 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.443 HG22 ' O ' ' A' ' 14' ' ' CYS . 0.9 OUTLIER -78.36 144.06 11.77 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 C-N-CA 118.993 -1.083 . . . . 0.0 110.349 179.93 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.6 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 0.1 OUTLIER -90.97 143.97 26.15 Favored 'General case' 0 C--N 1.286 -2.166 0 C-N-CA 118.813 -1.155 . . . . 0.0 110.621 173.325 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.658 ' O ' ' N ' ' A' ' 25' ' ' GLY . . . -113.63 110.47 2.46 Favored Glycine 0 CA--C 1.486 -1.779 0 N-CA-C 107.844 -2.102 . . . . 0.0 107.844 -174.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -37.36 -5.2 0.0 OUTLIER 'General case' 0 C--N 1.254 -3.565 0 CA-C-N 112.521 -1.84 . . . . 0.0 114.491 178.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.658 ' N ' ' O ' ' A' ' 23' ' ' GLY . . . -69.27 -9.57 61.02 Favored Glycine 0 C--N 1.263 -3.498 0 N-CA-C 106.695 -2.562 . . . . 0.0 106.695 173.332 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 47.2 m-20 -135.41 -167.3 1.99 Allowed 'General case' 0 N--CA 1.485 1.309 0 CA-C-N 113.594 -1.303 . . . . 0.0 108.069 178.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.555 ' N ' ' O ' ' A' ' 40' ' ' VAL . 0.2 OUTLIER -123.12 166.84 14.51 Favored 'General case' 0 N--CA 1.503 2.217 0 C-N-CA 119.578 -0.849 . . . . 0.0 110.923 179.756 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.6 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 0.6 OUTLIER -136.34 154.89 50.71 Favored 'General case' 0 CA--C 1.472 -2.023 0 CA-C-O 122.203 1.002 . . . . 0.0 110.016 175.492 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 26.4 mm -145.56 127.78 9.19 Favored 'Isoleucine or valine' 1 C--N 1.24 -4.182 0 CA-C-N 113.083 -1.872 . . . . 0.0 109.528 177.098 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.412 ' H ' ' HB3' ' A' ' 9' ' ' SER . 17.6 mt . . . . . 0 N--CA 1.49 1.559 0 C-N-CA 118.467 -1.293 . . . . 0.0 110.429 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.548 ' OD1' ' N ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.474 0.756 0 CA-C-O 120.817 0.342 . . . . 0.0 110.176 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -156.74 152.41 26.97 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 119.143 -1.023 . . . . 0.0 110.511 176.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.575 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 0.9 OUTLIER -125.42 87.65 2.74 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.562 -179.793 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.555 ' O ' ' N ' ' A' ' 27' ' ' LYS . 2.4 p -111.35 146.77 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.621 0 C-N-CA 118.447 -1.301 . . . . 0.0 112.773 -179.289 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.407 ' N ' ' CG2' ' A' ' 40' ' ' VAL . 6.1 t -43.76 161.48 0.02 OUTLIER 'General case' 0 C--N 1.285 -2.226 0 CA-C-N 113.328 -1.76 . . . . 0.0 112.035 178.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 120.93 143.55 6.76 Favored Glycine 0 N--CA 1.497 2.76 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -84.57 131.86 34.58 Favored 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 119.188 -1.005 . . . . 0.0 111.1 -178.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -131.79 -156.2 8.3 Favored Glycine 0 N--CA 1.496 2.668 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 179.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.503 ' O ' HG23 ' A' ' 45' ' ' THR . 14.4 t -102.48 127.87 29.45 Favored Pre-proline 0 N--CA 1.493 1.681 0 C-N-CA 119.476 -0.89 . . . . 0.0 110.351 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.431 ' O ' ' C ' ' A' ' 47' ' ' GLU . 1.4 Cg_endo -64.69 115.02 2.99 Favored 'Trans proline' 0 C--O 1.214 -0.687 0 C-N-CA 120.591 0.861 . . . . 0.0 110.822 178.56 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.431 ' C ' ' O ' ' A' ' 46' ' ' PRO . 1.2 tt0 . . . . . 0 N--CA 1.503 2.212 0 C-N-CA 120.229 -0.588 . . . . 0.0 110.702 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.491 HG12 ' H ' ' A' ' 3' ' ' TYR . 3.4 t . . . . . 0 N--CA 1.489 1.491 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.491 ' H ' HG12 ' A' ' 2' ' ' VAL . 33.1 m-85 -107.72 -167.38 1.25 Allowed 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 119.879 -0.729 . . . . 0.0 110.505 -179.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -96.9 176.91 5.8 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 178.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.537 ' N ' ' OD1' ' A' ' 5' ' ' ASP . 0.4 OUTLIER -89.96 157.09 18.0 Favored 'General case' 0 C--N 1.293 -1.856 0 C-N-CA 118.099 -1.441 . . . . 0.0 109.19 176.984 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.496 ' SG ' ' O ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -75.58 165.89 24.39 Favored 'General case' 0 C--N 1.285 -2.223 0 C-N-CA 119.745 -0.782 . . . . 0.0 110.708 178.571 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.779 ' H ' HE22 ' A' ' 11' ' ' GLN . 2.0 t -130.94 3.5 4.42 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.231 177.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.582 ' H ' HE22 ' A' ' 11' ' ' GLN . 2.7 mm-40 -162.34 161.55 27.53 Favored 'General case' 0 C--N 1.28 -2.456 0 CA-C-N 113.671 -1.604 . . . . 0.0 110.414 -179.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.462 ' HA ' ' H ' ' A' ' 30' ' ' LEU . 0.6 OUTLIER -77.24 154.84 32.61 Favored 'General case' 0 C--N 1.291 -1.962 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.323 -179.43 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.436 ' O ' ' O ' ' A' ' 11' ' ' GLN . . . 96.21 -33.47 5.59 Favored Glycine 0 N--CA 1.501 2.984 0 C-N-CA 119.27 -1.443 . . . . 0.0 112.296 -179.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.779 HE22 ' H ' ' A' ' 7' ' ' THR . 8.8 mt-30 -51.72 -176.63 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.181 0 C-N-CA 119.128 -1.029 . . . . 0.0 110.698 -178.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.517 ' O ' ' O ' ' A' ' 22' ' ' CYS . 1.5 m-20 -144.64 -64.4 0.35 Allowed 'General case' 0 N--CA 1.5 2.059 0 C-N-CA 118.45 -1.3 . . . . 0.0 113.97 -176.202 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 85.2 mt -76.87 50.05 0.69 Allowed 'General case' 0 C--N 1.271 -2.809 0 C-N-CA 117.596 -1.642 . . . . 0.0 110.101 -176.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.564 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 29.7 p -125.56 -152.01 0.5 Allowed 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.011 -0.995 . . . . 0.0 108.684 177.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.534 HD22 ' O ' ' A' ' 19' ' ' SER . 76.0 mt -117.37 117.23 28.94 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 115.179 -0.919 . . . . 0.0 108.918 176.365 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.564 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 1.5 m -126.36 17.35 7.67 Favored 'General case' 0 N--CA 1.498 1.958 0 C-N-CA 118.81 -1.156 . . . . 0.0 111.036 -176.294 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -152.3 83.3 1.25 Allowed 'General case' 0 C--N 1.295 -1.795 0 C-N-CA 119.662 -0.815 . . . . 0.0 108.9 178.239 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 67.32 -85.11 0.13 Allowed Glycine 0 N--CA 1.486 1.989 0 C-N-CA 119.193 -1.479 . . . . 0.0 109.727 -178.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.534 ' O ' HD22 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -140.42 -2.18 1.44 Allowed 'General case' 0 N--CA 1.486 1.361 0 CA-C-O 121.891 0.853 . . . . 0.0 111.14 179.363 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -82.88 144.99 29.69 Favored 'General case' 0 C--N 1.258 -3.402 0 CA-C-N 114.189 -1.369 . . . . 0.0 111.057 -179.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.2 t -71.96 144.8 12.83 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.523 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.545 ' O ' ' SG ' ' A' ' 28' ' ' CYS . 0.7 OUTLIER -146.4 127.47 14.64 Favored 'General case' 0 C--N 1.279 -2.487 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 177.353 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.512 ' C ' ' H ' ' A' ' 25' ' ' GLY . . . 166.82 -83.81 0.1 OUTLIER Glycine 0 N--CA 1.482 1.703 0 C-N-CA 116.465 -2.778 . . . . 0.0 113.764 -175.489 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -72.66 17.39 0.11 Allowed 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 118.712 -1.195 . . . . 0.0 112.691 -173.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.512 ' H ' ' C ' ' A' ' 23' ' ' GLY . . . -126.86 -11.35 3.59 Favored Glycine 0 C--N 1.264 -3.422 0 N-CA-C 107.937 -2.065 . . . . 0.0 107.937 173.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.44 ' O ' ' O ' ' A' ' 23' ' ' GLY . 1.5 m-80 -158.22 -146.65 0.16 Allowed 'General case' 0 C--O 1.213 -0.834 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 -177.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.579 ' N ' ' O ' ' A' ' 40' ' ' VAL . 0.0 OUTLIER -141.34 138.44 33.08 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 175.45 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.545 ' SG ' ' O ' ' A' ' 22' ' ' CYS . 36.3 m -101.82 148.6 25.11 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 118.108 -1.437 . . . . 0.0 111.808 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 35.1 mm -140.32 90.1 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.263 -3.156 0 CA-C-N 112.918 -1.947 . . . . 0.0 106.878 175.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.681 ' C ' HD12 ' A' ' 30' ' ' LEU . 0.4 OUTLIER . . . . . 0 C--N 1.305 -1.34 0 C-N-CA 118.955 -1.098 . . . . 0.0 110.296 -176.245 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.471 ' OD1' ' N ' ' A' ' 37' ' ' ASN . 1.6 m-20 . . . . . 0 N--CA 1.482 1.134 0 CA-C-O 121.098 0.475 . . . . 0.0 110.938 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.461 ' CG ' ' N ' ' A' ' 39' ' ' CYS . 13.7 tt0 -157.38 157.61 34.37 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 119.26 -0.976 . . . . 0.0 110.973 179.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.461 ' N ' ' CG ' ' A' ' 38' ' ' GLN . 82.0 m -115.82 74.33 0.89 Allowed 'General case' 0 N--CA 1.492 1.669 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.453 178.403 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.579 ' O ' ' N ' ' A' ' 27' ' ' LYS . 0.2 OUTLIER -81.01 143.21 12.69 Favored 'Isoleucine or valine' 0 C--O 1.193 -1.873 0 C-N-CA 118.684 -1.206 . . . . 0.0 111.548 -177.75 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.5 t -64.1 140.18 58.84 Favored 'General case' 0 C--N 1.272 -2.777 0 CA-C-N 114.596 -1.184 . . . . 0.0 111.551 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 163.8 -140.92 6.76 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 178.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -145.86 113.43 6.34 Favored 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 119.272 -0.971 . . . . 0.0 110.32 179.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -114.37 -163.37 14.58 Favored Glycine 0 N--CA 1.498 2.812 0 C-N-CA 119.966 -1.111 . . . . 0.0 110.89 -179.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -131.1 153.02 81.63 Favored Pre-proline 0 N--CA 1.498 1.97 0 C-N-CA 120.04 -0.664 . . . . 0.0 109.627 -179.612 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -54.12 160.18 6.65 Favored 'Trans proline' 0 C--O 1.216 -0.621 0 C-N-CA 121.604 1.536 . . . . 0.0 112.177 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.623 ' CD ' ' H ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.25 0 C-N-CA 119.519 -0.872 . . . . 0.0 108.796 178.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.472 HG12 ' N ' ' A' ' 3' ' ' TYR . 6.0 t . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.472 ' N ' HG12 ' A' ' 2' ' ' VAL . 25.1 m-85 -130.04 -167.62 1.84 Allowed 'General case' 0 N--CA 1.497 1.89 0 C-N-CA 119.779 -0.768 . . . . 0.0 109.948 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.0 p -98.42 176.95 5.51 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 119.541 -0.864 . . . . 0.0 108.866 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -88.06 153.07 21.56 Favored 'General case' 0 C--N 1.29 -1.979 0 C-N-CA 118.468 -1.293 . . . . 0.0 110.79 179.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.528 ' SG ' ' CB ' ' A' ' 11' ' ' GLN . 1.2 m -74.39 179.13 4.76 Favored 'General case' 0 C--N 1.287 -2.127 0 CA-C-N 114.754 -1.112 . . . . 0.0 111.564 176.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -152.81 13.41 0.53 Allowed 'General case' 0 C--N 1.29 -2.018 0 CA-C-N 113.657 -1.61 . . . . 0.0 110.015 176.404 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.596 ' CG ' ' NE2' ' A' ' 11' ' ' GLN . 0.9 OUTLIER -163.5 -171.81 2.7 Favored 'General case' 0 C--N 1.286 -2.157 0 CA-C-N 114.511 -1.222 . . . . 0.0 109.947 179.271 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.496 ' HB3' ' H ' ' A' ' 30' ' ' LEU . 0.8 OUTLIER -99.91 172.99 6.89 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 119.911 -0.716 . . . . 0.0 110.707 -178.007 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.488 ' H ' HD13 ' A' ' 29' ' ' ILE . . . 63.57 22.21 65.64 Favored Glycine 0 N--CA 1.502 3.063 0 C-N-CA 119.978 -1.106 . . . . 0.0 112.661 176.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.596 ' NE2' ' CG ' ' A' ' 8' ' ' GLU . 0.0 OUTLIER -89.2 -166.53 1.62 Allowed 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 118.95 -1.1 . . . . 0.0 111.213 178.804 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.836 ' OD1' ' HA2' ' A' ' 23' ' ' GLY . 2.0 m-20 -153.76 -70.37 0.14 Allowed 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 118.81 -1.156 . . . . 0.0 113.265 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.408 ' HA ' HD23 ' A' ' 13' ' ' LEU . 94.4 mt -77.97 45.6 0.53 Allowed 'General case' 0 C--N 1.282 -2.343 0 C-N-CA 118.64 -1.224 . . . . 0.0 111.291 -176.235 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.476 ' SG ' ' N ' ' A' ' 15' ' ' LEU . 15.3 p -123.82 -154.88 0.63 Allowed 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 174.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.535 HD22 ' O ' ' A' ' 19' ' ' SER . 63.3 mt -116.62 109.8 17.69 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-N 114.654 -1.157 . . . . 0.0 108.406 176.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.7 m -104.89 -58.97 1.81 Allowed 'General case' 0 C--N 1.288 -2.099 0 C-N-CA 118.939 -1.104 . . . . 0.0 111.027 -175.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -83.79 85.45 7.29 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 118.363 -1.335 . . . . 0.0 109.233 177.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.53 -116.8 5.28 Favored Glycine 0 N--CA 1.489 2.191 0 C-N-CA 119.384 -1.388 . . . . 0.0 110.317 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.535 ' O ' HD22 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -109.74 1.41 19.41 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-O 122.261 1.029 . . . . 0.0 109.91 -179.581 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 32.2 m120 -79.32 139.03 37.93 Favored 'General case' 0 C--N 1.26 -3.324 0 CA-C-N 113.244 -1.798 . . . . 0.0 111.081 -178.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.6 t -74.09 142.45 14.79 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 C-N-CA 118.987 -1.085 . . . . 0.0 110.206 179.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.515 ' O ' ' SG ' ' A' ' 28' ' ' CYS . 4.0 m -145.55 99.25 3.26 Favored 'General case' 0 C--N 1.284 -2.264 0 C-N-CA 118.873 -1.131 . . . . 0.0 109.408 177.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.836 ' HA2' ' OD1' ' A' ' 12' ' ' ASN . . . -161.91 -78.33 0.03 OUTLIER Glycine 0 C--N 1.297 -1.631 1 N-CA-C 131.482 7.353 . . . . 0.0 131.482 -177.489 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.527 ' O ' ' ND2' ' A' ' 26' ' ' ASN . 3.9 tt0 -45.9 124.56 5.43 Favored 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 119.506 -0.877 . . . . 0.0 111.188 -178.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.66 -26.15 2.77 Favored Glycine 0 N--CA 1.478 1.454 0 C-N-CA 119.61 -1.281 . . . . 0.0 110.255 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.548 ' N ' ' ND2' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -110.21 -167.58 1.21 Allowed 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 119.54 -0.864 . . . . 0.0 110.726 -178.92 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.537 ' O ' ' O ' ' A' ' 40' ' ' VAL . 16.6 tttt -148.08 166.08 28.87 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 119.466 -0.894 . . . . 0.0 110.056 179.2 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.515 ' SG ' ' O ' ' A' ' 22' ' ' CYS . 59.0 m -136.06 158.89 43.31 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.261 -0.975 . . . . 0.0 110.147 176.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.488 HD13 ' H ' ' A' ' 10' ' ' GLY . 22.3 mm -142.68 136.73 27.53 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.505 0 CA-C-N 114.793 -1.094 . . . . 0.0 110.536 177.229 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.496 ' H ' ' HB3' ' A' ' 9' ' ' SER . 18.1 mt . . . . . 0 N--CA 1.485 1.288 0 C-N-CA 119.943 -0.703 . . . . 0.0 110.967 177.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 1.073 HD22 ' N ' ' A' ' 38' ' ' GLN . 0.2 OUTLIER . . . . . 0 N--CA 1.439 -0.991 0 CA-C-O 121.165 0.507 . . . . 0.0 110.737 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 1.073 ' N ' HD22 ' A' ' 37' ' ' ASN . 13.1 tt0 -127.04 143.16 51.36 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 114.93 -1.032 . . . . 0.0 108.994 176.061 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 66.6 m -96.28 108.19 20.64 Favored 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 119.212 -0.995 . . . . 0.0 111.136 -178.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.537 ' O ' ' O ' ' A' ' 27' ' ' LYS . 0.2 OUTLIER -110.26 142.26 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.407 0 C-N-CA 118.908 -1.117 . . . . 0.0 111.285 177.007 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.415 ' O ' HG22 ' A' ' 40' ' ' VAL . 15.1 t -70.25 151.48 45.28 Favored 'General case' 0 C--N 1.273 -2.76 0 CA-C-N 114.692 -1.14 . . . . 0.0 110.314 178.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.444 ' H ' ' HA ' ' A' ' 26' ' ' ASN . . . 144.37 -116.54 0.96 Allowed Glycine 0 N--CA 1.493 2.472 1 N-CA-C 130.847 7.099 . . . . 0.0 130.847 -178.962 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 -116.26 72.61 0.82 Allowed 'General case' 0 N--CA 1.5 2.065 0 C-N-CA 119.957 -0.697 . . . . 0.0 110.556 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.441 ' O ' ' ND2' ' A' ' 12' ' ' ASN . . . -107.67 151.16 16.95 Favored Glycine 0 N--CA 1.497 2.704 0 C-N-CA 119.795 -1.193 . . . . 0.0 110.53 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -117.61 152.53 49.79 Favored Pre-proline 0 N--CA 1.496 1.839 0 C-N-CA 120.097 -0.641 . . . . 0.0 109.532 179.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -53.36 161.47 3.88 Favored 'Trans proline' 0 C--O 1.215 -0.629 0 C-N-CA 121.287 1.324 . . . . 0.0 111.137 177.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 . . . . . 0 C--N 1.307 -1.246 0 C-N-CA 118.987 -1.085 . . . . 0.0 111.048 178.022 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.48 1.075 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -82.53 -170.82 3.15 Favored 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 118.961 -1.096 . . . . 0.0 110.791 -179.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.51 ' OG1' ' N ' ' A' ' 5' ' ' ASP . 0.0 OUTLIER -118.76 -169.07 1.65 Allowed 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.35 179.608 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.51 ' N ' ' OG1' ' A' ' 4' ' ' THR . 0.0 OUTLIER -90.46 151.81 21.23 Favored 'General case' 0 C--N 1.288 -2.073 0 C-N-CA 118.774 -1.17 . . . . 0.0 111.903 -176.649 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.497 ' O ' HG23 ' A' ' 7' ' ' THR . 0.7 OUTLIER -75.57 179.48 5.3 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-N 114.215 -1.357 . . . . 0.0 112.28 177.348 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.798 ' H ' HE22 ' A' ' 11' ' ' GLN . 5.3 p -159.09 16.26 0.17 Allowed 'General case' 0 C--N 1.285 -2.204 0 CA-C-N 112.979 -1.919 . . . . 0.0 109.342 177.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.402 ' CG ' ' O ' ' A' ' 7' ' ' THR . 33.1 mt-10 -160.96 168.07 25.29 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 114.949 -1.023 . . . . 0.0 110.704 -178.179 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.48 ' HB3' ' H ' ' A' ' 30' ' ' LEU . 0.7 OUTLIER -88.33 159.42 18.08 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.06 -179.892 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.444 ' O ' ' O ' ' A' ' 11' ' ' GLN . . . 82.99 -28.47 3.64 Favored Glycine 0 N--CA 1.501 2.971 0 C-N-CA 119.446 -1.359 . . . . 0.0 112.531 177.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.798 HE22 ' H ' ' A' ' 7' ' ' THR . 5.6 mt-30 -49.55 -178.59 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.13 0 C-N-CA 119.496 -0.882 . . . . 0.0 110.817 -179.059 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.688 ' C ' ' HA3' ' A' ' 23' ' ' GLY . 13.2 m-20 -143.68 -67.83 0.34 Allowed 'General case' 0 N--CA 1.501 2.108 0 C-N-CA 118.493 -1.283 . . . . 0.0 114.289 -176.031 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 94.2 mt -77.78 48.28 0.68 Allowed 'General case' 0 C--N 1.275 -2.638 0 C-N-CA 118.803 -1.159 . . . . 0.0 111.399 -175.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 29.4 p -122.93 -159.35 0.83 Allowed 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 119.677 -0.809 . . . . 0.0 110.566 176.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 64.7 mt -117.17 121.93 42.62 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.958 177.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 63.5 m -110.18 -73.47 0.68 Allowed 'General case' 0 N--CA 1.5 2.07 0 C-N-CA 119.028 -1.069 . . . . 0.0 110.883 -179.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -79.69 93.23 5.5 Favored 'General case' 0 C--N 1.295 -1.767 0 C-N-CA 118.828 -1.149 . . . . 0.0 110.185 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 72.83 -118.9 6.66 Favored Glycine 0 N--CA 1.488 2.143 0 C-N-CA 119.494 -1.336 . . . . 0.0 110.73 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.42 ' O ' ' OG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -110.65 4.59 20.3 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-O 122.286 1.041 . . . . 0.0 109.947 -178.918 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 61.5 m-80 -78.37 135.24 37.42 Favored 'General case' 0 C--N 1.259 -3.366 0 CA-C-N 113.2 -1.818 . . . . 0.0 110.742 -179.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.1 t -75.67 144.67 11.7 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 C-N-CA 119.451 -0.9 . . . . 0.0 110.754 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.463 ' O ' ' O ' ' A' ' 12' ' ' ASN . 53.8 m -141.68 99.78 3.62 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 118.768 -1.173 . . . . 0.0 110.137 176.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.688 ' HA3' ' C ' ' A' ' 12' ' ' ASN . . . -176.14 -42.05 0.06 OUTLIER Glycine 0 N--CA 1.487 2.043 1 N-CA-C 129.921 6.728 . . . . 0.0 129.921 -178.012 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 12.1 tt0 -86.33 118.19 25.61 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 118.879 -1.128 . . . . 0.0 109.117 177.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.42 -22.6 29.24 Favored Glycine 0 C--N 1.294 -1.802 0 N-CA-C 108.719 -1.753 . . . . 0.0 108.719 -176.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.455 ' O ' ' O ' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -131.72 164.79 25.17 Favored 'General case' 0 C--O 1.209 -1.077 0 C-N-CA 120.021 -0.672 . . . . 0.0 110.035 179.156 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.539 ' O ' ' O ' ' A' ' 40' ' ' VAL . 10.0 ttpt -122.12 147.87 45.6 Favored 'General case' 0 N--CA 1.506 2.37 0 C-N-CA 119.752 -0.779 . . . . 0.0 110.189 178.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.436 ' SG ' ' O ' ' A' ' 38' ' ' GLN . 0.7 OUTLIER -109.37 163.1 13.71 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 118.289 -1.364 . . . . 0.0 111.282 176.917 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 18.8 mm -145.49 130.07 12.3 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.355 0 CA-C-N 112.286 -2.234 . . . . 0.0 109.462 177.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.48 ' H ' ' HB3' ' A' ' 9' ' ' SER . 24.3 mt . . . . . 0 C--N 1.302 -1.457 0 C-N-CA 118.518 -1.273 . . . . 0.0 109.39 178.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.458 ' OD1' ' N ' ' A' ' 37' ' ' ASN . 1.3 m120 . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 121.349 0.595 . . . . 0.0 111.994 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.436 ' O ' ' SG ' ' A' ' 28' ' ' CYS . 7.3 tt0 -154.76 161.16 41.61 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.771 177.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.426 ' H ' ' HG3' ' A' ' 38' ' ' GLN . 62.6 m -128.3 84.08 2.21 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 120.037 -0.665 . . . . 0.0 110.445 -179.159 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.539 ' O ' ' O ' ' A' ' 27' ' ' LYS . 0.2 OUTLIER -91.69 139.17 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.606 0 C-N-CA 118.124 -1.43 . . . . 0.0 112.317 -178.722 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.42 ' O ' HG22 ' A' ' 40' ' ' VAL . 3.9 t -47.61 163.17 0.05 Allowed 'General case' 0 C--N 1.277 -2.583 0 CA-C-N 114.137 -1.392 . . . . 0.0 111.599 -178.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 130.36 -150.5 19.21 Favored Glycine 0 N--CA 1.492 2.43 1 N-CA-C 130.289 6.875 . . . . 0.0 130.289 -179.335 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -123.72 141.86 51.62 Favored 'General case' 0 N--CA 1.498 1.934 0 C-N-CA 119.88 -0.728 . . . . 0.0 109.958 178.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -161.4 -177.56 34.59 Favored Glycine 0 N--CA 1.487 2.085 0 C-N-CA 119.224 -1.465 . . . . 0.0 110.614 -179.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.424 ' O ' ' O ' ' A' ' 46' ' ' PRO . 0.4 OUTLIER -101.86 154.8 37.08 Favored Pre-proline 0 N--CA 1.49 1.559 0 C-N-CA 119.849 -0.741 . . . . 0.0 109.388 -179.701 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.424 ' O ' ' O ' ' A' ' 45' ' ' THR . 4.6 Cg_exo -54.96 -159.81 0.01 OUTLIER 'Trans proline' 0 C--O 1.213 -0.757 0 C-N-CA 121.273 1.315 . . . . 0.0 110.708 176.416 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 . . . . . 0 C--N 1.306 -1.325 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.062 179.63 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.1 t . . . . . 0 N--CA 1.479 1.005 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -103.75 -167.19 1.34 Allowed 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 119.443 -0.903 . . . . 0.0 111.02 -178.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.96 174.13 7.09 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.278 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -94.52 150.83 19.86 Favored 'General case' 0 C--N 1.296 -1.73 0 C-N-CA 118.737 -1.185 . . . . 0.0 109.833 179.182 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.518 ' SG ' ' O ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -75.86 165.94 24.26 Favored 'General case' 0 C--N 1.292 -1.93 0 C-N-CA 119.655 -0.818 . . . . 0.0 111.028 178.919 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 34.2 p -135.96 12.02 3.36 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-N 114.61 -1.177 . . . . 0.0 108.871 175.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.626 ' CB ' HE22 ' A' ' 11' ' ' GLN . 2.1 tt0 -162.54 175.43 11.46 Favored 'General case' 0 C--N 1.284 -2.248 0 CA-C-N 114.321 -1.309 . . . . 0.0 111.729 -179.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -85.33 154.46 21.88 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 114.816 -1.084 . . . . 0.0 110.296 -179.266 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.449 ' O ' ' O ' ' A' ' 11' ' ' GLN . . . 89.42 -21.21 30.02 Favored Glycine 0 N--CA 1.502 3.077 0 C-N-CA 119.261 -1.447 . . . . 0.0 112.855 178.124 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.626 HE22 ' CB ' ' A' ' 8' ' ' GLU . 1.5 mp0 -49.66 179.35 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.338 0 C-N-CA 118.588 -1.245 . . . . 0.0 110.187 -179.012 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.603 ' O ' ' HA3' ' A' ' 23' ' ' GLY . 15.6 t-20 -138.12 -76.49 0.38 Allowed 'General case' 0 N--CA 1.497 1.879 0 C-N-CA 118.963 -1.095 . . . . 0.0 112.438 -178.105 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 83.1 mt -78.36 47.34 0.68 Allowed 'General case' 0 C--N 1.264 -3.149 0 C-N-CA 117.968 -1.493 . . . . 0.0 110.594 -177.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.41 ' HB2' ' N ' ' A' ' 6' ' ' CYS . 31.9 p -117.03 -157.13 0.65 Allowed 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 119.482 -0.887 . . . . 0.0 110.13 177.492 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.518 ' O ' ' SG ' ' A' ' 6' ' ' CYS . 4.6 mt -122.8 127.98 49.83 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.371 177.266 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 82.8 m -116.35 -64.61 1.29 Allowed 'General case' 0 N--CA 1.511 2.604 0 C-N-CA 119.287 -0.965 . . . . 0.0 110.951 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 85.3 mt-10 -79.23 76.35 5.77 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 119.08 -1.048 . . . . 0.0 110.287 -178.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 73.77 -108.57 2.54 Favored Glycine 0 N--CA 1.488 2.144 0 C-N-CA 119.481 -1.342 . . . . 0.0 111.123 179.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -108.2 0.26 21.36 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 122.119 0.962 . . . . 0.0 110.773 -177.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 72.9 m-20 -79.66 127.01 31.65 Favored 'General case' 0 C--N 1.256 -3.481 0 CA-C-N 113.838 -1.528 . . . . 0.0 110.435 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.2 t -66.68 148.69 11.98 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 C-N-CA 118.835 -1.146 . . . . 0.0 109.168 178.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.513 ' O ' ' O ' ' A' ' 12' ' ' ASN . 0.0 OUTLIER -143.55 113.59 7.24 Favored 'General case' 0 C--N 1.289 -2.053 0 C-N-CA 118.802 -1.159 . . . . 0.0 110.754 -178.574 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.603 ' HA3' ' O ' ' A' ' 12' ' ' ASN . . . 162.08 -57.59 0.3 Allowed Glycine 0 N--CA 1.483 1.824 1 N-CA-C 130.29 6.876 . . . . 0.0 130.29 -178.01 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.582 ' HA ' HD21 ' A' ' 12' ' ' ASN . 15.8 tt0 -61.47 126.69 28.27 Favored 'General case' 0 C--N 1.31 -1.137 0 C-N-CA 119.037 -1.065 . . . . 0.0 110.51 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.41 -25.56 8.0 Favored Glycine 0 N--CA 1.482 1.708 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -178.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.484 ' OD1' ' N ' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -123.11 -167.18 1.56 Allowed 'General case' 0 C--N 1.316 -0.867 0 C-N-CA 120.322 -0.551 . . . . 0.0 110.021 179.992 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.56 ' HZ1' HD11 ' A' ' 29' ' ' ILE . 15.4 tttp -145.65 115.93 7.51 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 178.136 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.51 ' SG ' ' O ' ' A' ' 38' ' ' GLN . 0.1 OUTLIER -80.11 163.72 23.91 Favored 'General case' 0 CA--C 1.477 -1.828 0 C-N-CA 117.528 -1.669 . . . . 0.0 112.415 178.503 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.56 HD11 ' HZ1' ' A' ' 27' ' ' LYS . 18.1 mm -149.39 124.7 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.265 -3.076 0 CA-C-N 111.982 -2.372 . . . . 0.0 108.218 178.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.499 HD22 HD22 ' A' ' 37' ' ' ASN . 26.9 mt . . . . . 0 N--CA 1.49 1.544 0 C-N-CA 118.337 -1.345 . . . . 0.0 110.421 -178.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.499 HD22 HD22 ' A' ' 30' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.209 0 CA-C-O 120.498 0.189 . . . . 0.0 110.647 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.51 ' O ' ' SG ' ' A' ' 28' ' ' CYS . 42.1 tt0 -157.33 152.83 26.44 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 118.791 -1.164 . . . . 0.0 111.223 178.379 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -113.1 107.24 15.67 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 115.226 -0.897 . . . . 0.0 112.058 178.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.483 ' CG2' ' N ' ' A' ' 41' ' ' THR . 1.6 p -110.45 155.99 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 C-N-CA 119.01 -1.076 . . . . 0.0 109.494 174.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.483 ' N ' ' CG2' ' A' ' 40' ' ' VAL . 6.0 t -78.87 152.28 31.32 Favored 'General case' 0 C--N 1.279 -2.479 0 CA-C-N 114.814 -1.084 . . . . 0.0 112.202 -177.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 153.28 -113.87 0.6 Allowed Glycine 0 N--CA 1.491 2.331 1 N-CA-C 128.945 6.338 . . . . 0.0 128.945 -179.529 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -154.62 101.34 2.32 Favored 'General case' 0 N--CA 1.494 1.753 0 C-N-CA 119.299 -0.961 . . . . 0.0 110.268 177.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -114.73 -165.69 15.1 Favored Glycine 0 N--CA 1.496 2.656 0 C-N-CA 120.013 -1.089 . . . . 0.0 110.579 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -134.32 148.25 66.94 Favored Pre-proline 0 N--CA 1.489 1.513 0 C-N-CA 119.965 -0.694 . . . . 0.0 110.152 -179.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -59.74 143.64 99.59 Favored 'Trans proline' 0 C--O 1.211 -0.83 0 C-N-CA 121.314 1.343 . . . . 0.0 110.997 176.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 . . . . . 0 CA--C 1.565 1.523 0 C-N-CA 119.628 -0.829 . . . . 0.0 110.588 -179.721 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.1 t . . . . . 0 N--CA 1.481 1.088 0 CA-C-O 121.065 0.459 . . . . 0.0 110.498 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -100.48 -165.07 1.17 Allowed 'General case' 0 N--CA 1.492 1.648 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.283 179.223 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -94.18 -179.58 4.99 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.125 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 5' ' ' ASP . 0.2 OUTLIER -93.05 154.65 17.99 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 118.462 -1.295 . . . . 0.0 110.781 179.478 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.404 ' N ' ' HB2' ' A' ' 14' ' ' CYS . 1.9 m -75.41 179.17 5.38 Favored 'General case' 0 C--N 1.294 -1.841 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.056 178.226 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.3 p -134.24 -2.54 2.81 Favored 'General case' 0 C--N 1.29 -2.019 0 CA-C-N 113.904 -1.498 . . . . 0.0 109.924 176.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -162.84 157.04 20.83 Favored 'General case' 0 C--N 1.279 -2.493 0 CA-C-N 114.237 -1.347 . . . . 0.0 110.053 179.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.585 ' OG ' ' N ' ' A' ' 30' ' ' LEU . 1.4 m -62.59 -175.79 0.09 Allowed 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 119.73 -0.788 . . . . 0.0 110.496 179.237 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.442 ' O ' ' O ' ' A' ' 11' ' ' GLN . . . 73.64 -42.58 1.07 Allowed Glycine 0 N--CA 1.5 2.919 0 C-N-CA 120.111 -1.042 . . . . 0.0 112.9 178.173 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.442 ' O ' ' O ' ' A' ' 10' ' ' GLY . 2.5 mp0 -53.79 -173.02 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.607 0 C-N-CA 119.022 -1.071 . . . . 0.0 110.222 -177.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.506 ' ND2' ' O ' ' A' ' 26' ' ' ASN . 11.4 m-20 -151.59 -57.63 0.15 Allowed 'General case' 0 N--CA 1.503 2.212 0 C-N-CA 117.691 -1.604 . . . . 0.0 114.707 -177.044 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.425 HD23 ' HA ' ' A' ' 13' ' ' LEU . 15.0 mt -75.7 49.75 0.53 Allowed 'General case' 0 C--N 1.287 -2.133 0 C-N-CA 118.989 -1.085 . . . . 0.0 110.107 -176.175 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.593 ' SG ' ' N ' ' A' ' 15' ' ' LEU . 19.5 p -130.37 -142.31 0.24 Allowed 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 114.662 -1.154 . . . . 0.0 108.821 176.207 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.646 HD22 ' O ' ' A' ' 19' ' ' SER . 88.1 mt -122.9 108.8 13.39 Favored 'General case' 0 C--N 1.288 -2.083 0 CA-C-N 114.592 -1.185 . . . . 0.0 109.365 176.523 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.426 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 8.6 m -111.22 -46.74 3.27 Favored 'General case' 0 C--N 1.288 -2.068 0 CA-C-N 113.941 -1.481 . . . . 0.0 110.598 -175.382 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -87.82 73.88 9.16 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 119.17 -1.012 . . . . 0.0 109.307 178.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 73.39 -107.61 2.28 Favored Glycine 0 N--CA 1.489 2.195 0 C-N-CA 119.304 -1.427 . . . . 0.0 109.938 -178.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.646 ' O ' HD22 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -111.31 -0.13 16.49 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-O 122.337 1.065 . . . . 0.0 109.89 179.897 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -82.75 145.62 29.46 Favored 'General case' 0 C--N 1.261 -3.256 0 CA-C-N 113.201 -1.818 . . . . 0.0 111.467 -179.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.4 t -84.17 142.2 13.7 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.258 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.503 ' O ' ' O ' ' A' ' 12' ' ' ASN . 0.0 OUTLIER -109.85 146.44 35.07 Favored 'General case' 0 N--CA 1.504 2.229 0 N-CA-C 106.012 -1.848 . . . . 0.0 106.012 168.637 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -105.13 -154.58 22.29 Favored Glycine 0 CA--C 1.49 -1.491 0 C-N-CA 118.256 -1.926 . . . . 0.0 111.13 -173.271 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.473 ' C ' ' H ' ' A' ' 26' ' ' ASN . 4.0 tt0 -92.82 170.89 9.34 Favored 'General case' 0 C--N 1.246 -3.926 0 CA-C-N 112.075 -2.063 . . . . 0.0 109.55 -177.25 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.415 ' H ' ' HG2' ' A' ' 24' ' ' GLN . . . 81.06 -35.32 2.36 Favored Glycine 0 N--CA 1.48 1.616 0 N-CA-C 108.595 -1.802 . . . . 0.0 108.595 -177.464 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.506 ' O ' ' ND2' ' A' ' 12' ' ' ASN . 0.0 OUTLIER -100.49 173.77 6.41 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 177.542 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.563 ' CE ' HD11 ' A' ' 29' ' ' ILE . 0.1 OUTLIER -128.76 131.53 47.85 Favored 'General case' 0 N--CA 1.502 2.155 0 C-N-CA 119.461 -0.896 . . . . 0.0 111.057 -179.388 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.425 ' O ' ' N ' ' A' ' 10' ' ' GLY . 81.3 m -93.01 153.71 18.56 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 118.359 -1.336 . . . . 0.0 110.067 176.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.563 HD11 ' CE ' ' A' ' 27' ' ' LYS . 30.3 mm -140.77 81.04 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.265 -3.091 0 CA-C-N 114.142 -1.39 . . . . 0.0 108.869 176.512 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.617 ' C ' HD12 ' A' ' 30' ' ' LEU . 1.1 pp . . . . . 0 C--N 1.304 -1.403 0 C-N-CA 119.257 -0.977 . . . . 0.0 110.998 -178.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.413 ' OD1' ' N ' ' A' ' 37' ' ' ASN . 4.3 m-20 . . . . . 0 N--CA 1.482 1.135 0 CA-C-O 121.141 0.495 . . . . 0.0 111.903 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.471 ' CG ' ' N ' ' A' ' 39' ' ' CYS . 7.0 tt0 -161.45 157.91 25.82 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.099 177.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.471 ' N ' ' CG ' ' A' ' 38' ' ' GLN . 0.9 OUTLIER -117.52 92.04 3.74 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 120.124 -0.63 . . . . 0.0 109.649 178.892 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.485 ' O ' ' O ' ' A' ' 27' ' ' LYS . 0.6 OUTLIER -101.23 134.33 41.76 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.267 0 C-N-CA 118.482 -1.287 . . . . 0.0 112.476 -178.417 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.427 ' O ' HG22 ' A' ' 40' ' ' VAL . 6.0 t -57.15 157.17 6.35 Favored 'General case' 0 C--N 1.273 -2.743 0 CA-C-N 113.044 -1.889 . . . . 0.0 111.019 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 148.69 -104.59 0.28 Allowed Glycine 0 N--CA 1.492 2.427 1 N-CA-C 130.866 7.106 . . . . 0.0 130.866 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -160.13 106.55 1.58 Allowed 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 119.441 -0.904 . . . . 0.0 110.368 -179.557 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -146.28 -174.63 18.59 Favored Glycine 0 N--CA 1.493 2.496 0 C-N-CA 119.548 -1.311 . . . . 0.0 110.437 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.7 t -107.47 144.77 29.89 Favored Pre-proline 0 N--CA 1.492 1.632 0 C-N-CA 119.781 -0.768 . . . . 0.0 110.37 -179.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -63.76 132.48 35.2 Favored 'Trans proline' 0 C--O 1.214 -0.699 0 C-N-CA 120.904 1.07 . . . . 0.0 110.53 174.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.488 1.451 0 C-N-CA 119.515 -0.874 . . . . 0.0 110.703 -179.143 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 1.6 t . . . . . 0 N--CA 1.484 1.238 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -92.52 -164.86 1.24 Allowed 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 119.55 -0.86 . . . . 0.0 110.93 -179.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.1 p -93.05 180.0 5.27 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.501 ' N ' ' OD1' ' A' ' 5' ' ' ASP . 0.0 OUTLIER -92.4 151.46 20.24 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 118.997 -1.081 . . . . 0.0 110.152 178.435 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.517 ' SG ' ' O ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -75.04 165.77 24.72 Favored 'General case' 0 C--N 1.296 -1.75 0 C-N-CA 120.017 -0.673 . . . . 0.0 111.189 178.445 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.0 p -141.67 12.47 2.09 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 119.446 -0.901 . . . . 0.0 110.062 177.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -162.78 179.51 7.6 Favored 'General case' 0 C--N 1.287 -2.126 0 CA-C-N 114.687 -1.142 . . . . 0.0 110.826 178.246 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.462 ' HB3' ' H ' ' A' ' 30' ' ' LEU . 0.8 OUTLIER -89.81 163.91 14.85 Favored 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 119.252 -0.979 . . . . 0.0 109.741 179.849 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 71.54 14.52 74.92 Favored Glycine 0 N--CA 1.495 2.585 0 C-N-CA 119.028 -1.558 . . . . 0.0 111.777 179.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.7 mm-40 -74.77 -167.43 0.57 Allowed 'General case' 0 N--CA 1.498 1.958 0 C-N-CA 118.977 -1.089 . . . . 0.0 109.991 179.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.477 ' O ' ' O ' ' A' ' 22' ' ' CYS . 0.9 OUTLIER -155.09 -80.31 0.09 Allowed 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 117.693 -1.603 . . . . 0.0 113.554 -179.45 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 92.6 mt -77.03 51.75 0.83 Allowed 'General case' 0 C--N 1.273 -2.755 0 C-N-CA 117.815 -1.554 . . . . 0.0 109.602 -176.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.419 ' HB2' ' N ' ' A' ' 6' ' ' CYS . 23.1 p -122.36 -156.07 0.67 Allowed 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.754 176.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.517 ' O ' ' SG ' ' A' ' 6' ' ' CYS . 8.6 mt -124.68 124.52 42.36 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 114.784 -1.098 . . . . 0.0 109.917 179.025 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.2 m -108.19 -68.24 0.92 Allowed 'General case' 0 N--CA 1.504 2.227 0 C-N-CA 119.058 -1.057 . . . . 0.0 111.519 -177.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -87.27 91.17 8.63 Favored 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 118.701 -1.2 . . . . 0.0 110.915 -177.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.06 -98.53 1.1 Allowed Glycine 0 N--CA 1.49 2.289 0 C-N-CA 119.632 -1.27 . . . . 0.0 111.598 177.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.406 ' O ' ' OG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -129.83 5.81 5.05 Favored 'General case' 0 N--CA 1.483 1.187 0 CA-C-O 122.293 1.044 . . . . 0.0 110.224 -177.763 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.672 HD22 ' N ' ' A' ' 20' ' ' ASN . 1.0 OUTLIER -81.35 130.81 35.19 Favored 'General case' 0 C--N 1.253 -3.605 0 CA-C-N 113.438 -1.71 . . . . 0.0 110.296 178.97 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.6 t -75.38 146.46 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 C-N-CA 119.377 -0.929 . . . . 0.0 110.459 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.477 ' O ' ' O ' ' A' ' 12' ' ' ASN . 21.2 m -143.36 109.95 5.48 Favored 'General case' 0 N--CA 1.505 2.283 0 C-N-CA 118.587 -1.245 . . . . 0.0 110.483 177.31 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.447 ' O ' ' O ' ' A' ' 26' ' ' ASN . . . -175.91 -91.39 0.08 OUTLIER Glycine 0 C--O 1.203 -1.784 0 C-N-CA 118.331 -1.89 . . . . 0.0 112.177 -178.038 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -50.77 120.75 5.05 Favored 'General case' 0 C--N 1.297 -1.677 0 C-N-CA 119.086 -1.046 . . . . 0.0 110.548 -178.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.68 -26.78 21.78 Favored Glycine 0 N--CA 1.481 1.667 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -178.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.447 ' O ' ' O ' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -137.17 -163.81 1.49 Allowed 'General case' 0 C--N 1.313 -0.994 0 C-N-CA 120.148 -0.621 . . . . 0.0 111.122 -179.508 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.561 ' NZ ' HD11 ' A' ' 29' ' ' ILE . 16.0 ttpt -142.38 165.46 27.35 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 177.417 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -130.79 163.37 27.48 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 118.893 -1.123 . . . . 0.0 110.494 175.374 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.561 HD11 ' NZ ' ' A' ' 27' ' ' LYS . 15.4 mm -151.42 129.47 2.58 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.104 0 CA-C-N 113.176 -1.829 . . . . 0.0 109.186 179.434 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.462 ' H ' ' HB3' ' A' ' 9' ' ' SER . 29.2 mt . . . . . 0 C--N 1.303 -1.454 0 C-N-CA 118.602 -1.239 . . . . 0.0 109.529 178.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.415 ' OD1' ' N ' ' A' ' 37' ' ' ASN . 1.6 m-20 . . . . . 0 N--CA 1.502 2.133 0 CA-C-O 121.062 0.458 . . . . 0.0 112.187 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -156.46 155.44 32.06 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 119.626 -0.829 . . . . 0.0 110.407 177.406 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 96.9 m -112.99 98.53 7.22 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 119.897 -0.721 . . . . 0.0 110.642 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.534 ' O ' ' N ' ' A' ' 27' ' ' LYS . 0.2 OUTLIER -98.48 142.78 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.237 0 C-N-CA 118.777 -1.169 . . . . 0.0 111.619 179.844 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.411 ' O ' HG22 ' A' ' 40' ' ' VAL . 1.9 t -63.42 150.04 44.54 Favored 'General case' 0 C--N 1.275 -2.636 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.949 179.685 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.416 ' H ' ' HA ' ' A' ' 26' ' ' ASN . . . 141.6 -147.54 19.12 Favored Glycine 0 N--CA 1.495 2.58 0 C-N-CA 119.697 -1.24 . . . . 0.0 110.428 -179.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -135.62 117.1 14.77 Favored 'General case' 0 N--CA 1.498 1.939 0 C-N-CA 119.798 -0.761 . . . . 0.0 110.349 179.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -113.33 177.17 17.92 Favored Glycine 0 N--CA 1.499 2.888 0 C-N-CA 119.965 -1.112 . . . . 0.0 110.409 -179.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.481 ' O ' HG23 ' A' ' 45' ' ' THR . 8.8 t -90.03 127.79 52.3 Favored Pre-proline 0 CA--C 1.566 1.594 0 C-N-CA 119.224 -0.99 . . . . 0.0 110.444 -179.681 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -59.78 147.84 90.65 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 121.266 1.311 . . . . 0.0 112.019 179.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.435 ' OE1' ' O ' ' A' ' 5' ' ' ASP . 28.0 tt0 . . . . . 0 CA--C 1.554 1.115 0 C-N-CA 119.674 -0.81 . . . . 0.0 111.896 177.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.404 HG12 ' H ' ' A' ' 3' ' ' TYR . 1.3 t . . . . . 0 N--CA 1.481 1.083 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.404 ' H ' HG12 ' A' ' 2' ' ' VAL . 38.4 m-85 -132.18 -174.13 3.35 Favored 'General case' 0 N--CA 1.495 1.789 0 C-N-CA 119.525 -0.87 . . . . 0.0 110.411 179.189 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.575 ' OG1' ' N ' ' A' ' 5' ' ' ASP . 0.1 OUTLIER -101.68 -178.18 3.64 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 178.857 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.575 ' N ' ' OG1' ' A' ' 4' ' ' THR . 0.0 OUTLIER -93.05 154.03 18.36 Favored 'General case' 0 C--N 1.288 -2.078 0 C-N-CA 119.162 -1.015 . . . . 0.0 109.605 178.074 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.418 ' SG ' ' HB2' ' A' ' 11' ' ' GLN . 3.7 m -73.99 174.89 7.95 Favored 'General case' 0 C--N 1.295 -1.784 0 C-N-CA 118.944 -1.102 . . . . 0.0 110.778 177.543 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.9 t -155.13 11.88 0.35 Allowed 'General case' 0 C--N 1.276 -2.588 0 CA-C-N 113.554 -1.657 . . . . 0.0 109.806 177.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -154.82 173.86 15.87 Favored 'General case' 0 C--N 1.29 -1.997 0 CA-C-N 114.313 -1.312 . . . . 0.0 109.498 -177.344 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.478 ' HB3' ' H ' ' A' ' 30' ' ' LEU . 0.9 OUTLIER -89.18 157.26 18.34 Favored 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 119.325 -0.95 . . . . 0.0 109.807 179.205 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 28' ' ' CYS . . . 94.12 -51.49 2.19 Favored Glycine 0 N--CA 1.502 3.054 0 C-N-CA 119.075 -1.536 . . . . 0.0 112.396 178.156 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.496 ' H ' ' NE2' ' A' ' 11' ' ' GLN . 3.9 mp0 -40.24 164.03 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.452 0 C-N-CA 120.29 -0.564 . . . . 0.0 111.91 -176.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.497 ' ND2' ' O ' ' A' ' 26' ' ' ASN . 85.1 m-20 -140.69 -50.45 0.45 Allowed 'General case' 0 N--CA 1.507 2.409 0 C-N-CA 119.149 -1.02 . . . . 0.0 113.413 -177.407 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.428 HD12 ' HB3' ' A' ' 46' ' ' PRO . 14.7 mt -77.35 43.47 0.38 Allowed 'General case' 0 C--N 1.295 -1.787 0 C-N-CA 119.09 -1.044 . . . . 0.0 110.359 -177.389 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.654 ' SG ' ' N ' ' A' ' 15' ' ' LEU . 14.1 p -123.05 -148.44 0.4 Allowed 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 114.725 -1.125 . . . . 0.0 108.491 176.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.654 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 83.3 mt -116.23 98.73 6.76 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 114.497 -1.229 . . . . 0.0 107.866 173.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.469 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 57.6 m -95.9 -51.24 4.55 Favored 'General case' 0 C--N 1.276 -2.595 0 CA-C-N 113.429 -1.714 . . . . 0.0 110.947 -173.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -94.49 94.0 7.97 Favored 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 119.433 -0.907 . . . . 0.0 109.89 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 62.81 -92.7 0.09 OUTLIER Glycine 0 N--CA 1.49 2.242 0 C-N-CA 119.335 -1.412 . . . . 0.0 110.315 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.45 ' O ' HD22 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -131.15 3.05 4.31 Favored 'General case' 0 N--CA 1.483 1.219 0 CA-C-O 122.138 0.971 . . . . 0.0 110.114 -179.901 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 68.6 m-80 -79.34 140.87 37.39 Favored 'General case' 0 C--N 1.258 -3.374 0 CA-C-N 113.409 -1.723 . . . . 0.0 110.544 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.1 t -82.55 135.57 24.61 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 C-N-CA 118.875 -1.13 . . . . 0.0 111.404 -179.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.495 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 0.1 OUTLIER -91.19 151.52 20.91 Favored 'General case' 0 N--CA 1.513 2.708 0 C-N-CA 118.559 -1.256 . . . . 0.0 108.057 169.682 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.459 ' O ' ' OD1' ' A' ' 26' ' ' ASN . . . -118.74 124.93 6.2 Favored Glycine 0 C--O 1.213 -1.211 0 C-N-CA 119.922 -1.132 . . . . 0.0 110.42 -170.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.434 ' C ' ' O ' ' A' ' 23' ' ' GLY . 2.8 tt0 -36.06 132.43 0.52 Allowed 'General case' 0 C--N 1.255 -3.52 0 CA-C-N 112.652 -1.774 . . . . 0.0 110.127 178.073 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 126.6 -30.14 4.3 Favored Glycine 0 N--CA 1.482 1.715 0 N-CA-C 107.716 -2.154 . . . . 0.0 107.716 -175.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.637 ' N ' ' ND2' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -102.13 -159.77 0.75 Allowed 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 177.47 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.765 ' NZ ' HD11 ' A' ' 29' ' ' ILE . 4.8 ttpp -152.81 104.5 2.87 Favored 'General case' 0 N--CA 1.498 1.945 0 C-N-CA 119.194 -1.003 . . . . 0.0 111.594 179.593 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.515 ' O ' ' N ' ' A' ' 10' ' ' GLY . 32.5 m -79.43 157.2 27.6 Favored 'General case' 0 C--O 1.201 -1.492 0 C-N-CA 117.617 -1.633 . . . . 0.0 110.071 178.183 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.765 HD11 ' NZ ' ' A' ' 27' ' ' LYS . 28.0 mm -140.73 138.1 35.32 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.487 0 CA-C-N 114.825 -1.08 . . . . 0.0 110.173 177.414 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.478 ' H ' ' HB3' ' A' ' 9' ' ' SER . 21.1 mt . . . . . 0 N--CA 1.493 1.709 0 C-N-CA 119.054 -1.058 . . . . 0.0 109.345 177.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.522 ' OD1' ' N ' ' A' ' 37' ' ' ASN . 0.6 OUTLIER . . . . . 0 N--CA 1.495 1.787 0 CA-C-O 121.374 0.607 . . . . 0.0 111.901 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -154.93 147.03 23.69 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 115.003 -0.998 . . . . 0.0 109.29 176.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.465 ' SG ' ' HB2' ' A' ' 16' ' ' CYS . 1.0 OUTLIER -104.15 91.34 3.9 Favored 'General case' 0 C--N 1.299 -1.604 0 C-N-CA 119.521 -0.872 . . . . 0.0 110.208 -179.984 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.573 HG22 ' N ' ' A' ' 41' ' ' THR . 3.4 p -106.76 160.15 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 C-N-CA 118.617 -1.233 . . . . 0.0 110.567 179.299 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.573 ' N ' HG22 ' A' ' 40' ' ' VAL . 8.8 t -80.14 154.81 27.79 Favored 'General case' 0 C--N 1.276 -2.606 0 CA-C-N 114.87 -1.059 . . . . 0.0 112.128 -178.613 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 166.94 -120.75 0.93 Allowed Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.906 -1.277 . . . . 0.0 109.906 178.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -142.98 123.74 14.19 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 119.374 -0.93 . . . . 0.0 110.109 179.145 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -142.11 -171.19 12.93 Favored Glycine 0 N--CA 1.489 2.186 1 N-CA-C 131.0 7.16 . . . . 0.0 131.0 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -136.16 154.0 77.06 Favored Pre-proline 0 N--CA 1.492 1.669 0 C-N-CA 119.904 -0.718 . . . . 0.0 109.48 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.428 ' HB3' HD12 ' A' ' 13' ' ' LEU . 5.8 Cg_exo -56.82 -175.88 0.05 OUTLIER 'Trans proline' 0 C--N 1.324 -0.719 0 C-N-CA 120.994 1.129 . . . . 0.0 110.396 175.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.656 ' CD ' ' H ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.304 -1.397 0 C-N-CA 118.814 -1.154 . . . . 0.0 109.202 178.518 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 1.6 t . . . . . 0 N--CA 1.485 1.318 0 CA-C-O 120.914 0.388 . . . . 0.0 110.807 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -107.77 -163.96 0.93 Allowed 'General case' 0 N--CA 1.495 1.814 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.707 -179.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.565 ' OG1' ' N ' ' A' ' 5' ' ' ASP . 0.5 OUTLIER -127.61 -172.91 2.78 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 177.052 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.565 ' N ' ' OG1' ' A' ' 4' ' ' THR . 0.3 OUTLIER -81.3 157.53 25.08 Favored 'General case' 0 C--N 1.288 -2.067 0 C-N-CA 118.358 -1.337 . . . . 0.0 111.332 -178.693 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.402 ' N ' ' HB2' ' A' ' 14' ' ' CYS . 0.0 OUTLIER -75.83 -179.69 4.96 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.242 177.459 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.1 t -138.34 -0.85 1.96 Allowed 'General case' 0 N--CA 1.497 1.892 0 C-N-CA 119.001 -1.08 . . . . 0.0 111.408 178.128 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.463 ' HA ' HD12 ' A' ' 30' ' ' LEU . 8.8 pt-20 -163.33 169.17 19.46 Favored 'General case' 0 C--N 1.273 -2.741 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.985 177.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.18 149.37 44.72 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.587 -178.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.59 -12.15 62.98 Favored Glycine 0 N--CA 1.504 3.229 0 C-N-CA 119.473 -1.346 . . . . 0.0 112.458 179.066 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.414 ' CA ' ' OE1' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -66.56 178.18 1.35 Allowed 'General case' 0 N--CA 1.503 2.203 0 C-N-CA 119.181 -1.008 . . . . 0.0 110.961 -179.043 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.72 HD21 ' HA3' ' A' ' 44' ' ' GLY . 44.5 m-20 -143.85 -72.18 0.29 Allowed 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 118.648 -1.221 . . . . 0.0 113.031 -178.472 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.425 HD12 ' HB3' ' A' ' 46' ' ' PRO . 12.9 mt -75.51 48.31 0.44 Allowed 'General case' 0 C--N 1.289 -2.042 0 C-N-CA 119.542 -0.863 . . . . 0.0 110.032 -176.488 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.438 ' H ' ' C ' ' A' ' 12' ' ' ASN . 31.5 p -122.39 -151.5 0.48 Allowed 'General case' 0 C--N 1.302 -1.5 0 CA-C-N 114.261 -1.336 . . . . 0.0 108.409 176.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.45 HD22 ' O ' ' A' ' 19' ' ' SER . 67.6 mt -114.63 110.93 20.52 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-N 115.097 -0.956 . . . . 0.0 108.852 175.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 69.7 m -107.4 -70.41 0.8 Allowed 'General case' 0 C--N 1.285 -2.21 0 CA-C-N 114.437 -1.256 . . . . 0.0 110.243 -175.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -79.03 89.9 4.79 Favored 'General case' 0 C--N 1.297 -1.682 0 C-N-CA 118.829 -1.149 . . . . 0.0 109.472 178.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 70.9 -127.5 15.47 Favored Glycine 0 N--CA 1.483 1.827 0 C-N-CA 119.416 -1.374 . . . . 0.0 110.032 -178.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.45 ' O ' HD22 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -101.63 2.42 38.79 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 122.279 1.038 . . . . 0.0 109.629 179.677 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -78.82 140.73 38.14 Favored 'General case' 0 C--N 1.26 -3.289 0 CA-C-N 113.227 -1.806 . . . . 0.0 110.466 -179.541 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.3 t -80.88 142.47 13.8 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.977 -178.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.568 ' O ' ' O ' ' A' ' 12' ' ' ASN . 0.0 OUTLIER -114.65 161.59 17.9 Favored 'General case' 0 N--CA 1.505 2.319 0 N-CA-C 104.908 -2.256 . . . . 0.0 104.908 168.849 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -137.79 -139.31 3.85 Favored Glycine 0 CA--C 1.483 -1.963 0 C-N-CA 116.809 -2.615 . . . . 0.0 112.134 -175.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -91.57 150.15 21.33 Favored 'General case' 0 C--N 1.253 -3.615 0 CA-C-N 112.343 -1.929 . . . . 0.0 110.543 -174.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.6 -31.96 8.04 Favored Glycine 0 C--N 1.297 -1.634 0 N-CA-C 108.948 -1.661 . . . . 0.0 108.948 -177.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -109.61 -174.74 2.57 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 119.767 -0.773 . . . . 0.0 109.415 179.41 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.403 ' O ' ' O ' ' A' ' 40' ' ' VAL . 51.1 tttp -142.53 114.69 8.29 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 118.994 -1.083 . . . . 0.0 110.01 176.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.472 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 28.9 m -84.38 151.12 24.9 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 117.519 -1.672 . . . . 0.0 110.241 178.008 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 6.3 mm -130.23 125.01 59.05 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.748 0 CA-C-N 113.926 -1.488 . . . . 0.0 109.185 177.32 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.463 HD12 ' HA ' ' A' ' 8' ' ' GLU . 18.5 mt . . . . . 0 N--CA 1.498 1.966 0 C-N-CA 118.475 -1.29 . . . . 0.0 110.126 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 . . . . . 0 N--CA 1.484 1.238 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -103.26 148.61 25.61 Favored 'General case' 0 C--N 1.308 -1.217 0 C-N-CA 119.375 -0.93 . . . . 0.0 110.483 -177.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.472 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 1.6 m -103.38 88.5 3.12 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 119.445 -0.902 . . . . 0.0 110.844 -179.335 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.418 HG22 ' O ' ' A' ' 41' ' ' THR . 0.2 OUTLIER -97.47 139.68 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 C-N-CA 118.41 -1.316 . . . . 0.0 110.332 179.047 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.418 ' O ' HG22 ' A' ' 40' ' ' VAL . 15.2 t -53.19 152.92 4.02 Favored 'General case' 0 C--N 1.272 -2.773 0 CA-C-N 113.887 -1.506 . . . . 0.0 111.021 -178.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 152.19 -167.17 31.22 Favored Glycine 0 N--CA 1.49 2.296 0 C-N-CA 119.08 -1.534 . . . . 0.0 110.797 179.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 18.5 mp0 -83.44 -176.77 6.47 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 119.396 -0.922 . . . . 0.0 110.367 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.72 ' HA3' HD21 ' A' ' 12' ' ' ASN . . . 177.76 172.23 42.02 Favored Glycine 0 N--CA 1.486 2.031 1 N-CA-C 129.575 6.59 . . . . 0.0 129.575 179.831 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -128.45 140.87 39.63 Favored Pre-proline 0 N--CA 1.486 1.363 0 C-N-CA 119.291 -0.964 . . . . 0.0 109.925 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.425 ' HB3' HD12 ' A' ' 13' ' ' LEU . 4.9 Cg_exo -58.54 -163.16 0.02 OUTLIER 'Trans proline' 0 C--O 1.214 -0.692 0 C-N-CA 121.067 1.178 . . . . 0.0 111.059 178.124 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 . . . . . 0 C--N 1.305 -1.353 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.409 178.614 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.1 t . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 110.319 -0.252 . . . . 0.0 110.319 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.479 ' CE2' HD22 ' A' ' 13' ' ' LEU . 28.0 m-85 -100.32 -169.44 1.73 Allowed 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 119.487 -0.885 . . . . 0.0 110.676 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.612 ' OG1' ' N ' ' A' ' 5' ' ' ASP . 0.1 OUTLIER -108.89 -175.42 2.76 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -179.953 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.612 ' N ' ' OG1' ' A' ' 4' ' ' THR . 0.0 OUTLIER -86.13 156.86 20.18 Favored 'General case' 0 C--N 1.293 -1.878 0 C-N-CA 118.982 -1.087 . . . . 0.0 110.619 -179.615 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.6 m -73.43 178.71 4.42 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 119.541 -0.864 . . . . 0.0 110.711 176.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 13.3 t -146.01 4.17 0.95 Allowed 'General case' 0 C--N 1.286 -2.182 0 CA-C-N 114.391 -1.277 . . . . 0.0 110.75 177.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.43 ' HB2' HE22 ' A' ' 11' ' ' GLN . 2.3 mt-10 -163.96 170.49 16.6 Favored 'General case' 0 C--N 1.282 -2.358 0 CA-C-N 114.575 -1.193 . . . . 0.0 110.284 178.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.445 ' HB3' ' H ' ' A' ' 30' ' ' LEU . 0.4 OUTLIER -83.31 151.37 25.61 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 119.603 -0.839 . . . . 0.0 109.117 178.479 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.13 -1.99 71.04 Favored Glycine 0 N--CA 1.493 2.447 0 C-N-CA 119.061 -1.542 . . . . 0.0 112.839 179.047 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.43 HE22 ' HB2' ' A' ' 8' ' ' GLU . 0.0 OUTLIER -76.24 -165.24 0.46 Allowed 'General case' 0 N--CA 1.501 2.095 0 C-N-CA 118.752 -1.179 . . . . 0.0 109.723 179.248 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.543 ' OD1' ' N ' ' A' ' 24' ' ' GLN . 12.7 t-20 -150.63 -77.33 0.14 Allowed 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 117.987 -1.485 . . . . 0.0 114.5 -177.324 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.538 ' H ' ' HA ' ' A' ' 46' ' ' PRO . 12.4 mt -76.22 53.91 0.85 Allowed 'General case' 0 C--N 1.273 -2.755 0 C-N-CA 118.557 -1.257 . . . . 0.0 110.857 -175.268 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.638 ' SG ' ' N ' ' A' ' 15' ' ' LEU . 8.8 p -123.53 -152.47 0.51 Allowed 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 114.85 -1.068 . . . . 0.0 108.802 176.012 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.638 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 51.7 mt -112.97 119.6 38.48 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 115.044 -0.98 . . . . 0.0 108.646 176.558 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.406 ' SG ' ' O ' ' A' ' 22' ' ' CYS . 1.6 m -122.47 7.91 9.57 Favored 'General case' 0 N--CA 1.502 2.138 0 C-N-CA 118.634 -1.227 . . . . 0.0 111.15 -176.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -157.51 82.2 0.9 Allowed 'General case' 0 C--N 1.298 -1.647 0 C-N-CA 119.412 -0.915 . . . . 0.0 109.35 177.114 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.83 -112.76 3.69 Favored Glycine 0 N--CA 1.485 1.939 0 C-N-CA 119.424 -1.369 . . . . 0.0 109.981 -178.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.48 0.39 14.7 Favored 'General case' 0 CA--C 1.493 -1.249 0 CA-C-O 122.336 1.065 . . . . 0.0 109.551 179.534 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 71.8 m-20 -79.52 128.78 33.79 Favored 'General case' 0 C--N 1.257 -3.435 0 CA-C-N 113.099 -1.864 . . . . 0.0 111.278 -178.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.5 t -69.13 143.99 14.51 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 C-N-CA 118.594 -1.242 . . . . 0.0 108.563 177.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.517 ' O ' ' SG ' ' A' ' 28' ' ' CYS . 0.9 OUTLIER -146.71 128.17 14.99 Favored 'General case' 0 C--N 1.272 -2.768 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 179.642 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.464 ' O ' ' O ' ' A' ' 26' ' ' ASN . . . 164.49 -79.85 0.13 Allowed Glycine 0 C--O 1.201 -1.908 0 C-N-CA 117.22 -2.419 . . . . 0.0 112.151 -176.373 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.543 ' N ' ' OD1' ' A' ' 12' ' ' ASN . 0.1 OUTLIER -44.78 125.13 4.76 Favored 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 119.647 -0.821 . . . . 0.0 111.66 -176.753 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.69 -26.2 8.6 Favored Glycine 0 N--CA 1.483 1.808 0 N-CA-C 109.899 -1.28 . . . . 0.0 109.899 -179.287 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.617 ' N ' ' ND2' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -129.53 -175.95 3.75 Favored 'General case' 0 C--N 1.311 -1.074 0 C-N-CA 120.22 -0.592 . . . . 0.0 111.066 -178.871 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.45 ' O ' ' N ' ' A' ' 40' ' ' VAL . 0.0 OUTLIER -120.56 153.83 36.2 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.038 175.187 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.517 ' SG ' ' O ' ' A' ' 22' ' ' CYS . 86.1 m -120.26 146.44 46.08 Favored 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 119.169 -1.013 . . . . 0.0 109.613 174.636 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.44 HD13 ' O ' ' A' ' 28' ' ' CYS . 2.3 mm -131.99 132.29 61.39 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.953 0 CA-C-N 114.314 -1.312 . . . . 0.0 109.93 179.489 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.445 ' H ' ' HB3' ' A' ' 9' ' ' SER . 14.8 mt . . . . . 0 N--CA 1.494 1.725 0 C-N-CA 118.327 -1.349 . . . . 0.0 108.891 176.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.522 ' OD1' ' N ' ' A' ' 37' ' ' ASN . 0.3 OUTLIER . . . . . 0 C--O 1.215 -0.717 0 CA-C-O 120.966 0.412 . . . . 0.0 110.829 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -120.78 149.56 42.36 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.144 -0.934 . . . . 0.0 109.727 178.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 3.0 m -100.33 105.73 17.28 Favored 'General case' 0 C--N 1.298 -1.658 0 C-N-CA 119.441 -0.904 . . . . 0.0 110.316 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.915 HG22 ' H ' ' A' ' 41' ' ' THR . 7.4 p -99.77 -176.81 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 C-N-CA 118.518 -1.273 . . . . 0.0 110.241 177.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.915 ' H ' HG22 ' A' ' 40' ' ' VAL . 12.5 t -91.67 160.05 15.56 Favored 'General case' 0 C--N 1.288 -2.068 0 CA-C-N 114.629 -1.169 . . . . 0.0 110.926 179.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 138.28 -147.47 19.25 Favored Glycine 0 N--CA 1.496 2.695 1 N-CA-C 131.793 7.477 . . . . 0.0 131.793 179.178 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -108.88 111.46 23.18 Favored 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 119.933 -0.707 . . . . 0.0 110.412 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -130.52 156.56 21.68 Favored Glycine 0 N--CA 1.491 2.363 1 N-CA-C 129.783 6.673 . . . . 0.0 129.783 178.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.462 HG23 ' O ' ' A' ' 46' ' ' PRO . 5.8 t -111.31 145.2 32.04 Favored Pre-proline 0 N--CA 1.495 1.823 0 C-N-CA 119.59 -0.844 . . . . 0.0 110.197 -178.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.538 ' HA ' ' H ' ' A' ' 13' ' ' LEU . 7.2 Cg_exo -52.44 -176.97 0.02 OUTLIER 'Trans proline' 0 C--O 1.211 -0.854 0 C-N-CA 120.9 1.066 . . . . 0.0 110.351 175.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.652 ' CD ' ' H ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.306 -1.322 0 C-N-CA 118.866 -1.134 . . . . 0.0 108.519 178.594 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.681 HG12 ' N ' ' A' ' 3' ' ' TYR . 38.6 t . . . . . 0 N--CA 1.489 1.497 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.681 ' N ' HG12 ' A' ' 2' ' ' VAL . 35.8 m-85 -139.5 -166.24 2.02 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 119.722 -0.791 . . . . 0.0 110.125 -179.381 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -93.09 -174.95 3.71 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 119.679 -0.809 . . . . 0.0 108.858 179.064 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -100.58 154.09 18.85 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 119.03 -1.068 . . . . 0.0 110.441 179.069 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.42 ' N ' ' HB2' ' A' ' 14' ' ' CYS . 4.3 m -74.67 174.91 8.43 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-O 122.144 0.973 . . . . 0.0 111.188 178.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -140.26 7.49 2.19 Favored 'General case' 0 C--N 1.285 -2.232 0 CA-C-N 113.549 -1.659 . . . . 0.0 109.471 177.592 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -163.13 162.64 25.72 Favored 'General case' 0 C--N 1.279 -2.481 0 CA-C-N 113.784 -1.553 . . . . 0.0 109.0 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.604 ' OG ' ' N ' ' A' ' 30' ' ' LEU . 0.9 OUTLIER -65.1 -168.11 0.03 OUTLIER 'General case' 0 C--N 1.293 -1.876 0 C-N-CA 118.992 -1.083 . . . . 0.0 110.057 -179.087 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.508 ' H ' HD13 ' A' ' 29' ' ' ILE . . . 37.1 6.05 0.0 OUTLIER Glycine 0 N--CA 1.505 3.281 1 N-CA-C 130.124 6.81 . . . . 0.0 130.124 -179.831 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -74.79 -167.0 0.52 Allowed 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 175.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.474 ' ND2' ' C ' ' A' ' 23' ' ' GLY . 1.4 m-20 -143.01 -70.24 0.33 Allowed 'General case' 0 N--CA 1.5 2.072 0 C-N-CA 117.55 -1.66 . . . . 0.0 114.987 -178.41 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.538 HD12 ' HB3' ' A' ' 46' ' ' PRO . 15.0 mt -77.67 50.45 0.83 Allowed 'General case' 0 C--N 1.27 -2.879 0 C-N-CA 117.244 -1.782 . . . . 0.0 111.111 -174.505 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.575 ' SG ' ' N ' ' A' ' 15' ' ' LEU . 15.6 p -119.76 -146.48 0.38 Allowed 'General case' 0 C--O 1.207 -1.146 0 CA-C-N 114.948 -1.023 . . . . 0.0 108.397 175.178 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.575 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 7.7 mt -128.85 130.77 47.34 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.822 177.657 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.421 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 7.9 m -139.0 21.47 2.63 Favored 'General case' 0 N--CA 1.498 1.971 0 C-N-CA 119.127 -1.029 . . . . 0.0 110.536 -179.417 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -146.41 55.16 1.14 Allowed 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 177.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.7 -66.92 2.01 Favored Glycine 0 N--CA 1.487 2.063 0 C-N-CA 119.479 -1.344 . . . . 0.0 110.19 -179.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.411 ' O ' ' OG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -144.4 1.72 1.08 Allowed 'General case' 0 C--N 1.309 -1.191 0 C-N-CA 119.445 -0.902 . . . . 0.0 111.57 -179.833 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -90.1 134.91 33.98 Favored 'General case' 0 C--N 1.253 -3.615 0 CA-C-N 114.37 -1.286 . . . . 0.0 110.464 179.033 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.567 HG22 ' O ' ' A' ' 14' ' ' CYS . 1.3 t -74.2 144.12 12.79 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 C-N-CA 119.459 -0.897 . . . . 0.0 109.718 179.693 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.466 ' O ' ' O ' ' A' ' 12' ' ' ASN . 1.2 m -141.82 121.28 13.24 Favored 'General case' 0 C--N 1.29 -1.979 0 C-N-CA 118.857 -1.137 . . . . 0.0 109.384 178.398 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.474 ' C ' ' ND2' ' A' ' 12' ' ' ASN . . . 173.91 -87.69 0.08 OUTLIER Glycine 0 C--O 1.205 -1.664 0 C-N-CA 117.851 -2.119 . . . . 0.0 111.803 -176.223 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -49.8 126.49 14.08 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 119.291 -0.964 . . . . 0.0 110.491 -178.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.52 -26.27 14.68 Favored Glycine 0 N--CA 1.482 1.716 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -178.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.449 ' O ' ' O ' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -138.88 -160.9 1.11 Allowed 'General case' 0 C--N 1.311 -1.087 0 C-N-CA 119.954 -0.699 . . . . 0.0 111.139 -179.855 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.534 ' O ' ' O ' ' A' ' 40' ' ' VAL . 21.1 ttpt -148.5 148.0 29.74 Favored 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 119.66 -0.816 . . . . 0.0 109.88 177.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.442 ' O ' ' HA2' ' A' ' 10' ' ' GLY . 87.3 m -99.59 160.45 14.29 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 118.31 -1.356 . . . . 0.0 111.053 178.511 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.508 HD13 ' H ' ' A' ' 10' ' ' GLY . 18.5 mm -151.77 90.46 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.274 -2.705 0 CA-C-N 113.574 -1.648 . . . . 0.0 106.711 175.693 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.681 ' C ' HD12 ' A' ' 30' ' ' LEU . 3.1 pp . . . . . 0 C--N 1.288 -2.069 0 C-N-CA 118.051 -1.46 . . . . 0.0 113.359 -173.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.562 ' HA ' ' HA ' ' A' ' 30' ' ' LEU . 58.4 m-80 . . . . . 0 C--O 1.216 -0.665 0 CA-C-O 120.246 0.07 . . . . 0.0 110.937 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -110.41 145.32 37.79 Favored 'General case' 0 C--N 1.309 -1.183 0 C-N-CA 119.595 -0.842 . . . . 0.0 110.172 178.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 86.5 m -110.84 85.17 2.06 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.715 179.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.534 ' O ' ' O ' ' A' ' 27' ' ' LYS . 1.2 p -97.27 141.74 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 C-N-CA 118.617 -1.233 . . . . 0.0 112.704 -177.52 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.6 t -62.68 140.13 58.69 Favored 'General case' 0 C--N 1.27 -2.876 0 CA-C-N 113.807 -1.542 . . . . 0.0 110.656 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 168.87 -136.06 3.89 Favored Glycine 0 N--CA 1.493 2.456 0 C-N-CA 119.396 -1.383 . . . . 0.0 110.692 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -140.96 113.73 8.3 Favored 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 119.752 -0.779 . . . . 0.0 109.864 -179.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -127.54 171.13 19.01 Favored Glycine 0 N--CA 1.501 3.032 0 C-N-CA 119.725 -1.226 . . . . 0.0 111.247 -178.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -104.83 150.22 38.41 Favored Pre-proline 0 C--N 1.307 -1.254 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 179.6 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.538 ' HB3' HD12 ' A' ' 13' ' ' LEU . 3.4 Cg_exo -53.51 -164.79 0.01 OUTLIER 'Trans proline' 0 C--O 1.215 -0.641 0 C-N-CA 121.392 1.395 . . . . 0.0 111.765 177.342 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 . . . . . 0 C--N 1.308 -1.234 0 CA-C-N 115.086 -0.961 . . . . 0.0 108.648 177.553 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.2 t . . . . . 0 N--CA 1.489 1.494 0 CA-C-O 122.043 0.925 . . . . 0.0 110.272 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.459 ' CZ ' HD22 ' A' ' 13' ' ' LEU . 36.4 m-85 -89.61 -178.29 5.51 Favored 'General case' 0 C--N 1.262 -3.235 0 CA-C-N 114.082 -1.417 . . . . 0.0 111.517 -178.563 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 23.2 p -116.38 -178.5 3.43 Favored 'General case' 0 N--CA 1.486 1.331 0 CA-C-N 114.821 -1.081 . . . . 0.0 108.857 179.19 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.1 154.23 22.18 Favored 'General case' 0 C--N 1.29 -1.998 0 C-N-CA 118.373 -1.331 . . . . 0.0 110.767 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.46 ' SG ' ' O ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -75.37 145.53 41.57 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.116 177.727 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.451 ' O ' ' OG1' ' A' ' 7' ' ' THR . 0.0 OUTLIER -114.69 8.14 16.13 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.703 -0.799 . . . . 0.0 109.506 178.525 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -162.3 171.01 17.94 Favored 'General case' 0 C--N 1.283 -2.287 0 CA-C-N 114.349 -1.296 . . . . 0.0 111.489 179.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -84.47 155.28 22.27 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 114.922 -1.035 . . . . 0.0 110.451 -178.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 87.66 -2.55 86.13 Favored Glycine 0 N--CA 1.498 2.783 0 C-N-CA 119.295 -1.431 . . . . 0.0 111.978 179.064 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -71.53 -174.91 1.18 Allowed 'General case' 0 N--CA 1.505 2.3 0 C-N-CA 119.232 -0.987 . . . . 0.0 110.219 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.741 ' O ' ' HA3' ' A' ' 23' ' ' GLY . 7.1 m120 -146.62 -71.67 0.23 Allowed 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 118.244 -1.382 . . . . 0.0 113.313 -179.106 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.699 HD12 ' HB3' ' A' ' 46' ' ' PRO . 24.6 mt -77.65 50.94 0.87 Allowed 'General case' 0 C--N 1.273 -2.718 0 C-N-CA 118.22 -1.392 . . . . 0.0 110.201 -177.618 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.432 ' HB2' ' N ' ' A' ' 6' ' ' CYS . 30.6 p -119.06 -156.44 0.65 Allowed 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.895 176.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.46 ' O ' ' SG ' ' A' ' 6' ' ' CYS . 6.0 mt -123.16 128.67 50.38 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 114.877 -1.056 . . . . 0.0 108.551 175.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 93.6 m -115.1 -44.0 3.05 Favored 'General case' 0 N--CA 1.518 2.969 0 C-N-CA 118.221 -1.391 . . . . 0.0 110.61 -179.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -102.19 116.25 32.26 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.058 -1.057 . . . . 0.0 110.057 178.326 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 47.87 -96.95 0.01 OUTLIER Glycine 0 N--CA 1.493 2.443 0 C-N-CA 119.546 -1.311 . . . . 0.0 111.299 179.213 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -131.44 6.72 4.47 Favored 'General case' 0 N--CA 1.485 1.32 0 CA-C-O 122.556 1.169 . . . . 0.0 110.211 -178.01 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 19.2 m-80 -80.11 132.18 35.89 Favored 'General case' 0 C--N 1.251 -3.674 0 CA-C-N 113.373 -1.739 . . . . 0.0 110.39 178.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.6 t -66.64 151.08 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 119.232 -0.987 . . . . 0.0 110.184 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.496 ' O ' ' O ' ' A' ' 12' ' ' ASN . 0.0 OUTLIER -150.74 112.82 4.57 Favored 'General case' 0 C--N 1.284 -2.28 0 C-N-CA 118.936 -1.106 . . . . 0.0 110.861 -179.882 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.741 ' HA3' ' O ' ' A' ' 12' ' ' ASN . . . 154.77 -45.56 0.55 Allowed Glycine 0 N--CA 1.483 1.771 1 N-CA-C 130.522 6.969 . . . . 0.0 130.522 -177.169 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.582 ' HA ' HE21 ' A' ' 24' ' ' GLN . 0.0 OUTLIER -56.92 133.45 54.68 Favored 'General case' 0 C--N 1.31 -1.134 0 C-N-CA 119.347 -0.941 . . . . 0.0 110.228 179.871 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 73.89 -23.8 1.07 Allowed Glycine 0 C--N 1.298 -1.578 0 C-N-CA 119.264 -1.446 . . . . 0.0 110.149 -179.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.537 ' O ' ' ND2' ' A' ' 12' ' ' ASN . 0.0 OUTLIER -111.14 -155.14 0.56 Allowed 'General case' 0 C--O 1.213 -0.849 0 C-N-CA 119.743 -0.783 . . . . 0.0 110.571 -179.311 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.612 ' CE ' HD11 ' A' ' 29' ' ' ILE . 0.3 OUTLIER -157.83 105.91 2.02 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.623 179.389 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.501 ' SG ' ' O ' ' A' ' 38' ' ' GLN . 0.0 OUTLIER -77.21 162.95 26.98 Favored 'General case' 0 CA--C 1.481 -1.68 0 C-N-CA 117.457 -1.697 . . . . 0.0 111.342 -179.055 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.612 HD11 ' CE ' ' A' ' 27' ' ' LYS . 23.7 mm -144.24 119.21 3.82 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.347 0 CA-C-N 112.276 -2.238 . . . . 0.0 108.273 -179.263 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 16.3 mt . . . . . 0 N--CA 1.488 1.444 0 C-N-CA 118.199 -1.4 . . . . 0.0 112.104 -176.707 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 65.1 m-20 . . . . . 0 N--CA 1.493 1.682 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.501 ' O ' ' SG ' ' A' ' 28' ' ' CYS . 10.2 tt0 -150.77 153.06 34.76 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 117.82 -1.552 . . . . 0.0 112.66 -178.151 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -108.03 114.42 28.31 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 114.602 -1.181 . . . . 0.0 112.004 179.334 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.596 HG22 ' N ' ' A' ' 41' ' ' THR . 5.8 p -128.24 158.74 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 C-N-CA 118.579 -1.248 . . . . 0.0 110.172 173.647 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.596 ' N ' HG22 ' A' ' 40' ' ' VAL . 0.5 OUTLIER -88.07 138.31 31.56 Favored 'General case' 0 C--N 1.27 -2.862 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.707 -179.876 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 178.48 -153.15 12.28 Favored Glycine 0 N--CA 1.489 2.184 0 C-N-CA 119.43 -1.367 . . . . 0.0 110.411 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -98.97 108.78 21.55 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 119.531 -0.867 . . . . 0.0 110.786 -179.463 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -129.49 170.28 20.46 Favored Glycine 0 N--CA 1.493 2.445 1 N-CA-C 129.34 6.496 . . . . 0.0 129.34 178.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.2 t -113.61 141.14 25.5 Favored Pre-proline 0 N--CA 1.496 1.843 0 C-N-CA 119.103 -1.039 . . . . 0.0 110.128 -179.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.699 ' HB3' HD12 ' A' ' 13' ' ' LEU . 9.5 Cg_endo -71.72 107.77 2.27 Favored 'Trans proline' 0 C--O 1.213 -0.755 0 C-N-CA 120.989 1.126 . . . . 0.0 110.123 174.675 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.441 ' C ' ' O ' ' A' ' 46' ' ' PRO . 3.6 tm-20 . . . . . 0 N--CA 1.503 2.187 0 C-N-CA 120.056 -0.658 . . . . 0.0 110.673 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.572 HG12 ' H ' ' A' ' 3' ' ' TYR . 0.5 OUTLIER . . . . . 0 N--CA 1.478 0.95 0 CA-C-O 120.936 0.398 . . . . 0.0 110.573 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.572 ' H ' HG12 ' A' ' 2' ' ' VAL . 22.4 m-85 -137.7 -164.71 1.65 Allowed 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.993 -0.683 . . . . 0.0 109.943 -179.323 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -93.98 167.49 11.57 Favored 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 119.266 -0.974 . . . . 0.0 109.281 -179.778 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.485 ' OD1' ' N ' ' A' ' 5' ' ' ASP . 0.0 OUTLIER -84.92 144.49 28.32 Favored 'General case' 0 C--N 1.291 -1.937 0 C-N-CA 118.464 -1.294 . . . . 0.0 109.979 179.599 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -72.11 -178.49 2.44 Favored 'General case' 0 C--N 1.287 -2.136 0 CA-C-O 122.147 0.975 . . . . 0.0 110.542 177.523 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.2 t -159.47 18.31 0.17 Allowed 'General case' 0 C--N 1.272 -2.784 0 CA-C-N 113.538 -1.665 . . . . 0.0 109.263 177.064 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -162.7 -178.46 6.2 Favored 'General case' 0 C--N 1.293 -1.866 0 CA-C-N 114.218 -1.355 . . . . 0.0 110.055 -178.122 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.493 ' HB3' ' H ' ' A' ' 30' ' ' LEU . 0.8 OUTLIER -98.24 166.26 11.48 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.303 -179.787 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.459 ' O ' ' O ' ' A' ' 11' ' ' GLN . . . 84.12 -43.65 3.22 Favored Glycine 0 N--CA 1.509 3.519 0 C-N-CA 119.584 -1.293 . . . . 0.0 113.235 176.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.459 ' O ' ' O ' ' A' ' 10' ' ' GLY . 10.9 mt-30 -47.65 178.68 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.563 0 C-N-CA 119.727 -0.789 . . . . 0.0 111.099 -177.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.551 ' O ' ' O ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -144.38 -59.21 0.38 Allowed 'General case' 0 N--CA 1.507 2.418 0 C-N-CA 118.16 -1.416 . . . . 0.0 114.372 -176.31 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.501 ' N ' ' CG ' ' A' ' 12' ' ' ASN . 12.7 mt -76.79 48.07 0.55 Allowed 'General case' 0 C--N 1.27 -2.866 0 C-N-CA 117.156 -1.818 . . . . 0.0 110.995 -176.269 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.586 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 25.0 p -123.38 -160.24 0.89 Allowed 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 176.325 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.496 HD22 ' O ' ' A' ' 19' ' ' SER . 70.6 mt -109.03 110.29 21.53 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 176.232 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.586 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 1.9 m -117.62 9.34 13.09 Favored 'General case' 0 N--CA 1.505 2.287 0 C-N-CA 119.19 -1.004 . . . . 0.0 110.345 -176.202 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.419 ' OE2' ' SG ' ' A' ' 22' ' ' CYS . 34.5 mt-10 -141.73 60.78 1.48 Allowed 'General case' 0 C--N 1.288 -2.07 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 177.189 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 79.66 -105.82 2.35 Favored Glycine 0 N--CA 1.484 1.862 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 -177.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.496 ' O ' HD22 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -109.37 -3.22 17.26 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-O 122.232 1.015 . . . . 0.0 109.708 179.165 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 -81.16 133.53 35.47 Favored 'General case' 0 C--N 1.262 -3.2 0 CA-C-N 113.327 -1.76 . . . . 0.0 111.443 -178.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.417 ' HA ' HD23 ' A' ' 15' ' ' LEU . 2.3 t -70.0 142.3 16.04 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 C-N-CA 119.015 -1.074 . . . . 0.0 109.708 178.588 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.58 ' O ' ' SG ' ' A' ' 28' ' ' CYS . 0.1 OUTLIER -143.49 119.79 10.88 Favored 'General case' 0 C--N 1.281 -2.39 0 C-N-CA 119.025 -1.07 . . . . 0.0 109.467 177.387 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.445 ' O ' ' O ' ' A' ' 26' ' ' ASN . . . 151.78 -39.55 0.78 Allowed Glycine 0 C--N 1.294 -1.759 1 N-CA-C 130.544 6.978 . . . . 0.0 130.544 -178.806 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -58.28 115.03 2.69 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 118.882 -1.127 . . . . 0.0 110.266 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.49 -23.33 8.73 Favored Glycine 0 C--N 1.3 -1.447 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -178.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.644 ' N ' ' ND2' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -115.31 -168.99 1.48 Allowed 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.638 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.529 ' HE3' HD11 ' A' ' 29' ' ' ILE . 7.4 tttt -148.59 135.94 20.34 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 118.523 -1.271 . . . . 0.0 110.078 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.58 ' SG ' ' O ' ' A' ' 22' ' ' CYS . 2.9 m -95.65 153.72 17.58 Favored 'General case' 0 C--N 1.307 -1.282 0 C-N-CA 118.289 -1.365 . . . . 0.0 111.458 179.513 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.529 HD11 ' HE3' ' A' ' 27' ' ' LYS . 14.9 mm -136.18 130.53 48.15 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.47 0 CA-C-N 114.05 -1.432 . . . . 0.0 109.811 174.678 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.493 ' H ' ' HB3' ' A' ' 9' ' ' SER . 23.3 mt . . . . . 0 N--CA 1.496 1.868 0 C-N-CA 119.271 -0.972 . . . . 0.0 108.473 177.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.558 ' OD1' ' N ' ' A' ' 37' ' ' ASN . 0.2 OUTLIER . . . . . 0 C--O 1.215 -0.719 0 CA-C-O 121.294 0.568 . . . . 0.0 111.0 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.77 145.93 27.81 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-N 115.267 -0.878 . . . . 0.0 109.64 178.602 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -83.75 116.62 22.78 Favored 'General case' 0 C--N 1.288 -2.106 0 CA-C-N 115.32 -0.854 . . . . 0.0 112.615 -177.624 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.509 ' O ' ' O ' ' A' ' 27' ' ' LYS . 0.9 OUTLIER -119.22 129.69 74.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 CA-C-O 122.606 1.193 . . . . 0.0 110.596 173.707 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 10.1 t -46.98 148.78 1.01 Allowed 'General case' 0 C--N 1.258 -3.378 0 CA-C-N 113.42 -1.718 . . . . 0.0 111.134 -178.032 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.401 ' O ' ' C ' ' A' ' 26' ' ' ASN . . . 149.37 149.66 5.04 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.954 -1.259 . . . . 0.0 109.954 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -80.01 63.4 4.52 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 119.035 -1.066 . . . . 0.0 110.873 -179.323 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -63.36 162.91 32.14 Favored Glycine 0 N--CA 1.49 2.296 0 C-N-CA 119.181 -1.485 . . . . 0.0 109.437 178.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.4 t -79.87 141.04 54.68 Favored Pre-proline 0 N--CA 1.488 1.474 0 C-N-CA 118.514 -1.275 . . . . 0.0 109.835 -179.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.436 ' HB3' HD12 ' A' ' 13' ' ' LEU . 8.4 Cg_endo -67.14 116.46 4.19 Favored 'Trans proline' 0 C--O 1.213 -0.768 0 C-N-CA 121.117 1.211 . . . . 0.0 111.36 178.263 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.414 ' C ' ' O ' ' A' ' 46' ' ' PRO . 0.4 OUTLIER . . . . . 0 N--CA 1.504 2.24 0 C-N-CA 120.284 -0.567 . . . . 0.0 110.929 179.741 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.408 HG12 ' H ' ' A' ' 3' ' ' TYR . 2.8 t . . . . . 0 N--CA 1.489 1.48 0 CA-C-O 120.866 0.365 . . . . 0.0 110.303 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.415 ' CZ ' HD22 ' A' ' 13' ' ' LEU . 45.5 m-85 -130.0 -164.59 1.43 Allowed 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 120.038 -0.665 . . . . 0.0 109.782 179.437 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -92.83 176.76 6.31 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 119.366 -0.934 . . . . 0.0 108.58 179.069 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.527 ' N ' ' OD1' ' A' ' 5' ' ' ASP . 0.2 OUTLIER -97.02 151.88 19.28 Favored 'General case' 0 C--N 1.294 -1.815 0 C-N-CA 118.889 -1.124 . . . . 0.0 109.554 178.013 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.428 ' N ' ' HB2' ' A' ' 14' ' ' CYS . 1.5 m -70.29 176.76 3.71 Favored 'General case' 0 C--N 1.285 -2.212 0 C-N-CA 119.216 -0.993 . . . . 0.0 110.165 177.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.827 ' H ' HE22 ' A' ' 11' ' ' GLN . 0.1 OUTLIER -153.9 7.72 0.35 Allowed 'General case' 0 C--N 1.274 -2.707 0 CA-C-N 114.112 -1.404 . . . . 0.0 110.474 177.795 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -166.46 173.02 10.28 Favored 'General case' 0 C--N 1.284 -2.248 0 CA-C-N 114.505 -1.225 . . . . 0.0 109.761 -179.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.5 136.19 33.53 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 119.375 -0.93 . . . . 0.0 109.124 -178.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.696 ' HA2' ' NZ ' ' A' ' 27' ' ' LYS . . . 112.13 -30.22 7.83 Favored Glycine 0 N--CA 1.493 2.486 1 N-CA-C 129.642 6.617 . . . . 0.0 129.642 -175.873 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.827 HE22 ' H ' ' A' ' 7' ' ' THR . 0.1 OUTLIER -56.21 -167.19 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.909 0 C-N-CA 119.34 -0.944 . . . . 0.0 109.672 178.7 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.602 ' O ' ' HA3' ' A' ' 23' ' ' GLY . 22.2 t-20 -142.18 -69.2 0.36 Allowed 'General case' 0 N--CA 1.496 1.837 0 C-N-CA 118.472 -1.291 . . . . 0.0 113.766 -176.343 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.557 HD12 ' HB3' ' A' ' 46' ' ' PRO . 14.1 mt -78.38 50.39 0.93 Allowed 'General case' 0 C--N 1.261 -3.258 0 C-N-CA 118.227 -1.389 . . . . 0.0 110.9 -176.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.56 ' SG ' ' N ' ' A' ' 15' ' ' LEU . 13.1 p -114.22 -153.14 0.52 Allowed 'General case' 0 N--CA 1.506 2.371 0 C-N-CA 118.788 -1.165 . . . . 0.0 110.719 177.345 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.56 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 7.7 mt -127.5 137.09 52.56 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 114.068 -1.424 . . . . 0.0 109.751 178.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.423 ' SG ' ' CB ' ' A' ' 22' ' ' CYS . 97.5 m -125.11 -77.85 0.59 Allowed 'General case' 0 N--CA 1.513 2.706 0 C-N-CA 118.998 -1.081 . . . . 0.0 111.531 179.504 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -80.07 112.33 17.28 Favored 'General case' 0 C--N 1.299 -1.604 0 C-N-CA 118.345 -1.342 . . . . 0.0 110.282 -178.141 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 66.06 -107.22 1.86 Allowed Glycine 0 N--CA 1.491 2.308 0 C-N-CA 119.497 -1.335 . . . . 0.0 110.36 -179.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.485 ' O ' ' OG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -134.87 11.43 3.65 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 122.981 1.372 . . . . 0.0 108.896 179.95 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.703 ' N ' HD22 ' A' ' 20' ' ' ASN . 0.8 OUTLIER -76.71 127.95 33.73 Favored 'General case' 0 C--N 1.255 -3.503 0 CA-C-N 112.712 -2.04 . . . . 0.0 109.479 178.366 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.3 t -63.57 146.54 12.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 C-N-CA 118.827 -1.149 . . . . 0.0 110.017 -179.01 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.507 ' O ' ' O ' ' A' ' 12' ' ' ASN . 0.0 OUTLIER -135.51 114.88 12.51 Favored 'General case' 0 C--N 1.299 -1.611 0 C-N-CA 119.164 -1.014 . . . . 0.0 109.773 179.566 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.602 ' HA3' ' O ' ' A' ' 12' ' ' ASN . . . 149.76 -55.14 0.48 Allowed Glycine 0 C--O 1.205 -1.712 1 N-CA-C 129.639 6.615 . . . . 0.0 129.639 -176.916 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.456 ' N ' ' OD1' ' A' ' 12' ' ' ASN . 1.1 tm0? -51.59 121.9 7.19 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 118.325 -1.35 . . . . 0.0 109.923 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.82 -26.34 6.05 Favored Glycine 0 C--N 1.297 -1.592 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 -177.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.489 ' N ' ' O ' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -126.0 -162.21 1.11 Allowed 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 119.974 -0.691 . . . . 0.0 111.263 -179.628 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.696 ' NZ ' ' HA2' ' A' ' 10' ' ' GLY . 0.5 OUTLIER -153.69 124.59 7.29 Favored 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 119.196 -1.002 . . . . 0.0 110.674 177.727 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.432 ' O ' HD13 ' A' ' 29' ' ' ILE . 0.1 OUTLIER -81.75 155.93 25.23 Favored 'General case' 0 CA--C 1.483 -1.628 0 C-N-CA 118.31 -1.356 . . . . 0.0 111.876 179.437 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.432 HD13 ' O ' ' A' ' 28' ' ' CYS . 4.2 mm -133.09 117.54 29.37 Favored 'Isoleucine or valine' 0 C--N 1.256 -3.467 0 CA-C-N 112.201 -2.272 . . . . 0.0 109.2 177.106 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 21.1 mt . . . . . 0 N--CA 1.505 2.281 0 C-N-CA 118.631 -1.228 . . . . 0.0 111.171 -178.867 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.558 ' OD1' ' N ' ' A' ' 37' ' ' ASN . 0.1 OUTLIER . . . . . 0 N--CA 1.475 0.797 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -121.98 151.25 40.99 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 119.67 -0.812 . . . . 0.0 110.916 -178.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -105.13 109.34 21.29 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.777 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.513 ' CG2' ' N ' ' A' ' 41' ' ' THR . 2.3 p -125.59 159.74 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.153 0 C-N-CA 118.869 -1.132 . . . . 0.0 110.06 175.14 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.513 ' N ' ' CG2' ' A' ' 40' ' ' VAL . 3.0 t -69.58 146.96 51.35 Favored 'General case' 0 C--N 1.275 -2.645 0 CA-C-N 115.124 -0.944 . . . . 0.0 111.183 -179.366 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 175.79 160.99 24.31 Favored Glycine 0 N--CA 1.489 2.217 0 C-N-CA 119.28 -1.438 . . . . 0.0 110.494 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -81.28 104.85 12.03 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 119.452 -0.899 . . . . 0.0 110.286 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -123.4 165.28 16.16 Favored Glycine 0 N--CA 1.492 2.395 1 N-CA-C 130.306 6.882 . . . . 0.0 130.306 179.474 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 14.3 t -100.38 142.86 25.43 Favored Pre-proline 0 N--CA 1.49 1.563 0 C-N-CA 119.266 -0.973 . . . . 0.0 110.564 -178.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.557 ' HB3' HD12 ' A' ' 13' ' ' LEU . 11.2 Cg_exo -53.5 171.88 0.27 Allowed 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 121.246 1.297 . . . . 0.0 111.187 175.178 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 . . . . . 0 CA--C 1.561 1.383 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.72 178.882 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.413 HG12 ' H ' ' A' ' 3' ' ' TYR . 2.6 t . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.413 ' H ' HG12 ' A' ' 2' ' ' VAL . 59.2 m-85 -126.29 -166.6 1.59 Allowed 'General case' 0 N--CA 1.496 1.827 0 C-N-CA 119.946 -0.702 . . . . 0.0 110.917 -178.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.0 p -102.43 179.17 4.38 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.099 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.469 ' OD1' HD12 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -84.92 152.38 23.56 Favored 'General case' 0 C--N 1.294 -1.836 0 C-N-CA 118.502 -1.279 . . . . 0.0 110.906 -179.751 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.447 ' N ' ' HB2' ' A' ' 14' ' ' CYS . 0.8 OUTLIER -74.82 -177.49 3.29 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.883 176.582 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.8 t -151.84 11.11 0.56 Allowed 'General case' 0 C--N 1.281 -2.413 0 CA-C-N 114.673 -1.149 . . . . 0.0 110.749 177.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -160.49 158.0 28.53 Favored 'General case' 0 C--N 1.29 -2.008 0 CA-C-N 114.557 -1.201 . . . . 0.0 109.514 -178.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.482 ' HA ' ' H ' ' A' ' 30' ' ' LEU . 0.3 OUTLIER -79.32 138.49 37.74 Favored 'General case' 0 C--N 1.293 -1.856 0 C-N-CA 119.605 -0.838 . . . . 0.0 108.995 -179.116 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.884 ' HA2' ' NZ ' ' A' ' 27' ' ' LYS . . . 107.27 -35.14 5.21 Favored Glycine 0 N--CA 1.5 2.912 1 N-CA-C 129.64 6.616 . . . . 0.0 129.64 -173.72 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 -56.86 -166.21 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.167 0 C-N-CA 119.729 -0.788 . . . . 0.0 110.22 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.475 ' ND2' ' C ' ' A' ' 23' ' ' GLY . 1.4 m-20 -141.37 -66.78 0.41 Allowed 'General case' 0 N--CA 1.508 2.46 0 N-CA-C 115.41 1.633 . . . . 0.0 115.41 -175.633 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.457 ' HA ' HD23 ' A' ' 13' ' ' LEU . 35.7 mt -76.51 51.81 0.75 Allowed 'General case' 0 C--N 1.277 -2.562 0 C-N-CA 118.048 -1.461 . . . . 0.0 111.022 -173.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.447 ' HB2' ' N ' ' A' ' 6' ' ' CYS . 27.3 p -123.62 -154.22 0.6 Allowed 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 114.908 -1.042 . . . . 0.0 108.943 176.285 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.469 HD12 ' OD1' ' A' ' 5' ' ' ASP . 70.8 mt -117.77 116.72 27.57 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 176.155 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.461 ' HB3' HD21 ' A' ' 37' ' ' ASN . 2.8 m -116.7 -7.06 11.57 Favored 'General case' 0 N--CA 1.5 2.027 0 C-N-CA 118.617 -1.233 . . . . 0.0 111.746 -176.747 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.5 ' OE1' ' SG ' ' A' ' 39' ' ' CYS . 0.3 OUTLIER -127.09 75.49 1.58 Allowed 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 119.245 -0.982 . . . . 0.0 109.255 177.194 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 71.59 -81.26 0.51 Allowed Glycine 0 N--CA 1.489 2.221 0 C-N-CA 119.475 -1.345 . . . . 0.0 110.605 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -135.38 0.88 2.84 Favored 'General case' 0 N--CA 1.486 1.348 0 CA-C-O 121.907 0.86 . . . . 0.0 110.89 -179.24 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.489 ' N ' ' OD1' ' A' ' 20' ' ' ASN . 0.9 OUTLIER -85.13 139.99 31.28 Favored 'General case' 0 C--N 1.257 -3.455 0 CA-C-N 113.824 -1.535 . . . . 0.0 111.234 -179.011 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.2 t -73.79 144.55 12.46 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 C-N-CA 118.704 -1.198 . . . . 0.0 109.867 178.03 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.484 ' O ' ' SG ' ' A' ' 28' ' ' CYS . 3.8 m -149.98 119.95 7.16 Favored 'General case' 0 C--N 1.278 -2.502 0 C-N-CA 118.775 -1.17 . . . . 0.0 108.593 178.07 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.475 ' C ' ' ND2' ' A' ' 12' ' ' ASN . . . 173.09 -84.8 0.08 OUTLIER Glycine 0 C--N 1.3 -1.466 0 C-N-CA 117.688 -2.196 . . . . 0.0 112.055 -176.241 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.485 ' C ' ' H ' ' A' ' 26' ' ' ASN . 25.9 tt0 -42.43 133.68 3.22 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.868 -0.733 . . . . 0.0 111.321 -178.003 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.475 ' C ' ' ND2' ' A' ' 26' ' ' ASN . . . 76.69 -27.51 1.59 Allowed Glycine 0 N--CA 1.479 1.547 0 C-N-CA 119.679 -1.248 . . . . 0.0 110.083 -179.533 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.518 ' ND2' ' N ' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -128.84 -159.94 0.99 Allowed 'General case' 0 C--N 1.316 -0.871 0 C-N-CA 119.696 -0.802 . . . . 0.0 111.6 -179.039 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.884 ' NZ ' ' HA2' ' A' ' 10' ' ' GLY . 3.4 ttpp -142.98 175.39 9.88 Favored 'General case' 0 N--CA 1.498 1.955 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.815 179.184 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.484 ' SG ' ' O ' ' A' ' 22' ' ' CYS . 57.3 m -138.55 160.66 39.01 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 118.965 -1.094 . . . . 0.0 111.173 176.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 7.8 mm -140.69 97.75 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.13 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 174.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.76 ' C ' HD12 ' A' ' 30' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--N 1.291 -1.944 0 C-N-CA 118.129 -1.428 . . . . 0.0 110.743 -176.216 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 1.082 HD22 ' N ' ' A' ' 38' ' ' GLN . 0.2 OUTLIER . . . . . 0 C--O 1.217 -0.656 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 1.082 ' N ' HD22 ' A' ' 37' ' ' ASN . 10.3 tt0 -131.89 143.29 50.04 Favored 'General case' 0 C--N 1.311 -1.086 0 C-N-CA 119.823 -0.751 . . . . 0.0 110.321 177.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.5 ' SG ' ' OE1' ' A' ' 17' ' ' GLU . 66.2 m -97.93 99.7 11.01 Favored 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 119.539 -0.864 . . . . 0.0 110.01 179.121 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.525 ' O ' ' N ' ' A' ' 27' ' ' LYS . 11.2 p -112.89 155.13 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.334 0 C-N-CA 118.436 -1.306 . . . . 0.0 111.532 179.513 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.488 ' N ' HG22 ' A' ' 40' ' ' VAL . 2.4 t -75.0 148.12 40.18 Favored 'General case' 0 C--N 1.265 -3.077 0 CA-C-N 113.836 -1.529 . . . . 0.0 111.292 -179.178 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 158.72 -179.82 34.1 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 110.119 -1.192 . . . . 0.0 110.119 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -90.8 110.66 21.86 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 119.332 -0.947 . . . . 0.0 110.423 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -128.71 165.76 21.45 Favored Glycine 0 N--CA 1.497 2.701 0 N-CA-C 110.235 -1.146 . . . . 0.0 110.235 179.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -104.5 145.14 30.12 Favored Pre-proline 0 N--CA 1.494 1.774 0 C-N-CA 119.649 -0.82 . . . . 0.0 109.953 -179.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -56.47 142.94 89.06 Favored 'Trans proline' 0 C--O 1.216 -0.617 0 C-N-CA 121.232 1.288 . . . . 0.0 111.297 177.296 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 . . . . . 0 CA--C 1.558 1.261 0 C-N-CA 119.5 -0.88 . . . . 0.0 112.418 -179.795 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.0 t . . . . . 0 N--CA 1.488 1.439 0 CA-C-O 121.043 0.449 . . . . 0.0 110.676 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.726 ' CE2' HD22 ' A' ' 13' ' ' LEU . 23.8 m-85 -94.13 -163.69 1.08 Allowed 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 119.714 -0.795 . . . . 0.0 110.07 179.463 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.583 ' OG1' ' N ' ' A' ' 5' ' ' ASP . 0.1 OUTLIER -96.39 179.48 5.01 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.705 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.583 ' N ' ' OG1' ' A' ' 4' ' ' THR . 0.0 OUTLIER -93.77 153.45 18.3 Favored 'General case' 0 C--N 1.289 -2.048 0 C-N-CA 118.92 -1.112 . . . . 0.0 109.858 179.856 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.499 ' SG ' ' OE1' ' A' ' 11' ' ' GLN . 1.2 m -74.13 177.07 5.99 Favored 'General case' 0 C--N 1.291 -1.945 0 C-N-CA 119.406 -0.918 . . . . 0.0 110.515 177.087 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.417 ' O ' HG23 ' A' ' 7' ' ' THR . 2.7 t -152.69 10.84 0.49 Allowed 'General case' 0 C--N 1.279 -2.48 0 CA-C-N 113.924 -1.489 . . . . 0.0 110.151 177.334 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -163.02 167.54 22.27 Favored 'General case' 0 C--N 1.283 -2.318 0 CA-C-N 114.453 -1.248 . . . . 0.0 109.939 178.758 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -84.41 145.16 28.33 Favored 'General case' 0 C--N 1.296 -1.726 0 C-N-CA 119.136 -1.026 . . . . 0.0 108.83 -178.798 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 102.41 -29.46 12.46 Favored Glycine 0 N--CA 1.512 3.706 1 N-CA-C 130.151 6.82 . . . . 0.0 130.151 -175.286 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.499 ' OE1' ' SG ' ' A' ' 6' ' ' CYS . 72.9 mt-30 -58.42 -158.92 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.065 0 C-N-CA 119.83 -0.748 . . . . 0.0 110.756 -179.777 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.635 ' O ' ' HA3' ' A' ' 23' ' ' GLY . 3.0 m-20 -147.41 -67.13 0.26 Allowed 'General case' 0 N--CA 1.503 2.202 0 C-N-CA 118.21 -1.396 . . . . 0.0 114.561 -177.37 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.726 HD22 ' CE2' ' A' ' 3' ' ' TYR . 32.9 mt -77.96 49.33 0.78 Allowed 'General case' 0 C--N 1.274 -2.708 0 C-N-CA 118.434 -1.306 . . . . 0.0 111.218 -174.946 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.695 ' O ' HG22 ' A' ' 21' ' ' VAL . 17.5 p -119.41 -154.46 0.57 Allowed 'General case' 0 N--CA 1.497 1.912 0 C-N-CA 119.155 -1.018 . . . . 0.0 110.374 176.484 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.401 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 7.2 mt -125.51 135.2 52.03 Favored 'General case' 0 N--CA 1.485 1.31 0 CA-C-N 114.569 -1.196 . . . . 0.0 110.526 179.764 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.3 m -120.35 -58.76 1.83 Allowed 'General case' 0 N--CA 1.508 2.44 0 C-N-CA 119.274 -0.97 . . . . 0.0 111.228 179.6 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.61 97.18 8.83 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 119.441 -0.903 . . . . 0.0 110.725 -178.499 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 68.77 -113.59 5.35 Favored Glycine 0 N--CA 1.488 2.125 0 C-N-CA 119.444 -1.36 . . . . 0.0 110.815 179.16 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.88 3.71 15.55 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-O 122.133 0.968 . . . . 0.0 110.24 -178.544 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -78.35 129.59 35.17 Favored 'General case' 0 C--N 1.256 -3.469 0 CA-C-N 113.589 -1.641 . . . . 0.0 110.39 -179.979 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.695 HG22 ' O ' ' A' ' 14' ' ' CYS . 0.9 OUTLIER -79.32 149.16 5.52 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 C-N-CA 119.473 -0.891 . . . . 0.0 110.227 -179.656 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.477 ' O ' ' O ' ' A' ' 12' ' ' ASN . 15.6 m -143.8 112.58 6.6 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 118.717 -1.193 . . . . 0.0 110.205 179.111 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.635 ' HA3' ' O ' ' A' ' 12' ' ' ASN . . . 178.51 -63.0 0.08 OUTLIER Glycine 0 N--CA 1.484 1.858 1 N-CA-C 130.007 6.763 . . . . 0.0 130.007 -177.274 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -63.54 120.62 12.08 Favored 'General case' 0 C--N 1.311 -1.093 0 C-N-CA 118.466 -1.294 . . . . 0.0 109.842 179.269 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.421 ' C ' HD22 ' A' ' 26' ' ' ASN . . . 95.48 -17.2 59.75 Favored Glycine 0 N--CA 1.485 1.918 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 -178.349 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.465 ' O ' ' O ' ' A' ' 23' ' ' GLY . 2.1 m-80 -139.26 -172.87 3.44 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.389 -0.924 . . . . 0.0 110.694 179.07 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.747 ' NZ ' HD11 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -138.74 125.68 21.13 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 119.502 -0.879 . . . . 0.0 109.148 177.623 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.49 ' SG ' ' O ' ' A' ' 38' ' ' GLN . 0.1 OUTLIER -82.14 164.9 20.98 Favored 'General case' 0 C--N 1.289 -2.051 0 C-N-CA 116.959 -1.896 . . . . 0.0 109.927 178.206 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.747 HD11 ' NZ ' ' A' ' 27' ' ' LYS . 26.8 mm -144.08 125.96 10.54 Favored 'Isoleucine or valine' 0 C--N 1.245 -3.938 0 CA-C-N 113.856 -1.52 . . . . 0.0 108.869 178.74 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 17.7 mt . . . . . 0 N--CA 1.495 1.783 0 C-N-CA 118.51 -1.276 . . . . 0.0 110.135 -179.066 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.215 -0.743 0 CA-C-O 121.89 0.852 . . . . 0.0 113.191 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.49 ' O ' ' SG ' ' A' ' 28' ' ' CYS . 15.8 tt0 -151.63 164.34 37.11 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 113.976 -1.466 . . . . 0.0 108.24 176.039 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.454 ' N ' ' CG ' ' A' ' 38' ' ' GLN . 29.0 m -127.12 97.43 4.93 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 119.407 -0.917 . . . . 0.0 110.86 -178.308 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.503 ' O ' ' O ' ' A' ' 27' ' ' LYS . 0.4 OUTLIER -111.84 140.79 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.485 0 C-N-CA 118.73 -1.188 . . . . 0.0 112.569 -179.719 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.426 ' O ' HG22 ' A' ' 40' ' ' VAL . 9.5 t -56.9 149.35 18.8 Favored 'General case' 0 C--N 1.279 -2.462 0 CA-C-N 113.563 -1.653 . . . . 0.0 111.672 177.943 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 145.16 -130.03 3.71 Favored Glycine 0 N--CA 1.489 2.228 1 N-CA-C 131.116 7.206 . . . . 0.0 131.116 179.622 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 31.9 mm-40 -112.75 106.07 14.34 Favored 'General case' 0 N--CA 1.499 2.007 0 C-N-CA 119.884 -0.726 . . . . 0.0 111.053 -179.044 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -140.02 178.86 19.49 Favored Glycine 0 N--CA 1.493 2.499 0 C-N-CA 119.659 -1.258 . . . . 0.0 110.152 179.377 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -128.61 146.38 59.87 Favored Pre-proline 0 N--CA 1.495 1.815 0 C-N-CA 119.903 -0.719 . . . . 0.0 109.511 179.681 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -57.65 164.06 8.06 Favored 'Trans proline' 0 C--O 1.216 -0.589 0 C-N-CA 121.179 1.253 . . . . 0.0 111.587 -178.809 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 52.3 tp10 . . . . . 0 C--N 1.314 -0.968 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.203 179.54 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.826 HG12 ' H ' ' A' ' 3' ' ' TYR . 22.0 t . . . . . 0 N--CA 1.493 1.719 0 CA-C-O 120.657 0.265 . . . . 0.0 110.652 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.826 ' H ' HG12 ' A' ' 2' ' ' VAL . 85.1 m-85 -114.89 -166.49 1.12 Allowed 'General case' 0 N--CA 1.5 2.063 0 C-N-CA 120.106 -0.638 . . . . 0.0 110.425 -179.939 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.599 ' OG1' ' N ' ' A' ' 5' ' ' ASP . 0.1 OUTLIER -113.01 -177.82 3.23 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 178.816 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.599 ' N ' ' OG1' ' A' ' 4' ' ' THR . 0.2 OUTLIER -90.33 154.2 19.87 Favored 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 118.681 -1.208 . . . . 0.0 110.746 -179.597 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -75.73 -178.85 4.41 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-N 115.001 -1.0 . . . . 0.0 112.005 178.567 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.4 t -157.15 15.18 0.27 Allowed 'General case' 0 C--N 1.291 -1.978 0 CA-C-N 113.435 -1.712 . . . . 0.0 110.02 177.848 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -161.42 172.01 17.23 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 114.505 -1.225 . . . . 0.0 109.533 -179.261 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.534 ' HB3' ' H ' ' A' ' 30' ' ' LEU . 0.9 OUTLIER -91.64 164.31 13.79 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 119.612 -0.835 . . . . 0.0 110.786 -179.303 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.436 ' O ' ' O ' ' A' ' 11' ' ' GLN . . . 79.69 -25.14 2.99 Favored Glycine 0 N--CA 1.499 2.895 0 C-N-CA 119.541 -1.314 . . . . 0.0 112.906 177.216 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.436 ' O ' ' O ' ' A' ' 10' ' ' GLY . 0.5 OUTLIER -54.93 -171.36 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.065 0 C-N-CA 118.495 -1.282 . . . . 0.0 110.577 -178.499 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.484 ' O ' ' O ' ' A' ' 22' ' ' CYS . 2.1 m-20 -148.4 -66.33 0.24 Allowed 'General case' 0 N--CA 1.501 2.076 0 N-CA-C 115.227 1.565 . . . . 0.0 115.227 -176.978 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 95.5 mt -77.17 49.8 0.71 Allowed 'General case' 0 C--N 1.268 -2.963 0 C-N-CA 117.978 -1.489 . . . . 0.0 111.284 -174.179 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 28.3 p -125.84 -156.42 0.73 Allowed 'General case' 0 C--O 1.207 -1.181 0 CA-C-N 114.988 -1.005 . . . . 0.0 109.082 176.499 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.573 HD12 ' OD1' ' A' ' 5' ' ' ASP . 58.1 mt -115.57 120.22 38.74 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 115.115 -0.948 . . . . 0.0 108.957 176.654 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.0 m -117.56 -61.29 1.72 Allowed 'General case' 0 C--N 1.293 -1.861 0 C-N-CA 119.147 -1.021 . . . . 0.0 110.955 -177.237 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.493 ' CG ' ' SG ' ' A' ' 39' ' ' CYS . 3.1 mm-40 -78.74 90.55 4.63 Favored 'General case' 0 C--N 1.295 -1.783 0 C-N-CA 117.81 -1.556 . . . . 0.0 109.708 179.512 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 71.52 -101.78 1.03 Allowed Glycine 0 N--CA 1.488 2.101 0 C-N-CA 119.481 -1.342 . . . . 0.0 109.904 -179.068 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.483 ' O ' HD22 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -128.66 2.96 5.5 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-O 122.35 1.071 . . . . 0.0 109.873 179.837 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -78.72 136.52 37.43 Favored 'General case' 0 C--N 1.258 -3.376 0 CA-C-N 113.313 -1.767 . . . . 0.0 110.228 -179.887 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.1 t -67.21 145.19 13.96 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 C-N-CA 118.438 -1.305 . . . . 0.0 109.493 178.999 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.529 ' O ' ' SG ' ' A' ' 28' ' ' CYS . 20.0 m -148.72 118.95 7.26 Favored 'General case' 0 C--N 1.277 -2.582 0 C-N-CA 118.426 -1.31 . . . . 0.0 109.333 176.82 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.471 ' O ' ' O ' ' A' ' 26' ' ' ASN . . . 171.64 -82.87 0.08 OUTLIER Glycine 0 C--N 1.291 -1.941 0 C-N-CA 118.557 -1.782 . . . . 0.0 110.395 -176.636 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -55.83 117.46 3.69 Favored 'General case' 0 C--N 1.292 -1.902 0 C-N-CA 119.132 -1.027 . . . . 0.0 109.64 179.058 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 102.26 -26.16 25.2 Favored Glycine 0 N--CA 1.484 1.871 0 N-CA-C 109.077 -1.609 . . . . 0.0 109.077 -177.683 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.471 ' O ' ' O ' ' A' ' 23' ' ' GLY . 0.1 OUTLIER -142.67 -154.83 0.54 Allowed 'General case' 0 C--N 1.309 -1.178 0 C-N-CA 119.943 -0.703 . . . . 0.0 110.147 179.767 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.5 ' N ' ' O ' ' A' ' 40' ' ' VAL . 10.0 tttp -148.21 160.01 43.38 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 176.85 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.529 ' SG ' ' O ' ' A' ' 22' ' ' CYS . 72.1 m -121.47 157.56 30.33 Favored 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 118.923 -1.111 . . . . 0.0 111.828 178.495 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 19.9 mm -146.5 133.76 14.64 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.501 0 CA-C-N 113.375 -1.739 . . . . 0.0 109.945 177.104 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.534 ' H ' ' HB3' ' A' ' 9' ' ' SER . 19.9 mt . . . . . 0 N--CA 1.505 2.277 0 C-N-CA 119.862 -0.735 . . . . 0.0 109.871 179.135 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.507 ' OD1' ' N ' ' A' ' 37' ' ' ASN . 0.4 OUTLIER . . . . . 0 C--O 1.217 -0.638 0 CA-C-O 120.806 0.336 . . . . 0.0 110.736 . . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -109.39 147.19 33.19 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.87 179.691 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.493 ' SG ' ' CG ' ' A' ' 17' ' ' GLU . 15.6 m -96.33 90.45 5.44 Favored 'General case' 0 C--N 1.293 -1.865 0 C-N-CA 119.423 -0.911 . . . . 0.0 110.63 -179.423 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.5 ' O ' ' N ' ' A' ' 27' ' ' LYS . 0.6 OUTLIER -90.08 142.81 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 C-N-CA 118.024 -1.471 . . . . 0.0 111.283 179.932 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -65.33 140.35 58.67 Favored 'General case' 0 C--N 1.274 -2.677 0 CA-C-N 114.225 -1.352 . . . . 0.0 110.831 178.844 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 152.89 -156.15 26.54 Favored Glycine 0 N--CA 1.488 2.11 0 C-N-CA 119.545 -1.312 . . . . 0.0 110.252 -179.903 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -114.29 133.37 55.7 Favored 'General case' 0 N--CA 1.497 1.923 0 C-N-CA 120.033 -0.667 . . . . 0.0 110.399 -179.74 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -137.39 158.69 24.53 Favored Glycine 0 N--CA 1.496 2.638 0 C-N-CA 119.704 -1.236 . . . . 0.0 110.455 -179.943 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 5.8 t -87.21 143.9 35.31 Favored Pre-proline 0 N--CA 1.488 1.456 0 C-N-CA 119.631 -0.827 . . . . 0.0 109.929 -179.858 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -58.16 143.69 96.41 Favored 'Trans proline' 0 C--O 1.218 -0.523 0 C-N-CA 121.006 1.137 . . . . 0.0 111.153 178.195 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.548 ' OE1' HG23 ' A' ' 4' ' ' THR . 1.9 tm-20 . . . . . 0 C--N 1.302 -1.458 0 C-N-CA 119.706 -0.798 . . . . 0.0 110.343 -179.819 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.532 HG12 ' H ' ' A' ' 3' ' ' TYR . 0.6 OUTLIER . . . . . 0 N--CA 1.476 0.844 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 . . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.532 ' H ' HG12 ' A' ' 2' ' ' VAL . 95.0 m-85 -143.15 -178.77 6.01 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 118.845 -1.142 . . . . 0.0 111.591 179.653 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 7.7 p -109.97 -179.58 3.84 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 114.772 -1.104 . . . . 0.0 108.862 -179.328 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.456 ' OD1' ' N ' ' A' ' 5' ' ' ASP . 0.1 OUTLIER -88.15 151.79 22.45 Favored 'General case' 0 C--N 1.291 -1.977 0 C-N-CA 118.344 -1.342 . . . . 0.0 109.351 177.424 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.465 ' N ' ' HB2' ' A' ' 14' ' ' CYS . 0.8 OUTLIER -71.79 -178.12 2.18 Favored 'General case' 0 C--N 1.285 -2.214 0 C-N-CA 119.401 -0.919 . . . . 0.0 110.2 178.894 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.0 t -157.46 17.65 0.27 Allowed 'General case' 0 C--N 1.279 -2.47 0 CA-C-N 114.323 -1.308 . . . . 0.0 110.16 178.662 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.531 ' N ' ' OE1' ' A' ' 8' ' ' GLU . 1.2 pm0 -165.45 169.43 15.61 Favored 'General case' 0 C--N 1.285 -2.236 0 CA-C-N 114.773 -1.103 . . . . 0.0 110.076 179.229 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.48 ' HB3' ' H ' ' A' ' 30' ' ' LEU . 0.3 OUTLIER -84.14 138.56 32.95 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 119.244 -0.983 . . . . 0.0 108.859 -179.525 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.542 ' HA2' ' HE3' ' A' ' 27' ' ' LYS . . . 104.53 -35.14 5.25 Favored Glycine 0 N--CA 1.501 2.982 1 N-CA-C 130.249 6.859 . . . . 0.0 130.249 -174.976 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.428 ' O ' ' O ' ' A' ' 10' ' ' GLY . 1.2 mt-30 -54.78 -170.03 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.128 0 C-N-CA 119.292 -0.963 . . . . 0.0 109.895 -179.82 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.466 ' O ' ' O ' ' A' ' 22' ' ' CYS . 4.8 m-20 -141.82 -66.92 0.4 Allowed 'General case' 0 N--CA 1.498 1.937 0 C-N-CA 118.055 -1.458 . . . . 0.0 114.631 -176.209 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.485 HD22 ' CZ ' ' A' ' 3' ' ' TYR . 13.0 mt -75.67 53.95 0.75 Allowed 'General case' 0 C--N 1.268 -2.943 0 C-N-CA 117.613 -1.635 . . . . 0.0 110.274 -175.777 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.465 ' HB2' ' N ' ' A' ' 6' ' ' CYS . 25.9 p -124.89 -160.64 0.96 Allowed 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.023 175.696 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 52.6 mt -118.1 126.72 52.81 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.147 178.446 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.3 m -110.92 -64.5 1.27 Allowed 'General case' 0 N--CA 1.502 2.131 0 C-N-CA 118.98 -1.088 . . . . 0.0 111.197 179.813 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -89.98 92.32 8.94 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 119.05 -1.06 . . . . 0.0 110.67 -178.875 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.43 -105.39 1.84 Allowed Glycine 0 N--CA 1.489 2.222 0 C-N-CA 119.723 -1.227 . . . . 0.0 111.153 178.601 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.404 ' O ' ' OG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -122.43 3.4 9.69 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 122.417 1.103 . . . . 0.0 109.997 -178.354 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 38.1 m-20 -77.22 138.08 39.22 Favored 'General case' 0 C--N 1.259 -3.35 0 CA-C-N 113.278 -1.783 . . . . 0.0 110.598 -179.841 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.0 t -81.68 146.82 6.74 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 C-N-CA 119.441 -0.904 . . . . 0.0 110.357 179.812 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.466 ' O ' ' O ' ' A' ' 12' ' ' ASN . 20.9 m -144.35 114.21 7.28 Favored 'General case' 0 N--CA 1.5 2.043 0 C-N-CA 118.939 -1.104 . . . . 0.0 109.263 177.362 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.484 ' O ' ' N ' ' A' ' 26' ' ' ASN . . . -179.77 -87.78 0.07 OUTLIER Glycine 0 N--CA 1.479 1.538 0 C-N-CA 117.156 -2.449 . . . . 0.0 113.449 -176.726 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.426 ' C ' ' H ' ' A' ' 26' ' ' ASN . 1.5 tt0 -42.15 129.75 3.68 Favored 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 119.931 -0.708 . . . . 0.0 111.681 -175.947 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 81.19 -30.04 2.74 Favored Glycine 0 N--CA 1.477 1.428 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 -179.09 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.484 ' N ' ' O ' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -122.4 -166.86 1.47 Allowed 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 119.935 -0.706 . . . . 0.0 111.412 -178.839 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.542 ' HE3' ' HA2' ' A' ' 10' ' ' GLY . 0.6 OUTLIER -153.15 127.11 8.97 Favored 'General case' 0 N--CA 1.505 2.287 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.237 -179.996 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -86.17 168.31 14.11 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 122.728 1.252 . . . . 0.0 112.337 -178.695 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 11.0 mm -146.31 131.89 12.67 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.754 0 CA-C-N 112.52 -2.127 . . . . 0.0 108.09 175.349 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.48 ' H ' ' HB3' ' A' ' 9' ' ' SER . 23.6 mt . . . . . 0 C--N 1.298 -1.643 0 C-N-CA 117.554 -1.659 . . . . 0.0 108.995 177.629 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.465 ' OD1' ' N ' ' A' ' 37' ' ' ASN . 1.1 m-20 . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 120.692 0.282 . . . . 0.0 111.228 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.495 ' CG ' ' N ' ' A' ' 39' ' ' CYS . 34.2 tt0 -151.94 159.96 43.64 Favored 'General case' 0 C--N 1.312 -1.034 0 C-N-CA 119.051 -1.06 . . . . 0.0 110.329 178.113 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.495 ' N ' ' CG ' ' A' ' 38' ' ' GLN . 91.5 m -131.73 94.28 3.48 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 119.886 -0.726 . . . . 0.0 110.472 -179.902 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.676 HG22 ' N ' ' A' ' 41' ' ' THR . 4.4 p -110.02 173.57 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.336 0 C-N-CA 119.105 -1.038 . . . . 0.0 110.217 179.577 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.676 ' N ' HG22 ' A' ' 40' ' ' VAL . 8.8 t -84.12 156.49 22.11 Favored 'General case' 0 C--N 1.283 -2.326 0 CA-C-N 115.353 -0.839 . . . . 0.0 111.142 178.727 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 159.39 -140.72 7.02 Favored Glycine 0 N--CA 1.492 2.404 0 C-N-CA 119.681 -1.247 . . . . 0.0 110.497 -179.973 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -146.08 89.56 1.89 Allowed 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 119.529 -0.868 . . . . 0.0 110.459 -179.826 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -97.98 -156.15 29.86 Favored Glycine 0 N--CA 1.492 2.395 0 C-N-CA 119.52 -1.324 . . . . 0.0 110.742 -179.538 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -139.91 153.01 69.23 Favored Pre-proline 0 N--CA 1.492 1.666 0 C-N-CA 119.571 -0.852 . . . . 0.0 110.418 -179.98 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.455 ' HB3' HD12 ' A' ' 13' ' ' LEU . 5.2 Cg_exo -53.47 153.97 16.53 Favored 'Trans proline' 0 CA--C 1.543 0.965 0 C-N-CA 122.112 1.875 . . . . 0.0 113.035 177.952 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.2 tm-20 . . . . . 0 N--CA 1.483 1.188 0 CA-C-N 115.937 -0.574 . . . . 0.0 112.292 177.671 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.684 HG12 ' N ' ' A' ' 3' ' ' TYR . 45.6 t . . . . . 0 N--CA 1.497 1.917 0 CA-C-O 120.995 0.426 . . . . 0.0 110.055 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.684 ' N ' HG12 ' A' ' 2' ' ' VAL . 10.8 m-85 -144.09 -167.53 2.63 Favored 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 119.896 -0.722 . . . . 0.0 109.89 179.905 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.589 ' OG1' ' N ' ' A' ' 5' ' ' ASP . 0.1 OUTLIER -104.74 -177.64 3.42 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 177.507 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.589 ' N ' ' OG1' ' A' ' 4' ' ' THR . 0.3 OUTLIER -92.1 154.37 18.77 Favored 'General case' 0 C--N 1.291 -1.955 0 C-N-CA 118.626 -1.229 . . . . 0.0 111.169 -179.429 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.482 ' SG ' ' O ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -73.11 170.16 15.51 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.526 177.388 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.39 7.37 2.16 Favored 'General case' 0 C--N 1.296 -1.761 0 C-N-CA 119.108 -1.037 . . . . 0.0 110.187 176.489 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.411 ' HA ' HD12 ' A' ' 30' ' ' LEU . 0.3 OUTLIER -163.97 -178.24 5.52 Favored 'General case' 0 C--N 1.288 -2.085 0 CA-C-N 114.449 -1.25 . . . . 0.0 110.198 179.395 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -86.01 164.37 17.41 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.369 -179.24 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.437 ' O ' ' O ' ' A' ' 11' ' ' GLN . . . 83.25 -30.77 3.27 Favored Glycine 0 N--CA 1.49 2.234 0 C-N-CA 119.189 -1.481 . . . . 0.0 111.32 179.531 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.514 ' OE1' ' N ' ' A' ' 11' ' ' GLN . 3.1 mp0 -44.09 168.39 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.068 0 C-N-CA 119.194 -1.002 . . . . 0.0 109.879 179.806 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.461 ' O ' ' O ' ' A' ' 22' ' ' CYS . 2.1 m-20 -141.9 -69.7 0.36 Allowed 'General case' 0 N--CA 1.5 2.051 0 C-N-CA 118.536 -1.266 . . . . 0.0 113.374 -177.647 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 81.7 mt -75.63 46.71 0.37 Allowed 'General case' 0 C--N 1.272 -2.765 0 C-N-CA 118.327 -1.349 . . . . 0.0 110.151 -177.0 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.442 ' HB2' ' N ' ' A' ' 6' ' ' CYS . 29.9 p -123.58 -156.93 0.73 Allowed 'General case' 0 C--O 1.205 -1.269 0 CA-C-N 115.265 -0.88 . . . . 0.0 109.597 179.046 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.482 ' O ' ' SG ' ' A' ' 6' ' ' CYS . 71.2 mt -116.09 109.12 17.06 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 114.934 -1.03 . . . . 0.0 108.237 175.687 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.575 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 0.5 OUTLIER -110.31 -51.44 2.87 Favored 'General case' 0 C--N 1.289 -2.054 0 C-N-CA 118.933 -1.107 . . . . 0.0 110.71 -174.673 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.508 ' N ' ' SG ' ' A' ' 16' ' ' CYS . 18.4 tp10 -88.63 75.55 8.26 Favored 'General case' 0 C--N 1.294 -1.816 0 C-N-CA 118.649 -1.221 . . . . 0.0 109.048 177.862 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.38 -121.89 6.61 Favored Glycine 0 N--CA 1.486 2.0 0 C-N-CA 119.143 -1.503 . . . . 0.0 110.013 -178.57 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.425 ' O ' HD22 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -99.81 -1.17 38.27 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 122.026 0.917 . . . . 0.0 110.22 -179.803 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -79.64 133.41 36.4 Favored 'General case' 0 C--N 1.26 -3.309 0 CA-C-N 113.719 -1.582 . . . . 0.0 110.861 -179.137 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.0 t -70.95 141.54 16.73 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.955 0 C-N-CA 118.879 -1.128 . . . . 0.0 109.081 177.71 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.461 ' O ' ' O ' ' A' ' 12' ' ' ASN . 0.1 OUTLIER -148.47 121.39 8.77 Favored 'General case' 0 C--N 1.277 -2.556 0 C-N-CA 118.346 -1.342 . . . . 0.0 109.458 177.304 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.482 ' O ' ' O ' ' A' ' 26' ' ' ASN . . . 175.0 -94.99 0.1 OUTLIER Glycine 0 C--O 1.201 -1.949 0 C-N-CA 118.304 -1.903 . . . . 0.0 111.505 -174.527 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -39.33 129.81 1.74 Allowed 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 120.494 -0.483 . . . . 0.0 111.553 -176.467 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.437 ' O ' ' OD1' ' A' ' 26' ' ' ASN . . . 90.65 -19.36 45.12 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -178.414 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.482 ' O ' ' O ' ' A' ' 23' ' ' GLY . 85.5 m-20 -155.96 -163.13 1.42 Allowed 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -179.862 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.676 ' NZ ' HD11 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -156.86 133.13 9.8 Favored 'General case' 0 N--CA 1.496 1.855 0 C-N-CA 117.871 -1.531 . . . . 0.0 111.345 176.143 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.502 ' SG ' ' OD1' ' A' ' 37' ' ' ASN . 0.1 OUTLIER -87.2 161.11 18.22 Favored 'General case' 0 CA--C 1.482 -1.663 0 CA-C-O 123.342 1.544 . . . . 0.0 113.028 179.897 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.676 HD11 ' NZ ' ' A' ' 27' ' ' LYS . 31.5 mm -134.47 124.13 44.23 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.265 0 CA-C-N 111.057 -2.792 . . . . 0.0 109.677 -179.764 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.411 HD12 ' HA ' ' A' ' 8' ' ' GLU . 33.2 mt . . . . . 0 N--CA 1.501 2.121 0 C-N-CA 118.804 -1.159 . . . . 0.0 110.684 -179.42 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.502 ' OD1' ' SG ' ' A' ' 28' ' ' CYS . 1.4 t30 . . . . . 0 C--O 1.214 -0.776 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.48 ' O ' ' SG ' ' A' ' 28' ' ' CYS . 22.8 tt0 -145.88 142.76 29.08 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 118.984 -1.087 . . . . 0.0 110.604 178.833 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.575 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 36.0 m -91.1 94.23 9.51 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.063 -178.486 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.468 ' O ' ' O ' ' A' ' 27' ' ' LYS . 1.2 p -105.94 139.22 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 C-N-CA 118.491 -1.284 . . . . 0.0 111.998 179.297 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.426 ' O ' HG22 ' A' ' 40' ' ' VAL . 4.9 t -58.65 143.2 47.33 Favored 'General case' 0 C--N 1.273 -2.76 0 CA-C-N 113.524 -1.671 . . . . 0.0 111.166 178.172 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 158.34 -141.25 7.54 Favored Glycine 0 N--CA 1.487 2.056 0 C-N-CA 119.6 -1.286 . . . . 0.0 110.007 179.671 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -130.5 131.76 45.28 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.837 -0.745 . . . . 0.0 109.816 179.25 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -137.11 -151.1 5.88 Favored Glycine 0 N--CA 1.489 2.198 0 C-N-CA 119.648 -1.263 . . . . 0.0 110.399 -179.515 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -145.48 152.32 49.34 Favored Pre-proline 0 C--N 1.302 -1.491 0 C-N-CA 119.54 -0.864 . . . . 0.0 109.703 179.989 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -56.16 -170.61 0.03 OUTLIER 'Trans proline' 0 C--O 1.214 -0.702 0 C-N-CA 121.124 1.216 . . . . 0.0 110.504 176.565 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 . . . . . 0 CA--C 1.56 1.352 0 C-N-CA 120.3 -0.56 . . . . 0.0 110.243 178.6 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 1.5 t . . . . . 0 N--CA 1.481 1.12 0 CA-C-O 120.818 0.342 . . . . 0.0 110.215 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.462 ' CG ' ' O ' ' A' ' 13' ' ' LEU . 7.3 m-85 -90.44 -164.98 1.25 Allowed 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 119.212 -0.995 . . . . 0.0 109.242 178.699 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.584 HG23 ' OE2' ' A' ' 47' ' ' GLU . 0.2 OUTLIER -116.65 -176.7 3.02 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 178.9 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.565 ' N ' ' OG1' ' A' ' 4' ' ' THR . 0.2 OUTLIER -79.35 156.17 28.11 Favored 'General case' 0 C--N 1.289 -2.053 0 C-N-CA 118.528 -1.269 . . . . 0.0 110.406 -179.366 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.405 ' N ' ' HB2' ' A' ' 14' ' ' CYS . 0.1 OUTLIER -70.72 152.01 44.27 Favored 'General case' 0 C--N 1.291 -1.967 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.719 176.654 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.415 ' O ' ' CG ' ' A' ' 8' ' ' GLU . 43.0 p -119.36 4.43 11.23 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-O 121.813 0.816 . . . . 0.0 108.96 178.812 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.415 ' CG ' ' O ' ' A' ' 7' ' ' THR . 29.4 mt-10 -161.93 167.47 24.56 Favored 'General case' 0 C--N 1.283 -2.284 0 CA-C-N 113.914 -1.494 . . . . 0.0 111.18 -178.971 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.422 ' HB3' ' H ' ' A' ' 30' ' ' LEU . 0.9 OUTLIER -79.5 156.47 27.79 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 115.038 -0.983 . . . . 0.0 108.868 177.517 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 28' ' ' CYS . . . 90.51 -13.92 64.15 Favored Glycine 0 N--CA 1.503 3.163 0 C-N-CA 118.739 -1.695 . . . . 0.0 112.45 179.264 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 47.5 mm-40 -61.17 -164.51 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.239 0 C-N-CA 119.139 -1.024 . . . . 0.0 111.073 -178.47 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.495 ' C ' ' H ' ' A' ' 14' ' ' CYS . 7.4 m-20 -160.51 -66.96 0.07 Allowed 'General case' 0 N--CA 1.5 2.057 0 C-N-CA 118.377 -1.329 . . . . 0.0 113.367 179.791 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.462 ' O ' ' CG ' ' A' ' 3' ' ' TYR . 86.1 mt -75.85 41.1 0.2 Allowed 'General case' 0 C--N 1.287 -2.123 0 C-N-CA 119.364 -0.934 . . . . 0.0 110.155 -178.396 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.495 ' H ' ' C ' ' A' ' 12' ' ' ASN . 29.1 p -120.3 -165.83 1.24 Allowed 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.232 178.607 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.567 HD22 ' O ' ' A' ' 19' ' ' SER . 47.1 mt -97.19 102.79 14.64 Favored 'General case' 0 C--N 1.294 -1.841 0 C-N-CA 119.248 -0.981 . . . . 0.0 109.441 178.188 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.413 ' CB ' ' SG ' ' A' ' 22' ' ' CYS . 0.5 OUTLIER -95.41 -35.31 11.78 Favored 'General case' 0 C--N 1.281 -2.397 0 CA-C-N 114.262 -1.336 . . . . 0.0 111.139 -176.021 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -114.19 89.65 3.14 Favored 'General case' 0 C--N 1.301 -1.513 0 C-N-CA 119.68 -0.808 . . . . 0.0 110.326 -179.143 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 73.96 -91.26 0.7 Allowed Glycine 0 N--CA 1.488 2.126 0 C-N-CA 119.511 -1.328 . . . . 0.0 110.486 179.418 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.567 ' O ' HD22 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -138.27 4.34 2.44 Favored 'General case' 0 N--CA 1.484 1.232 0 CA-C-O 122.026 0.917 . . . . 0.0 110.89 -178.841 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -85.03 138.89 32.16 Favored 'General case' 0 C--N 1.261 -3.257 0 CA-C-N 113.835 -1.529 . . . . 0.0 111.111 -179.556 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.54 HG12 ' O ' ' A' ' 22' ' ' CYS . 2.4 t -77.28 139.5 18.61 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.124 0 C-N-CA 118.95 -1.1 . . . . 0.0 110.032 179.039 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.54 ' O ' HG12 ' A' ' 21' ' ' VAL . 0.8 OUTLIER -80.7 -135.44 0.03 OUTLIER 'General case' 0 C--N 1.278 -2.502 0 C-N-CA 118.722 -1.191 . . . . 0.0 109.333 176.049 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.532 ' O ' ' ND2' ' A' ' 26' ' ' ASN . . . -172.68 107.14 0.24 Allowed Glycine 0 C--N 1.272 -3.028 0 C-N-CA 117.835 -2.126 . . . . 0.0 111.089 179.309 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.461 ' C ' ' O ' ' A' ' 23' ' ' GLY . 2.9 tt0 -34.32 131.92 0.3 Allowed 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 121.632 0.73 . . . . 0.0 110.422 178.665 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 131.23 -31.12 3.21 Favored Glycine 0 C--N 1.291 -1.96 0 N-CA-C 106.512 -2.635 . . . . 0.0 106.512 -174.714 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.589 ' N ' ' ND2' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -96.1 -161.2 0.85 Allowed 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 175.412 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.697 ' NZ ' HD11 ' A' ' 29' ' ' ILE . 10.7 ttpp -144.56 113.45 6.8 Favored 'General case' 0 C--N 1.287 -2.116 0 C-N-CA 119.436 -0.906 . . . . 0.0 109.616 177.329 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.566 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 5.3 m -84.31 156.82 21.74 Favored 'General case' 0 CA--C 1.482 -1.662 0 C-N-CA 117.392 -1.723 . . . . 0.0 111.603 -179.665 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.697 HD11 ' NZ ' ' A' ' 27' ' ' LYS . 33.2 mm -144.77 125.38 7.89 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.167 0 CA-C-N 113.235 -1.802 . . . . 0.0 109.92 177.943 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.422 ' H ' ' HB3' ' A' ' 9' ' ' SER . 23.4 mt . . . . . 0 N--CA 1.498 1.964 0 C-N-CA 118.826 -1.15 . . . . 0.0 109.951 178.498 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 . . . . . 0 N--CA 1.488 1.455 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 43.1 tt0 -161.22 151.61 17.74 Favored 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 119.042 -1.063 . . . . 0.0 110.174 177.098 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.566 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 0.0 OUTLIER -101.84 104.47 15.22 Favored 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 119.55 -0.86 . . . . 0.0 111.607 179.789 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.51 ' O ' ' N ' ' A' ' 27' ' ' LYS . 1.1 p -99.01 137.5 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 C-N-CA 118.307 -1.357 . . . . 0.0 109.994 175.356 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 6.3 t -63.93 145.5 55.73 Favored 'General case' 0 C--N 1.266 -3.039 0 CA-C-N 114.008 -1.451 . . . . 0.0 110.811 -178.752 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 152.29 -146.81 15.81 Favored Glycine 0 N--CA 1.49 2.26 0 C-N-CA 119.459 -1.353 . . . . 0.0 110.64 179.094 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -116.36 129.44 56.25 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 120.083 -0.647 . . . . 0.0 109.797 -179.951 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -145.9 -165.03 11.19 Favored Glycine 0 N--CA 1.494 2.534 0 C-N-CA 119.284 -1.436 . . . . 0.0 110.616 -179.62 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.3 t -120.41 144.92 39.35 Favored Pre-proline 0 N--CA 1.491 1.618 0 C-N-CA 119.933 -0.707 . . . . 0.0 110.147 -179.671 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.447 ' HB3' HD12 ' A' ' 13' ' ' LEU . 1.2 Cg_endo -64.69 176.27 3.0 Favored 'Trans proline' 0 C--O 1.213 -0.772 0 C-N-CA 120.948 1.099 . . . . 0.0 111.11 175.415 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.584 ' OE2' HG23 ' A' ' 4' ' ' THR . 2.8 tt0 . . . . . 0 C--N 1.313 -0.985 0 C-N-CA 120.307 -0.557 . . . . 0.0 110.967 -179.822 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 1.6 t . . . . . 0 N--CA 1.477 0.898 0 N-CA-C 109.549 -0.538 . . . . 0.0 109.549 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.427 ' CZ ' HD22 ' A' ' 13' ' ' LEU . 42.8 m-85 -118.35 -171.42 2.07 Favored 'General case' 0 N--CA 1.498 1.942 0 C-N-CA 119.735 -0.786 . . . . 0.0 110.789 -178.337 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.2 p -106.22 -179.87 4.07 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-N 115.304 -0.862 . . . . 0.0 108.838 179.248 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -91.02 149.5 21.81 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 118.572 -1.251 . . . . 0.0 111.134 -179.546 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.513 ' SG ' ' O ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -74.06 178.46 4.99 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.972 178.397 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.2 p -148.68 21.02 1.03 Allowed 'General case' 0 C--N 1.285 -2.2 0 CA-C-N 114.149 -1.387 . . . . 0.0 109.032 175.406 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -160.81 171.89 17.99 Favored 'General case' 0 C--N 1.292 -1.92 0 CA-C-N 114.274 -1.33 . . . . 0.0 110.516 -179.272 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.486 ' O ' ' N ' ' A' ' 11' ' ' GLN . 0.5 OUTLIER -71.32 -176.68 1.55 Allowed 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 119.703 -0.799 . . . . 0.0 109.558 179.785 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.678 ' HA2' ' O ' ' A' ' 28' ' ' CYS . . . 28.31 9.39 0.0 OUTLIER Glycine 0 N--CA 1.498 2.819 1 N-CA-C 130.224 6.85 . . . . 0.0 130.224 179.862 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.486 ' N ' ' O ' ' A' ' 9' ' ' SER . 0.0 OUTLIER -60.75 -165.1 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 176.45 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.473 ' O ' ' O ' ' A' ' 22' ' ' CYS . 1.4 m-20 -148.76 -70.26 0.21 Allowed 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 117.266 -1.773 . . . . 0.0 114.225 -179.795 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.427 HD22 ' CZ ' ' A' ' 3' ' ' TYR . 7.6 mt -75.74 47.46 0.42 Allowed 'General case' 0 C--N 1.263 -3.174 0 C-N-CA 117.936 -1.505 . . . . 0.0 110.663 -175.543 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.542 ' O ' HG22 ' A' ' 21' ' ' VAL . 28.0 p -124.74 -156.58 0.73 Allowed 'General case' 0 C--O 1.211 -0.934 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.2 177.182 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.513 ' O ' ' SG ' ' A' ' 6' ' ' CYS . 5.8 mt -115.56 127.29 55.15 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.029 176.199 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.575 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -141.38 21.88 2.21 Favored 'General case' 0 C--N 1.297 -1.703 0 C-N-CA 118.409 -1.316 . . . . 0.0 111.439 -174.516 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -157.03 77.43 0.88 Allowed 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 119.6 -0.84 . . . . 0.0 109.145 176.047 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 77.2 -88.52 0.99 Allowed Glycine 0 N--CA 1.486 1.976 0 C-N-CA 119.386 -1.388 . . . . 0.0 109.881 -178.388 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.48 ' O ' ' OG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -145.56 11.67 1.29 Allowed 'General case' 0 C--N 1.303 -1.432 0 CA-C-O 122.511 1.148 . . . . 0.0 109.988 179.606 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -95.57 138.46 33.21 Favored 'General case' 0 C--N 1.258 -3.392 0 CA-C-N 113.238 -1.801 . . . . 0.0 110.288 178.105 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.542 HG22 ' O ' ' A' ' 14' ' ' CYS . 1.4 t -72.64 145.21 12.19 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.059 -178.593 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.473 ' O ' ' O ' ' A' ' 12' ' ' ASN . 6.0 m -144.41 126.13 15.16 Favored 'General case' 0 N--CA 1.499 2.021 0 C-N-CA 118.732 -1.187 . . . . 0.0 109.436 177.212 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.436 ' O ' ' O ' ' A' ' 26' ' ' ASN . . . 175.5 -91.05 0.08 OUTLIER Glycine 0 C--O 1.206 -1.604 0 C-N-CA 117.349 -2.358 . . . . 0.0 112.737 -178.043 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -48.9 126.22 11.81 Favored 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 119.453 -0.899 . . . . 0.0 111.007 -176.7 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.18 -29.09 9.22 Favored Glycine 0 N--CA 1.48 1.591 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -178.447 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.436 ' O ' ' O ' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -132.11 -168.95 2.12 Favored 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 120.163 -0.615 . . . . 0.0 110.929 -179.49 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.51 ' O ' ' O ' ' A' ' 40' ' ' VAL . 0.1 OUTLIER -142.71 159.53 42.05 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 177.955 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.678 ' O ' ' HA2' ' A' ' 10' ' ' GLY . 74.0 m -127.03 163.27 24.1 Favored 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 118.657 -1.217 . . . . 0.0 111.917 178.666 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 10.8 mm -139.59 130.6 32.67 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.839 0 CA-C-N 113.081 -1.872 . . . . 0.0 109.545 176.494 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.454 HD23 ' HA ' ' A' ' 30' ' ' LEU . 16.7 mt . . . . . 0 N--CA 1.491 1.598 0 C-N-CA 118.091 -1.444 . . . . 0.0 108.31 176.894 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.505 ' OD1' ' N ' ' A' ' 37' ' ' ASN . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 120.935 0.398 . . . . 0.0 110.542 . . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.47 ' CG ' ' N ' ' A' ' 39' ' ' CYS . 36.6 tt0 -143.59 166.9 23.56 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 120.008 -0.677 . . . . 0.0 109.531 179.503 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.575 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 3.8 m -116.93 91.18 3.51 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 119.567 -0.853 . . . . 0.0 110.814 -179.611 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.51 ' O ' ' O ' ' A' ' 27' ' ' LYS . 0.2 OUTLIER -91.17 139.0 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.17 0 C-N-CA 118.235 -1.386 . . . . 0.0 111.432 179.261 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.421 ' O ' HG22 ' A' ' 40' ' ' VAL . 11.4 t -49.62 151.69 1.61 Allowed 'General case' 0 C--N 1.271 -2.829 0 CA-C-N 114.124 -1.398 . . . . 0.0 110.806 -178.767 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 146.78 -155.27 26.46 Favored Glycine 0 N--CA 1.489 2.209 0 C-N-CA 119.682 -1.247 . . . . 0.0 110.146 -179.378 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 81.4 mt-10 -144.39 143.15 30.79 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 119.497 -0.881 . . . . 0.0 110.282 179.844 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -146.95 -148.12 4.69 Favored Glycine 0 N--CA 1.494 2.53 0 C-N-CA 119.269 -1.443 . . . . 0.0 110.961 -179.525 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -132.56 155.92 80.68 Favored Pre-proline 0 N--CA 1.495 1.814 0 C-N-CA 120.183 -0.607 . . . . 0.0 109.64 -179.206 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -53.04 -168.92 0.01 OUTLIER 'Trans proline' 0 C--O 1.215 -0.657 0 C-N-CA 121.46 1.44 . . . . 0.0 111.44 176.933 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 . . . . . 0 C--N 1.312 -1.024 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.891 -179.706 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.545 HG12 ' N ' ' A' ' 3' ' ' TYR . 11.3 t . . . . . 0 N--CA 1.493 1.679 0 CA-C-O 120.777 0.323 . . . . 0.0 110.516 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.545 ' N ' HG12 ' A' ' 2' ' ' VAL . 37.0 m-85 -122.82 -167.74 1.63 Allowed 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 177.601 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.442 ' OG1' ' OE1' ' A' ' 47' ' ' GLU . 10.4 p -106.07 173.49 6.29 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 119.441 -0.904 . . . . 0.0 109.304 -179.837 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -85.4 147.72 26.35 Favored 'General case' 0 C--N 1.286 -2.176 0 C-N-CA 118.653 -1.219 . . . . 0.0 109.74 179.485 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -75.29 -176.37 3.07 Favored 'General case' 0 C--N 1.285 -2.223 0 C-N-CA 119.547 -0.861 . . . . 0.0 110.336 177.545 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.404 ' O ' ' OG1' ' A' ' 7' ' ' THR . 1.6 t -155.04 12.95 0.38 Allowed 'General case' 0 C--N 1.277 -2.566 0 CA-C-N 114.1 -1.409 . . . . 0.0 110.501 178.696 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -163.82 178.55 7.74 Favored 'General case' 0 C--N 1.282 -2.343 0 CA-C-N 114.647 -1.161 . . . . 0.0 110.088 179.388 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.452 ' O ' ' N ' ' A' ' 11' ' ' GLN . 0.5 OUTLIER -74.66 -160.11 0.1 Allowed 'General case' 0 C--N 1.297 -1.702 0 C-N-CA 119.808 -0.757 . . . . 0.0 109.809 179.864 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.709 ' HA2' ' CE ' ' A' ' 27' ' ' LYS . . . 27.79 10.75 0.0 OUTLIER Glycine 0 N--CA 1.5 2.945 1 N-CA-C 130.68 7.032 . . . . 0.0 130.68 178.557 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.456 ' O ' ' OD1' ' A' ' 12' ' ' ASN . 1.3 mt-30 -86.59 -174.68 5.11 Favored 'General case' 0 N--CA 1.499 1.995 0 C-N-CA 119.01 -1.076 . . . . 0.0 108.537 176.726 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.551 ' ND2' ' O ' ' A' ' 26' ' ' ASN . 16.8 m-20 -138.92 -65.63 0.49 Allowed 'General case' 0 N--CA 1.502 2.141 0 C-N-CA 118.247 -1.381 . . . . 0.0 114.675 -174.641 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.438 HD23 ' HA ' ' A' ' 13' ' ' LEU . 21.2 mt -77.94 47.33 0.63 Allowed 'General case' 0 C--N 1.272 -2.796 0 C-N-CA 117.939 -1.504 . . . . 0.0 111.573 -174.946 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 11.0 p -125.35 -167.4 1.68 Allowed 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 119.804 -0.758 . . . . 0.0 109.327 176.732 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.585 HD22 ' O ' ' A' ' 19' ' ' SER . 57.2 mt -102.09 116.05 31.86 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 177.06 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.637 ' HB3' HD21 ' A' ' 37' ' ' ASN . 6.5 m -111.4 -42.44 3.89 Favored 'General case' 0 N--CA 1.505 2.285 0 C-N-CA 118.854 -1.138 . . . . 0.0 111.919 -175.642 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.34 92.26 4.86 Favored 'General case' 0 N--CA 1.498 1.952 0 C-N-CA 118.968 -1.093 . . . . 0.0 109.776 178.381 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 76.03 -98.21 1.19 Allowed Glycine 0 N--CA 1.491 2.306 0 C-N-CA 119.319 -1.419 . . . . 0.0 110.308 -179.756 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.585 ' O ' HD22 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -134.89 3.02 3.18 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-O 122.231 1.015 . . . . 0.0 110.451 179.77 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -83.95 139.27 32.69 Favored 'General case' 0 C--N 1.26 -3.303 0 CA-C-N 113.51 -1.677 . . . . 0.0 110.728 -179.358 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.434 ' HA ' HD23 ' A' ' 15' ' ' LEU . 2.3 t -64.42 142.59 16.68 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.035 0 C-N-CA 118.95 -1.1 . . . . 0.0 110.153 179.511 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.517 ' O ' ' SG ' ' A' ' 28' ' ' CYS . 0.0 OUTLIER -149.72 122.72 8.81 Favored 'General case' 0 C--N 1.28 -2.432 0 C-N-CA 118.659 -1.217 . . . . 0.0 109.403 177.395 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.428 ' HA3' ' O ' ' A' ' 12' ' ' ASN . . . 148.91 -33.94 1.14 Allowed Glycine 0 C--N 1.296 -1.678 1 N-CA-C 130.077 6.791 . . . . 0.0 130.077 -177.234 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.444 ' C ' ' H ' ' A' ' 26' ' ' ASN . 0.6 OUTLIER -54.64 116.52 2.74 Favored 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 119.301 -0.959 . . . . 0.0 110.261 179.911 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 78.85 -20.7 4.33 Favored Glycine 0 N--CA 1.479 1.504 0 C-N-CA 119.317 -1.42 . . . . 0.0 109.749 -178.681 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.551 ' O ' ' ND2' ' A' ' 12' ' ' ASN . 0.0 OUTLIER -114.22 -170.53 1.74 Allowed 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 119.933 -0.707 . . . . 0.0 109.876 -179.8 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.709 ' CE ' ' HA2' ' A' ' 10' ' ' GLY . 0.2 OUTLIER -154.2 118.71 4.87 Favored 'General case' 0 N--CA 1.5 2.045 0 C-N-CA 119.084 -1.046 . . . . 0.0 111.205 -179.969 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.517 ' SG ' ' O ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -81.77 160.98 23.46 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 118.979 -1.088 . . . . 0.0 110.956 -179.174 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.537 HD11 ' CE ' ' A' ' 27' ' ' LYS . 36.5 mm -133.33 126.81 53.11 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 C-N-CA 119.385 -0.926 . . . . 0.0 110.455 179.685 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 13.3 mt . . . . . 0 N--CA 1.497 1.91 0 C-N-CA 118.612 -1.235 . . . . 0.0 109.935 178.065 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.868 HD22 ' C ' ' A' ' 37' ' ' ASN . 0.2 OUTLIER . . . . . 0 N--CA 1.432 -1.364 0 CA-C-O 121.12 0.486 . . . . 0.0 110.156 . . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.602 ' N ' HD22 ' A' ' 37' ' ' ASN . 19.9 tt0 -113.19 140.35 48.01 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.647 179.177 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 77.1 m -91.49 107.65 19.35 Favored 'General case' 0 C--N 1.294 -1.847 0 C-N-CA 119.124 -1.03 . . . . 0.0 111.073 -179.887 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.578 HG22 ' N ' ' A' ' 41' ' ' THR . 2.5 p -123.58 162.6 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.5 0 C-N-CA 118.833 -1.147 . . . . 0.0 110.862 177.807 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.578 ' N ' HG22 ' A' ' 40' ' ' VAL . 1.3 t -90.0 144.99 25.43 Favored 'General case' 0 C--N 1.284 -2.257 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.805 179.585 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 178.49 -93.4 0.09 OUTLIER Glycine 0 N--CA 1.491 2.344 1 N-CA-C 130.25 6.86 . . . . 0.0 130.25 179.899 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -157.8 93.03 1.24 Allowed 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 119.561 -0.856 . . . . 0.0 110.027 179.399 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.528 ' HA3' ' HG3' ' A' ' 27' ' ' LYS . . . -131.62 -178.76 15.67 Favored Glycine 0 N--CA 1.493 2.467 1 N-CA-C 131.711 7.444 . . . . 0.0 131.711 -178.963 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -106.84 118.63 53.73 Favored Pre-proline 0 CA--C 1.561 1.386 0 C-N-CA 120.462 -0.495 . . . . 0.0 111.422 -179.341 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.41 ' O ' ' C ' ' A' ' 47' ' ' GLU . 4.3 Cg_exo -64.46 102.95 0.42 Allowed 'Trans proline' 0 C--O 1.215 -0.652 0 C-N-CA 120.935 1.09 . . . . 0.0 110.784 174.894 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.442 ' OE1' ' OG1' ' A' ' 4' ' ' THR . 6.5 tm-20 . . . . . 0 CA--C 1.56 1.343 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.162 179.603 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.638 HG12 ' N ' ' A' ' 3' ' ' TYR . 23.1 t . . . . . 0 N--CA 1.488 1.455 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.638 ' N ' HG12 ' A' ' 2' ' ' VAL . 23.4 m-85 -96.61 -166.25 1.39 Allowed 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 119.39 -0.924 . . . . 0.0 111.057 -178.013 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 13.8 p -96.9 176.19 6.06 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 119.792 -0.763 . . . . 0.0 109.225 -179.321 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -89.71 144.67 25.79 Favored 'General case' 0 C--N 1.289 -2.052 0 C-N-CA 118.722 -1.191 . . . . 0.0 109.335 178.321 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -73.81 -177.93 3.0 Favored 'General case' 0 C--N 1.286 -2.175 0 CA-C-O 122.144 0.973 . . . . 0.0 111.535 -179.864 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.7 p -154.37 18.56 0.48 Allowed 'General case' 0 C--N 1.283 -2.286 0 CA-C-N 113.476 -1.693 . . . . 0.0 109.076 178.486 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -163.2 177.93 8.64 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-N 114.4 -1.273 . . . . 0.0 110.568 -178.98 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.496 ' O ' ' N ' ' A' ' 11' ' ' GLN . 0.6 OUTLIER -83.91 -158.52 0.32 Allowed 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.985 -179.763 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.529 ' HA2' ' HE3' ' A' ' 27' ' ' LYS . . . 22.85 21.41 0.0 OUTLIER Glycine 0 N--CA 1.498 2.779 1 N-CA-C 129.973 6.749 . . . . 0.0 129.973 178.762 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.496 ' N ' ' O ' ' A' ' 9' ' ' SER . 7.7 mt-30 -94.49 -164.18 1.14 Allowed 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 114.492 -0.854 . . . . 0.0 109.575 178.233 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.74 HD21 ' H ' ' A' ' 44' ' ' GLY . 24.7 m-20 -147.57 -62.59 0.27 Allowed 'General case' 0 N--CA 1.501 2.082 0 C-N-CA 118.086 -1.446 . . . . 0.0 114.54 -177.311 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.437 HD22 ' CZ ' ' A' ' 3' ' ' TYR . 16.2 mt -76.86 47.43 0.52 Allowed 'General case' 0 C--N 1.269 -2.909 0 C-N-CA 118.127 -1.429 . . . . 0.0 111.795 -174.586 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 7.0 p -129.85 -168.07 1.9 Allowed 'General case' 0 C--N 1.308 -1.203 0 C-N-CA 119.657 -0.817 . . . . 0.0 110.186 175.441 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 35.9 mt -104.41 120.12 40.51 Favored 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 119.586 -0.846 . . . . 0.0 108.935 178.232 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.1 m -119.67 -18.9 8.24 Favored 'General case' 0 N--CA 1.501 2.114 0 C-N-CA 119.163 -1.015 . . . . 0.0 111.816 -176.575 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.11 93.78 4.02 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 119.591 -0.844 . . . . 0.0 109.243 177.677 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 68.84 -101.75 0.83 Allowed Glycine 0 N--CA 1.486 2.001 0 C-N-CA 119.245 -1.455 . . . . 0.0 109.8 -178.268 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.442 ' O ' ' OG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -127.17 4.12 6.41 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 122.541 1.162 . . . . 0.0 109.269 178.931 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -78.09 140.1 39.06 Favored 'General case' 0 C--N 1.262 -3.211 0 CA-C-N 112.811 -1.995 . . . . 0.0 111.203 -179.077 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.1 t -77.27 145.75 9.61 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.19 0 C-N-CA 119.337 -0.945 . . . . 0.0 110.021 178.754 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.494 ' O ' ' SG ' ' A' ' 28' ' ' CYS . 15.0 m -146.57 109.89 4.78 Favored 'General case' 0 C--N 1.288 -2.099 0 C-N-CA 118.99 -1.084 . . . . 0.0 109.185 176.761 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.577 ' HA2' ' OD1' ' A' ' 12' ' ' ASN . . . -170.72 -78.75 0.04 OUTLIER Glycine 0 N--CA 1.479 1.523 1 N-CA-C 129.681 6.632 . . . . 0.0 129.681 -175.961 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.34 110.98 2.43 Favored 'General case' 0 C--N 1.311 -1.071 0 C-N-CA 118.308 -1.357 . . . . 0.0 109.309 179.441 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 105.44 -18.93 40.7 Favored Glycine 0 C--N 1.302 -1.359 0 N-CA-C 122.735 3.854 . . . . 0.0 122.735 -171.443 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.413 ' HA ' ' H ' ' A' ' 42' ' ' GLY . 0.0 OUTLIER -132.36 -167.94 1.97 Allowed 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 112.788 -1.706 . . . . 0.0 108.711 179.105 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.529 ' HE3' ' HA2' ' A' ' 10' ' ' GLY . 12.7 tttt -148.11 122.15 9.46 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 118.52 -1.272 . . . . 0.0 110.502 177.472 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.494 ' SG ' ' O ' ' A' ' 22' ' ' CYS . 19.2 m -86.55 153.58 21.72 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 117.825 -1.55 . . . . 0.0 110.819 178.624 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 13.6 mm -137.2 129.39 42.87 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.647 0 CA-C-N 114.492 -1.231 . . . . 0.0 109.303 175.839 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.461 ' HA ' HD23 ' A' ' 30' ' ' LEU . 17.2 mt . . . . . 0 N--CA 1.49 1.575 0 C-N-CA 118.191 -1.404 . . . . 0.0 108.914 178.001 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.431 ' OD1' ' N ' ' A' ' 37' ' ' ASN . 2.0 m-20 . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 40.2 tt0 -150.51 141.79 23.25 Favored 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 118.998 -1.081 . . . . 0.0 110.111 177.969 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 14.2 m -91.21 91.36 8.18 Favored 'General case' 0 C--N 1.293 -1.861 0 C-N-CA 119.49 -0.884 . . . . 0.0 111.173 -178.362 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.475 ' O ' ' O ' ' A' ' 27' ' ' LYS . 0.6 OUTLIER -95.53 139.69 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 C-N-CA 118.334 -1.347 . . . . 0.0 110.941 178.659 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.413 ' O ' HG22 ' A' ' 40' ' ' VAL . 8.8 t -56.8 147.27 23.66 Favored 'General case' 0 C--N 1.271 -2.831 0 CA-C-N 114.085 -1.416 . . . . 0.0 110.918 -179.567 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.413 ' H ' ' HA ' ' A' ' 26' ' ' ASN . . . 159.43 -141.25 7.39 Favored Glycine 0 N--CA 1.487 2.073 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 -179.263 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -146.57 106.44 3.98 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 119.34 -0.944 . . . . 0.0 110.229 179.785 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.74 ' H ' HD21 ' A' ' 12' ' ' ASN . . . -108.46 -156.54 18.46 Favored Glycine 0 N--CA 1.498 2.822 0 C-N-CA 119.834 -1.174 . . . . 0.0 111.1 -178.807 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -132.56 156.12 80.45 Favored Pre-proline 0 N--CA 1.497 1.876 0 C-N-CA 120.104 -0.638 . . . . 0.0 109.853 -178.941 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -53.84 165.33 1.92 Allowed 'Trans proline' 0 C--O 1.216 -0.623 0 C-N-CA 121.373 1.382 . . . . 0.0 111.092 175.828 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 . . . . . 0 CA--C 1.558 1.259 0 C-N-CA 119.293 -0.963 . . . . 0.0 110.952 177.958 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 4.2 t . . . . . 0 N--CA 1.485 1.314 0 CA-C-O 121.586 0.708 . . . . 0.0 110.768 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.463 ' CZ ' HD22 ' A' ' 13' ' ' LEU . 94.7 m-85 -138.32 -172.18 3.22 Favored 'General case' 0 C--N 1.273 -2.75 0 CA-C-N 114.509 -1.223 . . . . 0.0 111.182 179.808 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.6 p -123.22 -167.44 1.6 Allowed 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 114.797 -1.092 . . . . 0.0 108.563 178.314 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.428 ' OD1' HD12 ' A' ' 15' ' ' LEU . 0.1 OUTLIER -93.54 156.14 16.91 Favored 'General case' 0 C--N 1.288 -2.106 0 C-N-CA 119.05 -1.06 . . . . 0.0 111.434 -177.939 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.447 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 1.7 m -72.23 162.17 29.84 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 114.931 -1.031 . . . . 0.0 110.44 177.286 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.906 ' H ' HE22 ' A' ' 11' ' ' GLN . 0.2 OUTLIER -138.44 8.73 2.66 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 119.46 -0.896 . . . . 0.0 110.034 178.328 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.752 ' H ' HE22 ' A' ' 11' ' ' GLN . 11.4 pt-20 -164.75 161.09 20.37 Favored 'General case' 0 C--N 1.281 -2.376 0 CA-C-N 114.29 -1.323 . . . . 0.0 110.379 178.886 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.484 ' HB3' ' H ' ' A' ' 30' ' ' LEU . 0.7 OUTLIER -70.36 150.37 46.37 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.644 -0.823 . . . . 0.0 109.905 -179.783 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.426 ' O ' ' O ' ' A' ' 11' ' ' GLN . . . 101.66 -37.01 3.84 Favored Glycine 0 N--CA 1.502 3.085 0 C-N-CA 119.511 -1.328 . . . . 0.0 112.759 178.114 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.906 HE22 ' H ' ' A' ' 7' ' ' THR . 4.5 mt-30 -47.31 176.39 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.521 0 C-N-CA 119.539 -0.865 . . . . 0.0 111.583 -177.63 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.514 ' C ' ' H ' ' A' ' 14' ' ' CYS . 54.7 m-20 -147.93 -60.56 0.26 Allowed 'General case' 0 N--CA 1.502 2.164 0 C-N-CA 118.698 -1.201 . . . . 0.0 113.339 -178.161 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.495 HD12 ' HB3' ' A' ' 46' ' ' PRO . 19.0 mt -76.1 39.71 0.19 Allowed 'General case' 0 C--N 1.29 -2.016 0 C-N-CA 118.752 -1.179 . . . . 0.0 110.273 -177.88 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.587 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 17.2 p -122.27 -164.58 1.18 Allowed 'General case' 0 C--N 1.292 -1.908 0 CA-C-N 115.05 -0.977 . . . . 0.0 108.387 176.555 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.428 HD12 ' OD1' ' A' ' 5' ' ' ASP . 25.4 mt -100.29 99.39 10.05 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-O 122.286 1.041 . . . . 0.0 108.7 177.764 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.587 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 93.2 m -100.91 -61.62 1.35 Allowed 'General case' 0 C--N 1.276 -2.594 0 CA-C-N 113.273 -1.785 . . . . 0.0 110.708 -174.07 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -80.57 90.11 5.7 Favored 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 118.902 -1.119 . . . . 0.0 108.838 178.207 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 69.29 -127.59 21.07 Favored Glycine 0 N--CA 1.484 1.847 0 C-N-CA 118.953 -1.594 . . . . 0.0 109.465 -177.838 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -100.89 0.01 37.65 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 122.179 0.99 . . . . 0.0 109.966 179.688 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 67.7 m-80 -80.02 150.92 30.23 Favored 'General case' 0 C--N 1.261 -3.246 0 CA-C-N 113.483 -1.689 . . . . 0.0 111.256 -179.007 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.545 HG12 ' O ' ' A' ' 22' ' ' CYS . 2.4 t -82.92 141.36 15.03 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 C-N-CA 119.566 -0.853 . . . . 0.0 111.477 -179.176 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.602 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 0.1 OUTLIER -77.76 -130.85 0.01 OUTLIER 'General case' 0 N--CA 1.514 2.764 0 C-N-CA 118.765 -1.174 . . . . 0.0 108.867 172.468 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.452 ' O ' ' C ' ' A' ' 24' ' ' GLN . . . -179.71 111.2 0.31 Allowed Glycine 0 C--N 1.275 -2.845 0 C-N-CA 117.96 -2.067 . . . . 0.0 111.617 177.527 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.452 ' C ' ' O ' ' A' ' 23' ' ' GLY . 36.4 tt0 -36.61 129.69 0.77 Allowed 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 119.979 -0.688 . . . . 0.0 109.244 176.13 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 121.31 -25.91 6.85 Favored Glycine 0 N--CA 1.483 1.813 0 N-CA-C 107.532 -2.227 . . . . 0.0 107.532 -175.142 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.625 ' N ' ' ND2' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -107.5 -161.25 0.77 Allowed 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 176.894 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.543 ' O ' ' O ' ' A' ' 40' ' ' VAL . 29.4 tttp -153.7 105.7 2.82 Favored 'General case' 0 N--CA 1.5 2.041 0 C-N-CA 118.799 -1.16 . . . . 0.0 111.918 179.866 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.619 ' O ' HD13 ' A' ' 29' ' ' ILE . 3.3 m -78.55 154.81 30.09 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 118.39 -1.324 . . . . 0.0 110.146 178.71 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.619 HD13 ' O ' ' A' ' 28' ' ' CYS . 8.2 mm -134.3 133.72 55.25 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.152 0 CA-C-N 114.968 -1.014 . . . . 0.0 110.283 175.655 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.484 ' H ' ' HB3' ' A' ' 9' ' ' SER . 17.7 mt . . . . . 0 N--CA 1.497 1.885 0 C-N-CA 119.123 -1.031 . . . . 0.0 110.038 177.354 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.499 ' OD1' ' N ' ' A' ' 37' ' ' ASN . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 121.187 0.518 . . . . 0.0 111.498 . . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 -160.78 135.86 7.71 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.859 177.581 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.476 ' SG ' ' HB2' ' A' ' 16' ' ' CYS . 1.0 OUTLIER -91.53 108.77 20.13 Favored 'General case' 0 C--N 1.295 -1.787 0 C-N-CA 119.705 -0.798 . . . . 0.0 110.741 -179.557 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.561 HG22 ' N ' ' A' ' 41' ' ' THR . 3.7 p -130.95 157.69 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.25 0 C-N-CA 118.219 -1.393 . . . . 0.0 111.359 176.459 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.561 ' N ' HG22 ' A' ' 40' ' ' VAL . 14.0 t -73.24 151.03 41.57 Favored 'General case' 0 C--N 1.275 -2.633 0 CA-C-N 114.399 -1.273 . . . . 0.0 111.662 -179.13 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 164.31 -143.13 8.29 Favored Glycine 0 N--CA 1.489 2.2 0 C-N-CA 119.479 -1.343 . . . . 0.0 110.43 179.587 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -120.78 100.26 7.0 Favored 'General case' 0 N--CA 1.495 1.814 0 C-N-CA 120.092 -0.643 . . . . 0.0 109.904 179.588 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -127.28 -155.06 8.7 Favored Glycine 0 N--CA 1.495 2.621 0 N-CA-C 110.255 -1.138 . . . . 0.0 110.255 -179.73 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -144.41 151.05 49.97 Favored Pre-proline 0 N--CA 1.488 1.428 0 C-N-CA 119.431 -0.908 . . . . 0.0 109.954 179.713 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.495 ' HB3' HD12 ' A' ' 13' ' ' LEU . 9.3 Cg_endo -68.8 141.61 49.83 Favored 'Trans proline' 0 C--O 1.216 -0.612 0 C-N-CA 121.342 1.361 . . . . 0.0 111.336 177.177 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 . . . . . 0 CA--C 1.56 1.358 0 C-N-CA 119.488 -0.885 . . . . 0.0 109.512 178.506 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.674 HG12 ' N ' ' A' ' 3' ' ' TYR . 61.7 t . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 120.938 0.399 . . . . 0.0 109.983 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.674 ' N ' HG12 ' A' ' 2' ' ' VAL . 37.8 m-85 -114.39 -165.41 1.01 Allowed 'General case' 0 N--CA 1.493 1.685 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.67 -179.733 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.9 p -99.48 172.27 7.42 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 178.215 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -89.64 154.2 20.15 Favored 'General case' 0 C--N 1.285 -2.207 0 C-N-CA 118.2 -1.4 . . . . 0.0 110.366 -179.632 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.514 ' SG ' ' O ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -73.81 154.73 39.39 Favored 'General case' 0 C--N 1.291 -1.952 0 C-N-CA 119.729 -0.788 . . . . 0.0 110.223 177.35 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.4 t -129.94 14.35 5.79 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-O 122.055 0.931 . . . . 0.0 108.85 177.739 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.498 ' HG2' HE21 ' A' ' 11' ' ' GLN . 11.6 pt-20 -162.58 176.94 9.87 Favored 'General case' 0 C--N 1.281 -2.404 0 CA-C-N 113.695 -1.593 . . . . 0.0 109.58 179.488 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.461 ' O ' ' N ' ' A' ' 11' ' ' GLN . 0.5 OUTLIER -72.64 -163.75 0.14 Allowed 'General case' 0 C--N 1.297 -1.693 0 C-N-CA 119.264 -0.974 . . . . 0.0 109.5 -179.506 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.602 ' H ' HD13 ' A' ' 29' ' ' ILE . . . 24.66 19.73 0.0 OUTLIER Glycine 0 N--CA 1.494 2.541 1 N-CA-C 130.218 6.847 . . . . 0.0 130.218 179.264 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.498 HE21 ' HG2' ' A' ' 8' ' ' GLU . 7.9 mm-40 -71.09 -163.38 0.08 Allowed 'General case' 0 C--N 1.295 -1.799 0 C-N-CA 119.432 -0.907 . . . . 0.0 109.35 177.241 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.57 ' O ' ' HA3' ' A' ' 23' ' ' GLY . 26.2 t-20 -148.52 -77.55 0.16 Allowed 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 118.188 -1.405 . . . . 0.0 112.975 -177.876 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.428 HD12 ' HB3' ' A' ' 46' ' ' PRO . 14.1 mt -78.08 42.13 0.39 Allowed 'General case' 0 C--N 1.271 -2.833 0 C-N-CA 118.02 -1.472 . . . . 0.0 110.495 -177.8 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.42 ' H ' ' C ' ' A' ' 12' ' ' ASN . 29.4 p -113.33 -159.88 0.7 Allowed 'General case' 0 N--CA 1.496 1.833 0 C-N-CA 119.483 -0.887 . . . . 0.0 110.129 178.012 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.514 ' O ' ' SG ' ' A' ' 6' ' ' CYS . 3.5 mt -124.82 133.0 53.28 Favored 'General case' 0 N--CA 1.499 2.006 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.518 177.584 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 3.4 m -111.92 -74.42 0.64 Allowed 'General case' 0 N--CA 1.513 2.713 0 C-N-CA 119.064 -1.054 . . . . 0.0 110.308 179.094 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -78.23 125.69 29.72 Favored 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 118.319 -1.352 . . . . 0.0 107.845 177.228 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 28.55 -72.64 0.0 OUTLIER Glycine 0 N--CA 1.502 3.06 1 N-CA-C 128.931 6.332 . . . . 0.0 128.931 -176.7 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -137.53 0.27 2.25 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-O 122.149 0.976 . . . . 0.0 110.324 177.456 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 35.8 m120 -80.27 128.16 33.21 Favored 'General case' 0 C--N 1.261 -3.264 0 CA-C-N 113.557 -1.656 . . . . 0.0 110.448 -179.84 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.1 t -70.34 148.98 10.61 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 C-N-CA 119.282 -0.967 . . . . 0.0 109.954 179.621 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.546 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 0.4 OUTLIER -134.54 101.14 4.86 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 119.0 -1.08 . . . . 0.0 110.699 178.781 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.57 ' HA3' ' O ' ' A' ' 12' ' ' ASN . . . 164.98 -55.4 0.27 Allowed Glycine 0 C--N 1.297 -1.61 1 N-CA-C 131.485 7.354 . . . . 0.0 131.485 179.465 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.503 ' N ' ' OD1' ' A' ' 12' ' ' ASN . 28.7 tt0 -51.47 117.85 2.92 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 118.875 -1.13 . . . . 0.0 110.732 -178.045 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 80.26 -22.37 4.52 Favored Glycine 0 N--CA 1.482 1.711 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -178.506 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.527 ' N ' ' OD1' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -119.8 -159.17 0.77 Allowed 'General case' 0 C--N 1.312 -1.037 0 C-N-CA 120.432 -0.507 . . . . 0.0 109.99 -179.689 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.593 ' N ' ' O ' ' A' ' 40' ' ' VAL . 40.3 tttt -157.98 162.35 38.19 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.654 -179.95 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.546 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -122.97 168.81 11.85 Favored 'General case' 0 CA--C 1.481 -1.706 0 CA-C-O 123.125 1.441 . . . . 0.0 111.638 174.249 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.602 HD13 ' H ' ' A' ' 10' ' ' GLY . 21.6 mm -143.72 130.43 16.95 Favored 'Isoleucine or valine' 0 C--N 1.249 -3.782 0 CA-C-N 111.755 -2.475 . . . . 0.0 108.816 174.324 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.412 ' HA ' HD23 ' A' ' 30' ' ' LEU . 15.2 mt . . . . . 0 N--CA 1.49 1.54 0 C-N-CA 118.275 -1.37 . . . . 0.0 110.016 -179.73 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 14.6 m-20 . . . . . 0 N--CA 1.485 1.306 0 N-CA-C 109.751 -0.462 . . . . 0.0 109.751 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.519 ' O ' ' SG ' ' A' ' 28' ' ' CYS . 38.3 tt0 -160.54 147.25 15.53 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 119.383 -0.927 . . . . 0.0 110.488 178.333 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -103.44 107.38 18.19 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 119.885 -0.726 . . . . 0.0 112.378 -179.55 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.593 ' O ' ' N ' ' A' ' 27' ' ' LYS . 0.1 OUTLIER -100.25 141.46 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.571 0 C-N-CA 118.709 -1.196 . . . . 0.0 110.615 174.778 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.634 HG23 ' O ' ' A' ' 41' ' ' THR . 8.9 t -78.79 47.41 0.74 Allowed 'General case' 0 C--N 1.279 -2.471 0 CA-C-N 113.942 -1.481 . . . . 0.0 113.232 -177.882 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -118.47 -124.51 3.37 Favored Glycine 0 N--CA 1.505 3.294 1 N-CA-C 131.198 7.239 . . . . 0.0 131.198 178.172 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -98.1 73.39 2.21 Favored 'General case' 0 N--CA 1.499 1.992 0 C-N-CA 119.412 -0.915 . . . . 0.0 111.215 -178.489 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -92.15 165.22 28.95 Favored Glycine 0 N--CA 1.494 2.559 0 C-N-CA 119.405 -1.378 . . . . 0.0 110.854 -179.597 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.518 ' O ' ' N ' ' A' ' 12' ' ' ASN . 0.5 OUTLIER -129.95 148.3 69.04 Favored Pre-proline 0 N--CA 1.498 1.925 0 C-N-CA 120.128 -0.629 . . . . 0.0 109.721 179.971 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.436 ' O ' ' O ' ' A' ' 45' ' ' THR . 2.7 Cg_exo -52.77 -164.03 0.0 OUTLIER 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 121.414 1.41 . . . . 0.0 111.131 177.717 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 . . . . . 0 C--N 1.305 -1.353 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.077 178.111 . . . . . . . . 0 0 . 1 . 031 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.0 t . . . . . 0 N--CA 1.486 1.37 0 CA-C-O 121.057 0.456 . . . . 0.0 110.494 . . . . . . . . . 0 0 . 1 . 031 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -87.65 -164.53 1.11 Allowed 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 119.909 -0.716 . . . . 0.0 110.417 -179.897 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.2 p -97.59 178.38 5.19 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 119.793 -0.763 . . . . 0.0 108.956 179.742 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -91.17 154.44 19.32 Favored 'General case' 0 C--N 1.297 -1.69 0 C-N-CA 118.796 -1.162 . . . . 0.0 110.322 178.929 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.486 ' SG ' ' O ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -75.13 165.75 24.73 Favored 'General case' 0 C--N 1.299 -1.592 0 C-N-CA 119.886 -0.726 . . . . 0.0 110.899 177.827 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 43.2 p -143.72 17.5 1.81 Allowed 'General case' 0 C--N 1.294 -1.835 0 CA-C-N 114.881 -1.054 . . . . 0.0 108.596 177.123 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -161.15 167.55 25.98 Favored 'General case' 0 C--N 1.288 -2.086 0 CA-C-N 113.64 -1.618 . . . . 0.0 109.853 -179.03 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.515 ' O ' ' N ' ' A' ' 11' ' ' GLN . 0.8 OUTLIER -68.97 -168.37 0.13 Allowed 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 119.043 -1.063 . . . . 0.0 108.765 178.599 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.702 ' H ' HD13 ' A' ' 29' ' ' ILE . . . 24.35 16.89 0.0 OUTLIER Glycine 0 N--CA 1.492 2.421 1 N-CA-C 130.158 6.823 . . . . 0.0 130.158 179.865 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.528 ' NE2' ' OE1' ' A' ' 47' ' ' GLU . 10.8 mt-30 -69.67 -164.97 0.07 Allowed 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 176.218 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.442 ' OD1' ' O ' ' A' ' 11' ' ' GLN . 1.7 m-20 -150.43 -70.17 0.18 Allowed 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 117.551 -1.66 . . . . 0.0 113.952 -179.302 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.5 HD12 ' HB3' ' A' ' 46' ' ' PRO . 18.6 mt -77.28 48.96 0.66 Allowed 'General case' 0 C--N 1.272 -2.794 0 C-N-CA 117.705 -1.598 . . . . 0.0 110.189 -176.146 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.439 ' HB2' ' N ' ' A' ' 6' ' ' CYS . 26.7 p -125.39 -161.47 1.03 Allowed 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.01 -0.995 . . . . 0.0 109.184 176.517 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.486 ' O ' ' SG ' ' A' ' 6' ' ' CYS . 38.3 mt -112.6 120.84 42.95 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 123.973 0.795 . . . . 0.0 109.131 176.665 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 8.6 m -116.06 -38.54 3.6 Favored 'General case' 0 N--CA 1.503 2.207 0 C-N-CA 119.038 -1.065 . . . . 0.0 111.176 -177.074 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -100.04 76.63 1.94 Allowed 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 119.236 -0.986 . . . . 0.0 110.088 179.236 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 76.1 -94.49 1.01 Allowed Glycine 0 N--CA 1.49 2.282 0 C-N-CA 119.359 -1.401 . . . . 0.0 110.637 179.743 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -125.53 -2.84 7.36 Favored 'General case' 0 N--CA 1.485 1.302 0 CA-C-O 122.058 0.932 . . . . 0.0 110.518 -179.211 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 60.4 m-80 -81.32 136.78 35.78 Favored 'General case' 0 C--N 1.257 -3.452 0 CA-C-N 113.629 -1.623 . . . . 0.0 110.862 -179.248 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.1 t -71.67 147.17 10.95 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 C-N-CA 119.366 -0.934 . . . . 0.0 110.071 179.09 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.441 ' O ' ' O ' ' A' ' 12' ' ' ASN . 6.2 m -149.14 118.56 6.9 Favored 'General case' 0 C--N 1.288 -2.081 0 C-N-CA 118.819 -1.152 . . . . 0.0 108.876 176.486 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.46 ' O ' ' O ' ' A' ' 26' ' ' ASN . . . 179.36 -92.23 0.08 OUTLIER Glycine 0 C--O 1.203 -1.831 0 C-N-CA 117.622 -2.227 . . . . 0.0 112.218 -177.37 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 15.3 tt0 -45.37 131.22 8.31 Favored 'General case' 0 C--N 1.299 -1.612 0 C-N-CA 119.352 -0.939 . . . . 0.0 110.861 -177.472 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.56 -32.15 4.01 Favored Glycine 0 N--CA 1.479 1.515 0 N-CA-C 109.261 -1.536 . . . . 0.0 109.261 -177.819 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.46 ' O ' ' O ' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -129.67 -160.47 1.04 Allowed 'General case' 0 C--N 1.313 -1.0 0 C-N-CA 120.205 -0.598 . . . . 0.0 110.833 -179.801 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.554 ' CG ' ' N ' ' A' ' 28' ' ' CYS . 26.6 tttt -151.51 167.49 27.87 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 177.748 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.639 ' O ' ' HA2' ' A' ' 10' ' ' GLY . 59.6 m -127.62 164.66 21.55 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 119.132 -1.027 . . . . 0.0 111.261 177.001 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.702 HD13 ' H ' ' A' ' 10' ' ' GLY . 20.1 mm -146.2 133.61 15.04 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.278 0 CA-C-N 114.184 -1.371 . . . . 0.0 109.94 176.194 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 18.5 mt . . . . . 0 N--CA 1.496 1.834 0 C-N-CA 118.952 -1.099 . . . . 0.0 109.381 177.993 . . . . . . . . 0 0 . 1 . 031 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.463 ' OD1' ' N ' ' A' ' 37' ' ' ASN . 1.8 m-20 . . . . . 0 N--CA 1.496 1.835 0 CA-C-O 121.007 0.432 . . . . 0.0 111.139 . . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -160.58 139.7 10.57 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.94 -0.704 . . . . 0.0 109.64 176.758 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 20.9 m -87.94 103.02 15.29 Favored 'General case' 0 C--N 1.297 -1.677 0 C-N-CA 119.175 -1.01 . . . . 0.0 110.993 -178.772 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.514 ' O ' ' N ' ' A' ' 27' ' ' LYS . 0.4 OUTLIER -100.14 142.07 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.232 0 C-N-CA 118.677 -1.209 . . . . 0.0 111.586 178.837 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.3 t -69.66 141.35 53.63 Favored 'General case' 0 C--N 1.277 -2.584 0 CA-C-N 114.207 -1.36 . . . . 0.0 110.955 179.311 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 157.97 -114.12 0.6 Allowed Glycine 0 N--CA 1.492 2.4 1 N-CA-C 130.492 6.957 . . . . 0.0 130.492 179.686 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -139.43 100.26 3.94 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 119.631 -0.828 . . . . 0.0 109.978 179.286 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -126.46 -175.04 14.0 Favored Glycine 0 N--CA 1.496 2.634 0 N-CA-C 110.33 -1.108 . . . . 0.0 110.33 -179.415 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -137.77 148.47 61.05 Favored Pre-proline 0 N--CA 1.491 1.589 0 C-N-CA 119.84 -0.744 . . . . 0.0 109.78 -179.984 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.5 ' HB3' HD12 ' A' ' 13' ' ' LEU . 10.4 Cg_exo -48.35 177.2 0.02 OUTLIER 'Trans proline' 0 C--O 1.214 -0.682 0 C-N-CA 121.475 1.45 . . . . 0.0 111.511 179.766 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.528 ' OE1' ' NE2' ' A' ' 11' ' ' GLN . 5.1 tp10 . . . . . 0 CA--C 1.558 1.258 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.747 178.857 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.707 HG12 ' H ' ' A' ' 3' ' ' TYR . 6.8 t . . . . . 0 N--CA 1.489 1.513 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 . . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.707 ' H ' HG12 ' A' ' 2' ' ' VAL . 61.1 m-85 -143.07 -172.47 3.68 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.135 -1.026 . . . . 0.0 111.23 -179.794 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.5 ' OG1' ' N ' ' A' ' 5' ' ' ASP . 0.1 OUTLIER -114.45 -165.66 1.03 Allowed 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 115.105 -0.952 . . . . 0.0 108.556 179.232 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.5 ' N ' ' OG1' ' A' ' 4' ' ' THR . 0.7 OUTLIER -92.2 155.05 18.26 Favored 'General case' 0 C--N 1.287 -2.119 0 C-N-CA 118.371 -1.332 . . . . 0.0 110.904 -179.363 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.447 ' N ' ' HB2' ' A' ' 14' ' ' CYS . 0.0 OUTLIER -73.82 171.23 13.74 Favored 'General case' 0 C--N 1.287 -2.148 0 CA-C-N 114.575 -1.193 . . . . 0.0 110.272 178.289 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.5 p -140.94 13.31 2.26 Favored 'General case' 0 C--N 1.294 -1.816 0 C-N-CA 119.367 -0.933 . . . . 0.0 109.687 177.284 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -162.13 174.22 13.25 Favored 'General case' 0 C--N 1.288 -2.108 0 CA-C-N 114.065 -1.425 . . . . 0.0 110.228 179.659 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.448 ' HB3' ' H ' ' A' ' 30' ' ' LEU . 0.7 OUTLIER -85.58 167.2 15.59 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 119.804 -0.758 . . . . 0.0 109.724 -179.945 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 28' ' ' CYS . . . 71.34 14.63 74.47 Favored Glycine 0 N--CA 1.503 3.156 0 C-N-CA 119.182 -1.485 . . . . 0.0 112.225 178.693 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -84.52 -174.95 5.56 Favored 'General case' 0 N--CA 1.505 2.298 0 C-N-CA 119.034 -1.066 . . . . 0.0 110.616 179.159 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.481 ' C ' ' H ' ' A' ' 14' ' ' CYS . 10.3 m-20 -153.51 -69.51 0.14 Allowed 'General case' 0 N--CA 1.505 2.299 0 C-N-CA 118.403 -1.319 . . . . 0.0 113.514 -178.048 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.494 HD13 ' CZ ' ' A' ' 3' ' ' TYR . 70.2 mt -75.22 45.96 0.3 Allowed 'General case' 0 C--N 1.288 -2.106 0 C-N-CA 118.595 -1.242 . . . . 0.0 109.74 -178.588 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.481 ' H ' ' C ' ' A' ' 12' ' ' ASN . 31.8 p -122.37 -149.5 0.43 Allowed 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 115.233 -0.894 . . . . 0.0 108.884 177.606 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.445 HD23 ' HA ' ' A' ' 15' ' ' LEU . 71.5 mt -120.0 100.18 7.06 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-O 122.25 1.024 . . . . 0.0 109.091 176.347 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.574 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 0.5 OUTLIER -74.21 -69.1 0.47 Allowed 'General case' 0 C--N 1.276 -2.616 0 CA-C-N 113.358 -1.746 . . . . 0.0 110.51 -176.088 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -100.37 95.4 6.74 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 119.029 -1.068 . . . . 0.0 111.302 -179.128 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.17 -95.21 0.84 Allowed Glycine 0 N--CA 1.492 2.398 0 C-N-CA 119.739 -1.219 . . . . 0.0 111.735 177.285 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -127.2 2.49 6.42 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-O 122.061 0.934 . . . . 0.0 110.743 -177.054 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -78.54 129.34 34.71 Favored 'General case' 0 C--N 1.255 -3.501 0 CA-C-N 113.702 -1.59 . . . . 0.0 110.864 -179.868 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.581 HG12 ' O ' ' A' ' 22' ' ' CYS . 2.0 t -81.13 138.4 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 118.917 -1.113 . . . . 0.0 110.314 179.113 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.623 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 0.1 OUTLIER -77.94 -135.34 0.02 OUTLIER 'General case' 0 C--N 1.286 -2.184 0 C-N-CA 118.774 -1.171 . . . . 0.0 109.474 172.697 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.539 ' O ' ' ND2' ' A' ' 26' ' ' ASN . . . 179.49 115.83 0.48 Allowed Glycine 0 C--N 1.268 -3.196 0 C-N-CA 117.91 -2.091 . . . . 0.0 111.064 178.973 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.462 ' C ' ' O ' ' A' ' 23' ' ' GLY . 2.3 tt0 -36.22 135.19 0.37 Allowed 'General case' 0 C--N 1.284 -2.24 0 CA-C-N 114.872 -0.664 . . . . 0.0 109.773 176.721 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 116.79 -36.36 3.79 Favored Glycine 0 N--CA 1.486 1.979 0 N-CA-C 107.987 -2.045 . . . . 0.0 107.987 -175.632 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.539 ' ND2' ' O ' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -92.46 -162.46 0.93 Allowed 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 176.557 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.642 ' CE ' HD11 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -151.75 105.25 3.11 Favored 'General case' 0 C--N 1.284 -2.278 0 C-N-CA 118.66 -1.216 . . . . 0.0 110.41 179.284 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.623 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 9.9 m -77.62 159.47 29.19 Favored 'General case' 0 C--O 1.196 -1.725 0 C-N-CA 117.908 -1.517 . . . . 0.0 110.692 -179.595 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.642 HD11 ' CE ' ' A' ' 27' ' ' LYS . 27.9 mm -141.69 132.41 26.04 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.06 0 CA-C-N 114.005 -1.452 . . . . 0.0 110.207 177.817 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.448 ' H ' ' HB3' ' A' ' 9' ' ' SER . 20.3 mt . . . . . 0 N--CA 1.492 1.671 0 C-N-CA 119.338 -0.945 . . . . 0.0 110.156 177.799 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.58 ' OD1' ' N ' ' A' ' 37' ' ' ASN . 0.1 OUTLIER . . . . . 0 N--CA 1.484 1.257 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 . . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -154.75 137.18 15.01 Favored 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 119.492 -0.883 . . . . 0.0 109.368 176.694 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.574 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 2.0 m -78.97 105.99 10.69 Favored 'General case' 0 C--N 1.29 -1.994 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.844 -176.666 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.495 ' O ' ' O ' ' A' ' 27' ' ' LYS . 2.4 p -111.97 143.37 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.354 0 C-N-CA 118.395 -1.322 . . . . 0.0 110.996 175.85 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.2 t -66.24 150.2 49.16 Favored 'General case' 0 C--N 1.269 -2.899 0 CA-C-N 113.626 -1.625 . . . . 0.0 112.251 -178.348 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 165.31 -120.28 0.92 Allowed Glycine 0 N--CA 1.486 2.012 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 178.373 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -160.87 81.78 0.65 Allowed 'General case' 0 C--N 1.299 -1.587 0 C-N-CA 119.408 -0.917 . . . . 0.0 109.447 178.58 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -100.25 -158.88 28.15 Favored Glycine 0 N--CA 1.492 2.43 0 C-N-CA 119.853 -1.165 . . . . 0.0 110.949 -178.035 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -130.35 152.18 79.8 Favored Pre-proline 0 N--CA 1.493 1.681 0 C-N-CA 119.942 -0.703 . . . . 0.0 109.842 -179.759 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -55.85 -175.43 0.04 OUTLIER 'Trans proline' 0 C--O 1.214 -0.712 0 C-N-CA 121.475 1.45 . . . . 0.0 111.2 177.304 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 . . . . . 0 CA--C 1.558 1.255 0 C-N-CA 119.458 -0.897 . . . . 0.0 109.753 178.587 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 5.2 t . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.0 t -106.52 164.8 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.51 178.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.506 ' CE2' HD22 ' A' ' 13' ' ' LEU . 67.8 m-85 -126.05 -166.91 1.63 Allowed 'General case' 0 N--CA 1.499 1.981 0 C-N-CA 119.608 -0.837 . . . . 0.0 110.993 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 7.7 p -105.71 179.92 4.13 Favored 'General case' 0 C--O 1.199 -1.568 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.256 -179.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.471 ' OD1' ' N ' ' A' ' 5' ' ' ASP . 0.3 OUTLIER -83.54 156.84 22.6 Favored 'General case' 0 C--N 1.295 -1.802 0 C-N-CA 118.365 -1.334 . . . . 0.0 110.597 179.846 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.468 ' N ' ' HB2' ' A' ' 14' ' ' CYS . 0.1 OUTLIER -75.6 -178.64 4.24 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.666 178.127 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.467 HG23 HE22 ' A' ' 11' ' ' GLN . 1.3 p -123.72 -20.82 5.36 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 114.953 -1.022 . . . . 0.0 109.791 176.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.552 ' C ' HD21 ' A' ' 30' ' ' LEU . 2.8 mt-10 -162.52 162.44 27.38 Favored 'General case' 0 C--N 1.276 -2.587 0 CA-C-N 114.236 -1.347 . . . . 0.0 111.712 -178.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.425 ' HA ' ' H ' ' A' ' 30' ' ' LEU . 0.3 OUTLIER -62.87 143.07 57.97 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 115.014 -0.994 . . . . 0.0 108.753 179.439 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.527 ' HA2' ' HE3' ' A' ' 27' ' ' LYS . . . 108.24 -26.76 15.83 Favored Glycine 0 N--CA 1.487 2.094 1 N-CA-C 126.837 5.495 . . . . 0.0 126.837 -171.741 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.467 HE22 HG23 ' A' ' 7' ' ' THR . 11.0 mt-30 -71.26 -171.38 0.59 Allowed 'General case' 0 N--CA 1.497 1.9 0 CA-C-N 114.642 -0.779 . . . . 0.0 109.889 178.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.498 ' O ' ' HA3' ' A' ' 23' ' ' GLY . 4.3 m-20 -135.53 -69.98 0.49 Allowed 'General case' 0 N--CA 1.509 2.477 0 N-CA-C 114.558 1.318 . . . . 0.0 114.558 -175.284 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.506 HD22 ' CE2' ' A' ' 3' ' ' TYR . 50.9 mt -77.45 50.32 0.79 Allowed 'General case' 0 C--N 1.277 -2.565 0 C-N-CA 118.403 -1.319 . . . . 0.0 111.006 -175.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.468 ' HB2' ' N ' ' A' ' 6' ' ' CYS . 29.8 p -123.81 -161.02 0.95 Allowed 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 119.577 -0.849 . . . . 0.0 109.98 175.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.436 ' O ' ' SG ' ' A' ' 6' ' ' CYS . 39.9 mt -113.28 121.65 45.07 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.495 176.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -128.56 -31.42 2.25 Favored 'General case' 0 N--CA 1.51 2.565 0 C-N-CA 118.899 -1.121 . . . . 0.0 110.48 -179.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.418 ' O ' ' N ' ' A' ' 19' ' ' SER . 0.6 OUTLIER -87.16 82.13 7.77 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 119.09 -1.044 . . . . 0.0 108.796 177.708 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 64.94 -81.4 0.07 OUTLIER Glycine 0 N--CA 1.488 2.131 0 C-N-CA 119.23 -1.462 . . . . 0.0 109.593 -178.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.418 ' N ' ' O ' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -141.34 0.22 1.48 Allowed 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 122.018 0.914 . . . . 0.0 110.643 178.656 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -83.56 149.11 26.79 Favored 'General case' 0 C--N 1.26 -3.303 0 CA-C-N 113.84 -1.527 . . . . 0.0 110.333 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.5 t -68.56 148.19 11.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 C-N-CA 119.102 -1.039 . . . . 0.0 110.983 -178.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.56 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 0.0 OUTLIER -149.64 107.88 3.76 Favored 'General case' 0 C--N 1.287 -2.125 0 CA-C-N 114.832 -1.076 . . . . 0.0 109.852 -179.789 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.498 ' HA3' ' O ' ' A' ' 12' ' ' ASN . . . 159.47 -45.04 0.44 Allowed Glycine 0 N--CA 1.489 2.183 1 N-CA-C 131.612 7.405 . . . . 0.0 131.612 -177.244 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -53.88 118.81 4.27 Favored 'General case' 0 C--N 1.306 -1.296 0 C-N-CA 118.652 -1.219 . . . . 0.0 110.547 -179.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.72 -19.62 6.01 Favored Glycine 0 N--CA 1.48 1.582 0 C-N-CA 119.399 -1.381 . . . . 0.0 110.084 -179.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.451 ' O ' ' O ' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -121.15 -169.7 1.89 Allowed 'General case' 0 C--O 1.213 -0.86 0 C-N-CA 119.953 -0.699 . . . . 0.0 110.074 -179.712 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.527 ' HE3' ' HA2' ' A' ' 10' ' ' GLY . 21.0 ttpt -152.47 119.98 6.01 Favored 'General case' 0 N--CA 1.495 1.786 0 C-N-CA 118.573 -1.251 . . . . 0.0 110.978 177.193 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.56 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -83.75 165.63 18.7 Favored 'General case' 0 CA--C 1.476 -1.873 0 C-N-CA 117.6 -1.64 . . . . 0.0 111.805 179.228 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 7.5 mm -131.47 90.3 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.261 -3.252 0 CA-C-N 112.006 -2.361 . . . . 0.0 108.854 175.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.552 HD21 ' C ' ' A' ' 8' ' ' GLU . 2.1 pp -79.91 123.29 27.64 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 118.694 -1.202 . . . . 0.0 111.52 -177.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.544 ' N ' ' OD1' ' A' ' 37' ' ' ASN . . . 59.38 90.49 0.02 OUTLIER Glycine 0 N--CA 1.477 1.433 0 C-N-CA 118.992 -1.575 . . . . 0.0 109.509 179.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.555 ' O ' ' N ' ' A' ' 34' ' ' GLY . 67.6 m -68.45 -124.2 0.0 OUTLIER 'General case' 0 C--O 1.199 -1.557 0 C-N-CA 118.468 -1.293 . . . . 0.0 108.469 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -73.94 67.99 1.3 Allowed 'General case' 0 C--N 1.249 -3.802 0 CA-C-N 114.379 -1.282 . . . . 0.0 108.583 -174.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.555 ' N ' ' O ' ' A' ' 32' ' ' SER . . . 67.51 27.34 73.55 Favored Glycine 0 C--N 1.29 -2.019 0 N-CA-C 108.0 -2.04 . . . . 0.0 108.0 -177.206 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -116.47 -134.54 0.34 Allowed 'General case' 0 C--O 1.214 -0.773 0 CA-C-O 122.365 1.079 . . . . 0.0 112.599 -176.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 8.1 mtmp? -93.61 176.21 6.45 Favored 'General case' 0 C--N 1.271 -2.83 0 CA-C-N 112.96 -1.927 . . . . 0.0 113.603 -174.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.544 ' OD1' ' N ' ' A' ' 31' ' ' GLY . 3.5 m-20 -103.36 152.69 21.29 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 114.556 -1.202 . . . . 0.0 110.383 177.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 23.3 tt0 -161.82 156.0 22.12 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 119.302 -0.959 . . . . 0.0 110.394 176.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.51 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 0.1 OUTLIER -103.54 120.9 41.78 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 113.472 0.915 . . . . 0.0 113.472 179.934 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.512 ' CG2' ' N ' ' A' ' 41' ' ' THR . 2.4 p -131.44 158.75 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 CA-C-N 114.751 -1.113 . . . . 0.0 110.477 173.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.512 ' N ' ' CG2' ' A' ' 40' ' ' VAL . 0.0 OUTLIER -83.02 144.04 30.21 Favored 'General case' 0 C--N 1.278 -2.531 0 CA-C-N 114.76 -1.109 . . . . 0.0 111.755 179.995 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 177.94 -124.99 0.97 Allowed Glycine 0 N--CA 1.492 2.369 1 N-CA-C 131.092 7.197 . . . . 0.0 131.092 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -130.96 109.02 10.23 Favored 'General case' 0 N--CA 1.497 1.875 0 C-N-CA 119.998 -0.681 . . . . 0.0 110.058 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -158.12 -162.56 11.88 Favored Glycine 0 N--CA 1.494 2.535 0 C-N-CA 119.044 -1.55 . . . . 0.0 110.962 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -144.04 155.25 58.76 Favored Pre-proline 0 N--CA 1.489 1.508 0 C-N-CA 119.476 -0.89 . . . . 0.0 110.378 -179.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -54.46 148.8 41.31 Favored 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 121.836 1.691 . . . . 0.0 111.325 175.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.58 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 0.6 OUTLIER -82.7 -37.27 0.75 Allowed Pre-proline 0 CA--C 1.558 1.282 0 C-N-CA 119.462 -0.895 . . . . 0.0 112.57 178.793 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.58 ' CD ' ' N ' ' A' ' 47' ' ' GLU . 5.7 Cg_exo -61.37 141.04 91.19 Favored 'Trans proline' 0 C--O 1.214 -0.685 0 C-N-CA 120.458 0.772 . . . . 0.0 110.969 -177.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.5 pp0? . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 116.367 -1.778 . . . . 0.0 110.489 -179.732 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 1.9 p . . . . . 0 N--CA 1.489 1.513 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.486 HG12 ' N ' ' A' ' 3' ' ' TYR . 10.5 t -116.6 168.03 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 177.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.486 ' N ' HG12 ' A' ' 2' ' ' VAL . 44.5 m-85 -97.87 -168.95 1.75 Allowed 'General case' 0 C--N 1.298 -1.636 0 C-N-CA 119.095 -1.042 . . . . 0.0 110.31 -179.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.581 ' OG1' ' N ' ' A' ' 5' ' ' ASP . 0.1 OUTLIER -105.31 -178.36 3.63 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 179.543 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.581 ' N ' ' OG1' ' A' ' 4' ' ' THR . 0.3 OUTLIER -88.46 157.43 18.66 Favored 'General case' 0 C--N 1.287 -2.14 0 C-N-CA 118.559 -1.257 . . . . 0.0 110.297 179.543 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.408 ' SG ' ' CB ' ' A' ' 11' ' ' GLN . 1.5 m -73.17 176.7 5.63 Favored 'General case' 0 C--N 1.289 -2.056 0 CA-C-N 115.102 -0.953 . . . . 0.0 111.1 177.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.857 ' H ' HE22 ' A' ' 11' ' ' GLN . 1.2 p -123.56 -19.38 5.85 Favored 'General case' 0 C--N 1.289 -2.054 0 CA-C-N 113.792 -1.549 . . . . 0.0 109.793 176.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.505 ' C ' HD21 ' A' ' 30' ' ' LEU . 3.5 pt-20 -163.12 163.24 25.81 Favored 'General case' 0 C--N 1.269 -2.917 0 CA-C-N 113.824 -1.535 . . . . 0.0 110.46 178.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.436 ' HA ' ' H ' ' A' ' 30' ' ' LEU . 0.7 OUTLIER -66.58 159.93 26.39 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.982 -177.828 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.44 -23.42 32.15 Favored Glycine 0 N--CA 1.507 3.426 0 C-N-CA 119.282 -1.437 . . . . 0.0 112.03 -179.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.857 HE22 ' H ' ' A' ' 7' ' ' THR . 2.5 mt-30 -62.22 -166.08 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.266 0 C-N-CA 119.765 -0.774 . . . . 0.0 111.163 -178.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.528 ' N ' ' O ' ' A' ' 45' ' ' THR . 22.5 t-20 -144.2 -78.94 0.2 Allowed 'General case' 0 N--CA 1.502 2.158 0 N-CA-C 114.629 1.344 . . . . 0.0 114.629 -176.187 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.464 ' O ' ' OE2' ' A' ' 47' ' ' GLU . 87.1 mt -75.25 48.66 0.43 Allowed 'General case' 0 C--N 1.275 -2.672 0 C-N-CA 118.597 -1.241 . . . . 0.0 111.072 -173.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.744 ' O ' HG22 ' A' ' 21' ' ' VAL . 7.8 p -120.91 -151.87 0.49 Allowed 'General case' 0 N--CA 1.497 1.92 0 C-N-CA 119.183 -1.007 . . . . 0.0 110.729 177.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.654 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 7.7 mt -123.6 133.21 53.98 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 114.179 -1.373 . . . . 0.0 110.395 179.266 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.7 m -120.59 -68.1 0.93 Allowed 'General case' 0 N--CA 1.503 2.181 0 C-N-CA 119.306 -0.957 . . . . 0.0 110.401 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -84.55 88.0 7.29 Favored 'General case' 0 C--N 1.298 -1.65 0 C-N-CA 119.178 -1.009 . . . . 0.0 110.143 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 70.25 -123.69 12.57 Favored Glycine 0 N--CA 1.487 2.064 0 C-N-CA 119.562 -1.304 . . . . 0.0 111.21 178.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.406 ' O ' ' OG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -98.87 1.93 46.19 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 121.871 0.843 . . . . 0.0 110.974 -177.713 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -79.61 128.18 33.07 Favored 'General case' 0 C--N 1.253 -3.611 0 CA-C-N 114.003 -1.453 . . . . 0.0 110.726 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.744 HG22 ' O ' ' A' ' 14' ' ' CYS . 0.9 OUTLIER -78.59 148.75 5.98 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.026 0 C-N-CA 119.088 -1.045 . . . . 0.0 109.495 179.112 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.462 ' O ' ' O ' ' A' ' 12' ' ' ASN . 3.2 m -148.13 122.84 9.89 Favored 'General case' 0 C--N 1.285 -2.218 0 C-N-CA 118.418 -1.313 . . . . 0.0 110.547 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.452 ' O ' ' O ' ' A' ' 26' ' ' ASN . . . 170.66 -87.6 0.09 OUTLIER Glycine 0 C--O 1.197 -2.173 0 C-N-CA 118.425 -1.845 . . . . 0.0 111.76 -177.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.447 ' N ' ' OD1' ' A' ' 12' ' ' ASN . 43.2 tt0 -40.08 128.47 2.22 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 120.08 -0.648 . . . . 0.0 111.283 -177.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.623 ' C ' HD22 ' A' ' 26' ' ' ASN . . . 90.07 -24.08 17.7 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 109.012 -1.635 . . . . 0.0 109.012 -177.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.623 HD22 ' C ' ' A' ' 25' ' ' GLY . 2.3 m-80 -143.79 -162.33 1.44 Allowed 'General case' 0 N--CA 1.493 1.713 0 CA-C-N 114.773 -0.713 . . . . 0.0 109.737 179.311 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.469 ' O ' ' O ' ' A' ' 40' ' ' VAL . 0.5 OUTLIER -139.06 143.48 38.39 Favored 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 119.646 -0.822 . . . . 0.0 109.035 175.786 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -89.66 160.99 16.34 Favored 'General case' 0 C--N 1.298 -1.657 0 C-N-CA 117.719 -1.593 . . . . 0.0 111.101 179.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.436 HG22 ' O ' ' A' ' 29' ' ' ILE . 20.1 mm -147.54 94.28 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.255 -3.521 0 CA-C-N 112.523 -2.126 . . . . 0.0 108.496 176.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.505 HD21 ' C ' ' A' ' 8' ' ' GLU . 1.8 pp -94.38 134.18 37.16 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 118.815 -1.154 . . . . 0.0 112.501 -176.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.529 ' N ' ' OD1' ' A' ' 37' ' ' ASN . . . 55.64 92.66 0.01 OUTLIER Glycine 0 N--CA 1.48 1.622 0 C-N-CA 119.322 -1.418 . . . . 0.0 110.279 177.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.54 ' O ' ' N ' ' A' ' 34' ' ' GLY . 15.2 m -75.51 -128.54 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 118.688 -1.205 . . . . 0.0 108.604 179.2 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.435 ' OD1' ' OE2' ' A' ' 35' ' ' GLU . 10.4 p-10 -75.05 68.29 1.83 Allowed 'General case' 0 C--N 1.252 -3.657 0 CA-C-N 114.415 -1.266 . . . . 0.0 108.765 -173.261 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.54 ' N ' ' O ' ' A' ' 32' ' ' SER . . . 70.52 28.66 70.77 Favored Glycine 0 C--N 1.289 -2.05 0 N-CA-C 108.383 -1.887 . . . . 0.0 108.383 -177.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.435 ' OE2' ' OD1' ' A' ' 33' ' ' ASP . 13.3 mt-10 -120.42 -136.58 0.33 Allowed 'General case' 0 C--O 1.214 -0.769 0 C-N-CA 118.97 -1.092 . . . . 0.0 112.378 -177.193 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 6.1 mmtp -94.56 -179.14 4.79 Favored 'General case' 0 C--N 1.266 -3.025 0 CA-C-N 113.025 -1.898 . . . . 0.0 113.616 -173.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.529 ' OD1' ' N ' ' A' ' 31' ' ' GLY . 6.7 m-20 -104.56 160.46 14.92 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-N 114.43 -1.259 . . . . 0.0 111.114 179.224 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.414 ' CG ' ' N ' ' A' ' 39' ' ' CYS . 10.8 tt0 -161.71 157.49 24.48 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 119.179 -1.008 . . . . 0.0 111.11 179.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.414 ' N ' ' CG ' ' A' ' 38' ' ' GLN . 7.1 m -109.39 94.89 5.27 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.799 178.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.469 ' O ' ' O ' ' A' ' 27' ' ' LYS . 0.5 OUTLIER -102.54 145.59 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.568 0 C-N-CA 118.712 -1.195 . . . . 0.0 112.736 -177.892 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.5 t -66.18 143.85 57.01 Favored 'General case' 0 C--N 1.285 -2.235 0 CA-C-N 114.061 -1.427 . . . . 0.0 111.52 177.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 152.23 -159.27 28.28 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -179.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.401 ' O ' ' CG ' ' A' ' 43' ' ' GLU . 5.8 pt-20 -104.93 113.41 26.99 Favored 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 119.546 -0.861 . . . . 0.0 110.273 179.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -114.39 -168.54 16.17 Favored Glycine 0 N--CA 1.5 2.913 0 C-N-CA 120.053 -1.07 . . . . 0.0 110.555 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.528 ' O ' ' N ' ' A' ' 12' ' ' ASN . 0.5 OUTLIER -141.72 148.6 50.32 Favored Pre-proline 0 N--CA 1.493 1.676 0 C-N-CA 119.55 -0.86 . . . . 0.0 110.421 -179.767 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -57.17 167.72 3.16 Favored 'Trans proline' 0 C--O 1.214 -0.683 0 C-N-CA 121.724 1.616 . . . . 0.0 111.949 179.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.639 ' CD ' ' H ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -79.64 159.06 72.57 Favored Pre-proline 0 N--CA 1.489 1.524 0 C-N-CA 119.544 -0.863 . . . . 0.0 109.971 179.684 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -62.79 173.22 3.89 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 121.424 1.416 . . . . 0.0 111.868 -178.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 . . . . . 0 N--CA 1.495 1.812 0 CA-C-O 116.364 -1.779 . . . . 0.0 110.024 178.977 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 24.9 m . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 1.5 t -79.81 169.03 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 C-N-CA 119.436 -0.906 . . . . 0.0 110.044 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -131.08 -161.91 1.17 Allowed 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 119.865 -0.734 . . . . 0.0 111.301 -178.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.07 -176.82 3.54 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.024 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.509 ' N ' ' OD1' ' A' ' 5' ' ' ASP . 0.1 OUTLIER -97.48 156.54 16.44 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.139 -1.025 . . . . 0.0 110.493 178.127 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.503 ' SG ' ' O ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -74.91 151.7 38.89 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.518 177.857 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.475 HG22 ' O ' ' A' ' 7' ' ' THR . 1.4 m -116.65 -3.94 11.73 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 119.68 -0.808 . . . . 0.0 111.114 178.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.509 ' HA ' HD12 ' A' ' 30' ' ' LEU . 0.2 OUTLIER -160.34 178.2 9.84 Favored 'General case' 0 C--N 1.275 -2.647 0 CA-C-N 114.785 -1.098 . . . . 0.0 110.906 -179.289 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.401 ' HB3' ' H ' ' A' ' 30' ' ' LEU . 0.3 OUTLIER -79.27 140.64 37.54 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.912 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.572 ' HA2' ' HE3' ' A' ' 27' ' ' LYS . . . 98.65 -16.97 59.03 Favored Glycine 0 N--CA 1.507 3.369 1 N-CA-C 128.641 6.216 . . . . 0.0 128.641 -174.525 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.44 ' O ' ' O ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -51.89 -169.04 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 114.471 -0.864 . . . . 0.0 110.984 179.742 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.473 ' C ' ' H ' ' A' ' 14' ' ' CYS . 15.8 t-20 -140.68 -83.22 0.23 Allowed 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 118.486 -1.286 . . . . 0.0 113.044 -179.07 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.451 ' O ' ' OE2' ' A' ' 47' ' ' GLU . 60.6 mt -75.42 45.28 0.29 Allowed 'General case' 0 C--N 1.276 -2.627 0 C-N-CA 117.71 -1.596 . . . . 0.0 109.916 -175.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.486 ' HB2' ' N ' ' A' ' 6' ' ' CYS . 31.1 p -109.23 -158.16 0.64 Allowed 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 119.318 -0.953 . . . . 0.0 109.362 178.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.503 ' O ' ' SG ' ' A' ' 6' ' ' CYS . 6.0 mt -124.09 129.49 50.96 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.336 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 89.8 m -120.91 -65.95 1.1 Allowed 'General case' 0 N--CA 1.502 2.127 0 C-N-CA 119.408 -0.917 . . . . 0.0 111.498 -177.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -79.56 85.48 5.3 Favored 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 118.87 -1.132 . . . . 0.0 110.816 -178.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 72.54 -92.55 0.6 Allowed Glycine 0 N--CA 1.491 2.326 0 C-N-CA 119.526 -1.321 . . . . 0.0 110.827 179.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.448 ' O ' ' OG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -133.58 4.55 3.65 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-O 122.264 1.031 . . . . 0.0 110.463 -178.931 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 28.0 m-80 -80.54 130.46 35.15 Favored 'General case' 0 C--N 1.254 -3.577 0 CA-C-N 113.485 -1.689 . . . . 0.0 109.787 178.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.401 HG22 ' O ' ' A' ' 14' ' ' CYS . 1.4 t -69.8 149.24 10.79 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 C-N-CA 119.195 -1.002 . . . . 0.0 110.547 -179.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.452 ' O ' ' O ' ' A' ' 12' ' ' ASN . 12.7 m -145.82 116.17 7.53 Favored 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 118.453 -1.299 . . . . 0.0 110.419 177.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 26' ' ' ASN . . . 170.39 -68.08 0.15 Allowed Glycine 0 C--O 1.203 -1.793 0 C-N-CA 118.261 -1.923 . . . . 0.0 112.598 -177.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -56.91 111.61 1.08 Allowed 'General case' 0 C--N 1.298 -1.65 0 C-N-CA 118.917 -1.113 . . . . 0.0 110.827 -177.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.418 ' C ' ' ND2' ' A' ' 26' ' ' ASN . . . 99.27 -14.77 60.88 Favored Glycine 0 N--CA 1.484 1.844 0 N-CA-C 109.959 -1.256 . . . . 0.0 109.959 -179.022 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.463 ' O ' ' O ' ' A' ' 23' ' ' GLY . 8.6 m-80 -149.3 -167.72 2.91 Favored 'General case' 0 N--CA 1.494 1.762 0 C-N-CA 119.255 -0.978 . . . . 0.0 111.409 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.572 ' HE3' ' HA2' ' A' ' 10' ' ' GLY . 12.6 tttp -134.61 165.17 25.84 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.155 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.513 ' N ' ' CG ' ' A' ' 27' ' ' LYS . 0.1 OUTLIER -127.4 160.3 31.83 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 118.889 -1.124 . . . . 0.0 110.686 177.968 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.444 HD13 ' O ' ' A' ' 28' ' ' CYS . 7.7 mm -138.85 126.75 27.6 Favored 'Isoleucine or valine' 0 C--N 1.255 -3.506 0 CA-C-N 113.088 -1.869 . . . . 0.0 109.639 177.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.509 HD12 ' HA ' ' A' ' 8' ' ' GLU . 19.5 mt -78.2 124.43 28.06 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 118.28 -1.368 . . . . 0.0 110.307 178.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 79.65 100.56 0.27 Allowed Glycine 0 C--N 1.302 -1.341 0 C-N-CA 118.996 -1.573 . . . . 0.0 110.229 178.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.558 ' O ' ' N ' ' A' ' 34' ' ' GLY . 89.8 p -80.87 -123.41 0.02 OUTLIER 'General case' 0 C--O 1.202 -1.413 0 C-N-CA 118.455 -1.298 . . . . 0.0 108.858 179.288 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.447 ' N ' ' OG ' ' A' ' 32' ' ' SER . 1.1 m-20 -73.76 64.04 0.91 Allowed 'General case' 0 C--N 1.256 -3.488 0 CA-C-N 114.577 -1.192 . . . . 0.0 109.444 -172.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.558 ' N ' ' O ' ' A' ' 32' ' ' SER . . . 74.06 29.42 62.7 Favored Glycine 0 C--N 1.288 -2.103 0 N-CA-C 108.48 -1.848 . . . . 0.0 108.48 -177.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 59.7 mm-40 -127.53 -134.25 0.24 Allowed 'General case' 0 C--O 1.213 -0.826 0 C-N-CA 118.773 -1.171 . . . . 0.0 112.495 -177.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 10.5 mtmm -98.17 -167.3 1.49 Allowed 'General case' 0 C--N 1.276 -2.623 0 CA-C-N 112.671 -2.059 . . . . 0.0 113.199 -175.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.5 ' OD1' ' N ' ' A' ' 37' ' ' ASN . 0.1 OUTLIER -59.75 157.23 12.43 Favored 'General case' 0 N--CA 1.485 1.307 0 CA-C-N 114.492 -1.231 . . . . 0.0 111.678 178.116 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -159.2 152.92 22.98 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.286 175.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 9.6 m -112.14 112.48 24.12 Favored 'General case' 0 C--N 1.298 -1.66 0 C-N-CA 119.729 -0.788 . . . . 0.0 111.737 -177.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.465 ' O ' ' O ' ' A' ' 27' ' ' LYS . 1.3 p -123.43 140.82 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.323 0 C-N-CA 118.745 -1.182 . . . . 0.0 112.668 177.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.5 t -41.28 157.44 0.02 OUTLIER 'General case' 0 C--N 1.283 -2.304 0 CA-C-N 113.371 -1.74 . . . . 0.0 111.255 178.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.433 ' O ' ' OE1' ' A' ' 43' ' ' GLU . . . 150.04 -120.43 1.14 Allowed Glycine 0 N--CA 1.49 2.275 1 N-CA-C 130.274 6.87 . . . . 0.0 130.274 179.557 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.433 ' OE1' ' O ' ' A' ' 42' ' ' GLY . 1.3 tp10 -154.34 104.53 2.6 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 119.37 -0.932 . . . . 0.0 109.974 179.161 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -128.57 179.94 16.29 Favored Glycine 0 N--CA 1.495 2.579 0 C-N-CA 119.867 -1.158 . . . . 0.0 110.695 -179.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -130.54 153.65 81.48 Favored Pre-proline 0 N--CA 1.495 1.817 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -53.16 163.97 2.02 Favored 'Trans proline' 0 C--O 1.214 -0.688 0 C-N-CA 121.153 1.236 . . . . 0.0 110.477 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.656 ' CD ' ' H ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -76.13 155.98 84.15 Favored Pre-proline 0 N--CA 1.49 1.534 0 C-N-CA 118.911 -1.116 . . . . 0.0 109.755 -179.383 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -52.69 127.67 25.38 Favored 'Trans proline' 0 C--O 1.214 -0.691 0 C-N-CA 121.497 1.465 . . . . 0.0 111.877 -177.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 . . . . . 0 N--CA 1.488 1.472 0 CA-C-O 116.297 -1.811 . . . . 0.0 110.227 179.343 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.571 ' O ' HG13 ' A' ' 1' ' ' VAL . 8.7 p . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.516 HG12 ' N ' ' A' ' 3' ' ' TYR . 12.8 t -136.03 169.27 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 C-N-CA 119.696 -0.802 . . . . 0.0 110.019 179.366 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.516 ' N ' HG12 ' A' ' 2' ' ' VAL . 8.4 m-85 -112.29 -166.09 1.05 Allowed 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 119.986 -0.686 . . . . 0.0 109.666 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.431 ' OG1' ' OE1' ' A' ' 47' ' ' GLU . 2.9 p -97.51 177.75 5.41 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 178.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.405 ' O ' ' OE2' ' A' ' 47' ' ' GLU . 0.2 OUTLIER -88.46 155.51 19.63 Favored 'General case' 0 C--N 1.293 -1.864 0 C-N-CA 118.458 -1.297 . . . . 0.0 110.066 178.583 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.42 ' SG ' ' O ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -75.4 166.66 23.26 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.693 178.108 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 14.0 p -133.95 2.33 3.37 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 119.431 -0.908 . . . . 0.0 110.39 177.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.496 ' HA ' HD12 ' A' ' 30' ' ' LEU . 0.3 OUTLIER -162.52 -178.7 6.41 Favored 'General case' 0 C--N 1.28 -2.435 0 CA-C-N 114.631 -1.168 . . . . 0.0 111.253 178.894 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -82.27 158.71 23.38 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.535 -178.215 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.498 ' N ' ' O ' ' A' ' 28' ' ' CYS . . . 82.87 -18.0 18.44 Favored Glycine 0 N--CA 1.497 2.706 0 C-N-CA 119.853 -1.165 . . . . 0.0 112.573 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -53.05 170.35 0.08 Allowed 'General case' 0 N--CA 1.501 2.12 0 C-N-CA 119.03 -1.068 . . . . 0.0 110.226 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.504 ' C ' ' H ' ' A' ' 14' ' ' CYS . 22.0 m-20 -144.56 -63.42 0.36 Allowed 'General case' 0 N--CA 1.499 2.011 0 C-N-CA 118.317 -1.353 . . . . 0.0 113.433 -179.088 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 49.7 mt -76.5 41.85 0.26 Allowed 'General case' 0 C--N 1.287 -2.136 0 C-N-CA 119.011 -1.076 . . . . 0.0 109.811 -177.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.504 ' H ' ' C ' ' A' ' 12' ' ' ASN . 31.6 p -121.94 -157.67 0.74 Allowed 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 114.906 -1.043 . . . . 0.0 108.801 177.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.45 HD22 ' O ' ' A' ' 19' ' ' SER . 40.6 mt -108.7 107.12 17.45 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 115.21 -0.904 . . . . 0.0 108.679 175.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.407 ' HB2' ' SG ' ' A' ' 39' ' ' CYS . 68.4 m -96.32 -74.29 0.57 Allowed 'General case' 0 C--N 1.278 -2.532 0 CA-C-N 114.167 -1.379 . . . . 0.0 111.235 -174.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -84.73 115.62 22.79 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 118.601 -1.239 . . . . 0.0 110.102 179.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 66.42 -107.69 2.09 Favored Glycine 0 N--CA 1.489 2.193 0 C-N-CA 119.324 -1.417 . . . . 0.0 110.448 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.45 ' O ' HD22 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -134.6 4.68 3.38 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-O 122.197 0.999 . . . . 0.0 110.185 -179.804 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -79.13 152.87 30.51 Favored 'General case' 0 C--N 1.261 -3.281 0 CA-C-N 113.431 -1.713 . . . . 0.0 110.607 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.2 t -85.9 142.39 13.2 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 C-N-CA 119.195 -1.002 . . . . 0.0 112.117 -177.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.454 ' O ' ' O ' ' A' ' 12' ' ' ASN . 0.1 OUTLIER -99.96 150.32 22.53 Favored 'General case' 0 N--CA 1.508 2.457 0 CA-C-N 114.964 -1.016 . . . . 0.0 108.94 169.295 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.448 ' O ' ' C ' ' A' ' 24' ' ' GLN . . . -113.81 110.81 2.51 Favored Glycine 0 CA--C 1.482 -2.031 0 C-N-CA 119.652 -1.261 . . . . 0.0 110.487 -169.118 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.497 HE21 ' HG3' ' A' ' 46' ' ' PRO . 4.2 tt0 -32.93 117.29 0.25 Allowed 'General case' 0 C--N 1.252 -3.64 0 CA-C-N 111.974 -2.113 . . . . 0.0 109.941 175.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 146.28 -25.69 1.71 Allowed Glycine 0 C--N 1.283 -2.401 0 N-CA-C 105.005 -3.238 . . . . 0.0 105.005 -174.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.539 ' N ' ' OD1' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -110.72 -172.39 2.02 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 113.208 -1.496 . . . . 0.0 107.292 175.056 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.462 ' O ' ' O ' ' A' ' 40' ' ' VAL . 21.9 tttm -144.18 108.86 4.9 Favored 'General case' 0 N--CA 1.502 2.133 0 C-N-CA 118.512 -1.275 . . . . 0.0 110.933 178.217 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.562 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 3.6 m -84.17 152.2 24.41 Favored 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 117.722 -1.591 . . . . 0.0 110.136 178.075 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.448 HD12 ' HZ1' ' A' ' 27' ' ' LYS . 2.1 mm -127.68 131.0 70.38 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.288 0 CA-C-N 114.382 -1.281 . . . . 0.0 109.39 177.212 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.496 HD12 ' HA ' ' A' ' 8' ' ' GLU . 17.5 mt -79.03 136.3 37.15 Favored 'General case' 0 N--CA 1.497 1.909 0 C-N-CA 118.471 -1.292 . . . . 0.0 110.162 178.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.457 ' H ' ' C ' ' A' ' 36' ' ' LYS . . . -43.89 -78.08 0.08 OUTLIER Glycine 0 N--CA 1.487 2.06 0 C-N-CA 118.868 -1.634 . . . . 0.0 109.553 177.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.909 ' H ' ' CA ' ' A' ' 35' ' ' GLU . 1.0 OUTLIER 80.65 -54.35 0.33 Allowed 'General case' 0 CA--C 1.474 -1.975 0 CA-C-O 121.6 0.714 . . . . 0.0 109.137 177.968 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.516 ' N ' ' OG ' ' A' ' 32' ' ' SER . 1.1 t70 -78.34 4.75 12.12 Favored 'General case' 0 C--N 1.249 -3.785 0 N-CA-C 104.882 -2.266 . . . . 0.0 104.882 171.262 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.752 ' O ' ' N ' ' A' ' 36' ' ' LYS . . . -171.04 24.58 0.09 OUTLIER Glycine 0 C--N 1.29 -2.012 0 CA-C-N 111.005 -2.816 . . . . 0.0 107.949 177.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.909 ' CA ' ' H ' ' A' ' 32' ' ' SER . 1.8 tm-20 10.79 33.13 0.0 OUTLIER 'General case' 1 N--CA 1.56 5.061 0 CA-C-O 123.301 1.524 . . . . 0.0 115.004 -176.366 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.752 ' N ' ' O ' ' A' ' 34' ' ' GLY . 18.2 mtpt -84.96 -153.63 0.17 Allowed 'General case' 1 C--N 1.216 -5.201 0 CA-C-N 112.136 -2.302 . . . . 0.0 107.733 174.322 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -163.89 154.66 15.7 Favored 'General case' 0 C--N 1.277 -2.548 0 C-N-CA 119.244 -0.982 . . . . 0.0 111.815 178.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -155.37 149.72 26.01 Favored 'General case' 0 C--N 1.295 -1.782 0 CA-C-N 114.828 -1.078 . . . . 0.0 108.982 176.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.562 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 1.3 m -107.92 93.32 4.47 Favored 'General case' 0 C--N 1.296 -1.741 0 C-N-CA 119.608 -0.837 . . . . 0.0 111.2 -177.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.462 ' O ' ' O ' ' A' ' 27' ' ' LYS . 0.9 OUTLIER -107.7 143.41 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.31 0 C-N-CA 118.816 -1.154 . . . . 0.0 110.759 179.027 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.413 ' O ' HG22 ' A' ' 40' ' ' VAL . 7.1 t -50.94 157.89 0.77 Allowed 'General case' 0 C--N 1.274 -2.697 0 CA-C-N 114.31 -1.314 . . . . 0.0 111.036 -178.366 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 153.52 -154.97 25.86 Favored Glycine 0 N--CA 1.492 2.424 0 C-N-CA 119.528 -1.32 . . . . 0.0 110.748 179.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -122.83 67.52 0.97 Allowed 'General case' 0 N--CA 1.498 1.947 0 C-N-CA 120.039 -0.664 . . . . 0.0 110.215 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -74.01 173.34 50.56 Favored Glycine 0 N--CA 1.491 2.346 0 C-N-CA 119.425 -1.369 . . . . 0.0 110.523 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -106.22 145.56 31.21 Favored Pre-proline 0 N--CA 1.491 1.616 0 C-N-CA 119.679 -0.808 . . . . 0.0 109.527 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.497 ' HG3' HE21 ' A' ' 24' ' ' GLN . 1.7 Cg_endo -62.63 130.85 31.15 Favored 'Trans proline' 0 C--O 1.216 -0.615 0 C-N-CA 120.901 1.067 . . . . 0.0 110.872 176.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.431 ' OE1' ' OG1' ' A' ' 4' ' ' THR . 1.0 OUTLIER -51.66 116.07 7.37 Favored Pre-proline 0 C--N 1.3 -1.566 0 C-N-CA 119.547 -0.861 . . . . 0.0 110.362 -179.992 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -60.44 105.46 0.3 Allowed 'Trans proline' 0 C--O 1.216 -0.606 0 C-N-CA 120.419 0.746 . . . . 0.0 111.013 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 . . . . . 0 N--CA 1.489 1.506 0 CA-C-O 116.46 -1.733 . . . . 0.0 110.436 -179.839 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.51 HG12 ' H ' ' A' ' 3' ' ' TYR . 2.7 t -103.05 171.13 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 C-N-CA 119.835 -0.746 . . . . 0.0 111.143 -178.027 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.51 ' H ' HG12 ' A' ' 2' ' ' VAL . 52.1 m-85 -123.94 -173.69 2.81 Favored 'General case' 0 N--CA 1.5 2.026 0 C-N-CA 119.931 -0.707 . . . . 0.0 110.652 179.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -101.52 173.0 6.63 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 115.171 -0.922 . . . . 0.0 108.557 178.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.531 ' N ' ' OD1' ' A' ' 5' ' ' ASP . 0.0 OUTLIER -91.06 152.23 20.72 Favored 'General case' 0 C--N 1.294 -1.826 0 C-N-CA 118.489 -1.285 . . . . 0.0 108.877 176.684 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.412 ' N ' ' HB2' ' A' ' 14' ' ' CYS . 1.3 m -75.41 179.88 4.95 Favored 'General case' 0 C--N 1.29 -2.018 0 C-N-CA 119.221 -0.992 . . . . 0.0 111.019 179.154 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.1 t -150.56 16.84 0.8 Allowed 'General case' 0 C--N 1.281 -2.412 0 CA-C-N 113.601 -1.636 . . . . 0.0 109.393 177.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -159.42 175.08 13.75 Favored 'General case' 0 C--N 1.29 -1.991 0 CA-C-N 114.443 -1.253 . . . . 0.0 110.643 -178.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -76.88 -170.27 1.56 Allowed 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.265 179.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.572 ' HA2' ' O ' ' A' ' 28' ' ' CYS . . . 26.1 18.23 0.0 OUTLIER Glycine 0 N--CA 1.503 3.126 1 N-CA-C 130.913 7.125 . . . . 0.0 130.913 178.974 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -87.76 -166.88 1.71 Allowed 'General case' 0 N--CA 1.503 2.216 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 176.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.496 ' C ' ' H ' ' A' ' 14' ' ' CYS . 10.6 m120 -151.48 -55.5 0.14 Allowed 'General case' 0 N--CA 1.503 2.183 0 N-CA-C 116.612 2.078 . . . . 0.0 116.612 -178.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.453 HD22 ' CZ ' ' A' ' 3' ' ' TYR . 24.3 mt -75.79 41.7 0.22 Allowed 'General case' 0 C--N 1.29 -1.981 0 C-N-CA 118.134 -1.426 . . . . 0.0 110.716 -174.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.699 ' O ' HG22 ' A' ' 21' ' ' VAL . 30.5 p -124.21 -148.23 0.39 Allowed 'General case' 0 C--N 1.288 -2.073 0 CA-C-N 114.817 -1.083 . . . . 0.0 108.298 176.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.437 HD12 ' OD1' ' A' ' 5' ' ' ASP . 6.2 mt -119.21 110.72 17.35 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 176.038 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.435 ' HB2' ' SG ' ' A' ' 39' ' ' CYS . 55.9 m -104.56 -61.51 1.45 Allowed 'General case' 0 C--N 1.281 -2.396 0 CA-C-N 114.009 -1.45 . . . . 0.0 112.085 -172.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -96.27 94.52 7.52 Favored 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 118.76 -1.176 . . . . 0.0 110.392 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 73.15 -108.93 2.64 Favored Glycine 0 N--CA 1.492 2.378 0 C-N-CA 119.467 -1.349 . . . . 0.0 110.788 179.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -119.29 1.82 11.31 Favored 'General case' 0 CA--C 1.492 -1.286 0 CA-C-O 122.34 1.067 . . . . 0.0 109.896 -179.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -78.52 127.74 32.58 Favored 'General case' 0 C--N 1.257 -3.454 0 CA-C-N 113.204 -1.816 . . . . 0.0 109.758 179.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.699 HG22 ' O ' ' A' ' 14' ' ' CYS . 0.9 OUTLIER -78.33 137.97 21.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 C-N-CA 118.961 -1.096 . . . . 0.0 110.103 179.736 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.549 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 0.1 OUTLIER -86.66 146.22 26.39 Favored 'General case' 0 C--N 1.283 -2.289 0 C-N-CA 118.29 -1.364 . . . . 0.0 109.589 173.186 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.488 ' O ' ' ND2' ' A' ' 26' ' ' ASN . . . -116.07 104.42 1.27 Allowed Glycine 0 C--N 1.296 -1.656 0 N-CA-C 108.809 -1.716 . . . . 0.0 108.809 -174.193 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.485 HE21 ' C ' ' A' ' 24' ' ' GLN . 0.0 OUTLIER -31.86 124.52 0.27 Allowed 'General case' 0 C--N 1.26 -3.29 0 CA-C-N 112.632 -1.784 . . . . 0.0 110.941 179.186 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 140.79 -23.25 2.64 Favored Glycine 0 C--N 1.29 -1.972 0 N-CA-C 105.139 -3.184 . . . . 0.0 105.139 -173.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.509 ' OD1' ' N ' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -111.41 -162.29 0.79 Allowed 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 112.907 -1.647 . . . . 0.0 107.282 175.601 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.538 ' O ' ' N ' ' A' ' 40' ' ' VAL . 14.9 tttp -144.6 147.54 33.27 Favored 'General case' 0 C--N 1.297 -1.703 0 C-N-CA 118.661 -1.216 . . . . 0.0 109.949 175.317 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.572 ' O ' ' HA2' ' A' ' 10' ' ' GLY . 56.6 m -111.99 157.53 20.61 Favored 'General case' 0 CA--C 1.483 -1.603 0 C-N-CA 118.711 -1.195 . . . . 0.0 109.775 177.29 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 11.3 mm -140.05 126.96 23.24 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.7 0 CA-C-N 114.629 -1.169 . . . . 0.0 109.954 175.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' A' ' 30' ' ' LEU . 15.3 mt -76.76 115.0 16.13 Favored 'General case' 0 N--CA 1.496 1.856 0 C-N-CA 118.671 -1.212 . . . . 0.0 110.094 178.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.737 ' HA3' ' HB2' ' A' ' 36' ' ' LYS . . . -33.83 -68.76 0.19 Allowed Glycine 0 N--CA 1.493 2.494 1 N-CA-C 128.899 6.32 . . . . 0.0 128.899 -179.402 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.493 ' O ' ' N ' ' A' ' 34' ' ' GLY . 0.8 OUTLIER -139.28 -137.99 0.13 Allowed 'General case' 0 C--O 1.203 -1.342 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 178.119 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.62 68.46 1.65 Allowed 'General case' 0 C--N 1.253 -3.612 0 CA-C-O 122.568 1.175 . . . . 0.0 109.398 -173.445 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.493 ' N ' ' O ' ' A' ' 32' ' ' SER . . . 74.28 27.43 65.98 Favored Glycine 0 C--N 1.285 -2.259 0 N-CA-C 108.073 -2.011 . . . . 0.0 108.073 -178.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.439 ' O ' ' O ' ' A' ' 36' ' ' LYS . 21.8 mt-10 -106.0 -117.28 0.24 Allowed 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 119.336 -0.946 . . . . 0.0 111.684 -177.227 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.737 ' HB2' ' HA3' ' A' ' 31' ' ' GLY . 0.9 OUTLIER -45.39 175.47 0.0 OUTLIER 'General case' 0 C--N 1.264 -3.119 0 CA-C-N 113.79 -1.55 . . . . 0.0 112.054 -177.556 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 1.029 HD22 ' N ' ' A' ' 38' ' ' GLN . 0.3 OUTLIER -174.67 133.28 0.36 Allowed 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 -178.361 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 1.029 ' N ' HD22 ' A' ' 37' ' ' ASN . 23.5 tt0 -140.59 155.75 46.48 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 119.447 -0.901 . . . . 0.0 110.773 -179.636 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.435 ' SG ' ' HB2' ' A' ' 16' ' ' CYS . 1.5 m -101.47 89.03 3.6 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 119.662 -0.815 . . . . 0.0 110.843 -179.191 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.538 ' N ' ' O ' ' A' ' 27' ' ' LYS . 0.3 OUTLIER -94.87 141.71 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.675 0 C-N-CA 118.299 -1.36 . . . . 0.0 112.029 179.835 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.413 ' O ' HG22 ' A' ' 40' ' ' VAL . 3.5 t -54.13 145.4 17.22 Favored 'General case' 0 C--N 1.276 -2.59 0 CA-C-N 114.661 -1.154 . . . . 0.0 110.633 -179.527 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 157.81 -173.43 35.12 Favored Glycine 0 N--CA 1.494 2.536 0 C-N-CA 119.164 -1.493 . . . . 0.0 110.778 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -111.23 122.16 47.16 Favored 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 120.081 -0.648 . . . . 0.0 110.362 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -138.41 -145.28 4.8 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 179.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -139.81 153.2 69.66 Favored Pre-proline 0 N--CA 1.491 1.607 0 C-N-CA 119.59 -0.844 . . . . 0.0 109.997 179.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -60.48 -169.25 0.05 OUTLIER 'Trans proline' 0 C--O 1.216 -0.622 0 C-N-CA 121.417 1.412 . . . . 0.0 111.515 178.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.437 ' OE2' ' O ' ' A' ' 5' ' ' ASP . 3.8 tt0 -126.97 77.06 75.52 Favored Pre-proline 0 C--N 1.312 -1.036 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.043 179.09 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -59.91 123.98 14.36 Favored 'Trans proline' 0 C--O 1.214 -0.713 0 C-N-CA 121.303 1.336 . . . . 0.0 111.412 -176.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 116.43 -1.748 . . . . 0.0 110.22 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.401 HG12 ' N ' ' A' ' 2' ' ' VAL . 39.6 t . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.42 HG12 ' N ' ' A' ' 3' ' ' TYR . 3.6 t -81.92 164.48 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 C-N-CA 119.087 -1.045 . . . . 0.0 110.081 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.42 ' N ' HG12 ' A' ' 2' ' ' VAL . 24.5 m-85 -150.56 -169.91 3.51 Favored 'General case' 0 C--N 1.297 -1.7 0 C-N-CA 119.774 -0.77 . . . . 0.0 109.808 179.115 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.552 ' OG1' ' N ' ' A' ' 5' ' ' ASP . 0.0 OUTLIER -109.76 174.97 5.62 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 177.891 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.552 ' N ' ' OG1' ' A' ' 4' ' ' THR . 0.2 OUTLIER -84.2 151.24 24.96 Favored 'General case' 0 C--N 1.28 -2.456 0 C-N-CA 118.106 -1.438 . . . . 0.0 110.322 -178.199 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.506 ' O ' HG23 ' A' ' 7' ' ' THR . 0.1 OUTLIER -76.65 -176.79 3.94 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-O 122.147 0.975 . . . . 0.0 111.756 178.62 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.506 HG23 ' O ' ' A' ' 6' ' ' CYS . 1.3 p -157.02 15.87 0.28 Allowed 'General case' 0 C--N 1.283 -2.292 0 CA-C-N 113.391 -1.731 . . . . 0.0 109.709 177.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.449 ' N ' HE22 ' A' ' 11' ' ' GLN . 2.0 mt-10 -163.24 174.3 12.27 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-N 114.935 -1.03 . . . . 0.0 111.513 179.247 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.412 ' HB3' ' H ' ' A' ' 30' ' ' LEU . 0.4 OUTLIER -88.38 170.06 11.27 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.175 -178.21 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.456 ' O ' ' O ' ' A' ' 11' ' ' GLN . . . 73.44 -33.54 0.82 Allowed Glycine 0 N--CA 1.504 3.197 0 C-N-CA 119.668 -1.253 . . . . 0.0 112.378 177.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.456 ' O ' ' O ' ' A' ' 10' ' ' GLY . 12.4 mt-30 -51.8 -173.6 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.241 0 C-N-CA 119.507 -0.877 . . . . 0.0 110.153 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.502 ' C ' ' H ' ' A' ' 14' ' ' CYS . 1.6 m120 -158.85 -51.88 0.06 Allowed 'General case' 0 N--CA 1.503 2.176 0 C-N-CA 117.043 -1.863 . . . . 0.0 115.29 -179.199 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 67.1 mt -76.49 40.1 0.22 Allowed 'General case' 0 C--N 1.288 -2.091 0 C-N-CA 118.642 -1.223 . . . . 0.0 110.639 -175.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.502 ' H ' ' C ' ' A' ' 12' ' ' ASN . 10.0 p -124.76 -158.36 0.82 Allowed 'General case' 0 C--N 1.29 -1.995 0 CA-C-N 114.502 -1.226 . . . . 0.0 108.831 178.21 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 6.6 mt -109.91 116.17 31.15 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 119.65 -0.82 . . . . 0.0 110.662 178.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -111.93 -68.96 0.89 Allowed 'General case' 0 C--N 1.295 -1.786 0 CA-C-N 114.403 -1.271 . . . . 0.0 110.838 -177.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -79.38 99.01 6.97 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 119.585 -0.846 . . . . 0.0 110.376 -179.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.0 -113.56 5.48 Favored Glycine 0 N--CA 1.486 1.975 0 C-N-CA 119.408 -1.377 . . . . 0.0 110.451 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.422 ' O ' ' OG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -111.71 3.78 18.05 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-O 122.43 1.11 . . . . 0.0 109.694 -179.544 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -78.5 129.27 34.67 Favored 'General case' 0 C--N 1.256 -3.491 0 CA-C-N 113.229 -1.805 . . . . 0.0 110.248 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.443 HG22 ' O ' ' A' ' 14' ' ' CYS . 0.9 OUTLIER -78.36 144.06 11.77 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 C-N-CA 118.993 -1.083 . . . . 0.0 110.349 179.93 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.6 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 0.1 OUTLIER -90.97 143.97 26.15 Favored 'General case' 0 C--N 1.286 -2.166 0 C-N-CA 118.813 -1.155 . . . . 0.0 110.621 173.325 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.658 ' O ' ' N ' ' A' ' 25' ' ' GLY . . . -113.63 110.47 2.46 Favored Glycine 0 CA--C 1.486 -1.779 0 N-CA-C 107.844 -2.102 . . . . 0.0 107.844 -174.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -37.36 -5.2 0.0 OUTLIER 'General case' 0 C--N 1.254 -3.565 0 CA-C-N 112.521 -1.84 . . . . 0.0 114.491 178.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.658 ' N ' ' O ' ' A' ' 23' ' ' GLY . . . -69.27 -9.57 61.02 Favored Glycine 0 C--N 1.263 -3.498 0 N-CA-C 106.695 -2.562 . . . . 0.0 106.695 173.332 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 47.2 m-20 -135.41 -167.3 1.99 Allowed 'General case' 0 N--CA 1.485 1.309 0 CA-C-N 113.594 -1.303 . . . . 0.0 108.069 178.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.555 ' N ' ' O ' ' A' ' 40' ' ' VAL . 0.2 OUTLIER -123.12 166.84 14.51 Favored 'General case' 0 N--CA 1.503 2.217 0 C-N-CA 119.578 -0.849 . . . . 0.0 110.923 179.756 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.6 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 0.6 OUTLIER -136.34 154.89 50.71 Favored 'General case' 0 CA--C 1.472 -2.023 0 CA-C-O 122.203 1.002 . . . . 0.0 110.016 175.492 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 26.4 mm -145.56 127.78 9.19 Favored 'Isoleucine or valine' 1 C--N 1.24 -4.182 0 CA-C-N 113.083 -1.872 . . . . 0.0 109.528 177.098 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.412 ' H ' ' HB3' ' A' ' 9' ' ' SER . 17.6 mt -78.36 132.96 37.61 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 118.467 -1.293 . . . . 0.0 110.429 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.507 ' N ' ' O ' ' A' ' 36' ' ' LYS . . . -45.1 -75.52 0.17 Allowed Glycine 0 N--CA 1.486 1.973 0 C-N-CA 119.106 -1.521 . . . . 0.0 109.94 178.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.431 ' O ' ' N ' ' A' ' 34' ' ' GLY . 4.7 t -139.0 -137.68 0.13 Allowed 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 119.621 -0.832 . . . . 0.0 110.041 179.085 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -75.63 70.14 2.42 Favored 'General case' 0 C--N 1.252 -3.651 0 CA-C-N 113.783 -1.553 . . . . 0.0 110.415 -170.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' A' ' 32' ' ' SER . . . 75.24 21.7 77.43 Favored Glycine 0 C--N 1.281 -2.486 0 N-CA-C 108.242 -1.943 . . . . 0.0 108.242 -179.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 70.5 mt-10 -98.01 -115.07 0.14 Allowed 'General case' 0 C--N 1.307 -1.259 0 C-N-CA 119.171 -1.011 . . . . 0.0 110.593 -178.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.507 ' O ' ' N ' ' A' ' 31' ' ' GLY . 1.3 mtpp -62.79 167.23 4.76 Favored 'General case' 0 C--N 1.26 -3.313 0 CA-C-N 114.304 -1.317 . . . . 0.0 110.369 -178.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.548 ' OD1' ' N ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -143.94 165.57 27.36 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.176 179.575 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -156.74 152.41 26.97 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 119.143 -1.023 . . . . 0.0 110.511 176.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.575 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 0.9 OUTLIER -125.42 87.65 2.74 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.562 -179.793 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.555 ' O ' ' N ' ' A' ' 27' ' ' LYS . 2.4 p -111.35 146.77 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.621 0 C-N-CA 118.447 -1.301 . . . . 0.0 112.773 -179.289 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.407 ' N ' ' CG2' ' A' ' 40' ' ' VAL . 6.1 t -43.76 161.48 0.02 OUTLIER 'General case' 0 C--N 1.285 -2.226 0 CA-C-N 113.328 -1.76 . . . . 0.0 112.035 178.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 120.93 143.55 6.76 Favored Glycine 0 N--CA 1.497 2.76 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -84.57 131.86 34.58 Favored 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 119.188 -1.005 . . . . 0.0 111.1 -178.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -131.79 -156.2 8.3 Favored Glycine 0 N--CA 1.496 2.668 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 179.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.503 ' O ' HG23 ' A' ' 45' ' ' THR . 14.4 t -102.48 127.87 29.45 Favored Pre-proline 0 N--CA 1.493 1.681 0 C-N-CA 119.476 -0.89 . . . . 0.0 110.351 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.431 ' O ' ' C ' ' A' ' 47' ' ' GLU . 1.4 Cg_endo -64.69 115.02 2.99 Favored 'Trans proline' 0 C--O 1.214 -0.687 0 C-N-CA 120.591 0.861 . . . . 0.0 110.822 178.56 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.431 ' C ' ' O ' ' A' ' 46' ' ' PRO . 1.2 tt0 -36.01 98.52 0.15 Allowed Pre-proline 0 N--CA 1.503 2.212 0 C-N-CA 120.229 -0.588 . . . . 0.0 110.702 -179.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -58.42 104.3 0.18 Allowed 'Trans proline' 0 C--O 1.215 -0.635 0 C-N-CA 120.778 0.985 . . . . 0.0 110.967 -177.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 . . . . . 0 C--N 1.302 -1.458 0 CA-C-O 116.251 -1.833 . . . . 0.0 110.41 -179.06 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 2.2 t . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.491 HG12 ' H ' ' A' ' 3' ' ' TYR . 3.4 t -84.28 169.12 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 C-N-CA 119.336 -0.945 . . . . 0.0 109.961 179.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.491 ' H ' HG12 ' A' ' 2' ' ' VAL . 33.1 m-85 -107.72 -167.38 1.25 Allowed 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 119.879 -0.729 . . . . 0.0 110.505 -179.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -96.9 176.91 5.8 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 178.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.537 ' N ' ' OD1' ' A' ' 5' ' ' ASP . 0.4 OUTLIER -89.96 157.09 18.0 Favored 'General case' 0 C--N 1.293 -1.856 0 C-N-CA 118.099 -1.441 . . . . 0.0 109.19 176.984 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.496 ' SG ' ' O ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -75.58 165.89 24.39 Favored 'General case' 0 C--N 1.285 -2.223 0 C-N-CA 119.745 -0.782 . . . . 0.0 110.708 178.571 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.779 ' H ' HE22 ' A' ' 11' ' ' GLN . 2.0 t -130.94 3.5 4.42 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.231 177.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.582 ' H ' HE22 ' A' ' 11' ' ' GLN . 2.7 mm-40 -162.34 161.55 27.53 Favored 'General case' 0 C--N 1.28 -2.456 0 CA-C-N 113.671 -1.604 . . . . 0.0 110.414 -179.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.462 ' HA ' ' H ' ' A' ' 30' ' ' LEU . 0.6 OUTLIER -77.24 154.84 32.61 Favored 'General case' 0 C--N 1.291 -1.962 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.323 -179.43 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.436 ' O ' ' O ' ' A' ' 11' ' ' GLN . . . 96.21 -33.47 5.59 Favored Glycine 0 N--CA 1.501 2.984 0 C-N-CA 119.27 -1.443 . . . . 0.0 112.296 -179.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.779 HE22 ' H ' ' A' ' 7' ' ' THR . 8.8 mt-30 -51.72 -176.63 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.181 0 C-N-CA 119.128 -1.029 . . . . 0.0 110.698 -178.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.517 ' O ' ' O ' ' A' ' 22' ' ' CYS . 1.5 m-20 -144.64 -64.4 0.35 Allowed 'General case' 0 N--CA 1.5 2.059 0 C-N-CA 118.45 -1.3 . . . . 0.0 113.97 -176.202 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 85.2 mt -76.87 50.05 0.69 Allowed 'General case' 0 C--N 1.271 -2.809 0 C-N-CA 117.596 -1.642 . . . . 0.0 110.101 -176.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.564 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 29.7 p -125.56 -152.01 0.5 Allowed 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.011 -0.995 . . . . 0.0 108.684 177.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.534 HD22 ' O ' ' A' ' 19' ' ' SER . 76.0 mt -117.37 117.23 28.94 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 115.179 -0.919 . . . . 0.0 108.918 176.365 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.564 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 1.5 m -126.36 17.35 7.67 Favored 'General case' 0 N--CA 1.498 1.958 0 C-N-CA 118.81 -1.156 . . . . 0.0 111.036 -176.294 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -152.3 83.3 1.25 Allowed 'General case' 0 C--N 1.295 -1.795 0 C-N-CA 119.662 -0.815 . . . . 0.0 108.9 178.239 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 67.32 -85.11 0.13 Allowed Glycine 0 N--CA 1.486 1.989 0 C-N-CA 119.193 -1.479 . . . . 0.0 109.727 -178.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.534 ' O ' HD22 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -140.42 -2.18 1.44 Allowed 'General case' 0 N--CA 1.486 1.361 0 CA-C-O 121.891 0.853 . . . . 0.0 111.14 179.363 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -82.88 144.99 29.69 Favored 'General case' 0 C--N 1.258 -3.402 0 CA-C-N 114.189 -1.369 . . . . 0.0 111.057 -179.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.2 t -71.96 144.8 12.83 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.523 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.545 ' O ' ' SG ' ' A' ' 28' ' ' CYS . 0.7 OUTLIER -146.4 127.47 14.64 Favored 'General case' 0 C--N 1.279 -2.487 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 177.353 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.512 ' C ' ' H ' ' A' ' 25' ' ' GLY . . . 166.82 -83.81 0.1 OUTLIER Glycine 0 N--CA 1.482 1.703 0 C-N-CA 116.465 -2.778 . . . . 0.0 113.764 -175.489 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -72.66 17.39 0.11 Allowed 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 118.712 -1.195 . . . . 0.0 112.691 -173.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.512 ' H ' ' C ' ' A' ' 23' ' ' GLY . . . -126.86 -11.35 3.59 Favored Glycine 0 C--N 1.264 -3.422 0 N-CA-C 107.937 -2.065 . . . . 0.0 107.937 173.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.44 ' O ' ' O ' ' A' ' 23' ' ' GLY . 1.5 m-80 -158.22 -146.65 0.16 Allowed 'General case' 0 C--O 1.213 -0.834 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 -177.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.579 ' N ' ' O ' ' A' ' 40' ' ' VAL . 0.0 OUTLIER -141.34 138.44 33.08 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 175.45 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.545 ' SG ' ' O ' ' A' ' 22' ' ' CYS . 36.3 m -101.82 148.6 25.11 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 118.108 -1.437 . . . . 0.0 111.808 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 35.1 mm -140.32 90.1 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.263 -3.156 0 CA-C-N 112.918 -1.947 . . . . 0.0 106.878 175.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.681 ' C ' HD12 ' A' ' 30' ' ' LEU . 0.4 OUTLIER -78.41 130.79 36.51 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 118.955 -1.098 . . . . 0.0 110.296 -176.245 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.499 ' H ' ' HA ' ' A' ' 37' ' ' ASN . . . 60.02 86.75 0.03 OUTLIER Glycine 0 N--CA 1.483 1.796 0 C-N-CA 119.044 -1.55 . . . . 0.0 109.466 -178.062 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.566 ' O ' ' N ' ' A' ' 34' ' ' GLY . 67.8 m -68.32 -122.94 0.0 OUTLIER 'General case' 0 C--O 1.196 -1.715 0 C-N-CA 118.594 -1.242 . . . . 0.0 108.564 -179.505 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -73.54 66.88 1.04 Allowed 'General case' 0 C--N 1.252 -3.646 0 CA-C-N 114.523 -1.217 . . . . 0.0 108.518 -174.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.566 ' N ' ' O ' ' A' ' 32' ' ' SER . . . 66.08 26.95 72.54 Favored Glycine 0 C--N 1.286 -2.2 0 N-CA-C 107.741 -2.143 . . . . 0.0 107.741 -176.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -113.62 -136.67 0.37 Allowed 'General case' 0 C--O 1.216 -0.702 0 CA-C-O 122.418 1.104 . . . . 0.0 112.042 -176.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 6.2 mmmt -93.46 -176.12 4.01 Favored 'General case' 0 C--N 1.267 -2.997 0 CA-C-N 112.938 -1.937 . . . . 0.0 112.181 -176.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.499 ' HA ' ' H ' ' A' ' 31' ' ' GLY . 1.6 m-20 -90.95 162.79 14.6 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.938 178.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.461 ' CG ' ' N ' ' A' ' 39' ' ' CYS . 13.7 tt0 -157.38 157.61 34.37 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 119.26 -0.976 . . . . 0.0 110.973 179.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.461 ' N ' ' CG ' ' A' ' 38' ' ' GLN . 82.0 m -115.82 74.33 0.89 Allowed 'General case' 0 N--CA 1.492 1.669 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.453 178.403 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.579 ' O ' ' N ' ' A' ' 27' ' ' LYS . 0.2 OUTLIER -81.01 143.21 12.69 Favored 'Isoleucine or valine' 0 C--O 1.193 -1.873 0 C-N-CA 118.684 -1.206 . . . . 0.0 111.548 -177.75 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.5 t -64.1 140.18 58.84 Favored 'General case' 0 C--N 1.272 -2.777 0 CA-C-N 114.596 -1.184 . . . . 0.0 111.551 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 163.8 -140.92 6.76 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 178.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -145.86 113.43 6.34 Favored 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 119.272 -0.971 . . . . 0.0 110.32 179.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -114.37 -163.37 14.58 Favored Glycine 0 N--CA 1.498 2.812 0 C-N-CA 119.966 -1.111 . . . . 0.0 110.89 -179.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -131.1 153.02 81.63 Favored Pre-proline 0 N--CA 1.498 1.97 0 C-N-CA 120.04 -0.664 . . . . 0.0 109.627 -179.612 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -54.12 160.18 6.65 Favored 'Trans proline' 0 C--O 1.216 -0.621 0 C-N-CA 121.604 1.536 . . . . 0.0 112.177 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.623 ' CD ' ' H ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -74.19 148.01 86.04 Favored Pre-proline 0 N--CA 1.484 1.25 0 C-N-CA 119.519 -0.872 . . . . 0.0 108.796 178.44 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_endo -61.41 123.04 12.01 Favored 'Trans proline' 0 C--O 1.214 -0.677 0 C-N-CA 120.991 1.127 . . . . 0.0 111.783 -175.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 116.308 -1.806 . . . . 0.0 110.115 178.96 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 3.9 t . . . . . 0 N--CA 1.488 1.474 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.472 HG12 ' N ' ' A' ' 3' ' ' TYR . 6.0 t -119.22 169.0 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 C-N-CA 120.016 -0.674 . . . . 0.0 109.51 178.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.472 ' N ' HG12 ' A' ' 2' ' ' VAL . 25.1 m-85 -130.04 -167.62 1.84 Allowed 'General case' 0 N--CA 1.497 1.89 0 C-N-CA 119.779 -0.768 . . . . 0.0 109.948 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.0 p -98.42 176.95 5.51 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 119.541 -0.864 . . . . 0.0 108.866 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -88.06 153.07 21.56 Favored 'General case' 0 C--N 1.29 -1.979 0 C-N-CA 118.468 -1.293 . . . . 0.0 110.79 179.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.528 ' SG ' ' CB ' ' A' ' 11' ' ' GLN . 1.2 m -74.39 179.13 4.76 Favored 'General case' 0 C--N 1.287 -2.127 0 CA-C-N 114.754 -1.112 . . . . 0.0 111.564 176.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -152.81 13.41 0.53 Allowed 'General case' 0 C--N 1.29 -2.018 0 CA-C-N 113.657 -1.61 . . . . 0.0 110.015 176.404 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.596 ' CG ' ' NE2' ' A' ' 11' ' ' GLN . 0.9 OUTLIER -163.5 -171.81 2.7 Favored 'General case' 0 C--N 1.286 -2.157 0 CA-C-N 114.511 -1.222 . . . . 0.0 109.947 179.271 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.496 ' HB3' ' H ' ' A' ' 30' ' ' LEU . 0.8 OUTLIER -99.91 172.99 6.89 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 119.911 -0.716 . . . . 0.0 110.707 -178.007 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.488 ' H ' HD13 ' A' ' 29' ' ' ILE . . . 63.57 22.21 65.64 Favored Glycine 0 N--CA 1.502 3.063 0 C-N-CA 119.978 -1.106 . . . . 0.0 112.661 176.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.596 ' NE2' ' CG ' ' A' ' 8' ' ' GLU . 0.0 OUTLIER -89.2 -166.53 1.62 Allowed 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 118.95 -1.1 . . . . 0.0 111.213 178.804 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.836 ' OD1' ' HA2' ' A' ' 23' ' ' GLY . 2.0 m-20 -153.76 -70.37 0.14 Allowed 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 118.81 -1.156 . . . . 0.0 113.265 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.408 ' HA ' HD23 ' A' ' 13' ' ' LEU . 94.4 mt -77.97 45.6 0.53 Allowed 'General case' 0 C--N 1.282 -2.343 0 C-N-CA 118.64 -1.224 . . . . 0.0 111.291 -176.235 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.476 ' SG ' ' N ' ' A' ' 15' ' ' LEU . 15.3 p -123.82 -154.88 0.63 Allowed 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 174.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.535 HD22 ' O ' ' A' ' 19' ' ' SER . 63.3 mt -116.62 109.8 17.69 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-N 114.654 -1.157 . . . . 0.0 108.406 176.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.7 m -104.89 -58.97 1.81 Allowed 'General case' 0 C--N 1.288 -2.099 0 C-N-CA 118.939 -1.104 . . . . 0.0 111.027 -175.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -83.79 85.45 7.29 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 118.363 -1.335 . . . . 0.0 109.233 177.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.53 -116.8 5.28 Favored Glycine 0 N--CA 1.489 2.191 0 C-N-CA 119.384 -1.388 . . . . 0.0 110.317 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.535 ' O ' HD22 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -109.74 1.41 19.41 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-O 122.261 1.029 . . . . 0.0 109.91 -179.581 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 32.2 m120 -79.32 139.03 37.93 Favored 'General case' 0 C--N 1.26 -3.324 0 CA-C-N 113.244 -1.798 . . . . 0.0 111.081 -178.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.6 t -74.09 142.45 14.79 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 C-N-CA 118.987 -1.085 . . . . 0.0 110.206 179.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.515 ' O ' ' SG ' ' A' ' 28' ' ' CYS . 4.0 m -145.55 99.25 3.26 Favored 'General case' 0 C--N 1.284 -2.264 0 C-N-CA 118.873 -1.131 . . . . 0.0 109.408 177.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.836 ' HA2' ' OD1' ' A' ' 12' ' ' ASN . . . -161.91 -78.33 0.03 OUTLIER Glycine 0 C--N 1.297 -1.631 1 N-CA-C 131.482 7.353 . . . . 0.0 131.482 -177.489 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.527 ' O ' ' ND2' ' A' ' 26' ' ' ASN . 3.9 tt0 -45.9 124.56 5.43 Favored 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 119.506 -0.877 . . . . 0.0 111.188 -178.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.66 -26.15 2.77 Favored Glycine 0 N--CA 1.478 1.454 0 C-N-CA 119.61 -1.281 . . . . 0.0 110.255 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.548 ' N ' ' ND2' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -110.21 -167.58 1.21 Allowed 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 119.54 -0.864 . . . . 0.0 110.726 -178.92 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.537 ' O ' ' O ' ' A' ' 40' ' ' VAL . 16.6 tttt -148.08 166.08 28.87 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 119.466 -0.894 . . . . 0.0 110.056 179.2 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.515 ' SG ' ' O ' ' A' ' 22' ' ' CYS . 59.0 m -136.06 158.89 43.31 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.261 -0.975 . . . . 0.0 110.147 176.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.488 HD13 ' H ' ' A' ' 10' ' ' GLY . 22.3 mm -142.68 136.73 27.53 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.505 0 CA-C-N 114.793 -1.094 . . . . 0.0 110.536 177.229 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.496 ' H ' ' HB3' ' A' ' 9' ' ' SER . 18.1 mt -77.48 147.35 35.92 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 119.943 -0.703 . . . . 0.0 110.967 177.34 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.402 ' H ' ' C ' ' A' ' 36' ' ' LYS . . . -125.44 -112.13 1.87 Allowed Glycine 0 N--CA 1.475 1.246 0 CA-C-N 114.538 -1.21 . . . . 0.0 110.163 175.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.482 ' O ' ' CA ' ' A' ' 36' ' ' LYS . 7.5 m -152.91 -136.56 0.06 Allowed 'General case' 0 C--N 1.311 -1.108 0 CA-C-O 122.567 1.175 . . . . 0.0 111.967 -178.195 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -84.77 69.03 10.65 Favored 'General case' 0 C--N 1.265 -3.077 0 CA-C-N 113.001 -1.909 . . . . 0.0 110.635 -173.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 139.87 -12.28 3.13 Favored Glycine 0 C--N 1.277 -2.725 0 N-CA-C 108.227 -1.949 . . . . 0.0 108.227 179.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.662 ' O ' ' N ' ' A' ' 37' ' ' ASN . 6.3 mt-10 -138.36 14.63 2.79 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-O 122.663 1.22 . . . . 0.0 108.321 179.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.482 ' CA ' ' O ' ' A' ' 32' ' ' SER . 0.0 OUTLIER -35.21 -20.07 0.0 OUTLIER 'General case' 0 C--N 1.249 -3.765 0 CA-C-N 111.402 -2.636 . . . . 0.0 113.209 -175.504 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 1.073 HD22 ' N ' ' A' ' 38' ' ' GLN . 0.2 OUTLIER -174.37 131.37 0.37 Allowed 'General case' 0 C--N 1.253 -3.61 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.737 178.992 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 1.073 ' N ' HD22 ' A' ' 37' ' ' ASN . 13.1 tt0 -127.04 143.16 51.36 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 114.93 -1.032 . . . . 0.0 108.994 176.061 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 66.6 m -96.28 108.19 20.64 Favored 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 119.212 -0.995 . . . . 0.0 111.136 -178.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.537 ' O ' ' O ' ' A' ' 27' ' ' LYS . 0.2 OUTLIER -110.26 142.26 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.407 0 C-N-CA 118.908 -1.117 . . . . 0.0 111.285 177.007 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.415 ' O ' HG22 ' A' ' 40' ' ' VAL . 15.1 t -70.25 151.48 45.28 Favored 'General case' 0 C--N 1.273 -2.76 0 CA-C-N 114.692 -1.14 . . . . 0.0 110.314 178.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.444 ' H ' ' HA ' ' A' ' 26' ' ' ASN . . . 144.37 -116.54 0.96 Allowed Glycine 0 N--CA 1.493 2.472 1 N-CA-C 130.847 7.099 . . . . 0.0 130.847 -178.962 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 -116.26 72.61 0.82 Allowed 'General case' 0 N--CA 1.5 2.065 0 C-N-CA 119.957 -0.697 . . . . 0.0 110.556 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.441 ' O ' ' ND2' ' A' ' 12' ' ' ASN . . . -107.67 151.16 16.95 Favored Glycine 0 N--CA 1.497 2.704 0 C-N-CA 119.795 -1.193 . . . . 0.0 110.53 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -117.61 152.53 49.79 Favored Pre-proline 0 N--CA 1.496 1.839 0 C-N-CA 120.097 -0.641 . . . . 0.0 109.532 179.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -53.36 161.47 3.88 Favored 'Trans proline' 0 C--O 1.215 -0.629 0 C-N-CA 121.287 1.324 . . . . 0.0 111.137 177.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.477 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 2.6 tt0 -73.8 -45.8 6.97 Favored Pre-proline 0 C--N 1.307 -1.246 0 C-N-CA 118.987 -1.085 . . . . 0.0 111.048 178.022 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.477 ' HD2' ' N ' ' A' ' 47' ' ' GLU . 1.9 Cg_endo -64.98 139.92 63.76 Favored 'Trans proline' 0 C--O 1.214 -0.7 0 C-N-CA 120.429 0.753 . . . . 0.0 110.585 175.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 116.384 -1.77 . . . . 0.0 110.435 -179.882 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.525 ' O ' HG13 ' A' ' 1' ' ' VAL . 7.9 p . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -102.88 159.76 4.46 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 C-N-CA 119.937 -0.705 . . . . 0.0 109.767 179.421 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -82.53 -170.82 3.15 Favored 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 118.961 -1.096 . . . . 0.0 110.791 -179.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.51 ' OG1' ' N ' ' A' ' 5' ' ' ASP . 0.0 OUTLIER -118.76 -169.07 1.65 Allowed 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.35 179.608 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.51 ' N ' ' OG1' ' A' ' 4' ' ' THR . 0.0 OUTLIER -90.46 151.81 21.23 Favored 'General case' 0 C--N 1.288 -2.073 0 C-N-CA 118.774 -1.17 . . . . 0.0 111.903 -176.649 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.497 ' O ' HG23 ' A' ' 7' ' ' THR . 0.7 OUTLIER -75.57 179.48 5.3 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-N 114.215 -1.357 . . . . 0.0 112.28 177.348 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.798 ' H ' HE22 ' A' ' 11' ' ' GLN . 5.3 p -159.09 16.26 0.17 Allowed 'General case' 0 C--N 1.285 -2.204 0 CA-C-N 112.979 -1.919 . . . . 0.0 109.342 177.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.402 ' CG ' ' O ' ' A' ' 7' ' ' THR . 33.1 mt-10 -160.96 168.07 25.29 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 114.949 -1.023 . . . . 0.0 110.704 -178.179 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.48 ' HB3' ' H ' ' A' ' 30' ' ' LEU . 0.7 OUTLIER -88.33 159.42 18.08 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.06 -179.892 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.444 ' O ' ' O ' ' A' ' 11' ' ' GLN . . . 82.99 -28.47 3.64 Favored Glycine 0 N--CA 1.501 2.971 0 C-N-CA 119.446 -1.359 . . . . 0.0 112.531 177.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.798 HE22 ' H ' ' A' ' 7' ' ' THR . 5.6 mt-30 -49.55 -178.59 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.13 0 C-N-CA 119.496 -0.882 . . . . 0.0 110.817 -179.059 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.688 ' C ' ' HA3' ' A' ' 23' ' ' GLY . 13.2 m-20 -143.68 -67.83 0.34 Allowed 'General case' 0 N--CA 1.501 2.108 0 C-N-CA 118.493 -1.283 . . . . 0.0 114.289 -176.031 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 94.2 mt -77.78 48.28 0.68 Allowed 'General case' 0 C--N 1.275 -2.638 0 C-N-CA 118.803 -1.159 . . . . 0.0 111.399 -175.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 29.4 p -122.93 -159.35 0.83 Allowed 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 119.677 -0.809 . . . . 0.0 110.566 176.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 64.7 mt -117.17 121.93 42.62 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.958 177.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 63.5 m -110.18 -73.47 0.68 Allowed 'General case' 0 N--CA 1.5 2.07 0 C-N-CA 119.028 -1.069 . . . . 0.0 110.883 -179.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -79.69 93.23 5.5 Favored 'General case' 0 C--N 1.295 -1.767 0 C-N-CA 118.828 -1.149 . . . . 0.0 110.185 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 72.83 -118.9 6.66 Favored Glycine 0 N--CA 1.488 2.143 0 C-N-CA 119.494 -1.336 . . . . 0.0 110.73 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.42 ' O ' ' OG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -110.65 4.59 20.3 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-O 122.286 1.041 . . . . 0.0 109.947 -178.918 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 61.5 m-80 -78.37 135.24 37.42 Favored 'General case' 0 C--N 1.259 -3.366 0 CA-C-N 113.2 -1.818 . . . . 0.0 110.742 -179.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.1 t -75.67 144.67 11.7 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 C-N-CA 119.451 -0.9 . . . . 0.0 110.754 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.463 ' O ' ' O ' ' A' ' 12' ' ' ASN . 53.8 m -141.68 99.78 3.62 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 118.768 -1.173 . . . . 0.0 110.137 176.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.688 ' HA3' ' C ' ' A' ' 12' ' ' ASN . . . -176.14 -42.05 0.06 OUTLIER Glycine 0 N--CA 1.487 2.043 1 N-CA-C 129.921 6.728 . . . . 0.0 129.921 -178.012 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 12.1 tt0 -86.33 118.19 25.61 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 118.879 -1.128 . . . . 0.0 109.117 177.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.42 -22.6 29.24 Favored Glycine 0 C--N 1.294 -1.802 0 N-CA-C 108.719 -1.753 . . . . 0.0 108.719 -176.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.455 ' O ' ' O ' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -131.72 164.79 25.17 Favored 'General case' 0 C--O 1.209 -1.077 0 C-N-CA 120.021 -0.672 . . . . 0.0 110.035 179.156 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.539 ' O ' ' O ' ' A' ' 40' ' ' VAL . 10.0 ttpt -122.12 147.87 45.6 Favored 'General case' 0 N--CA 1.506 2.37 0 C-N-CA 119.752 -0.779 . . . . 0.0 110.189 178.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.436 ' SG ' ' O ' ' A' ' 38' ' ' GLN . 0.7 OUTLIER -109.37 163.1 13.71 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 118.289 -1.364 . . . . 0.0 111.282 176.917 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 18.8 mm -145.49 130.07 12.3 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.355 0 CA-C-N 112.286 -2.234 . . . . 0.0 109.462 177.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.48 ' H ' ' HB3' ' A' ' 9' ' ' SER . 24.3 mt -77.41 115.9 17.56 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 118.518 -1.273 . . . . 0.0 109.39 178.55 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.441 ' H ' ' HA ' ' A' ' 37' ' ' ASN . . . 96.93 107.03 2.42 Favored Glycine 0 N--CA 1.479 1.518 0 C-N-CA 119.116 -1.516 . . . . 0.0 110.308 -179.416 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.561 ' N ' ' O ' ' A' ' 36' ' ' LYS . 8.9 t -76.14 -129.61 0.01 OUTLIER 'General case' 0 C--O 1.199 -1.581 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 178.25 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.408 ' O ' ' OD2' ' A' ' 33' ' ' ASP . 6.7 p-10 -74.23 65.12 1.15 Allowed 'General case' 0 C--N 1.252 -3.673 0 CA-C-N 114.902 -1.045 . . . . 0.0 108.636 -175.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 32' ' ' SER . . . 76.1 28.95 59.46 Favored Glycine 0 C--N 1.289 -2.056 0 N-CA-C 108.602 -1.799 . . . . 0.0 108.602 -177.518 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -127.0 -128.94 0.23 Allowed 'General case' 0 C--O 1.214 -0.783 0 C-N-CA 118.992 -1.083 . . . . 0.0 112.499 -177.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.561 ' O ' ' N ' ' A' ' 32' ' ' SER . 21.3 mtmt -95.36 -171.66 2.45 Favored 'General case' 0 C--N 1.277 -2.554 0 CA-C-N 113.241 -1.8 . . . . 0.0 113.145 -176.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.458 ' OD1' ' N ' ' A' ' 37' ' ' ASN . 1.3 m120 -49.28 161.02 0.19 Allowed 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 114.851 -1.068 . . . . 0.0 111.994 179.349 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.436 ' O ' ' SG ' ' A' ' 28' ' ' CYS . 7.3 tt0 -154.76 161.16 41.61 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.771 177.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.426 ' H ' ' HG3' ' A' ' 38' ' ' GLN . 62.6 m -128.3 84.08 2.21 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 120.037 -0.665 . . . . 0.0 110.445 -179.159 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.539 ' O ' ' O ' ' A' ' 27' ' ' LYS . 0.2 OUTLIER -91.69 139.17 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.606 0 C-N-CA 118.124 -1.43 . . . . 0.0 112.317 -178.722 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.42 ' O ' HG22 ' A' ' 40' ' ' VAL . 3.9 t -47.61 163.17 0.05 Allowed 'General case' 0 C--N 1.277 -2.583 0 CA-C-N 114.137 -1.392 . . . . 0.0 111.599 -178.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 130.36 -150.5 19.21 Favored Glycine 0 N--CA 1.492 2.43 1 N-CA-C 130.289 6.875 . . . . 0.0 130.289 -179.335 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -123.72 141.86 51.62 Favored 'General case' 0 N--CA 1.498 1.934 0 C-N-CA 119.88 -0.728 . . . . 0.0 109.958 178.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -161.4 -177.56 34.59 Favored Glycine 0 N--CA 1.487 2.085 0 C-N-CA 119.224 -1.465 . . . . 0.0 110.614 -179.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.424 ' O ' ' O ' ' A' ' 46' ' ' PRO . 0.4 OUTLIER -101.86 154.8 37.08 Favored Pre-proline 0 N--CA 1.49 1.559 0 C-N-CA 119.849 -0.741 . . . . 0.0 109.388 -179.701 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.424 ' O ' ' O ' ' A' ' 45' ' ' THR . 4.6 Cg_exo -54.96 -159.81 0.01 OUTLIER 'Trans proline' 0 C--O 1.213 -0.757 0 C-N-CA 121.273 1.315 . . . . 0.0 110.708 176.416 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -112.22 88.71 10.92 Favored Pre-proline 0 C--N 1.306 -1.325 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.062 179.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -66.27 117.94 5.11 Favored 'Trans proline' 0 C--O 1.216 -0.604 0 C-N-CA 120.913 1.075 . . . . 0.0 110.779 177.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 . . . . . 0 C--N 1.302 -1.477 0 CA-C-O 116.337 -1.792 . . . . 0.0 110.493 -179.724 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 5.7 m . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.418 ' H ' HG23 ' A' ' 2' ' ' VAL . 2.1 t -79.3 161.97 4.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 C-N-CA 118.994 -1.082 . . . . 0.0 109.262 179.157 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -103.75 -167.19 1.34 Allowed 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 119.443 -0.903 . . . . 0.0 111.02 -178.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.96 174.13 7.09 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.278 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -94.52 150.83 19.86 Favored 'General case' 0 C--N 1.296 -1.73 0 C-N-CA 118.737 -1.185 . . . . 0.0 109.833 179.182 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.518 ' SG ' ' O ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -75.86 165.94 24.26 Favored 'General case' 0 C--N 1.292 -1.93 0 C-N-CA 119.655 -0.818 . . . . 0.0 111.028 178.919 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 34.2 p -135.96 12.02 3.36 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-N 114.61 -1.177 . . . . 0.0 108.871 175.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.626 ' CB ' HE22 ' A' ' 11' ' ' GLN . 2.1 tt0 -162.54 175.43 11.46 Favored 'General case' 0 C--N 1.284 -2.248 0 CA-C-N 114.321 -1.309 . . . . 0.0 111.729 -179.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -85.33 154.46 21.88 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 114.816 -1.084 . . . . 0.0 110.296 -179.266 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.449 ' O ' ' O ' ' A' ' 11' ' ' GLN . . . 89.42 -21.21 30.02 Favored Glycine 0 N--CA 1.502 3.077 0 C-N-CA 119.261 -1.447 . . . . 0.0 112.855 178.124 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.626 HE22 ' CB ' ' A' ' 8' ' ' GLU . 1.5 mp0 -49.66 179.35 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.338 0 C-N-CA 118.588 -1.245 . . . . 0.0 110.187 -179.012 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.603 ' O ' ' HA3' ' A' ' 23' ' ' GLY . 15.6 t-20 -138.12 -76.49 0.38 Allowed 'General case' 0 N--CA 1.497 1.879 0 C-N-CA 118.963 -1.095 . . . . 0.0 112.438 -178.105 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 83.1 mt -78.36 47.34 0.68 Allowed 'General case' 0 C--N 1.264 -3.149 0 C-N-CA 117.968 -1.493 . . . . 0.0 110.594 -177.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.41 ' HB2' ' N ' ' A' ' 6' ' ' CYS . 31.9 p -117.03 -157.13 0.65 Allowed 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 119.482 -0.887 . . . . 0.0 110.13 177.492 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.518 ' O ' ' SG ' ' A' ' 6' ' ' CYS . 4.6 mt -122.8 127.98 49.83 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.371 177.266 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 82.8 m -116.35 -64.61 1.29 Allowed 'General case' 0 N--CA 1.511 2.604 0 C-N-CA 119.287 -0.965 . . . . 0.0 110.951 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 85.3 mt-10 -79.23 76.35 5.77 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 119.08 -1.048 . . . . 0.0 110.287 -178.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 73.77 -108.57 2.54 Favored Glycine 0 N--CA 1.488 2.144 0 C-N-CA 119.481 -1.342 . . . . 0.0 111.123 179.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -108.2 0.26 21.36 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 122.119 0.962 . . . . 0.0 110.773 -177.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 72.9 m-20 -79.66 127.01 31.65 Favored 'General case' 0 C--N 1.256 -3.481 0 CA-C-N 113.838 -1.528 . . . . 0.0 110.435 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.2 t -66.68 148.69 11.98 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 C-N-CA 118.835 -1.146 . . . . 0.0 109.168 178.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.513 ' O ' ' O ' ' A' ' 12' ' ' ASN . 0.0 OUTLIER -143.55 113.59 7.24 Favored 'General case' 0 C--N 1.289 -2.053 0 C-N-CA 118.802 -1.159 . . . . 0.0 110.754 -178.574 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.603 ' HA3' ' O ' ' A' ' 12' ' ' ASN . . . 162.08 -57.59 0.3 Allowed Glycine 0 N--CA 1.483 1.824 1 N-CA-C 130.29 6.876 . . . . 0.0 130.29 -178.01 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.582 ' HA ' HD21 ' A' ' 12' ' ' ASN . 15.8 tt0 -61.47 126.69 28.27 Favored 'General case' 0 C--N 1.31 -1.137 0 C-N-CA 119.037 -1.065 . . . . 0.0 110.51 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.41 -25.56 8.0 Favored Glycine 0 N--CA 1.482 1.708 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -178.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.484 ' OD1' ' N ' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -123.11 -167.18 1.56 Allowed 'General case' 0 C--N 1.316 -0.867 0 C-N-CA 120.322 -0.551 . . . . 0.0 110.021 179.992 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.56 ' HZ1' HD11 ' A' ' 29' ' ' ILE . 15.4 tttp -145.65 115.93 7.51 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 178.136 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.51 ' SG ' ' O ' ' A' ' 38' ' ' GLN . 0.1 OUTLIER -80.11 163.72 23.91 Favored 'General case' 0 CA--C 1.477 -1.828 0 C-N-CA 117.528 -1.669 . . . . 0.0 112.415 178.503 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.56 HD11 ' HZ1' ' A' ' 27' ' ' LYS . 18.1 mm -149.39 124.7 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.265 -3.076 0 CA-C-N 111.982 -2.372 . . . . 0.0 108.218 178.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.499 HD22 HD22 ' A' ' 37' ' ' ASN . 26.9 mt -77.33 137.44 38.76 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 118.337 -1.345 . . . . 0.0 110.421 -178.505 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.53 ' C ' ' H ' ' A' ' 33' ' ' ASP . . . -85.81 -86.93 0.99 Allowed Glycine 0 N--CA 1.492 2.419 0 C-N-CA 117.982 -2.056 . . . . 0.0 108.338 177.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.521 ' O ' ' N ' ' A' ' 34' ' ' GLY . 0.6 OUTLIER 73.87 -18.91 0.37 Allowed 'General case' 0 C--O 1.195 -1.788 0 C-N-CA 119.516 -0.873 . . . . 0.0 111.76 175.408 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.53 ' H ' ' C ' ' A' ' 31' ' ' GLY . 24.8 t0 -77.57 63.87 2.78 Favored 'General case' 0 C--N 1.256 -3.488 0 N-CA-C 106.544 -1.65 . . . . 0.0 106.544 -176.179 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 32' ' ' SER . . . 66.48 26.13 72.75 Favored Glycine 0 C--N 1.286 -2.199 0 N-CA-C 104.416 -3.474 . . . . 0.0 104.416 -171.213 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -140.86 170.78 15.1 Favored 'General case' 0 N--CA 1.419 -1.991 0 CA-C-O 123.345 1.545 . . . . 0.0 110.993 -174.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.75 170.09 9.02 Favored 'General case' 1 C--N 1.227 -4.752 0 CA-C-N 111.592 -2.549 . . . . 0.0 111.566 178.791 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.499 HD22 HD22 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -54.93 169.46 0.23 Allowed 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.647 174.676 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.51 ' O ' ' SG ' ' A' ' 28' ' ' CYS . 42.1 tt0 -157.33 152.83 26.44 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 118.791 -1.164 . . . . 0.0 111.223 178.379 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -113.1 107.24 15.67 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 115.226 -0.897 . . . . 0.0 112.058 178.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.483 ' CG2' ' N ' ' A' ' 41' ' ' THR . 1.6 p -110.45 155.99 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 C-N-CA 119.01 -1.076 . . . . 0.0 109.494 174.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.483 ' N ' ' CG2' ' A' ' 40' ' ' VAL . 6.0 t -78.87 152.28 31.32 Favored 'General case' 0 C--N 1.279 -2.479 0 CA-C-N 114.814 -1.084 . . . . 0.0 112.202 -177.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 153.28 -113.87 0.6 Allowed Glycine 0 N--CA 1.491 2.331 1 N-CA-C 128.945 6.338 . . . . 0.0 128.945 -179.529 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -154.62 101.34 2.32 Favored 'General case' 0 N--CA 1.494 1.753 0 C-N-CA 119.299 -0.961 . . . . 0.0 110.268 177.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -114.73 -165.69 15.1 Favored Glycine 0 N--CA 1.496 2.656 0 C-N-CA 120.013 -1.089 . . . . 0.0 110.579 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -134.32 148.25 66.94 Favored Pre-proline 0 N--CA 1.489 1.513 0 C-N-CA 119.965 -0.694 . . . . 0.0 110.152 -179.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -59.74 143.64 99.59 Favored 'Trans proline' 0 C--O 1.211 -0.83 0 C-N-CA 121.314 1.343 . . . . 0.0 110.997 176.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -72.31 117.65 60.51 Favored Pre-proline 0 CA--C 1.565 1.523 0 C-N-CA 119.628 -0.829 . . . . 0.0 110.588 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_endo -68.3 117.76 5.17 Favored 'Trans proline' 0 C--O 1.216 -0.596 0 C-N-CA 120.822 1.015 . . . . 0.0 111.17 178.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.494 1.768 0 CA-C-O 116.372 -1.775 . . . . 0.0 110.365 179.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 2.2 t . . . . . 0 N--CA 1.488 1.464 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.1 t -92.93 160.96 2.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 C-N-CA 119.205 -0.998 . . . . 0.0 110.498 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -100.48 -165.07 1.17 Allowed 'General case' 0 N--CA 1.492 1.648 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.283 179.223 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -94.18 -179.58 4.99 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.125 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 5' ' ' ASP . 0.2 OUTLIER -93.05 154.65 17.99 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 118.462 -1.295 . . . . 0.0 110.781 179.478 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.404 ' N ' ' HB2' ' A' ' 14' ' ' CYS . 1.9 m -75.41 179.17 5.38 Favored 'General case' 0 C--N 1.294 -1.841 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.056 178.226 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.3 p -134.24 -2.54 2.81 Favored 'General case' 0 C--N 1.29 -2.019 0 CA-C-N 113.904 -1.498 . . . . 0.0 109.924 176.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -162.84 157.04 20.83 Favored 'General case' 0 C--N 1.279 -2.493 0 CA-C-N 114.237 -1.347 . . . . 0.0 110.053 179.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.585 ' OG ' ' N ' ' A' ' 30' ' ' LEU . 1.4 m -62.59 -175.79 0.09 Allowed 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 119.73 -0.788 . . . . 0.0 110.496 179.237 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.442 ' O ' ' O ' ' A' ' 11' ' ' GLN . . . 73.64 -42.58 1.07 Allowed Glycine 0 N--CA 1.5 2.919 0 C-N-CA 120.111 -1.042 . . . . 0.0 112.9 178.173 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.442 ' O ' ' O ' ' A' ' 10' ' ' GLY . 2.5 mp0 -53.79 -173.02 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.607 0 C-N-CA 119.022 -1.071 . . . . 0.0 110.222 -177.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.506 ' ND2' ' O ' ' A' ' 26' ' ' ASN . 11.4 m-20 -151.59 -57.63 0.15 Allowed 'General case' 0 N--CA 1.503 2.212 0 C-N-CA 117.691 -1.604 . . . . 0.0 114.707 -177.044 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.425 HD23 ' HA ' ' A' ' 13' ' ' LEU . 15.0 mt -75.7 49.75 0.53 Allowed 'General case' 0 C--N 1.287 -2.133 0 C-N-CA 118.989 -1.085 . . . . 0.0 110.107 -176.175 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.593 ' SG ' ' N ' ' A' ' 15' ' ' LEU . 19.5 p -130.37 -142.31 0.24 Allowed 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 114.662 -1.154 . . . . 0.0 108.821 176.207 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.646 HD22 ' O ' ' A' ' 19' ' ' SER . 88.1 mt -122.9 108.8 13.39 Favored 'General case' 0 C--N 1.288 -2.083 0 CA-C-N 114.592 -1.185 . . . . 0.0 109.365 176.523 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.426 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 8.6 m -111.22 -46.74 3.27 Favored 'General case' 0 C--N 1.288 -2.068 0 CA-C-N 113.941 -1.481 . . . . 0.0 110.598 -175.382 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -87.82 73.88 9.16 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 119.17 -1.012 . . . . 0.0 109.307 178.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 73.39 -107.61 2.28 Favored Glycine 0 N--CA 1.489 2.195 0 C-N-CA 119.304 -1.427 . . . . 0.0 109.938 -178.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.646 ' O ' HD22 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -111.31 -0.13 16.49 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-O 122.337 1.065 . . . . 0.0 109.89 179.897 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -82.75 145.62 29.46 Favored 'General case' 0 C--N 1.261 -3.256 0 CA-C-N 113.201 -1.818 . . . . 0.0 111.467 -179.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.4 t -84.17 142.2 13.7 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.258 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.503 ' O ' ' O ' ' A' ' 12' ' ' ASN . 0.0 OUTLIER -109.85 146.44 35.07 Favored 'General case' 0 N--CA 1.504 2.229 0 N-CA-C 106.012 -1.848 . . . . 0.0 106.012 168.637 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -105.13 -154.58 22.29 Favored Glycine 0 CA--C 1.49 -1.491 0 C-N-CA 118.256 -1.926 . . . . 0.0 111.13 -173.271 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.473 ' C ' ' H ' ' A' ' 26' ' ' ASN . 4.0 tt0 -92.82 170.89 9.34 Favored 'General case' 0 C--N 1.246 -3.926 0 CA-C-N 112.075 -2.063 . . . . 0.0 109.55 -177.25 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.415 ' H ' ' HG2' ' A' ' 24' ' ' GLN . . . 81.06 -35.32 2.36 Favored Glycine 0 N--CA 1.48 1.616 0 N-CA-C 108.595 -1.802 . . . . 0.0 108.595 -177.464 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.506 ' O ' ' ND2' ' A' ' 12' ' ' ASN . 0.0 OUTLIER -100.49 173.77 6.41 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 177.542 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.563 ' CE ' HD11 ' A' ' 29' ' ' ILE . 0.1 OUTLIER -128.76 131.53 47.85 Favored 'General case' 0 N--CA 1.502 2.155 0 C-N-CA 119.461 -0.896 . . . . 0.0 111.057 -179.388 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.425 ' O ' ' N ' ' A' ' 10' ' ' GLY . 81.3 m -93.01 153.71 18.56 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 118.359 -1.336 . . . . 0.0 110.067 176.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.563 HD11 ' CE ' ' A' ' 27' ' ' LYS . 30.3 mm -140.77 81.04 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.265 -3.091 0 CA-C-N 114.142 -1.39 . . . . 0.0 108.869 176.512 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.617 ' C ' HD12 ' A' ' 30' ' ' LEU . 1.1 pp -78.51 133.76 37.37 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 119.257 -0.977 . . . . 0.0 110.998 -178.138 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.406 ' O ' ' O ' ' A' ' 32' ' ' SER . . . 57.15 89.58 0.01 OUTLIER Glycine 0 N--CA 1.477 1.428 0 C-N-CA 118.483 -1.818 . . . . 0.0 108.585 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.512 ' O ' ' N ' ' A' ' 34' ' ' GLY . 1.7 t -67.13 -134.0 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.468 0 C-N-CA 118.825 -1.15 . . . . 0.0 108.463 -178.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -75.14 65.38 1.52 Allowed 'General case' 1 C--N 1.243 -4.038 0 CA-C-N 114.727 -1.124 . . . . 0.0 108.783 -174.347 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' A' ' 32' ' ' SER . . . 78.21 25.69 61.16 Favored Glycine 0 C--N 1.286 -2.232 0 N-CA-C 108.348 -1.901 . . . . 0.0 108.348 -177.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -121.44 -135.19 0.31 Allowed 'General case' 0 C--O 1.215 -0.762 0 CA-C-O 122.306 1.05 . . . . 0.0 112.147 -177.086 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.413 ' O ' ' N ' ' A' ' 32' ' ' SER . 13.7 mmtm -94.39 -173.34 3.03 Favored 'General case' 0 C--N 1.272 -2.783 0 CA-C-N 113.037 -1.892 . . . . 0.0 112.787 -175.31 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.413 ' OD1' ' N ' ' A' ' 37' ' ' ASN . 4.3 m-20 -101.32 164.7 11.65 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.903 179.59 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.471 ' CG ' ' N ' ' A' ' 39' ' ' CYS . 7.0 tt0 -161.45 157.91 25.82 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.099 177.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.471 ' N ' ' CG ' ' A' ' 38' ' ' GLN . 0.9 OUTLIER -117.52 92.04 3.74 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 120.124 -0.63 . . . . 0.0 109.649 178.892 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.485 ' O ' ' O ' ' A' ' 27' ' ' LYS . 0.6 OUTLIER -101.23 134.33 41.76 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.267 0 C-N-CA 118.482 -1.287 . . . . 0.0 112.476 -178.417 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.427 ' O ' HG22 ' A' ' 40' ' ' VAL . 6.0 t -57.15 157.17 6.35 Favored 'General case' 0 C--N 1.273 -2.743 0 CA-C-N 113.044 -1.889 . . . . 0.0 111.019 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 148.69 -104.59 0.28 Allowed Glycine 0 N--CA 1.492 2.427 1 N-CA-C 130.866 7.106 . . . . 0.0 130.866 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -160.13 106.55 1.58 Allowed 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 119.441 -0.904 . . . . 0.0 110.368 -179.557 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -146.28 -174.63 18.59 Favored Glycine 0 N--CA 1.493 2.496 0 C-N-CA 119.548 -1.311 . . . . 0.0 110.437 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.7 t -107.47 144.77 29.89 Favored Pre-proline 0 N--CA 1.492 1.632 0 C-N-CA 119.781 -0.768 . . . . 0.0 110.37 -179.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -63.76 132.48 35.2 Favored 'Trans proline' 0 C--O 1.214 -0.699 0 C-N-CA 120.904 1.07 . . . . 0.0 110.53 174.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -53.15 114.79 6.45 Favored Pre-proline 0 N--CA 1.488 1.451 0 C-N-CA 119.515 -0.874 . . . . 0.0 110.703 -179.143 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -62.28 114.02 2.16 Favored 'Trans proline' 0 C--O 1.214 -0.7 0 C-N-CA 120.44 0.76 . . . . 0.0 110.991 177.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 116.412 -1.756 . . . . 0.0 110.473 -179.868 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 3.6 t . . . . . 0 N--CA 1.492 1.627 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.43 ' H ' HG23 ' A' ' 2' ' ' VAL . 1.6 t -82.09 163.77 3.05 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 C-N-CA 119.697 -0.801 . . . . 0.0 110.039 179.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -92.52 -164.86 1.24 Allowed 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 119.55 -0.86 . . . . 0.0 110.93 -179.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.1 p -93.05 180.0 5.27 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.501 ' N ' ' OD1' ' A' ' 5' ' ' ASP . 0.0 OUTLIER -92.4 151.46 20.24 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 118.997 -1.081 . . . . 0.0 110.152 178.435 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.517 ' SG ' ' O ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -75.04 165.77 24.72 Favored 'General case' 0 C--N 1.296 -1.75 0 C-N-CA 120.017 -0.673 . . . . 0.0 111.189 178.445 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.0 p -141.67 12.47 2.09 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 119.446 -0.901 . . . . 0.0 110.062 177.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -162.78 179.51 7.6 Favored 'General case' 0 C--N 1.287 -2.126 0 CA-C-N 114.687 -1.142 . . . . 0.0 110.826 178.246 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.462 ' HB3' ' H ' ' A' ' 30' ' ' LEU . 0.8 OUTLIER -89.81 163.91 14.85 Favored 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 119.252 -0.979 . . . . 0.0 109.741 179.849 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 71.54 14.52 74.92 Favored Glycine 0 N--CA 1.495 2.585 0 C-N-CA 119.028 -1.558 . . . . 0.0 111.777 179.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.7 mm-40 -74.77 -167.43 0.57 Allowed 'General case' 0 N--CA 1.498 1.958 0 C-N-CA 118.977 -1.089 . . . . 0.0 109.991 179.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.477 ' O ' ' O ' ' A' ' 22' ' ' CYS . 0.9 OUTLIER -155.09 -80.31 0.09 Allowed 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 117.693 -1.603 . . . . 0.0 113.554 -179.45 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 92.6 mt -77.03 51.75 0.83 Allowed 'General case' 0 C--N 1.273 -2.755 0 C-N-CA 117.815 -1.554 . . . . 0.0 109.602 -176.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.419 ' HB2' ' N ' ' A' ' 6' ' ' CYS . 23.1 p -122.36 -156.07 0.67 Allowed 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.754 176.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.517 ' O ' ' SG ' ' A' ' 6' ' ' CYS . 8.6 mt -124.68 124.52 42.36 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 114.784 -1.098 . . . . 0.0 109.917 179.025 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.2 m -108.19 -68.24 0.92 Allowed 'General case' 0 N--CA 1.504 2.227 0 C-N-CA 119.058 -1.057 . . . . 0.0 111.519 -177.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -87.27 91.17 8.63 Favored 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 118.701 -1.2 . . . . 0.0 110.915 -177.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.06 -98.53 1.1 Allowed Glycine 0 N--CA 1.49 2.289 0 C-N-CA 119.632 -1.27 . . . . 0.0 111.598 177.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.406 ' O ' ' OG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -129.83 5.81 5.05 Favored 'General case' 0 N--CA 1.483 1.187 0 CA-C-O 122.293 1.044 . . . . 0.0 110.224 -177.763 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.672 ' N ' HD22 ' A' ' 20' ' ' ASN . 1.0 OUTLIER -81.35 130.81 35.19 Favored 'General case' 0 C--N 1.253 -3.605 0 CA-C-N 113.438 -1.71 . . . . 0.0 110.296 178.97 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.6 t -75.38 146.46 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 C-N-CA 119.377 -0.929 . . . . 0.0 110.459 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.477 ' O ' ' O ' ' A' ' 12' ' ' ASN . 21.2 m -143.36 109.95 5.48 Favored 'General case' 0 N--CA 1.505 2.283 0 C-N-CA 118.587 -1.245 . . . . 0.0 110.483 177.31 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.447 ' O ' ' O ' ' A' ' 26' ' ' ASN . . . -175.91 -91.39 0.08 OUTLIER Glycine 0 C--O 1.203 -1.784 0 C-N-CA 118.331 -1.89 . . . . 0.0 112.177 -178.038 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -50.77 120.75 5.05 Favored 'General case' 0 C--N 1.297 -1.677 0 C-N-CA 119.086 -1.046 . . . . 0.0 110.548 -178.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.68 -26.78 21.78 Favored Glycine 0 N--CA 1.481 1.667 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -178.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.447 ' O ' ' O ' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -137.17 -163.81 1.49 Allowed 'General case' 0 C--N 1.313 -0.994 0 C-N-CA 120.148 -0.621 . . . . 0.0 111.122 -179.508 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.561 ' NZ ' HD11 ' A' ' 29' ' ' ILE . 16.0 ttpt -142.38 165.46 27.35 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 177.417 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -130.79 163.37 27.48 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 118.893 -1.123 . . . . 0.0 110.494 175.374 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.561 HD11 ' NZ ' ' A' ' 27' ' ' LYS . 15.4 mm -151.42 129.47 2.58 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.104 0 CA-C-N 113.176 -1.829 . . . . 0.0 109.186 179.434 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.462 ' H ' ' HB3' ' A' ' 9' ' ' SER . 29.2 mt -78.06 119.53 21.61 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 118.602 -1.239 . . . . 0.0 109.529 178.245 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.45 ' H ' ' HA ' ' A' ' 37' ' ' ASN . . . 94.64 106.74 2.02 Favored Glycine 0 N--CA 1.478 1.474 0 C-N-CA 119.027 -1.558 . . . . 0.0 110.513 -179.553 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.559 ' N ' ' O ' ' A' ' 36' ' ' LYS . 18.0 t -74.54 -128.2 0.01 OUTLIER 'General case' 0 C--O 1.197 -1.679 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -73.68 63.4 0.85 Allowed 'General case' 0 C--N 1.256 -3.458 0 CA-C-N 114.337 -1.301 . . . . 0.0 108.342 -175.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.555 ' N ' ' O ' ' A' ' 32' ' ' SER . . . 75.08 28.01 63.16 Favored Glycine 0 C--N 1.289 -2.034 0 N-CA-C 108.134 -1.986 . . . . 0.0 108.134 -176.483 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -123.67 -130.09 0.26 Allowed 'General case' 0 C--O 1.212 -0.87 0 C-N-CA 119.197 -1.001 . . . . 0.0 112.323 -176.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.559 ' O ' ' N ' ' A' ' 32' ' ' SER . 3.1 pttm -94.87 -172.22 2.65 Favored 'General case' 0 C--N 1.28 -2.435 0 CA-C-N 113.609 -1.632 . . . . 0.0 113.511 -177.567 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.45 ' HA ' ' H ' ' A' ' 31' ' ' GLY . 1.6 m-20 -52.52 154.53 2.54 Favored 'General case' 0 N--CA 1.502 2.133 0 CA-C-N 114.997 -1.002 . . . . 0.0 112.187 179.342 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.546 ' NE2' ' OG ' ' A' ' 32' ' ' SER . 5.8 tt0 -156.46 155.44 32.06 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 119.626 -0.829 . . . . 0.0 110.407 177.406 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 96.9 m -112.99 98.53 7.22 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 119.897 -0.721 . . . . 0.0 110.642 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.534 ' O ' ' N ' ' A' ' 27' ' ' LYS . 0.2 OUTLIER -98.48 142.78 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.237 0 C-N-CA 118.777 -1.169 . . . . 0.0 111.619 179.844 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.411 ' O ' HG22 ' A' ' 40' ' ' VAL . 1.9 t -63.42 150.04 44.54 Favored 'General case' 0 C--N 1.275 -2.636 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.949 179.685 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.416 ' H ' ' HA ' ' A' ' 26' ' ' ASN . . . 141.6 -147.54 19.12 Favored Glycine 0 N--CA 1.495 2.58 0 C-N-CA 119.697 -1.24 . . . . 0.0 110.428 -179.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -135.62 117.1 14.77 Favored 'General case' 0 N--CA 1.498 1.939 0 C-N-CA 119.798 -0.761 . . . . 0.0 110.349 179.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -113.33 177.17 17.92 Favored Glycine 0 N--CA 1.499 2.888 0 C-N-CA 119.965 -1.112 . . . . 0.0 110.409 -179.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.481 ' O ' HG23 ' A' ' 45' ' ' THR . 8.8 t -90.03 127.79 52.3 Favored Pre-proline 0 CA--C 1.566 1.594 0 C-N-CA 119.224 -0.99 . . . . 0.0 110.444 -179.681 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -59.78 147.84 90.65 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 121.266 1.311 . . . . 0.0 112.019 179.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.63 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 28.0 tt0 -84.35 -37.53 0.64 Allowed Pre-proline 0 CA--C 1.554 1.115 0 C-N-CA 119.674 -0.81 . . . . 0.0 111.896 177.523 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.63 ' CD ' ' N ' ' A' ' 47' ' ' GLU . 4.8 Cg_endo -74.85 -173.25 1.48 Allowed 'Trans proline' 0 C--O 1.213 -0.728 0 C-N-CA 121.1 1.2 . . . . 0.0 111.097 -176.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 116.761 -1.59 . . . . 0.0 109.92 179.122 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 8.9 p . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.404 HG12 ' H ' ' A' ' 3' ' ' TYR . 1.3 t -94.34 175.79 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 C-N-CA 119.643 -0.823 . . . . 0.0 109.475 179.333 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.404 ' H ' HG12 ' A' ' 2' ' ' VAL . 38.4 m-85 -132.18 -174.13 3.35 Favored 'General case' 0 N--CA 1.495 1.789 0 C-N-CA 119.525 -0.87 . . . . 0.0 110.411 179.189 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.575 ' OG1' ' N ' ' A' ' 5' ' ' ASP . 0.1 OUTLIER -101.68 -178.18 3.64 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 178.857 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.575 ' N ' ' OG1' ' A' ' 4' ' ' THR . 0.0 OUTLIER -93.05 154.03 18.36 Favored 'General case' 0 C--N 1.288 -2.078 0 C-N-CA 119.162 -1.015 . . . . 0.0 109.605 178.074 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.418 ' SG ' ' HB2' ' A' ' 11' ' ' GLN . 3.7 m -73.99 174.89 7.95 Favored 'General case' 0 C--N 1.295 -1.784 0 C-N-CA 118.944 -1.102 . . . . 0.0 110.778 177.543 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.9 t -155.13 11.88 0.35 Allowed 'General case' 0 C--N 1.276 -2.588 0 CA-C-N 113.554 -1.657 . . . . 0.0 109.806 177.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -154.82 173.86 15.87 Favored 'General case' 0 C--N 1.29 -1.997 0 CA-C-N 114.313 -1.312 . . . . 0.0 109.498 -177.344 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.478 ' HB3' ' H ' ' A' ' 30' ' ' LEU . 0.9 OUTLIER -89.18 157.26 18.34 Favored 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 119.325 -0.95 . . . . 0.0 109.807 179.205 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 28' ' ' CYS . . . 94.12 -51.49 2.19 Favored Glycine 0 N--CA 1.502 3.054 0 C-N-CA 119.075 -1.536 . . . . 0.0 112.396 178.156 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.496 ' H ' ' NE2' ' A' ' 11' ' ' GLN . 3.9 mp0 -40.24 164.03 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.452 0 C-N-CA 120.29 -0.564 . . . . 0.0 111.91 -176.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.497 ' ND2' ' O ' ' A' ' 26' ' ' ASN . 85.1 m-20 -140.69 -50.45 0.45 Allowed 'General case' 0 N--CA 1.507 2.409 0 C-N-CA 119.149 -1.02 . . . . 0.0 113.413 -177.407 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.428 HD12 ' HB3' ' A' ' 46' ' ' PRO . 14.7 mt -77.35 43.47 0.38 Allowed 'General case' 0 C--N 1.295 -1.787 0 C-N-CA 119.09 -1.044 . . . . 0.0 110.359 -177.389 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.654 ' SG ' ' N ' ' A' ' 15' ' ' LEU . 14.1 p -123.05 -148.44 0.4 Allowed 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 114.725 -1.125 . . . . 0.0 108.491 176.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.654 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 83.3 mt -116.23 98.73 6.76 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 114.497 -1.229 . . . . 0.0 107.866 173.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.469 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 57.6 m -95.9 -51.24 4.55 Favored 'General case' 0 C--N 1.276 -2.595 0 CA-C-N 113.429 -1.714 . . . . 0.0 110.947 -173.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -94.49 94.0 7.97 Favored 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 119.433 -0.907 . . . . 0.0 109.89 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 62.81 -92.7 0.09 OUTLIER Glycine 0 N--CA 1.49 2.242 0 C-N-CA 119.335 -1.412 . . . . 0.0 110.315 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.45 ' O ' HD22 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -131.15 3.05 4.31 Favored 'General case' 0 N--CA 1.483 1.219 0 CA-C-O 122.138 0.971 . . . . 0.0 110.114 -179.901 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 68.6 m-80 -79.34 140.87 37.39 Favored 'General case' 0 C--N 1.258 -3.374 0 CA-C-N 113.409 -1.723 . . . . 0.0 110.544 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.1 t -82.55 135.57 24.61 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 C-N-CA 118.875 -1.13 . . . . 0.0 111.404 -179.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.495 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 0.1 OUTLIER -91.19 151.52 20.91 Favored 'General case' 0 N--CA 1.513 2.708 0 C-N-CA 118.559 -1.256 . . . . 0.0 108.057 169.682 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.459 ' O ' ' OD1' ' A' ' 26' ' ' ASN . . . -118.74 124.93 6.2 Favored Glycine 0 C--O 1.213 -1.211 0 C-N-CA 119.922 -1.132 . . . . 0.0 110.42 -170.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.434 ' C ' ' O ' ' A' ' 23' ' ' GLY . 2.8 tt0 -36.06 132.43 0.52 Allowed 'General case' 0 C--N 1.255 -3.52 0 CA-C-N 112.652 -1.774 . . . . 0.0 110.127 178.073 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 126.6 -30.14 4.3 Favored Glycine 0 N--CA 1.482 1.715 0 N-CA-C 107.716 -2.154 . . . . 0.0 107.716 -175.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.637 ' N ' ' ND2' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -102.13 -159.77 0.75 Allowed 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 177.47 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.765 ' NZ ' HD11 ' A' ' 29' ' ' ILE . 4.8 ttpp -152.81 104.5 2.87 Favored 'General case' 0 N--CA 1.498 1.945 0 C-N-CA 119.194 -1.003 . . . . 0.0 111.594 179.593 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.515 ' O ' ' N ' ' A' ' 10' ' ' GLY . 32.5 m -79.43 157.2 27.6 Favored 'General case' 0 C--O 1.201 -1.492 0 C-N-CA 117.617 -1.633 . . . . 0.0 110.071 178.183 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.765 HD11 ' NZ ' ' A' ' 27' ' ' LYS . 28.0 mm -140.73 138.1 35.32 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.487 0 CA-C-N 114.825 -1.08 . . . . 0.0 110.173 177.414 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.478 ' H ' ' HB3' ' A' ' 9' ' ' SER . 21.1 mt -77.72 108.58 11.03 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 119.054 -1.058 . . . . 0.0 109.345 177.205 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.47 ' H ' ' HA ' ' A' ' 37' ' ' ASN . . . 105.47 110.84 3.54 Favored Glycine 0 N--CA 1.484 1.892 0 C-N-CA 119.69 -1.243 . . . . 0.0 110.513 -179.569 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.613 ' N ' ' O ' ' A' ' 36' ' ' LYS . 1.8 t -87.41 -133.92 0.08 Allowed 'General case' 0 C--O 1.203 -1.362 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.329 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -74.33 66.35 1.31 Allowed 'General case' 0 C--N 1.254 -3.582 0 CA-C-N 114.661 -1.154 . . . . 0.0 108.39 -175.525 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 32' ' ' SER . . . 76.93 28.05 59.43 Favored Glycine 0 C--N 1.288 -2.132 0 N-CA-C 108.626 -1.79 . . . . 0.0 108.626 -177.63 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 35.9 mm-40 -130.08 -132.88 0.21 Allowed 'General case' 0 C--O 1.212 -0.887 0 C-N-CA 118.999 -1.08 . . . . 0.0 112.005 -177.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.613 ' O ' ' N ' ' A' ' 32' ' ' SER . 8.8 mmtm -96.74 -164.24 1.13 Allowed 'General case' 0 C--N 1.278 -2.518 0 CA-C-N 112.995 -1.911 . . . . 0.0 112.88 -176.204 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.522 ' OD1' ' N ' ' A' ' 37' ' ' ASN . 0.6 OUTLIER -55.91 157.37 4.46 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.901 178.739 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -154.93 147.03 23.69 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 115.003 -0.998 . . . . 0.0 109.29 176.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.465 ' SG ' ' HB2' ' A' ' 16' ' ' CYS . 1.0 OUTLIER -104.15 91.34 3.9 Favored 'General case' 0 C--N 1.299 -1.604 0 C-N-CA 119.521 -0.872 . . . . 0.0 110.208 -179.984 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.573 HG22 ' N ' ' A' ' 41' ' ' THR . 3.4 p -106.76 160.15 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 C-N-CA 118.617 -1.233 . . . . 0.0 110.567 179.299 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.573 ' N ' HG22 ' A' ' 40' ' ' VAL . 8.8 t -80.14 154.81 27.79 Favored 'General case' 0 C--N 1.276 -2.606 0 CA-C-N 114.87 -1.059 . . . . 0.0 112.128 -178.613 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 166.94 -120.75 0.93 Allowed Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.906 -1.277 . . . . 0.0 109.906 178.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -142.98 123.74 14.19 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 119.374 -0.93 . . . . 0.0 110.109 179.145 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -142.11 -171.19 12.93 Favored Glycine 0 N--CA 1.489 2.186 1 N-CA-C 131.0 7.16 . . . . 0.0 131.0 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -136.16 154.0 77.06 Favored Pre-proline 0 N--CA 1.492 1.669 0 C-N-CA 119.904 -0.718 . . . . 0.0 109.48 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.428 ' HB3' HD12 ' A' ' 13' ' ' LEU . 5.8 Cg_exo -56.82 -175.88 0.05 OUTLIER 'Trans proline' 0 C--N 1.324 -0.719 0 C-N-CA 120.994 1.129 . . . . 0.0 110.396 175.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.656 ' CD ' ' H ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -83.82 158.69 61.89 Favored Pre-proline 0 C--N 1.304 -1.397 0 C-N-CA 118.814 -1.154 . . . . 0.0 109.202 178.518 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -55.4 -178.75 0.06 OUTLIER 'Trans proline' 0 C--N 1.325 -0.678 0 C-N-CA 121.119 1.213 . . . . 0.0 110.964 -178.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 116.278 -1.82 . . . . 0.0 110.327 -179.899 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 25.1 m . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 1.6 t -90.05 162.59 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 C-N-CA 119.623 -0.831 . . . . 0.0 110.807 -178.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -107.77 -163.96 0.93 Allowed 'General case' 0 N--CA 1.495 1.814 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.707 -179.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.565 ' OG1' ' N ' ' A' ' 5' ' ' ASP . 0.5 OUTLIER -127.61 -172.91 2.78 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 177.052 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.565 ' N ' ' OG1' ' A' ' 4' ' ' THR . 0.3 OUTLIER -81.3 157.53 25.08 Favored 'General case' 0 C--N 1.288 -2.067 0 C-N-CA 118.358 -1.337 . . . . 0.0 111.332 -178.693 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.402 ' N ' ' HB2' ' A' ' 14' ' ' CYS . 0.0 OUTLIER -75.83 -179.69 4.96 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.242 177.459 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.1 t -138.34 -0.85 1.96 Allowed 'General case' 0 N--CA 1.497 1.892 0 C-N-CA 119.001 -1.08 . . . . 0.0 111.408 178.128 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.463 ' HA ' HD12 ' A' ' 30' ' ' LEU . 8.8 pt-20 -163.33 169.17 19.46 Favored 'General case' 0 C--N 1.273 -2.741 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.985 177.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.18 149.37 44.72 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.587 -178.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.59 -12.15 62.98 Favored Glycine 0 N--CA 1.504 3.229 0 C-N-CA 119.473 -1.346 . . . . 0.0 112.458 179.066 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.414 ' CA ' ' OE1' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -66.56 178.18 1.35 Allowed 'General case' 0 N--CA 1.503 2.203 0 C-N-CA 119.181 -1.008 . . . . 0.0 110.961 -179.043 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.72 HD21 ' HA3' ' A' ' 44' ' ' GLY . 44.5 m-20 -143.85 -72.18 0.29 Allowed 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 118.648 -1.221 . . . . 0.0 113.031 -178.472 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.425 HD12 ' HB3' ' A' ' 46' ' ' PRO . 12.9 mt -75.51 48.31 0.44 Allowed 'General case' 0 C--N 1.289 -2.042 0 C-N-CA 119.542 -0.863 . . . . 0.0 110.032 -176.488 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.438 ' H ' ' C ' ' A' ' 12' ' ' ASN . 31.5 p -122.39 -151.5 0.48 Allowed 'General case' 0 C--N 1.302 -1.5 0 CA-C-N 114.261 -1.336 . . . . 0.0 108.409 176.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.45 HD22 ' O ' ' A' ' 19' ' ' SER . 67.6 mt -114.63 110.93 20.52 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-N 115.097 -0.956 . . . . 0.0 108.852 175.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 69.7 m -107.4 -70.41 0.8 Allowed 'General case' 0 C--N 1.285 -2.21 0 CA-C-N 114.437 -1.256 . . . . 0.0 110.243 -175.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -79.03 89.9 4.79 Favored 'General case' 0 C--N 1.297 -1.682 0 C-N-CA 118.829 -1.149 . . . . 0.0 109.472 178.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 70.9 -127.5 15.47 Favored Glycine 0 N--CA 1.483 1.827 0 C-N-CA 119.416 -1.374 . . . . 0.0 110.032 -178.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.45 ' O ' HD22 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -101.63 2.42 38.79 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 122.279 1.038 . . . . 0.0 109.629 179.677 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -78.82 140.73 38.14 Favored 'General case' 0 C--N 1.26 -3.289 0 CA-C-N 113.227 -1.806 . . . . 0.0 110.466 -179.541 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.3 t -80.88 142.47 13.8 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.977 -178.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.568 ' O ' ' O ' ' A' ' 12' ' ' ASN . 0.0 OUTLIER -114.65 161.59 17.9 Favored 'General case' 0 N--CA 1.505 2.319 0 N-CA-C 104.908 -2.256 . . . . 0.0 104.908 168.849 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -137.79 -139.31 3.85 Favored Glycine 0 CA--C 1.483 -1.963 0 C-N-CA 116.809 -2.615 . . . . 0.0 112.134 -175.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -91.57 150.15 21.33 Favored 'General case' 0 C--N 1.253 -3.615 0 CA-C-N 112.343 -1.929 . . . . 0.0 110.543 -174.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.6 -31.96 8.04 Favored Glycine 0 C--N 1.297 -1.634 0 N-CA-C 108.948 -1.661 . . . . 0.0 108.948 -177.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -109.61 -174.74 2.57 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 119.767 -0.773 . . . . 0.0 109.415 179.41 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.403 ' O ' ' O ' ' A' ' 40' ' ' VAL . 51.1 tttp -142.53 114.69 8.29 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 118.994 -1.083 . . . . 0.0 110.01 176.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.472 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 28.9 m -84.38 151.12 24.9 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 117.519 -1.672 . . . . 0.0 110.241 178.008 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 6.3 mm -130.23 125.01 59.05 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.748 0 CA-C-N 113.926 -1.488 . . . . 0.0 109.185 177.32 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.463 HD12 ' HA ' ' A' ' 8' ' ' GLU . 18.5 mt -76.5 133.58 39.74 Favored 'General case' 0 N--CA 1.498 1.966 0 C-N-CA 118.475 -1.29 . . . . 0.0 110.126 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 36' ' ' LYS . . . -69.44 -96.61 0.05 OUTLIER Glycine 0 N--CA 1.487 2.038 0 C-N-CA 119.162 -1.494 . . . . 0.0 110.219 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.515 ' O ' ' N ' ' A' ' 34' ' ' GLY . 3.4 m -109.96 -127.35 0.27 Allowed 'General case' 0 C--O 1.202 -1.434 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.206 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -73.97 69.29 1.42 Allowed 'General case' 0 C--N 1.255 -3.525 0 CA-C-N 114.703 -1.135 . . . . 0.0 108.723 -174.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 32' ' ' SER . . . 69.52 25.52 75.42 Favored Glycine 0 C--N 1.284 -2.344 0 N-CA-C 107.773 -2.131 . . . . 0.0 107.773 -177.471 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.527 ' O ' ' N ' ' A' ' 37' ' ' ASN . 42.7 mt-10 -91.59 -111.28 0.09 Allowed 'General case' 0 C--N 1.312 -1.044 0 C-N-CA 118.774 -1.17 . . . . 0.0 112.207 -177.083 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.506 ' O ' ' N ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -58.52 76.94 0.01 OUTLIER 'General case' 0 C--N 1.266 -3.035 0 CA-C-N 113.717 -1.583 . . . . 0.0 112.493 -175.905 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.527 ' N ' ' O ' ' A' ' 35' ' ' GLU . 3.2 m-20 -90.7 99.35 12.4 Favored 'General case' 0 C--N 1.289 -2.056 0 CA-C-N 114.378 -1.283 . . . . 0.0 109.106 176.483 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -103.26 148.61 25.61 Favored 'General case' 0 C--N 1.308 -1.217 0 C-N-CA 119.375 -0.93 . . . . 0.0 110.483 -177.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.472 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 1.6 m -103.38 88.5 3.12 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 119.445 -0.902 . . . . 0.0 110.844 -179.335 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.418 HG22 ' O ' ' A' ' 41' ' ' THR . 0.2 OUTLIER -97.47 139.68 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 C-N-CA 118.41 -1.316 . . . . 0.0 110.332 179.047 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.418 ' O ' HG22 ' A' ' 40' ' ' VAL . 15.2 t -53.19 152.92 4.02 Favored 'General case' 0 C--N 1.272 -2.773 0 CA-C-N 113.887 -1.506 . . . . 0.0 111.021 -178.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 152.19 -167.17 31.22 Favored Glycine 0 N--CA 1.49 2.296 0 C-N-CA 119.08 -1.534 . . . . 0.0 110.797 179.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 18.5 mp0 -83.44 -176.77 6.47 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 119.396 -0.922 . . . . 0.0 110.367 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.72 ' HA3' HD21 ' A' ' 12' ' ' ASN . . . 177.76 172.23 42.02 Favored Glycine 0 N--CA 1.486 2.031 1 N-CA-C 129.575 6.59 . . . . 0.0 129.575 179.831 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -128.45 140.87 39.63 Favored Pre-proline 0 N--CA 1.486 1.363 0 C-N-CA 119.291 -0.964 . . . . 0.0 109.925 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.425 ' HB3' HD12 ' A' ' 13' ' ' LEU . 4.9 Cg_exo -58.54 -163.16 0.02 OUTLIER 'Trans proline' 0 C--O 1.214 -0.692 0 C-N-CA 121.067 1.178 . . . . 0.0 111.059 178.124 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -119.14 96.01 49.75 Favored Pre-proline 0 C--N 1.305 -1.353 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.409 178.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -68.28 166.58 24.8 Favored 'Trans proline' 0 C--O 1.214 -0.704 0 C-N-CA 120.781 0.987 . . . . 0.0 110.639 -178.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 24.6 pt20 . . . . . 0 N--CA 1.489 1.502 0 CA-C-O 116.37 -1.776 . . . . 0.0 110.277 179.995 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 9.3 m . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.1 t -102.07 169.29 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 C-N-CA 119.849 -0.741 . . . . 0.0 110.319 -179.339 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.479 ' CE2' HD22 ' A' ' 13' ' ' LEU . 28.0 m-85 -100.32 -169.44 1.73 Allowed 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 119.487 -0.885 . . . . 0.0 110.676 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.612 ' OG1' ' N ' ' A' ' 5' ' ' ASP . 0.1 OUTLIER -108.89 -175.42 2.76 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -179.953 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.612 ' N ' ' OG1' ' A' ' 4' ' ' THR . 0.0 OUTLIER -86.13 156.86 20.18 Favored 'General case' 0 C--N 1.293 -1.878 0 C-N-CA 118.982 -1.087 . . . . 0.0 110.619 -179.615 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.6 m -73.43 178.71 4.42 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 119.541 -0.864 . . . . 0.0 110.711 176.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 13.3 t -146.01 4.17 0.95 Allowed 'General case' 0 C--N 1.286 -2.182 0 CA-C-N 114.391 -1.277 . . . . 0.0 110.75 177.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.43 ' HB2' HE22 ' A' ' 11' ' ' GLN . 2.3 mt-10 -163.96 170.49 16.6 Favored 'General case' 0 C--N 1.282 -2.358 0 CA-C-N 114.575 -1.193 . . . . 0.0 110.284 178.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.445 ' HB3' ' H ' ' A' ' 30' ' ' LEU . 0.4 OUTLIER -83.31 151.37 25.61 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 119.603 -0.839 . . . . 0.0 109.117 178.479 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.13 -1.99 71.04 Favored Glycine 0 N--CA 1.493 2.447 0 C-N-CA 119.061 -1.542 . . . . 0.0 112.839 179.047 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.43 HE22 ' HB2' ' A' ' 8' ' ' GLU . 0.0 OUTLIER -76.24 -165.24 0.46 Allowed 'General case' 0 N--CA 1.501 2.095 0 C-N-CA 118.752 -1.179 . . . . 0.0 109.723 179.248 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.543 ' OD1' ' N ' ' A' ' 24' ' ' GLN . 12.7 t-20 -150.63 -77.33 0.14 Allowed 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 117.987 -1.485 . . . . 0.0 114.5 -177.324 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.538 ' H ' ' HA ' ' A' ' 46' ' ' PRO . 12.4 mt -76.22 53.91 0.85 Allowed 'General case' 0 C--N 1.273 -2.755 0 C-N-CA 118.557 -1.257 . . . . 0.0 110.857 -175.268 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.638 ' SG ' ' N ' ' A' ' 15' ' ' LEU . 8.8 p -123.53 -152.47 0.51 Allowed 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 114.85 -1.068 . . . . 0.0 108.802 176.012 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.638 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 51.7 mt -112.97 119.6 38.48 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 115.044 -0.98 . . . . 0.0 108.646 176.558 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.406 ' SG ' ' O ' ' A' ' 22' ' ' CYS . 1.6 m -122.47 7.91 9.57 Favored 'General case' 0 N--CA 1.502 2.138 0 C-N-CA 118.634 -1.227 . . . . 0.0 111.15 -176.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -157.51 82.2 0.9 Allowed 'General case' 0 C--N 1.298 -1.647 0 C-N-CA 119.412 -0.915 . . . . 0.0 109.35 177.114 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.83 -112.76 3.69 Favored Glycine 0 N--CA 1.485 1.939 0 C-N-CA 119.424 -1.369 . . . . 0.0 109.981 -178.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.48 0.39 14.7 Favored 'General case' 0 CA--C 1.493 -1.249 0 CA-C-O 122.336 1.065 . . . . 0.0 109.551 179.534 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 71.8 m-20 -79.52 128.78 33.79 Favored 'General case' 0 C--N 1.257 -3.435 0 CA-C-N 113.099 -1.864 . . . . 0.0 111.278 -178.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.5 t -69.13 143.99 14.51 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 C-N-CA 118.594 -1.242 . . . . 0.0 108.563 177.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.517 ' O ' ' SG ' ' A' ' 28' ' ' CYS . 0.9 OUTLIER -146.71 128.17 14.99 Favored 'General case' 0 C--N 1.272 -2.768 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 179.642 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.464 ' O ' ' O ' ' A' ' 26' ' ' ASN . . . 164.49 -79.85 0.13 Allowed Glycine 0 C--O 1.201 -1.908 0 C-N-CA 117.22 -2.419 . . . . 0.0 112.151 -176.373 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.543 ' N ' ' OD1' ' A' ' 12' ' ' ASN . 0.1 OUTLIER -44.78 125.13 4.76 Favored 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 119.647 -0.821 . . . . 0.0 111.66 -176.753 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.69 -26.2 8.6 Favored Glycine 0 N--CA 1.483 1.808 0 N-CA-C 109.899 -1.28 . . . . 0.0 109.899 -179.287 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.617 ' N ' ' ND2' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -129.53 -175.95 3.75 Favored 'General case' 0 C--N 1.311 -1.074 0 C-N-CA 120.22 -0.592 . . . . 0.0 111.066 -178.871 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.45 ' O ' ' N ' ' A' ' 40' ' ' VAL . 0.0 OUTLIER -120.56 153.83 36.2 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.038 175.187 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.517 ' SG ' ' O ' ' A' ' 22' ' ' CYS . 86.1 m -120.26 146.44 46.08 Favored 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 119.169 -1.013 . . . . 0.0 109.613 174.636 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.44 HD13 ' O ' ' A' ' 28' ' ' CYS . 2.3 mm -131.99 132.29 61.39 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.953 0 CA-C-N 114.314 -1.312 . . . . 0.0 109.93 179.489 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.445 ' H ' ' HB3' ' A' ' 9' ' ' SER . 14.8 mt -76.56 121.65 23.48 Favored 'General case' 0 N--CA 1.494 1.725 0 C-N-CA 118.327 -1.349 . . . . 0.0 108.891 176.542 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -96.86 -124.69 4.8 Favored Glycine 0 C--O 1.215 -1.069 0 C-N-CA 118.537 -1.792 . . . . 0.0 111.009 -178.33 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.502 ' OG ' ' N ' ' A' ' 33' ' ' ASP . 19.7 p -152.56 -145.81 0.18 Allowed 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 122.571 1.177 . . . . 0.0 111.047 -179.328 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.502 ' N ' ' OG ' ' A' ' 32' ' ' SER . 2.5 m-20 -86.8 68.87 10.24 Favored 'General case' 0 C--N 1.261 -3.262 0 CA-C-N 112.825 -1.988 . . . . 0.0 110.729 -173.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 139.62 -9.82 3.16 Favored Glycine 0 C--N 1.276 -2.755 0 N-CA-C 108.14 -1.984 . . . . 0.0 108.14 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.74 ' O ' ' O ' ' A' ' 36' ' ' LYS . 3.5 mm-40 -137.94 11.04 2.87 Favored 'General case' 0 C--O 1.196 -1.721 0 CA-C-N 114.303 -0.948 . . . . 0.0 110.213 -179.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.74 ' O ' ' O ' ' A' ' 35' ' ' GLU . 10.2 tttp -31.42 -157.4 0.0 OUTLIER 'General case' 0 C--N 1.262 -3.197 0 O-C-N 126.446 2.341 . . . . 0.0 114.984 -173.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.522 ' OD1' ' N ' ' A' ' 37' ' ' ASN . 0.3 OUTLIER -55.97 114.96 2.14 Favored 'General case' 0 C--N 1.268 -2.964 0 C-N-CA 117.908 -1.517 . . . . 0.0 110.829 -176.639 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -120.78 149.56 42.36 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.144 -0.934 . . . . 0.0 109.727 178.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 3.0 m -100.33 105.73 17.28 Favored 'General case' 0 C--N 1.298 -1.658 0 C-N-CA 119.441 -0.904 . . . . 0.0 110.316 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.915 HG22 ' H ' ' A' ' 41' ' ' THR . 7.4 p -99.77 -176.81 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 C-N-CA 118.518 -1.273 . . . . 0.0 110.241 177.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.915 ' H ' HG22 ' A' ' 40' ' ' VAL . 12.5 t -91.67 160.05 15.56 Favored 'General case' 0 C--N 1.288 -2.068 0 CA-C-N 114.629 -1.169 . . . . 0.0 110.926 179.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 138.28 -147.47 19.25 Favored Glycine 0 N--CA 1.496 2.695 1 N-CA-C 131.793 7.477 . . . . 0.0 131.793 179.178 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -108.88 111.46 23.18 Favored 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 119.933 -0.707 . . . . 0.0 110.412 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -130.52 156.56 21.68 Favored Glycine 0 N--CA 1.491 2.363 1 N-CA-C 129.783 6.673 . . . . 0.0 129.783 178.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.462 HG23 ' O ' ' A' ' 46' ' ' PRO . 5.8 t -111.31 145.2 32.04 Favored Pre-proline 0 N--CA 1.495 1.823 0 C-N-CA 119.59 -0.844 . . . . 0.0 110.197 -178.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.538 ' HA ' ' H ' ' A' ' 13' ' ' LEU . 7.2 Cg_exo -52.44 -176.97 0.02 OUTLIER 'Trans proline' 0 C--O 1.211 -0.854 0 C-N-CA 120.9 1.066 . . . . 0.0 110.351 175.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.652 ' CD ' ' H ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -80.1 164.39 52.8 Favored Pre-proline 0 C--N 1.306 -1.322 0 C-N-CA 118.866 -1.134 . . . . 0.0 108.519 178.594 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -57.84 157.81 22.82 Favored 'Trans proline' 0 C--O 1.215 -0.673 0 C-N-CA 121.113 1.209 . . . . 0.0 111.734 -174.165 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 116.268 -1.825 . . . . 0.0 110.405 179.994 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 2.7 m . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.681 HG12 ' N ' ' A' ' 3' ' ' TYR . 38.6 t -81.93 174.97 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 C-N-CA 119.402 -0.919 . . . . 0.0 109.973 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.681 ' N ' HG12 ' A' ' 2' ' ' VAL . 35.8 m-85 -139.5 -166.24 2.02 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 119.722 -0.791 . . . . 0.0 110.125 -179.381 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -93.09 -174.95 3.71 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 119.679 -0.809 . . . . 0.0 108.858 179.064 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -100.58 154.09 18.85 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 119.03 -1.068 . . . . 0.0 110.441 179.069 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.42 ' N ' ' HB2' ' A' ' 14' ' ' CYS . 4.3 m -74.67 174.91 8.43 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-O 122.144 0.973 . . . . 0.0 111.188 178.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -140.26 7.49 2.19 Favored 'General case' 0 C--N 1.285 -2.232 0 CA-C-N 113.549 -1.659 . . . . 0.0 109.471 177.592 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -163.13 162.64 25.72 Favored 'General case' 0 C--N 1.279 -2.481 0 CA-C-N 113.784 -1.553 . . . . 0.0 109.0 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.604 ' OG ' ' N ' ' A' ' 30' ' ' LEU . 0.9 OUTLIER -65.1 -168.11 0.03 OUTLIER 'General case' 0 C--N 1.293 -1.876 0 C-N-CA 118.992 -1.083 . . . . 0.0 110.057 -179.087 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.508 ' H ' HD13 ' A' ' 29' ' ' ILE . . . 37.1 6.05 0.0 OUTLIER Glycine 0 N--CA 1.505 3.281 1 N-CA-C 130.124 6.81 . . . . 0.0 130.124 -179.831 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -74.79 -167.0 0.52 Allowed 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 175.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.474 ' ND2' ' C ' ' A' ' 23' ' ' GLY . 1.4 m-20 -143.01 -70.24 0.33 Allowed 'General case' 0 N--CA 1.5 2.072 0 C-N-CA 117.55 -1.66 . . . . 0.0 114.987 -178.41 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.538 HD12 ' HB3' ' A' ' 46' ' ' PRO . 15.0 mt -77.67 50.45 0.83 Allowed 'General case' 0 C--N 1.27 -2.879 0 C-N-CA 117.244 -1.782 . . . . 0.0 111.111 -174.505 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.575 ' SG ' ' N ' ' A' ' 15' ' ' LEU . 15.6 p -119.76 -146.48 0.38 Allowed 'General case' 0 C--O 1.207 -1.146 0 CA-C-N 114.948 -1.023 . . . . 0.0 108.397 175.178 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.575 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 7.7 mt -128.85 130.77 47.34 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.822 177.657 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.421 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 7.9 m -139.0 21.47 2.63 Favored 'General case' 0 N--CA 1.498 1.971 0 C-N-CA 119.127 -1.029 . . . . 0.0 110.536 -179.417 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -146.41 55.16 1.14 Allowed 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 177.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.7 -66.92 2.01 Favored Glycine 0 N--CA 1.487 2.063 0 C-N-CA 119.479 -1.344 . . . . 0.0 110.19 -179.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.411 ' O ' ' OG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -144.4 1.72 1.08 Allowed 'General case' 0 C--N 1.309 -1.191 0 C-N-CA 119.445 -0.902 . . . . 0.0 111.57 -179.833 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -90.1 134.91 33.98 Favored 'General case' 0 C--N 1.253 -3.615 0 CA-C-N 114.37 -1.286 . . . . 0.0 110.464 179.033 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.567 HG22 ' O ' ' A' ' 14' ' ' CYS . 1.3 t -74.2 144.12 12.79 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 C-N-CA 119.459 -0.897 . . . . 0.0 109.718 179.693 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.466 ' O ' ' O ' ' A' ' 12' ' ' ASN . 1.2 m -141.82 121.28 13.24 Favored 'General case' 0 C--N 1.29 -1.979 0 C-N-CA 118.857 -1.137 . . . . 0.0 109.384 178.398 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.474 ' C ' ' ND2' ' A' ' 12' ' ' ASN . . . 173.91 -87.69 0.08 OUTLIER Glycine 0 C--O 1.205 -1.664 0 C-N-CA 117.851 -2.119 . . . . 0.0 111.803 -176.223 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -49.8 126.49 14.08 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 119.291 -0.964 . . . . 0.0 110.491 -178.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.52 -26.27 14.68 Favored Glycine 0 N--CA 1.482 1.716 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -178.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.449 ' O ' ' O ' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -138.88 -160.9 1.11 Allowed 'General case' 0 C--N 1.311 -1.087 0 C-N-CA 119.954 -0.699 . . . . 0.0 111.139 -179.855 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.534 ' O ' ' O ' ' A' ' 40' ' ' VAL . 21.1 ttpt -148.5 148.0 29.74 Favored 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 119.66 -0.816 . . . . 0.0 109.88 177.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.442 ' O ' ' HA2' ' A' ' 10' ' ' GLY . 87.3 m -99.59 160.45 14.29 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 118.31 -1.356 . . . . 0.0 111.053 178.511 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.508 HD13 ' H ' ' A' ' 10' ' ' GLY . 18.5 mm -151.77 90.46 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.274 -2.705 0 CA-C-N 113.574 -1.648 . . . . 0.0 106.711 175.693 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.681 ' C ' HD12 ' A' ' 30' ' ' LEU . 3.1 pp -80.6 149.27 29.95 Favored 'General case' 0 C--N 1.288 -2.069 0 C-N-CA 118.051 -1.46 . . . . 0.0 113.359 -173.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.51 ' H ' ' C ' ' A' ' 36' ' ' LYS . . . -144.57 -90.3 0.11 Allowed Glycine 0 N--CA 1.492 2.418 1 N-CA-C 133.816 8.287 . . . . 0.0 133.816 -179.162 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.528 ' OG ' ' N ' ' A' ' 33' ' ' ASP . 59.6 p -149.35 -130.78 0.05 Allowed 'General case' 0 C--O 1.215 -0.75 0 CA-C-O 122.52 1.152 . . . . 0.0 113.459 -175.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.528 ' N ' ' OG ' ' A' ' 32' ' ' SER . 5.6 m-20 -79.32 65.75 4.57 Favored 'General case' 0 C--N 1.275 -2.672 0 CA-C-N 112.746 -2.024 . . . . 0.0 111.671 -172.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 127.34 -7.88 7.07 Favored Glycine 0 C--N 1.28 -2.552 0 N-CA-C 107.72 -2.152 . . . . 0.0 107.72 179.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.598 ' O ' ' N ' ' A' ' 37' ' ' ASN . 8.0 mt-10 -123.16 -0.54 8.86 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-N 113.618 -1.291 . . . . 0.0 109.931 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.51 ' C ' ' H ' ' A' ' 31' ' ' GLY . 0.1 OUTLIER -34.75 -31.22 0.01 OUTLIER 'General case' 0 C--N 1.27 -2.863 0 CA-C-N 112.734 -2.03 . . . . 0.0 111.397 -174.461 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.598 ' N ' ' O ' ' A' ' 35' ' ' GLU . 58.4 m-80 -160.6 108.01 1.56 Allowed 'General case' 1 C--N 1.242 -4.081 0 CA-C-N 113.895 -1.502 . . . . 0.0 110.937 176.073 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -110.41 145.32 37.79 Favored 'General case' 0 C--N 1.309 -1.183 0 C-N-CA 119.595 -0.842 . . . . 0.0 110.172 178.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 86.5 m -110.84 85.17 2.06 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.715 179.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.534 ' O ' ' O ' ' A' ' 27' ' ' LYS . 1.2 p -97.27 141.74 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 C-N-CA 118.617 -1.233 . . . . 0.0 112.704 -177.52 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.6 t -62.68 140.13 58.69 Favored 'General case' 0 C--N 1.27 -2.876 0 CA-C-N 113.807 -1.542 . . . . 0.0 110.656 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 168.87 -136.06 3.89 Favored Glycine 0 N--CA 1.493 2.456 0 C-N-CA 119.396 -1.383 . . . . 0.0 110.692 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -140.96 113.73 8.3 Favored 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 119.752 -0.779 . . . . 0.0 109.864 -179.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -127.54 171.13 19.01 Favored Glycine 0 N--CA 1.501 3.032 0 C-N-CA 119.725 -1.226 . . . . 0.0 111.247 -178.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -104.83 150.22 38.41 Favored Pre-proline 0 C--N 1.307 -1.254 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 179.6 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.538 ' HB3' HD12 ' A' ' 13' ' ' LEU . 3.4 Cg_exo -53.51 -164.79 0.01 OUTLIER 'Trans proline' 0 C--O 1.215 -0.641 0 C-N-CA 121.392 1.395 . . . . 0.0 111.765 177.342 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -131.76 74.54 77.45 Favored Pre-proline 0 C--N 1.308 -1.234 0 CA-C-N 115.086 -0.961 . . . . 0.0 108.648 177.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -60.48 135.02 58.31 Favored 'Trans proline' 0 C--O 1.215 -0.658 0 C-N-CA 121.647 1.565 . . . . 0.0 112.164 -173.174 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 . . . . . 0 N--CA 1.487 1.402 0 CA-C-O 116.261 -1.828 . . . . 0.0 110.291 179.136 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.494 ' O ' HG23 ' A' ' 1' ' ' VAL . 31.4 m . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.047 0.451 . . . . 0.0 109.799 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.2 t -101.02 6.53 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 CA-C-O 122.043 0.925 . . . . 0.0 110.272 -179.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.459 ' CZ ' HD22 ' A' ' 13' ' ' LEU . 36.4 m-85 -89.61 -178.29 5.51 Favored 'General case' 0 C--N 1.262 -3.235 0 CA-C-N 114.082 -1.417 . . . . 0.0 111.517 -178.563 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 23.2 p -116.38 -178.5 3.43 Favored 'General case' 0 N--CA 1.486 1.331 0 CA-C-N 114.821 -1.081 . . . . 0.0 108.857 179.19 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.1 154.23 22.18 Favored 'General case' 0 C--N 1.29 -1.998 0 C-N-CA 118.373 -1.331 . . . . 0.0 110.767 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.46 ' SG ' ' O ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -75.37 145.53 41.57 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.116 177.727 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.451 ' O ' ' OG1' ' A' ' 7' ' ' THR . 0.0 OUTLIER -114.69 8.14 16.13 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.703 -0.799 . . . . 0.0 109.506 178.525 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -162.3 171.01 17.94 Favored 'General case' 0 C--N 1.283 -2.287 0 CA-C-N 114.349 -1.296 . . . . 0.0 111.489 179.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -84.47 155.28 22.27 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 114.922 -1.035 . . . . 0.0 110.451 -178.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 87.66 -2.55 86.13 Favored Glycine 0 N--CA 1.498 2.783 0 C-N-CA 119.295 -1.431 . . . . 0.0 111.978 179.064 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -71.53 -174.91 1.18 Allowed 'General case' 0 N--CA 1.505 2.3 0 C-N-CA 119.232 -0.987 . . . . 0.0 110.219 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.741 ' O ' ' HA3' ' A' ' 23' ' ' GLY . 7.1 m120 -146.62 -71.67 0.23 Allowed 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 118.244 -1.382 . . . . 0.0 113.313 -179.106 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.699 HD12 ' HB3' ' A' ' 46' ' ' PRO . 24.6 mt -77.65 50.94 0.87 Allowed 'General case' 0 C--N 1.273 -2.718 0 C-N-CA 118.22 -1.392 . . . . 0.0 110.201 -177.618 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.432 ' HB2' ' N ' ' A' ' 6' ' ' CYS . 30.6 p -119.06 -156.44 0.65 Allowed 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.895 176.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.46 ' O ' ' SG ' ' A' ' 6' ' ' CYS . 6.0 mt -123.16 128.67 50.38 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 114.877 -1.056 . . . . 0.0 108.551 175.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 93.6 m -115.1 -44.0 3.05 Favored 'General case' 0 N--CA 1.518 2.969 0 C-N-CA 118.221 -1.391 . . . . 0.0 110.61 -179.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -102.19 116.25 32.26 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.058 -1.057 . . . . 0.0 110.057 178.326 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 47.87 -96.95 0.01 OUTLIER Glycine 0 N--CA 1.493 2.443 0 C-N-CA 119.546 -1.311 . . . . 0.0 111.299 179.213 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -131.44 6.72 4.47 Favored 'General case' 0 N--CA 1.485 1.32 0 CA-C-O 122.556 1.169 . . . . 0.0 110.211 -178.01 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 19.2 m-80 -80.11 132.18 35.89 Favored 'General case' 0 C--N 1.251 -3.674 0 CA-C-N 113.373 -1.739 . . . . 0.0 110.39 178.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.6 t -66.64 151.08 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 119.232 -0.987 . . . . 0.0 110.184 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.496 ' O ' ' O ' ' A' ' 12' ' ' ASN . 0.0 OUTLIER -150.74 112.82 4.57 Favored 'General case' 0 C--N 1.284 -2.28 0 C-N-CA 118.936 -1.106 . . . . 0.0 110.861 -179.882 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.741 ' HA3' ' O ' ' A' ' 12' ' ' ASN . . . 154.77 -45.56 0.55 Allowed Glycine 0 N--CA 1.483 1.771 1 N-CA-C 130.522 6.969 . . . . 0.0 130.522 -177.169 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.582 ' HA ' HE21 ' A' ' 24' ' ' GLN . 0.0 OUTLIER -56.92 133.45 54.68 Favored 'General case' 0 C--N 1.31 -1.134 0 C-N-CA 119.347 -0.941 . . . . 0.0 110.228 179.871 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 73.89 -23.8 1.07 Allowed Glycine 0 C--N 1.298 -1.578 0 C-N-CA 119.264 -1.446 . . . . 0.0 110.149 -179.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.537 ' O ' ' ND2' ' A' ' 12' ' ' ASN . 0.0 OUTLIER -111.14 -155.14 0.56 Allowed 'General case' 0 C--O 1.213 -0.849 0 C-N-CA 119.743 -0.783 . . . . 0.0 110.571 -179.311 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.612 ' CE ' HD11 ' A' ' 29' ' ' ILE . 0.3 OUTLIER -157.83 105.91 2.02 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.623 179.389 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.501 ' SG ' ' O ' ' A' ' 38' ' ' GLN . 0.0 OUTLIER -77.21 162.95 26.98 Favored 'General case' 0 CA--C 1.481 -1.68 0 C-N-CA 117.457 -1.697 . . . . 0.0 111.342 -179.055 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.612 HD11 ' CE ' ' A' ' 27' ' ' LYS . 23.7 mm -144.24 119.21 3.82 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.347 0 CA-C-N 112.276 -2.238 . . . . 0.0 108.273 -179.263 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 16.3 mt -78.89 146.55 33.52 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 118.199 -1.4 . . . . 0.0 112.104 -176.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.496 ' O ' ' C ' ' A' ' 35' ' ' GLU . . . -138.69 106.46 0.52 Allowed Glycine 0 C--O 1.199 -2.061 0 N-CA-C 104.527 -3.429 . . . . 0.0 104.527 174.525 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.528 ' O ' ' N ' ' A' ' 34' ' ' GLY . 27.0 t -136.8 2.24 2.61 Favored 'General case' 0 C--N 1.261 -3.251 0 C-N-CA 120.019 -0.673 . . . . 0.0 110.178 -177.345 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -77.58 59.39 1.94 Allowed 'General case' 0 C--N 1.272 -2.793 0 N-CA-C 105.117 -2.179 . . . . 0.0 105.117 -179.045 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 32' ' ' SER . . . 74.15 18.55 79.77 Favored Glycine 0 C--N 1.286 -2.246 0 N-CA-C 105.279 -3.128 . . . . 0.0 105.279 -169.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.496 ' C ' ' O ' ' A' ' 31' ' ' GLY . 54.2 mt-10 -118.88 -178.3 3.52 Favored 'General case' 0 N--CA 1.425 -1.706 0 CA-C-O 123.131 1.444 . . . . 0.0 111.288 -175.757 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.461 ' C ' ' O ' ' A' ' 31' ' ' GLY . 39.4 pttt -101.02 141.32 34.07 Favored 'General case' 0 C--N 1.246 -3.893 0 CA-C-N 112.011 -2.359 . . . . 0.0 113.919 -179.039 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.415 ' HA ' ' H ' ' A' ' 31' ' ' GLY . 65.1 m-20 -63.2 152.77 36.57 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 168.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.501 ' O ' ' SG ' ' A' ' 28' ' ' CYS . 10.2 tt0 -150.77 153.06 34.76 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 117.82 -1.552 . . . . 0.0 112.66 -178.151 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -108.03 114.42 28.31 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 114.602 -1.181 . . . . 0.0 112.004 179.334 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.596 HG22 ' N ' ' A' ' 41' ' ' THR . 5.8 p -128.24 158.74 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 C-N-CA 118.579 -1.248 . . . . 0.0 110.172 173.647 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.596 ' N ' HG22 ' A' ' 40' ' ' VAL . 0.5 OUTLIER -88.07 138.31 31.56 Favored 'General case' 0 C--N 1.27 -2.862 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.707 -179.876 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 178.48 -153.15 12.28 Favored Glycine 0 N--CA 1.489 2.184 0 C-N-CA 119.43 -1.367 . . . . 0.0 110.411 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -98.97 108.78 21.55 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 119.531 -0.867 . . . . 0.0 110.786 -179.463 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -129.49 170.28 20.46 Favored Glycine 0 N--CA 1.493 2.445 1 N-CA-C 129.34 6.496 . . . . 0.0 129.34 178.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.2 t -113.61 141.14 25.5 Favored Pre-proline 0 N--CA 1.496 1.843 0 C-N-CA 119.103 -1.039 . . . . 0.0 110.128 -179.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.699 ' HB3' HD12 ' A' ' 13' ' ' LEU . 9.5 Cg_endo -71.72 107.77 2.27 Favored 'Trans proline' 0 C--O 1.213 -0.755 0 C-N-CA 120.989 1.126 . . . . 0.0 110.123 174.675 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.441 ' C ' ' O ' ' A' ' 46' ' ' PRO . 3.6 tm-20 -35.02 97.07 0.12 Allowed Pre-proline 0 N--CA 1.503 2.187 0 C-N-CA 120.056 -0.658 . . . . 0.0 110.673 -179.769 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.412 ' N ' ' O ' ' A' ' 46' ' ' PRO . 1.9 Cg_endo -63.49 113.75 2.23 Favored 'Trans proline' 0 C--O 1.217 -0.565 0 C-N-CA 120.897 1.065 . . . . 0.0 111.351 -174.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.495 1.788 0 CA-C-O 116.269 -1.824 . . . . 0.0 110.083 179.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.572 HG12 ' H ' ' A' ' 3' ' ' TYR . 0.5 OUTLIER -85.46 -166.18 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 C-N-CA 119.642 -0.823 . . . . 0.0 110.573 -178.952 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.572 ' H ' HG12 ' A' ' 2' ' ' VAL . 22.4 m-85 -137.7 -164.71 1.65 Allowed 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.993 -0.683 . . . . 0.0 109.943 -179.323 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -93.98 167.49 11.57 Favored 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 119.266 -0.974 . . . . 0.0 109.281 -179.778 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.485 ' OD1' ' N ' ' A' ' 5' ' ' ASP . 0.0 OUTLIER -84.92 144.49 28.32 Favored 'General case' 0 C--N 1.291 -1.937 0 C-N-CA 118.464 -1.294 . . . . 0.0 109.979 179.599 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -72.11 -178.49 2.44 Favored 'General case' 0 C--N 1.287 -2.136 0 CA-C-O 122.147 0.975 . . . . 0.0 110.542 177.523 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.2 t -159.47 18.31 0.17 Allowed 'General case' 0 C--N 1.272 -2.784 0 CA-C-N 113.538 -1.665 . . . . 0.0 109.263 177.064 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -162.7 -178.46 6.2 Favored 'General case' 0 C--N 1.293 -1.866 0 CA-C-N 114.218 -1.355 . . . . 0.0 110.055 -178.122 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.493 ' HB3' ' H ' ' A' ' 30' ' ' LEU . 0.8 OUTLIER -98.24 166.26 11.48 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.303 -179.787 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.459 ' O ' ' O ' ' A' ' 11' ' ' GLN . . . 84.12 -43.65 3.22 Favored Glycine 0 N--CA 1.509 3.519 0 C-N-CA 119.584 -1.293 . . . . 0.0 113.235 176.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.459 ' O ' ' O ' ' A' ' 10' ' ' GLY . 10.9 mt-30 -47.65 178.68 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.563 0 C-N-CA 119.727 -0.789 . . . . 0.0 111.099 -177.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.551 ' O ' ' O ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -144.38 -59.21 0.38 Allowed 'General case' 0 N--CA 1.507 2.418 0 C-N-CA 118.16 -1.416 . . . . 0.0 114.372 -176.31 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.501 ' N ' ' CG ' ' A' ' 12' ' ' ASN . 12.7 mt -76.79 48.07 0.55 Allowed 'General case' 0 C--N 1.27 -2.866 0 C-N-CA 117.156 -1.818 . . . . 0.0 110.995 -176.269 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.586 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 25.0 p -123.38 -160.24 0.89 Allowed 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 176.325 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.496 HD22 ' O ' ' A' ' 19' ' ' SER . 70.6 mt -109.03 110.29 21.53 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 176.232 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.586 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 1.9 m -117.62 9.34 13.09 Favored 'General case' 0 N--CA 1.505 2.287 0 C-N-CA 119.19 -1.004 . . . . 0.0 110.345 -176.202 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.419 ' OE2' ' SG ' ' A' ' 22' ' ' CYS . 34.5 mt-10 -141.73 60.78 1.48 Allowed 'General case' 0 C--N 1.288 -2.07 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 177.189 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 79.66 -105.82 2.35 Favored Glycine 0 N--CA 1.484 1.862 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 -177.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.496 ' O ' HD22 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -109.37 -3.22 17.26 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-O 122.232 1.015 . . . . 0.0 109.708 179.165 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 -81.16 133.53 35.47 Favored 'General case' 0 C--N 1.262 -3.2 0 CA-C-N 113.327 -1.76 . . . . 0.0 111.443 -178.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.417 ' HA ' HD23 ' A' ' 15' ' ' LEU . 2.3 t -70.0 142.3 16.04 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 C-N-CA 119.015 -1.074 . . . . 0.0 109.708 178.588 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.58 ' O ' ' SG ' ' A' ' 28' ' ' CYS . 0.1 OUTLIER -143.49 119.79 10.88 Favored 'General case' 0 C--N 1.281 -2.39 0 C-N-CA 119.025 -1.07 . . . . 0.0 109.467 177.387 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.445 ' O ' ' O ' ' A' ' 26' ' ' ASN . . . 151.78 -39.55 0.78 Allowed Glycine 0 C--N 1.294 -1.759 1 N-CA-C 130.544 6.978 . . . . 0.0 130.544 -178.806 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -58.28 115.03 2.69 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 118.882 -1.127 . . . . 0.0 110.266 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.49 -23.33 8.73 Favored Glycine 0 C--N 1.3 -1.447 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -178.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.644 ' N ' ' ND2' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -115.31 -168.99 1.48 Allowed 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.638 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.529 ' HE3' HD11 ' A' ' 29' ' ' ILE . 7.4 tttt -148.59 135.94 20.34 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 118.523 -1.271 . . . . 0.0 110.078 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.58 ' SG ' ' O ' ' A' ' 22' ' ' CYS . 2.9 m -95.65 153.72 17.58 Favored 'General case' 0 C--N 1.307 -1.282 0 C-N-CA 118.289 -1.365 . . . . 0.0 111.458 179.513 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.529 HD11 ' HE3' ' A' ' 27' ' ' LYS . 14.9 mm -136.18 130.53 48.15 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.47 0 CA-C-N 114.05 -1.432 . . . . 0.0 109.811 174.678 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.493 ' H ' ' HB3' ' A' ' 9' ' ' SER . 23.3 mt -73.04 123.82 24.29 Favored 'General case' 0 N--CA 1.496 1.868 0 C-N-CA 119.271 -0.972 . . . . 0.0 108.473 177.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -91.66 -118.06 2.26 Favored Glycine 0 N--CA 1.481 1.658 0 C-N-CA 118.573 -1.775 . . . . 0.0 112.181 -176.543 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 9.1 m -154.14 -147.02 0.2 Allowed 'General case' 0 C--O 1.204 -1.292 0 CA-C-O 122.44 1.114 . . . . 0.0 111.232 -176.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -84.45 65.71 9.08 Favored 'General case' 0 C--N 1.264 -3.149 0 CA-C-N 113.094 -1.867 . . . . 0.0 111.325 -172.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 130.2 -3.94 5.94 Favored Glycine 0 C--N 1.28 -2.578 0 N-CA-C 108.305 -1.918 . . . . 0.0 108.305 179.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.727 ' O ' ' O ' ' A' ' 36' ' ' LYS . 3.7 mm-40 -128.62 9.6 5.99 Favored 'General case' 0 C--O 1.196 -1.734 0 CA-C-N 114.161 -1.02 . . . . 0.0 109.112 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.727 ' O ' ' O ' ' A' ' 35' ' ' GLU . 6.2 mtpp -25.88 -156.12 0.0 OUTLIER 'General case' 0 N--CA 1.523 3.224 0 O-C-N 126.974 2.671 . . . . 0.0 115.089 -174.281 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.558 ' OD1' ' N ' ' A' ' 37' ' ' ASN . 0.2 OUTLIER -57.75 133.68 55.58 Favored 'General case' 0 C--N 1.283 -2.315 0 C-N-CA 118.934 -1.107 . . . . 0.0 111.0 -178.432 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.77 145.93 27.81 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-N 115.267 -0.878 . . . . 0.0 109.64 178.602 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -83.75 116.62 22.78 Favored 'General case' 0 C--N 1.288 -2.106 0 CA-C-N 115.32 -0.854 . . . . 0.0 112.615 -177.624 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.509 ' O ' ' O ' ' A' ' 27' ' ' LYS . 0.9 OUTLIER -119.22 129.69 74.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 CA-C-O 122.606 1.193 . . . . 0.0 110.596 173.707 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 10.1 t -46.98 148.78 1.01 Allowed 'General case' 0 C--N 1.258 -3.378 0 CA-C-N 113.42 -1.718 . . . . 0.0 111.134 -178.032 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.401 ' O ' ' C ' ' A' ' 26' ' ' ASN . . . 149.37 149.66 5.04 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.954 -1.259 . . . . 0.0 109.954 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -80.01 63.4 4.52 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 119.035 -1.066 . . . . 0.0 110.873 -179.323 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -63.36 162.91 32.14 Favored Glycine 0 N--CA 1.49 2.296 0 C-N-CA 119.181 -1.485 . . . . 0.0 109.437 178.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.4 t -79.87 141.04 54.68 Favored Pre-proline 0 N--CA 1.488 1.474 0 C-N-CA 118.514 -1.275 . . . . 0.0 109.835 -179.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.436 ' HB3' HD12 ' A' ' 13' ' ' LEU . 8.4 Cg_endo -67.14 116.46 4.19 Favored 'Trans proline' 0 C--O 1.213 -0.768 0 C-N-CA 121.117 1.211 . . . . 0.0 111.36 178.263 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.414 ' C ' ' O ' ' A' ' 46' ' ' PRO . 0.4 OUTLIER -36.74 101.05 0.21 Allowed Pre-proline 0 N--CA 1.504 2.24 0 C-N-CA 120.284 -0.567 . . . . 0.0 110.929 179.741 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -69.08 104.89 1.28 Allowed 'Trans proline' 0 C--O 1.214 -0.692 0 C-N-CA 120.754 0.969 . . . . 0.0 111.176 -178.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.589 0 C-N-CA 119.209 -0.996 . . . . 0.0 . 179.572 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.607 ' O ' HG23 ' A' ' 1' ' ' VAL . 33.3 m . . . . . 0 N--CA 1.493 1.68 0 N-CA-C 109.576 -0.528 . . . . 0.0 109.576 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.408 HG12 ' H ' ' A' ' 3' ' ' TYR . 2.8 t -95.68 166.54 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 C-N-CA 119.409 -0.917 . . . . 0.0 110.303 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.415 ' CZ ' HD22 ' A' ' 13' ' ' LEU . 45.5 m-85 -130.0 -164.59 1.43 Allowed 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 120.038 -0.665 . . . . 0.0 109.782 179.437 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -92.83 176.76 6.31 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 119.366 -0.934 . . . . 0.0 108.58 179.069 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.527 ' N ' ' OD1' ' A' ' 5' ' ' ASP . 0.2 OUTLIER -97.02 151.88 19.28 Favored 'General case' 0 C--N 1.294 -1.815 0 C-N-CA 118.889 -1.124 . . . . 0.0 109.554 178.013 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.428 ' N ' ' HB2' ' A' ' 14' ' ' CYS . 1.5 m -70.29 176.76 3.71 Favored 'General case' 0 C--N 1.285 -2.212 0 C-N-CA 119.216 -0.993 . . . . 0.0 110.165 177.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.827 ' H ' HE22 ' A' ' 11' ' ' GLN . 0.1 OUTLIER -153.9 7.72 0.35 Allowed 'General case' 0 C--N 1.274 -2.707 0 CA-C-N 114.112 -1.404 . . . . 0.0 110.474 177.795 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -166.46 173.02 10.28 Favored 'General case' 0 C--N 1.284 -2.248 0 CA-C-N 114.505 -1.225 . . . . 0.0 109.761 -179.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.5 136.19 33.53 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 119.375 -0.93 . . . . 0.0 109.124 -178.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.696 ' HA2' ' NZ ' ' A' ' 27' ' ' LYS . . . 112.13 -30.22 7.83 Favored Glycine 0 N--CA 1.493 2.486 1 N-CA-C 129.642 6.617 . . . . 0.0 129.642 -175.873 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.827 HE22 ' H ' ' A' ' 7' ' ' THR . 0.1 OUTLIER -56.21 -167.19 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.909 0 C-N-CA 119.34 -0.944 . . . . 0.0 109.672 178.7 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.602 ' O ' ' HA3' ' A' ' 23' ' ' GLY . 22.2 t-20 -142.18 -69.2 0.36 Allowed 'General case' 0 N--CA 1.496 1.837 0 C-N-CA 118.472 -1.291 . . . . 0.0 113.766 -176.343 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.557 HD12 ' HB3' ' A' ' 46' ' ' PRO . 14.1 mt -78.38 50.39 0.93 Allowed 'General case' 0 C--N 1.261 -3.258 0 C-N-CA 118.227 -1.389 . . . . 0.0 110.9 -176.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.56 ' SG ' ' N ' ' A' ' 15' ' ' LEU . 13.1 p -114.22 -153.14 0.52 Allowed 'General case' 0 N--CA 1.506 2.371 0 C-N-CA 118.788 -1.165 . . . . 0.0 110.719 177.345 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.56 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 7.7 mt -127.5 137.09 52.56 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 114.068 -1.424 . . . . 0.0 109.751 178.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.423 ' SG ' ' CB ' ' A' ' 22' ' ' CYS . 97.5 m -125.11 -77.85 0.59 Allowed 'General case' 0 N--CA 1.513 2.706 0 C-N-CA 118.998 -1.081 . . . . 0.0 111.531 179.504 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -80.07 112.33 17.28 Favored 'General case' 0 C--N 1.299 -1.604 0 C-N-CA 118.345 -1.342 . . . . 0.0 110.282 -178.141 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 66.06 -107.22 1.86 Allowed Glycine 0 N--CA 1.491 2.308 0 C-N-CA 119.497 -1.335 . . . . 0.0 110.36 -179.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.485 ' O ' ' OG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -134.87 11.43 3.65 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 122.981 1.372 . . . . 0.0 108.896 179.95 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.703 ' N ' HD22 ' A' ' 20' ' ' ASN . 0.8 OUTLIER -76.71 127.95 33.73 Favored 'General case' 0 C--N 1.255 -3.503 0 CA-C-N 112.712 -2.04 . . . . 0.0 109.479 178.366 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.3 t -63.57 146.54 12.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 C-N-CA 118.827 -1.149 . . . . 0.0 110.017 -179.01 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.507 ' O ' ' O ' ' A' ' 12' ' ' ASN . 0.0 OUTLIER -135.51 114.88 12.51 Favored 'General case' 0 C--N 1.299 -1.611 0 C-N-CA 119.164 -1.014 . . . . 0.0 109.773 179.566 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.602 ' HA3' ' O ' ' A' ' 12' ' ' ASN . . . 149.76 -55.14 0.48 Allowed Glycine 0 C--O 1.205 -1.712 1 N-CA-C 129.639 6.615 . . . . 0.0 129.639 -176.916 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.456 ' N ' ' OD1' ' A' ' 12' ' ' ASN . 1.1 tm0? -51.59 121.9 7.19 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 118.325 -1.35 . . . . 0.0 109.923 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.82 -26.34 6.05 Favored Glycine 0 C--N 1.297 -1.592 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 -177.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.489 ' N ' ' O ' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -126.0 -162.21 1.11 Allowed 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 119.974 -0.691 . . . . 0.0 111.263 -179.628 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.696 ' NZ ' ' HA2' ' A' ' 10' ' ' GLY . 0.5 OUTLIER -153.69 124.59 7.29 Favored 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 119.196 -1.002 . . . . 0.0 110.674 177.727 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.432 ' O ' HD13 ' A' ' 29' ' ' ILE . 0.1 OUTLIER -81.75 155.93 25.23 Favored 'General case' 0 CA--C 1.483 -1.628 0 C-N-CA 118.31 -1.356 . . . . 0.0 111.876 179.437 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.432 HD13 ' O ' ' A' ' 28' ' ' CYS . 4.2 mm -133.09 117.54 29.37 Favored 'Isoleucine or valine' 0 C--N 1.256 -3.467 0 CA-C-N 112.201 -2.272 . . . . 0.0 109.2 177.106 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 21.1 mt -77.15 130.77 37.76 Favored 'General case' 0 N--CA 1.505 2.281 0 C-N-CA 118.631 -1.228 . . . . 0.0 111.171 -178.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 1.005 ' HA3' ' O ' ' A' ' 35' ' ' GLU . . . -120.68 -109.08 2.17 Favored Glycine 0 N--CA 1.48 1.611 1 N-CA-C 132.0 7.56 . . . . 0.0 132.0 176.481 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.719 ' H ' ' N ' ' A' ' 36' ' ' LYS . 9.4 p -167.34 -149.42 0.09 Allowed 'General case' 0 C--N 1.3 -1.574 0 CA-C-O 122.22 1.01 . . . . 0.0 110.136 -178.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.499 ' N ' ' OG ' ' A' ' 32' ' ' SER . 25.7 t0 -81.28 58.68 3.66 Favored 'General case' 0 C--N 1.261 -3.262 0 CA-C-N 113.222 -1.808 . . . . 0.0 109.882 -176.658 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 144.85 -14.47 1.96 Allowed Glycine 0 C--N 1.28 -2.574 0 N-CA-C 107.858 -2.097 . . . . 0.0 107.858 -178.342 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 1.005 ' O ' ' HA3' ' A' ' 31' ' ' GLY . 13.9 mm-40 -125.02 7.19 7.96 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 114.014 -1.093 . . . . 0.0 109.125 178.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.719 ' N ' ' H ' ' A' ' 32' ' ' SER . 0.0 OUTLIER -31.78 -175.56 0.0 OUTLIER 'General case' 0 N--CA 1.519 2.976 0 CA-C-N 111.459 -2.61 . . . . 0.0 113.694 -177.37 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.558 ' OD1' ' N ' ' A' ' 37' ' ' ASN . 0.1 OUTLIER -61.62 106.17 0.63 Allowed 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 118.0 -1.48 . . . . 0.0 109.132 179.121 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -121.98 151.25 40.99 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 119.67 -0.812 . . . . 0.0 110.916 -178.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -105.13 109.34 21.29 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.777 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.513 ' CG2' ' N ' ' A' ' 41' ' ' THR . 2.3 p -125.59 159.74 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.153 0 C-N-CA 118.869 -1.132 . . . . 0.0 110.06 175.14 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.513 ' N ' ' CG2' ' A' ' 40' ' ' VAL . 3.0 t -69.58 146.96 51.35 Favored 'General case' 0 C--N 1.275 -2.645 0 CA-C-N 115.124 -0.944 . . . . 0.0 111.183 -179.366 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 175.79 160.99 24.31 Favored Glycine 0 N--CA 1.489 2.217 0 C-N-CA 119.28 -1.438 . . . . 0.0 110.494 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -81.28 104.85 12.03 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 119.452 -0.899 . . . . 0.0 110.286 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -123.4 165.28 16.16 Favored Glycine 0 N--CA 1.492 2.395 1 N-CA-C 130.306 6.882 . . . . 0.0 130.306 179.474 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 14.3 t -100.38 142.86 25.43 Favored Pre-proline 0 N--CA 1.49 1.563 0 C-N-CA 119.266 -0.973 . . . . 0.0 110.564 -178.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.557 ' HB3' HD12 ' A' ' 13' ' ' LEU . 11.2 Cg_exo -53.5 171.88 0.27 Allowed 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 121.246 1.297 . . . . 0.0 111.187 175.178 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -101.93 106.57 48.11 Favored Pre-proline 0 CA--C 1.561 1.383 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.72 178.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -62.79 156.67 52.11 Favored 'Trans proline' 0 C--O 1.215 -0.631 0 C-N-CA 120.753 0.969 . . . . 0.0 111.277 -177.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 116.317 -1.801 . . . . 0.0 110.298 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 21.2 m . . . . . 0 N--CA 1.492 1.665 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.413 HG12 ' H ' ' A' ' 3' ' ' TYR . 2.6 t -103.18 167.59 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 C-N-CA 119.973 -0.691 . . . . 0.0 109.848 179.739 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.413 ' H ' HG12 ' A' ' 2' ' ' VAL . 59.2 m-85 -126.29 -166.6 1.59 Allowed 'General case' 0 N--CA 1.496 1.827 0 C-N-CA 119.946 -0.702 . . . . 0.0 110.917 -178.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.0 p -102.43 179.17 4.38 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.099 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.469 ' OD1' HD12 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -84.92 152.38 23.56 Favored 'General case' 0 C--N 1.294 -1.836 0 C-N-CA 118.502 -1.279 . . . . 0.0 110.906 -179.751 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.447 ' N ' ' HB2' ' A' ' 14' ' ' CYS . 0.8 OUTLIER -74.82 -177.49 3.29 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.883 176.582 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.8 t -151.84 11.11 0.56 Allowed 'General case' 0 C--N 1.281 -2.413 0 CA-C-N 114.673 -1.149 . . . . 0.0 110.749 177.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -160.49 158.0 28.53 Favored 'General case' 0 C--N 1.29 -2.008 0 CA-C-N 114.557 -1.201 . . . . 0.0 109.514 -178.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.482 ' HA ' ' H ' ' A' ' 30' ' ' LEU . 0.3 OUTLIER -79.32 138.49 37.74 Favored 'General case' 0 C--N 1.293 -1.856 0 C-N-CA 119.605 -0.838 . . . . 0.0 108.995 -179.116 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.884 ' HA2' ' NZ ' ' A' ' 27' ' ' LYS . . . 107.27 -35.14 5.21 Favored Glycine 0 N--CA 1.5 2.912 1 N-CA-C 129.64 6.616 . . . . 0.0 129.64 -173.72 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 -56.86 -166.21 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.167 0 C-N-CA 119.729 -0.788 . . . . 0.0 110.22 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.475 ' ND2' ' C ' ' A' ' 23' ' ' GLY . 1.4 m-20 -141.37 -66.78 0.41 Allowed 'General case' 0 N--CA 1.508 2.46 0 N-CA-C 115.41 1.633 . . . . 0.0 115.41 -175.633 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.457 ' HA ' HD23 ' A' ' 13' ' ' LEU . 35.7 mt -76.51 51.81 0.75 Allowed 'General case' 0 C--N 1.277 -2.562 0 C-N-CA 118.048 -1.461 . . . . 0.0 111.022 -173.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.447 ' HB2' ' N ' ' A' ' 6' ' ' CYS . 27.3 p -123.62 -154.22 0.6 Allowed 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 114.908 -1.042 . . . . 0.0 108.943 176.285 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.469 HD12 ' OD1' ' A' ' 5' ' ' ASP . 70.8 mt -117.77 116.72 27.57 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 176.155 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.461 ' HB3' HD21 ' A' ' 37' ' ' ASN . 2.8 m -116.7 -7.06 11.57 Favored 'General case' 0 N--CA 1.5 2.027 0 C-N-CA 118.617 -1.233 . . . . 0.0 111.746 -176.747 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.5 ' OE1' ' SG ' ' A' ' 39' ' ' CYS . 0.3 OUTLIER -127.09 75.49 1.58 Allowed 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 119.245 -0.982 . . . . 0.0 109.255 177.194 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 71.59 -81.26 0.51 Allowed Glycine 0 N--CA 1.489 2.221 0 C-N-CA 119.475 -1.345 . . . . 0.0 110.605 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -135.38 0.88 2.84 Favored 'General case' 0 N--CA 1.486 1.348 0 CA-C-O 121.907 0.86 . . . . 0.0 110.89 -179.24 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.489 ' N ' ' OD1' ' A' ' 20' ' ' ASN . 0.9 OUTLIER -85.13 139.99 31.28 Favored 'General case' 0 C--N 1.257 -3.455 0 CA-C-N 113.824 -1.535 . . . . 0.0 111.234 -179.011 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.2 t -73.79 144.55 12.46 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 C-N-CA 118.704 -1.198 . . . . 0.0 109.867 178.03 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.484 ' O ' ' SG ' ' A' ' 28' ' ' CYS . 3.8 m -149.98 119.95 7.16 Favored 'General case' 0 C--N 1.278 -2.502 0 C-N-CA 118.775 -1.17 . . . . 0.0 108.593 178.07 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.475 ' C ' ' ND2' ' A' ' 12' ' ' ASN . . . 173.09 -84.8 0.08 OUTLIER Glycine 0 C--N 1.3 -1.466 0 C-N-CA 117.688 -2.196 . . . . 0.0 112.055 -176.241 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.485 ' C ' ' H ' ' A' ' 26' ' ' ASN . 25.9 tt0 -42.43 133.68 3.22 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.868 -0.733 . . . . 0.0 111.321 -178.003 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.475 ' C ' ' ND2' ' A' ' 26' ' ' ASN . . . 76.69 -27.51 1.59 Allowed Glycine 0 N--CA 1.479 1.547 0 C-N-CA 119.679 -1.248 . . . . 0.0 110.083 -179.533 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.518 ' ND2' ' N ' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -128.84 -159.94 0.99 Allowed 'General case' 0 C--N 1.316 -0.871 0 C-N-CA 119.696 -0.802 . . . . 0.0 111.6 -179.039 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.884 ' NZ ' ' HA2' ' A' ' 10' ' ' GLY . 3.4 ttpp -142.98 175.39 9.88 Favored 'General case' 0 N--CA 1.498 1.955 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.815 179.184 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.484 ' SG ' ' O ' ' A' ' 22' ' ' CYS . 57.3 m -138.55 160.66 39.01 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 118.965 -1.094 . . . . 0.0 111.173 176.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 7.8 mm -140.69 97.75 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.13 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 174.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.76 ' C ' HD12 ' A' ' 30' ' ' LEU . 0.3 OUTLIER -79.35 130.19 35.2 Favored 'General case' 0 C--N 1.291 -1.944 0 C-N-CA 118.129 -1.428 . . . . 0.0 110.743 -176.216 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.496 ' N ' ' O ' ' A' ' 36' ' ' LYS . . . -50.83 -88.9 0.01 OUTLIER Glycine 0 N--CA 1.489 2.17 0 C-N-CA 120.307 -0.949 . . . . 0.0 111.816 -176.771 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.447 ' O ' ' N ' ' A' ' 34' ' ' GLY . 9.7 t -138.96 -132.15 0.12 Allowed 'General case' 0 C--N 1.309 -1.195 0 C-N-CA 119.425 -0.91 . . . . 0.0 111.526 -177.079 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 81.5 m-20 -74.64 71.14 1.89 Allowed 'General case' 0 C--N 1.258 -3.402 0 CA-C-N 113.577 -1.647 . . . . 0.0 110.108 -170.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 32' ' ' SER . . . 70.23 22.57 77.49 Favored Glycine 0 C--N 1.281 -2.5 0 N-CA-C 107.704 -2.158 . . . . 0.0 107.704 -179.035 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 -93.82 -116.6 0.1 Allowed 'General case' 0 C--N 1.307 -1.256 0 C-N-CA 119.111 -1.035 . . . . 0.0 110.666 -177.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.496 ' O ' ' N ' ' A' ' 31' ' ' GLY . 0.1 OUTLIER -69.36 169.51 12.19 Favored 'General case' 0 C--N 1.26 -3.283 0 CA-C-N 113.913 -1.494 . . . . 0.0 110.608 -178.611 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 1.082 HD22 ' N ' ' A' ' 38' ' ' GLN . 0.2 OUTLIER -178.19 136.11 0.16 Allowed 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 -179.951 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 1.082 ' N ' HD22 ' A' ' 37' ' ' ASN . 10.3 tt0 -131.89 143.29 50.04 Favored 'General case' 0 C--N 1.311 -1.086 0 C-N-CA 119.823 -0.751 . . . . 0.0 110.321 177.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.5 ' SG ' ' OE1' ' A' ' 17' ' ' GLU . 66.2 m -97.93 99.7 11.01 Favored 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 119.539 -0.864 . . . . 0.0 110.01 179.121 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.525 ' O ' ' N ' ' A' ' 27' ' ' LYS . 11.2 p -112.89 155.13 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.334 0 C-N-CA 118.436 -1.306 . . . . 0.0 111.532 179.513 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.488 ' N ' HG22 ' A' ' 40' ' ' VAL . 2.4 t -75.0 148.12 40.18 Favored 'General case' 0 C--N 1.265 -3.077 0 CA-C-N 113.836 -1.529 . . . . 0.0 111.292 -179.178 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 158.72 -179.82 34.1 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 110.119 -1.192 . . . . 0.0 110.119 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -90.8 110.66 21.86 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 119.332 -0.947 . . . . 0.0 110.423 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -128.71 165.76 21.45 Favored Glycine 0 N--CA 1.497 2.701 0 N-CA-C 110.235 -1.146 . . . . 0.0 110.235 179.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -104.5 145.14 30.12 Favored Pre-proline 0 N--CA 1.494 1.774 0 C-N-CA 119.649 -0.82 . . . . 0.0 109.953 -179.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -56.47 142.94 89.06 Favored 'Trans proline' 0 C--O 1.216 -0.617 0 C-N-CA 121.232 1.288 . . . . 0.0 111.297 177.296 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.5 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 6.4 tt0 -64.18 -44.51 77.22 Favored Pre-proline 0 CA--C 1.558 1.261 0 C-N-CA 119.5 -0.88 . . . . 0.0 112.418 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.5 ' HD2' ' N ' ' A' ' 47' ' ' GLU . 5.9 Cg_exo -58.11 99.81 0.1 Allowed 'Trans proline' 0 C--O 1.216 -0.586 0 C-N-CA 120.345 0.697 . . . . 0.0 111.031 -179.309 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.345 0 CA-C-O 116.325 -1.797 . . . . 0.0 110.425 -179.957 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 2.9 m . . . . . 0 N--CA 1.493 1.676 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.0 t -100.56 161.54 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 C-N-CA 119.686 -0.806 . . . . 0.0 110.676 -179.114 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.726 ' CE2' HD22 ' A' ' 13' ' ' LEU . 23.8 m-85 -94.13 -163.69 1.08 Allowed 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 119.714 -0.795 . . . . 0.0 110.07 179.463 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.583 ' OG1' ' N ' ' A' ' 5' ' ' ASP . 0.1 OUTLIER -96.39 179.48 5.01 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.705 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.583 ' N ' ' OG1' ' A' ' 4' ' ' THR . 0.0 OUTLIER -93.77 153.45 18.3 Favored 'General case' 0 C--N 1.289 -2.048 0 C-N-CA 118.92 -1.112 . . . . 0.0 109.858 179.856 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.499 ' SG ' ' OE1' ' A' ' 11' ' ' GLN . 1.2 m -74.13 177.07 5.99 Favored 'General case' 0 C--N 1.291 -1.945 0 C-N-CA 119.406 -0.918 . . . . 0.0 110.515 177.087 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.417 ' O ' HG23 ' A' ' 7' ' ' THR . 2.7 t -152.69 10.84 0.49 Allowed 'General case' 0 C--N 1.279 -2.48 0 CA-C-N 113.924 -1.489 . . . . 0.0 110.151 177.334 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -163.02 167.54 22.27 Favored 'General case' 0 C--N 1.283 -2.318 0 CA-C-N 114.453 -1.248 . . . . 0.0 109.939 178.758 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -84.41 145.16 28.33 Favored 'General case' 0 C--N 1.296 -1.726 0 C-N-CA 119.136 -1.026 . . . . 0.0 108.83 -178.798 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 102.41 -29.46 12.46 Favored Glycine 0 N--CA 1.512 3.706 1 N-CA-C 130.151 6.82 . . . . 0.0 130.151 -175.286 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.499 ' OE1' ' SG ' ' A' ' 6' ' ' CYS . 72.9 mt-30 -58.42 -158.92 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.065 0 C-N-CA 119.83 -0.748 . . . . 0.0 110.756 -179.777 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.635 ' O ' ' HA3' ' A' ' 23' ' ' GLY . 3.0 m-20 -147.41 -67.13 0.26 Allowed 'General case' 0 N--CA 1.503 2.202 0 C-N-CA 118.21 -1.396 . . . . 0.0 114.561 -177.37 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.726 HD22 ' CE2' ' A' ' 3' ' ' TYR . 32.9 mt -77.96 49.33 0.78 Allowed 'General case' 0 C--N 1.274 -2.708 0 C-N-CA 118.434 -1.306 . . . . 0.0 111.218 -174.946 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.695 ' O ' HG22 ' A' ' 21' ' ' VAL . 17.5 p -119.41 -154.46 0.57 Allowed 'General case' 0 N--CA 1.497 1.912 0 C-N-CA 119.155 -1.018 . . . . 0.0 110.374 176.484 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.401 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 7.2 mt -125.51 135.2 52.03 Favored 'General case' 0 N--CA 1.485 1.31 0 CA-C-N 114.569 -1.196 . . . . 0.0 110.526 179.764 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.3 m -120.35 -58.76 1.83 Allowed 'General case' 0 N--CA 1.508 2.44 0 C-N-CA 119.274 -0.97 . . . . 0.0 111.228 179.6 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.61 97.18 8.83 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 119.441 -0.903 . . . . 0.0 110.725 -178.499 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 68.77 -113.59 5.35 Favored Glycine 0 N--CA 1.488 2.125 0 C-N-CA 119.444 -1.36 . . . . 0.0 110.815 179.16 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.88 3.71 15.55 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-O 122.133 0.968 . . . . 0.0 110.24 -178.544 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -78.35 129.59 35.17 Favored 'General case' 0 C--N 1.256 -3.469 0 CA-C-N 113.589 -1.641 . . . . 0.0 110.39 -179.979 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.695 HG22 ' O ' ' A' ' 14' ' ' CYS . 0.9 OUTLIER -79.32 149.16 5.52 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 C-N-CA 119.473 -0.891 . . . . 0.0 110.227 -179.656 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.477 ' O ' ' O ' ' A' ' 12' ' ' ASN . 15.6 m -143.8 112.58 6.6 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 118.717 -1.193 . . . . 0.0 110.205 179.111 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.635 ' HA3' ' O ' ' A' ' 12' ' ' ASN . . . 178.51 -63.0 0.08 OUTLIER Glycine 0 N--CA 1.484 1.858 1 N-CA-C 130.007 6.763 . . . . 0.0 130.007 -177.274 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -63.54 120.62 12.08 Favored 'General case' 0 C--N 1.311 -1.093 0 C-N-CA 118.466 -1.294 . . . . 0.0 109.842 179.269 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.421 ' C ' HD22 ' A' ' 26' ' ' ASN . . . 95.48 -17.2 59.75 Favored Glycine 0 N--CA 1.485 1.918 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 -178.349 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.465 ' O ' ' O ' ' A' ' 23' ' ' GLY . 2.1 m-80 -139.26 -172.87 3.44 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.389 -0.924 . . . . 0.0 110.694 179.07 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.747 ' NZ ' HD11 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -138.74 125.68 21.13 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 119.502 -0.879 . . . . 0.0 109.148 177.623 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.49 ' SG ' ' O ' ' A' ' 38' ' ' GLN . 0.1 OUTLIER -82.14 164.9 20.98 Favored 'General case' 0 C--N 1.289 -2.051 0 C-N-CA 116.959 -1.896 . . . . 0.0 109.927 178.206 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.747 HD11 ' NZ ' ' A' ' 27' ' ' LYS . 26.8 mm -144.08 125.96 10.54 Favored 'Isoleucine or valine' 0 C--N 1.245 -3.938 0 CA-C-N 113.856 -1.52 . . . . 0.0 108.869 178.74 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 17.7 mt -76.57 131.67 39.06 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 118.51 -1.276 . . . . 0.0 110.135 -179.066 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.423 ' H ' ' C ' ' A' ' 36' ' ' LYS . . . -95.96 -105.38 2.14 Favored Glycine 0 N--CA 1.491 2.328 0 C-N-CA 118.936 -1.602 . . . . 0.0 111.591 -178.281 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.437 ' H ' ' C ' ' A' ' 35' ' ' GLU . 10.7 t -160.02 -131.71 0.03 OUTLIER 'General case' 0 C--O 1.21 -0.993 0 C-N-CA 118.467 -1.293 . . . . 0.0 112.871 -177.362 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -79.86 73.18 6.62 Favored 'General case' 0 C--N 1.272 -2.791 0 CA-C-N 112.807 -1.997 . . . . 0.0 111.803 -172.241 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 116.49 -8.09 17.76 Favored Glycine 0 C--N 1.273 -2.951 0 N-CA-C 107.362 -2.295 . . . . 0.0 107.362 178.947 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.695 ' O ' ' N ' ' A' ' 37' ' ' ASN . 1.4 mm-40 -123.08 8.49 9.24 Favored 'General case' 0 C--N 1.286 -2.17 0 CA-C-N 113.041 -1.58 . . . . 0.0 107.948 179.22 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.423 ' C ' ' H ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -35.4 -18.44 0.0 OUTLIER 'General case' 0 C--N 1.26 -3.311 0 CA-C-N 111.627 -2.533 . . . . 0.0 113.723 -173.588 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.695 ' N ' ' O ' ' A' ' 35' ' ' GLU . 0.3 OUTLIER -153.16 153.46 32.81 Favored 'General case' 0 C--N 1.258 -3.394 0 C-N-CA 118.403 -1.319 . . . . 0.0 113.191 178.058 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.49 ' O ' ' SG ' ' A' ' 28' ' ' CYS . 15.8 tt0 -151.63 164.34 37.11 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 113.976 -1.466 . . . . 0.0 108.24 176.039 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.454 ' N ' ' CG ' ' A' ' 38' ' ' GLN . 29.0 m -127.12 97.43 4.93 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 119.407 -0.917 . . . . 0.0 110.86 -178.308 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.503 ' O ' ' O ' ' A' ' 27' ' ' LYS . 0.4 OUTLIER -111.84 140.79 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.485 0 C-N-CA 118.73 -1.188 . . . . 0.0 112.569 -179.719 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.426 ' O ' HG22 ' A' ' 40' ' ' VAL . 9.5 t -56.9 149.35 18.8 Favored 'General case' 0 C--N 1.279 -2.462 0 CA-C-N 113.563 -1.653 . . . . 0.0 111.672 177.943 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 145.16 -130.03 3.71 Favored Glycine 0 N--CA 1.489 2.228 1 N-CA-C 131.116 7.206 . . . . 0.0 131.116 179.622 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 31.9 mm-40 -112.75 106.07 14.34 Favored 'General case' 0 N--CA 1.499 2.007 0 C-N-CA 119.884 -0.726 . . . . 0.0 111.053 -179.044 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -140.02 178.86 19.49 Favored Glycine 0 N--CA 1.493 2.499 0 C-N-CA 119.659 -1.258 . . . . 0.0 110.152 179.377 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -128.61 146.38 59.87 Favored Pre-proline 0 N--CA 1.495 1.815 0 C-N-CA 119.903 -0.719 . . . . 0.0 109.511 179.681 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -57.65 164.06 8.06 Favored 'Trans proline' 0 C--O 1.216 -0.589 0 C-N-CA 121.179 1.253 . . . . 0.0 111.587 -178.809 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 52.3 tp10 -123.73 80.02 55.89 Favored Pre-proline 0 C--N 1.314 -0.968 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.203 179.54 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -62.59 135.79 54.9 Favored 'Trans proline' 0 C--N 1.324 -0.738 0 C-N-CA 121.026 1.151 . . . . 0.0 110.325 179.891 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 116.302 -1.809 . . . . 0.0 110.315 -178.943 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.408 ' O ' HG22 ' A' ' 1' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 . . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.826 HG12 ' H ' ' A' ' 3' ' ' TYR . 22.0 t -82.69 -178.69 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 C-N-CA 119.884 -0.726 . . . . 0.0 110.652 -178.976 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.826 ' H ' HG12 ' A' ' 2' ' ' VAL . 85.1 m-85 -114.89 -166.49 1.12 Allowed 'General case' 0 N--CA 1.5 2.063 0 C-N-CA 120.106 -0.638 . . . . 0.0 110.425 -179.939 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.599 ' OG1' ' N ' ' A' ' 5' ' ' ASP . 0.1 OUTLIER -113.01 -177.82 3.23 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 178.816 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.599 ' N ' ' OG1' ' A' ' 4' ' ' THR . 0.2 OUTLIER -90.33 154.2 19.87 Favored 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 118.681 -1.208 . . . . 0.0 110.746 -179.597 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -75.73 -178.85 4.41 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-N 115.001 -1.0 . . . . 0.0 112.005 178.567 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.4 t -157.15 15.18 0.27 Allowed 'General case' 0 C--N 1.291 -1.978 0 CA-C-N 113.435 -1.712 . . . . 0.0 110.02 177.848 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -161.42 172.01 17.23 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 114.505 -1.225 . . . . 0.0 109.533 -179.261 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.534 ' HB3' ' H ' ' A' ' 30' ' ' LEU . 0.9 OUTLIER -91.64 164.31 13.79 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 119.612 -0.835 . . . . 0.0 110.786 -179.303 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.436 ' O ' ' O ' ' A' ' 11' ' ' GLN . . . 79.69 -25.14 2.99 Favored Glycine 0 N--CA 1.499 2.895 0 C-N-CA 119.541 -1.314 . . . . 0.0 112.906 177.216 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.436 ' O ' ' O ' ' A' ' 10' ' ' GLY . 0.5 OUTLIER -54.93 -171.36 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.065 0 C-N-CA 118.495 -1.282 . . . . 0.0 110.577 -178.499 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.484 ' O ' ' O ' ' A' ' 22' ' ' CYS . 2.1 m-20 -148.4 -66.33 0.24 Allowed 'General case' 0 N--CA 1.501 2.076 0 N-CA-C 115.227 1.565 . . . . 0.0 115.227 -176.978 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 95.5 mt -77.17 49.8 0.71 Allowed 'General case' 0 C--N 1.268 -2.963 0 C-N-CA 117.978 -1.489 . . . . 0.0 111.284 -174.179 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 28.3 p -125.84 -156.42 0.73 Allowed 'General case' 0 C--O 1.207 -1.181 0 CA-C-N 114.988 -1.005 . . . . 0.0 109.082 176.499 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.573 HD12 ' OD1' ' A' ' 5' ' ' ASP . 58.1 mt -115.57 120.22 38.74 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 115.115 -0.948 . . . . 0.0 108.957 176.654 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.0 m -117.56 -61.29 1.72 Allowed 'General case' 0 C--N 1.293 -1.861 0 C-N-CA 119.147 -1.021 . . . . 0.0 110.955 -177.237 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.493 ' CG ' ' SG ' ' A' ' 39' ' ' CYS . 3.1 mm-40 -78.74 90.55 4.63 Favored 'General case' 0 C--N 1.295 -1.783 0 C-N-CA 117.81 -1.556 . . . . 0.0 109.708 179.512 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 71.52 -101.78 1.03 Allowed Glycine 0 N--CA 1.488 2.101 0 C-N-CA 119.481 -1.342 . . . . 0.0 109.904 -179.068 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.483 ' O ' HD22 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -128.66 2.96 5.5 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-O 122.35 1.071 . . . . 0.0 109.873 179.837 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -78.72 136.52 37.43 Favored 'General case' 0 C--N 1.258 -3.376 0 CA-C-N 113.313 -1.767 . . . . 0.0 110.228 -179.887 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.1 t -67.21 145.19 13.96 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 C-N-CA 118.438 -1.305 . . . . 0.0 109.493 178.999 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.529 ' O ' ' SG ' ' A' ' 28' ' ' CYS . 20.0 m -148.72 118.95 7.26 Favored 'General case' 0 C--N 1.277 -2.582 0 C-N-CA 118.426 -1.31 . . . . 0.0 109.333 176.82 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.471 ' O ' ' O ' ' A' ' 26' ' ' ASN . . . 171.64 -82.87 0.08 OUTLIER Glycine 0 C--N 1.291 -1.941 0 C-N-CA 118.557 -1.782 . . . . 0.0 110.395 -176.636 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -55.83 117.46 3.69 Favored 'General case' 0 C--N 1.292 -1.902 0 C-N-CA 119.132 -1.027 . . . . 0.0 109.64 179.058 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 102.26 -26.16 25.2 Favored Glycine 0 N--CA 1.484 1.871 0 N-CA-C 109.077 -1.609 . . . . 0.0 109.077 -177.683 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.471 ' O ' ' O ' ' A' ' 23' ' ' GLY . 0.1 OUTLIER -142.67 -154.83 0.54 Allowed 'General case' 0 C--N 1.309 -1.178 0 C-N-CA 119.943 -0.703 . . . . 0.0 110.147 179.767 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.5 ' N ' ' O ' ' A' ' 40' ' ' VAL . 10.0 tttp -148.21 160.01 43.38 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 176.85 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.529 ' SG ' ' O ' ' A' ' 22' ' ' CYS . 72.1 m -121.47 157.56 30.33 Favored 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 118.923 -1.111 . . . . 0.0 111.828 178.495 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 19.9 mm -146.5 133.76 14.64 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.501 0 CA-C-N 113.375 -1.739 . . . . 0.0 109.945 177.104 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.534 ' H ' ' HB3' ' A' ' 9' ' ' SER . 19.9 mt -76.77 128.8 35.3 Favored 'General case' 0 N--CA 1.505 2.277 0 C-N-CA 119.862 -0.735 . . . . 0.0 109.871 179.135 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -110.42 -123.26 4.51 Favored Glycine 0 N--CA 1.482 1.701 0 C-N-CA 119.128 -1.511 . . . . 0.0 111.227 179.104 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.484 ' N ' ' HA ' ' A' ' 36' ' ' LYS . 22.2 m -155.82 -137.56 0.06 Allowed 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 122.485 1.136 . . . . 0.0 111.941 -178.876 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -80.0 67.12 5.7 Favored 'General case' 0 C--N 1.268 -2.965 0 CA-C-N 112.906 -1.952 . . . . 0.0 112.366 -171.435 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 123.29 -6.15 9.33 Favored Glycine 0 N--CA 1.496 2.649 0 N-CA-C 108.337 -1.905 . . . . 0.0 108.337 177.967 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.674 ' O ' ' O ' ' A' ' 36' ' ' LYS . 14.2 mt-10 -126.29 8.24 7.18 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-N 113.988 -1.106 . . . . 0.0 108.584 179.356 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.674 ' O ' ' O ' ' A' ' 35' ' ' GLU . 8.2 tttm -32.53 -153.55 0.0 OUTLIER 'General case' 0 C--N 1.265 -3.079 0 O-C-N 127.122 2.764 . . . . 0.0 115.215 -174.371 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.507 ' OD1' ' N ' ' A' ' 37' ' ' ASN . 0.4 OUTLIER -64.23 109.38 1.86 Allowed 'General case' 0 C--N 1.268 -2.952 0 C-N-CA 118.629 -1.228 . . . . 0.0 110.736 -177.86 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -109.39 147.19 33.19 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.87 179.691 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.493 ' SG ' ' CG ' ' A' ' 17' ' ' GLU . 15.6 m -96.33 90.45 5.44 Favored 'General case' 0 C--N 1.293 -1.865 0 C-N-CA 119.423 -0.911 . . . . 0.0 110.63 -179.423 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.5 ' O ' ' N ' ' A' ' 27' ' ' LYS . 0.6 OUTLIER -90.08 142.81 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 C-N-CA 118.024 -1.471 . . . . 0.0 111.283 179.932 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -65.33 140.35 58.67 Favored 'General case' 0 C--N 1.274 -2.677 0 CA-C-N 114.225 -1.352 . . . . 0.0 110.831 178.844 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 152.89 -156.15 26.54 Favored Glycine 0 N--CA 1.488 2.11 0 C-N-CA 119.545 -1.312 . . . . 0.0 110.252 -179.903 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -114.29 133.37 55.7 Favored 'General case' 0 N--CA 1.497 1.923 0 C-N-CA 120.033 -0.667 . . . . 0.0 110.399 -179.74 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -137.39 158.69 24.53 Favored Glycine 0 N--CA 1.496 2.638 0 C-N-CA 119.704 -1.236 . . . . 0.0 110.455 -179.943 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 5.8 t -87.21 143.9 35.31 Favored Pre-proline 0 N--CA 1.488 1.456 0 C-N-CA 119.631 -0.827 . . . . 0.0 109.929 -179.858 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -58.16 143.69 96.41 Favored 'Trans proline' 0 C--O 1.218 -0.523 0 C-N-CA 121.006 1.137 . . . . 0.0 111.153 178.195 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.548 ' OE1' HG23 ' A' ' 4' ' ' THR . 1.9 tm-20 -73.22 117.7 62.48 Favored Pre-proline 0 C--N 1.302 -1.458 0 C-N-CA 119.706 -0.798 . . . . 0.0 110.343 -179.819 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -60.04 138.42 81.9 Favored 'Trans proline' 0 C--O 1.215 -0.641 0 C-N-CA 120.38 0.72 . . . . 0.0 110.76 179.576 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.5 0 CA-C-O 116.565 -1.683 . . . . 0.0 110.703 -179.597 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 9.4 m . . . . . 0 N--CA 1.489 1.499 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.532 HG12 ' H ' ' A' ' 3' ' ' TYR . 0.6 OUTLIER -79.45 -162.64 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 C-N-CA 119.465 -0.894 . . . . 0.0 109.044 178.484 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.532 ' H ' HG12 ' A' ' 2' ' ' VAL . 95.0 m-85 -143.15 -178.77 6.01 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 118.845 -1.142 . . . . 0.0 111.591 179.653 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 7.7 p -109.97 -179.58 3.84 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 114.772 -1.104 . . . . 0.0 108.862 -179.328 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.456 ' OD1' ' N ' ' A' ' 5' ' ' ASP . 0.1 OUTLIER -88.15 151.79 22.45 Favored 'General case' 0 C--N 1.291 -1.977 0 C-N-CA 118.344 -1.342 . . . . 0.0 109.351 177.424 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.465 ' N ' ' HB2' ' A' ' 14' ' ' CYS . 0.8 OUTLIER -71.79 -178.12 2.18 Favored 'General case' 0 C--N 1.285 -2.214 0 C-N-CA 119.401 -0.919 . . . . 0.0 110.2 178.894 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.0 t -157.46 17.65 0.27 Allowed 'General case' 0 C--N 1.279 -2.47 0 CA-C-N 114.323 -1.308 . . . . 0.0 110.16 178.662 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.531 ' N ' ' OE1' ' A' ' 8' ' ' GLU . 1.2 pm0 -165.45 169.43 15.61 Favored 'General case' 0 C--N 1.285 -2.236 0 CA-C-N 114.773 -1.103 . . . . 0.0 110.076 179.229 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.48 ' HB3' ' H ' ' A' ' 30' ' ' LEU . 0.3 OUTLIER -84.14 138.56 32.95 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 119.244 -0.983 . . . . 0.0 108.859 -179.525 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.542 ' HA2' ' HE3' ' A' ' 27' ' ' LYS . . . 104.53 -35.14 5.25 Favored Glycine 0 N--CA 1.501 2.982 1 N-CA-C 130.249 6.859 . . . . 0.0 130.249 -174.976 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.428 ' O ' ' O ' ' A' ' 10' ' ' GLY . 1.2 mt-30 -54.78 -170.03 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.128 0 C-N-CA 119.292 -0.963 . . . . 0.0 109.895 -179.82 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.466 ' O ' ' O ' ' A' ' 22' ' ' CYS . 4.8 m-20 -141.82 -66.92 0.4 Allowed 'General case' 0 N--CA 1.498 1.937 0 C-N-CA 118.055 -1.458 . . . . 0.0 114.631 -176.209 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.485 HD22 ' CZ ' ' A' ' 3' ' ' TYR . 13.0 mt -75.67 53.95 0.75 Allowed 'General case' 0 C--N 1.268 -2.943 0 C-N-CA 117.613 -1.635 . . . . 0.0 110.274 -175.777 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.465 ' HB2' ' N ' ' A' ' 6' ' ' CYS . 25.9 p -124.89 -160.64 0.96 Allowed 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.023 175.696 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 52.6 mt -118.1 126.72 52.81 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.147 178.446 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.3 m -110.92 -64.5 1.27 Allowed 'General case' 0 N--CA 1.502 2.131 0 C-N-CA 118.98 -1.088 . . . . 0.0 111.197 179.813 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -89.98 92.32 8.94 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 119.05 -1.06 . . . . 0.0 110.67 -178.875 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.43 -105.39 1.84 Allowed Glycine 0 N--CA 1.489 2.222 0 C-N-CA 119.723 -1.227 . . . . 0.0 111.153 178.601 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.404 ' O ' ' OG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -122.43 3.4 9.69 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 122.417 1.103 . . . . 0.0 109.997 -178.354 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 38.1 m-20 -77.22 138.08 39.22 Favored 'General case' 0 C--N 1.259 -3.35 0 CA-C-N 113.278 -1.783 . . . . 0.0 110.598 -179.841 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.0 t -81.68 146.82 6.74 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 C-N-CA 119.441 -0.904 . . . . 0.0 110.357 179.812 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.466 ' O ' ' O ' ' A' ' 12' ' ' ASN . 20.9 m -144.35 114.21 7.28 Favored 'General case' 0 N--CA 1.5 2.043 0 C-N-CA 118.939 -1.104 . . . . 0.0 109.263 177.362 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.484 ' O ' ' N ' ' A' ' 26' ' ' ASN . . . -179.77 -87.78 0.07 OUTLIER Glycine 0 N--CA 1.479 1.538 0 C-N-CA 117.156 -2.449 . . . . 0.0 113.449 -176.726 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.426 ' C ' ' H ' ' A' ' 26' ' ' ASN . 1.5 tt0 -42.15 129.75 3.68 Favored 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 119.931 -0.708 . . . . 0.0 111.681 -175.947 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 81.19 -30.04 2.74 Favored Glycine 0 N--CA 1.477 1.428 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 -179.09 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.484 ' N ' ' O ' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -122.4 -166.86 1.47 Allowed 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 119.935 -0.706 . . . . 0.0 111.412 -178.839 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.542 ' HE3' ' HA2' ' A' ' 10' ' ' GLY . 0.6 OUTLIER -153.15 127.11 8.97 Favored 'General case' 0 N--CA 1.505 2.287 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.237 -179.996 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -86.17 168.31 14.11 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 122.728 1.252 . . . . 0.0 112.337 -178.695 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 11.0 mm -146.31 131.89 12.67 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.754 0 CA-C-N 112.52 -2.127 . . . . 0.0 108.09 175.349 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.48 ' H ' ' HB3' ' A' ' 9' ' ' SER . 23.6 mt -75.09 106.32 6.54 Favored 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 117.554 -1.659 . . . . 0.0 108.995 177.629 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.62 ' H ' ' HA ' ' A' ' 37' ' ' ASN . . . 114.56 90.95 1.78 Allowed Glycine 0 N--CA 1.488 2.161 1 N-CA-C 130.07 6.788 . . . . 0.0 130.07 -176.78 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.585 ' O ' ' N ' ' A' ' 34' ' ' GLY . 94.0 p -68.25 -120.6 0.0 OUTLIER 'General case' 0 C--O 1.2 -1.534 0 C-N-CA 118.528 -1.269 . . . . 0.0 108.977 -179.805 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.453 ' N ' ' OG ' ' A' ' 32' ' ' SER . 6.5 m-20 -69.06 69.24 0.19 Allowed 'General case' 0 C--N 1.258 -3.407 0 CA-C-N 114.335 -1.302 . . . . 0.0 108.952 -174.419 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.585 ' N ' ' O ' ' A' ' 32' ' ' SER . . . 58.61 33.94 74.33 Favored Glycine 0 C--N 1.285 -2.295 0 N-CA-C 107.621 -2.192 . . . . 0.0 107.621 -176.67 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -109.8 -129.69 0.29 Allowed 'General case' 0 C--O 1.214 -0.777 0 CA-C-O 122.487 1.137 . . . . 0.0 113.268 -175.71 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.609 ' O ' ' N ' ' A' ' 31' ' ' GLY . 28.7 mttp -93.86 -86.21 0.27 Allowed 'General case' 0 C--N 1.273 -2.749 0 CA-C-N 112.777 -2.01 . . . . 0.0 114.077 -172.801 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.62 ' HA ' ' H ' ' A' ' 31' ' ' GLY . 1.1 m-20 -120.57 159.75 24.61 Favored 'General case' 0 C--N 1.269 -2.925 0 CA-C-N 113.514 -1.675 . . . . 0.0 111.228 -176.574 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.495 ' CG ' ' N ' ' A' ' 39' ' ' CYS . 34.2 tt0 -151.94 159.96 43.64 Favored 'General case' 0 C--N 1.312 -1.034 0 C-N-CA 119.051 -1.06 . . . . 0.0 110.329 178.113 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.495 ' N ' ' CG ' ' A' ' 38' ' ' GLN . 91.5 m -131.73 94.28 3.48 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 119.886 -0.726 . . . . 0.0 110.472 -179.902 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.676 HG22 ' N ' ' A' ' 41' ' ' THR . 4.4 p -110.02 173.57 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.336 0 C-N-CA 119.105 -1.038 . . . . 0.0 110.217 179.577 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.676 ' N ' HG22 ' A' ' 40' ' ' VAL . 8.8 t -84.12 156.49 22.11 Favored 'General case' 0 C--N 1.283 -2.326 0 CA-C-N 115.353 -0.839 . . . . 0.0 111.142 178.727 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 159.39 -140.72 7.02 Favored Glycine 0 N--CA 1.492 2.404 0 C-N-CA 119.681 -1.247 . . . . 0.0 110.497 -179.973 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -146.08 89.56 1.89 Allowed 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 119.529 -0.868 . . . . 0.0 110.459 -179.826 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -97.98 -156.15 29.86 Favored Glycine 0 N--CA 1.492 2.395 0 C-N-CA 119.52 -1.324 . . . . 0.0 110.742 -179.538 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -139.91 153.01 69.23 Favored Pre-proline 0 N--CA 1.492 1.666 0 C-N-CA 119.571 -0.852 . . . . 0.0 110.418 -179.98 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.455 ' HB3' HD12 ' A' ' 13' ' ' LEU . 5.2 Cg_exo -53.47 153.97 16.53 Favored 'Trans proline' 0 CA--C 1.543 0.965 0 C-N-CA 122.112 1.875 . . . . 0.0 113.035 177.952 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.597 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 9.2 tm-20 -81.87 -42.59 1.04 Allowed Pre-proline 0 N--CA 1.483 1.188 0 CA-C-N 115.937 -0.574 . . . . 0.0 112.292 177.671 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.597 ' CD ' ' N ' ' A' ' 47' ' ' GLU . 1.3 Cg_endo -65.39 167.95 15.58 Favored 'Trans proline' 0 C--O 1.214 -0.691 0 C-N-CA 120.846 1.031 . . . . 0.0 111.234 -174.451 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 116.355 -1.783 . . . . 0.0 110.279 -179.966 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 99.3 t . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.684 HG12 ' N ' ' A' ' 3' ' ' TYR . 45.6 t -123.47 172.98 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 C-N-CA 119.926 -0.709 . . . . 0.0 110.055 179.996 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.684 ' N ' HG12 ' A' ' 2' ' ' VAL . 10.8 m-85 -144.09 -167.53 2.63 Favored 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 119.896 -0.722 . . . . 0.0 109.89 179.905 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.589 ' OG1' ' N ' ' A' ' 5' ' ' ASP . 0.1 OUTLIER -104.74 -177.64 3.42 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 177.507 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.589 ' N ' ' OG1' ' A' ' 4' ' ' THR . 0.3 OUTLIER -92.1 154.37 18.77 Favored 'General case' 0 C--N 1.291 -1.955 0 C-N-CA 118.626 -1.229 . . . . 0.0 111.169 -179.429 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.482 ' SG ' ' O ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -73.11 170.16 15.51 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.526 177.388 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.39 7.37 2.16 Favored 'General case' 0 C--N 1.296 -1.761 0 C-N-CA 119.108 -1.037 . . . . 0.0 110.187 176.489 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.411 ' HA ' HD12 ' A' ' 30' ' ' LEU . 0.3 OUTLIER -163.97 -178.24 5.52 Favored 'General case' 0 C--N 1.288 -2.085 0 CA-C-N 114.449 -1.25 . . . . 0.0 110.198 179.395 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -86.01 164.37 17.41 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.369 -179.24 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.437 ' O ' ' O ' ' A' ' 11' ' ' GLN . . . 83.25 -30.77 3.27 Favored Glycine 0 N--CA 1.49 2.234 0 C-N-CA 119.189 -1.481 . . . . 0.0 111.32 179.531 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.514 ' OE1' ' N ' ' A' ' 11' ' ' GLN . 3.1 mp0 -44.09 168.39 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.068 0 C-N-CA 119.194 -1.002 . . . . 0.0 109.879 179.806 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.461 ' O ' ' O ' ' A' ' 22' ' ' CYS . 2.1 m-20 -141.9 -69.7 0.36 Allowed 'General case' 0 N--CA 1.5 2.051 0 C-N-CA 118.536 -1.266 . . . . 0.0 113.374 -177.647 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 81.7 mt -75.63 46.71 0.37 Allowed 'General case' 0 C--N 1.272 -2.765 0 C-N-CA 118.327 -1.349 . . . . 0.0 110.151 -177.0 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.442 ' HB2' ' N ' ' A' ' 6' ' ' CYS . 29.9 p -123.58 -156.93 0.73 Allowed 'General case' 0 C--O 1.205 -1.269 0 CA-C-N 115.265 -0.88 . . . . 0.0 109.597 179.046 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.482 ' O ' ' SG ' ' A' ' 6' ' ' CYS . 71.2 mt -116.09 109.12 17.06 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 114.934 -1.03 . . . . 0.0 108.237 175.687 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.575 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 0.5 OUTLIER -110.31 -51.44 2.87 Favored 'General case' 0 C--N 1.289 -2.054 0 C-N-CA 118.933 -1.107 . . . . 0.0 110.71 -174.673 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.508 ' N ' ' SG ' ' A' ' 16' ' ' CYS . 18.4 tp10 -88.63 75.55 8.26 Favored 'General case' 0 C--N 1.294 -1.816 0 C-N-CA 118.649 -1.221 . . . . 0.0 109.048 177.862 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.38 -121.89 6.61 Favored Glycine 0 N--CA 1.486 2.0 0 C-N-CA 119.143 -1.503 . . . . 0.0 110.013 -178.57 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.425 ' O ' HD22 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -99.81 -1.17 38.27 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 122.026 0.917 . . . . 0.0 110.22 -179.803 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -79.64 133.41 36.4 Favored 'General case' 0 C--N 1.26 -3.309 0 CA-C-N 113.719 -1.582 . . . . 0.0 110.861 -179.137 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.0 t -70.95 141.54 16.73 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.955 0 C-N-CA 118.879 -1.128 . . . . 0.0 109.081 177.71 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.461 ' O ' ' O ' ' A' ' 12' ' ' ASN . 0.1 OUTLIER -148.47 121.39 8.77 Favored 'General case' 0 C--N 1.277 -2.556 0 C-N-CA 118.346 -1.342 . . . . 0.0 109.458 177.304 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.482 ' O ' ' O ' ' A' ' 26' ' ' ASN . . . 175.0 -94.99 0.1 OUTLIER Glycine 0 C--O 1.201 -1.949 0 C-N-CA 118.304 -1.903 . . . . 0.0 111.505 -174.527 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -39.33 129.81 1.74 Allowed 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 120.494 -0.483 . . . . 0.0 111.553 -176.467 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.437 ' O ' ' OD1' ' A' ' 26' ' ' ASN . . . 90.65 -19.36 45.12 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -178.414 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.482 ' O ' ' O ' ' A' ' 23' ' ' GLY . 85.5 m-20 -155.96 -163.13 1.42 Allowed 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -179.862 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.676 ' NZ ' HD11 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -156.86 133.13 9.8 Favored 'General case' 0 N--CA 1.496 1.855 0 C-N-CA 117.871 -1.531 . . . . 0.0 111.345 176.143 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.502 ' SG ' ' OD1' ' A' ' 37' ' ' ASN . 0.1 OUTLIER -87.2 161.11 18.22 Favored 'General case' 0 CA--C 1.482 -1.663 0 CA-C-O 123.342 1.544 . . . . 0.0 113.028 179.897 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.676 HD11 ' NZ ' ' A' ' 27' ' ' LYS . 31.5 mm -134.47 124.13 44.23 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.265 0 CA-C-N 111.057 -2.792 . . . . 0.0 109.677 -179.764 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.411 HD12 ' HA ' ' A' ' 8' ' ' GLU . 33.2 mt -76.38 121.04 22.46 Favored 'General case' 0 N--CA 1.501 2.121 0 C-N-CA 118.804 -1.159 . . . . 0.0 110.684 -179.42 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 83.4 104.12 0.52 Allowed Glycine 0 C--N 1.302 -1.317 0 C-N-CA 119.224 -1.465 . . . . 0.0 110.846 178.034 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.587 ' O ' ' N ' ' A' ' 34' ' ' GLY . 27.6 t -78.76 -127.46 0.01 OUTLIER 'General case' 0 C--O 1.198 -1.653 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 176.993 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -71.06 66.25 0.39 Allowed 'General case' 0 C--N 1.253 -3.597 0 CA-C-N 114.814 -1.084 . . . . 0.0 108.684 -176.434 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.587 ' N ' ' O ' ' A' ' 32' ' ' SER . . . 69.8 29.47 71.04 Favored Glycine 0 C--N 1.29 -1.989 0 N-CA-C 108.583 -1.807 . . . . 0.0 108.583 -177.245 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -125.7 -124.17 0.25 Allowed 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 118.829 -1.149 . . . . 0.0 113.137 -176.329 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.548 ' O ' ' N ' ' A' ' 32' ' ' SER . 16.2 mtmt -94.96 -173.02 2.85 Favored 'General case' 0 C--N 1.278 -2.506 0 CA-C-N 113.256 -1.793 . . . . 0.0 112.822 -175.517 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.502 ' OD1' ' SG ' ' A' ' 28' ' ' CYS . 1.4 t30 -82.28 151.75 26.63 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 114.859 -1.064 . . . . 0.0 109.076 177.907 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.48 ' O ' ' SG ' ' A' ' 28' ' ' CYS . 22.8 tt0 -145.88 142.76 29.08 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 118.984 -1.087 . . . . 0.0 110.604 178.833 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.575 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 36.0 m -91.1 94.23 9.51 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.063 -178.486 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.468 ' O ' ' O ' ' A' ' 27' ' ' LYS . 1.2 p -105.94 139.22 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 C-N-CA 118.491 -1.284 . . . . 0.0 111.998 179.297 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.426 ' O ' HG22 ' A' ' 40' ' ' VAL . 4.9 t -58.65 143.2 47.33 Favored 'General case' 0 C--N 1.273 -2.76 0 CA-C-N 113.524 -1.671 . . . . 0.0 111.166 178.172 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 158.34 -141.25 7.54 Favored Glycine 0 N--CA 1.487 2.056 0 C-N-CA 119.6 -1.286 . . . . 0.0 110.007 179.671 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -130.5 131.76 45.28 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.837 -0.745 . . . . 0.0 109.816 179.25 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -137.11 -151.1 5.88 Favored Glycine 0 N--CA 1.489 2.198 0 C-N-CA 119.648 -1.263 . . . . 0.0 110.399 -179.515 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -145.48 152.32 49.34 Favored Pre-proline 0 C--N 1.302 -1.491 0 C-N-CA 119.54 -0.864 . . . . 0.0 109.703 179.989 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -56.16 -170.61 0.03 OUTLIER 'Trans proline' 0 C--O 1.214 -0.702 0 C-N-CA 121.124 1.216 . . . . 0.0 110.504 176.565 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -107.54 100.29 33.52 Favored Pre-proline 0 CA--C 1.56 1.352 0 C-N-CA 120.3 -0.56 . . . . 0.0 110.243 178.6 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -62.68 154.71 63.59 Favored 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 120.707 0.938 . . . . 0.0 110.919 -178.045 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 116.303 -1.808 . . . . 0.0 110.35 -179.568 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.423 ' O ' HG13 ' A' ' 1' ' ' VAL . 7.7 p . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 1.5 t -95.76 160.36 2.81 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 C-N-CA 119.552 -0.859 . . . . 0.0 110.215 179.603 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.462 ' CG ' ' O ' ' A' ' 13' ' ' LEU . 7.3 m-85 -90.44 -164.98 1.25 Allowed 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 119.212 -0.995 . . . . 0.0 109.242 178.699 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.584 HG23 ' OE2' ' A' ' 47' ' ' GLU . 0.2 OUTLIER -116.65 -176.7 3.02 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 178.9 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.565 ' N ' ' OG1' ' A' ' 4' ' ' THR . 0.2 OUTLIER -79.35 156.17 28.11 Favored 'General case' 0 C--N 1.289 -2.053 0 C-N-CA 118.528 -1.269 . . . . 0.0 110.406 -179.366 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.405 ' N ' ' HB2' ' A' ' 14' ' ' CYS . 0.1 OUTLIER -70.72 152.01 44.27 Favored 'General case' 0 C--N 1.291 -1.967 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.719 176.654 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.415 ' O ' ' CG ' ' A' ' 8' ' ' GLU . 43.0 p -119.36 4.43 11.23 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-O 121.813 0.816 . . . . 0.0 108.96 178.812 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.415 ' CG ' ' O ' ' A' ' 7' ' ' THR . 29.4 mt-10 -161.93 167.47 24.56 Favored 'General case' 0 C--N 1.283 -2.284 0 CA-C-N 113.914 -1.494 . . . . 0.0 111.18 -178.971 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.422 ' HB3' ' H ' ' A' ' 30' ' ' LEU . 0.9 OUTLIER -79.5 156.47 27.79 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 115.038 -0.983 . . . . 0.0 108.868 177.517 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 28' ' ' CYS . . . 90.51 -13.92 64.15 Favored Glycine 0 N--CA 1.503 3.163 0 C-N-CA 118.739 -1.695 . . . . 0.0 112.45 179.264 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 47.5 mm-40 -61.17 -164.51 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.239 0 C-N-CA 119.139 -1.024 . . . . 0.0 111.073 -178.47 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.495 ' C ' ' H ' ' A' ' 14' ' ' CYS . 7.4 m-20 -160.51 -66.96 0.07 Allowed 'General case' 0 N--CA 1.5 2.057 0 C-N-CA 118.377 -1.329 . . . . 0.0 113.367 179.791 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.462 ' O ' ' CG ' ' A' ' 3' ' ' TYR . 86.1 mt -75.85 41.1 0.2 Allowed 'General case' 0 C--N 1.287 -2.123 0 C-N-CA 119.364 -0.934 . . . . 0.0 110.155 -178.396 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.495 ' H ' ' C ' ' A' ' 12' ' ' ASN . 29.1 p -120.3 -165.83 1.24 Allowed 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.232 178.607 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.567 HD22 ' O ' ' A' ' 19' ' ' SER . 47.1 mt -97.19 102.79 14.64 Favored 'General case' 0 C--N 1.294 -1.841 0 C-N-CA 119.248 -0.981 . . . . 0.0 109.441 178.188 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.413 ' CB ' ' SG ' ' A' ' 22' ' ' CYS . 0.5 OUTLIER -95.41 -35.31 11.78 Favored 'General case' 0 C--N 1.281 -2.397 0 CA-C-N 114.262 -1.336 . . . . 0.0 111.139 -176.021 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -114.19 89.65 3.14 Favored 'General case' 0 C--N 1.301 -1.513 0 C-N-CA 119.68 -0.808 . . . . 0.0 110.326 -179.143 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 73.96 -91.26 0.7 Allowed Glycine 0 N--CA 1.488 2.126 0 C-N-CA 119.511 -1.328 . . . . 0.0 110.486 179.418 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.567 ' O ' HD22 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -138.27 4.34 2.44 Favored 'General case' 0 N--CA 1.484 1.232 0 CA-C-O 122.026 0.917 . . . . 0.0 110.89 -178.841 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -85.03 138.89 32.16 Favored 'General case' 0 C--N 1.261 -3.257 0 CA-C-N 113.835 -1.529 . . . . 0.0 111.111 -179.556 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.54 HG12 ' O ' ' A' ' 22' ' ' CYS . 2.4 t -77.28 139.5 18.61 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.124 0 C-N-CA 118.95 -1.1 . . . . 0.0 110.032 179.039 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.54 ' O ' HG12 ' A' ' 21' ' ' VAL . 0.8 OUTLIER -80.7 -135.44 0.03 OUTLIER 'General case' 0 C--N 1.278 -2.502 0 C-N-CA 118.722 -1.191 . . . . 0.0 109.333 176.049 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.532 ' O ' ' ND2' ' A' ' 26' ' ' ASN . . . -172.68 107.14 0.24 Allowed Glycine 0 C--N 1.272 -3.028 0 C-N-CA 117.835 -2.126 . . . . 0.0 111.089 179.309 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.461 ' C ' ' O ' ' A' ' 23' ' ' GLY . 2.9 tt0 -34.32 131.92 0.3 Allowed 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 121.632 0.73 . . . . 0.0 110.422 178.665 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 131.23 -31.12 3.21 Favored Glycine 0 C--N 1.291 -1.96 0 N-CA-C 106.512 -2.635 . . . . 0.0 106.512 -174.714 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.589 ' N ' ' ND2' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -96.1 -161.2 0.85 Allowed 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 175.412 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.697 ' NZ ' HD11 ' A' ' 29' ' ' ILE . 10.7 ttpp -144.56 113.45 6.8 Favored 'General case' 0 C--N 1.287 -2.116 0 C-N-CA 119.436 -0.906 . . . . 0.0 109.616 177.329 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.566 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 5.3 m -84.31 156.82 21.74 Favored 'General case' 0 CA--C 1.482 -1.662 0 C-N-CA 117.392 -1.723 . . . . 0.0 111.603 -179.665 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.697 HD11 ' NZ ' ' A' ' 27' ' ' LYS . 33.2 mm -144.77 125.38 7.89 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.167 0 CA-C-N 113.235 -1.802 . . . . 0.0 109.92 177.943 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.422 ' H ' ' HB3' ' A' ' 9' ' ' SER . 23.4 mt -76.77 121.56 23.5 Favored 'General case' 0 N--CA 1.498 1.964 0 C-N-CA 118.826 -1.15 . . . . 0.0 109.951 178.498 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.439 ' O ' ' O ' ' A' ' 32' ' ' SER . . . 77.65 100.89 0.18 Allowed Glycine 0 C--N 1.303 -1.281 0 C-N-CA 118.468 -1.825 . . . . 0.0 109.855 178.686 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.575 ' O ' ' N ' ' A' ' 34' ' ' GLY . 14.8 m -66.01 -127.78 0.0 OUTLIER 'General case' 0 C--O 1.198 -1.637 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 178.389 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -71.83 64.67 0.49 Allowed 'General case' 0 C--N 1.252 -3.664 0 CA-C-N 114.573 -1.194 . . . . 0.0 108.809 -175.822 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.575 ' N ' ' O ' ' A' ' 32' ' ' SER . . . 72.82 32.46 61.18 Favored Glycine 0 C--N 1.29 -1.988 0 N-CA-C 108.551 -1.82 . . . . 0.0 108.551 -177.252 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -125.7 -125.91 0.24 Allowed 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 118.981 -1.087 . . . . 0.0 112.707 -177.131 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.435 ' O ' ' N ' ' A' ' 32' ' ' SER . 19.9 mttp -97.52 179.93 4.69 Favored 'General case' 0 C--N 1.277 -2.565 0 CA-C-N 113.332 -1.758 . . . . 0.0 113.057 -176.263 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.4 ' HA ' ' H ' ' A' ' 31' ' ' GLY . 7.3 m-20 -64.16 152.08 41.64 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.598 175.968 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 43.1 tt0 -161.22 151.61 17.74 Favored 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 119.042 -1.063 . . . . 0.0 110.174 177.098 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.566 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 0.0 OUTLIER -101.84 104.47 15.22 Favored 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 119.55 -0.86 . . . . 0.0 111.607 179.789 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.51 ' O ' ' N ' ' A' ' 27' ' ' LYS . 1.1 p -99.01 137.5 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 C-N-CA 118.307 -1.357 . . . . 0.0 109.994 175.356 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 6.3 t -63.93 145.5 55.73 Favored 'General case' 0 C--N 1.266 -3.039 0 CA-C-N 114.008 -1.451 . . . . 0.0 110.811 -178.752 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 152.29 -146.81 15.81 Favored Glycine 0 N--CA 1.49 2.26 0 C-N-CA 119.459 -1.353 . . . . 0.0 110.64 179.094 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -116.36 129.44 56.25 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 120.083 -0.647 . . . . 0.0 109.797 -179.951 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -145.9 -165.03 11.19 Favored Glycine 0 N--CA 1.494 2.534 0 C-N-CA 119.284 -1.436 . . . . 0.0 110.616 -179.62 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.3 t -120.41 144.92 39.35 Favored Pre-proline 0 N--CA 1.491 1.618 0 C-N-CA 119.933 -0.707 . . . . 0.0 110.147 -179.671 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.447 ' HB3' HD12 ' A' ' 13' ' ' LEU . 1.2 Cg_endo -64.69 176.27 3.0 Favored 'Trans proline' 0 C--O 1.213 -0.772 0 C-N-CA 120.948 1.099 . . . . 0.0 111.11 175.415 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.584 ' OE2' HG23 ' A' ' 4' ' ' THR . 2.8 tt0 -116.35 85.76 16.59 Favored Pre-proline 0 C--N 1.313 -0.985 0 C-N-CA 120.307 -0.557 . . . . 0.0 110.967 -179.822 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -63.15 165.86 15.98 Favored 'Trans proline' 0 C--O 1.216 -0.599 0 C-N-CA 120.945 1.097 . . . . 0.0 110.687 179.221 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 116.255 -1.831 . . . . 0.0 110.493 -179.3 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.741 ' O ' HG13 ' A' ' 1' ' ' VAL . 8.2 p . . . . . 0 N--CA 1.489 1.496 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.421 ' H ' HG23 ' A' ' 2' ' ' VAL . 1.6 t -78.48 158.97 4.81 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 C-N-CA 119.078 -1.049 . . . . 0.0 109.549 179.479 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.427 ' CZ ' HD22 ' A' ' 13' ' ' LEU . 42.8 m-85 -118.35 -171.42 2.07 Favored 'General case' 0 N--CA 1.498 1.942 0 C-N-CA 119.735 -0.786 . . . . 0.0 110.789 -178.337 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.2 p -106.22 -179.87 4.07 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-N 115.304 -0.862 . . . . 0.0 108.838 179.248 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -91.02 149.5 21.81 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 118.572 -1.251 . . . . 0.0 111.134 -179.546 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.513 ' SG ' ' O ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -74.06 178.46 4.99 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.972 178.397 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.2 p -148.68 21.02 1.03 Allowed 'General case' 0 C--N 1.285 -2.2 0 CA-C-N 114.149 -1.387 . . . . 0.0 109.032 175.406 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -160.81 171.89 17.99 Favored 'General case' 0 C--N 1.292 -1.92 0 CA-C-N 114.274 -1.33 . . . . 0.0 110.516 -179.272 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.486 ' O ' ' N ' ' A' ' 11' ' ' GLN . 0.5 OUTLIER -71.32 -176.68 1.55 Allowed 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 119.703 -0.799 . . . . 0.0 109.558 179.785 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.678 ' HA2' ' O ' ' A' ' 28' ' ' CYS . . . 28.31 9.39 0.0 OUTLIER Glycine 0 N--CA 1.498 2.819 1 N-CA-C 130.224 6.85 . . . . 0.0 130.224 179.862 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.486 ' N ' ' O ' ' A' ' 9' ' ' SER . 0.0 OUTLIER -60.75 -165.1 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 176.45 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.473 ' O ' ' O ' ' A' ' 22' ' ' CYS . 1.4 m-20 -148.76 -70.26 0.21 Allowed 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 117.266 -1.773 . . . . 0.0 114.225 -179.795 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.427 HD22 ' CZ ' ' A' ' 3' ' ' TYR . 7.6 mt -75.74 47.46 0.42 Allowed 'General case' 0 C--N 1.263 -3.174 0 C-N-CA 117.936 -1.505 . . . . 0.0 110.663 -175.543 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.542 ' O ' HG22 ' A' ' 21' ' ' VAL . 28.0 p -124.74 -156.58 0.73 Allowed 'General case' 0 C--O 1.211 -0.934 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.2 177.182 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.513 ' O ' ' SG ' ' A' ' 6' ' ' CYS . 5.8 mt -115.56 127.29 55.15 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.029 176.199 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.575 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -141.38 21.88 2.21 Favored 'General case' 0 C--N 1.297 -1.703 0 C-N-CA 118.409 -1.316 . . . . 0.0 111.439 -174.516 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -157.03 77.43 0.88 Allowed 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 119.6 -0.84 . . . . 0.0 109.145 176.047 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 77.2 -88.52 0.99 Allowed Glycine 0 N--CA 1.486 1.976 0 C-N-CA 119.386 -1.388 . . . . 0.0 109.881 -178.388 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.48 ' O ' ' OG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -145.56 11.67 1.29 Allowed 'General case' 0 C--N 1.303 -1.432 0 CA-C-O 122.511 1.148 . . . . 0.0 109.988 179.606 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -95.57 138.46 33.21 Favored 'General case' 0 C--N 1.258 -3.392 0 CA-C-N 113.238 -1.801 . . . . 0.0 110.288 178.105 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.542 HG22 ' O ' ' A' ' 14' ' ' CYS . 1.4 t -72.64 145.21 12.19 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.059 -178.593 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.473 ' O ' ' O ' ' A' ' 12' ' ' ASN . 6.0 m -144.41 126.13 15.16 Favored 'General case' 0 N--CA 1.499 2.021 0 C-N-CA 118.732 -1.187 . . . . 0.0 109.436 177.212 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.436 ' O ' ' O ' ' A' ' 26' ' ' ASN . . . 175.5 -91.05 0.08 OUTLIER Glycine 0 C--O 1.206 -1.604 0 C-N-CA 117.349 -2.358 . . . . 0.0 112.737 -178.043 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -48.9 126.22 11.81 Favored 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 119.453 -0.899 . . . . 0.0 111.007 -176.7 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.18 -29.09 9.22 Favored Glycine 0 N--CA 1.48 1.591 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -178.447 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.436 ' O ' ' O ' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -132.11 -168.95 2.12 Favored 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 120.163 -0.615 . . . . 0.0 110.929 -179.49 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.51 ' O ' ' O ' ' A' ' 40' ' ' VAL . 0.1 OUTLIER -142.71 159.53 42.05 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 177.955 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.678 ' O ' ' HA2' ' A' ' 10' ' ' GLY . 74.0 m -127.03 163.27 24.1 Favored 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 118.657 -1.217 . . . . 0.0 111.917 178.666 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 10.8 mm -139.59 130.6 32.67 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.839 0 CA-C-N 113.081 -1.872 . . . . 0.0 109.545 176.494 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.454 HD23 ' HA ' ' A' ' 30' ' ' LEU . 16.7 mt -75.5 117.44 17.29 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 118.091 -1.444 . . . . 0.0 108.31 176.894 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.66 101.77 0.79 Allowed Glycine 0 N--CA 1.482 1.732 0 N-CA-C 108.669 -1.772 . . . . 0.0 108.669 -176.747 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.586 ' N ' ' O ' ' A' ' 36' ' ' LYS . 0.8 OUTLIER -83.3 -134.48 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 119.943 -0.703 . . . . 0.0 109.807 -176.951 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.411 ' H ' ' HB2' ' A' ' 32' ' ' SER . 16.0 t70 -71.42 64.25 0.4 Allowed 'General case' 0 C--N 1.255 -3.53 0 CA-C-N 114.153 -1.385 . . . . 0.0 108.878 -175.426 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 32' ' ' SER . . . 76.51 27.49 61.24 Favored Glycine 0 C--N 1.285 -2.256 0 N-CA-C 108.124 -1.99 . . . . 0.0 108.124 -176.989 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -126.71 -136.0 0.25 Allowed 'General case' 0 C--O 1.213 -0.857 0 CA-C-O 122.215 1.007 . . . . 0.0 111.41 -177.567 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.586 ' O ' ' N ' ' A' ' 32' ' ' SER . 8.2 mttm -102.89 -154.84 0.5 Allowed 'General case' 0 C--N 1.269 -2.894 0 CA-C-N 113.005 -1.907 . . . . 0.0 112.206 -176.811 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.505 ' OD1' ' N ' ' A' ' 37' ' ' ASN . 0.9 OUTLIER -70.7 141.72 51.55 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 115.063 -0.972 . . . . 0.0 110.542 178.024 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.47 ' CG ' ' N ' ' A' ' 39' ' ' CYS . 36.6 tt0 -143.59 166.9 23.56 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 120.008 -0.677 . . . . 0.0 109.531 179.503 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.575 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 3.8 m -116.93 91.18 3.51 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 119.567 -0.853 . . . . 0.0 110.814 -179.611 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.51 ' O ' ' O ' ' A' ' 27' ' ' LYS . 0.2 OUTLIER -91.17 139.0 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.17 0 C-N-CA 118.235 -1.386 . . . . 0.0 111.432 179.261 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.421 ' O ' HG22 ' A' ' 40' ' ' VAL . 11.4 t -49.62 151.69 1.61 Allowed 'General case' 0 C--N 1.271 -2.829 0 CA-C-N 114.124 -1.398 . . . . 0.0 110.806 -178.767 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 146.78 -155.27 26.46 Favored Glycine 0 N--CA 1.489 2.209 0 C-N-CA 119.682 -1.247 . . . . 0.0 110.146 -179.378 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 81.4 mt-10 -144.39 143.15 30.79 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 119.497 -0.881 . . . . 0.0 110.282 179.844 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -146.95 -148.12 4.69 Favored Glycine 0 N--CA 1.494 2.53 0 C-N-CA 119.269 -1.443 . . . . 0.0 110.961 -179.525 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -132.56 155.92 80.68 Favored Pre-proline 0 N--CA 1.495 1.814 0 C-N-CA 120.183 -0.607 . . . . 0.0 109.64 -179.206 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -53.04 -168.92 0.01 OUTLIER 'Trans proline' 0 C--O 1.215 -0.657 0 C-N-CA 121.46 1.44 . . . . 0.0 111.44 176.933 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -118.75 86.04 29.12 Favored Pre-proline 0 C--N 1.312 -1.024 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.891 -179.706 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -65.05 169.58 11.78 Favored 'Trans proline' 0 C--N 1.325 -0.695 0 C-N-CA 121.071 1.181 . . . . 0.0 110.831 178.741 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 47.0 mm-40 . . . . . 0 N--CA 1.491 1.575 0 CA-C-O 116.368 -1.777 . . . . 0.0 110.379 -179.849 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 4.6 t . . . . . 0 N--CA 1.489 1.496 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.545 HG12 ' N ' ' A' ' 3' ' ' TYR . 11.3 t -101.64 169.51 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 C-N-CA 119.736 -0.786 . . . . 0.0 110.516 -179.264 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.545 ' N ' HG12 ' A' ' 2' ' ' VAL . 37.0 m-85 -122.82 -167.74 1.63 Allowed 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 177.601 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.442 ' OG1' ' OE1' ' A' ' 47' ' ' GLU . 10.4 p -106.07 173.49 6.29 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 119.441 -0.904 . . . . 0.0 109.304 -179.837 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -85.4 147.72 26.35 Favored 'General case' 0 C--N 1.286 -2.176 0 C-N-CA 118.653 -1.219 . . . . 0.0 109.74 179.485 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -75.29 -176.37 3.07 Favored 'General case' 0 C--N 1.285 -2.223 0 C-N-CA 119.547 -0.861 . . . . 0.0 110.336 177.545 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.404 ' O ' ' OG1' ' A' ' 7' ' ' THR . 1.6 t -155.04 12.95 0.38 Allowed 'General case' 0 C--N 1.277 -2.566 0 CA-C-N 114.1 -1.409 . . . . 0.0 110.501 178.696 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -163.82 178.55 7.74 Favored 'General case' 0 C--N 1.282 -2.343 0 CA-C-N 114.647 -1.161 . . . . 0.0 110.088 179.388 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.452 ' O ' ' N ' ' A' ' 11' ' ' GLN . 0.5 OUTLIER -74.66 -160.11 0.1 Allowed 'General case' 0 C--N 1.297 -1.702 0 C-N-CA 119.808 -0.757 . . . . 0.0 109.809 179.864 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.709 ' HA2' ' CE ' ' A' ' 27' ' ' LYS . . . 27.79 10.75 0.0 OUTLIER Glycine 0 N--CA 1.5 2.945 1 N-CA-C 130.68 7.032 . . . . 0.0 130.68 178.557 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.456 ' O ' ' OD1' ' A' ' 12' ' ' ASN . 1.3 mt-30 -86.59 -174.68 5.11 Favored 'General case' 0 N--CA 1.499 1.995 0 C-N-CA 119.01 -1.076 . . . . 0.0 108.537 176.726 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.551 ' ND2' ' O ' ' A' ' 26' ' ' ASN . 16.8 m-20 -138.92 -65.63 0.49 Allowed 'General case' 0 N--CA 1.502 2.141 0 C-N-CA 118.247 -1.381 . . . . 0.0 114.675 -174.641 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.438 HD23 ' HA ' ' A' ' 13' ' ' LEU . 21.2 mt -77.94 47.33 0.63 Allowed 'General case' 0 C--N 1.272 -2.796 0 C-N-CA 117.939 -1.504 . . . . 0.0 111.573 -174.946 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 11.0 p -125.35 -167.4 1.68 Allowed 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 119.804 -0.758 . . . . 0.0 109.327 176.732 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.585 HD22 ' O ' ' A' ' 19' ' ' SER . 57.2 mt -102.09 116.05 31.86 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 177.06 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.637 ' HB3' HD21 ' A' ' 37' ' ' ASN . 6.5 m -111.4 -42.44 3.89 Favored 'General case' 0 N--CA 1.505 2.285 0 C-N-CA 118.854 -1.138 . . . . 0.0 111.919 -175.642 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.34 92.26 4.86 Favored 'General case' 0 N--CA 1.498 1.952 0 C-N-CA 118.968 -1.093 . . . . 0.0 109.776 178.381 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 76.03 -98.21 1.19 Allowed Glycine 0 N--CA 1.491 2.306 0 C-N-CA 119.319 -1.419 . . . . 0.0 110.308 -179.756 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.585 ' O ' HD22 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -134.89 3.02 3.18 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-O 122.231 1.015 . . . . 0.0 110.451 179.77 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -83.95 139.27 32.69 Favored 'General case' 0 C--N 1.26 -3.303 0 CA-C-N 113.51 -1.677 . . . . 0.0 110.728 -179.358 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.434 ' HA ' HD23 ' A' ' 15' ' ' LEU . 2.3 t -64.42 142.59 16.68 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.035 0 C-N-CA 118.95 -1.1 . . . . 0.0 110.153 179.511 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.517 ' O ' ' SG ' ' A' ' 28' ' ' CYS . 0.0 OUTLIER -149.72 122.72 8.81 Favored 'General case' 0 C--N 1.28 -2.432 0 C-N-CA 118.659 -1.217 . . . . 0.0 109.403 177.395 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.428 ' HA3' ' O ' ' A' ' 12' ' ' ASN . . . 148.91 -33.94 1.14 Allowed Glycine 0 C--N 1.296 -1.678 1 N-CA-C 130.077 6.791 . . . . 0.0 130.077 -177.234 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.444 ' C ' ' H ' ' A' ' 26' ' ' ASN . 0.6 OUTLIER -54.64 116.52 2.74 Favored 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 119.301 -0.959 . . . . 0.0 110.261 179.911 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 78.85 -20.7 4.33 Favored Glycine 0 N--CA 1.479 1.504 0 C-N-CA 119.317 -1.42 . . . . 0.0 109.749 -178.681 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.551 ' O ' ' ND2' ' A' ' 12' ' ' ASN . 0.0 OUTLIER -114.22 -170.53 1.74 Allowed 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 119.933 -0.707 . . . . 0.0 109.876 -179.8 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.709 ' CE ' ' HA2' ' A' ' 10' ' ' GLY . 0.2 OUTLIER -154.2 118.71 4.87 Favored 'General case' 0 N--CA 1.5 2.045 0 C-N-CA 119.084 -1.046 . . . . 0.0 111.205 -179.969 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.517 ' SG ' ' O ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -81.77 160.98 23.46 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 118.979 -1.088 . . . . 0.0 110.956 -179.174 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.537 HD11 ' CE ' ' A' ' 27' ' ' LYS . 36.5 mm -133.33 126.81 53.11 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 C-N-CA 119.385 -0.926 . . . . 0.0 110.455 179.685 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 13.3 mt -78.57 132.6 37.21 Favored 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 118.612 -1.235 . . . . 0.0 109.935 178.065 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.939 ' HA3' ' O ' ' A' ' 35' ' ' GLU . . . -117.72 -112.08 2.58 Favored Glycine 0 C--O 1.216 -0.985 1 N-CA-C 130.954 7.141 . . . . 0.0 130.954 177.331 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.506 ' H ' ' C ' ' A' ' 35' ' ' GLU . 50.0 m -164.08 -129.7 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.248 0 CA-C-O 122.568 1.175 . . . . 0.0 112.484 -177.554 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 38.3 m-20 -80.11 69.95 6.62 Favored 'General case' 0 C--N 1.27 -2.848 0 CA-C-N 112.971 -1.922 . . . . 0.0 111.051 -173.076 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 104.94 2.45 42.4 Favored Glycine 0 C--N 1.278 -2.647 0 N-CA-C 107.111 -2.396 . . . . 0.0 107.111 -179.428 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.939 ' O ' ' HA3' ' A' ' 31' ' ' GLY . 3.7 mm-40 -119.54 10.41 11.79 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 113.21 -1.495 . . . . 0.0 108.809 -179.745 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.693 ' O ' ' O ' ' A' ' 35' ' ' GLU . 31.7 mttt -36.23 -157.59 0.0 OUTLIER 'General case' 0 C--N 1.271 -2.836 0 CA-C-N 111.65 -2.523 . . . . 0.0 112.801 -179.439 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.868 HD22 ' C ' ' A' ' 37' ' ' ASN . 0.2 OUTLIER -71.66 110.25 6.1 Favored 'General case' 0 C--N 1.28 -2.449 0 C-N-CA 118.983 -1.087 . . . . 0.0 110.156 -179.999 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.602 ' N ' HD22 ' A' ' 37' ' ' ASN . 19.9 tt0 -113.19 140.35 48.01 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.647 179.177 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 77.1 m -91.49 107.65 19.35 Favored 'General case' 0 C--N 1.294 -1.847 0 C-N-CA 119.124 -1.03 . . . . 0.0 111.073 -179.887 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.578 HG22 ' N ' ' A' ' 41' ' ' THR . 2.5 p -123.58 162.6 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.5 0 C-N-CA 118.833 -1.147 . . . . 0.0 110.862 177.807 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.578 ' N ' HG22 ' A' ' 40' ' ' VAL . 1.3 t -90.0 144.99 25.43 Favored 'General case' 0 C--N 1.284 -2.257 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.805 179.585 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 178.49 -93.4 0.09 OUTLIER Glycine 0 N--CA 1.491 2.344 1 N-CA-C 130.25 6.86 . . . . 0.0 130.25 179.899 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -157.8 93.03 1.24 Allowed 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 119.561 -0.856 . . . . 0.0 110.027 179.399 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.528 ' HA3' ' HG3' ' A' ' 27' ' ' LYS . . . -131.62 -178.76 15.67 Favored Glycine 0 N--CA 1.493 2.467 1 N-CA-C 131.711 7.444 . . . . 0.0 131.711 -178.963 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -106.84 118.63 53.73 Favored Pre-proline 0 CA--C 1.561 1.386 0 C-N-CA 120.462 -0.495 . . . . 0.0 111.422 -179.341 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.41 ' O ' ' C ' ' A' ' 47' ' ' GLU . 4.3 Cg_exo -64.46 102.95 0.42 Allowed 'Trans proline' 0 C--O 1.215 -0.652 0 C-N-CA 120.935 1.09 . . . . 0.0 110.784 174.894 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.442 ' OE1' ' OG1' ' A' ' 4' ' ' THR . 6.5 tm-20 -39.64 106.52 0.4 Allowed Pre-proline 0 CA--C 1.56 1.343 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.162 179.603 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.415 ' O ' ' OE2' ' A' ' 47' ' ' GLU . 1.4 Cg_endo -63.93 132.32 34.21 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 120.672 0.914 . . . . 0.0 111.421 -175.563 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 116.341 -1.79 . . . . 0.0 110.182 179.43 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 3.1 t . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.638 HG12 ' N ' ' A' ' 3' ' ' TYR . 23.1 t -85.19 173.34 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 119.009 -1.076 . . . . 0.0 110.047 179.708 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.638 ' N ' HG12 ' A' ' 2' ' ' VAL . 23.4 m-85 -96.61 -166.25 1.39 Allowed 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 119.39 -0.924 . . . . 0.0 111.057 -178.013 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 13.8 p -96.9 176.19 6.06 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 119.792 -0.763 . . . . 0.0 109.225 -179.321 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -89.71 144.67 25.79 Favored 'General case' 0 C--N 1.289 -2.052 0 C-N-CA 118.722 -1.191 . . . . 0.0 109.335 178.321 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -73.81 -177.93 3.0 Favored 'General case' 0 C--N 1.286 -2.175 0 CA-C-O 122.144 0.973 . . . . 0.0 111.535 -179.864 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.7 p -154.37 18.56 0.48 Allowed 'General case' 0 C--N 1.283 -2.286 0 CA-C-N 113.476 -1.693 . . . . 0.0 109.076 178.486 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -163.2 177.93 8.64 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-N 114.4 -1.273 . . . . 0.0 110.568 -178.98 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.496 ' O ' ' N ' ' A' ' 11' ' ' GLN . 0.6 OUTLIER -83.91 -158.52 0.32 Allowed 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.985 -179.763 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.529 ' HA2' ' HE3' ' A' ' 27' ' ' LYS . . . 22.85 21.41 0.0 OUTLIER Glycine 0 N--CA 1.498 2.779 1 N-CA-C 129.973 6.749 . . . . 0.0 129.973 178.762 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.496 ' N ' ' O ' ' A' ' 9' ' ' SER . 7.7 mt-30 -94.49 -164.18 1.14 Allowed 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 114.492 -0.854 . . . . 0.0 109.575 178.233 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.74 HD21 ' H ' ' A' ' 44' ' ' GLY . 24.7 m-20 -147.57 -62.59 0.27 Allowed 'General case' 0 N--CA 1.501 2.082 0 C-N-CA 118.086 -1.446 . . . . 0.0 114.54 -177.311 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.437 HD22 ' CZ ' ' A' ' 3' ' ' TYR . 16.2 mt -76.86 47.43 0.52 Allowed 'General case' 0 C--N 1.269 -2.909 0 C-N-CA 118.127 -1.429 . . . . 0.0 111.795 -174.586 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 7.0 p -129.85 -168.07 1.9 Allowed 'General case' 0 C--N 1.308 -1.203 0 C-N-CA 119.657 -0.817 . . . . 0.0 110.186 175.441 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 35.9 mt -104.41 120.12 40.51 Favored 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 119.586 -0.846 . . . . 0.0 108.935 178.232 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.1 m -119.67 -18.9 8.24 Favored 'General case' 0 N--CA 1.501 2.114 0 C-N-CA 119.163 -1.015 . . . . 0.0 111.816 -176.575 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.11 93.78 4.02 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 119.591 -0.844 . . . . 0.0 109.243 177.677 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 68.84 -101.75 0.83 Allowed Glycine 0 N--CA 1.486 2.001 0 C-N-CA 119.245 -1.455 . . . . 0.0 109.8 -178.268 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.442 ' O ' ' OG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -127.17 4.12 6.41 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 122.541 1.162 . . . . 0.0 109.269 178.931 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -78.09 140.1 39.06 Favored 'General case' 0 C--N 1.262 -3.211 0 CA-C-N 112.811 -1.995 . . . . 0.0 111.203 -179.077 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.1 t -77.27 145.75 9.61 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.19 0 C-N-CA 119.337 -0.945 . . . . 0.0 110.021 178.754 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.494 ' O ' ' SG ' ' A' ' 28' ' ' CYS . 15.0 m -146.57 109.89 4.78 Favored 'General case' 0 C--N 1.288 -2.099 0 C-N-CA 118.99 -1.084 . . . . 0.0 109.185 176.761 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.577 ' HA2' ' OD1' ' A' ' 12' ' ' ASN . . . -170.72 -78.75 0.04 OUTLIER Glycine 0 N--CA 1.479 1.523 1 N-CA-C 129.681 6.632 . . . . 0.0 129.681 -175.961 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.34 110.98 2.43 Favored 'General case' 0 C--N 1.311 -1.071 0 C-N-CA 118.308 -1.357 . . . . 0.0 109.309 179.441 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 105.44 -18.93 40.7 Favored Glycine 0 C--N 1.302 -1.359 0 N-CA-C 122.735 3.854 . . . . 0.0 122.735 -171.443 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.413 ' HA ' ' H ' ' A' ' 42' ' ' GLY . 0.0 OUTLIER -132.36 -167.94 1.97 Allowed 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 112.788 -1.706 . . . . 0.0 108.711 179.105 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.529 ' HE3' ' HA2' ' A' ' 10' ' ' GLY . 12.7 tttt -148.11 122.15 9.46 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 118.52 -1.272 . . . . 0.0 110.502 177.472 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.494 ' SG ' ' O ' ' A' ' 22' ' ' CYS . 19.2 m -86.55 153.58 21.72 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 117.825 -1.55 . . . . 0.0 110.819 178.624 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 13.6 mm -137.2 129.39 42.87 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.647 0 CA-C-N 114.492 -1.231 . . . . 0.0 109.303 175.839 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.461 ' HA ' HD23 ' A' ' 30' ' ' LEU . 17.2 mt -75.55 111.55 10.98 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 118.191 -1.404 . . . . 0.0 108.914 178.001 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.51 100.38 0.96 Allowed Glycine 0 C--N 1.299 -1.526 0 C-N-CA 118.821 -1.657 . . . . 0.0 109.303 -178.275 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.56 ' O ' ' N ' ' A' ' 34' ' ' GLY . 6.7 t -72.19 -130.48 0.0 OUTLIER 'General case' 0 C--O 1.2 -1.519 0 C-N-CA 119.147 -1.021 . . . . 0.0 108.407 -179.01 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -72.07 65.05 0.55 Allowed 'General case' 0 C--N 1.253 -3.603 0 CA-C-N 114.332 -1.303 . . . . 0.0 108.881 -175.697 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.56 ' N ' ' O ' ' A' ' 32' ' ' SER . . . 75.35 26.56 65.58 Favored Glycine 0 C--N 1.289 -2.054 0 N-CA-C 108.521 -1.832 . . . . 0.0 108.521 -177.381 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.426 ' OE2' ' O ' ' A' ' 34' ' ' GLY . 11.0 mm-40 -122.27 -131.3 0.28 Allowed 'General case' 0 C--O 1.214 -0.767 0 C-N-CA 119.251 -0.979 . . . . 0.0 111.873 -177.455 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.519 ' O ' ' N ' ' A' ' 32' ' ' SER . 8.9 mttp -101.72 -168.59 1.57 Allowed 'General case' 0 C--N 1.272 -2.769 0 CA-C-N 113.23 -1.805 . . . . 0.0 112.861 -176.958 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.431 ' OD1' ' N ' ' A' ' 37' ' ' ASN . 2.0 m-20 -64.32 139.55 58.78 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.648 176.65 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 40.2 tt0 -150.51 141.79 23.25 Favored 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 118.998 -1.081 . . . . 0.0 110.111 177.969 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 14.2 m -91.21 91.36 8.18 Favored 'General case' 0 C--N 1.293 -1.861 0 C-N-CA 119.49 -0.884 . . . . 0.0 111.173 -178.362 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.475 ' O ' ' O ' ' A' ' 27' ' ' LYS . 0.6 OUTLIER -95.53 139.69 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 C-N-CA 118.334 -1.347 . . . . 0.0 110.941 178.659 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.413 ' O ' HG22 ' A' ' 40' ' ' VAL . 8.8 t -56.8 147.27 23.66 Favored 'General case' 0 C--N 1.271 -2.831 0 CA-C-N 114.085 -1.416 . . . . 0.0 110.918 -179.567 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.413 ' H ' ' HA ' ' A' ' 26' ' ' ASN . . . 159.43 -141.25 7.39 Favored Glycine 0 N--CA 1.487 2.073 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 -179.263 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -146.57 106.44 3.98 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 119.34 -0.944 . . . . 0.0 110.229 179.785 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.74 ' H ' HD21 ' A' ' 12' ' ' ASN . . . -108.46 -156.54 18.46 Favored Glycine 0 N--CA 1.498 2.822 0 C-N-CA 119.834 -1.174 . . . . 0.0 111.1 -178.807 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -132.56 156.12 80.45 Favored Pre-proline 0 N--CA 1.497 1.876 0 C-N-CA 120.104 -0.638 . . . . 0.0 109.853 -178.941 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -53.84 165.33 1.92 Allowed 'Trans proline' 0 C--O 1.216 -0.623 0 C-N-CA 121.373 1.382 . . . . 0.0 111.092 175.828 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.496 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 2.7 tt0 -90.08 -43.49 0.41 Allowed Pre-proline 0 CA--C 1.558 1.259 0 C-N-CA 119.293 -0.963 . . . . 0.0 110.952 177.958 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.496 ' CD ' ' N ' ' A' ' 47' ' ' GLU . 3.9 Cg_endo -72.21 135.63 25.24 Favored 'Trans proline' 0 C--O 1.216 -0.602 0 C-N-CA 120.786 0.991 . . . . 0.0 110.721 176.889 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 5.4 mp0 . . . . . 0 N--CA 1.497 1.887 0 CA-C-O 116.294 -1.812 . . . . 0.0 110.373 179.799 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.778 HG12 ' H ' ' A' ' 3' ' ' TYR . 65.5 t . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 4.2 t -79.99 5.1 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 C-N-CA 119.573 -0.851 . . . . 0.0 110.768 -178.936 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.778 ' H ' HG12 ' A' ' 1' ' ' VAL . 94.7 m-85 -138.32 -172.18 3.22 Favored 'General case' 0 C--N 1.273 -2.75 0 CA-C-N 114.509 -1.223 . . . . 0.0 111.182 179.808 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.6 p -123.22 -167.44 1.6 Allowed 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 114.797 -1.092 . . . . 0.0 108.563 178.314 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.428 ' OD1' HD12 ' A' ' 15' ' ' LEU . 0.1 OUTLIER -93.54 156.14 16.91 Favored 'General case' 0 C--N 1.288 -2.106 0 C-N-CA 119.05 -1.06 . . . . 0.0 111.434 -177.939 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.447 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 1.7 m -72.23 162.17 29.84 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 114.931 -1.031 . . . . 0.0 110.44 177.286 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.906 ' H ' HE22 ' A' ' 11' ' ' GLN . 0.2 OUTLIER -138.44 8.73 2.66 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 119.46 -0.896 . . . . 0.0 110.034 178.328 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.752 ' H ' HE22 ' A' ' 11' ' ' GLN . 11.4 pt-20 -164.75 161.09 20.37 Favored 'General case' 0 C--N 1.281 -2.376 0 CA-C-N 114.29 -1.323 . . . . 0.0 110.379 178.886 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.484 ' HB3' ' H ' ' A' ' 30' ' ' LEU . 0.7 OUTLIER -70.36 150.37 46.37 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.644 -0.823 . . . . 0.0 109.905 -179.783 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.426 ' O ' ' O ' ' A' ' 11' ' ' GLN . . . 101.66 -37.01 3.84 Favored Glycine 0 N--CA 1.502 3.085 0 C-N-CA 119.511 -1.328 . . . . 0.0 112.759 178.114 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.906 HE22 ' H ' ' A' ' 7' ' ' THR . 4.5 mt-30 -47.31 176.39 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.521 0 C-N-CA 119.539 -0.865 . . . . 0.0 111.583 -177.63 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.514 ' C ' ' H ' ' A' ' 14' ' ' CYS . 54.7 m-20 -147.93 -60.56 0.26 Allowed 'General case' 0 N--CA 1.502 2.164 0 C-N-CA 118.698 -1.201 . . . . 0.0 113.339 -178.161 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.495 HD12 ' HB3' ' A' ' 46' ' ' PRO . 19.0 mt -76.1 39.71 0.19 Allowed 'General case' 0 C--N 1.29 -2.016 0 C-N-CA 118.752 -1.179 . . . . 0.0 110.273 -177.88 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.587 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 17.2 p -122.27 -164.58 1.18 Allowed 'General case' 0 C--N 1.292 -1.908 0 CA-C-N 115.05 -0.977 . . . . 0.0 108.387 176.555 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.428 HD12 ' OD1' ' A' ' 5' ' ' ASP . 25.4 mt -100.29 99.39 10.05 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-O 122.286 1.041 . . . . 0.0 108.7 177.764 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.587 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 93.2 m -100.91 -61.62 1.35 Allowed 'General case' 0 C--N 1.276 -2.594 0 CA-C-N 113.273 -1.785 . . . . 0.0 110.708 -174.07 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -80.57 90.11 5.7 Favored 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 118.902 -1.119 . . . . 0.0 108.838 178.207 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 69.29 -127.59 21.07 Favored Glycine 0 N--CA 1.484 1.847 0 C-N-CA 118.953 -1.594 . . . . 0.0 109.465 -177.838 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -100.89 0.01 37.65 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 122.179 0.99 . . . . 0.0 109.966 179.688 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 67.7 m-80 -80.02 150.92 30.23 Favored 'General case' 0 C--N 1.261 -3.246 0 CA-C-N 113.483 -1.689 . . . . 0.0 111.256 -179.007 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.545 HG12 ' O ' ' A' ' 22' ' ' CYS . 2.4 t -82.92 141.36 15.03 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 C-N-CA 119.566 -0.853 . . . . 0.0 111.477 -179.176 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.602 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 0.1 OUTLIER -77.76 -130.85 0.01 OUTLIER 'General case' 0 N--CA 1.514 2.764 0 C-N-CA 118.765 -1.174 . . . . 0.0 108.867 172.468 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.452 ' O ' ' C ' ' A' ' 24' ' ' GLN . . . -179.71 111.2 0.31 Allowed Glycine 0 C--N 1.275 -2.845 0 C-N-CA 117.96 -2.067 . . . . 0.0 111.617 177.527 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.452 ' C ' ' O ' ' A' ' 23' ' ' GLY . 36.4 tt0 -36.61 129.69 0.77 Allowed 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 119.979 -0.688 . . . . 0.0 109.244 176.13 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 121.31 -25.91 6.85 Favored Glycine 0 N--CA 1.483 1.813 0 N-CA-C 107.532 -2.227 . . . . 0.0 107.532 -175.142 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.625 ' N ' ' ND2' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -107.5 -161.25 0.77 Allowed 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 176.894 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.543 ' O ' ' O ' ' A' ' 40' ' ' VAL . 29.4 tttp -153.7 105.7 2.82 Favored 'General case' 0 N--CA 1.5 2.041 0 C-N-CA 118.799 -1.16 . . . . 0.0 111.918 179.866 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.619 ' O ' HD13 ' A' ' 29' ' ' ILE . 3.3 m -78.55 154.81 30.09 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 118.39 -1.324 . . . . 0.0 110.146 178.71 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.619 HD13 ' O ' ' A' ' 28' ' ' CYS . 8.2 mm -134.3 133.72 55.25 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.152 0 CA-C-N 114.968 -1.014 . . . . 0.0 110.283 175.655 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.484 ' H ' ' HB3' ' A' ' 9' ' ' SER . 17.7 mt -75.64 122.33 23.79 Favored 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 119.123 -1.031 . . . . 0.0 110.038 177.354 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 89.5 107.86 1.19 Allowed Glycine 0 N--CA 1.48 1.585 0 C-N-CA 118.993 -1.575 . . . . 0.0 110.786 178.21 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.601 ' N ' ' O ' ' A' ' 36' ' ' LYS . 4.6 t -84.42 -134.13 0.05 OUTLIER 'General case' 0 C--O 1.201 -1.488 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 178.281 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -72.66 61.51 0.53 Allowed 'General case' 0 C--N 1.254 -3.557 0 CA-C-N 114.807 -1.088 . . . . 0.0 109.353 -175.282 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.558 ' N ' ' O ' ' A' ' 32' ' ' SER . . . 81.57 27.69 46.33 Favored Glycine 0 C--N 1.286 -2.24 0 N-CA-C 108.564 -1.814 . . . . 0.0 108.564 -177.553 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 80.3 mt-10 -129.0 -128.84 0.22 Allowed 'General case' 0 C--O 1.213 -0.855 0 C-N-CA 118.89 -1.124 . . . . 0.0 112.293 -177.405 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.601 ' O ' ' N ' ' A' ' 32' ' ' SER . 16.4 mttp -98.66 -162.93 0.99 Allowed 'General case' 0 C--N 1.277 -2.555 0 CA-C-N 113.207 -1.815 . . . . 0.0 112.802 -176.049 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.499 ' OD1' ' N ' ' A' ' 37' ' ' ASN . 0.1 OUTLIER -65.69 166.35 10.97 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-N 114.922 -1.035 . . . . 0.0 111.498 179.374 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 -160.78 135.86 7.71 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.859 177.581 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.476 ' SG ' ' HB2' ' A' ' 16' ' ' CYS . 1.0 OUTLIER -91.53 108.77 20.13 Favored 'General case' 0 C--N 1.295 -1.787 0 C-N-CA 119.705 -0.798 . . . . 0.0 110.741 -179.557 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.561 HG22 ' N ' ' A' ' 41' ' ' THR . 3.7 p -130.95 157.69 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.25 0 C-N-CA 118.219 -1.393 . . . . 0.0 111.359 176.459 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.561 ' N ' HG22 ' A' ' 40' ' ' VAL . 14.0 t -73.24 151.03 41.57 Favored 'General case' 0 C--N 1.275 -2.633 0 CA-C-N 114.399 -1.273 . . . . 0.0 111.662 -179.13 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 164.31 -143.13 8.29 Favored Glycine 0 N--CA 1.489 2.2 0 C-N-CA 119.479 -1.343 . . . . 0.0 110.43 179.587 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -120.78 100.26 7.0 Favored 'General case' 0 N--CA 1.495 1.814 0 C-N-CA 120.092 -0.643 . . . . 0.0 109.904 179.588 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -127.28 -155.06 8.7 Favored Glycine 0 N--CA 1.495 2.621 0 N-CA-C 110.255 -1.138 . . . . 0.0 110.255 -179.73 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -144.41 151.05 49.97 Favored Pre-proline 0 N--CA 1.488 1.428 0 C-N-CA 119.431 -0.908 . . . . 0.0 109.954 179.713 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.495 ' HB3' HD12 ' A' ' 13' ' ' LEU . 9.3 Cg_endo -68.8 141.61 49.83 Favored 'Trans proline' 0 C--O 1.216 -0.612 0 C-N-CA 121.342 1.361 . . . . 0.0 111.336 177.177 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -62.79 118.02 37.81 Favored Pre-proline 0 CA--C 1.56 1.358 0 C-N-CA 119.488 -0.885 . . . . 0.0 109.512 178.506 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -59.93 -176.8 0.13 Allowed 'Trans proline' 0 C--O 1.216 -0.624 0 C-N-CA 120.677 0.918 . . . . 0.0 111.578 -175.901 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 116.312 -1.804 . . . . 0.0 110.402 179.872 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 98.3 t . . . . . 0 N--CA 1.491 1.624 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.674 HG12 ' N ' ' A' ' 3' ' ' TYR . 61.7 t -81.06 173.01 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 C-N-CA 119.481 -0.888 . . . . 0.0 109.983 -179.996 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.674 ' N ' HG12 ' A' ' 2' ' ' VAL . 37.8 m-85 -114.39 -165.41 1.01 Allowed 'General case' 0 N--CA 1.493 1.685 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.67 -179.733 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.9 p -99.48 172.27 7.42 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 178.215 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -89.64 154.2 20.15 Favored 'General case' 0 C--N 1.285 -2.207 0 C-N-CA 118.2 -1.4 . . . . 0.0 110.366 -179.632 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.514 ' SG ' ' O ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -73.81 154.73 39.39 Favored 'General case' 0 C--N 1.291 -1.952 0 C-N-CA 119.729 -0.788 . . . . 0.0 110.223 177.35 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.4 t -129.94 14.35 5.79 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-O 122.055 0.931 . . . . 0.0 108.85 177.739 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.498 ' HG2' HE21 ' A' ' 11' ' ' GLN . 11.6 pt-20 -162.58 176.94 9.87 Favored 'General case' 0 C--N 1.281 -2.404 0 CA-C-N 113.695 -1.593 . . . . 0.0 109.58 179.488 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.461 ' O ' ' N ' ' A' ' 11' ' ' GLN . 0.5 OUTLIER -72.64 -163.75 0.14 Allowed 'General case' 0 C--N 1.297 -1.693 0 C-N-CA 119.264 -0.974 . . . . 0.0 109.5 -179.506 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.602 ' H ' HD13 ' A' ' 29' ' ' ILE . . . 24.66 19.73 0.0 OUTLIER Glycine 0 N--CA 1.494 2.541 1 N-CA-C 130.218 6.847 . . . . 0.0 130.218 179.264 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.498 HE21 ' HG2' ' A' ' 8' ' ' GLU . 7.9 mm-40 -71.09 -163.38 0.08 Allowed 'General case' 0 C--N 1.295 -1.799 0 C-N-CA 119.432 -0.907 . . . . 0.0 109.35 177.241 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.57 ' O ' ' HA3' ' A' ' 23' ' ' GLY . 26.2 t-20 -148.52 -77.55 0.16 Allowed 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 118.188 -1.405 . . . . 0.0 112.975 -177.876 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.428 HD12 ' HB3' ' A' ' 46' ' ' PRO . 14.1 mt -78.08 42.13 0.39 Allowed 'General case' 0 C--N 1.271 -2.833 0 C-N-CA 118.02 -1.472 . . . . 0.0 110.495 -177.8 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.42 ' H ' ' C ' ' A' ' 12' ' ' ASN . 29.4 p -113.33 -159.88 0.7 Allowed 'General case' 0 N--CA 1.496 1.833 0 C-N-CA 119.483 -0.887 . . . . 0.0 110.129 178.012 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.514 ' O ' ' SG ' ' A' ' 6' ' ' CYS . 3.5 mt -124.82 133.0 53.28 Favored 'General case' 0 N--CA 1.499 2.006 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.518 177.584 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 3.4 m -111.92 -74.42 0.64 Allowed 'General case' 0 N--CA 1.513 2.713 0 C-N-CA 119.064 -1.054 . . . . 0.0 110.308 179.094 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -78.23 125.69 29.72 Favored 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 118.319 -1.352 . . . . 0.0 107.845 177.228 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 28.55 -72.64 0.0 OUTLIER Glycine 0 N--CA 1.502 3.06 1 N-CA-C 128.931 6.332 . . . . 0.0 128.931 -176.7 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -137.53 0.27 2.25 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-O 122.149 0.976 . . . . 0.0 110.324 177.456 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 35.8 m120 -80.27 128.16 33.21 Favored 'General case' 0 C--N 1.261 -3.264 0 CA-C-N 113.557 -1.656 . . . . 0.0 110.448 -179.84 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.1 t -70.34 148.98 10.61 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 C-N-CA 119.282 -0.967 . . . . 0.0 109.954 179.621 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.546 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 0.4 OUTLIER -134.54 101.14 4.86 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 119.0 -1.08 . . . . 0.0 110.699 178.781 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.57 ' HA3' ' O ' ' A' ' 12' ' ' ASN . . . 164.98 -55.4 0.27 Allowed Glycine 0 C--N 1.297 -1.61 1 N-CA-C 131.485 7.354 . . . . 0.0 131.485 179.465 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.503 ' N ' ' OD1' ' A' ' 12' ' ' ASN . 28.7 tt0 -51.47 117.85 2.92 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 118.875 -1.13 . . . . 0.0 110.732 -178.045 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 80.26 -22.37 4.52 Favored Glycine 0 N--CA 1.482 1.711 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -178.506 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.527 ' N ' ' OD1' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -119.8 -159.17 0.77 Allowed 'General case' 0 C--N 1.312 -1.037 0 C-N-CA 120.432 -0.507 . . . . 0.0 109.99 -179.689 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.593 ' N ' ' O ' ' A' ' 40' ' ' VAL . 40.3 tttt -157.98 162.35 38.19 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.654 -179.95 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.546 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -122.97 168.81 11.85 Favored 'General case' 0 CA--C 1.481 -1.706 0 CA-C-O 123.125 1.441 . . . . 0.0 111.638 174.249 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.602 HD13 ' H ' ' A' ' 10' ' ' GLY . 21.6 mm -143.72 130.43 16.95 Favored 'Isoleucine or valine' 0 C--N 1.249 -3.782 0 CA-C-N 111.755 -2.475 . . . . 0.0 108.816 174.324 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.412 ' HA ' HD23 ' A' ' 30' ' ' LEU . 15.2 mt -76.86 126.24 30.64 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 118.275 -1.37 . . . . 0.0 110.016 -179.73 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 36' ' ' LYS . . . -45.24 -73.03 0.3 Allowed Glycine 0 N--CA 1.483 1.794 0 C-N-CA 119.13 -1.51 . . . . 0.0 110.551 179.509 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -125.15 -148.94 0.41 Allowed 'General case' 0 C--O 1.21 -1.002 0 CA-C-O 121.549 0.69 . . . . 0.0 109.19 -179.785 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -77.17 67.47 3.15 Favored 'General case' 0 C--N 1.251 -3.691 0 CA-C-N 114.216 -1.356 . . . . 0.0 110.571 -171.31 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 85.92 21.45 52.88 Favored Glycine 0 C--N 1.282 -2.418 0 N-CA-C 108.518 -1.833 . . . . 0.0 108.518 -179.764 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -104.26 -113.4 0.24 Allowed 'General case' 0 C--N 1.312 -1.056 0 C-N-CA 119.319 -0.952 . . . . 0.0 111.153 -178.365 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.449 ' O ' ' OD1' ' A' ' 37' ' ' ASN . 6.2 mttm -58.91 173.15 0.46 Allowed 'General case' 0 C--N 1.264 -3.137 0 CA-C-N 113.847 -1.524 . . . . 0.0 110.904 -177.819 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.449 ' OD1' ' O ' ' A' ' 36' ' ' LYS . 14.6 m-20 -149.59 162.61 39.85 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.751 -177.805 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.519 ' O ' ' SG ' ' A' ' 28' ' ' CYS . 38.3 tt0 -160.54 147.25 15.53 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 119.383 -0.927 . . . . 0.0 110.488 178.333 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -103.44 107.38 18.19 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 119.885 -0.726 . . . . 0.0 112.378 -179.55 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.593 ' O ' ' N ' ' A' ' 27' ' ' LYS . 0.1 OUTLIER -100.25 141.46 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.571 0 C-N-CA 118.709 -1.196 . . . . 0.0 110.615 174.778 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.634 HG23 ' O ' ' A' ' 41' ' ' THR . 8.9 t -78.79 47.41 0.74 Allowed 'General case' 0 C--N 1.279 -2.471 0 CA-C-N 113.942 -1.481 . . . . 0.0 113.232 -177.882 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -118.47 -124.51 3.37 Favored Glycine 0 N--CA 1.505 3.294 1 N-CA-C 131.198 7.239 . . . . 0.0 131.198 178.172 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -98.1 73.39 2.21 Favored 'General case' 0 N--CA 1.499 1.992 0 C-N-CA 119.412 -0.915 . . . . 0.0 111.215 -178.489 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -92.15 165.22 28.95 Favored Glycine 0 N--CA 1.494 2.559 0 C-N-CA 119.405 -1.378 . . . . 0.0 110.854 -179.597 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.518 ' O ' ' N ' ' A' ' 12' ' ' ASN . 0.5 OUTLIER -129.95 148.3 69.04 Favored Pre-proline 0 N--CA 1.498 1.925 0 C-N-CA 120.128 -0.629 . . . . 0.0 109.721 179.971 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.436 ' O ' ' O ' ' A' ' 45' ' ' THR . 2.7 Cg_exo -52.77 -164.03 0.0 OUTLIER 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 121.414 1.41 . . . . 0.0 111.131 177.717 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -137.39 71.52 52.85 Favored Pre-proline 0 C--N 1.305 -1.353 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.077 178.111 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -68.39 -168.75 0.23 Allowed 'Trans proline' 0 C--N 1.327 -0.585 0 C-N-CA 121.85 1.7 . . . . 0.0 111.882 -174.806 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 . . . . . 0 C--N 1.305 -1.334 0 CA-C-O 116.318 -1.801 . . . . 0.0 110.393 179.474 . . . . . . . . 0 0 . 1 . 031 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 74.6 t . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 . . . . . . . . . 0 0 . 1 . 031 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.0 t -96.0 161.84 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 C-N-CA 119.486 -0.886 . . . . 0.0 110.494 -179.581 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -87.65 -164.53 1.11 Allowed 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 119.909 -0.716 . . . . 0.0 110.417 -179.897 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.2 p -97.59 178.38 5.19 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 119.793 -0.763 . . . . 0.0 108.956 179.742 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -91.17 154.44 19.32 Favored 'General case' 0 C--N 1.297 -1.69 0 C-N-CA 118.796 -1.162 . . . . 0.0 110.322 178.929 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.486 ' SG ' ' O ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -75.13 165.75 24.73 Favored 'General case' 0 C--N 1.299 -1.592 0 C-N-CA 119.886 -0.726 . . . . 0.0 110.899 177.827 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 43.2 p -143.72 17.5 1.81 Allowed 'General case' 0 C--N 1.294 -1.835 0 CA-C-N 114.881 -1.054 . . . . 0.0 108.596 177.123 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -161.15 167.55 25.98 Favored 'General case' 0 C--N 1.288 -2.086 0 CA-C-N 113.64 -1.618 . . . . 0.0 109.853 -179.03 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.515 ' O ' ' N ' ' A' ' 11' ' ' GLN . 0.8 OUTLIER -68.97 -168.37 0.13 Allowed 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 119.043 -1.063 . . . . 0.0 108.765 178.599 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.702 ' H ' HD13 ' A' ' 29' ' ' ILE . . . 24.35 16.89 0.0 OUTLIER Glycine 0 N--CA 1.492 2.421 1 N-CA-C 130.158 6.823 . . . . 0.0 130.158 179.865 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.528 ' NE2' ' OE1' ' A' ' 47' ' ' GLU . 10.8 mt-30 -69.67 -164.97 0.07 Allowed 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 176.218 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.442 ' OD1' ' O ' ' A' ' 11' ' ' GLN . 1.7 m-20 -150.43 -70.17 0.18 Allowed 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 117.551 -1.66 . . . . 0.0 113.952 -179.302 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.5 HD12 ' HB3' ' A' ' 46' ' ' PRO . 18.6 mt -77.28 48.96 0.66 Allowed 'General case' 0 C--N 1.272 -2.794 0 C-N-CA 117.705 -1.598 . . . . 0.0 110.189 -176.146 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.439 ' HB2' ' N ' ' A' ' 6' ' ' CYS . 26.7 p -125.39 -161.47 1.03 Allowed 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.01 -0.995 . . . . 0.0 109.184 176.517 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.486 ' O ' ' SG ' ' A' ' 6' ' ' CYS . 38.3 mt -112.6 120.84 42.95 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 123.973 0.795 . . . . 0.0 109.131 176.665 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 8.6 m -116.06 -38.54 3.6 Favored 'General case' 0 N--CA 1.503 2.207 0 C-N-CA 119.038 -1.065 . . . . 0.0 111.176 -177.074 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -100.04 76.63 1.94 Allowed 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 119.236 -0.986 . . . . 0.0 110.088 179.236 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 76.1 -94.49 1.01 Allowed Glycine 0 N--CA 1.49 2.282 0 C-N-CA 119.359 -1.401 . . . . 0.0 110.637 179.743 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -125.53 -2.84 7.36 Favored 'General case' 0 N--CA 1.485 1.302 0 CA-C-O 122.058 0.932 . . . . 0.0 110.518 -179.211 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 60.4 m-80 -81.32 136.78 35.78 Favored 'General case' 0 C--N 1.257 -3.452 0 CA-C-N 113.629 -1.623 . . . . 0.0 110.862 -179.248 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.1 t -71.67 147.17 10.95 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 C-N-CA 119.366 -0.934 . . . . 0.0 110.071 179.09 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.441 ' O ' ' O ' ' A' ' 12' ' ' ASN . 6.2 m -149.14 118.56 6.9 Favored 'General case' 0 C--N 1.288 -2.081 0 C-N-CA 118.819 -1.152 . . . . 0.0 108.876 176.486 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.46 ' O ' ' O ' ' A' ' 26' ' ' ASN . . . 179.36 -92.23 0.08 OUTLIER Glycine 0 C--O 1.203 -1.831 0 C-N-CA 117.622 -2.227 . . . . 0.0 112.218 -177.37 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 15.3 tt0 -45.37 131.22 8.31 Favored 'General case' 0 C--N 1.299 -1.612 0 C-N-CA 119.352 -0.939 . . . . 0.0 110.861 -177.472 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.56 -32.15 4.01 Favored Glycine 0 N--CA 1.479 1.515 0 N-CA-C 109.261 -1.536 . . . . 0.0 109.261 -177.819 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.46 ' O ' ' O ' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -129.67 -160.47 1.04 Allowed 'General case' 0 C--N 1.313 -1.0 0 C-N-CA 120.205 -0.598 . . . . 0.0 110.833 -179.801 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.554 ' CG ' ' N ' ' A' ' 28' ' ' CYS . 26.6 tttt -151.51 167.49 27.87 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 177.748 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.639 ' O ' ' HA2' ' A' ' 10' ' ' GLY . 59.6 m -127.62 164.66 21.55 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 119.132 -1.027 . . . . 0.0 111.261 177.001 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.702 HD13 ' H ' ' A' ' 10' ' ' GLY . 20.1 mm -146.2 133.61 15.04 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.278 0 CA-C-N 114.184 -1.371 . . . . 0.0 109.94 176.194 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 18.5 mt -77.42 108.88 10.89 Favored 'General case' 0 N--CA 1.496 1.834 0 C-N-CA 118.952 -1.099 . . . . 0.0 109.381 177.993 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.422 ' H ' ' HA ' ' A' ' 37' ' ' ASN . . . 97.1 106.78 2.42 Favored Glycine 0 N--CA 1.477 1.403 0 C-N-CA 119.021 -1.561 . . . . 0.0 110.693 179.423 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.532 ' N ' ' O ' ' A' ' 36' ' ' LYS . 1.9 m -76.99 -129.28 0.01 OUTLIER 'General case' 0 C--O 1.2 -1.523 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 178.139 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.494 ' N ' ' OD1' ' A' ' 33' ' ' ASP . 0.6 OUTLIER -74.59 65.88 1.35 Allowed 'General case' 0 C--N 1.25 -3.73 0 CA-C-N 114.702 -1.135 . . . . 0.0 108.512 -175.302 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 32' ' ' SER . . . 75.68 24.23 70.59 Favored Glycine 0 C--N 1.289 -2.05 0 N-CA-C 108.286 -1.926 . . . . 0.0 108.286 -177.433 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -120.3 -134.13 0.31 Allowed 'General case' 0 C--O 1.213 -0.867 0 C-N-CA 119.268 -0.973 . . . . 0.0 111.695 -177.357 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.532 ' O ' ' N ' ' A' ' 32' ' ' SER . 13.6 mmtm -97.49 -168.45 1.69 Allowed 'General case' 0 C--N 1.272 -2.763 0 CA-C-N 113.375 -1.739 . . . . 0.0 113.312 -177.477 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.463 ' OD1' ' N ' ' A' ' 37' ' ' ASN . 1.8 m-20 -59.21 155.18 14.68 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.139 178.249 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -160.58 139.7 10.57 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.94 -0.704 . . . . 0.0 109.64 176.758 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 20.9 m -87.94 103.02 15.29 Favored 'General case' 0 C--N 1.297 -1.677 0 C-N-CA 119.175 -1.01 . . . . 0.0 110.993 -178.772 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.514 ' O ' ' N ' ' A' ' 27' ' ' LYS . 0.4 OUTLIER -100.14 142.07 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.232 0 C-N-CA 118.677 -1.209 . . . . 0.0 111.586 178.837 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.3 t -69.66 141.35 53.63 Favored 'General case' 0 C--N 1.277 -2.584 0 CA-C-N 114.207 -1.36 . . . . 0.0 110.955 179.311 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 157.97 -114.12 0.6 Allowed Glycine 0 N--CA 1.492 2.4 1 N-CA-C 130.492 6.957 . . . . 0.0 130.492 179.686 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -139.43 100.26 3.94 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 119.631 -0.828 . . . . 0.0 109.978 179.286 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -126.46 -175.04 14.0 Favored Glycine 0 N--CA 1.496 2.634 0 N-CA-C 110.33 -1.108 . . . . 0.0 110.33 -179.415 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -137.77 148.47 61.05 Favored Pre-proline 0 N--CA 1.491 1.589 0 C-N-CA 119.84 -0.744 . . . . 0.0 109.78 -179.984 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.5 ' HB3' HD12 ' A' ' 13' ' ' LEU . 10.4 Cg_exo -48.35 177.2 0.02 OUTLIER 'Trans proline' 0 C--O 1.214 -0.682 0 C-N-CA 121.475 1.45 . . . . 0.0 111.511 179.766 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.591 ' H ' ' CD ' ' A' ' 48' ' ' PRO . 5.1 tp10 -107.02 -41.79 0.14 Allowed Pre-proline 0 CA--C 1.558 1.258 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.747 178.857 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.591 ' CD ' ' H ' ' A' ' 47' ' ' GLU . 4.3 Cg_endo -72.74 130.66 16.08 Favored 'Trans proline' 0 C--O 1.214 -0.688 0 C-N-CA 120.88 1.054 . . . . 0.0 111.165 -176.343 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.691 0 CA-C-O 116.443 -1.742 . . . . 0.0 110.122 179.445 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 43.4 t . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 . . . . . . . . . 0 0 . 1 . 032 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.707 HG12 ' H ' ' A' ' 3' ' ' TYR . 6.8 t -79.21 177.76 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 C-N-CA 119.132 -1.027 . . . . 0.0 109.623 179.787 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.707 ' H ' HG12 ' A' ' 2' ' ' VAL . 61.1 m-85 -143.07 -172.47 3.68 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.135 -1.026 . . . . 0.0 111.23 -179.794 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.5 ' OG1' ' N ' ' A' ' 5' ' ' ASP . 0.1 OUTLIER -114.45 -165.66 1.03 Allowed 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 115.105 -0.952 . . . . 0.0 108.556 179.232 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.5 ' N ' ' OG1' ' A' ' 4' ' ' THR . 0.7 OUTLIER -92.2 155.05 18.26 Favored 'General case' 0 C--N 1.287 -2.119 0 C-N-CA 118.371 -1.332 . . . . 0.0 110.904 -179.363 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.447 ' N ' ' HB2' ' A' ' 14' ' ' CYS . 0.0 OUTLIER -73.82 171.23 13.74 Favored 'General case' 0 C--N 1.287 -2.148 0 CA-C-N 114.575 -1.193 . . . . 0.0 110.272 178.289 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.5 p -140.94 13.31 2.26 Favored 'General case' 0 C--N 1.294 -1.816 0 C-N-CA 119.367 -0.933 . . . . 0.0 109.687 177.284 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -162.13 174.22 13.25 Favored 'General case' 0 C--N 1.288 -2.108 0 CA-C-N 114.065 -1.425 . . . . 0.0 110.228 179.659 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.448 ' HB3' ' H ' ' A' ' 30' ' ' LEU . 0.7 OUTLIER -85.58 167.2 15.59 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 119.804 -0.758 . . . . 0.0 109.724 -179.945 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 28' ' ' CYS . . . 71.34 14.63 74.47 Favored Glycine 0 N--CA 1.503 3.156 0 C-N-CA 119.182 -1.485 . . . . 0.0 112.225 178.693 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -84.52 -174.95 5.56 Favored 'General case' 0 N--CA 1.505 2.298 0 C-N-CA 119.034 -1.066 . . . . 0.0 110.616 179.159 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.481 ' C ' ' H ' ' A' ' 14' ' ' CYS . 10.3 m-20 -153.51 -69.51 0.14 Allowed 'General case' 0 N--CA 1.505 2.299 0 C-N-CA 118.403 -1.319 . . . . 0.0 113.514 -178.048 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.494 HD13 ' CZ ' ' A' ' 3' ' ' TYR . 70.2 mt -75.22 45.96 0.3 Allowed 'General case' 0 C--N 1.288 -2.106 0 C-N-CA 118.595 -1.242 . . . . 0.0 109.74 -178.588 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.481 ' H ' ' C ' ' A' ' 12' ' ' ASN . 31.8 p -122.37 -149.5 0.43 Allowed 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 115.233 -0.894 . . . . 0.0 108.884 177.606 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.445 HD23 ' HA ' ' A' ' 15' ' ' LEU . 71.5 mt -120.0 100.18 7.06 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-O 122.25 1.024 . . . . 0.0 109.091 176.347 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.574 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 0.5 OUTLIER -74.21 -69.1 0.47 Allowed 'General case' 0 C--N 1.276 -2.616 0 CA-C-N 113.358 -1.746 . . . . 0.0 110.51 -176.088 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -100.37 95.4 6.74 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 119.029 -1.068 . . . . 0.0 111.302 -179.128 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.17 -95.21 0.84 Allowed Glycine 0 N--CA 1.492 2.398 0 C-N-CA 119.739 -1.219 . . . . 0.0 111.735 177.285 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -127.2 2.49 6.42 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-O 122.061 0.934 . . . . 0.0 110.743 -177.054 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -78.54 129.34 34.71 Favored 'General case' 0 C--N 1.255 -3.501 0 CA-C-N 113.702 -1.59 . . . . 0.0 110.864 -179.868 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.581 HG12 ' O ' ' A' ' 22' ' ' CYS . 2.0 t -81.13 138.4 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 118.917 -1.113 . . . . 0.0 110.314 179.113 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.623 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 0.1 OUTLIER -77.94 -135.34 0.02 OUTLIER 'General case' 0 C--N 1.286 -2.184 0 C-N-CA 118.774 -1.171 . . . . 0.0 109.474 172.697 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.539 ' O ' ' ND2' ' A' ' 26' ' ' ASN . . . 179.49 115.83 0.48 Allowed Glycine 0 C--N 1.268 -3.196 0 C-N-CA 117.91 -2.091 . . . . 0.0 111.064 178.973 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.462 ' C ' ' O ' ' A' ' 23' ' ' GLY . 2.3 tt0 -36.22 135.19 0.37 Allowed 'General case' 0 C--N 1.284 -2.24 0 CA-C-N 114.872 -0.664 . . . . 0.0 109.773 176.721 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 116.79 -36.36 3.79 Favored Glycine 0 N--CA 1.486 1.979 0 N-CA-C 107.987 -2.045 . . . . 0.0 107.987 -175.632 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.539 ' ND2' ' O ' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -92.46 -162.46 0.93 Allowed 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 176.557 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.642 ' CE ' HD11 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -151.75 105.25 3.11 Favored 'General case' 0 C--N 1.284 -2.278 0 C-N-CA 118.66 -1.216 . . . . 0.0 110.41 179.284 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.623 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 9.9 m -77.62 159.47 29.19 Favored 'General case' 0 C--O 1.196 -1.725 0 C-N-CA 117.908 -1.517 . . . . 0.0 110.692 -179.595 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.642 HD11 ' CE ' ' A' ' 27' ' ' LYS . 27.9 mm -141.69 132.41 26.04 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.06 0 CA-C-N 114.005 -1.452 . . . . 0.0 110.207 177.817 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.448 ' H ' ' HB3' ' A' ' 9' ' ' SER . 20.3 mt -77.99 121.71 24.57 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 119.338 -0.945 . . . . 0.0 110.156 177.799 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.71 104.66 0.71 Allowed Glycine 0 N--CA 1.483 1.825 0 C-N-CA 119.23 -1.462 . . . . 0.0 110.603 178.06 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.578 ' O ' ' N ' ' A' ' 34' ' ' GLY . 19.3 m -90.94 -125.64 0.08 Allowed 'General case' 0 C--O 1.196 -1.731 0 C-N-CA 119.211 -0.995 . . . . 0.0 109.062 178.739 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -69.66 63.03 0.18 Allowed 'General case' 0 C--N 1.263 -3.166 0 CA-C-N 114.33 -1.304 . . . . 0.0 109.243 -175.14 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.578 ' N ' ' O ' ' A' ' 32' ' ' SER . . . 69.27 29.34 71.98 Favored Glycine 0 C--N 1.285 -2.28 0 N-CA-C 107.953 -2.059 . . . . 0.0 107.953 -176.336 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -124.93 -132.69 0.26 Allowed 'General case' 0 C--O 1.214 -0.774 0 CA-C-O 122.24 1.019 . . . . 0.0 112.223 -176.753 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.541 ' O ' ' N ' ' A' ' 32' ' ' SER . 53.6 mttp -97.0 -161.69 0.89 Allowed 'General case' 0 C--N 1.275 -2.649 0 CA-C-N 113.062 -1.881 . . . . 0.0 111.744 -177.421 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.58 ' OD1' ' N ' ' A' ' 37' ' ' ASN . 0.1 OUTLIER -75.31 155.83 36.21 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.751 178.243 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -154.75 137.18 15.01 Favored 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 119.492 -0.883 . . . . 0.0 109.368 176.694 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.574 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 2.0 m -78.97 105.99 10.69 Favored 'General case' 0 C--N 1.29 -1.994 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.844 -176.666 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.495 ' O ' ' O ' ' A' ' 27' ' ' LYS . 2.4 p -111.97 143.37 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.354 0 C-N-CA 118.395 -1.322 . . . . 0.0 110.996 175.85 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.2 t -66.24 150.2 49.16 Favored 'General case' 0 C--N 1.269 -2.899 0 CA-C-N 113.626 -1.625 . . . . 0.0 112.251 -178.348 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 165.31 -120.28 0.92 Allowed Glycine 0 N--CA 1.486 2.012 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 178.373 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -160.87 81.78 0.65 Allowed 'General case' 0 C--N 1.299 -1.587 0 C-N-CA 119.408 -0.917 . . . . 0.0 109.447 178.58 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -100.25 -158.88 28.15 Favored Glycine 0 N--CA 1.492 2.43 0 C-N-CA 119.853 -1.165 . . . . 0.0 110.949 -178.035 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -130.35 152.18 79.8 Favored Pre-proline 0 N--CA 1.493 1.681 0 C-N-CA 119.942 -0.703 . . . . 0.0 109.842 -179.759 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -55.85 -175.43 0.04 OUTLIER 'Trans proline' 0 C--O 1.214 -0.712 0 C-N-CA 121.475 1.45 . . . . 0.0 111.2 177.304 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -87.02 123.17 70.66 Favored Pre-proline 0 CA--C 1.558 1.255 0 C-N-CA 119.458 -0.897 . . . . 0.0 109.753 178.587 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -59.76 156.36 38.23 Favored 'Trans proline' 0 C--O 1.216 -0.619 0 C-N-CA 120.403 0.735 . . . . 0.0 111.092 179.942 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 116.234 -1.841 . . . . 0.0 110.381 179.921 . . . . . . . . 0 0 . 1 stop_ save_